index,trialid,source_register,date_registration,date_enrollement,retrospective_registration,normed_spon_names,recruitment_status,phase,study_type,countries,public_title,study_category,intervention,target_enrollment,primary_completion_date,full_completion_date,web_address,results_type,results_publication_date,results_link,last_refreshed_on,first_seen,cross_registrations
0,ChiCTR2000029953,ChiCTR,2020-02-17,2020-02-01,True,Zhongnan Hospital of Wuhan University,Not Recruiting,Not Applicable,Observational,China,Construction and Analysis of Prognostic Predictive Model of Novel Coronavirus Pneumonia (COVID-19),Prognosis,No Intervention,400,Not Available,2021-05-01,http://www.chictr.org.cn/showproj.aspx?proj=49217,No Results,No Results,No Results,2020-02-17,2020-08-03,None
1,ChiCTR2000029949,ChiCTR,2020-02-16,2020-02-16,False,Zhongnan Hospital of Wuhan University,Not Recruiting,Not Applicable,Observational,China,A Medical Records Based Study for the Effectiveness of Extracorporeal Membrane Oxygenation in Patients with Severe Novel Coronavirus Pneumonia (COVID-19),Drug,Oxygen,40,Not Available,2020-12-28,http://www.chictr.org.cn/showproj.aspx?proj=49181,No Results,No Results,No Results,2020-02-17,2020-08-03,None
2,ChiCTR2000029935,ChiCTR,2020-02-16,2020-02-06,True,"Hwa Mei Hospital, University of Chinese Academy of Sciences",Recruiting,Not Applicable,Interventional,China,A Single-arm Clinical Trial for Chloroquine Phosphate in the treatment of Novel Coronavirus Pneumonia 2019 (COVID-19),Drug,Chloroquine,100,Not Available,2021-02-06,http://www.chictr.org.cn/showproj.aspx?proj=49607,No Results,No Results,No Results,2020-02-17,2020-08-03,None
3,ChiCTR2000029850,ChiCTR,2020-02-15,2020-02-15,False,The First Affiliated Hospital of Zhejiang University School of Medicine,Recruiting,Not Applicable,Interventional,China,Study on convalescent plasma treatment for severe patients with novel coronavirus pneumonia (COVID-19),ATMP,Plasma,20,Not Available,2022-02-15,http://www.chictr.org.cn/showproj.aspx?proj=49533,No Results,No Results,No Results,2020-02-17,2020-08-03,None
4,ChiCTR2000029947,ChiCTR,2020-02-16,2020-03-01,False,Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine,Not Recruiting,Not Applicable,Interventional,China,A Randomized Controlled Trial for Qingyi No. 4 Compound in the treatment of Convalescence Patients of Novel Coronavirus Pneumonia (COVID-19),Traditional Medicine (Drug),Traditional Medicine,200,Not Available,2020-06-01,http://www.chictr.org.cn/showproj.aspx?proj=49599,No Results,No Results,No Results,2020-02-17,2020-03-18,None
5,ChiCTR2000029814,ChiCTR,2020-02-14,2020-02-14,False,Children's Hospital of Fudan University,Recruiting,Not Applicable,Interventional,China,Clinical Trial for Integrated Chinese and Western Medicine in the Treatment of Children with Novel Coronavirus Pneumonia (COVID-19),Traditional Medicine + Western Medicine,Traditional Medicine,30,Not Available,2020-12-31,http://www.chictr.org.cn/showproj.aspx?proj=49387,No Results,No Results,No Results,2020-02-17,2020-08-03,None
6,ChiCTR2000029896,ChiCTR,2020-02-16,2020-01-31,True,Affiliated Hospital of Changchun University of Traditional Chinese Medicine,Recruiting,Not Applicable,Observational,China,Evaluate the effectiveness of Traditional Chinese medicine in the treatment of novel coronavirus pneumonia (COVID-19),Traditional Medicine (Unspecified),Traditional Medicine,100,Not Available,2020-12-31,http://www.chictr.org.cn/showproj.aspx?proj=49432,No Results,No Results,No Results,2020-02-17,2020-03-18,None
7,ChiCTR2000029805,ChiCTR,2020-02-14,2020-02-12,True,Wuhan Jinyintan Hospital (Wuhan Infectious Diseases Hospital),Recruiting,Not Applicable,Observational,China,Analysis of clinical characteristics of severe novel coronavirus pneumonia (COVID-19),Clinical Presentation,No Intervention,100,Not Available,2021-01-31,http://www.chictr.org.cn/showproj.aspx?proj=49188,No Results,No Results,No Results,2020-02-17,2020-08-03,None
8,ChiCTR2000029811,ChiCTR,2020-02-14,2020-02-20,False,"Guangzhou reborn health management consultation co., LTD",Not Recruiting,Not Applicable,Interventional,No Country Given,Clinical Study for Anti-aging Active Freeze-dried Powder Granules in the Treatment of Acute Novel Coronavirus Pneumonia (COVID-19),Traditional Medicine (Drug),Traditional Medicine,60,Not Available,2021-02-20,http://www.chictr.org.cn/showproj.aspx?proj=49355,No Results,No Results,No Results,2020-02-17,2020-08-03,None
9,ChiCTR2000029789,ChiCTR,2020-02-13,2020-02-15,False,The First Affiliated Hospital of He'nan University of Chinese Medicine,Recruiting,Not Applicable,Interventional,China,Randomized controlled trial for TCM syndrome differentiation treatment impacting quality of life of post-discharge patients with novel coronavirus pneumonia (COVID-19),Traditional Medicine (Other),Traditional Medicine,100,Not Available,2021-06-30,http://www.chictr.org.cn/showproj.aspx?proj=49348,No Results,No Results,No Results,2020-02-17,2020-08-03,None
10,ChiCTR2000029782,ChiCTR,2020-02-13,2020-01-30,True,Zhejiang Provincial People's Hospital,Not Recruiting,Not Applicable,Observational,China,Clinical study for the changes in mental state of medical staff in the department of radiotherapy in a comprehensive tertiary hospital in Zhejiang Province during the epidemic of novel coronavirus infection (COVID-19),Other (psych),No Intervention,27,Not Available,2020-02-29,http://www.chictr.org.cn/showproj.aspx?proj=49445,No Results,No Results,No Results,2020-02-17,2020-08-03,None
11,ChiCTR2000029810,ChiCTR,2020-02-14,2020-02-16,False,Shenzhen Second People's Hospital,Recruiting,Not Applicable,Diagnostic test,China,Clinical study of a novel high sensitivity nucleic acid assay for novel coronavirus pneumonia (COVID-19) based on CRISPR-cas protein,Diagnostics,Diagnostic Test or Assessment,10000,Not Available,2020-03-20,http://www.chictr.org.cn/showproj.aspx?proj=49407,No Results,No Results,No Results,2020-02-17,2020-08-03,None
12,ChiCTR2000029764,ChiCTR,2020-02-13,2020-02-16,False,West China Hospital of Sichuan University,Not Recruiting,Not Applicable,Observational,China,Imaging Features and Mechanisms of Novel Coronavirus Pneumonia (COVID-19): a Multicenter Study,Clinical Presentation,No Intervention,100,Not Available,2020-12-31,http://www.chictr.org.cn/showproj.aspx?proj=49388,No Results,No Results,No Results,2020-02-17,2020-08-03,None
13,ChiCTR2000029779,ChiCTR,2020-02-13,2020-02-14,False,Wuxi People's Hospital,Recruiting,Not Applicable,Diagnostic test,China,Study for the key issues of the diagnosis and treatment of novel coronavirus pneumonia (COVID-19) based on the medical imaging,Clinical Presentation,No Intervention,0,Not Available,2020-05-31,http://www.chictr.org.cn/showproj.aspx?proj=49378,No Results,No Results,No Results,2020-02-17,2020-08-03,None
14,NCT04260594,ClinicalTrials.gov,2020-02-06,2020-02-07,False,Jieming QU,Not Recruiting,Phase 4,Interventional,No Country Given,Clinical Study of Arbidol Hydrochloride Tablets in the Treatment of Pneumonia Caused by Novel Coronavirus,Drug,Umifenovir,380,2020-07-01,2020-12-30,https://clinicaltrials.gov/show/NCT04260594,No Results,No Results,No Results,2020-02-17,2020-08-03,None
15,NCT04261426,ClinicalTrials.gov,2020-02-06,2020-02-10,False,Peking Union Medical College Hospital,Not Recruiting,Phase 2/Phase 3,Interventional,No Country Given,The Efficacy of Intravenous Immunoglobulin Therapy for Severe 2019-nCoV Infected Pneumonia,ATMP,Immunoglobulin,80,2020-04-30,2020-06-30,https://clinicaltrials.gov/show/NCT04261426,No Results,No Results,No Results,2020-02-17,2020-08-03,None
16,ChiCTR2000029695,ChiCTR,2020-02-10,2020-03-01,False,Shenzhen Third People's Hospital,Not Recruiting,Not Applicable,Diagnostic test,China,Early Detection of Novel Coronavirus Pneumonia (COVID-19) Based on a Novel High-Throughput Mass Spectrometry Analysis With Exhaled Breath,Diagnostics,Diagnostic Test or Assessment,300,Not Available,2021-03-31,http://www.chictr.org.cn/showproj.aspx?proj=49219,No Results,No Results,No Results,2020-02-17,2020-08-03,None
17,ChiCTR2000029778,ChiCTR,2020-02-13,2020-02-14,False,Shanghai University of Traditional Chinese Medicine,Recruiting,Not Applicable,Interventional,China,Clinical Study for Traditional Chinese Medicine Combined With Western Medicine in Treatment of Novel Coronavirus Pneumonia (COVID-19),Traditional Medicine + Western Medicine,Traditional Medicine,600,Not Available,2020-05-13,http://www.chictr.org.cn/showproj.aspx?proj=49422,No Results,No Results,No Results,2020-02-17,2020-08-03,None
18,ChiCTR2000029656,ChiCTR,2020-02-09,2020-02-14,False,Wuhan Pulmonary Hosptial,Not Recruiting,Not Applicable,Interventional,China,"A randomized, open-label study to evaluate the efficacy and safety of low-dose corticosteroids in hospitalized patients with novel coronavirus pneumonia (COVID-19)",Drug,Corticosteroids,100,Not Available,2020-04-14,http://www.chictr.org.cn/showproj.aspx?proj=49086,No Results,No Results,No Results,2020-02-17,2020-08-03,None
19,ChiCTR2000029626,ChiCTR,2020-02-07,2020-02-17,False,The First Affiliated Hospital of Zhejiang University School of Medicine,Not Recruiting,Not Applicable,Basic Science,China,Immune Repertoire (TCR & BCR) Evaluation and Immunotherapy Research in Peripheral Blood of Novel Coronavirus Pneumonia (COVID-19),Clinical Presentation,No Intervention,20,Not Available,2020-08-01,http://www.chictr.org.cn/showproj.aspx?proj=49170,No Results,No Results,No Results,2020-02-17,2020-08-03,None
20,ChiCTR2000029777,ChiCTR,2020-02-13,2020-02-05,True,Huangshi Hospital of Traditional Chinese Medicine,Recruiting,Not Applicable,Interventional,China,"A multicenter, randomized, controlled trial for integrated chinese and western medicine in the treatment of novel coronavirus pneumonia (COVID-19) based on the 'Truncated Torsion' strategy",Traditional Medicine + Western Medicine,Traditional Medicine,160,Not Available,2020-06-30,http://www.chictr.org.cn/showproj.aspx?proj=49380,No Results,No Results,No Results,2020-02-17,2020-08-03,None
21,NCT04252885,ClinicalTrials.gov,2020-01-30,2020-01-28,True,Guangzhou 8th People's Hospital,Recruiting,Phase 4,Interventional,China,The Efficacy of Lopinavir Plus Ritonavir and Arbidol Against Novel Coronavirus Infection,Drug,Lopinavir/ritonavir vs. umifenovir,125,2020-05-30,2020-07-31,https://clinicaltrials.gov/show/NCT04252885,Pre-Print Article,2020-03-23,https://doi.org/10.1101/2020.03.19.20038984,2020-02-17,2020-03-18,None
22,NCT04255940,ClinicalTrials.gov,2020-02-03,2020-01-20,True,Qilu Hospital of Shandong University,Recruiting,Not Applicable,Observational,China,2019-nCoV Outbreak and Cardiovascular Diseases,Clinical Presentation,No Intervention,12000,2020-04-30,2020-04-30,https://clinicaltrials.gov/show/NCT04255940,No Results,No Results,No Results,2020-02-17,2020-08-03,None
23,ChiCTR2000029776,ChiCTR,2020-02-13,2020-02-11,True,The First Affiliated Hospital of Wenzhou Medical University,Recruiting,Phase 4,Interventional,China,"A randomized, open-label, blank-controlled, multicenter trial for Polyinosinic-Polycytidylic Acid Injection in the treatment of novel coronavirus pneumonia (COVID-19)",Drug,Polyinosinic-polycytidylic acid,40,Not Available,2020-12-31,http://www.chictr.org.cn/showproj.aspx?proj=49342,No Results,No Results,No Results,2020-02-17,2020-08-03,None
24,ChiCTR2000029624,ChiCTR,2020-02-07,2020-02-08,False,Shanghai Public Health Clinical Center,Not Recruiting,Not Applicable,Observational,China,A real world study for traditional Chinese Medicine in the treatment of novel coronavirus pneumonia (COVID-19),Traditional Medicine (Unspecified),Traditional Medicine,500,Not Available,2021-02-07,http://www.chictr.org.cn/showproj.aspx?proj=49132,No Results,No Results,No Results,2020-02-17,2020-08-03,None
25,ChiCTR2000029601,ChiCTR,2020-02-06,2020-02-01,True,Hubei Hospital of Traditional Chinese Medicine,Recruiting,Not Applicable,Interventional,China,Community based prevention and control for Chinese medicine in the treatment of novel coronavirus pneumonia (COVID-19) in the isolate suspected and confirmed population,Traditional Medicine (Other),Traditional Medicine,400,Not Available,2020-08-01,http://www.chictr.org.cn/showproj.aspx?proj=48988,No Results,No Results,No Results,2020-02-17,2020-08-03,None
26,ChiCTR2000029742,ChiCTR,2020-02-11,2020-02-10,True,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Phase 4,Interventional,China,"A randomized, parallel controlled trial for the efficacy and safety of Sodium Aescinate Injection in the treatment of patients with pneumonia (COVID-19)",Traditional Medicine (Drug),Traditional Medicine,90,Not Available,2020-12-31,http://www.chictr.org.cn/showproj.aspx?proj=49297,No Results,No Results,No Results,2020-02-17,2020-08-03,None
27,ChiCTR2000029569,ChiCTR,2020-02-04,2020-02-05,False,Xiangyang First People's Hospital,Not Recruiting,Not Applicable,Interventional,China,Safety and efficacy of umbilical cord blood mononuclear cells conditioned medium in the treatment of severe and critically novel coronavirus pneumonia (COVID-19): a randomized controlled trial,ATMP,Cells (mononuclear),30,Not Available,2021-04-30,http://www.chictr.org.cn/showproj.aspx?proj=49062,No Results,No Results,No Results,2020-02-17,2020-08-03,None
28,NCT04261907,ClinicalTrials.gov,2020-02-06,2020-02-07,False,The First Affiliated Hospital of Zhejiang University,Not Recruiting,Not Applicable,Interventional,No Country Given,Evaluating and Comparing the Safety and Efficiency of ASC09/Ritonavir and Lopinavir/Ritonavir for Novel Coronavirus Infection,Drug,SC09 + ritonavir vs. lopinavir/ritonavir,160,2020-05-31,2020-06-30,https://clinicaltrials.gov/show/NCT04261907,No Results,No Results,No Results,2020-02-17,2020-08-03,None
29,ChiCTR2000029941,ChiCTR,2020-02-16,2020-03-01,False,Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine,Not Recruiting,Not Applicable,Interventional,China,A randomized controlled trial for Traditional Chinese Medicine in the treatment for Novel Coronavirus Pneumonia (COVID-19),Traditional Medicine (Unspecified),Traditional Medicine,200,Not Available,2020-06-01,http://www.chictr.org.cn/showproj.aspx?proj=49596,No Results,No Results,No Results,2020-02-17,2020-08-03,None
30,ChiCTR2000029542,ChiCTR,2020-02-03,2020-02-03,False,Sun Yat sen Memorial Hospital of Sun Yat sen University,Recruiting,Phase 4,Interventional,China,Study for the efficacy of chloroquine in patients with novel coronavirus pneumonia (COVID-19),Drug,Chloroquine,20,Not Available,2020-07-30,http://www.chictr.org.cn/showproj.aspx?proj=48968,No Results,No Results,No Results,2020-02-17,2020-08-03,None
31,ChiCTR2000029741,ChiCTR,2020-02-11,2020-02-12,False,The Fifth Affiliated Hospital of Sun Yat-Sen University,Recruiting,Phase 4,Interventional,China,"Efficacy of Chloroquine and Lopinavir/ Ritonavir in mild/general novel coronavirus (CoVID-19) infections: a prospective, open-label, multicenter randomized controlled clinical study",Drug,Lopinavir/ritonavir vs. chloroquine,112,Not Available,2020-12-31,http://www.chictr.org.cn/showproj.aspx?proj=49263,No Results,No Results,No Results,2020-02-17,2020-08-03,None
32,ChiCTR2000029939,ChiCTR,2020-02-16,2020-02-10,True,"Hwa Mei Hospital, University of Chinese Academy of Sciences",Recruiting,Not Applicable,Interventional,China,"A Single-blind, Randomized, Controlled Clinical Trial for Chloroquine Phosphate in the treatment of Novel Coronavirus Pneumonia 2019 (COVID-19)",Drug,Chloroquine,100,Not Available,2021-02-06,http://www.chictr.org.cn/showproj.aspx?proj=49612,No Results,No Results,No Results,2020-02-17,2020-08-03,None
33,ChiCTR2000029539,ChiCTR,2020-02-03,2020-02-04,False,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Not Applicable,Interventional,China,"A randomized, open-label study to evaluate the efficacy and safety of Lopinavir-Ritonavir in patients with mild novel coronavirus pneumonia (COVID-19)",Drug,Lopinavir/ritonavir,328,Not Available,2021-02-02,http://www.chictr.org.cn/showproj.aspx?proj=48991,No Results,No Results,No Results,2020-02-17,2020-08-03,None
34,ChiCTR2000029637,ChiCTR,2020-02-08,2020-02-07,True,Guangdong Provincial Hospital of Chinese Medicine,Not Recruiting,Not Applicable,Observational,China,An observational study for Xin-Guan-1 formula  in the treatment of novel coronavirus pneumonia (COVID-19),Traditional Medicine (Drug),Traditional Medicine,100,Not Available,2020-04-10,http://www.chictr.org.cn/showproj.aspx?proj=49127,No Results,No Results,No Results,2020-02-17,2020-08-03,None
35,NCT04260308,ClinicalTrials.gov,2020-02-03,2020-02-03,False,Huazhong University of Science and Technology,Recruiting,Not Applicable,Observational,China,A Survey of Psychological Status of Medical Workers and Residents in the Context of 2019 Novel Coronavirus Pneumonia,Other (psych),No Intervention,30000,2020-04-15,2020-04-20,https://clinicaltrials.gov/show/NCT04260308,Pre-Print Article,2020-03-06,https://doi.org/10.1101/2020.03.03.20030874,2020-02-17,2020-03-18,None
36,ChiCTR2000029883,ChiCTR,2020-02-16,2020-02-17,False,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Not Recruiting,Not Applicable,Diagnostic test,China,A comparative study on the sensitivity of nasopharyngeal and oropharyngeal swabbing for the detection of SARS-CoV-2 by real-time PCR,Diagnostics,Diagnostic Test or Assessment,200,Not Available,2020-03-31,http://www.chictr.org.cn/showproj.aspx?proj=49549,No Results,No Results,No Results,2020-02-17,2020-08-03,None
37,ChiCTR2000029907,ChiCTR,2020-02-16,2020-02-16,False,West China Hospital of Sichuan University,Not Recruiting,Not Applicable,Observational,China,Study for construction and assessment of early warning score of the clinical risk of novel coronavirus (COVID-19) infected patients,Clinical Presentation,No Intervention,1000,Not Available,2020-12-31,http://www.chictr.org.cn/showproj.aspx?proj=49587,No Results,No Results,No Results,2020-02-17,2020-08-03,None
38,ChiCTR2000029462,ChiCTR,2020-02-02,2020-02-01,True,The First Affiliated Hospital of He'nan University of Chinese Medicine,Not Recruiting,Not Applicable,Observational,China,Study for clinical characteristics and distribution of TCM syndrome of novel coronavirus pneumonia (COVID-19),Traditional Medicine (Other),Traditional Medicine,200,Not Available,2020-12-31,http://www.chictr.org.cn/showproj.aspx?proj=48922,No Results,No Results,No Results,2020-02-17,2020-08-03,None
39,ChiCTR2000029438,ChiCTR,2020-02-01,2020-02-04,False,Beijing Hospital of Traditional Chinese Medicine; Hubei Provincial Hospital of Integrated Chinese and Western Medicine,Not Recruiting,Phase 4,Interventional,China,A randomized controlled trial of integrated TCM and Western Medicine in the treatment of severe novel coronavirus pneumonia (COVID-19),Traditional Medicine + Western Medicine,Traditional Medicine,100,Not Available,2021-12-01,http://www.chictr.org.cn/showproj.aspx?proj=48911,No Results,No Results,No Results,2020-02-17,2020-08-03,None
40,ChiCTR2000029869,ChiCTR,2020-02-15,2020-02-10,True,Huangshi Hospital of Traditional Chinese Medicine,Not Recruiting,Phase 4,Interventional,China,"A multicenter, randomized, controlled trial for integrated Chinese and western medicine in the treatment of ordinary novel coronavirus pneumonia (COVID-19) based on the ' Internal and External Relieving -Truncated Torsion' strategy",Traditional Medicine + Western Medicine,Traditional Medicine,300,Not Available,2020-06-30,http://www.chictr.org.cn/showproj.aspx?proj=49486,No Results,No Results,No Results,2020-02-17,2020-08-03,None
41,ChiCTR2000029905,ChiCTR,2020-02-16,2020-02-10,True,Zhongnan Hospital of Wuhan University,Recruiting,Not Applicable,Observational,China,A medical records based study of novel coronavirus pneumonia (COVID-19) and influenza virus co-infection,Clinical Presentation,No Intervention,271,Not Available,2020-03-15,http://www.chictr.org.cn/showproj.aspx?proj=49595,No Results,No Results,No Results,2020-02-17,2020-08-03,None
42,ChiCTR2000029636,ChiCTR,2020-02-08,2020-02-09,False,"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Not Applicable,Interventional,China,Efficacy and safety of aerosol inhalation of vMIP in the treatment of novel coronavirus pneumonia (COVID-19): a single arm clinical trial,ATMP,Vaccine,40,Not Available,2020-07-30,http://www.chictr.org.cn/showproj.aspx?proj=49215,No Results,No Results,No Results,2020-02-17,2020-08-03,None
43,ChiCTR2000029870,ChiCTR,2020-02-15,2020-02-15,False,Jiangsu Institute of Parasitic Diseases,Recruiting,Not Applicable,Diagnostic test,China,Evaluation of Rapid Diagnostic Kit (IgM/IgG) for Novel Coronavirus Pneumonia (COVID-19),Diagnostics,Diagnostic Test or Assessment,500,Not Available,2020-12-31,http://www.chictr.org.cn/showproj.aspx?proj=49563,No Results,No Results,No Results,2020-02-17,2020-08-03,None
44,ChiCTR2000029436,ChiCTR,2020-02-01,2020-02-01,False,The First Hospital of He'nan University of Chinese Medicine,Not Recruiting,Not Applicable,Interventional,China,A single arm study for evaluation of integrated traditional Chinese and western medicine in the treatment of novel coronavirus pneumonia (COVID-19),Traditional Medicine + Western Medicine,Traditional Medicine,100,Not Available,2020-12-31,http://www.chictr.org.cn/showproj.aspx?proj=48884,No Results,No Results,No Results,2020-02-17,2020-08-03,None
45,ChiCTR2000029867,ChiCTR,2020-02-15,2020-02-15,False,"Beijing You'an Hospital, Capital Medical University",Recruiting,Phase 4,Interventional,China,"The efficacy and safety of carrimycin treatment in patients with novel coronavirus pneumonia (COVID-19): a multicenter, randomized, open-label, controlled trial",Drug,Carrimycin vs. lopinavir/ritonavir,520,Not Available,2021-02-28,http://www.chictr.org.cn/showproj.aspx?proj=49514,No Results,No Results,No Results,2020-02-17,2020-08-03,None
46,ChiCTR2000029589,ChiCTR,2020-02-05,2020-02-06,False,Beijing Hospital of Traditional Chinese Medicine; Hubei Provincial Hospital of Integrated Chinese and Western Medicine,Recruiting,Not Applicable,Interventional,China,"An open, prospective, multicenter clinical study for the efficacy and safety of Reduning injection in the treatment of ovel coronavirus pneumonia (COVID-19)",Traditional Medicine (Drug),Traditional Medicine,60,Not Available,2021-12-31,http://www.chictr.org.cn/showproj.aspx?proj=49104,No Results,No Results,No Results,2020-02-17,2020-08-03,None
47,ChiCTR2000029855,ChiCTR,2020-02-15,2020-02-15,False,The First Affiliated Hospital of Zhejiang University School of Medicine,Recruiting,Not Applicable,Interventional,China,"A randomized, open and controlled clinical trial for traditional Chinese medicine in the treatment of novel coronavirus pneumonia (COVID-19)",Traditional Medicine (Unspecified),Traditional Medicine,180,Not Available,Not Available,http://www.chictr.org.cn/showproj.aspx?proj=49543,No Results,No Results,No Results,2020-02-17,2020-08-03,None
48,ChiCTR2000029849,ChiCTR,2020-02-15,2020-02-01,True,The First Affiliated Hospital of Zhengzhou University,Recruiting,Not Applicable,Interventional,China,Application of Regulating Intestinal Flora in the Treatment of Severe Novel Coronavirus Pneumonia (COVID-19),ATMP,Intestinal microbiome,60,Not Available,2021-02-01,http://www.chictr.org.cn/showproj.aspx?proj=49530,No Results,No Results,No Results,2020-02-17,2020-08-03,None
49,ChiCTR2000029418,ChiCTR,2020-01-30,2020-02-03,False,Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine,Recruiting,Not Applicable,Interventional,China,Chinese Herbal medicine for Severe nevel coronavirus pneumonia (COVID-19): a Randomized Controlled Trial,Traditional Medicine (Drug),Traditional Medicine,42,Not Available,2020-08-31,http://www.chictr.org.cn/showproj.aspx?proj=48886,Pre-Print Article,2020-04-01,https://doi.org/10.1101/2020.03.27.20044974,2020-02-17,2020-08-03,None
50,ChiCTR2000029578,ChiCTR,2020-02-05,2020-02-06,False,Zhejiang Chinese Medical University,Recruiting,Not Applicable,Interventional,China,"Chinese medicine prevention and treatment program for novel coronavirus pneumonia (COVID-19): a perspective, sing-arm trial",Traditional Medicine (Unspecified),Traditional Medicine,1000,Not Available,2020-04-30,http://www.chictr.org.cn/showproj.aspx?proj=49080,No Results,No Results,No Results,2020-02-17,2020-08-03,None
51,ChiCTR2000029853,ChiCTR,2020-02-15,2020-02-16,False,People's Hospital of Guangshan County,Recruiting,Not Applicable,Interventional,China,"A randomized, open-label, controlled clinical trial for azvudine in the treatment of novel coronavirus pneumonia (COVID-19)",Drug,Azvudine,20,Not Available,2020-04-16,http://www.chictr.org.cn/showproj.aspx?proj=49532,No Results,No Results,No Results,2020-02-17,2020-08-03,None
52,ChiCTR2000029822,ChiCTR,2020-02-14,2020-02-07,True,Nanjing Second Hospital,Recruiting,Not Applicable,Interventional,No Country Given,A randomized controlled trial for honeysuckle decoction in the treatment of patients with novel coronavirus (COVID-19) infection,Traditional Medicine (Drug),Traditional Medicine,110,Not Available,2020-04-30,http://www.chictr.org.cn/showproj.aspx?proj=49502,No Results,No Results,No Results,2020-02-17,2020-08-03,None
53,ChiCTR2000030173,ChiCTR,2020-02-24,2020-02-17,True,"Hunan yuanpin Cell Biotechnology Co., Ltd",Not Recruiting,Not Applicable,Interventional,China,Key techniques of umbilical cord mesenchymal stem cells for the treatment of novel coronavirus pneumonia (COVID-19) and clinical application demonstration,ATMP,Cells (mesenchymal),60,Not Available,2020-04-17,http://www.chictr.org.cn/showproj.aspx?proj=49229,No Results,No Results,No Results,2020-02-25,2020-08-03,None
54,ChiCTR2000029518,ChiCTR,2020-02-03,2020-02-04,False,Zhejiang Chinese Medical University,Recruiting,Not Applicable,Interventional,China,"Chinese medicine prevention and treatment program for novel coronavirus pneumonia (COVID-19): a perspective, double-blind, placebo, randomised controlled trial",Traditional Medicine (Unspecified),Traditional Medicine,140,Not Available,2020-04-30,http://www.chictr.org.cn/showproj.aspx?proj=48860,No Results,No Results,No Results,2020-02-17,2020-08-03,None
55,ChiCTR2000029839,ChiCTR,2020-02-15,2020-02-10,True,Ningbo First Hospital,Recruiting,Not Applicable,Observational,China,"An observational study on the clinical characteristics, treatment and outcome of novel coronavirus pneumonia (COVID-19)",Clinical Presentation,No Intervention,100,Not Available,2020-03-31,http://www.chictr.org.cn/showproj.aspx?proj=49439,No Results,No Results,No Results,2020-02-17,2020-08-03,None
56,ChiCTR2000029815,ChiCTR,2020-02-14,2020-02-01,True,Guangdong Provincial Hospital of Chinese Medicine,Recruiting,Not Applicable,Observational,China,Psychological survey of frontline medical staff in various regions of China during the epidemic of novel coronavirus pneumonia (COVID-19),Other (psych),No Intervention,800,Not Available,2020-04-15,http://www.chictr.org.cn/showproj.aspx?proj=49346,No Results,No Results,No Results,2020-02-17,2020-03-18,None
57,ChiCTR2000029517,ChiCTR,2020-02-03,2020-02-04,False,Zhejiang Chinese Medical University,Recruiting,Not Applicable,Interventional,China,"Chinese medicine prevention and treatment program for suspected novel coronavirus pneumonia (COVID-19): a perspective, double-blind, placebo, randomised controlled trial",Traditional Medicine (Unspecified),Traditional Medicine,100,Not Available,2020-04-30,http://www.chictr.org.cn/showproj.aspx?proj=48861,No Results,No Results,No Results,2020-02-17,2020-08-03,None
58,ChiCTR2000030166,ChiCTR,2020-02-24,2020-02-25,False,The Fifth Medical Center of PLA General Hospital,Not Recruiting,Not Applicable,Interventional,China,"Randomized, parallel control, open trial for Qing-Wen Bai-Du-Yin combined with antiviral therapy in the treatment of novel coronavirus pneumonia (COVID-19)",Traditional Medicine (Drug),Traditional Medicine,20,Not Available,2020-05-14,http://www.chictr.org.cn/showproj.aspx?proj=49696,No Results,No Results,No Results,2020-02-25,2020-08-03,None
59,ChiCTR2000029821,ChiCTR,2020-02-14,2020-02-14,False,Deyang Integrated Traditional Chinese and Western Medicine Hospital,Not Recruiting,Not Applicable,Prevention,China,Based on Delphi Method to Preliminarily Construct a Recommended Protocol for the Prevention of Novel Coronavirus Pneumonia (COVID-19) in Deyang Area by Using Chinese Medicine Technology and its Clinical Application Evaluation,Traditional Medicine (Unspecified),Traditional Medicine,400,Not Available,2020-06-01,http://www.chictr.org.cn/showproj.aspx?proj=49306,No Results,No Results,No Results,2020-02-17,2020-08-03,None
60,ChiCTR2000029813,ChiCTR,2020-02-14,2020-02-14,False,Shanghai Public Health Clinical Center,Recruiting,Not Applicable,Interventional,China,Clinical Trial for Tanreqing Capsules in the Treatment of Novel Coronavirus Pneumonia (COVID-19),Traditional Medicine (Other),Traditional Medicine,72,Not Available,2020-08-14,http://www.chictr.org.cn/showproj.aspx?proj=49425,No Results,No Results,No Results,2020-02-17,2020-08-03,None
61,ChiCTR2000029495,ChiCTR,2020-02-02,2020-02-03,False,"Xinhua Affiliated Hospital, Hubei University of Chinese Medicine; Hubei Provincial Hospital of Integrated Chinese and Western Medicine",Not Recruiting,Not Applicable,Interventional,China,"Traditional Chinese Medicine, Psychological Intervention and Investigation of Mental Health for Patients With Novel Coronavirus Pneumonia (COVID-19) in Convalescent Period",Traditional Medicine (Other),Traditional Medicine,90,Not Available,2021-12-31,http://www.chictr.org.cn/showproj.aspx?proj=48971,No Results,No Results,No Results,2020-02-17,2020-08-03,None
62,ChiCTR2000030118,ChiCTR,2020-02-23,2020-02-24,False,Shenzhen National Medicine Inheritance Medical Research Institute co. LTD,Not Recruiting,Not Applicable,Interventional,China,A clinical study for ''Huo-Shen'' particles in the treatment of novel coronavirus pneumonia (COVID-19),Traditional Medicine (Drug),Traditional Medicine,120,Not Available,2020-06-29,http://www.chictr.org.cn/showproj.aspx?proj=49594,No Results,No Results,No Results,2020-02-25,2020-08-03,None
63,ChiCTR2000029819,ChiCTR,2020-02-14,2020-02-11,True,"Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University",Recruiting,Phase 4,Interventional,China,Ba-Bao-Dan in the adjuvant therapy of novel coronavirus pneumonia (COVID-19) patients,Traditional Medicine (Drug),Traditional Medicine,80,Not Available,2020-08-11,http://www.chictr.org.cn/showproj.aspx?proj=49490,No Results,No Results,No Results,2020-02-17,2020-08-03,None
64,ChiCTR2000029806,ChiCTR,2020-02-14,2020-02-12,True,Wuhan Jinyintan Hospital (Wuhan Infectious Diseases Hospital),Recruiting,Not Applicable,Interventional,China,Immunomodulatory Therapy for Severe Novel Coronavirus Pneumonia (COVID-19),Drug,PD1 vs. thymosin,120,Not Available,2021-01-31,http://www.chictr.org.cn/showproj.aspx?proj=49161,No Results,No Results,No Results,2020-02-17,2020-08-03,None
65,ChiCTR2000029804,ChiCTR,2020-02-14,2020-02-12,True,Wuhan Jinyintan Hospital (Wuhan Infectious Diseases Hospital),Recruiting,Not Applicable,Prognosis,China,Clinical Application of ECMO in the Treatment of Patients with Very Serious Respiratory Failure due to novel Coronavirus Pneumonia (COVID-19),Drug,Oxygen,100,Not Available,2021-01-31,http://www.chictr.org.cn/showproj.aspx?proj=49178,No Results,No Results,No Results,2020-02-17,2020-08-03,None
66,ChiCTR2000030116,ChiCTR,2020-02-23,2020-02-01,True,The First Affiliated Hospital of Nanchang University,Recruiting,Not Applicable,Interventional,China,Safety and effectiveness of human umbilical cord mesenchymal stem cells in the treatment of acute respiratory distress syndrome of severe novel coronavirus pneumonia (COVID-19),ATMP,Cells (mesenchymal),16,Not Available,2020-08-31,http://www.chictr.org.cn/showproj.aspx?proj=49901,No Results,No Results,No Results,2020-02-25,2020-08-03,None
67,ChiCTR2000029493,ChiCTR,2020-02-02,2020-02-03,False,"Xinhua Affiliated Hospital, Hubei University of Chinese Medicine; Hubei Provincial Hospital of Integrated Chinese and Western Medicine",Not Recruiting,Not Applicable,Interventional,China,"Traditional Chinese Medicine for Pulmonary Fibrosis, Pulmonary Function and Quality of Life in Patients With Novel Coronavirus Pneumonia (COVID-19) in Convalescent Period: a Randomized Controlled Trial",Traditional Medicine (Unspecified),Traditional Medicine,100,Not Available,2021-12-31,http://www.chictr.org.cn/showproj.aspx?proj=48931,No Results,No Results,No Results,2020-02-17,2020-08-03,None
68,ChiCTR2000029769,ChiCTR,2020-02-13,2020-02-15,False,Enze Hospital of Taizhou Enze Medical Center (Group),Not Recruiting,Not Applicable,Interventional,China,Babaodan Capsule used for the adjuvant treatment of severe novel coronavirus pneumonia (COVID-19),Traditional Medicine (Drug),Traditional Medicine,40,Not Available,2020-04-30,http://www.chictr.org.cn/showproj.aspx?proj=49415,No Results,No Results,No Results,2020-02-17,2020-08-03,None
69,ChiCTR2000029790,ChiCTR,2020-02-13,2020-02-17,False,Shanghai Pulmonary Hospital,Recruiting,Not Applicable,Interventional,China,Clinical study for the integration of traditional Chinese and western medicine in the treatment of novel coronavirus pneumonia (COVID-19),Traditional Medicine + Western Medicine,Traditional Medicine,120,Not Available,2020-10-31,http://www.chictr.org.cn/showproj.aspx?proj=49453,No Results,No Results,No Results,2020-02-17,2020-08-03,None
70,ChiCTR2000030093,ChiCTR,2020-02-23,2020-03-01,False,The Second Hospital of Shanxi Medical University,Not Recruiting,Not Applicable,Interventional,China,Study for application of simplified cognitive-behavioral therapy for related emergency psychological stress reaction of medical providers working in the position of treatment and control of novel coronavirus pneumonia (COVID-19),Other (psych),Psychological,60,Not Available,2021-03-31,http://www.chictr.org.cn/showproj.aspx?proj=49932,No Results,No Results,No Results,2020-02-25,2020-08-03,None
71,ChiCTR2000029768,ChiCTR,2020-02-13,2020-02-12,True,Zhongnan Hospital of Wuhan University,Recruiting,Not Applicable,Interventional,China,"A randomized, open, controlled trial for diammonium glycyrrhizinate enteric-coated capsules combined with vitamin C tablets in the treatment of common novel coronavirus pneumonia (COVID-19) in the basic of clinical standard antiviral treatment to evaluate the safety and efficiency",Drug,Diammonium glycyrrhizinate + Vitamin C,60,Not Available,2020-05-12,http://www.chictr.org.cn/showproj.aspx?proj=49131,No Results,No Results,No Results,2020-02-17,2020-08-03,None
72,ChiCTR2000029788,ChiCTR,2020-02-13,2020-03-01,False,Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine,Not Recruiting,Not Applicable,Interventional,China,Traditional Chinese medicine cooperative therapy for patients with novel coronavirus pneumonia (COVID-19): a randomized controlled trial,Traditional Medicine (Unspecified),Traditional Medicine,60,Not Available,2020-12-30,http://www.chictr.org.cn/showproj.aspx?proj=49452,No Results,No Results,No Results,2020-02-17,2020-08-03,None
73,ChiCTR2000029754,ChiCTR,2020-02-12,2020-02-10,True,West China Hospital of Sichuan University,Recruiting,Not Applicable,Observational,China,Study for the Effect of Novel Coronavirus Pneumonia (COVID-19) on the Health of Different People,Clinical Presentation,No Intervention,1500,Not Available,2022-02-10,http://www.chictr.org.cn/showproj.aspx?proj=49370,No Results,No Results,No Results,2020-02-17,2020-08-03,None
74,ChiCTR2000030084,ChiCTR,2020-02-22,2020-02-24,False,The First Hospital of Shanxi Medical University,Recruiting,Not Applicable,Interventional,China,A multicenter study for efficacy of intelligent psychosomatic adjustment system intervention in the treatment of novel coronavirus pneumonia (COVID-19) patients with mild to moderate anxiety and depression,Other (psych),Psychological,180,Not Available,2022-02-01,http://www.chictr.org.cn/showproj.aspx?proj=49952,No Results,No Results,No Results,2020-02-25,2020-08-03,None
75,ChiCTR2000029765,ChiCTR,2020-02-13,2020-02-10,True,The First Affiliated Hospital of University of Science and Technology of China (Anhui Provincial Hospital),Recruiting,Phase 4,Interventional,China,"A multicenter, randomized controlled trial for the efficacy and safety of tocilizumab in the treatment of new coronavirus pneumonia (COVID-19)",Drug,Tocilizumab,188,Not Available,2020-05-10,http://www.chictr.org.cn/showproj.aspx?proj=49409,No Results,No Results,No Results,2020-02-17,2020-08-03,None
76,ChiCTR2000029751,ChiCTR,2020-02-12,2020-02-01,True,The First Affiliated Hospital of Zhejiang University of Traditional Chinese Medicine,Recruiting,Not Applicable,Observational,China,Clinical Study for Traditional Chinese Medicine in the Prevention and Treatment of Novel Coronavirus Pneumonia (COVID-19),Traditional Medicine (Unspecified),Traditional Medicine,350,Not Available,2020-12-31,http://www.chictr.org.cn/showproj.aspx?proj=49354,No Results,No Results,No Results,2020-02-17,2020-08-03,None
77,ChiCTR2000030043,ChiCTR,2020-02-21,2020-02-21,False,Peking University Third Hospital,Not Recruiting,Phase 4,Interventional,China,"Shen-Fu injection in the treatment of severe novel coronavirus pneumonia (COVID-19): a multicenter, randomized, open-label, controlled trial",Traditional Medicine (Drug),Traditional Medicine,300,Not Available,2020-12-31,http://www.chictr.org.cn/showproj.aspx?proj=49866,No Results,No Results,No Results,2020-02-25,2020-08-03,None
78,ChiCTR2000029763,ChiCTR,2020-02-12,2020-02-13,False,China Academy of Chinese Medical Sciences; Zhongnan Hospital of Wuhan University,Recruiting,Not Applicable,Interventional,China,"The efficacy of traditional chinese medicine on Novel Coronavirus Pneumonia (COVID-19) patients treated in square cabin hospital: a prospective, randomized controlled trial",Traditional Medicine (Unspecified),Traditional Medicine,408,Not Available,2020-05-31,http://www.chictr.org.cn/showproj.aspx?proj=49408,No Results,No Results,No Results,2020-02-17,2020-08-03,None
79,ChiCTR2000029735,ChiCTR,2020-02-10,2020-01-26,True,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Not Applicable,Observational,China,Risks of Death and Severe cases in Patients with 2019 Novel Coronavirus Pneumonia (COVID-19),Prognosis,No Intervention,500,Not Available,2020-03-31,http://www.chictr.org.cn/showproj.aspx?proj=49279,No Results,No Results,No Results,2020-02-17,2020-08-03,None
80,ChiCTR2000030041,ChiCTR,2020-02-21,2020-02-25,False,Zhongnan Hospital of Wuhan University,Not Recruiting,Not Applicable,Interventional,China,"A single-arm, single-center clinical trial for Azivudine tablets in the treatment of adult novel coronavirus pneumonia (COVID-19)",Drug,Azvudine,40,Not Available,2020-06-30,http://www.chictr.org.cn/showproj.aspx?proj=49891,No Results,No Results,No Results,2020-02-25,2020-08-03,None
81,ChiCTR2000029758,ChiCTR,2020-02-12,2020-02-03,True,West China Hospital of Sichuan University,Recruiting,Not Applicable,Observational,China,Cohort Study of Novel Coronavirus Pneumonia (COVID-19) Critical Ill Patients,Clinical Presentation,No Intervention,100,Not Available,2022-02-01,http://www.chictr.org.cn/showproj.aspx?proj=49295,Pre-Print Article,2020-03-06,https://doi.org/10.1101/2020.03.22.20041277,2020-02-17,2020-08-03,None
82,ChiCTR2000029734,ChiCTR,2020-02-10,2020-02-08,True,The First People's Hospital of Huaihua,Recruiting,Not Applicable,Observational,China,Epidemiological investigation and clinical characteristics analysis of novel coronavirus pneumonia (COVID-19),Clinical Presentation (Epidemiology),No Intervention,40,Not Available,2020-08-07,http://www.chictr.org.cn/showproj.aspx?proj=48868,Pre-Print Article,2020-03-06,https://doi.org/10.1101/2020.03.04.20026005,2020-02-17,2020-08-03,None
83,ChiCTR2000030034,ChiCTR,2020-02-21,2020-02-07,True,Tongde Hospital of Zhejiang Province,Recruiting,Not Applicable,Interventional,China,"Traditional Chinese Medicine in the treatment of novel coronavirus pneumonia (COVID-19): a multicentre, randomized controlled trial",Traditional Medicine (Unspecified),Traditional Medicine,132,Not Available,2020-06-30,http://www.chictr.org.cn/showproj.aspx?proj=49647,No Results,No Results,No Results,2020-02-25,2020-08-03,None
84,ChiCTR2000029756,ChiCTR,2020-02-12,2020-02-15,False,Renmin Hospital of Wuhan University,Recruiting,Not Applicable,Interventional,China,Clinical study of nebulized Xiyanping injection in the treatment of novel coronavirus pneumonia (COVID-19),Traditional Medicine (Drug),Traditional Medicine,238,Not Available,2022-02-15,http://www.chictr.org.cn/showproj.aspx?proj=49222,No Results,No Results,No Results,2020-02-17,2020-08-03,None
85,ChiCTR2000030032,ChiCTR,2020-02-21,2020-02-10,True,Xi'an Chest Hospital,Recruiting,Not Applicable,Observational,China,Study on ultrasonographic manifestations of new type of novel coronavirus pneumonia (covid-19) in non-critical stage of pulmonary lesions,Clinical Presentation,No Intervention,20,Not Available,2020-02-28,http://www.chictr.org.cn/showproj.aspx?proj=49816,No Results,No Results,No Results,2020-02-25,2020-08-03,None
86,ChiCTR2000029621,ChiCTR,2020-02-07,2020-02-07,False,"Ruijin Hospital, Shanghai Jiao Tong University School of Medicine",Recruiting,Phase 4,Interventional,China,Clinical study of arbidol hydrochloride tablets in the treatment of novel coronavirus pneumonia (COVID-19),Drug,Umifenovir,380,Not Available,2020-12-31,http://www.chictr.org.cn/showproj.aspx?proj=49165,No Results,No Results,No Results,2020-02-17,2020-08-03,None
87,ChiCTR2000029747,ChiCTR,2020-02-11,2020-02-11,False,The First Affiliated Hospital of Anhui University of Traditional Chinese Medicine,Recruiting,Not Applicable,Interventional,China,Effect evaluation and prognosis of Chinese medicine based on Novel Coronavirus Pneumonia (COVID-19),Prognosis,No Intervention,200,Not Available,2021-02-10,http://www.chictr.org.cn/showproj.aspx?proj=49287,No Results,No Results,No Results,2020-02-17,2020-08-03,None
88,ChiCTR2000030016,ChiCTR,2020-02-19,2020-02-04,True,Guangxi Medical University,Recruiting,Phase 4,Interventional,China,Basic and clinical study of inhalation of inactivated mycobacterium vaccine in the treatment of Novel coronavirus pneumonia (COVID-19),ATMP,Vaccine,60,Not Available,2022-12-31,http://www.chictr.org.cn/showproj.aspx?proj=49799,No Results,No Results,No Results,2020-02-25,2020-08-03,None
89,ChiCTR2000029609,ChiCTR,2020-02-06,2020-02-10,False,The Fifth Affiliated Hospital of Sun Yat-Sen University,Not Recruiting,Phase 4,Interventional,China,"A prospective, open-label, multiple-center study for the efficacy of chloroquine phosphate in patients with novel coronavirus pneumonia (COVID-19)",Drug,Chloroquine vs. lopinavir/ritonavir,205,Not Available,2020-12-31,http://www.chictr.org.cn/showproj.aspx?proj=49145,Pre-Print Article,2020-05-04,https://doi.org/10.1101/2020.04.26.20081059,2020-02-17,2020-08-03,None
90,ChiCTR2000029739,ChiCTR,2020-02-11,2020-02-12,False,The First Affiliated Hospital of Guangzhou Medical University,Recruiting,Not Applicable,Interventional,China,"A Multicenter, Randomized, Parallel Controlled Clinical Study of Hydrogen-Oxygen Nebulizer to Improve the Symptoms of Patients With Novel Coronavirus Pneumonia (COVID-19)",Drug,Hydrogen + Oxygen vs Oxygen,440,Not Available,2021-08-31,http://www.chictr.org.cn/showproj.aspx?proj=49283,No Results,No Results,No Results,2020-02-17,2020-08-03,None
91,ChiCTR2000030007,ChiCTR,2020-02-19,2020-02-03,True,The First Affiliated Hospital of Guangzhou Medical University,Not Recruiting,Not Applicable,Interventional,China,Multicenter randomized controlled trial for rhG-CSF in the treatment of novel coronavirus pneumonia (COVID-19),Drug,G-CSF,200,Not Available,2020-04-10,http://www.chictr.org.cn/showproj.aspx?proj=49619,No Results,No Results,No Results,2020-02-25,2020-08-03,None
92,ChiCTR2000029606,ChiCTR,2020-02-07,2020-01-25,True,The First Affiliated Hospital of Zhejiang University School of Medicine,Recruiting,Not Applicable,Interventional,China,Clinical Study for Human Menstrual Blood-Derived Stem Cells in the Treatment of Acute Novel Coronavirus Pneumonia (COVID-19),ATMP,Cells (stem cells),63,Not Available,2022-12-31,http://www.chictr.org.cn/showproj.aspx?proj=49146,No Results,No Results,No Results,2020-02-17,2020-08-03,None
93,ChiCTR2000030000,ChiCTR,2020-02-19,2020-02-16,True,The Ninth Hospital of Nanchang,Recruiting,Phase 4,Interventional,China,"An open, controlled clinical trial for evaluation of ganovo combined with ritonavir and integrated traditional Chinese and Western medicine in the treatment of novel coronavirus infection (COVID-19)",Traditional Medicine + Western Medicine,Traditional Medicine,50,Not Available,Not Available,http://www.chictr.org.cn/showproj.aspx?proj=49748,No Results,No Results,No Results,2020-02-25,2020-03-18,None
94,ChiCTR2000029732,ChiCTR,2020-02-10,2020-02-10,False,West China Hospital of Sichuan University,Not Recruiting,Not Applicable,Observational,China,Impact of vitamin D deficiency on prognosis of patients with novel coronavirus pneumonia (COVID-19),Prognosis,No Intervention,156,Not Available,2020-04-10,http://www.chictr.org.cn/showproj.aspx?proj=49302,No Results,No Results,No Results,2020-02-17,2020-08-03,None
95,ChiCTR2000029605,ChiCTR,2020-02-07,2020-02-06,True,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Phase 4,Interventional,China,"A randomized, open-label, blank-controlled, multicenter trial for Shuang-Huang-Lian oral solution in the treatment of ovel coronavirus pneumonia (COVID-19)",Traditional Medicine (Drug),Traditional Medicine,400,Not Available,2021-02-05,http://www.chictr.org.cn/showproj.aspx?proj=49051,No Results,No Results,No Results,2020-02-17,2020-03-18,None
96,ChiCTR2000029956,ChiCTR,2020-02-17,2020-02-18,False,Hospital of Chengdu University of Traditional Chinese Medicine,Not Recruiting,Not Applicable,Interventional,China,Chinese Medicine Promotes Rehabilitation Recommendations after 2019 Novel Coronavirus Infection (COVID-19),Traditional Medicine (Unspecified),Traditional Medicine,120,Not Available,2020-07-01,http://www.chictr.org.cn/showproj.aspx?proj=49618,No Results,No Results,No Results,2020-02-25,2020-08-03,None
97,ChiCTR2000029639,ChiCTR,2020-02-08,2020-02-10,False,The Fifth Affiliated Hospital of Sun Yat-Sen University,Recruiting,Not Applicable,Interventional,China,"Study for Mental health and psychological status of doctors, nurses and patients in novel coronavirus pneumonia (COVID-19) designated hospital and effect of interventions",Other (psych),No Intervention,192,Not Available,2020-09-30,http://www.chictr.org.cn/showproj.aspx?proj=49187,No Results,No Results,No Results,2020-02-17,2020-03-18,None
98,ChiCTR2000029603,ChiCTR,2020-02-06,2020-02-06,False,The First Affiliated Hospital of Zhejiang University School of Medicine,Recruiting,Not Applicable,Interventional,China,"A Randomized, Open-Label, Multi-Centre Clinical Trial Evaluating and Comparing the Safety and Efficiency of ASC09/Ritonavir and Lopinavir/Ritonavir for Confirmed Cases of Novel Coronavirus Pneumonia (COVID-19)",Drug,ASCO9 + Ritonavir vs. Lopinavir/ritonavir,160,Not Available,2020-05-31,http://www.chictr.org.cn/showproj.aspx?proj=49075,No Results,No Results,No Results,2020-02-17,2020-08-03,None
99,ChiCTR2000029781,ChiCTR,2020-02-13,2020-02-14,False,"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Phase 4,Interventional,China,"A multicenter, randomized, open and controlled trial for the efficacy and safety of Kang-Bing-Du granules in the treatment of novel coronavirus pneumonia (COVID-19)",Traditional Medicine (Drug),Traditional Medicine,160,Not Available,2020-06-30,http://www.chictr.org.cn/showproj.aspx?proj=49138,No Results,No Results,No Results,2020-02-25,2020-08-03,None
100,ChiCTR2000029558,ChiCTR,2020-02-04,2020-01-29,True,Hospital of Chengdu University of Traditional Chinese Medicine,Recruiting,Not Applicable,Interventional,China,Recommendations of Integrated Traditional Chinese and Western Medicine for Diagnosis and Treatment of Novel Coronavirus Pneumonia (COVID-19) in Sichuan Province,Traditional Medicine + Western Medicine,Traditional Medicine,200,Not Available,2020-05-01,http://www.chictr.org.cn/showproj.aspx?proj=48792,No Results,No Results,No Results,2020-02-17,2020-08-03,None
101,ChiCTR2000029628,ChiCTR,2020-02-07,2020-02-07,False,Guangdong Provincial Hospital of Chinese Medicine,Not Recruiting,Not Applicable,Observational,China,A clinical observational study for Xin-Guan-2 formula in the treatment of suspected novel coronavirus pneumonia (COVID-19),Traditional Medicine (Drug),Traditional Medicine,100,Not Available,2020-04-10,http://www.chictr.org.cn/showproj.aspx?proj=49155,No Results,No Results,No Results,2020-02-17,2020-08-03,None
102,ChiCTR2000029740,ChiCTR,2020-02-11,2020-02-11,False,The First Hospital of Peking University,Recruiting,Phase 4,Interventional,China,Efficacy of therapeutic effects of hydroxycholoroquine in novel coronavirus pneumonia (COVID-19) patients(randomized open-label control clinical trial),Drug,Hydroxychloroquine,78,Not Available,2020-02-29,http://www.chictr.org.cn/showproj.aspx?proj=49317,No Results,No Results,No Results,2020-02-25,2020-08-03,None
103,ChiCTR2000029548,ChiCTR,2020-02-04,2020-02-04,False,The First Affiliated Hospital of Zhejiang University School of Medicine,Not Recruiting,Not Applicable,Interventional,China,"Randomized, open-label, controlled trial for evaluating of the efficacy and safety of Baloxavir Marboxil, Favipiravir, and Lopinavir-Ritonavir in the treatment of novel coronavirus pneumonia (COVID-19) patients",Drug,Baloxavir + Marboxil vs. Favipiravir vs. Lopinavir/ritonavir,30,Not Available,2020-06-03,http://www.chictr.org.cn/showproj.aspx?proj=49015,No Results,No Results,No Results,2020-02-17,2020-08-03,None
104,ChiCTR2000029625,ChiCTR,2020-02-07,2020-02-17,False,The First Affiliated Hospital of Zhejiang University School of Medicine,Not Recruiting,Not Applicable,Diagnostic test,China,Construction of Early Warning and Prediction System for Patients with Severe / Critical Novel Coronavirus Pneumonia (COVID-19),Prognosis,No Intervention,80,Not Available,2020-08-01,http://www.chictr.org.cn/showproj.aspx?proj=49177,No Results,No Results,No Results,2020-02-17,2020-08-03,None
105,ChiCTR2000029461,ChiCTR,2020-02-02,2020-02-03,False,"Xinhua Affiliated Hospital, Hubei University of Chinese Medicine; Hubei Provincial Hospital of Integrated Chinese and Western Medicine",Not Recruiting,Not Applicable,Interventional,China,A Randomized Controlled Trial for Integrated Traditional Chinese Medicine and Western Medicine in the Treatment of Common Type Novel Coronavirus Pneumonia (COVID-19),Traditional Medicine + Western Medicine,Traditional Medicine,100,Not Available,2021-12-31,http://www.chictr.org.cn/showproj.aspx?proj=48927,No Results,No Results,No Results,2020-02-17,2020-08-03,None
106,ChiCTR2000029602,ChiCTR,2020-02-06,2020-02-01,True,Hubei Hospital of Traditional Chinese Medicine,Recruiting,Not Applicable,Interventional,China,Clinical study for community based prevention and control strategy of novel coronavirus pneumonia (COVID-19) in the isolate suspected and confirmed population,Clinical Presentation (Epidemiology),No Intervention,600,Not Available,2020-08-01,http://www.chictr.org.cn/showproj.aspx?proj=48985,No Results,No Results,No Results,2020-02-17,2020-08-03,None
107,ChiCTR2000029460,ChiCTR,2020-02-02,2020-02-02,False,"Xinhua Affiliated Hospital, Hubei University of Chinese Medicine; Hubei Provincial Hospital of Integrated Chinese and Western Medicine",Not Recruiting,Not Applicable,Interventional,China,The effect of shadowboxing for pulmonary function and quality of life in patients with novel coronavirus pneumonia (COVID-19) in rehabilitation period,Other (exercise),Exercise,100,Not Available,2021-12-31,http://www.chictr.org.cn/showproj.aspx?proj=48930,No Results,No Results,No Results,2020-02-17,2020-08-03,None
108,ChiCTR2000029600,ChiCTR,2020-02-06,2020-01-30,True,The Third People's Hospital of Shenzhen,Recruiting,Not Applicable,Interventional,China,Clinical study for safety and efficacy of Favipiravir in the treatment of novel coronavirus pneumonia (COVID-19),Drug,Favipiravir + interferon alpha vs. interferon alpha + lopinavir/ritonavir + interferon alpha vs. interferon alpha,90,Not Available,2020-04-29,http://www.chictr.org.cn/showproj.aspx?proj=49042,Journal Article,2020-03-18,https://doi.org/10.1016/j.eng.2020.03.007,2020-02-17,2020-08-03,None
109,ChiCTR2000029459,ChiCTR,2020-02-02,2020-02-03,False,"Xinhua Affiliated Hospital, Hubei University of Chinese Medicine; Hubei Provincial Hospital of Integrated Chinese and Western Medicine",Not Recruiting,Not Applicable,Interventional,China,The effect of pulmonary rehabilitation for pulmonary function and quality of life in patients with novel coronavirus pneumonia (COVID-19) in rehabilitation period,Other (physio),Physio,100,Not Available,2021-12-31,http://www.chictr.org.cn/showproj.aspx?proj=48929,No Results,No Results,No Results,2020-02-17,2020-08-03,None
110,NCT04270383,ClinicalTrials.gov,2020-02-11,2020-02-15,False,Beijing Children's Hospital,Not Recruiting,Not Applicable,Observational,China,Clinical Characteristics and Long-term Prognosis of 2019-nCoV Infection in Children,Clinical Presentation,No Intervention,500,2020-12-31,2020-12-31,https://clinicaltrials.gov/show/NCT04270383,No Results,No Results,No Results,2020-03-02,2020-08-03,None
111,NCT04275947,ClinicalTrials.gov,2020-02-17,2020-02-14,True,Chinese Alliance Against Lung Cancer,Recruiting,Not Applicable,Observational,China,The COVID-19 Mobile Health Study (CMHS),Diagnostics,Diagnostic Test or Assessment,450,2020-04-30,2020-05-31,https://clinicaltrials.gov/show/NCT04275947,No Results,No Results,No Results,2020-03-02,2020-08-03,None
112,ChiCTR2000029572,ChiCTR,2020-02-05,2020-02-05,False,Xiangyang First People's Hospital,Recruiting,Not Applicable,Interventional,China,Safety and efficacy of umbilical cord blood mononuclear cells in the treatment of severe and critically novel coronavirus pneumonia(COVID-19): a randomized controlled clinical trial,ATMP,Cells (mononuclear),30,Not Available,2021-04-30,http://www.chictr.org.cn/showproj.aspx?proj=41760,No Results,No Results,No Results,2020-02-17,2020-08-03,None
113,ChiCTR2000029432,ChiCTR,2020-02-01,2020-02-01,False,The First Affiliated Hospital of Guangzhou University of Traditional Chinese Medicine,Not Recruiting,Phase 4,Interventional,China,A Real World Study for the Efficacy and Safety of Large Dose Tanreqing Injection in the Treatment of Patients with Novel Coronavirus Pneumonia (COVID-19),Traditional Medicine (Drug),Traditional Medicine,72,Not Available,2020-04-30,http://www.chictr.org.cn/showproj.aspx?proj=48881,No Results,No Results,No Results,2020-02-17,2020-08-03,None
114,ChiCTR2000029439,ChiCTR,2020-02-01,2020-02-02,False,Beijing Hospital of Traditional Chinese Medicine; Hubei Provincial Hospital of Integrated Chinese and Western Medicine,Not Recruiting,Not Applicable,Interventional,China,Combination of traditional Chinese medicine and western medicine in the treatment of common type novel coronavirus pneumonia (COVID-19),Traditional Medicine + Western Medicine,Traditional Medicine,120,Not Available,2021-12-31,http://www.chictr.org.cn/showproj.aspx?proj=48904,No Results,No Results,No Results,2020-02-17,2020-08-03,None
115,ChiCTR2000029559,ChiCTR,2020-02-04,2020-01-31,True,Renmin Hospital of Wuhan University,Recruiting,Phase 4,Interventional,China,Therapeutic effect of hydroxychloroquine on novel coronavirus pneumonia (COVID-19),Drug,Hydroxychloroquine,300,Not Available,2020-02-29,http://www.chictr.org.cn/showproj.aspx?proj=48880,Pre-Print Article,2020-03-31,https://doi.org/10.1101/2020.03.22.20040758,2020-02-17,2020-08-03,None
116,ChiCTR2000030420,ChiCTR,2020-03-01,2020-03-01,False,"Institute of Integrative Medicine of Dalian Medical University, Dalian, China",Not Recruiting,Not Applicable,Interventional,China,A Clinical Trial Study for the Influence of TCM Psychotherapy on Negative Emotion of Patients with Novel Coronavirus Pneumonia (COVID-19) Based on Network Platform,Other (psych),Psychological,60,Not Available,2020-08-31,http://www.chictr.org.cn/showproj.aspx?proj=50286,No Results,No Results,No Results,2020-03-02,2020-08-03,None
117,ChiCTR2000029381,ChiCTR,2020-01-27,2020-01-24,True,The First Affiliated Hospital of Guangzhou Medical University,Not Recruiting,Phase 4,Interventional,China,A prospective comparative study for Xue-Bi-Jing injection in the treatment of novel coronavirus pneumonia (COVID-19),Traditional Medicine (Drug),Traditional Medicine,400,Not Available,2020-12-31,http://www.chictr.org.cn/showproj.aspx?proj=48768,No Results,No Results,No Results,2020-02-17,2020-08-03,None
118,ChiCTR2000029544,ChiCTR,2020-02-03,2020-02-04,False,The First Affiliated Hospital of Zhejiang University School of Medicine,Not Recruiting,Not Applicable,Interventional,China,"A randomized controlled trial for the efficacy and safety of Baloxavir Marboxil, Favipiravir tablets in novel coronavirus pneumonia (COVID-19) patients who are still positive on virus detection under the current antiviral therapy",Drug,Baloxavir + Marboxil vs. Favipiravir,30,Not Available,2020-05-31,http://www.chictr.org.cn/showproj.aspx?proj=49013,Pre-Print Article,2020-05-05,https://doi.org/10.1101/2020.04.29.20085761,2020-02-17,2020-08-03,None
119,ChiCTR2000030390,ChiCTR,2020-03-01,2020-01-01,True,Key Laboratory of Ministry of Industry and Information Technology of Biomedical Engineering and Translational Medicine,Recruiting,Not Applicable,Diagnostic test,China,Research and Development of Diagnostic Assistance Decision Support System for novel coronavirus pneumonia (COVID-19) Based on Big Data Technology,Diagnostics,Diagnostic Test or Assessment,3000,Not Available,2020-06-01,http://www.chictr.org.cn/showproj.aspx?proj=50224,Pre-Print Article,2020-05-15,https://doi.org/10.1101/2020.05.11.20093732,2020-03-02,2020-08-03,None
120,ChiCTR2000029541,ChiCTR,2020-02-03,2020-02-10,False,Zhongnan Hospital of Wuhan University,Not Recruiting,Not Applicable,Interventional,China,"A randomised, open, controlled trial for darunavir/cobicistat or Lopinavir/ritonavir combined with thymosin a1 in the treatment of novel coronavirus pneumonia (COVID-19)",Drug,Darunavir + Cobicistat vs. Lopinavir/ritonavir,100,Not Available,2020-12-01,http://www.chictr.org.cn/showproj.aspx?proj=48992,No Results,No Results,No Results,2020-02-17,2020-08-03,None
121,ChiCTR2000029487,ChiCTR,2020-02-02,2020-02-10,False,Wuhan Hospital of Integrated Traditional Chinese and Western Medicine,Not Recruiting,Not Applicable,Prevention,China,Clinical Study for Gu-Biao Jie-Du-Ling in Preventing of Novel Coronavirus Pneumonia (COVID-19) in Children,Traditional Medicine (Drug),Traditional Medicine,200,Not Available,2020-03-31,http://www.chictr.org.cn/showproj.aspx?proj=48965,No Results,No Results,No Results,2020-02-17,2020-08-03,None
122,ChiCTR2000030363,ChiCTR,2020-02-29,2020-02-23,True,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Not Applicable,Observational,China,"Novel Coronavirus Infected Disease (COVID-19) in children: epidemiology, clinical features and treatment outcome",Clinical Presentation (Epidemiology),No Intervention,120,Not Available,2020-06-30,http://www.chictr.org.cn/showproj.aspx?proj=49984,No Results,No Results,No Results,2020-03-02,2020-08-03,None
123,ChiCTR2000029431,ChiCTR,2020-02-01,2020-01-29,True,Affiliated Zhongshan Hospital of Dalian University,Recruiting,Not Applicable,Interventional,China,Clinical study for the remedy of M1 macrophages target in the treatment of novel coronavirus pneumonia (COVID-19),Traditional Medicine (Drug),Traditional Medicine,45,Not Available,2021-12-31,http://www.chictr.org.cn/showproj.aspx?proj=48907,Pre-Print Article,2020-04-14,https://doi.org/10.1101/2020.04.07.20054767,2020-02-17,2020-08-03,None
124,NCT04269525,ClinicalTrials.gov,2020-02-07,2020-02-06,True,ZhiYong Peng,Recruiting,Phase 2,Interventional,China,Umbilical Cord(UC)-Derived Mesenchymal Stem Cells(MSCs) Treatment for the 2019-novel Coronavirus(nCOV) Pneumonia,ATMP,Cells (mesenchymal),10,2020-04-30,2020-09-30,https://clinicaltrials.gov/show/NCT04269525,No Results,No Results,No Results,2020-02-24,2020-08-03,None
125,ChiCTR2000030188,ChiCTR,2020-02-24,2020-02-15,True,Guangdong Provincial Hospital of Chinese Medicine - Zhuhai Hospital,Recruiting,Not Applicable,Interventional,China,Clinical Study on Syndrome Differentiation of TCM in Treating Severe and Critical novel coronavirus pneumonia (COVID-19),Traditional Medicine (Unspecified),Traditional Medicine,120,Not Available,2020-03-30,http://www.chictr.org.cn/showproj.aspx?proj=50025,No Results,No Results,No Results,2020-02-25,2020-08-03,None
126,ChiCTR2000030322,ChiCTR,2020-02-28,2020-02-01,True,Xinyang Central Hospital,Recruiting,Not Applicable,Observational,China,Identification and Clinical Treatment of Severe novel coronavirus pneumonia (COVID-19) Patients,Clinical Presentation,No Intervention,210,Not Available,2020-12-31,http://www.chictr.org.cn/showproj.aspx?proj=50240,No Results,No Results,No Results,2020-03-02,2020-08-03,None
127,ChiCTR2000029468,ChiCTR,2020-02-02,2020-02-01,True,"Institute of Emergency Medicine and Disaster Medicine Sichuan People's Hospital, Sichuan Academy of Medical Sciences",Not Recruiting,Not Applicable,Interventional,China,A real-world  study for lopinavir/ritonavir (LPV/r) and emtritabine (FTC) / Tenofovir alafenamide Fumarate tablets (TAF) regimen in the treatment of novel coronavirus pneumonia (COVID-19),Drug,Lopinavir/ritonavir + emtricitabine + tenofovir vs. lopinavir/ritonavir,120,Not Available,2020-06-30,http://www.chictr.org.cn/showproj.aspx?proj=48919,No Results,No Results,No Results,2020-02-17,2020-08-03,None
128,ChiCTR2000030170,ChiCTR,2020-02-24,2020-02-15,True,Shanghai Public Health Clinical Center,Recruiting,Not Applicable,Interventional,China,Study for safety and efficacy of Jakotinib hydrochloride tablets in the treatment severe and acute exacerbation patients of novel coronavirus pneumonia (COVID-19),Drug,Jakotinib,16,Not Available,2020-07-31,http://www.chictr.org.cn/showproj.aspx?proj=50017,No Results,No Results,No Results,2020-02-25,2020-08-03,None
129,ChiCTR2000030314,ChiCTR,2020-02-28,2020-02-28,False,"Xiangyang Central Hospital, Affiliated Hospital of Hubei University of Arts and Sciences",Not Recruiting,Not Applicable,Interventional,No Country Given,Traditional Chinese medicine Ma-Xing-Shi-Gan-Tang and Sheng-Jiang-San in the treatment of children with novel coronavirus pneumonia (COVID-19),Traditional Medicine (Drug),Traditional Medicine,40,Not Available,2020-04-28,http://www.chictr.org.cn/showproj.aspx?proj=50248,No Results,No Results,No Results,2020-03-02,2020-03-18,None
130,ChiCTR2000029437,ChiCTR,2020-02-01,2020-02-03,False,Hubei Provincial Hospital of Integrated Chinese and Western Medicine,Not Recruiting,Not Applicable,Observational,China,A single arm study for combination of traditional Chinese and Western Medicine in the treatment of novel coronavirus pneumonia (COVID-19),Traditional Medicine + Western Medicine,Traditional Medicine,300,Not Available,2021-12-01,http://www.chictr.org.cn/showproj.aspx?proj=48913,No Results,No Results,No Results,2020-02-17,2020-08-03,None
131,ChiCTR2000030305,ChiCTR,2020-02-28,2020-03-09,False,Li Caixia,Not Recruiting,Not Applicable,Observational,China,Multiomics study and emergency plan optimization of spleen strengthening clearing damp and stomach therapy combined with antiviral therapy for novel coronavirus pneumonia (COVID-19),Genomics,No Intervention,20,Not Available,2020-12-31,http://www.chictr.org.cn/showproj.aspx?proj=50223,No Results,No Results,No Results,2020-03-02,2020-08-03,None
132,ChiCTR2000030138,ChiCTR,2020-02-24,2020-02-24,False,Chinese PLA General Hospital,Not Recruiting,Phase 2,Interventional,China,Clinical Trial for Human Mesenchymal Stem Cells in the Treatment of Severe Novel Coronavirus Pneumonia (COVID-19),ATMP,Cells (mesenchymal),60,Not Available,2020-05-31,http://www.chictr.org.cn/showproj.aspx?proj=50004,No Results,No Results,No Results,2020-02-25,2020-08-03,None
133,ChiCTR2000030260,ChiCTR,2020-02-26,2020-02-27,False,"Ganzi Hospital of West China Hospital, Sichuan University",Not Recruiting,Not Applicable,Interventional,China,Clinical study for individualized nutritional assessment and supportive treatment of novel coronavirus pneumonia (COVID-19) patients in Tibetan Plateau,Other (nutrition),Nutrition,20,Not Available,2021-02-26,http://www.chictr.org.cn/showproj.aspx?proj=50130,No Results,No Results,No Results,2020-03-02,2020-08-03,None
134,ChiCTR2000030255,ChiCTR,2020-02-26,2020-03-01,False,Shanghai University of Traditional Chinese Medicine,Not Recruiting,Phase 4,Interventional,China,Efficacy and Safety of Jing-Yin Granule in the treatment of novel coronavirus pneumonia (COVID-19) wind-heat syndrome,Traditional Medicine (Drug),Traditional Medicine,300,Not Available,2020-07-31,http://www.chictr.org.cn/showproj.aspx?proj=50089,No Results,No Results,No Results,2020-03-02,2020-08-03,None
135,ChiCTR2000029435,ChiCTR,2020-02-01,2020-02-01,False,Wuhan First Hospital,Not Recruiting,Not Applicable,Interventional,China,Randomized controlled trial for traditional Chinese medicine in the prevention of novel coronavirus pneumonia (COVID-19) in high risk population,Traditional Medicine (Unspecified),Traditional Medicine,120,Not Available,2020-03-31,http://www.chictr.org.cn/showproj.aspx?proj=48827,No Results,No Results,No Results,2020-02-17,2020-08-03,None
136,ChiCTR2000030137,ChiCTR,2020-02-24,2020-02-24,False,The Second Affiliated Hospital of Xi'an Jiaotong University,Not Recruiting,Not Applicable,Observational,China,Humanistic Care in Healthcare Workers in Novel Coronavirus Pneumonia (COVID-19),Other,Humanistic Care,130,Not Available,2020-05-15,http://www.chictr.org.cn/showproj.aspx?proj=50007,No Results,No Results,No Results,2020-02-25,2020-08-03,None
137,ChiCTR2000030253,ChiCTR,2020-02-26,2020-02-27,False,"Ganzi Hospital of West China Hospital, Sichuan University",Not Recruiting,Phase 1,Diagnostic test,China,Exploration and Research for a new method for detection of novel coronavirus (COVID-19) nucleic acid,Diagnostics,Diagnostic Test or Assessment,30,Not Available,2021-02-26,http://www.chictr.org.cn/showproj.aspx?proj=50143,No Results,No Results,No Results,2020-03-02,2020-08-03,None
138,ChiCTR2000029430,ChiCTR,2020-02-01,2020-02-03,False,Hubei Provincial Hospital of Integrated Chinese and Western Medicine,Not Recruiting,Not Applicable,Observational,China,Study for the TCM syndrome characteristics of novel coronavirus pneumonia (COVID-19),Traditional Medicine (Unspecified),Traditional Medicine,600,Not Available,2020-12-01,http://www.chictr.org.cn/showproj.aspx?proj=48902,No Results,No Results,No Results,2020-02-17,2020-08-03,None
139,ChiCTR2000030136,ChiCTR,2020-02-24,2020-02-24,False,The Second Affiliated Hospital of Xi'an Jiaotong University,Not Recruiting,Not Applicable,Interventional,China,Humanistic Care in Patients With Novel Coronavirus Pneumonia (COVID-19),Other,Humanistic Care,130,Not Available,2020-05-15,http://www.chictr.org.cn/showproj.aspx?proj=50005,No Results,No Results,No Results,2020-02-25,2020-03-18,None
140,ChiCTR2000030219,ChiCTR,2020-02-25,2020-01-21,True,The First Teaching Hospital of Tianjin University of Traditional Chinese Medicine,Recruiting,Not Applicable,Interventional,China,Study for evaluation of integrated traditional Chinese and Western Medicine in the treatment of Novel Coronavirus Pneumonia (COVID-19),Traditional Medicine + Western Medicine,Traditional Medicine,120,Not Available,2020-12-31,http://www.chictr.org.cn/showproj.aspx?proj=50110,No Results,No Results,No Results,2020-03-02,2020-08-03,None
141,ChiCTR2000029400,ChiCTR,2020-01-29,2020-01-29,False,China Academy of Chinese Medical Sciences,Recruiting,Not Applicable,Interventional,China,Clinical Controlled Trial for Traditional Chinese Medicine in the treatment of Novel Coronavirus Pneumonia (COVID-19),Traditional Medicine (Unspecified),Traditional Medicine,60,Not Available,2020-12-31,http://www.chictr.org.cn/showproj.aspx?proj=48824,No Results,No Results,No Results,2020-02-17,2020-08-03,None
142,ChiCTR2000030185,ChiCTR,2020-02-24,2020-02-24,False,West China Hospital of Sichuan University,Recruiting,Not Applicable,Diagnostic test,China,"The Value of Critical Care Ultrasound in Rapid Screening, Diagnosis, Evaluation of Effectiveness and Intensive Prevention of Novel Coronavirus Pneumonia (COVID-19)",Diagnostics,Diagnostic Test or Assessment,40,Not Available,2020-12-31,http://www.chictr.org.cn/showproj.aspx?proj=50058,No Results,No Results,No Results,2020-02-25,2020-08-03,None
143,ChiCTR2000030102,ChiCTR,2020-02-23,2020-02-24,False,Tianjin Huanhu Hospital,Recruiting,Not Applicable,Interventional,China,A multicenter randomized controlled trial for ozone autohemotherapy in the treatment of novel coronavirus pneumonia (COVID-19),Drug,Ozone,180,Not Available,2020-05-31,http://www.chictr.org.cn/showproj.aspx?proj=49747,No Results,No Results,No Results,2020-02-25,2020-08-03,None
144,ChiCTR2000030091,ChiCTR,2020-02-23,2020-02-22,True,West China Hospital of Sichuan University,Not Recruiting,Not Applicable,Interventional,China,A prospective randomized controlled trial for the home exercise prescription intervention in nursing students during epidemic of novel coronary pneumonia (COVID-19),Other (exercise),Exercise,200,Not Available,2020-03-22,http://www.chictr.org.cn/showproj.aspx?proj=49914,No Results,No Results,No Results,2020-03-02,2020-08-03,None
145,ChiCTR2000030167,ChiCTR,2020-02-24,2020-03-02,False,Renmin Hospital of Wuhan University,Not Recruiting,Not Applicable,Interventional,China,Clinical Trial for Recombinant Human Interleukin-2 in the Treatment of Novel Coronavirus Pneumonia (COVID-19),Drug,Interleukin-2,80,Not Available,2020-09-01,http://www.chictr.org.cn/showproj.aspx?proj=49567,No Results,No Results,No Results,2020-02-25,2020-08-03,None
146,ChiCTR2000030089,ChiCTR,2020-02-22,2020-02-28,False,Shanghai Changzheng Hospital,Not Recruiting,Phase 4,Interventional,China,A clinical study for the efficacy and safety of Adalimumab Injection in the treatment of patients with severe novel coronavirus pneumonia (COVID-19),Drug,Adalimumab,60,Not Available,2020-08-31,http://www.chictr.org.cn/showproj.aspx?proj=49889,No Results,No Results,No Results,2020-02-25,2020-08-03,None
147,ChiCTR2000030165,ChiCTR,2020-02-24,2020-02-24,False,Tianjin University,Recruiting,Not Applicable,Interventional,China,Clinical study for ozonated autohemotherapy in the treatment of Novel Coronavirus Pneumonia (COVID-19),Drug,Ozone,60,Not Available,2020-12-31,http://www.chictr.org.cn/showproj.aspx?proj=49947,No Results,No Results,No Results,2020-02-25,2020-08-03,None
148,ChiCTR2000030088,ChiCTR,2020-02-22,2020-03-01,False,The Sixth Medical Center of PLA General Hospital,Not Recruiting,Not Applicable,Interventional,China,Umbilical cord Wharton's Jelly derived mesenchymal stem cells in the treatment of severe novel coronavirus pneumonia (COVID-19),ATMP,Cells (mesenchymal),40,Not Available,2021-12-31,http://www.chictr.org.cn/showproj.aspx?proj=49902,No Results,No Results,No Results,2020-02-25,2020-08-03,None
149,ChiCTR2000029975,ChiCTR,2020-02-18,2020-02-24,False,The First Hospital of Jilin University,Not Recruiting,Phase 4,Interventional,China,Single arm study for exploration of chloroquine phosphate aerosol inhalation in the treatment of novel coronavirus pneumonia (COVID-19),Drug,Chloroquine,10,Not Available,2020-05-31,http://www.chictr.org.cn/showproj.aspx?proj=49592,No Results,No Results,No Results,2020-03-02,2020-08-03,None
150,ChiCTR2000030117,ChiCTR,2020-02-23,2020-02-15,True,Shanghai Public Health Clinical Center,Recruiting,Phase 4,Interventional,China,"A multicenter, randomized, open, parallel controlled trial for the evaluation of the effectiveness and safety of Xiyanping injection in the treatment of common type novel coronavirus pneumonia (COVID-19)",Traditional Medicine (Drug),Traditional Medicine,348,Not Available,2021-12-14,http://www.chictr.org.cn/showproj.aspx?proj=49762,No Results,No Results,No Results,2020-02-25,2020-08-03,None
151,ChiCTR2000030087,ChiCTR,2020-02-22,2020-02-12,True,"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Not Applicable,Observational,China,Clinical study for the diagnostic value of pulmonary ultrasound for novel coronavirus pneumonia (COVID-19),Diagnostics,Diagnostic Test or Assessment,800,Not Available,2023-02-12,http://www.chictr.org.cn/showproj.aspx?proj=49919,No Results,No Results,No Results,2020-02-25,2020-08-03,None
152,ChiCTR2000030115,ChiCTR,2020-02-23,2020-02-27,False,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Not Recruiting,Not Applicable,Observational,China,A clinical research for the changes of Blood cortisol ACTH level and adrenal morphology in blood cortisol to guide the application of individualized hormone in severe novel coronavirus pneumonia (COVID-19) patients,Clinical Presentation,No Intervention,50,Not Available,2020-04-30,http://www.chictr.org.cn/showproj.aspx?proj=49964,No Results,No Results,No Results,2020-02-25,2020-08-03,None
153,ChiCTR2000030086,ChiCTR,2020-02-22,2020-02-24,False,"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Not Applicable,Observational,China,Study for the effects on medical providers' infection rate and mental health after performing different anesthesia schemes in cesarean section for novel coronavirus pneumonia (COVID-19) puerperae,Clinical Presentation,No Intervention,210,Not Available,Not Available,http://www.chictr.org.cn/showproj.aspx?proj=49934,No Results,No Results,No Results,2020-02-25,2020-08-03,None
154,ChiCTR2000030092,ChiCTR,2020-02-23,2020-02-12,True,"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Not Applicable,Observational,China,Assessment of cardiac function in patients with Novel Coronavirus Pneumonia (COVID-19) by echocardiography and its new techniques,Clinical Presentation,No Intervention,800,Not Available,2022-02-12,http://www.chictr.org.cn/showproj.aspx?proj=49880,No Results,No Results,No Results,2020-02-25,2020-08-03,None
155,ChiCTR2000030054,ChiCTR,2020-02-22,2020-02-22,False,Zhongshan Hospital Affiliated to Xiamen University,Not Recruiting,Not Applicable,Interventional,China,"A prospective, open label, randomized, control trial for chloroquine or hydroxychloroquine in patients with mild and common novel coronavirus pulmonary (COVIP-19)",Drug,Chloroquine + Hydroxychloroquine,100,Not Available,2020-05-21,http://www.chictr.org.cn/showproj.aspx?proj=49869,No Results,No Results,No Results,2020-02-25,2020-08-03,None
156,NCT04286503,ClinicalTrials.gov,2020-02-25,2020-02-23,True,"Beijing You'an Hospital, Capital Medical University",Not Recruiting,Phase 4,Interventional,No Country Given,The Clinical Study of Carrimycin on Treatment Patients With COVID-19,Drug,Carrimycin vs. lopinavir/ritonavir or Umifenovir or chloroquine,520,2021-02-28,2021-02-28,https://clinicaltrials.gov/show/NCT04286503,No Results,No Results,No Results,2020-03-09,2020-08-03,None
157,ChiCTR2000030581,ChiCTR,2020-03-08,2020-02-02,True,West China Hospital of Sichuan University,Recruiting,Not Applicable,Observational,China,The immediate psychological impact of novel coronavirus pneumonia (COVID-19) outbreak on medical students in anesthesiology and how the cope,Other (psych),No Intervention,192,Not Available,2021-03-02,http://www.chictr.org.cn/showproj.aspx?proj=50394,No Results,No Results,No Results,2020-03-09,2020-08-03,None
158,ChiCTR2000030090,ChiCTR,2020-02-22,2020-02-22,False,West China Hospital of Sichuan University,Not Recruiting,Not Applicable,Interventional,China,A Prospective Randomized Controlled Trial for Home Exercise Prescription Intervention During Epidemic of Novel Coronary Pneumonia (COVID-19) in College Students,Other (exercise),Exercise,400,Not Available,2020-03-22,http://www.chictr.org.cn/showproj.aspx?proj=49910,No Results,No Results,No Results,2020-02-25,2020-08-03,None
159,ChiCTR2000030039,ChiCTR,2020-02-21,2020-05-31,False,Affiliated Hospital of Xuzhou Medical University,Recruiting,Not Applicable,Interventional,China,Clinical study for infusing convalescent plasma to treat patients with new coronavirus pneumonia (COVID-19),ATMP,Plasma,90,Not Available,2020-02-01,http://www.chictr.org.cn/showproj.aspx?proj=49544,No Results,No Results,No Results,2020-02-25,2020-08-03,None
160,ChiCTR2000030574,ChiCTR,2020-03-07,2020-03-08,False,"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Not Applicable,Observational,China,Research on peripheral immunity function monitoring and its clinical application in patients with novel coronavirus pneumonia (COVID-19),Clinical Presentation,No Intervention,500,Not Available,2021-03-08,http://www.chictr.org.cn/showproj.aspx?proj=49953,No Results,No Results,No Results,2020-03-09,2020-08-03,None
161,ChiCTR2000030058,ChiCTR,2020-02-22,2020-03-10,False,Renmin Hospital of Wuhan University,Not Recruiting,Phase 3,Interventional,China,"A multicenter, randomized, double-blind, controlled clinical trial for leflunomide in the treatment of novel coronavirus pneumonia (COVID-19)",Drug,Leflunomide,200,Not Available,2020-05-30,http://www.chictr.org.cn/showproj.aspx?proj=49831,No Results,No Results,No Results,2020-02-25,2020-08-03,None
162,NCT04259892,ClinicalTrials.gov,2020-02-05,2020-02-04,True,INSERM,Recruiting,Not Applicable,Observational,France,Viral Excretion in Contact Subjects at High/Moderate Risk of Coronavirus 2019-nCoV Infection,Clinical Presentation,No Intervention,300,2020-10-04,2021-02-04,https://clinicaltrials.gov/show/NCT04259892,No Results,No Results,No Results,2020-02-24,2020-08-03,None
163,NCT04268537,ClinicalTrials.gov,2020-02-08,2020-02-10,False,"Southeast University, China",Not Recruiting,Phase 2,Interventional,No Country Given,Immunoregulatory Therapy for 2019-nCoV,Drug,PD1 vs. thymosin,120,2020-04-30,2020-10-31,https://clinicaltrials.gov/show/NCT04268537,No Results,No Results,No Results,2020-02-24,2020-08-03,None
164,ChiCTR2000030556,ChiCTR,2020-03-07,2020-03-15,False,Anhui Cancer Hospital,Not Recruiting,Not Applicable,Diagnostic test,China,Clinical study of nano-nose and its extended technology in diagnosis of novel coronavirus pneumonia (COVID-19),Diagnostics,Diagnostic Test or Assessment,200,Not Available,2020-06-01,http://www.chictr.org.cn/showproj.aspx?proj=50672,No Results,No Results,No Results,2020-03-09,2020-08-03,None
165,ChiCTR2000030056,ChiCTR,2020-02-22,2020-02-23,False,"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology",Not Recruiting,Not Applicable,Observational,China,Study for the effect of early endotracheal intubation on the outcome of novel coronavirus pneumonia (COVID-19) patients,Other (physical),Endotracheal Intubation,100,Not Available,Not Available,http://www.chictr.org.cn/showproj.aspx?proj=49904,No Results,No Results,No Results,2020-02-25,2020-08-03,None
166,ChiCTR2000030021,ChiCTR,2020-02-20,2020-02-20,False,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Not Applicable,Observational,China,A medical records based analysis for the clinical characteristics of novel coronavirus pneumonia (COVID-19) in immunocompromised patients,Clinical Presentation,No Intervention,10,Not Available,2020-02-29,http://www.chictr.org.cn/showproj.aspx?proj=49690,No Results,No Results,No Results,2020-02-25,2020-08-03,None
167,ChiCTR2000030542,ChiCTR,2020-03-06,2020-03-09,False,West China Hospital of Sichuan University,Recruiting,Not Applicable,Observational,China,"A clinical study about the diagnosis and prognosis evaluation of novel coronacirus pneumonia (COVID-19) based on viral genome, host genomic sequencing, relative cytokines and other laboratory indexes.",Genomics,No Intervention,600,Not Available,2020-07-30,http://www.chictr.org.cn/showproj.aspx?proj=50608,Pre-Print Article,2020-03-21,https://doi.org/10.1101/2020.03.18.20035816,2020-03-09,2020-08-03,None
168,ChiCTR2000030033,ChiCTR,2020-02-21,2020-02-24,False,The First Affiliated Hospital of Guangzhou Medical University,Not Recruiting,Not Applicable,Interventional,China,A study for the intervention of Xiangxue antiviral oral solution and Wu-Zhi-Fang-Guan-Fang on close contacts of novel coronavirus pneumonia (COVID-19),Traditional Medicine (Drug),Traditional Medicine,828,Not Available,2020-06-30,http://www.chictr.org.cn/showproj.aspx?proj=49703,No Results,No Results,No Results,2020-02-25,2020-08-03,None
169,ChiCTR2000030020,ChiCTR,2020-02-20,2020-02-06,True,"Second Hospital of University of South China, Hengyang",Recruiting,Not Applicable,Interventional,China,The clinical application and basic research related to mesenchymal stem cells to treat novel coronavirus pneumonia (COVID-19),ATMP,Cells (mesenchymal),20,Not Available,2022-02-05,http://www.chictr.org.cn/showproj.aspx?proj=49812,No Results,No Results,No Results,2020-02-25,2020-08-03,None
170,ChiCTR2000030017,ChiCTR,2020-02-20,2020-02-17,True,Renmin Hospital of Wuhan University,Recruiting,Not Applicable,Observational,China,Feature of Multiple Organs in Ultrasound Investigation for Clinical Management and Prognostic Evaluation of Novel Coronavirus Pneumonia (COVID-19),Prognosis,No Intervention,200,Not Available,2020-12-31,http://www.chictr.org.cn/showproj.aspx?proj=49798,No Results,No Results,No Results,2020-02-25,2020-08-03,None
171,ChiCTR2000030540,ChiCTR,2020-03-06,2020-03-08,False,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Not Recruiting,Not Applicable,Interventional,China,Research for the mechanism of improvement of novel coronavirus pneumonia (COVID-19) patients' pulmonary exudation by continuous renal replacement therapy,Other (renal),Renal replacement therapy,152,Not Available,2020-06-08,http://www.chictr.org.cn/showproj.aspx?proj=50658,No Results,No Results,No Results,2020-03-09,2020-08-03,None
172,ChiCTR2000030015,ChiCTR,2020-02-20,2020-02-19,True,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Not Applicable,Basic Science,China,Study for the correlation between the incidence and outcome of novel coronary pneumonia (COVID-2019) and ovarian function in women,Clinical Presentation,No Intervention,300,Not Available,2020-08-19,http://www.chictr.org.cn/showproj.aspx?proj=49800,Pre-Print Article,2020-03-30,https://doi.org/10.1101/2020.03.26.20043943,2020-02-25,2020-08-03,None
173,ChiCTR2000030019,ChiCTR,2020-02-20,2020-02-28,False,"Zhongshan Hospital, Fudan University",Not Recruiting,Not Applicable,Observational,China,"The COVID-19 Mobile Health Study (CMHS), a large-scale clinical observational registration study using nCapp",Clinical Presentation,No Intervention,600,Not Available,2021-05-31,http://www.chictr.org.cn/showproj.aspx?proj=49768,No Results,No Results,No Results,2020-02-25,2020-08-03,None
174,ChiCTR2000030492,ChiCTR,2020-03-04,2020-03-04,False,The First Affiliated Hospital of Hu'nan University of Traditional Chinese Medicine,Not Recruiting,Not Applicable,Observational,China,Retrospective study for integrate Chinese and conventional medicine  treatment of novel coronavirus pneumonia (COVID-19) in Hu'nan province,Traditional Medicine + Western Medicine,Traditional Medicine,200,Not Available,2020-06-30,http://www.chictr.org.cn/showproj.aspx?proj=50549,No Results,No Results,No Results,2020-03-09,2020-08-03,None
175,ChiCTR2000030008,ChiCTR,2020-02-19,2020-02-12,True,The Fifth Affiliated Hospital of Sun Yat-Sen University,Recruiting,Not Applicable,Observational,China,Correalation between anxiety as well as depression and gut microbiome among staff of hospital during the novel coronavirus pneumonia (COVID-19) outbreak,Other (psych),No Intervention,100,Not Available,2021-02-12,http://www.chictr.org.cn/showproj.aspx?proj=49426,No Results,No Results,No Results,2020-02-25,2020-08-03,None
176,ChiCTR2000030004,ChiCTR,2020-02-19,2020-02-20,False,West China Hospital of Sichuan University,Not Recruiting,Not Applicable,Observational,China,Effect of Novel Coronavirus Pneumonia (COVID-19) on the Mental Health of College Students,Other (psych),No Intervention,150000,Not Available,2023-01-31,http://www.chictr.org.cn/showproj.aspx?proj=49783,No Results,No Results,No Results,2020-02-25,2020-03-18,None
177,ChiCTR2000030490,ChiCTR,2020-03-04,2020-02-01,True,Huo-Shen-Shan Hospital,Recruiting,Not Applicable,Interventional,No Country Given,To evaluate the efficacy and safety of diammonium glycyrrhizinate enteric-coated capsules combined with hydrogen-rich water in the treatment of novel coronavirus pneumonia (COVID-19),Drug,Diammonium glycyrrhizinate + Hydrogen,100,Not Available,2020-03-31,http://www.chictr.org.cn/showproj.aspx?proj=50487,No Results,No Results,No Results,2020-03-09,2020-08-03,None
178,ChiCTR2000030006,ChiCTR,2020-02-19,2020-02-19,False,"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Not Applicable,Interventional,China,A randomized controlled trial for the efficacy of ozonated autohemotherapy in the treatment of Novel Coronavirus Pneumonia (COVID-19),Drug,Ozone,60,Not Available,2020-05-19,http://www.chictr.org.cn/showproj.aspx?proj=49737,No Results,No Results,No Results,2020-02-25,2020-08-03,None
179,ChiCTR2000030003,ChiCTR,2020-02-19,2020-02-19,False,Hospital of Chengdu University of Traditional Chinese Medicine,Not Recruiting,Not Applicable,Interventional,China,Optimization Protocal of Integrated Traditional Chinese and Western Medicine in the Treatment for Novel Coronavirus Pneumonia (COVID-19),Traditional Medicine + Western Medicine,Traditional Medicine,480,Not Available,2020-07-01,http://www.chictr.org.cn/showproj.aspx?proj=49770,No Results,No Results,No Results,2020-02-25,2020-08-03,None
180,ChiCTR2000030481,ChiCTR,2020-03-03,2020-03-01,True,Zhongnan Hospital of Wuhan University,Recruiting,Phase 4,Interventional,China,The clinical value of corticosteroid therapy timing in the treatment of novel coronavirus pneumonia (COVID-19): a prospective randomized controlled trial,Drug,Corticosteroids,200,Not Available,2020-04-30,http://www.chictr.org.cn/showproj.aspx?proj=50453,No Results,No Results,No Results,2020-03-09,2020-08-03,None
181,ChiCTR2000030001,ChiCTR,2020-02-19,2020-02-15,True,Health commission of Heilongjiang province,Recruiting,Phase 3,Interventional,China,"The efficacy and safety of Triazavirin for 2019 novel coronary pneumonia (COVID-19): a multicenter, randomized, double blinded, placebo-controlled trial",Drug,Triazavirin,240,Not Available,2020-05-28,http://www.chictr.org.cn/showproj.aspx?proj=49723,No Results,No Results,No Results,2020-02-25,2020-08-03,None
182,ChiCTR2000030467,ChiCTR,2020-03-02,2020-03-01,True,"Dalian Medical University, Dalian, China.",Not Recruiting,Not Applicable,Interventional,China,A Randomized  Controlled Trial  for the Influence of TCM Psychotherapy on Negative Emotion of Patients with Novel Coronavirus Pneumonia (COVID-19) Based on Network Platform,Traditional Medicine + Western Medicine,Traditional Medicine,60,Not Available,2020-08-31,http://www.chictr.org.cn/showproj.aspx?proj=50378,No Results,No Results,No Results,2020-03-09,2020-08-03,None
183,ChiCTR2000030002,ChiCTR,2020-02-19,2020-02-15,True,The First Affiliated Hospital of University of Science and Technology of China (Anhui Provincial Hospital),Recruiting,Phase 4,Interventional,China,Clinical study of novel NLRP Inflammasome inhibitor (Tranilast) in the treatment of novel coronavirus pneumonia (COVID-19),Drug,Tranilast,60,Not Available,2020-07-30,http://www.chictr.org.cn/showproj.aspx?proj=49738,No Results,No Results,No Results,2020-02-25,2020-08-03,None
184,ChiCTR2000029999,ChiCTR,2020-02-19,2020-02-20,False,Shanghai 10th People's Hospital,Not Recruiting,Not Applicable,Interventional,China,A clinical study for probiotics in the regulation of intestinal function and microflora structure of novel coronavirus pneumonia (COVID-19),Supplement,Probiotics,60,Not Available,Not Available,http://www.chictr.org.cn/showproj.aspx?proj=49717,No Results,No Results,No Results,2020-02-25,2020-03-18,None
185,ChiCTR2000029992,ChiCTR,2020-02-18,2020-02-17,True,Zhongshan Hospital Affiliated to Xiamen University,Not Recruiting,Phase 4,Interventional,China,"A prospective, randomized, open label, controlled trial for chloroquine and hydroxychloroquine in patients with severe novel coronavirus pneumonia (COVID-19)",Drug,Chloroquine + Hydroxychloroquine,100,Not Available,2020-05-20,http://www.chictr.org.cn/showproj.aspx?proj=49574,No Results,No Results,No Results,2020-02-25,2020-08-03,None
186,ChiCTR2000029989,ChiCTR,2020-02-18,2020-02-20,False,Chinese PLA General Hospital,Not Recruiting,Phase 4,Interventional,China,A randomized controlled Trial for therapeutic efficacy of Recombinant Human Interferon alpha 1b Eye Drops in the treatment of elderly with novel coronavirus pneumonia (COVID-19),Drug,Interferon alfa,300,Not Available,2020-05-31,http://www.chictr.org.cn/showproj.aspx?proj=49720,No Results,No Results,No Results,2020-02-25,2020-08-03,None
187,ChiCTR2000029580,ChiCTR,2020-02-05,2020-01-31,True,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Not Applicable,Interventional,China,"Severe novel coronavirus pneumonia (COVID-19) patients treated with ruxolitinib in combination with mesenchymal stem cells: a prospective, single blind, randomized controlled clinical trial",Drug (+ ATMP),Ruxolimab + Cells (mesenchymal),70,Not Available,2020-12-31,http://www.chictr.org.cn/showproj.aspx?proj=49088,No Results,No Results,No Results,2020-03-09,2020-08-03,None
188,ChiCTR2000029990,ChiCTR,2020-02-18,2020-01-30,True,"Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences",Recruiting,Phase 1/Phase 2,Interventional,China,Clinical trials of mesenchymal stem cells for the treatment of pneumonitis caused by novel coronavirus pneumonia (COVID-19),ATMP,Cells (mesenchymal),120,Not Available,2020-03-31,http://www.chictr.org.cn/showproj.aspx?proj=49674,Journal Article,2020-03-13,https://doi.org/10.14336/AD.2020.0228,2020-02-25,2020-03-18,None
189,ChiCTR2000029988,ChiCTR,2020-02-18,2020-02-13,True,Zhongnan Hospital of Wuhan University,Recruiting,Phase 4,Interventional,China,Clinical Study of Chloroquine Phosphate in the Treatment of Severe Novel Coronavirus Pneumonia (COVID-19),Drug,Chloroquine,80,Not Available,2020-05-31,http://www.chictr.org.cn/showproj.aspx?proj=49218,No Results,No Results,No Results,2020-02-25,2020-08-03,None
190,ChiCTR2000030179,ChiCTR,2020-02-24,2020-02-24,False,The First Affiliated Hospital of Nanchang University,Recruiting,Not Applicable,Interventional,China,Experimental study of novel coronavirus pneumonia rehabilitation plasma therapy severe novel coronavirus pneumonia (COVID-19),ATMP,Plasma,100,Not Available,2020-04-24,http://www.chictr.org.cn/showproj.aspx?proj=50059,No Results,No Results,No Results,2020-02-25,2020-08-03,None
191,ChiCTR2000029981,ChiCTR,2020-02-18,2020-02-18,False,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Not Applicable,Diagnostic test,China,Study for nucleic acid detection of novel coronavirus pneumonia (COVID-2019) in female vaginal secretions,Diagnostics,Diagnostic Test or Assessment,60,Not Available,2020-05-18,http://www.chictr.org.cn/showproj.aspx?proj=49692,Pre-Print Article,2020-03-03,https://doi.org/10.1101/2020.02.26.20028225,2020-02-25,2020-08-03,None
192,NCT04292327,ClinicalTrials.gov,2020-02-23,2020-01-01,True,Fujian Provincial Hospital,Not Recruiting,Not Applicable,Observational,China,Clinical Progressive Characteristics and Treatment Effects of 2019-novel Coronavirus,Clinical Presentation,No Intervention,400,2020-04-30,2020-07-31,https://clinicaltrials.gov/show/NCT04292327,No Results,No Results,No Results,2020-03-16,2020-03-18,None
193,NCT04295551,ClinicalTrials.gov,2020-03-03,2020-03-14,False,Jiangxi Qingfeng Pharmaceutical Co. Ltd.,Not Recruiting,Not Applicable,Interventional,No Country Given,Multicenter Clinical Study on the Efficacy and Safety of Xiyanping Injection in the Treatment of New Coronavirus Infection Pneumonia (General and Severe),Traditional Medicine (Drug),Traditional Medicine,80,2020-07-14,2021-04-14,https://clinicaltrials.gov/show/NCT04295551,No Results,No Results,No Results,2020-03-16,2020-08-03,None
194,ChiCTR2000029985,ChiCTR,2020-02-18,2020-02-10,True,Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital,Recruiting,Not Applicable,Observational,China,Study for mental health status and influencing factors of nurses during epidemic prevention of novel coronavirus pneumonia (COVID-19),Other (psych),No Intervention,1853,Not Available,2020-02-29,http://www.chictr.org.cn/showproj.aspx?proj=49711,No Results,No Results,No Results,2020-02-25,2020-03-18,None
195,ChiCTR2000029974,ChiCTR,2020-02-18,2020-02-09,True,"Qingdao East Sea Pharmaceutical Co., Ltd.",Recruiting,Not Applicable,Interventional,China,"A prospective, multicenter, open-label, randomized, parallel-controlled trial for probiotics to evaluate efficacy and safety in patients infected with 2019 novel coronavirus pneumonia (COVID-19)",Supplement,Probiotics,300,Not Available,2020-08-31,http://www.chictr.org.cn/showproj.aspx?proj=49321,No Results,No Results,No Results,2020-02-25,2020-08-03,None
196,ChiCTR2000029972,ChiCTR,2020-02-17,2020-02-17,False,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Not Applicable,Interventional,China,A randomized controlled trial for the Efficacy of Ultra Short Wave Electrotherapy in the treatment of Novel Coronavirus Pneumonia (COVID-19),Other (physical),Ultra short wave electrotherapy,40,Not Available,2020-05-17,http://www.chictr.org.cn/showproj.aspx?proj=49664,No Results,No Results,No Results,2020-02-25,2020-08-03,None
197,ChiCTR2000029803,ChiCTR,2020-02-14,2020-02-20,False,Renmin Hospital of Wuhan University,Not Recruiting,Not Applicable,Interventional,China,"A prospective, randomized, open-label, controlled clinical study to evaluate the preventive effect of hydroxychloroquine on close contacts after exposure to the Novel Coronavirus Pneumonia (COVID-19)",Drug,Hydroxychloroquine vs. Umeprevir,320,Not Available,2021-02-20,http://www.chictr.org.cn/showproj.aspx?proj=49428,No Results,No Results,No Results,2020-02-25,2020-08-03,None
198,ChiCTR2000029954,ChiCTR,2020-02-17,2020-04-30,False,Hubei Hospital of Traditional Chinese Medicine,Recruiting,Phase 4,Interventional,China,"Efficacy and safety of honeysuckle oral liquid in the treatment of novel coronavirus pneumonia (COVID-19): a multicenter, randomized, controlled, open clinical trial",Traditional Medicine (Drug),Traditional Medicine,300,Not Available,2020-02-10,http://www.chictr.org.cn/showproj.aspx?proj=49402,No Results,No Results,No Results,2020-02-25,2020-08-03,None
199,ChiCTR2000029780,ChiCTR,2020-02-13,2020-02-14,False,"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Phase 4,Interventional,China,"A multicenter, randomized, open, controlled trial for the efficacy and safety of Shen-Qi Fu-Zheng injection in the treatment of novel coronavirus pneumonia (COVID-19)",Traditional Medicine (Drug),Traditional Medicine,160,Not Available,2020-06-09,http://www.chictr.org.cn/showproj.aspx?proj=49220,No Results,No Results,No Results,2020-02-25,2020-08-03,None
200,ChiCTR2000030164,ChiCTR,2020-02-24,2020-02-24,False,Wuhan Jinyintan Hospital (Wuhan Infectious Diseases Hospital),Not Recruiting,Not Applicable,Observational,China,A cross-sectional study of novel coronavirus pneumonia (COVID-19) patients in ICU,Clinical Presentation,No Intervention,10,Not Available,2020-03-24,http://www.chictr.org.cn/showproj.aspx?proj=49983,No Results,No Results,No Results,2020-02-25,2020-08-03,None
201,NCT04296643,ClinicalTrials.gov,2020-03-03,2020-04-01,False,McMaster University,Not Recruiting,Not Applicable,Interventional,No Country Given,Medical Masks vs N95 Respirators for COVID-19,Other (device),Masks,576,2020-12-01,2021-01-01,https://clinicaltrials.gov/show/NCT04296643,No Results,No Results,No Results,2020-03-16,2020-03-18,None
202,NCT04299711,ClinicalTrials.gov,2020-03-04,2020-10-15,False,University of Macau,Not Recruiting,Not Applicable,Observational,No Country Given,Mental Health and Its Correlates Among Chinese Adolescents Exposed to the Novel Coronavirus Disease 2019,Other (psych),No Intervention,3428,2020-11-15,2022-03-15,https://clinicaltrials.gov/show/NCT04299711,No Results,No Results,No Results,2020-03-16,2020-03-18,None
203,NCT04279899,ClinicalTrials.gov,2020-02-18,2020-02-01,True,Children's Hospital of Fudan University,Recruiting,Not Applicable,Observational,China,The Investigation of the Neonates With or With Risk of COVID-19,Clinical Presentation,No Intervention,100,2020-11-30,2020-12-31,https://clinicaltrials.gov/show/NCT04279899,No Results,No Results,No Results,2020-03-02,2020-03-18,None
204,ChiCTR2000030433,ChiCTR,2020-03-01,2020-03-01,False,The First Affiliated Hospital of Fujian Medical University,Not Recruiting,Phase 1,Interventional,China,Application of Rehabilitation and Lung Eight-segment Exercise in Home Rehabilitation of Survivors from novel coronavirus pneumonia (COVID-19),Other (physio),Physio,80,Not Available,2020-10-01,http://www.chictr.org.cn/showproj.aspx?proj=50273,No Results,No Results,No Results,2020-03-02,2020-08-03,None
205,ChiCTR2000030418,ChiCTR,2020-03-01,2020-03-01,False,The First Affiliated Hospital of Fujian Medical University,Recruiting,Not Applicable,Interventional,China,Application of rehabilitation lung exercise eight-segment exercise in patients with novel coronavirus pneumonia (COVID-19),Other (physio),Physio,80,Not Available,2021-03-01,http://www.chictr.org.cn/showproj.aspx?proj=50341,No Results,No Results,No Results,2020-03-02,2020-08-03,None
206,ChiCTR2000030897,ChiCTR,2020-03-16,2020-02-10,True,"Hwa Mei Hospital, University of Chinese Academy of Sciences",Recruiting,Not Applicable,Interventional,China,Evaluation of the effect of taking Newgen beta-gluten probiotic composite powder to nutrition intervention of patients with novel coronavirus pneumonia (COVID-19),Supplement,Probiotics,20,Not Available,2021-05-01,http://www.chictr.org.cn/showproj.aspx?proj=50462,No Results,No Results,No Results,2020-03-16,2020-03-18,None
207,ChiCTR2000030113,ChiCTR,2020-02-23,2020-02-22,True,The Third People's Hospital of Shenzhen,Recruiting,Not Applicable,Interventional,No Country Given,Randomized controlled trial for safety and efficacy of Favipiravir in the treatment of novel coronavirus pneumonia (COVID-19) with poorly responsive ritonavir/ritonavir,Drug,Favipiravir vs. ritonavir,30,Not Available,2020-05-31,http://www.chictr.org.cn/showproj.aspx?proj=49988,No Results,No Results,No Results,2020-02-25,2020-08-03,None
208,ChiCTR2000030892,ChiCTR,2020-03-16,2020-03-06,True,The First Affiliated Hospital of Guangzhou Medical University,Recruiting,Not Applicable,Interventional,China,Efficacy and Safety of Pirfenidone in the Treatment of Severe Post-Novel Coronavirus Pneumonia (COVID-19) Fibrosis: a prospective exploratory experimental medical study,Drug,Pirfenidone,40,Not Available,2020-12-30,http://www.chictr.org.cn/showproj.aspx?proj=51118,No Results,No Results,No Results,2020-03-16,2020-03-18,None
209,ChiCTR2000030386,ChiCTR,2020-02-18,2020-03-01,False,Hunan University of Chinese Medicine,Not Recruiting,Not Applicable,Interventional,China,Study for moxibustion in the preventing of novel coronavirus pneumonia (COVID-19),Traditional Medicine (Other),Traditional Medicine,1000,Not Available,2020-12-31,http://www.chictr.org.cn/showproj.aspx?proj=50323,No Results,No Results,No Results,2020-03-02,2020-03-18,None
210,ChiCTR2000030883,ChiCTR,2020-03-16,2020-02-18,True,"Affiliated Hospital of Traditional Chinese Medicine, Southwest Medical University",Recruiting,Not Applicable,Observational,China,Clinical research and preparation development of qingfei detoxification decoction (mixture) for prevention and treatment of novel coronavirus pneumonia (COVID-19),Traditional Medicine (Drug),Traditional Medicine,100,Not Available,2020-12-31,http://www.chictr.org.cn/showproj.aspx?proj=50960,No Results,No Results,No Results,2020-03-16,2020-03-18,None
211,ChiCTR2000030382,ChiCTR,2020-02-17,2020-03-01,False,Hubei Hospital of Traditional Chinese Medicine,Recruiting,Not Applicable,Observational,China,Construction and application of non-contact doctor-patient interactive diagnosis and treatment mode of moxibustion therapy for novel coronary pneumonia (COVID-19) based on mobile internet,Traditional Medicine (Other),Traditional Medicine,50,Not Available,2020-05-31,http://www.chictr.org.cn/showproj.aspx?proj=50325,No Results,No Results,No Results,2020-03-02,2020-03-18,None
212,ChiCTR2000030865,ChiCTR,2020-03-16,2020-02-01,True,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Not Applicable,Observational,China,Establishment of an early warning model for maternal and child vertical transmission of COVID-19 infection,Clinical Presentation,No Intervention,200,Not Available,2020-04-30,http://www.chictr.org.cn/showproj.aspx?proj=49933,No Results,No Results,No Results,2020-03-16,2020-03-18,None
213,NCT04275245,ClinicalTrials.gov,2020-02-06,2020-02-03,True,Tang-Du Hospital,Recruiting,Phase 1/Phase 2,Interventional,China,Clinical Study of Anti-CD147 Humanized Meplazumab for Injection to Treat With 2019-nCoV Pneumonia,Drug,Mepolizumab,20,2020-12-31,2020-12-31,https://clinicaltrials.gov/show/NCT04275245,Pre-Print Article,2020-03-24,https://doi.org/10.1101/2020.03.21.20040691,2020-03-02,2020-08-03,None
214,NCT04275388,ClinicalTrials.gov,2020-02-17,2020-02-14,True,Jiangxi Qingfeng Pharmaceutical Co. Ltd.,Not Recruiting,Not Applicable,Interventional,No Country Given,Xiyanping Injection for the Treatment of New Coronavirus Infected Pneumonia,Traditional Medicine (Drug),Traditional Medicine,348,2020-05-14,2021-12-14,https://clinicaltrials.gov/show/NCT04275388,No Results,No Results,No Results,2020-03-02,2020-03-18,None
215,ChiCTR2000030334,ChiCTR,2020-02-28,2020-02-19,True,Nanjing Second Hospital,Recruiting,Not Applicable,Diagnostic test,China,microRNA as a marker for early diagnosis of novel coronavirus infection (COVID-19),Diagnostics,Diagnostic Test or Assessment,25,Not Available,2020-06-19,http://www.chictr.org.cn/showproj.aspx?proj=49491,No Results,No Results,No Results,2020-03-02,2020-08-03,None
216,ChiCTR2000030858,ChiCTR,2020-03-16,2020-02-06,True,Hubei Cancer Hospital,Recruiting,Not Applicable,Observational,China,"Clinical characteristics and outcomes of 483 mild patients with novel coronavirus pneumonia (COVID-19) in Wuhan, China during the outbreak: A single-center, retrospective study from the mobile cabin hospital",Clinical Presentation,No Intervention,483,Not Available,2020-03-15,http://www.chictr.org.cn/showproj.aspx?proj=51097,No Results,No Results,No Results,2020-03-16,2020-03-18,None
217,ChiCTR2000030096,ChiCTR,2020-02-23,2020-02-17,True,Peking University First Hospital,Not Recruiting,Not Applicable,Observational,China,Study for establishment of correlation between virological dynamics and clinical features in noveal coronavirus pneumonia (COVID-19),Clinical Presentation,No Intervention,120,Not Available,2020-08-31,http://www.chictr.org.cn/showproj.aspx?proj=49794,No Results,No Results,No Results,2020-02-25,2020-08-03,None
218,NCT04279197,ClinicalTrials.gov,2020-02-15,2020-02-15,False,ShuGuang Hospital,Recruiting,Phase 2,Interventional,China,Treatment of Pulmonary Fibrosis Due to 2019-nCoV Pneumonia With Fuzheng Huayu,Traditional Medicine (Drug),Traditional Medicine,136,2022-12-01,2022-12-01,https://clinicaltrials.gov/show/NCT04279197,No Results,No Results,No Results,2020-03-02,2020-08-03,None
219,NCT04280588,ClinicalTrials.gov,2020-02-20,2020-02-22,False,The First Affiliated Hospital of Fujian Medical University,Recruiting,Phase 2,Interventional,China,Fingolimod in COVID-19,Drug,Fingolimod,30,2020-07-01,2020-07-01,https://clinicaltrials.gov/show/NCT04280588,No Results,No Results,No Results,2020-03-02,2020-08-03,None
220,ChiCTR2000030856,ChiCTR,2020-03-16,2020-02-15,True,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Not Applicable,Diagnostic test,China,An artificial intelligence assistant system for suspected novel coronavirus pneumonia (COVID-19) based on chest CT,Diagnostics,Diagnostic Test or Assessment,600,Not Available,2020-05-15,http://www.chictr.org.cn/showproj.aspx?proj=51091,No Results,No Results,No Results,2020-03-16,2020-03-18,None
221,ChiCTR2000030333,ChiCTR,2020-02-28,2020-03-04,False,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Not Applicable,Interventional,China,"A randomized, open-label controlled trial for the efficacy and safety of Pirfenidone in patients with severe and critical novel coronavirus pneumonia (COVID-19)",Drug,Pirfenidone,292,Not Available,2020-07-07,http://www.chictr.org.cn/showproj.aspx?proj=48801,No Results,No Results,No Results,2020-03-02,2020-08-03,None
222,ChiCTR2000030432,ChiCTR,2020-03-01,2020-03-02,False,The First Affiliated Hospital of Fujian Medical University,Not Recruiting,Not Applicable,Interventional,China,Application of rehabilitation and Lung eight-segment exercise in front-line nurses in the prevention of novel coronavirus pneumonia (COVID-19) epidemic,Other (physio),Physio,80,Not Available,2020-08-27,http://www.chictr.org.cn/showproj.aspx?proj=50268,No Results,No Results,No Results,2020-03-02,2020-08-03,None
223,ChiCTR2000030094,ChiCTR,2020-02-23,2020-03-01,False,Chengdu University of Traditional Chinese Medicine,Not Recruiting,Not Applicable,Observational,China,"Effects of novel coronavirus pneumonia (COVID-19) on menstruation, TCM body construction and psychological state for female at different ages",Traditional Medicine (Unspecified),Traditional Medicine,200,Not Available,2021-02-28,http://www.chictr.org.cn/showproj.aspx?proj=49970,No Results,No Results,No Results,2020-02-25,2020-08-03,None
224,ChiCTR2000030849,ChiCTR,2020-03-15,2020-03-16,False,Zhengzhou People's Hospital,Not Recruiting,Not Applicable,Interventional,China,Investigation on psychological status of novel coronavirus pneumonia (COVID-19) rehabilitation patients in Zhengzhou City and research on coping strategies,Other (psych),No Intervention,81,Not Available,2021-03-01,http://www.chictr.org.cn/showproj.aspx?proj=51086,No Results,No Results,No Results,2020-03-16,2020-03-18,None
225,ChiCTR2000030317,ChiCTR,2020-02-28,2020-03-01,False,West China Hospital of Sichuan University,Not Recruiting,Not Applicable,Interventional,China,Clinical study for a new type of Gastroscope isolation mask for preventing and controlling the novel coronavirus pneumonia (COVID-19) Epidemic period,Other (physical),Gastroscope mask,300,Not Available,2021-03-30,http://www.chictr.org.cn/showproj.aspx?proj=50247,No Results,No Results,No Results,2020-03-02,2020-08-03,None
226,ChiCTR2000030398,ChiCTR,2020-03-01,2020-02-27,True,Wuhan Jinyintan Hospital (Wuhan Infectious Diseases Hospital),Not Recruiting,Not Applicable,Interventional,China,"A randomized, double-blind, placebo-controlled trial for evaluation of  the efficacy and safety of bismuth potassium citrate capsules in the treatment of patients with novel coronavirus pneumonia (COVID-19).",Drug,Bismuth potassium citrate,340,Not Available,Not Available,http://www.chictr.org.cn/showproj.aspx?proj=50173,No Results,No Results,No Results,2020-03-02,2020-08-03,None
227,ChiCTR2000030833,ChiCTR,2020-03-15,2020-03-22,False,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Not Recruiting,Not Applicable,Diagnostic test,China,Clinical validation and application of high-throughput novel coronavirus (2019-nCoV) screening detection kit,Diagnostics,Diagnostic Test or Assessment,400,Not Available,2020-03-31,http://www.chictr.org.cn/showproj.aspx?proj=51035,No Results,No Results,No Results,2020-03-16,2020-03-18,None
228,ChiCTR2000030315,ChiCTR,2020-02-28,2020-01-01,True,Affiliated Hospital of Changchun University of Traditional Chinese Medicine,Recruiting,Not Applicable,Observational,China,Clinical Study for Traditional Chinese Medicine in the Prevention and Treatment of Novel Coronavirus Pneumonia (COVID-19),Traditional Medicine (Unspecified),Traditional Medicine,120,Not Available,2020-12-31,http://www.chictr.org.cn/showproj.aspx?proj=50255,No Results,No Results,No Results,2020-03-02,2020-08-03,None
229,ChiCTR2000030389,ChiCTR,2020-03-01,2020-02-29,True,Hubei Hospital of Traditional Chinese Medicine,Recruiting,Not Applicable,Observational,China,A Comparative Study for the Effectiveness of ''triple energizer treatment'' Method in Repairing Lung Injury in Patients with Novel coronavirus pneumonia (COVID-19),Traditional Medicine (Other),Traditional Medicine,120,Not Available,2020-08-23,http://www.chictr.org.cn/showproj.aspx?proj=50278,No Results,No Results,No Results,2020-03-02,2020-08-03,None
230,ChiCTR2000030046,ChiCTR,2020-02-21,2020-02-07,True,"The First People's Hospital of Jiangxia District, Wuhan (Union Jiangnan Hospital)",Recruiting,Not Applicable,Interventional,China,A single arm trial to evaluate the efficacy and safety of anti-2019-nCoV inactivated convalescent plasma in the treatment of novel coronavirus pneumonia patient (COVID-19),ATMP,Plasma,10,Not Available,2020-04-07,http://www.chictr.org.cn/showproj.aspx?proj=49861,Journal Article,2020-04-06,https://doi.org/10.1073/pnas.2004168117,2020-02-25,2020-08-03,None
231,ChiCTR2000030831,ChiCTR,2020-03-15,2020-01-01,True,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Not Recruiting,Not Applicable,Observational,China,The analysis of related factors on improving oxygenation status by endotracheal intubation ventilation in severe patients suffered from novel coronavirus pneumonia (COVID-19): a single center and descriptive study in Wuhan,Prognosis,No Intervention,75,Not Available,2020-06-15,http://www.chictr.org.cn/showproj.aspx?proj=51036,No Results,No Results,No Results,2020-03-16,2020-03-18,None
232,ChiCTR2000030283,ChiCTR,2020-02-27,2020-02-27,False,Xianning Central Hospital,Recruiting,Not Applicable,Observational,China,Correlation between imaging characteristics and laboratory tests of new coronavirus pneumonia (COVID-19),Clinical Presentation,No Intervention,100,Not Available,2020-03-31,http://www.chictr.org.cn/showproj.aspx?proj=50119,No Results,No Results,No Results,2020-03-02,2020-08-03,None
233,ChiCTR2000030387,ChiCTR,2020-03-01,2020-03-01,False,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Not Applicable,Observational,China,Clinical observation and research of multiple organs injury in severe patients with novel coronavirus pneumonia (COVID-19),Clinical Presentation,No Intervention,130,Not Available,2020-12-31,http://www.chictr.org.cn/showproj.aspx?proj=50329,No Results,No Results,No Results,2020-03-02,2020-08-03,None
234,ChiCTR2000030030,ChiCTR,2020-02-20,2020-02-20,False,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Not Applicable,Observational,China,A medical records based study for acute kidney injury in novel coronavirus pneumonia (COVID-19),Clinical Presentation,No Intervention,2000,Not Available,2021-05-01,http://www.chictr.org.cn/showproj.aspx?proj=49841,No Results,No Results,No Results,2020-02-25,2020-08-03,None
235,ChiCTR2000030816,ChiCTR,2020-03-15,2020-02-24,True,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Not Recruiting,Not Applicable,Observational,China,Nutritional risk assessment and outcome prediction of critically ill novel coronavirus pneumonia (COVID-19) patients,Prognosis,No Intervention,200,Not Available,2021-02-23,http://www.chictr.org.cn/showproj.aspx?proj=51048,No Results,No Results,No Results,2020-03-16,2020-03-18,None
236,ChiCTR2000030263,ChiCTR,2020-02-26,2020-02-20,True,Beijing Geriatric Hospital,Not Recruiting,Not Applicable,Epidemiological research,China,Investigation and analysis of psychological status of hospital staff during the novel coronavirus pneumonia (COVID-19) epidemic,Other (psych),No Intervention,200,Not Available,2020-08-20,http://www.chictr.org.cn/showproj.aspx?proj=50140,No Results,No Results,No Results,2020-03-02,2020-03-18,None
237,ChiCTR2000030265,ChiCTR,2020-02-26,2020-02-24,True,The First Affiliated Hospital of Harbin Medical University,Not Recruiting,Not Applicable,Interventional,China,Study for continuous renal replacement therapy with adsorption filter in the treatment of the novel coronavirus pneumonia (COVID-19),Other (renal),Renal replacement therapy,30,Not Available,2021-02-23,http://www.chictr.org.cn/showproj.aspx?proj=49691,No Results,No Results,No Results,2020-03-02,2020-08-03,None
238,ChiCTR2000030814,ChiCTR,2020-03-15,2020-02-20,True,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Not Recruiting,Not Applicable,Observational,China,A medical records based analysis of clinical evidence of human-to-human transmission of 2019 novel coronavirus pneumonia (COVID-19) by conjunctival route,Clinical Presentation,No Intervention,100,Not Available,2020-04-30,http://www.chictr.org.cn/showproj.aspx?proj=51042,No Results,No Results,No Results,2020-03-16,2020-03-18,None
239,ChiCTR2000030029,ChiCTR,2020-02-21,2020-02-20,True,The First Affiliated Hospital of Zhejiang University School of Medicine,Not Recruiting,Not Applicable,Interventional,China,A multi-center study on the efficacy and safety of suramin sodium in adult patients with novel coronavirus pneumonia (COVID-19),Drug,Suramin,20,Not Available,2020-05-30,http://www.chictr.org.cn/showproj.aspx?proj=49824,No Results,No Results,No Results,2020-02-25,2020-08-03,None
240,ChiCTR2000030261,ChiCTR,2020-02-26,2020-03-01,False,Wuxi Fifth People's Hospital,Not Recruiting,Not Applicable,Interventional,China,A study for the key technology of mesenchymal stem cells exosomes atomization in the treatment of novel coronavirus pneumonia (COVID-19),ATMP,Cells (mesenchymal),26,Not Available,2020-05-31,http://www.chictr.org.cn/showproj.aspx?proj=49963,No Results,No Results,No Results,2020-03-02,2020-08-03,None
241,ChiCTR2000030264,ChiCTR,2020-02-26,2020-02-28,False,Zhongnan Hospital of Wuhan University,Not Recruiting,Not Applicable,Observational,China,ICU healthcare personnel burnout investigation during the fight against novel coronavirus pneumonia (COVID-19),Other (psych),No Intervention,1000,Not Available,2020-06-01,http://www.chictr.org.cn/showproj.aspx?proj=50161,No Results,No Results,No Results,2020-03-02,2020-08-03,None
242,ChiCTR2000030807,ChiCTR,2020-03-15,2020-02-15,True,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Not Applicable,Observational,China,Clinical characteristics and prognosis of cancer patients with novel coronavirus pneumonia (COVID-19),Prognosis,No Intervention,100,Not Available,2020-03-30,http://www.chictr.org.cn/showproj.aspx?proj=51019,No Results,No Results,No Results,2020-03-16,2020-03-18,None
243,ChiCTR2000030805,ChiCTR,2020-03-15,2020-02-15,True,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Not Recruiting,Not Applicable,Observational,No Country Given,Quantitative CT characteristic estimate the severity of novel coronavirus pneumonia (COVID-19),Diagnostics,Diagnostic Test or Assessment,200,Not Available,2020-06-30,http://www.chictr.org.cn/showproj.aspx?proj=51026,No Results,No Results,No Results,2020-03-16,2020-03-18,None
244,ChiCTR2000030215,ChiCTR,2020-02-25,2020-02-26,False,"The First Affiliated Hospital of Nanchang University, Ten layers pulse Research Institute of traditional Chinese medicine, Nanchang University",Not Recruiting,Not Applicable,Interventional,China,Study for the efficacy of Kangguan No. 1-3 prescription in the treatment of novel coronavirus pneumonia (COVID19),Traditional Medicine (Drug),Traditional Medicine,120,Not Available,2020-12-31,http://www.chictr.org.cn/showproj.aspx?proj=50107,No Results,No Results,No Results,2020-03-02,2020-08-03,None
245,ChiCTR2000030218,ChiCTR,2020-02-25,2020-01-22,True,The Fifth People's Hospital of Ganzhou,Recruiting,Not Applicable,Interventional,China,Study of Pinavir / Ritonavir Tablets (Trade Name: Kelizhi) Combined with Xiyanping Injection for Novel Coronavirus Pneumonia (COVID-19),Drug,Lopinavir/ritonavir (+ Tradtional Medicine),80,Not Available,2020-06-25,http://www.chictr.org.cn/showproj.aspx?proj=50115,No Results,No Results,No Results,2020-03-02,2020-08-03,None
246,ChiCTR2000030196,ChiCTR,2020-02-25,2020-02-20,True,Central South Hospital of Wuhan University,Not Recruiting,Phase 2,Interventional,China,"A multicenter, single arm, open label trial for the efficacy and safety of CMAB806 in the treatment of cytokine release syndrome of novel coronavirus pneumonia (COVID-19)",Drug,Tocilizumab,60,Not Available,2020-05-31,http://www.chictr.org.cn/showproj.aspx?proj=49883,No Results,No Results,No Results,2020-03-02,2020-08-03,None
247,ChiCTR2000030798,ChiCTR,2020-03-15,2020-02-10,True,Wuhan Third Hospital,Recruiting,Not Applicable,Observational,China,A medical records based study for clinical characteristics of novel coronavirus pneumonia (COVID-19),Clinical Presentation,No Intervention,100,Not Available,2020-05-01,http://www.chictr.org.cn/showproj.aspx?proj=50994,No Results,No Results,No Results,2020-03-16,2020-03-18,None
248,ChiCTR2000030022,ChiCTR,2020-02-20,2020-02-22,False,The First Affiliated Hospital of Anhui Medical University,Not Recruiting,Phase 4,Interventional,China,"A parallel, randomized controlled clinical trial for the efficacy and safety of Pediatric Huatanzhike granules (containing ipecacuanha tincture) in the treatment of mild and moderate novel coronavirus pneumonia (COVID-19)",Traditional Medicine (Drug),Traditional Medicine,100,Not Available,2020-05-22,http://www.chictr.org.cn/showproj.aspx?proj=49797,No Results,No Results,No Results,2020-03-02,2020-08-03,None
249,ChiCTR2000030796,ChiCTR,2020-03-15,2020-01-29,True,The Second Hospital of Hebei Medical University,Recruiting,Not Applicable,Observational,No Country Given,Clinical characteristics and treatment of novel coronavirus pneumonia (COVID-19),Clinical Presentation,No Intervention,500,Not Available,2022-01-31,http://www.chictr.org.cn/showproj.aspx?proj=50991,No Results,No Results,No Results,2020-03-16,2020-03-18,None
250,ChiCTR2000029900,ChiCTR,2020-02-16,2020-02-17,False,Renmin Hospital of Wuhan University,Not Recruiting,Not Applicable,Observational,China,Research for Risks Associated with Novel Coronavirus Pneumonia (COVID-19) in the Hospital Workers and Nosocomial  Prevention and Control Strategy,Clinical Presentation,No Intervention,200,Not Available,2020-02-29,http://www.chictr.org.cn/showproj.aspx?proj=49377,No Results,No Results,No Results,2020-03-02,2020-08-03,None
251,ChiCTR2000030782,ChiCTR,2020-03-14,2020-02-01,True,Cangzhou People's Hospital,Recruiting,Not Applicable,Observational,No Country Given,"The value of CD4 / CD8 cells, CRP / ALB and APCHEII in novel coronavirus pneumonia (COVID-19)",Prognosis,No Intervention,20,Not Available,2020-03-31,http://www.chictr.org.cn/showproj.aspx?proj=50976,No Results,No Results,No Results,2020-03-16,2020-03-18,None
252,ChiCTR2000030013,ChiCTR,2020-02-19,2020-02-20,False,Chinese PLA General Hospital,Not Recruiting,Phase 4,Interventional,China,A prospective clinical study for recombinant human interferon alpha 1b spray in the prevention of novel coronavirus (COVID-19) infection in highly exposed medical staffs.,Drug,Interferon alfa,450,Not Available,2020-06-30,http://www.chictr.org.cn/showproj.aspx?proj=49796,No Results,No Results,No Results,2020-03-02,2020-08-03,None
253,ChiCTR2000030773,ChiCTR,2020-03-14,2020-02-12,True,Huashan Hospital; Fudan Universtiy,Recruiting,Not Applicable,Interventional,China,Application of blood purification in the treatment of novel coronavirus pneumonia (COVID-19),Other (physical),Blood purification,20,Not Available,2020-07-12,http://www.chictr.org.cn/showproj.aspx?proj=50934,No Results,No Results,No Results,2020-03-16,2020-03-18,None
254,ChiCTR2000029991,ChiCTR,2020-02-18,2020-02-18,False,The First Affiliated Hospital of Nanchang University,Recruiting,Phase 4,Interventional,China,"A randomized, open-label, controlled trial for the safety and efficiency of Kesuting syrup and Keqing capsule in the treatment of mild and moderate novel coronavirus pneumonia (COVID-19)",Traditional Medicine (Drug),Traditional Medicine,72,Not Available,2020-07-18,http://www.chictr.org.cn/showproj.aspx?proj=49666,No Results,No Results,No Results,2020-03-02,2020-08-03,None
255,ChiCTR2000030764,ChiCTR,2020-03-13,2020-03-07,True,"Xiyuan Hospital, Chinese Academy of Traditional Chinese Medicine",Recruiting,Not Applicable,Observational,China,"Research for the influence of epidemic of novel coronavirus pneumonia (COVID-19) on sleep, psychological and chronic diseases among different populations",Clinical Presentation,No Intervention,2800,Not Available,2020-12-01,http://www.chictr.org.cn/showproj.aspx?proj=50852,No Results,No Results,No Results,2020-03-16,2020-03-18,None
256,ChiCTR2000029755,ChiCTR,2020-02-12,2020-02-15,False,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Phase 4,Interventional,China,"A randomized, open, parallel-controlled clinical trial on the efficacy and safety of Jingyebaidu granules in treating novel coronavirus pneumonia (COVID-19)",Traditional Medicine (Drug),Traditional Medicine,120,Not Available,2020-05-30,http://www.chictr.org.cn/showproj.aspx?proj=49301,No Results,No Results,No Results,2020-03-02,2020-08-03,None
257,ChiCTR2000030762,ChiCTR,2020-03-13,2019-12-01,True,The Second Affiliated Hospital of Guizhou University of traditional Chinese Medicine,Not Recruiting,Not Applicable,Epidemiological research,China,Diagnosis and treatment of novel coronavirus pneumonia (COVID-19) in common and severe cases based on the theory of ''Shi-Du-Yi (damp and plague)'',Traditional Medicine (Other),Traditional Medicine,100,Not Available,2021-12-31,http://www.chictr.org.cn/showproj.aspx?proj=50950,No Results,No Results,No Results,2020-03-16,2020-03-18,None
258,ChiCTR2000029386,ChiCTR,2020-01-29,2020-01-29,False,Chongqing Public Health Medical Center,Recruiting,Not Applicable,Interventional,China,Effectiveness of glucocorticoid therapy in patients with severe novel coronavirus pneumonia: a randomized controlled trial,Drug,Corticosteroids,48,Not Available,2021-01-29,http://www.chictr.org.cn/showproj.aspx?proj=48777,No Results,No Results,No Results,2020-03-02,2020-08-03,None
259,ChiCTR2000029728,ChiCTR,2020-02-10,2020-02-15,False,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Not Recruiting,Not Applicable,Observational,China,A Retrospective Study for Preventive Medication in Tongji Hospital During the Epidemic of Novel Coronavirus Pneumonia (COVID-19),Traditional Medicine (Unspecified),Traditional Medicine,500,Not Available,2020-05-30,http://www.chictr.org.cn/showproj.aspx?proj=49250,No Results,No Results,No Results,2020-03-02,2020-08-03,None
260,ChiCTR2000030760,ChiCTR,2020-03-13,2020-03-13,False,Zhejiang Hospital,Not Recruiting,Not Applicable,Observational,China,"A medical records based study for clinical characteristics of 2019 novel coronavirus pneumonia (COVID-19) in Zhejiang province, China",Clinical Presentation,No Intervention,74,Not Available,2020-03-02,http://www.chictr.org.cn/showproj.aspx?proj=50955,No Results,No Results,No Results,2020-03-16,2020-03-18,None
261,ChiCTR2000029387,ChiCTR,2020-01-29,2020-01-25,True,Chongqing Public Health Medical Center,Recruiting,Not Applicable,Interventional,China,"Comparative effectiveness and safety of ribavirin plus interferon-alpha, lopinavir/ritonavir plus interferon-alpha and ribavirin plus lopinavir/ritonavir plus interferon-alphain in patients with mild to moderate novel coronavirus pneumonia",Drug,"Ribavirin + Interferon alfa
vs. lopinavir/ritonavir + interferon alfa
vs. ribavirin + interferon alfa vs. lopinavir/ritonavir",108,Not Available,2021-01-25,http://www.chictr.org.cn/showproj.aspx?proj=48782,No Results,No Results,No Results,2020-03-02,2020-08-03,None
262,ChiCTR2000030755,ChiCTR,2020-03-13,2020-03-15,False,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Not Recruiting,Not Applicable,Observational,China,"A medical records based study for characteristics, prognosis of ederly patients with Novel Coronavirus Pneumonia (COVID-19) in Wuhan area",Prognosis,No Intervention,400,Not Available,2020-09-15,http://www.chictr.org.cn/showproj.aspx?proj=50945,No Results,No Results,No Results,2020-03-16,2020-03-18,None
263,ChiCTR2000030753,ChiCTR,2020-03-13,2020-02-01,True,Shandong Provincial Chest hospital,No Status Given,Not Applicable,Observational,China,A medical records based analysis of the Incidence and Risk Factors of Ventilator-associated Pneumonia in ARDS Patients with Novel Coronavirus Pneumonia (COVID-19),Clinical Presentation,No Intervention,100,Not Available,2020-08-31,http://www.chictr.org.cn/showproj.aspx?proj=50901,No Results,No Results,No Results,2020-03-16,2020-03-18,None
264,ChiCTR2000030027,ChiCTR,2020-02-20,2020-02-20,False,Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine,Recruiting,Not Applicable,Interventional,China,Traditional Chinese medicine cooperative therapy for patients with Novel coronavirus pneumonia (COVID-19) and its effect on spermatogenesis: a randomized controlled trial,Traditional Medicine (Unspecified),Traditional Medicine,60,Not Available,2021-02-18,http://www.chictr.org.cn/showproj.aspx?proj=49852,No Results,No Results,No Results,2020-02-25,2020-08-03,None
265,ChiCTR2000030744,ChiCTR,2020-03-13,2020-02-01,True,Shandong Provincial Chest hospital,Recruiting,Not Applicable,Interventional,China,Clinical Application of ECMO(or Ultra-Protective Lung Mechanical Ventilation) in the Treatment of Patients with ARDS due to novel Coronavirus Pneumonia (COVID-19),Drug,Oxygen,30,Not Available,2020-06-30,http://www.chictr.org.cn/showproj.aspx?proj=50910,No Results,No Results,No Results,2020-03-16,2020-03-18,None
266,ChiCTR2000030012,ChiCTR,2020-02-19,2020-02-19,False,"The First People's Hospital of Chenzhou, Institute of Translational Medicine,University of South China",Not Recruiting,Not Applicable,Interventional,China,Development of anti-2019-nCoV therapeutic antibody from the recovered novel coronavirus pneumonia patients (COVID-19),ATMP,Antibody,20,Not Available,Not Available,http://www.chictr.org.cn/showproj.aspx?proj=49718,No Results,No Results,No Results,2020-02-25,2020-08-03,None
267,ChiCTR2000030739,ChiCTR,2020-03-13,2020-02-01,True,Shandong Provincial Chest hospital,Recruiting,Not Applicable,Observational,China,Exploration of the Clinical Characteristics of Patients with Novel Coronavirus Pneumonia (COVID-19) and Its Differences from Patients with Severe Influenza A and MERS,Clinical Presentation,No Intervention,100,Not Available,2020-06-30,http://www.chictr.org.cn/showproj.aspx?proj=50896,No Results,No Results,No Results,2020-03-16,2020-03-18,None
268,ChiCTR2000030010,ChiCTR,2020-02-19,2020-02-19,False,Wuhan Jinyintan Hospital (Wuhan Infectious Diseases Hospital),Not Recruiting,Not Applicable,Interventional,China,"A randomized, double-blind, parallel-controlled, trial to evaluate the efficacy and safety of anti-SARS-CoV-2 virus inactivated plasma in the treatment of severe novel coronavirus pneumonia patients (COVID-19)",ATMP,Plasma,100,Not Available,2020-05-31,http://www.chictr.org.cn/showproj.aspx?proj=49777,No Results,No Results,No Results,2020-02-25,2020-08-03,None
269,ChiCTR2000030721,ChiCTR,2020-03-12,2020-03-16,False,Affiliated Hospital of Guangdong Medical University,Not Recruiting,Not Applicable,Diagnostic test,China,A comparative study for the sensitivity of induced sputum and throat swabs for the detection of SARS-CoV-2 by real-time PCR in patients with novel coronavirus pneumonia (COVID-19),Diagnostics,Diagnostic Test or Assessment,50,Not Available,2020-04-26,http://www.chictr.org.cn/showproj.aspx?proj=50759,No Results,No Results,No Results,2020-03-16,2020-03-18,None
270,ChiCTR2000029996,ChiCTR,2020-02-20,2020-02-20,False,"Beijing Chaoyang Hospital, Capital Medical University",Recruiting,Phase 2,Interventional,China,"A randomized, open-label, controlled trial for the efficacy and safety of Farpiravir Tablets in the treatment of patients with novel coronavirus pneumonia (COVID-19)",Drug,Favipiravir,60,Not Available,2020-04-20,http://www.chictr.org.cn/showproj.aspx?proj=49510,No Results,No Results,No Results,2020-02-25,2020-08-03,None
271,ChiCTR2000030719,ChiCTR,2020-03-11,2020-03-01,True,Wuhan Hospital of Integrated Traditional Chinese and Western Medicine,Recruiting,Not Applicable,Observational,China,A retrospective cohort study for integrated traditional Chinese and western medicine in the treatment of 1071 patients with novel coronavirus pneumonia (COVID-19) in Wuhan,Traditional Medicine + Western Medicine,Traditional Medicine,1071,Not Available,2020-12-31,http://www.chictr.org.cn/showproj.aspx?proj=50867,No Results,No Results,No Results,2020-03-16,2020-03-18,None
272,ChiCTR2000030703,ChiCTR,2020-03-10,2020-03-10,False,Xiangya Hospital of Central South University,Recruiting,Not Applicable,Interventional,China,"A randomized, blinded, controlled, multicenter clinical trial to evaluate the efficacy and safety of Ixekizumab combined with conventional antiviral drugs in patients with novel coronavirus pneumonia (COVID-19)",Drug,"Ixekizumab + up to three of interferon-alfa, lopinavir/ritonavir, chloroquine, ribavirin, umifenovir",40,Not Available,2020-05-31,http://www.chictr.org.cn/showproj.aspx?proj=50251,No Results,No Results,No Results,2020-03-16,2020-03-18,None
273,ChiCTR2000029995,ChiCTR,2020-02-19,2020-02-20,False,Shanghai General Hospital of Shanghai Jiaotong University,Recruiting,Not Applicable,Observational,China,Study on anxiety of different populations under novel coronavirus (COVID-19) infection,Other (psych),No Intervention,200,Not Available,2020-12-31,http://www.chictr.org.cn/showproj.aspx?proj=49418,No Results,No Results,No Results,2020-02-25,2020-08-03,None
274,ChiCTR2000030687,ChiCTR,2020-03-09,2020-02-01,True,"Wuhan Children's Hospital, Tongji Medical College, Huazhong University of Science & Technology",Not Recruiting,Not Applicable,Basic Science,China,Novel coronavirus pneumonia (COVID-19) associated kidney injury in children,Clinical Presentation,No Intervention,120,Not Available,2020-10-31,http://www.chictr.org.cn/showproj.aspx?proj=50572,No Results,No Results,No Results,2020-03-16,2020-03-18,None
275,ChiCTR2000029994,ChiCTR,2020-02-18,2020-02-19,False,Shanghai University of Traditional Chinese Medicine,Not Recruiting,Not Applicable,Interventional,China,Liu-Zi-Jue Qigong and Acupressure Therapy for Pulmonary Function and Quality of Life in Patient with Severe novel coronavirus pneumonia (COVID-19): A Randomized Controlled Trial,Traditional Medicine (Drug),Traditional Medicine,200,Not Available,2020-08-19,http://www.chictr.org.cn/showproj.aspx?proj=49309,No Results,No Results,No Results,2020-02-25,2020-08-03,None
276,NCT04276987,ClinicalTrials.gov,2020-02-16,2020-02-15,True,Ruijin Hospital,Not Recruiting,Phase 1,Interventional,No Country Given,A Pilot Clinical Study on Inhalation of Mesenchymal Stem Cells Exosomes Treating Severe Novel Coronavirus Pneumonia,ATMP,Cells (mesenchymal),30,2020-05-31,2020-07-31,https://clinicaltrials.gov/show/NCT04276987,No Results,No Results,No Results,2020-03-09,2020-03-18,None
277,ChiCTR2000030593,ChiCTR,2020-03-08,2020-03-10,False,The First Affiliated Hospital of Zhejiang University School of Medicine,Not Recruiting,Not Applicable,Observational,China,"Novel coronavirus pneumonia (COVID-19) antiviral related liver dysfunction: a multicenter, retrospective, observational study",Clinical Presentation,No Intervention,150,Not Available,2020-04-09,http://www.chictr.org.cn/showproj.aspx?proj=50228,No Results,No Results,No Results,2020-03-09,2020-08-03,None
278,ChiCTR2000030545,ChiCTR,2020-03-06,2020-02-04,True,Hubei Hospital of Traditional Chinese Medicine,Recruiting,Phase 4,Interventional,China,"Efficacy and safety of honeysuckle oral liquid in the treatment of novel coronavirus pneumonia (COVID-19): a multicenter, randomized, controlled, open clinical trial",Traditional Medicine (Drug),Traditional Medicine,300,Not Available,2020-04-30,http://www.chictr.org.cn/showproj.aspx?proj=50126,No Results,No Results,No Results,2020-03-16,2020-08-03,None
279,ChiCTR2000029978,ChiCTR,2020-02-18,2020-02-21,False,Yueyang Hospital of Integrated Traditional Chinese Medicine and Western Medicine Affiliated to Shanghai University of Tranditional Medicine,Not Recruiting,Not Applicable,Interventional,China,A randomized controlled trial for the efficacy of Dao-Yin in the prevention and controlling novel coronavirus pneumonia (COVID-19),Traditional Medicine (Drug),Traditional Medicine,186,Not Available,2020-07-31,http://www.chictr.org.cn/showproj.aspx?proj=49702,No Results,No Results,No Results,2020-02-25,2020-08-03,None
280,ChiCTR2000030559,ChiCTR,2020-03-07,2020-03-07,False,The First Affiliated Hospital of Zhejiang University School of Medicine,Recruiting,Not Applicable,Observational,China,A medical records based study for the safety of artificial liver cluster nursing in critically ill patients with novel coronavirus pneumonia (COVID-19),Clinical Presentation,No Intervention,12,Not Available,2020-06-30,http://www.chictr.org.cn/showproj.aspx?proj=50583,No Results,No Results,No Results,2020-03-09,2020-08-03,None
281,NCT04281693,ClinicalTrials.gov,2020-02-20,2020-02-01,True,Affiliated Hospital to Academy of Military Medical Sciences,Not Recruiting,Not Applicable,Interventional,China,A New Screening Strategy for 2019 Novel Coronavirus Infection,Diagnostics,Diagnostic Test or Assessment,230,2020-03-01,2020-03-01,https://clinicaltrials.gov/show/NCT04281693,No Results,No Results,No Results,2020-03-09,2020-03-18,None
282,NCT04282902,ClinicalTrials.gov,2020-02-10,2020-02-04,True,Huilan Zhang,Recruiting,Phase 3,Interventional,China,A Study to Evaluate the Efficacy and Safety of Pirfenidone With Novel Coronavirus Infection,Drug,Pirfenidone,294,2020-04-30,2020-06-01,https://clinicaltrials.gov/show/NCT04282902,No Results,No Results,No Results,2020-03-09,2020-03-18,None
283,ChiCTR2000030557,ChiCTR,2020-03-07,2020-03-10,False,The Third Affiliated Hospital of the Second Military Medical University,Recruiting,Not Applicable,Observational,China,"A retrospective study on virus typing, Hematological Immunology and case Review of novel coronavirus infected and convalescent patients (COVID-19)",Clinical Presentation,No Intervention,1030,Not Available,2021-03-10,http://www.chictr.org.cn/showproj.aspx?proj=50667,No Results,No Results,No Results,2020-03-09,2020-08-03,None
284,ChiCTR2000030388,ChiCTR,2020-03-01,2020-02-18,True,Jingzhou First People's Hospital,Recruiting,Not Applicable,Interventional,China,Efficacy and safety of Xue-Bi-Jing injection in the treatment of severe cases of novel coronavirus pneumonia (COVID-19),Traditional Medicine (Drug),Traditional Medicine,60,Not Available,Not Available,http://www.chictr.org.cn/showproj.aspx?proj=50306,No Results,No Results,No Results,2020-03-16,2020-08-03,None
285,NCT04284046,ClinicalTrials.gov,2020-02-22,2020-01-31,True,Shanghai General Hospital of Shanghai Jiaotong University,Not Recruiting,Not Applicable,Observational,China,CT Scores Predict Mortality in 2019-nCoV Pneumonia,Prognosis,No Intervention,39,2020-02-18,2020-02-18,https://clinicaltrials.gov/show/NCT04284046,No Results,No Results,No Results,2020-03-09,2020-03-18,None
286,NCT04285190,ClinicalTrials.gov,2020-02-19,2020-02-26,False,"Tasly Pharmaceuticals, Inc.",Not Recruiting,Not Applicable,Interventional,No Country Given,The Effect of T89 on Improving Oxygen Saturation and Clinical Symptoms in Patients With COVID-19,Traditional Medicine (Drug),Traditional Medicine,120,2020-06-15,2020-09-15,https://clinicaltrials.gov/show/NCT04285190,No Results,No Results,No Results,2020-03-09,2020-03-18,None
287,ChiCTR2000030543,ChiCTR,2020-03-06,2020-02-14,True,Central Theater General Hospital of PLA,Recruiting,Not Applicable,Observational,China,Detection of coronavirus in simultaneously collecting tears and throat swab samples collected from the patients with novel coronavirus pneumonia (COVID-19),Diagnostics,Diagnostic Test or Assessment,35,Not Available,2020-03-31,http://www.chictr.org.cn/showproj.aspx?proj=50541,No Results,No Results,No Results,2020-03-09,2020-08-03,None
288,ChiCTR2000030114,ChiCTR,2020-02-23,2020-02-24,False,Peking University People's Hospital,Not Recruiting,Not Applicable,Diagnostic test,China,"Lung ultrasound in the diagnosis, treatment and prognosis of pulmonary lesions of novel coronavirus pneumonia (COVID-19)",Diagnostics,Diagnostic Test or Assessment,150,Not Available,2020-08-24,http://www.chictr.org.cn/showproj.aspx?proj=49987,No Results,No Results,No Results,2020-03-16,2020-03-18,None
289,ChiCTR2000030627,ChiCTR,2020-03-08,2020-02-01,True,The First Affiliated Hospital of Zhengzhou University,Recruiting,Not Applicable,Interventional,China,Study for using the healed novel coronavirus pneumonia (COVID-19) patients plasma in the treatment of severe critical cases,ATMP,Plasma,30,Not Available,2020-05-30,http://www.chictr.org.cn/showproj.aspx?proj=50727,No Results,No Results,No Results,2020-03-09,2020-08-03,None
290,ChiCTR2000030541,ChiCTR,2020-03-06,2020-03-06,False,"Xiamen Medical College,Shijiazhuang Medical College",Not Recruiting,Not Applicable,Observational,China,Novel coronavirus pneumonia (COVID-19) epidemic survey of medical students in various provinces and municipalities throughout the country,Clinical Presentation,No Intervention,1300,Not Available,2020-03-13,http://www.chictr.org.cn/showproj.aspx?proj=50623,No Results,No Results,No Results,2020-03-09,2020-08-03,None
291,ChiCTR2000030579,ChiCTR,2020-03-08,2020-02-15,True,Shandong Provincial Hospital,Not Recruiting,Not Applicable,Observational,China,Risk Factors for Outcomes of Novel Coronavirus Pneumonia (COVID-19),Prognosis,No Intervention,200,Not Available,2020-05-01,http://www.chictr.org.cn/showproj.aspx?proj=50692,No Results,No Results,No Results,2020-03-09,2020-08-03,None
292,ChiCTR2000030518,ChiCTR,2020-03-05,2020-02-29,True,The Second Affiliated Hospital of Wenzhou Medical University,Recruiting,Not Applicable,Interventional,China,"Zedoary Turmeric Oil for Injection in the treatment of Novel Coronavirus Pneumonia (COVID-19): a randomized, open, controlled trial",Traditional Medicine (Drug),Traditional Medicine,60,Not Available,2020-05-31,http://www.chictr.org.cn/showproj.aspx?proj=50586,No Results,No Results,No Results,2020-03-09,2020-08-03,None
293,ChiCTR2000030578,ChiCTR,2020-03-08,2020-03-07,True,Shandong Provincial Hospital,Not Recruiting,Not Applicable,Interventional,China,Clinical Prediction and Intervention of Pulmonary Function Impairment in Patients with Novel Coronavirus Pneumonia (COVID-19),Clinical Presentation,No Intervention,40,Not Available,2021-02-01,http://www.chictr.org.cn/showproj.aspx?proj=50690,No Results,No Results,No Results,2020-03-09,2020-08-03,None
294,ChiCTR2000030491,ChiCTR,2020-03-04,2020-03-03,True,West China Hospital of Sichuan University,Recruiting,Not Applicable,Observational,China,A medical records based study for Comparing Differences of Clinical Features and Outcomes of Novel Coronavirus Pneumonia (COVID-19) Patients between Sichuan Province and Wuhan City,Clinical Presentation,No Intervention,100,Not Available,2022-02-01,http://www.chictr.org.cn/showproj.aspx?proj=50552,No Results,No Results,No Results,2020-03-09,2020-08-03,None
295,ChiCTR2000030564,ChiCTR,2020-03-07,2020-03-15,False,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Not Applicable,Observational,China,Psychological Intervention of Children with Novel Coronavirus Disease (COVID-19),Other (psych),Psychological,120,Not Available,2020-06-30,http://www.chictr.org.cn/showproj.aspx?proj=50653,No Results,No Results,No Results,2020-03-09,2020-08-03,None
296,ChiCTR2000030489,ChiCTR,2020-03-04,2020-02-01,True,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Not Applicable,Epidemiological research,China,Study for the route of ocular surface transmission of novel coronavirus pneumonia (COVID-19) infection and related eye diseases,Clinical Presentation,No Intervention,1000,Not Available,2020-06-30,http://www.chictr.org.cn/showproj.aspx?proj=50490,Pre-Print Article,2020-03-16,https://doi.org/10.1101/2020.03.12.20034678,2020-03-09,2020-08-03,None
297,ChiCTR2000030544,ChiCTR,2020-03-06,2020-02-24,True,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Not Recruiting,Not Applicable,Observational,China,Study for the risk factors of critically ill patients with novel coronavirus pneumonia (COVID-19),Prognosis,No Intervention,1500,Not Available,2021-02-01,http://www.chictr.org.cn/showproj.aspx?proj=50134,No Results,No Results,No Results,2020-03-09,2020-08-03,None
298,ChiCTR2000030493,ChiCTR,2020-03-04,2020-03-04,False,Renmin Hospital of Wuhan University,Not Recruiting,Not Applicable,Observational,China,"Survey for sleep, anxiety and depression status of Chinese residents during the outbreak of novel coronavirus infected disases (COVID-19)",Other (psych),No Intervention,1300,Not Available,2020-09-03,http://www.chictr.org.cn/showproj.aspx?proj=50547,No Results,No Results,No Results,2020-03-09,2020-03-18,None
299,ChiCTR2000030484,ChiCTR,2020-03-03,2020-02-02,True,Hubei Shiyan Taihe hospital,Not Recruiting,Not Applicable,Interventional,China,HUMSCs and Exosomes Treating Patients with Lung Injury following Novel Coronavirus Pneumonia (COVID-19),ATMP,Cells (mesenchymal),90,Not Available,2021-01-31,http://www.chictr.org.cn/showproj.aspx?proj=50263,No Results,No Results,No Results,2020-03-09,2020-03-18,None
300,ChiCTR2000030480,ChiCTR,2020-03-03,2020-03-03,False,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Phase 4,Interventional,China,"Randomized, open, blank controlled trial for the efficacy and safety of recombinant human interferon alpha 1beta in the treatment of Wuhan patients with novel coronavirus pneumonia (COVID-19)",Drug,Interferon alfa,328,Not Available,2020-07-03,http://www.chictr.org.cn/showproj.aspx?proj=50470,No Results,No Results,No Results,2020-03-09,2020-08-03,None
301,NCT04302519,ClinicalTrials.gov,2020-02-27,2020-03-05,False,"CAR-T (Shanghai) Biotechnology Co., Ltd.",Not Recruiting,Phase 1,Interventional,No Country Given,Novel Coronavirus Induced Severe Pneumonia Treated by Dental Pulp Mesenchymal Stem Cells,ATMP,Cells (mesenchymal),24,2021-06-30,2021-07-30,https://clinicaltrials.gov/show/NCT04302519,No Results,No Results,No Results,2020-03-23,2020-03-18,None
302,ChiCTR2000031163,ChiCTR,2020-03-23,2020-02-16,True,The People's Hospital of Guangxi Zhuang Autonomous Region,Not Recruiting,Not Applicable,Observational,China,The relationship between Vitamin D andnovel coronavirus pneumonia (COVID-19),Clinical Presentation,No Intervention,80,Not Available,2022-02-16,http://www.chictr.org.cn/showproj.aspx?proj=51390,No Results,No Results,No Results,2020-03-23,2020-03-25,None
303,ChiCTR2000030482,ChiCTR,2020-03-03,2020-03-06,False,Peking University First Hospital,Not Recruiting,Not Applicable,Observational,China,"A Multicenter, Long- term Follow-up and Registration Study for Myocardial Injury and Prognosis of Novel coronavirus pneumonia (COVID-19)",Clinical Presentation,No Intervention,8000,Not Available,2023-12-31,http://www.chictr.org.cn/showproj.aspx?proj=50353,No Results,No Results,No Results,2020-03-09,2020-08-03,None
304,ChiCTR2000030479,ChiCTR,2020-03-03,2020-02-26,True,"Affiliated Hospital of Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine",Not Recruiting,Not Applicable,Interventional,China,Study for the Effectiveness and Safety of Yi-Qi Hua-shi Jie-Du-Fang in the Treatment of the Novel Coronavirus Pneumonia (COVID-19),Traditional Medicine (Drug),Traditional Medicine,100,Not Available,2021-02-25,http://www.chictr.org.cn/showproj.aspx?proj=50450,No Results,No Results,No Results,2020-03-09,2020-08-03,None
305,ChiCTR2000031140,ChiCTR,2020-03-22,2020-02-01,True,"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Not Applicable,Observational,China,Study for the impact on fetus and neonates of vertical transmission of 2019-nCoV,Clinical Presentation,No Intervention,300,Not Available,2020-08-31,http://www.chictr.org.cn/showproj.aspx?proj=50605,No Results,No Results,No Results,2020-03-23,2020-03-25,None
306,ChiCTR2000030475,ChiCTR,2020-03-03,2020-03-04,False,Chinese Academy of Medical Sciences Peking Union Medical College Hospital,Not Recruiting,Not Applicable,Interventional,China,Cytosorb in Treating Critically Ill Hospitalized Adult Patients with novel coronavirus pneumonia (COVID-19),Other (physical),Extracorporeal blood purification ,19,Not Available,2020-06-25,http://www.chictr.org.cn/showproj.aspx?proj=50452,No Results,No Results,No Results,2020-03-09,2020-08-03,None
307,ChiCTR2000031138,ChiCTR,2020-03-22,2020-02-26,True,"The Third Xiangya Hospital, Central South University",Recruiting,Not Applicable,Interventional,China,Prospective exploratory clinical research on the efficacy and safety of pirfenidone capsules in the treatment of severe novel coronavirus pneumonia (COVID-19),Drug,Pirfenidone,40,Not Available,2020-12-31,http://www.chictr.org.cn/showproj.aspx?proj=51416,No Results,No Results,No Results,2020-03-23,2020-03-25,None
308,ChiCTR2000030477,ChiCTR,2020-03-03,2020-03-04,False,Chinese Academy of Medical Sciences Peking Union Medical College Hospital,Not Recruiting,Not Applicable,Interventional,China,oXiris Membrane in Treating Critically Ill Hospitalized Adult Patients with novel coronavirus pneumonia (COVID-19),Traditional Medicine (Other),Traditional Medicine,19,Not Available,2020-06-25,http://www.chictr.org.cn/showproj.aspx?proj=50458,No Results,No Results,No Results,2020-03-09,2020-08-03,None
309,ChiCTR2000030464,ChiCTR,2020-03-02,2020-03-03,False,"The Third Xiangya Hospital, Central South University",Recruiting,Not Applicable,Epidemiological research,No Country Given,Study for the clinical characteristics of novel coronavirus pneumonia (COVID-19),Clinical Presentation,No Intervention,200,Not Available,2020-04-01,http://www.chictr.org.cn/showproj.aspx?proj=50382,No Results,No Results,No Results,2020-03-09,2020-08-03,None
310,ChiCTR2000031090,ChiCTR,2020-03-22,2020-03-23,False,Ningbo Kangning Hospital,Not Recruiting,Not Applicable,Interventional,China,Psychological Support for Diagnosed Patients with novel coronavirus pneumonia (COVID-19),Other (psych),Psychological,60,Not Available,2022-03-23,http://www.chictr.org.cn/showproj.aspx?proj=51148,No Results,No Results,No Results,2020-03-23,2020-03-25,None
311,ChiCTR2000030163,ChiCTR,2020-02-24,2020-02-25,False,Yueyang Hospital of Integrated Traditional Chinese Medicine and Western Medicine Affiliated to Shanghai University of Tranditional Medicine,Not Recruiting,Not Applicable,Observational,China,A Medical Based Retrospective Real World Study for Assessment of Effectiveness of Comprehensive Traditional Chinese Medicine in the treatment of Novel Coronavirus Pneumonia (COVID-19),Traditional Medicine (Unspecified),Traditional Medicine,256,Not Available,2020-12-31,http://www.chictr.org.cn/showproj.aspx?proj=50031,No Results,No Results,No Results,2020-03-09,2020-08-03,None
312,ChiCTR2000030436,ChiCTR,2020-03-01,2020-03-06,False,Shanghai Sixth People's Hospital,Not Recruiting,Not Applicable,Observational,China,Application of flash glucose monitoring to evaluate the effect of blood glucose changes on prognosis in patients with novel coronavirus pneumonia (COVID-19),Prognosis,No Intervention,100,Not Available,2020-05-31,http://www.chictr.org.cn/showproj.aspx?proj=50297,No Results,No Results,No Results,2020-03-09,2020-08-03,None
313,ChiCTR2000030996,ChiCTR,2020-03-20,2020-03-18,True,"Xiyuan Hospital, Chinese Academy of Traditional Chinese Medicine",Recruiting,Not Applicable,Interventional,China,Effect of Auricular point pressing on insomnia of novel coronavirus pneumonia (COVID-19) patients: a randomized controlled trial.,Traditional Medicine (Other),Traditional Medicine,60,Not Available,2020-10-26,http://www.chictr.org.cn/showproj.aspx?proj=51349,No Results,No Results,No Results,2020-03-23,2020-03-25,None
314,ChiCTR2000029958,ChiCTR,2020-02-17,2020-02-17,False,Zhongnan Hospital of Wuhan University,Not Recruiting,Not Applicable,Observational,China,A medical records based study for the clinical characteristics of anesthesia novel coronavirus pneumonia (COVID-19) patients during perioperative period and assessment of infection and mental health of Anesthesiology Department,Clinical Presentation,No Intervention,260,Not Available,Not Available,http://www.chictr.org.cn/showproj.aspx?proj=49635,No Results,No Results,No Results,2020-03-09,2020-08-03,None
315,ChiCTR2000029993,ChiCTR,2020-02-18,2020-02-20,False,The First Affiliated Hospital of Guangzhou Medical University,Recruiting,Not Applicable,Interventional,China,A pilot study for Integrated Chinese and Western Medicine in the treatment of non-critical novel coronavirus pneumonia (COVID-19),Traditional Medicine + Western Medicine,Traditional Medicine,40,Not Available,2020-08-20,http://www.chictr.org.cn/showproj.aspx?proj=49435,No Results,No Results,No Results,2020-03-09,2020-08-03,None
316,ChiCTR2000030986,ChiCTR,2020-03-20,2020-03-20,False,Shenzhen Third People's Hospital,Recruiting,Not Applicable,Observational,China,Correlation of T lymphocytes level and clinical severity in novel coronavirus pneumonia (COVID-19) patients: a medical records based retrospective study,Clinical Presentation,No Intervention,200,Not Available,2020-03-01,http://www.chictr.org.cn/showproj.aspx?proj=51316,No Results,No Results,No Results,2020-03-23,2020-03-25,None
317,ChiCTR2000029757,ChiCTR,2020-02-12,2020-02-14,False,China-Japan Friendship Hospital,Recruiting,Not Applicable,Interventional,China,Convalescent plasma for the treatment of severe and critical novel coronavirus pneumonia (COVID-19): a prospective randomized controlled trial,ATMP,Plasma,200,Not Available,2021-02-05,http://www.chictr.org.cn/showproj.aspx?proj=49081,No Results,No Results,No Results,2020-03-09,2020-08-03,None
318,ChiCTR2000029960,ChiCTR,2020-02-17,2020-02-28,False,The First Affiliated Hospital of Hu'nan University of Traditional Chinese Medicine,Not Recruiting,Not Applicable,Interventional,China,Comparative study for integrate Chinese and conventional medicine the the treatment of novel coronavirus pneumonia (COVID-19) in Hu'nan province,Traditional Medicine + Western Medicine,Traditional Medicine,100,Not Available,2020-05-31,http://www.chictr.org.cn/showproj.aspx?proj=49639,No Results,No Results,No Results,2020-02-25,2020-08-03,None
319,ChiCTR2000029638,ChiCTR,2020-02-08,2020-02-03,True,West China Hospital of Sichuan University,Recruiting,Not Applicable,Interventional,China,"A Multicenter, Randomized, Controlled trial for Recombinant Super-Compound Interferon (rSIFN-co) in the Treatment of 2019 Novel Coronavirus (2019-nCoV) Infected Pneumonia",Drug,Interferon,100,Not Available,2020-08-01,http://www.chictr.org.cn/showproj.aspx?proj=49224,No Results,No Results,No Results,2020-03-09,2020-08-03,None
320,ChiCTR2000029959,ChiCTR,2020-02-17,2020-01-25,True,"West China Second Hospital, Sichuan University",Recruiting,Not Applicable,Observational,China,Clinical observation and research of  Severe acute respiratory syndrome coronavirus 2(COVID-19) infection in perinatal newborns,Clinical Presentation,No Intervention,30,Not Available,2021-01-01,http://www.chictr.org.cn/showproj.aspx?proj=49636,No Results,No Results,No Results,2020-02-25,2020-08-03,None
321,ChiCTR2000030961,ChiCTR,2020-03-20,2020-01-01,True,"Changzheng Hospital, Naval Military Medical University, Shanghai",Recruiting,Not Applicable,Observational,No Country Given,"A Medical Records Based Retrospective Study for Clinical Characteristics, Treatments and Prognosis of Patients with Novel Coronavirus Pneumonia (COVID-19) in WuHan",Clinical Presentation,No Intervention,2000,Not Available,2020-12-31,http://www.chictr.org.cn/showproj.aspx?proj=51291,No Results,No Results,No Results,2020-03-23,2020-03-25,None
322,ChiCTR2000029579,ChiCTR,2020-02-05,2020-01-31,True,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Not Applicable,Observational,China,The investigation of cytokine expression profile of novel coronavirus pneumonia (COVID-19) and its clinical significance,Clinical Presentation,No Intervention,200,Not Available,2020-12-31,http://www.chictr.org.cn/showproj.aspx?proj=49045,No Results,No Results,No Results,2020-03-09,2020-08-03,None
323,ChiCTR2000029866,ChiCTR,2020-02-15,2020-02-17,False,Enze Hospital of Taizhou Enze Medical Center (Group),Recruiting,Not Applicable,Diagnostic test,China,Early warning prediction of patients with severe novel coronavirus pneumonia (COVID-19) based on multiomics,Genomics,No Intervention,120,Not Available,2020-05-31,http://www.chictr.org.cn/showproj.aspx?proj=49519,No Results,No Results,No Results,2020-02-25,2020-08-03,None
324,NCT04292340,ClinicalTrials.gov,2020-02-25,2020-02-01,True,Shanghai Public Health Clinical Center,Recruiting,Not Applicable,Observational,China,Anti-SARS-CoV-2 Inactivated Convalescent Plasma in the Treatment of COVID-19,ATMP,Plasma,15,2020-07-31,2020-12-31,https://clinicaltrials.gov/show/NCT04292340,No Results,No Results,No Results,2020-03-16,2020-03-18,None
325,NCT04293887,ClinicalTrials.gov,2020-02-15,2020-03-01,False,Tongji Hospital,Not Recruiting,Phase 1,Interventional,No Country Given,Efficacy and Safety of IFN-a2 in the Treatment of Novel Coronavirus Patients,Drug,Interferon alfa,328,2020-05-30,2020-06-30,https://clinicaltrials.gov/show/NCT04293887,No Results,No Results,No Results,2020-03-16,2020-03-18,None
326,ChiCTR2000030952,ChiCTR,2020-03-19,2020-01-18,True,The Fifth Affiliated Hospital of Sun Yat-Sen University,Recruiting,Not Applicable,Observational,China,Myocardial injury and arrythmias in the novel coronavirus pneumonia (COVID-19) patients,Clinical Presentation,No Intervention,93,Not Available,2020-04-01,http://www.chictr.org.cn/showproj.aspx?proj=51278,No Results,No Results,No Results,2020-03-23,2020-03-25,None
327,ChiCTR2000029308,ChiCTR,2020-01-23,2020-01-10,True,Wuhan Jinyintan Hospital (Wuhan Infectious Diseases Hospital),Recruiting,Not Applicable,Interventional,China,"A randomized, controlled open-label trial to evaluate the efficacy and safety of lopinavir-ritonavir in hospitalized patients with novel coronavirus pneumonia (COVID-19)",Drug,Lopinavir/ritonavir,160,Not Available,2021-01-10,http://www.chictr.org.cn/showproj.aspx?proj=48684,Journal Article,2020-03-18,doi.org/10.1056/NEJMoa2001282,2020-03-09,2020-08-03,None
328,ChiCTR2000030902,ChiCTR,2020-03-16,2020-02-10,True,Jingzhou Mental Health Center,Recruiting,Not Applicable,Observational,China,Analysis for the mental health status of residents in Jingzhou during the outbreak of the novel coronavirus pneumonia (COVID-19) and corresponding influencing factors,Other (psych),No Intervention,1000,Not Available,2020-04-30,http://www.chictr.org.cn/showproj.aspx?proj=51130,No Results,No Results,No Results,2020-03-16,2020-03-18,None
329,NCT04298814,ClinicalTrials.gov,2020-02-26,2020-03-07,False,Tongji Hospital,Not Recruiting,Not Applicable,Observational,No Country Given,Safety Related Factors of Endotracheal Intubation in Patients With Severe Covid-19 Pneumonia,Other (physical),Endotracheal Intubation,120,2020-05-30,2020-07-30,https://clinicaltrials.gov/show/NCT04298814,No Results,No Results,No Results,2020-03-16,2020-03-18,None
330,ChiCTR2000030898,ChiCTR,2020-03-16,2020-01-27,True,The Affiliated Hospital to Changchun University of Traditional Chinese Medicine,Recruiting,Not Applicable,Observational,China,Evaluation on the effect of Chushifangyi prescription in preventing novel coronavirus pneumonia (COVID-19),Traditional Medicine (Drug),Traditional Medicine,1000,Not Available,2020-12-31,http://www.chictr.org.cn/showproj.aspx?proj=50780,No Results,No Results,No Results,2020-03-16,2020-03-18,None
331,ChiCTR2000030950,ChiCTR,2020-03-19,2020-02-10,True,West China Hospital of Sichuan University,Recruiting,Not Applicable,Basic Science,China,Study for novel coronavirus pneumonia (COVID-19) patients etiology and immune response and guidance for vaccine design,Clinical Presentation,No Intervention,50,Not Available,2022-02-10,http://www.chictr.org.cn/showproj.aspx?proj=51272,No Results,No Results,No Results,2020-03-23,2020-03-25,None
332,ChiCTR2000030901,ChiCTR,2020-03-16,2020-03-09,True,The Chinese University of Hong Kong,Not Recruiting,Not Applicable,Observational,China,Retrospective analysis of epidemiology and transmission dynamics of patients confirmed with Coronavirus Disease (COVID-19) in Hong Kong,Clinical Presentation ,No Intervention,100,Not Available,2020-03-14,http://www.chictr.org.cn/showproj.aspx?proj=51064,No Results,No Results,No Results,2020-03-16,2020-03-18,None
333,ChiCTR2000030866,ChiCTR,2020-03-16,2020-02-01,True,The First Hospital of Changsha,Recruiting,Not Applicable,Observational,China,"Open-label, observational study of human umbilical cord derived mesenchymal stem cells in the treatment of severe and critical patients with novel coronavirus pneumonia (COVID-19)",ATMP,Cells (mesenchymal),30,Not Available,2020-12-31,http://www.chictr.org.cn/showproj.aspx?proj=50299,No Results,No Results,No Results,2020-03-16,2020-03-18,None
334,ChiCTR2000030854,ChiCTR,2020-03-16,2020-01-22,True,Li Lanjuan,Not Recruiting,Not Applicable,Observational,China,"A clinical multicenter study for the occurrence, development and prognosis of novel coronavirus pneumonia (COVID-19)",Clinical Presentation,No Intervention,237,Not Available,2020-03-15,http://www.chictr.org.cn/showproj.aspx?proj=51083,No Results,No Results,No Results,2020-03-16,2020-03-18,None
335,ChiCTR2000030943,ChiCTR,2020-03-18,2020-03-31,False,Shandong Provincial Hospital,Not Recruiting,Not Applicable,Observational,China,Venous Thrombosis Risk of novel coronavirus pneumonia (COVID-19) Patients: A Prospective Study,Prognosis,No Intervention,200,Not Available,2020-05-31,http://www.chictr.org.cn/showproj.aspx?proj=50898,No Results,No Results,No Results,2020-03-23,2020-03-25,None
336,ChiCTR2000030853,ChiCTR,2020-03-16,2020-02-01,True,Third Affiliated Hospital of Zunyi Medical University,Not Recruiting,Not Applicable,Interventional,No Country Given,Evaluation of the protective effect of dexmedetomidine on patients with severe novel coronavirus pneumonia (COVID-19),Drug,Dexmedetomidine,200,Not Available,2020-05-31,http://www.chictr.org.cn/showproj.aspx?proj=51081,No Results,No Results,No Results,2020-03-16,2020-03-18,None
337,ChiCTR2000030864,ChiCTR,2020-03-16,2020-02-01,True,Xiangyang First People's Hospital,Recruiting,Not Applicable,Interventional,China,Traditional Chinese Medicine for novel coronavirus pneumonia (COVID-19),Traditional Medicine (Unspecified),Traditional Medicine,50,Not Available,2020-07-31,http://www.chictr.org.cn/showproj.aspx?proj=50662,No Results,No Results,No Results,2020-03-16,2020-03-18,None
338,ChiCTR2000030934,ChiCTR,2020-03-18,2020-03-01,True,The Fifth Affiliated Hospital of Sun Yat-Sen University,Recruiting,Not Applicable,Observational,China,A Platform for Rapid Immuno-detection and Emergency Vaccine Development of Novel Coronavirus (2019-COV),Other (software),No Intervention,90,Not Available,2021-02-28,http://www.chictr.org.cn/showproj.aspx?proj=51160,No Results,No Results,No Results,2020-03-23,2020-03-25,None
339,ChiCTR2000030852,ChiCTR,2020-03-16,2020-01-27,True,"Beijing An Zhen Hospital, Capital Medical University",Not Recruiting,Not Applicable,Observational,China,Factors associated with death in patients with novel coronavirus pneumonia (COVID-19),Prognosis,No Intervention,150,Not Available,2020-02-27,http://www.chictr.org.cn/showproj.aspx?proj=51077,Journal Article,2020-03-11,https://doi.org/10.1016/S0140-6736(20)30566-3,2020-03-16,2020-03-18,None
340,ChiCTR2000030859,ChiCTR,2020-03-16,2020-03-01,True,Wuhan Third Hospital,Not Recruiting,Not Applicable,Observational,China,A medical based analysis for influencing factors of death of novel coronavirus pneumonia (COVID-19) patients in Wuhan third hospital,Prognosis,No Intervention,1305,Not Available,2020-06-01,http://www.chictr.org.cn/showproj.aspx?proj=51025,No Results,No Results,No Results,2020-03-16,2020-03-18,None
341,ChiCTR2000030929,ChiCTR,2020-03-17,2020-03-17,False,Renmin Hospital of Wuhan University,Not Recruiting,Not Applicable,Interventional,China,"A randomized, double-blind, parallel-controlled trial to evaluate the efficacy and safety of anti-SARS-CoV-2 virus inactivated plasma in the treatment of severe novel coronavirus pneumonia (COVID-19)",ATMP,Plasma,60,Not Available,2020-06-16,http://www.chictr.org.cn/showproj.aspx?proj=50696,No Results,No Results,No Results,2020-03-23,2020-03-25,None
342,ChiCTR2000030838,ChiCTR,2020-03-15,2020-01-20,True,Zhongnan Hospital of Wuhan University,Not Recruiting,Not Applicable,Diagnostic test,China,Development of warning system with clinical differential diagnosis and prediction for severe type of novel coronavirus pneumonia (COVID-19) patients based on artificial intelligence and CT images,Diagnostics,Diagnostic Test or Assessment,1000,Not Available,2020-05-06,http://www.chictr.org.cn/showproj.aspx?proj=51071,No Results,No Results,No Results,2020-03-16,2020-03-18,None
343,ChiCTR2000030857,ChiCTR,2020-03-16,2020-03-01,True,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Not Applicable,Observational,China,Clinical study for bronchoscopic alveolar lavage in the treatment of critically trachea intubation patients with new coronavirus pneumonia (COVID-19),Other (physical),Bronchoscopic lavage,30,Not Available,2020-04-30,http://www.chictr.org.cn/showproj.aspx?proj=51040,No Results,No Results,No Results,2020-03-16,2020-03-18,None
344,ChiCTR2000030920,ChiCTR,2020-03-17,2020-02-20,True,"Hwa Mei Hospital, University of Chinese Academy of Sciences",Recruiting,Not Applicable,Interventional,China,"Evaluation of the effect of taking tricholoma matsutake, cannabis sativa capsule and dendrobium candidum to nutrition intervention of patients with novel coronavirus pneumonia (COVID-19) during convalescence.",Traditional Medicine (Drug),Traditional Medicine,100,Not Available,2021-05-01,http://www.chictr.org.cn/showproj.aspx?proj=50476,No Results,No Results,No Results,2020-03-23,2020-03-25,None
345,ChiCTR2000030836,ChiCTR,2020-03-15,2020-02-01,True,Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine,Not Recruiting,Phase 4,Interventional,China,Novel coronavirus pneumonia (COVID-19) combined with Chinese and Western medicine based on ''Internal and External Relieving -Truncated Torsion'' strategy,Traditional Medicine + Western Medicine,Traditional Medicine,300,Not Available,2020-06-30,http://www.chictr.org.cn/showproj.aspx?proj=51054,No Results,No Results,No Results,2020-03-16,2020-03-18,None
346,ChiCTR2000030855,ChiCTR,2020-03-16,2020-02-01,True,Third Affiliated Hospital of Zunyi Medical University,Not Recruiting,Phase 1,Interventional,No Country Given,Study for the effect of external diaphragmatic pacing assisted invasive ventilation and weaning in patients with severe novel coronavirus pneumonia (COVID-19),Other (physical),Mechanical ventilation,200,Not Available,2020-05-01,http://www.chictr.org.cn/showproj.aspx?proj=51090,No Results,No Results,No Results,2020-03-16,2020-03-18,None
347,ChiCTR2000029955,ChiCTR,2020-02-17,2020-03-01,False,"West China Second Hospital, Sichuan University",Not Recruiting,Not Applicable,Diagnostic test,China,Evaluation of myocardial injury of novel coronavirus pneumonia (COVID-19) assessed by multimodal MRI imaging,Clinical Presentation,No Intervention,80,Not Available,2020-03-01,http://www.chictr.org.cn/showproj.aspx?proj=49531,No Results,No Results,No Results,2020-03-23,2020-08-03,None
348,ChiCTR2000030835,ChiCTR,2020-03-15,2020-02-14,True,The First Affiliated Hospital of Xinxiang Medical University,Recruiting,Not Applicable,Interventional,China,Clinical study for the efficacy of Mesenchymal stem cells (MSC) in the treatment of severe novel coronavirus pneumonia (COVID-19),ATMP,Cells (mesenchymal),20,Not Available,2020-02-14,http://www.chictr.org.cn/showproj.aspx?proj=51050,No Results,No Results,No Results,2020-03-16,2020-03-18,None
349,ChiCTR2000029865,ChiCTR,2020-02-15,2020-02-20,False,"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Not Applicable,Observational,China,Descriptive study on the clinical characteristics and outcomes of novel coronavirus pneumonia (COVID-19) in cardiovascular patients,Prognosis,No Intervention,1200,Not Available,2020-04-20,http://www.chictr.org.cn/showproj.aspx?proj=49545,No Results,No Results,No Results,2020-02-25,2020-08-03,None
350,ChiCTR2000030850,ChiCTR,2020-03-15,2020-03-15,False,The First Affiliated Hospital of Guangzhou University of Traditional Chinese Medicine,Not Recruiting,Not Applicable,Observational,China,Study for the physical and mental health status of medical workers under the novel coronavirus pneumonia (COVID-19) epidemic,Other (psych),No Intervention,226,Not Available,2020-04-30,http://www.chictr.org.cn/showproj.aspx?proj=51056,No Results,No Results,No Results,2020-03-16,2020-03-18,None
351,ChiCTR2000029830,ChiCTR,2020-02-15,2020-02-14,True,The Fifth Affiliated Hospital of Sun Yat-Sen University,Not Recruiting,Not Applicable,Observational,China,"A study for the psychological status, social support, and care needs of tumor patients admitted to a general hospital during the novel coronavirus pneumonia (COVID-19) outbreak",Other (psych),No Intervention,400,Not Available,2020-04-12,http://www.chictr.org.cn/showproj.aspx?proj=49511,No Results,No Results,No Results,2020-03-23,2020-03-18,None
352,ChiCTR2000030834,ChiCTR,2020-03-15,2020-03-16,False,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Not Recruiting,Not Applicable,Observational,China,Epidemiological Characteristics and Antibody Levels of novel coronavirus pneumonia (COVID-19) of Pediatric Medical Staff working in Quarantine Area,Clinical Presentation (Epidemiology),No Intervention,500,Not Available,2020-03-31,http://www.chictr.org.cn/showproj.aspx?proj=51047,No Results,No Results,No Results,2020-03-16,2020-03-18,None
353,ChiCTR2000029851,ChiCTR,2020-02-15,2020-02-19,False,"Zhongshan Hospital, Fudan University",Recruiting,Phase 4,Interventional,China,"A multicenter, randomized controlled trial for the efficacy and safety of Alpha lipoic acid (iv) in the treatment of patients of severe novel coronavirus pneumonia (COVID-19)",Supplement,Alpha lipoic acid,68,Not Available,2020-03-10,http://www.chictr.org.cn/showproj.aspx?proj=49534,Pre-Print Article,2020-04-21,https://doi.org/10.1101/2020.04.15.20066266,2020-02-25,2020-08-03,None
354,ChiCTR2000030841,ChiCTR,2020-03-15,2020-02-17,True,"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Not Applicable,Interventional,China,Exploratory study for Immunoglobulin From Cured COVID-19 Patients in the Treatment of Acute Severe novel coronavirus pneuvirus (COVID-19),ATMP,Immunoglobulin,10,Not Available,2020-05-31,http://www.chictr.org.cn/showproj.aspx?proj=51072,No Results,No Results,No Results,2020-03-16,2020-03-18,None
355,EUCTR2020-000890-25-FR,EU Clinical Trials Register,2020-03-10,2020-03-05,True,Fondation Mditerrane Infection (FMI) - IHU Mditerrane Infection,Authorised,Phase 3,Interventional,France,Hydroxychloroquine as a treatment for coronavirus disease COVID-19,Drug,Hydroxychloroquine,25,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-000890-25,Journal Article,2020-03-20,https://doi.org/10.1016/j.ijantimicag.2020.105949,2020-03-23,2020-03-25,None
356,JPRN-UMIN000039686,JPRN,2020-03-06,2020-02-01,True,The Prince Charles Hospital,Recruiting,Not Applicable,Observational,"Japan, Australia, Asia, Europe",ExtraCorporeal Membrane Oxygenation for 2019 novel Coronavirus Acute Respiratory Disease,Drug,Oxygen,500,Not Available,2021-08-31,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000045268,No Results,No Results,No Results,2020-03-23,2020-03-25,None
357,ChiCTR2000030819,ChiCTR,2020-03-15,2020-03-01,True,Wuhan Third Hospital,Not Recruiting,Not Applicable,Observational,China,"Retrospective analysis of digestive system symptoms in 600 cases of novel coronavirus pneumonia (COVID-19) in Guanggu district, Wuhan",Clinical Presentation,No Intervention,600,Not Available,2020-12-31,http://www.chictr.org.cn/showproj.aspx?proj=51039,No Results,No Results,No Results,2020-03-16,2020-03-18,None
358,ChiCTR2000030839,ChiCTR,2020-03-15,2020-03-01,True,"Tongren Hospital, Shanghai Jiao Tong University School of Medicine",Not Recruiting,Not Applicable,Screening,China,Preliminary screening of novel coronavirus pneumonia (COVID-19) by special laboratory examination and CT imaging before surgery,Diagnostics,Diagnostic Test or Assessment,100,Not Available,2020-04-30,http://www.chictr.org.cn/showproj.aspx?proj=50904,No Results,No Results,No Results,2020-03-16,2020-03-18,None
359,ChiCTR2000030818,ChiCTR,2020-03-15,2020-01-31,True,"The First Affiliated Hospital, Henan Traditional Chinese Medicine University",Not Recruiting,Not Applicable,Observational,China,A medical records based study for the value of Lymphocyte subsets in the diagnose and treatment of novel coronavirus pneumonia (COVID-19),Clinical Presentation,No Intervention,10,Not Available,2020-02-24,http://www.chictr.org.cn/showproj.aspx?proj=51037,No Results,No Results,No Results,2020-03-16,2020-03-18,None
360,ChiCTR2000030832,ChiCTR,2020-03-15,2020-03-16,False,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Not Recruiting,Not Applicable,Interventional,No Country Given,Study for the pathogenesis and effective intervention of mood disorders caused by the novel coronavirus pneumonia (COVID-19),Other (psych),Psychological,800,Not Available,2020-07-30,http://www.chictr.org.cn/showproj.aspx?proj=51044,No Results,No Results,No Results,2020-03-16,2020-03-18,None
361,NCT04276896,ClinicalTrials.gov,2020-02-17,2020-03-24,False,Shenzhen Geno-Immune Medical Institute,Recruiting,Phase 1/Phase 2,Interventional,China,Immunity and Safety of Covid-19 Synthetic Minigene Vaccine,ATMP,Vaccine,100,2023-07-31,2024-12-31,https://clinicaltrials.gov/show/NCT04276896,No Results,No Results,No Results,2020-03-30,2020-03-18,None
362,NCT04291053,ClinicalTrials.gov,2020-02-27,2020-04-01,False,Tongji Hospital,Not Recruiting,Phase 2/Phase 3,Interventional,No Country Given,The Efficacy and Safety of Huai er in the Adjuvant Treatment of COVID-19,Traditional Medicine (Drug),Traditional Medicine,550,2020-08-01,2020-09-01,https://clinicaltrials.gov/show/NCT04291053,No Results,No Results,No Results,2020-03-30,2020-03-18,None
363,ChiCTR2000030803,ChiCTR,2020-03-15,2020-01-31,True,"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Not Applicable,Observational,No Country Given,Collection and analysis of clinical data in severe and critically ill patients with novel coronavirus pneumonia (COVID-19),Clinical Presentation,No Intervention,400,Not Available,2020-04-30,http://www.chictr.org.cn/showproj.aspx?proj=51007,No Results,No Results,No Results,2020-03-16,2020-03-18,None
364,ChiCTR2000030830,ChiCTR,2020-03-15,2020-01-01,True,"Hwa Mei Hospital, University of Chinese Academy of Sciences",Recruiting,Not Applicable,Observational,China,Development and application of novel coronavirus pneumonia (COVID-19) intelligent image classification system based on deep learning,Diagnostics,Diagnostic Test or Assessment,150,Not Available,2020-12-31,http://www.chictr.org.cn/showproj.aspx?proj=51009,No Results,No Results,No Results,2020-03-16,2020-03-18,None
365,ChiCTR2000030802,ChiCTR,2020-03-15,2020-01-27,True,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Not Recruiting,Not Applicable,Observational,China,A retrospective study of clinical drug therapy in patients with novel coronavirus pneumonia (COVID-19),Drug,Unspecified Drug,2000,Not Available,2020-06-30,http://www.chictr.org.cn/showproj.aspx?proj=51004,No Results,No Results,No Results,2020-03-16,2020-03-18,None
366,ChiCTR2000030806,ChiCTR,2020-03-15,2020-02-01,True,Wuhan Third Hospital,Recruiting,Not Applicable,Observational,China,Retrospective study for the efficacy of ulinastatin combined with ''clear lung detoxification soup'' in the treatment of novel coronavirus pneumonia (COVID-19),Traditional Medicine (Drug),Traditional Medicine,20,Not Available,2020-03-31,http://www.chictr.org.cn/showproj.aspx?proj=51029,No Results,No Results,No Results,2020-03-16,2020-03-18,None
367,NCT04293692,ClinicalTrials.gov,2020-02-24,2020-02-24,False,Puren Hospital Affiliated to Wuhan University of Science and Technology,Not Recruiting,Not Applicable,Interventional,China,Therapy for Pneumonia Patients iInfected by 2019 Novel Coronavirus,ATMP,Cells (mesenchymal),Not Available,2020-02-25,2020-02-25,https://clinicaltrials.gov/show/NCT04293692,No Results,No Results,No Results,2020-03-30,2020-03-18,None
368,NCT04305574,ClinicalTrials.gov,2020-03-08,2020-03-08,False,Jean Liu,Recruiting,Not Applicable,Observational,Singapore,Social Media Use During COVID-19,Other,No Intervention,5000,2020-05-31,2020-05-31,https://clinicaltrials.gov/show/NCT04305574,No Results,No Results,No Results,2020-03-30,2020-03-18,None
369,ChiCTR2000030801,ChiCTR,2020-03-15,2020-01-23,True,The Third Hospital of Wuhan,Recruiting,Not Applicable,Observational,China,Analysis of risk factors affecting prognosis of elderly patients infected with novel coronavirus pneumonia (COVID-19): a single-center retrospective observational study,Prognosis,No Intervention,100,Not Available,2020-02-29,http://www.chictr.org.cn/showproj.aspx?proj=50998,No Results,No Results,No Results,2020-03-16,2020-03-18,None
370,NCT04273529,ClinicalTrials.gov,2020-02-14,2020-02-20,False,The First Affiliated Hospital of Wenzhou Medical University,Not Recruiting,Phase 2,Interventional,No Country Given,The Efficacy and Safety of Thalidomide in the Adjuvant Treatment of Moderate New Coronavirus (COVID-19) Pneumonia,Drug,Thalidomide,100,2020-05-30,2020-06-30,https://clinicaltrials.gov/show/NCT04273529,No Results,No Results,No Results,2020-03-02,2020-08-03,None
371,NCT04273581,ClinicalTrials.gov,2020-02-14,2020-02-18,False,The First Affiliated Hospital of Wenzhou Medical University,Not Recruiting,Phase 2,Interventional,No Country Given,The Efficacy and Safety of Thalidomide Combined With Low-dose Hormones in the Treatment of Severe COVID-19,Drug,Thalidomide + Corticosteroids,40,2020-04-30,2020-05-30,https://clinicaltrials.gov/show/NCT04273581,No Results,No Results,No Results,2020-03-02,2020-08-03,None
372,ChiCTR2000030804,ChiCTR,2020-03-15,2020-02-01,True,Maoming People's Hospital,Recruiting,Phase 4,Interventional,China,Exocarpium Citri Grandis Relieves Symptoms of Novel Coronavirus Pneunomia (COVID-19): a Randomized Controlled Clinical Trial,Traditional Medicine (Drug),Traditional Medicine,128,Not Available,2021-03-31,http://www.chictr.org.cn/showproj.aspx?proj=51018,No Results,No Results,No Results,2020-03-16,2020-03-18,None
373,ChiCTR2000030799,ChiCTR,2020-03-15,2020-01-20,True,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Not Recruiting,Not Applicable,Diagnostic test,China,Establishment and validation of Premonitory model of deterioration of the 2019 novel corona virus pneumonia (COVID-19),Prognosis,No Intervention,1000,Not Available,2020-06-30,http://www.chictr.org.cn/showproj.aspx?proj=50995,No Results,No Results,No Results,2020-03-16,2020-03-18,None
374,ChiCTR2000030784,ChiCTR,2020-03-14,2020-01-17,True,The People's Hospital of Guangxi Zhuang Autonomous Region,Recruiting,Not Applicable,Observational,China,A study for clinical characteristics of novel coronavirus pneumonia (COVID-19) patients follow-up in Guangxi,Clinical Presentation,No Intervention,150,Not Available,2020-01-17,http://www.chictr.org.cn/showproj.aspx?proj=50307,No Results,No Results,No Results,2020-03-16,2020-03-18,None
375,NCT04279782,ClinicalTrials.gov,2020-02-15,2020-01-20,True,"Third Affiliated Hospital, Sun Yat-Sen University",Recruiting,Not Applicable,Observational,China,Clinical Features of Suspected and Confirmed Patients of 2019 Novel Coronavirus Infection,Clinical Presentation,No Intervention,100,2021-01-31,2021-02-28,https://clinicaltrials.gov/show/NCT04279782,No Results,No Results,No Results,2020-03-02,2020-03-18,None
376,NCT04279795,ClinicalTrials.gov,2020-02-19,2020-01-20,True,"Third Affiliated Hospital, Sun Yat-Sen University",Recruiting,Not Applicable,Observational,China,Detection of 2019 Novel Coronavirus in Multiple Organ System and Its Relationship With Clinical Manifestations,Clinical Presentation,No Intervention,20,2021-01-31,2021-02-28,https://clinicaltrials.gov/show/NCT04279795,No Results,No Results,No Results,2020-03-02,2020-03-18,None
377,NCT04310865,ClinicalTrials.gov,2020-03-15,2020-03-20,False,Zhong Wang,Not Recruiting,Phase 2/Phase 3,Interventional,China,Yinhu Qingwen Granula for the Treatment of Severe CoVID-19,Traditional Medicine (Drug),Traditional Medicine,116,2021-03-30,2021-06-30,https://clinicaltrials.gov/show/NCT04310865,No Results,No Results,No Results,2020-03-30,2020-03-25,None
378,NCT04311398,ClinicalTrials.gov,2020-03-14,2020-03-14,False,Huashan Hospital,Not Recruiting,Not Applicable,Observational,China,Development and Verification of a New Coronavirus Multiplex Nucleic Acid Detection System,Diagnostics,Diagnostic Test or Assessment,100,2020-06-01,2020-12-01,https://clinicaltrials.gov/show/NCT04311398,No Results,No Results,No Results,2020-03-30,2020-03-25,None
379,ChiCTR2000030797,ChiCTR,2020-03-15,2020-03-07,True,"Shanghai Fifth People's Hospital, Fudan University",Recruiting,Not Applicable,Observational,China,clinical study for hemodynamics and cardiac arrhythmia of novel coronavirus pneumonia (COVID-19) patients,Clinical Presentation,No Intervention,100,Not Available,2021-07-07,http://www.chictr.org.cn/showproj.aspx?proj=50988,No Results,No Results,No Results,2020-03-16,2020-03-18,None
380,ChiCTR2000030768,ChiCTR,2020-03-14,2020-02-01,True,Zhongnan Hospital of Wuhan University,Recruiting,Not Applicable,Epidemiological research,China,Study for the Psychological Status of Medical Staff of Otolaryngology Head and Neck Surgery in Hubei Province under the Epidemic of novel coronavirus pneumonia (COVID-19),Other (psych),No Intervention,450,Not Available,2021-02-01,http://www.chictr.org.cn/showproj.aspx?proj=50968,No Results,No Results,No Results,2020-03-16,2020-03-18,None
381,ChiCTR2000030779,ChiCTR,2020-03-14,2020-03-16,False,Shanghai Changzheng Hospital,Recruiting,Phase 4,Interventional,China,A clinical trial for Ulinastatin Injection in the treatment of patients with severe novel coronavirus pneumonia (COVID-19),Traditional Medicine (Drug),Traditional Medicine,100,Not Available,2020-05-31,http://www.chictr.org.cn/showproj.aspx?proj=50973,No Results,No Results,No Results,2020-03-16,2020-03-18,None
382,ChiCTR2000030442,ChiCTR,2020-03-02,2020-03-05,False,The Second Affiliated Hospital of Xi'an Jiaotong University,Not Recruiting,Not Applicable,Interventional,No Country Given,"Combination of Tocilizumab, IVIG and CRRT in severe patients with novel coronavirus pneumonia (COVID-19)",Drug (+ ATMP + Other (renal)),Tocilizumab + immunoglobulin + renal replacement therapy,100,Not Available,2020-05-15,http://www.chictr.org.cn/showproj.aspx?proj=50380,No Results,No Results,No Results,2020-03-02,2020-03-18,None
383,ChiCTR2000030751,ChiCTR,2020-03-13,2020-01-25,True,Affiliated Hospital of Inner Mongolia University for the Nationalities,Not Recruiting,Not Applicable,Interventional,China,Clinical Research for Traditional Mongolian Medicine in the treatment of novel coronavirus pneumonia (COVID-19),Traditional Medicine (Unspecified),Traditional Medicine,60,Not Available,2020-12-25,http://www.chictr.org.cn/showproj.aspx?proj=50941,No Results,No Results,No Results,2020-03-16,2020-03-18,None
384,NCT04314271,ClinicalTrials.gov,2020-03-16,2020-03-20,False,Xiangya Hospital of Central South University,Recruiting,Not Applicable,Observational,China,The Observational Study of Cardiac and Pulmonary Ultrasound and Evaluation of Treatment of Severe Patients With Novel Coronavirus Pneumonia,Clinical Presentation,No Intervention,80,2020-05-01,2020-05-31,https://clinicaltrials.gov/show/NCT04314271,No Results,No Results,No Results,2020-03-30,2020-03-25,None
385,NCT04315870,ClinicalTrials.gov,2020-03-18,2020-01-01,True,Federico II University,Recruiting,Not Applicable,Observational,Italy,Clinical Characteristics of Coronavirus Disease 2019 (COVID-19) in Pregnancy: The Italian Registry on Coronavirus in Pregnancy.,Clinical Presentation,No Intervention,20,2020-04-20,2020-04-30,https://clinicaltrials.gov/show/NCT04315870,No Results,No Results,No Results,2020-03-30,2020-03-25,None
386,ChiCTR2000030763,ChiCTR,2020-03-13,2020-02-01,True,Shandong Provincial Chest hospital,Recruiting,Not Applicable,Observational,China,A Medical Records Based analysis for Risk Factors for Outcomes After Respiratory Support in Patients with ARDS Due to Novel Coronavirus Pneumonia (COVID-19),Clinical Presentation,No Intervention,100,Not Available,2020-08-31,http://www.chictr.org.cn/showproj.aspx?proj=50921,No Results,No Results,No Results,2020-03-16,2020-03-18,None
387,ChiCTR2000030718,ChiCTR,2020-03-11,2020-02-12,True,Zhongnan Hospital of Wuhan University,Recruiting,Phase 4,Interventional,China,Randomized controlled trial for Chloroquine Phosphate in the Treatment of novel coronavirus pneumonia (COVID-19),Drug,Chloroquine,80,Not Available,2020-05-30,http://www.chictr.org.cn/showproj.aspx?proj=50843,No Results,No Results,No Results,2020-03-16,2020-03-18,None
388,ChiCTR2000030761,ChiCTR,2020-03-13,2020-05-31,False,"Renji Hospital, Shanghai Jiaotong University School of Medicine",Not Recruiting,Not Applicable,Interventional,China,Continuous renal replacement therapy (CRRT) alleviating inflammatory response in severe patients with novel coronavirus pneumonia (COVID-19) associated with renal injury: A Prospective study,Other (renal),Renal replacement therapy,20,Not Available,2020-04-01,http://www.chictr.org.cn/showproj.aspx?proj=50956,No Results,No Results,No Results,2020-03-16,2020-03-18,None
389,ChiCTR2000030717,ChiCTR,2020-03-11,2020-04-01,False,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Not Recruiting,Not Applicable,Observational,China,A medical records based study for risk assessment and treatment timing of invasive fungal infection in novel coronavirus pneumonia (COVID-19) critical patients,Clinical Presentation,No Intervention,260,Not Available,2020-08-31,http://www.chictr.org.cn/showproj.aspx?proj=50860,No Results,No Results,No Results,2020-03-16,2020-03-18,None
390,ChiCTR2000030424,ChiCTR,2020-03-01,2020-03-02,False,Henan Provincial People's Hospital,Not Recruiting,Not Applicable,Interventional,China,"A single-center, single-arm clinical trial for azvudine in the treatment of novel coronavirus pneumonia (COVID-19)",Drug,Azvudine,30,Not Available,2022-05-02,http://www.chictr.org.cn/showproj.aspx?proj=50174,No Results,No Results,No Results,2020-03-02,2020-08-03,None
391,ChiCTR2000030754,ChiCTR,2020-03-13,2020-03-11,True,The Third Affiliated Hospital of Sun Yat-sen University,Not Recruiting,Not Applicable,Diagnostic test,China,Medical records based study for the accuracy of SARS-CoV-2 IgM antibody screening for diagnosis of novel coronavirus pneumonia (COVID-19),Diagnostics,Diagnostic Test or Assessment,30,Not Available,2020-06-30,http://www.chictr.org.cn/showproj.aspx?proj=50824,No Results,No Results,No Results,2020-03-16,2020-03-18,None
392,NCT04316728,ClinicalTrials.gov,2020-03-14,2020-03-01,True,"Centro Studi Internazionali, Italy",Not Recruiting,Not Applicable,Interventional,Italy,Clinical Performance of the VivaDiag  COVID-19 lgM / IgG Rapid Test in Early Detecting the Infection of COVID-19,Diagnostics,Diagnostic Test or Assessment,200,2020-09-01,2020-11-01,https://clinicaltrials.gov/show/NCT04316728,No Results,No Results,No Results,2020-03-30,2020-03-25,None
393,ChiCTR2000031337,ChiCTR,2020-03-28,2020-03-18,True,Shandong Eye Institute,Recruiting,Not Applicable,Observational,China,"The relationship between habits of using eyes, degree of visual fatigue and myopia progression in students during the novel coronavirus pneumonia (COVID-19) pandemic",Clinical Presentation,No Intervention,400,Not Available,2021-06-18,http://www.chictr.org.cn/showproj.aspx?proj=51170,No Results,No Results,No Results,2020-03-30,2020-04-01,None
394,ChiCTR2000030716,ChiCTR,2020-03-11,2020-03-05,True,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Not Applicable,Observational,China,Shedding of SARS-CoV-2 in human semen and evaluation of reproductive health of novel coronavirus pneumonia (COVID-19) male patients,Clinical Presentation,No Intervention,150,Not Available,2020-06-30,http://www.chictr.org.cn/showproj.aspx?proj=50850,No Results,No Results,No Results,2020-03-16,2020-03-18,None
395,ChiCTR2000030752,ChiCTR,2020-03-13,2020-02-01,True,Shandong Provincial Chest hospital,Recruiting,Not Applicable,Observational,China,A medical records based analysis for risk factors for death in patients with Novel Coronavirus Pneumonia (COVID-19),Prognosis,No Intervention,500,Not Available,2020-08-31,http://www.chictr.org.cn/showproj.aspx?proj=50925,No Results,No Results,No Results,2020-03-16,2020-03-18,None
396,ChiCTR2000031271,ChiCTR,2020-03-26,2020-04-01,False,The Third Affiliated Hospital of Sun Yat-sen University,Not Recruiting,Not Applicable,Interventional,China,Metabolic abnormalities and rearrangement reversal treatment of patient with novel coronavirus pneumonia (COVID-19),Clinical Presentation,No Intervention,80,Not Available,2021-03-31,http://www.chictr.org.cn/showproj.aspx?proj=51194,No Results,No Results,No Results,2020-03-30,2020-04-01,None
397,ChiCTR2000030391,ChiCTR,2020-03-01,2020-03-01,False,Lishui Central Hospital,Not Recruiting,Not Applicable,Observational,China,A medical records based analysis for antiviral therapy effect on novel coronavirus pneumonia COVID-19 patients,Clinical Presentation,No Intervention,100,Not Available,Not Available,http://www.chictr.org.cn/showproj.aspx?proj=30796,Pre-Print Article,2020-04-29,https://doi.org/10.1101/2020.04.25.20079079,2020-03-02,2020-08-03,None
398,ChiCTR2000030701,ChiCTR,2020-03-10,2020-03-10,False,The Third People's Hospital of Shenzhen,Not Recruiting,Not Applicable,Interventional,China,"A randomized, parallel controlled open-label trial for the efficacy and safety of Prolongin (Enoxaparin Sodium Injection) in the treatment of adult patients with novel coronavirus pneumonia (COVID-19)",Drug,LMWH (Enoxaparin),60,Not Available,2020-09-30,http://www.chictr.org.cn/showproj.aspx?proj=50795,No Results,No Results,No Results,2020-03-16,2020-03-18,None
399,ChiCTR2000030747,ChiCTR,2020-03-13,2020-02-22,True,Hubei Hospital of Traditional Chinese Medicine,Recruiting,Not Applicable,Observational,China,A prospective cohort  study for comprehensive treatment of Chinese medicine in the treatment of convalescent patients of novel coronavirus pneumonia (COVID-19),Traditional Medicine (Unspecified),Traditional Medicine,1500,Not Available,2020-08-01,http://www.chictr.org.cn/showproj.aspx?proj=50000,No Results,No Results,No Results,2020-03-16,2020-03-18,None
400,ChiCTR2000031245,ChiCTR,2020-03-25,2020-01-25,True,Renmin Hospital of Wuhan University,Recruiting,Not Applicable,Observational,China,Epidemiologic and Clinical Characteristics of novel coronavirus pneumonia (COVID-19) in surgical patients: a medical records based retrospective study,Clinical Presentation (Epidemiology),No Intervention,2000,Not Available,2020-03-12,http://www.chictr.org.cn/showproj.aspx?proj=51518,No Results,No Results,No Results,2020-03-30,2020-04-01,None
401,ChiCTR2000030327,ChiCTR,2020-02-28,2020-01-21,True,The Second Affiliated hospital of Anhui Medical University,Recruiting,Not Applicable,Observational,China,Analysis of clinical characteristics of novel coronavirus pneumonia (COVID-19),Clinical Presentation,No Intervention,200,Not Available,2020-03-08,http://www.chictr.org.cn/showproj.aspx?proj=50214,No Results,No Results,No Results,2020-03-02,2020-08-03,None
402,ChiCTR2000030722,ChiCTR,2020-03-12,2020-03-09,True,Shanghai First People's Hospital,Not Recruiting,Not Applicable,Observational,China,Auscultatory characteristics of novel coronavirus pneumonia (COVID-19),Clinical Presentation,No Intervention,30,Not Available,2020-06-30,http://www.chictr.org.cn/showproj.aspx?proj=50338,No Results,No Results,No Results,2020-03-16,2020-03-18,None
403,ChiCTR2000030700,ChiCTR,2020-03-10,2020-03-09,True,"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology",Not Recruiting,Not Applicable,Interventional,China,Study for the efficacy and safety of Prolongin (Enoxaparin Sodium Injection) in treatment of novel coronavirus pneumonia (COVID-19) adult common patients,Drug,LMWH (Enoxaparin),60,Not Available,2020-09-30,http://www.chictr.org.cn/showproj.aspx?proj=50786,No Results,No Results,No Results,2020-03-16,2020-03-18,None
404,ChiCTR2000031227,ChiCTR,2020-03-25,2020-03-26,False,Renmin Hospital of Wuhan University,Not Recruiting,Not Applicable,Observational,No Country Given,"Clinical features and prognosis of invasive echanicalventilation patients with novel coronavirus pneumonia (COVID-19) in Wuhan, China: a single-centered, retrospective, observational study",Other (physical),Mechanical ventilation,40,Not Available,2020-04-06,http://www.chictr.org.cn/showproj.aspx?proj=51473,No Results,No Results,No Results,2020-03-30,2020-04-01,None
405,ChiCTR2000030720,ChiCTR,2020-03-11,2020-03-01,True,Hubei Hospital of Traditional Chinese Medicine,Recruiting,Not Applicable,Interventional,China,Prognosis Investigation and Intervention Study on Patients with novel coronavirus pneumonia (COVID-19) in recovery period Based on Community Health Management,Prognosis,No Intervention,120,Not Available,2020-08-31,http://www.chictr.org.cn/showproj.aspx?proj=50793,No Results,No Results,No Results,2020-03-16,2020-03-18,None
406,ChiCTR2000030683,ChiCTR,2020-03-09,2020-03-09,False,The Sixth Affiliated Hospital of Sun Yat-sen University,Not Recruiting,Not Applicable,Diagnostic test,China,The prediction value of prognosis of novel coronavirus pneumonia (COVID-19) in elderly patients by modified early warning score (MEWS): a medical records based retrospective observational study,Prognosis,No Intervention,234,Not Available,2020-12-31,http://www.chictr.org.cn/showproj.aspx?proj=50633,No Results,No Results,No Results,2020-03-16,2020-03-18,None
407,ChiCTR2000030940,ChiCTR,2020-03-18,2020-02-01,True,Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine,Not Recruiting,Not Applicable,Interventional,China,Study for ''Bai-Du Duan Fang'' application on the acupoint in the treatment of general type novel coronavirus pneumonia (COVID-19),Traditional Medicine (Other),Traditional Medicine,76,Not Available,2020-06-30,http://www.chictr.org.cn/showproj.aspx?proj=51061,No Results,No Results,No Results,2020-03-30,2020-03-25,None
408,ChiCTR2000030702,ChiCTR,2020-03-10,2020-02-15,True,China-Japan Friendship Hospital,Recruiting,Not Applicable,Interventional,China,Plasma of the convalescent in the treatment of novel coronavirus pneumonia (COVID-19) common patient: a prospective clinical trial,ATMP,Plasma,50,Not Available,2020-08-15,http://www.chictr.org.cn/showproj.aspx?proj=50537,No Results,No Results,No Results,2020-03-16,2020-03-18,None
409,ChiCTR2000030681,ChiCTR,2020-03-09,2020-03-16,False,Liaocheng People's Hospital,Not Recruiting,Not Applicable,Interventional,China,An anaesthesia procedure and extubation strategy for reducing patient agitation and cough after extubation that can be used to prevent the spread of Novel Coronavirus Pneumonia (COVID-19) and other infectious viruses in the operating Room,Other (physical),Extubation,240,Not Available,2021-11-16,http://www.chictr.org.cn/showproj.aspx?proj=50763,No Results,No Results,No Results,2020-03-16,2020-03-18,None
410,ChiCTR2000030937,ChiCTR,2020-03-18,2020-03-19,False,The First Affiliated Hospital of Guangzhou Medical University,Recruiting,Phase 4,Interventional,China,"A randomized, open-label, controlled trial for Gu-Shen Ding-Chuan-Wan in the treatment of patients with novel coronavirus pneumonia (COVID-19) at recovery phase with Fei-Pi-Qi-Xu Zhen",Traditional Medicine (Drug),Traditional Medicine,144,Not Available,2020-08-30,http://www.chictr.org.cn/showproj.aspx?proj=51240,No Results,No Results,No Results,2020-03-30,2020-03-25,None
411,ChiCTR2000030697,ChiCTR,2020-03-10,2020-03-10,False,Ningbo First Hospital,Not Recruiting,Not Applicable,Observational,China,"A multi-center, open-label observation study for psychological status and intervention efficacy of doctors, nurses, patients and their families in novel coronavirus pneumonia (COVID-19) designated hospitals",Other (psych),Psychological,1500,Not Available,2021-03-10,http://www.chictr.org.cn/showproj.aspx?proj=50781,Pre-Print Article,No Results,"https://doi.org/10.1101/2020.03.13.20033290

https://doi.org/10.1101/2020.03.22.20040899",2020-03-16,2020-03-18,None
412,ChiCTR2000030619,ChiCTR,2020-03-08,2020-02-01,True,The First Affiliated Hospital of Bengbu Medical College,Not Recruiting,Not Applicable,Observational,China,A medical records based real world study for the characteristics and correlation mechanism of traditional Chinese medicine combined with western medicine in the treatment of patients with novel coronavirus pneumonia (COVID-19),Clinical Presentation,No Intervention,160,Not Available,2020-05-31,http://www.chictr.org.cn/showproj.aspx?proj=50656,No Results,No Results,No Results,2020-03-16,2020-08-03,None
413,ChiCTR2000030686,ChiCTR,2020-03-09,2020-03-03,True,Peking University Third Hospital,Recruiting,Not Applicable,Observational,China,The effects of prevention and control measures on treatment and psychological status of cancer patients during the novel coronavirus pneumonia (COVID-19) outbreak,Other (psych),Psychological,300,Not Available,2020-07-03,http://www.chictr.org.cn/showproj.aspx?proj=50714,No Results,No Results,No Results,2020-03-16,2020-03-18,None
414,ChiCTR2000030704,ChiCTR,2020-03-10,2020-02-10,True,The First People's Hospital of Jiangxia District,No Status Given,Phase 4,Interventional,China,Observation Of Clinical Efficacy And Safety Of Bufonis Venenum Injection In The Treatment Of Severe Novel Coronavirus Pneumonia (COVID-19),Traditional Medicine (Drug),Traditional Medicine,50,Not Available,2020-03-10,http://www.chictr.org.cn/showproj.aspx?proj=50778,No Results,No Results,No Results,2020-03-30,2020-04-01,None
415,ChiCTR2000030679,ChiCTR,2020-03-09,2020-01-28,True,"Wuhan Children's Hospital, Tongji Medical College, Huazhong University of Science & Technology",Recruiting,Not Applicable,Observational,China,Cohort study of Novel Coronavirus Infected Diseases (COVID-19) in children,Clinical Presentation,No Intervention,500,Not Available,2022-12-31,http://www.chictr.org.cn/showproj.aspx?proj=50730,No Results,No Results,No Results,2020-03-16,2020-03-18,None
416,ChiCTR2000030028,ChiCTR,2020-02-20,2020-02-24,False,West China Hospital,Not Recruiting,Not Applicable,Interventional,China,Clinical comparative study of PD-1 mAb in the treatment of severe and critical patients with novel coronavirus pneumonia (COVID-19),Drug,PD1,40,Not Available,2020-08-31,http://www.chictr.org.cn/showproj.aspx?proj=49840,No Results,No Results,No Results,2020-03-30,2020-08-03,None
417,ChiCTR2000030606,ChiCTR,2020-03-08,2020-03-09,False,"Xiyuan Hospital, Chinese Academy of Traditional Chinese Medicine",Not Recruiting,Not Applicable,Observational,China,Medical records based study for the correlation between Chinese medicine certificate and lung image of novel coronavirus pneumonia (COVID-19),Traditional Medicine (Other),Traditional Medicine,120,Not Available,2021-12-31,http://www.chictr.org.cn/showproj.aspx?proj=50713,No Results,No Results,No Results,2020-03-16,2020-03-18,None
418,ChiCTR2000030055,ChiCTR,2020-02-22,2020-02-10,True,The First Affiliated Hospital of Guangzhou Medical University,Recruiting,Phase 4,Prognosis,China,Multicenter study for the treatment of Dipyridamole with novel coronavirus pneumonia (COVID-19),Drug,Dipyridamole,460,Not Available,2020-04-10,http://www.chictr.org.cn/showproj.aspx?proj=49864,Pre-Print Article,2020-02-29,https://doi.org/10.1101/2020.02.27.20027557,2020-03-16,2020-08-03,None
419,EUCTR2020-001243-15-BE,EU Clinical Trials Register,2020-03-27,2020-03-26,True,UZLeuven,Authorised,Phase 2,Interventional,Belgium,"Covid-19: A randomized, open-label, adaptive, proof-of- concept clinical trial of new antiviral drug candidates against SARS-CoV-2.",Drug,Itraconazole,200,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001243-15,No Results,No Results,No Results,2020-03-30,2020-04-01,None
420,ChiCTR2000030597,ChiCTR,2020-03-08,2020-03-09,False,China Academy of Chinese Medical Science,Not Recruiting,Not Applicable,Observational,China,Medical records based study for the correlation between Chinese medicine certificate and lung image of novel coronavirus pneumonia (COVID-19),Clinical Presentation,No Intervention,150,Not Available,2021-12-31,http://www.chictr.org.cn/showproj.aspx?proj=50702,No Results,No Results,No Results,2020-03-16,2020-08-03,None
421,ChiCTR2000030528,ChiCTR,2020-03-06,2020-03-06,False,The Second Clinical College of Guangzhou University of Chinese Medicine,Not Recruiting,Not Applicable,Observational,China,Application of TCM Nursing Scheme in Patients with Novel Coronavirus Pneumonia (COVID-19),Traditional Medicine (Other),Traditional Medicine,60,Not Available,2020-05-25,http://www.chictr.org.cn/showproj.aspx?proj=50641,No Results,No Results,No Results,2020-03-16,2020-08-03,None
422,ChiCTR2000030005,ChiCTR,2020-02-19,2020-02-21,False,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Not Recruiting,Not Applicable,Diagnostic test,China,Nucleic acid analysis of novel coronavirus pneumonia (COVID-19) in morning sputum samples and pharyngeal swabs-a prospectively diagnostic test,Diagnostics,Diagnostic Test or Assessment,200,Not Available,2020-04-21,http://www.chictr.org.cn/showproj.aspx?proj=49669,No Results,No Results,No Results,2020-03-16,2020-08-03,None
423,ChiCTR2000030325,ChiCTR,2020-02-28,2020-02-28,False,"Xiangyang Central Hospital, Affiliated Hospital of Hubei University of Arts and Sciences",Not Recruiting,Not Applicable,Observational,China,A survey of mental health of first-line medical service providers and construction of crisis intervention model for novel coronavirus pneumonia (COVID-19) in Xiangyang,Other (psych),No Intervention,500,Not Available,2020-04-28,http://www.chictr.org.cn/showproj.aspx?proj=50227,No Results,No Results,No Results,2020-03-02,2020-08-03,None
424,ChiCTR2000029592,ChiCTR,2020-02-05,2020-02-07,False,"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology",Not Recruiting,Not Applicable,Observational,China,Clinical Study of Arbidol Hydrochloride Using for Post-exposure Prophylaxis of 2019-nCoV in High-risk Population Including Medical Staff,Drug (Chemoprophylaxis),Umifenovir,1000,Not Available,2020-08-31,http://www.chictr.org.cn/showproj.aspx?proj=49069,No Results,No Results,No Results,2020-03-16,2020-08-03,None
425,ChiCTR2000030324,ChiCTR,2020-02-28,2020-02-28,False,"Xiangyang Central Hospital, Affiliated Hospital of Hubei University of Arts and Sciences",Not Recruiting,Not Applicable,Interventional,China,Traditional Chinese Medicine 'Zang-Fu Point-pressing' massage for children with novel coronavirus pneumonia (COVID-19),Traditional Medicine (Other),Traditional Medicine,40,Not Available,2020-05-28,http://www.chictr.org.cn/showproj.aspx?proj=50231,No Results,No Results,No Results,2020-03-02,2020-08-03,None
426,ChiCTR2000030476,ChiCTR,2020-03-03,2020-03-03,False,"Cancer Institute, Longhua Hospital, Shanghai University of Traditional Chinese Medicine",Recruiting,Not Applicable,Interventional,China,Study for meditation assists for the rehabilitation of patients with novel coronaviruse pneumonia (COVID-19),Traditional Medicine (Other),Traditional Medicine,200,Not Available,2020-07-01,http://www.chictr.org.cn/showproj.aspx?proj=50455,No Results,No Results,No Results,2020-03-16,2020-08-03,None
427,NCT04307693,ClinicalTrials.gov,2020-03-10,2020-03-11,False,Asan Medical Center,Recruiting,Phase 2,Interventional,South Korea,Comparison of Lopinavir/Ritonavir or Hydroxychloroquine in Patients With Mild Coronavirus Disease (COVID-19),Drug,Lopinavir/ritonavir vs. hydroxychloroquine,150,2020-05-01,2020-05-01,https://clinicaltrials.gov/show/NCT04307693,No Results,No Results,No Results,2020-03-23,2020-03-18,None
428,ChiCTR2000031104,ChiCTR,2020-03-22,2020-02-05,True,The Fifth Affiliated Hospital of Sun Yat-Sen University,Recruiting,Not Applicable,Observational,China,Study for metagenomics of patients with novel coronavirus pneumonia (COVID-19),Genomics,No Intervention,200,Not Available,2020-12-01,http://www.chictr.org.cn/showproj.aspx?proj=51185,No Results,No Results,No Results,2020-03-23,2020-03-25,None
429,ChiCTR2000031088,ChiCTR,2020-03-22,2020-02-09,True,Xiangyang First People's Hospital,Recruiting,Not Applicable,Observational,China,A prognosis study of novel coronavirus pneumonia (COVID-19),Prognosis,No Intervention,314,Not Available,2022-02-09,http://www.chictr.org.cn/showproj.aspx?proj=51132,No Results,No Results,No Results,2020-03-23,2020-03-25,None
430,ChiCTR2000031023,ChiCTR,2020-03-21,2020-03-16,True,Hu'nan Cancer Hospital,Recruiting,Not Applicable,Interventional,China,Perioperative immune prediction and intervention of tumor patients undergoing surgery during the novel coronavirus pneumonia (COVID-19) outbreak period,Prognosis,No Intervention,320,Not Available,2020-05-16,http://www.chictr.org.cn/showproj.aspx?proj=50984,No Results,No Results,No Results,2020-03-23,2020-03-25,None
431,ChiCTR2000031014,ChiCTR,2020-03-21,2020-03-19,True,"Hwa Mei Hospital, University of Chinese Academy of Sciences",Not Recruiting,Not Applicable,Observational,China,A Study for SARS-COV-2 RNA Level in Blood and Excrement of Novel Coronavirus Pneumonia (COVID-19) Convalescent Patients,Clinical Presentation,No Intervention,100,Not Available,2020-09-19,http://www.chictr.org.cn/showproj.aspx?proj=51348,No Results,No Results,No Results,2020-03-23,2020-03-25,None
432,ChiCTR2000030947,ChiCTR,2020-03-19,2020-02-11,True,"Beijing Chaoyang Hospital, Capital Medical University",Recruiting,Not Applicable,Observational,China,A medical records based study for clinical application of extracorporeal membrane oxygenation in the treatment of severe respiratory failure patients with novel coronavirus pneumonia (COVID-19),Drug,Oxygen,34,Not Available,2020-04-30,http://www.chictr.org.cn/showproj.aspx?proj=51267,No Results,No Results,No Results,2020-03-23,2020-03-25,None
433,ChiCTR2000030946,ChiCTR,2020-03-19,2020-02-10,True,The First Affiliated Hospital of Guangzhou Medical University,Recruiting,Phase 4,Interventional,China,Effects of different VTE prevention methods on the prognosis of hospitalized patients with novel coronavirus pneumonia (COVID-19),Drug,LMWH,120,Not Available,2020-04-10,http://www.chictr.org.cn/showproj.aspx?proj=51265,No Results,No Results,No Results,2020-03-23,2020-03-25,None
434,ChiCTR2000030933,ChiCTR,2020-03-18,2020-03-31,False,The First Affiliated Hospital of Nanchang University,Not Recruiting,Not Applicable,Interventional,China,Effectiveness of ''Liu-Zi-Jue'' combined with respiratory muscle training for respiratory function in novel coronavirus pneumonia (COVID-19) patients: a randomized controlled trial,Traditional Medicine (Other),Traditional Medicine,108,Not Available,2020-12-31,http://www.chictr.org.cn/showproj.aspx?proj=51184,No Results,No Results,No Results,2020-03-23,2020-03-25,None
435,ChiCTR2000030932,ChiCTR,2020-03-18,2020-02-01,True,Anqing Municipal Hospital,Recruiting,Not Applicable,Observational,China,Correlation between virological negative conversion and clinical factors and prognosis in patients with novel coronavirus pneumonia (COVID-19),Prognosis,No Intervention,100,Not Available,2020-06-30,http://www.chictr.org.cn/showproj.aspx?proj=51230,No Results,No Results,No Results,2020-03-23,2020-03-25,None
436,ChiCTR2000030931,ChiCTR,2020-03-18,2020-03-23,False,HuiZhou Municipal Central Hospital,Not Recruiting,Not Applicable,Observational,China,A Medical Records Based Study for Clinical Characteristic and Outcomes of Hospitalized Patients With Novel Coronavirus Pneumonia (COVID-19),Clinical Presentation,No Intervention,60,Not Available,2020-05-22,http://www.chictr.org.cn/showproj.aspx?proj=51212,No Results,No Results,No Results,2020-03-23,2020-03-25,None
437,ChiCTR2000029770,ChiCTR,2020-02-13,2020-02-13,False,"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Not Applicable,Observational,China,"Study for epidemiology, diagnosis and treatment of novel coronavirus pneumonia (COVID-19)",Clinical Presentation (Epidemiology),No Intervention,500,Not Available,2020-05-31,http://www.chictr.org.cn/showproj.aspx?proj=49412,No Results,No Results,No Results,2020-03-16,2020-08-03,None
438,ChiCTR2000030293,ChiCTR,2020-02-27,2020-03-01,False,Shanghai Public Health Clinical Center,Recruiting,Not Applicable,Observational,China,Clinical observation and research plan of novel coronavirus pneumonia (COVID-19) patients,Clinical Presentation,No Intervention,300,Not Available,2020-05-31,http://www.chictr.org.cn/showproj.aspx?proj=50195,No Results,No Results,No Results,2020-03-02,2020-08-03,None
439,ChiCTR2000030771,ChiCTR,2020-03-14,2020-03-01,True,The Second Xiangya Hospital of Central South University,Not Recruiting,Not Applicable,Diagnostic test,China,Screening and identification of peripheral blood biomarkers in patients with COVID-19 infection based on multiomics studies,Genomics,No Intervention,30,Not Available,2021-03-01,http://www.chictr.org.cn/showproj.aspx?proj=50961,No Results,No Results,No Results,2020-03-23,2020-03-25,None
440,NCT04285801,ClinicalTrials.gov,2020-02-24,2020-02-14,True,Chinese University of Hong Kong,Not Recruiting,Not Applicable,Observational,Hong Kong,Critically Ill Patients With COVID-19 in Hong Kong: a Multicentre Observational Cohort Study,Clinical Presentation,No Intervention,8,2020-02-25,2020-02-25,https://clinicaltrials.gov/show/NCT04285801,No Results,No Results,No Results,2020-03-23,2020-08-03,None
441,NCT04299724,ClinicalTrials.gov,2020-03-05,2020-02-15,True,Shenzhen Geno-Immune Medical Institute,Recruiting,Phase 1,Interventional,China,Safety and Immunity of Covid-19 aAPC Vaccine,ATMP,Plasma,100,2023-07-31,2024-12-31,https://clinicaltrials.gov/show/NCT04299724,No Results,No Results,No Results,2020-03-23,2020-03-18,None
442,ChiCTR2000030290,ChiCTR,2020-02-27,2020-02-11,True,Xiamen University,Not Recruiting,Not Applicable,Observational,China,Health related quality of life and its influencing factors among front line nurses caring patients with new coronavirus pneumonia (COVID-19) from two hospitals in China,Other (psych),No Intervention,2000,Not Available,2020-02-27,http://www.chictr.org.cn/showproj.aspx?proj=50175,No Results,No Results,No Results,2020-03-02,2020-08-03,None
443,ChiCTR2000029658,ChiCTR,2020-02-09,2020-02-10,False,Central Theater General Hospital of PLA,No Status Given,Not Applicable,Interventional,China,Nasal high-fow preoxygenation assisted fibre-optic bronchoscope intubation in patients with critical novel coronavirus pneumonia (COVID-19),Other (physical),Mechanical ventilation,60,Not Available,2020-04-06,http://www.chictr.org.cn/showproj.aspx?proj=49074,Correspondence,2020-03-19,https://doi.org/10.1016/j.bja.2020.02.020,2020-03-23,2020-08-03,None
444,NCT04302688,ClinicalTrials.gov,2020-03-07,2019-12-10,True,Renmin Hospital of Wuhan University,Not Recruiting,Not Applicable,Observational,China,Accurate Classification System for Patients With COVID-19 Pneumonitis,Prognosis,No Intervention,669,2020-02-10,2020-03-04,https://clinicaltrials.gov/show/NCT04302688,No Results,No Results,No Results,2020-03-23,2020-03-18,None
445,ChiCTR2000031150,ChiCTR,2020-03-23,2020-04-01,False,"Hwa Mei Hospital, University of Chinese Academy of Sciences",Recruiting,Not Applicable,Health services research,China,Application of radiology in the prevention and control system of emergency respiratory infectious diseases,Other (radiology),Radiology,150,Not Available,2020-12-31,http://www.chictr.org.cn/showproj.aspx?proj=51021,No Results,No Results,No Results,2020-03-23,2020-03-25,None
446,ChiCTR2000029573,ChiCTR,2020-02-05,2020-02-06,False,The First Affiliated Hospital of Zhejiang University School of Medicine,Recruiting,Phase 4,Interventional,China,"A multicenter, randomized, open, controlled clinical study to evaluate the efficacy and safety of recombinant cytokine gene-derived protein injection in combination with standard therapy in patients with novel coronavirus infection",ATMP,Gene-derived protein,480,Not Available,2020-06-30,http://www.chictr.org.cn/showproj.aspx?proj=49065,No Results,No Results,No Results,2020-03-23,2020-08-03,None
447,ChiCTR2000030259,ChiCTR,2020-02-26,2020-02-22,True,Shanghai Changzheng Hospital,Recruiting,Not Applicable,Interventional,China,"Evaluation Danorevir sodium tablets combined with ritonavir in the treatment of novel coronavirus pneumonia (COVID-19): a randomized, open and controlled trial",Drug,Danoprevir + Ritonavir,60,Not Available,2020-04-30,http://www.chictr.org.cn/showproj.aspx?proj=49918,No Results,No Results,No Results,2020-03-02,2020-08-03,None
448,ChiCTR2000031139,ChiCTR,2020-03-22,2020-03-20,True,Wuhan Jinyintan Hospital (Wuhan Infectious Diseases Hospital),Recruiting,Not Applicable,Interventional,China,Safety and Effectiveness of Human embryonic stem cell-derived M cells (CAStem) for Pulmonary Fibrosis Correlated with novel coronavirus pneumonia (COVID-19),ATMP,Cells (stem cells),20,Not Available,2021-03-19,http://www.chictr.org.cn/showproj.aspx?proj=51404,No Results,No Results,No Results,2020-03-23,2020-03-25,None
449,ChiCTR2000029496,ChiCTR,2020-02-03,2020-01-29,True,The First Hospital of Changsha; The Second Xiangya Hospital of Central South University,Recruiting,Phase 4,Interventional,China,"A randomized, open label, parallel controlled trial of evaluating the efficacy of recombinant cytokine gene-derived protein injection for clearing novel coronavirus in patients with novel coronavirus pneumonia (COVID-19)",ATMP,Gene-derived protein,90,Not Available,2021-01-29,http://www.chictr.org.cn/showproj.aspx?proj=48809,Pre-Print Article,2020-04-29,https://doi.org/10.1101/2020.04.24.20077735,2020-03-23,2020-08-03,None
450,ChiCTR2000031089,ChiCTR,2020-03-22,2020-03-13,True,Guangzhou Eighth People's Hospital,Not Recruiting,Not Applicable,Interventional,China,A medical records based study for Tou-Jie-Qu-Wen Granules in the Treatment of mild and moderate patients with novel coronavirus pneumonia (COVID-19),Traditional Medicine (Drug),Traditional Medicine,300,Not Available,2020-04-30,http://www.chictr.org.cn/showproj.aspx?proj=51136,No Results,No Results,No Results,2020-03-23,2020-03-25,None
451,ChiCTR2000030258,ChiCTR,2020-02-26,2020-02-21,True,The Fourth Affiliated Hospital of Harbin Medical University,Not Recruiting,Not Applicable,Interventional,China,"A multicenter, randomized, controlled trial for efficacy and safety of hydrogen inhalation in the treatment of novel coronavirus pneumonia (COVID-19) patients",Drug,Hydrogen,60,Not Available,2020-08-20,http://www.chictr.org.cn/showproj.aspx?proj=49887,No Results,No Results,No Results,2020-03-02,2020-08-03,None
452,ChiCTR2000030993,ChiCTR,2020-03-20,2020-03-12,True,Renmin Hospital of Wuhan University,Not Recruiting,Not Applicable,Diagnostic test,China,A medical records based study for the value of Upper Respiratory Tract Virus Detection in the assessment of rehabilitation of novel coronavirus pneumonia (COVID-19) patient,Prognosis,No Intervention,300,Not Available,2020-06-12,http://www.chictr.org.cn/showproj.aspx?proj=51342,No Results,No Results,No Results,2020-03-23,2020-03-25,None
453,ChiCTR2000030257,ChiCTR,2020-02-26,2020-03-09,False,Puren Hospital of Wuhan City,Not Recruiting,Not Applicable,Observational,China,The coagulation function of novel coronavirus pneumonia (COVID-19) patients,Clinical Presentation,No Intervention,100,Not Available,2020-05-31,http://www.chictr.org.cn/showproj.aspx?proj=50006,No Results,No Results,No Results,2020-03-02,2020-08-03,None
454,NCT04251767,ClinicalTrials.gov,2020-01-30,2020-02-05,False,The Second Hospital of Nanjing Medical University,Not Recruiting,Not Applicable,Interventional,China,Washed Microbiota Transplantation for Patients With 2019-nCoV Infection,ATMP,Intestinal microbiome,Not Available,2020-04-30,2020-04-30,https://clinicaltrials.gov/show/NCT04251767,No Results,No Results,No Results,2020-03-30,2020-08-03,None
455,NCT04254874,ClinicalTrials.gov,2020-02-02,2020-02-01,True,Tongji Hospital,Recruiting,Phase 4,Interventional,China,"A Prospective/Retrospective,Randomized Controlled Clinical Study of Interferon Atomization in the 2019-nCoV Pneumonia",Drug,Interferon + Umifenovir vs. Umifenovir,100,2020-06-01,2020-07-01,https://clinicaltrials.gov/show/NCT04254874,No Results,No Results,No Results,2020-03-30,2020-08-03,None
456,NCT04319900,ClinicalTrials.gov,2020-03-20,2020-03-05,True,"Beijing Chaoyang Hospital, Capital Medical University",Recruiting,Phase 2/Phase 3,Interventional,China,Clinical Trial of Favipiravir Tablets Combine With Chloroquine Phosphate in the Treatment of Novel Coronavirus Pneumonia,Drug,Chloroquine + Favipiravir vs. Favipiravir,150,2020-04-30,2020-06-25,https://clinicaltrials.gov/show/NCT04319900,No Results,No Results,No Results,2020-04-06,2020-04-01,None
457,NCT04323514,ClinicalTrials.gov,2020-03-18,2020-03-13,True,University of Palermo,Recruiting,Not Applicable,Interventional,Italy,Use of Ascorbic Acid in Patients With COVID 19,Drug,Vitamin C,500,2021-03-13,2021-03-13,https://clinicaltrials.gov/show/NCT04323514,No Results,No Results,No Results,2020-04-06,2020-04-01,None
458,ChiCTR2000030987,ChiCTR,2020-03-20,2020-03-05,True,"Beijing Chaoyang Hospital, Capital Medical University",Recruiting,Phase 2/Phase 3,Interventional,China,A Randomized Controlled Trial for Favipiravir Tablets Combine With Chloroquine Phosphate in the Treatment of Novel Coronavirus Pneumonia (COVID-19),Drug,Favipiravir + chloroquine vs. favipiravir,150,Not Available,2020-06-25,http://www.chictr.org.cn/showproj.aspx?proj=51329,No Results,No Results,No Results,2020-03-23,2020-03-25,None
459,NCT04323631,ClinicalTrials.gov,2020-03-25,2020-03-01,True,Rambam Health Care Campus,Not Recruiting,Phase 1,Interventional,No Country Given,Hydroxychloroquine for the Treatment of Patients With Mild to Moderate COVID-19 to Prevent Progression to Severe Infection or Death,Drug,Hydroxychloroquine,1116,2020-12-01,2020-12-01,https://clinicaltrials.gov/show/NCT04323631,No Results,No Results,No Results,2020-04-06,2020-04-01,None
460,NCT04325919,ClinicalTrials.gov,2020-03-24,2020-02-24,True,Chinese University of Hong Kong,Recruiting,Not Applicable,Observational,Hong Kong,Coronavirus Disease 2019 (COVID-19) Study of Hospitalized Patients in Hong Kong,Clinical Presentation,No Intervention,170,2021-02-28,2021-06-17,https://clinicaltrials.gov/show/NCT04325919,No Results,No Results,No Results,2020-04-06,2020-04-07,None
461,ChiCTR2000030985,ChiCTR,2020-03-20,2020-03-04,True,Renmin Hospital of Wuhan University,Not Recruiting,Not Applicable,Observational,China,"Psychological Responses of Medical Staff during the Metaphase of novel coronavirus pneumonia (COVID-19) Outbreak in Hubei, China",Other (psych),No Intervention,1300,Not Available,2020-03-09,http://www.chictr.org.cn/showproj.aspx?proj=51311,No Results,No Results,No Results,2020-03-23,2020-03-25,None
462,ChiCTR2000030226,ChiCTR,2020-02-26,2020-02-01,True,The Fourth Hospital of Hebei Medical University,Recruiting,Not Applicable,Observational,China,"The treatment status and risk factors related to prognosis of hospitalized patients with novel coronavirus pneumonia (COVID-19) in intensive care unit, Hebei, China: a descriptive study",Prognosis,No Intervention,40,Not Available,2020-06-30,http://www.chictr.org.cn/showproj.aspx?proj=49855,No Results,No Results,No Results,2020-03-02,2020-08-03,None
463,ChiCTR2000030951,ChiCTR,2020-03-19,2020-03-20,False,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Not Recruiting,Not Applicable,Diagnostic test,China,Developing and evaluating of artificial intelligence triage system for suspected novel coronavirus pneumonia (COVID-19): a retrospective study,Other (software),No Intervention,2500,Not Available,2020-06-30,http://www.chictr.org.cn/showproj.aspx?proj=51283,No Results,No Results,No Results,2020-03-23,2020-03-25,None
464,NCT04255017,ClinicalTrials.gov,2020-02-02,2020-02-01,True,Tongji Hospital,Recruiting,Phase 4,Interventional,China,"A Prospective/Retrospective,Randomized Controlled Clinical Study of Antiviral Therapy in the 2019-nCoV Pneumonia",Drug,Umeprevir vs. Oseltamivir vs. lopinavir/ritonavir,400,2020-06-01,2020-07-01,https://clinicaltrials.gov/show/NCT04255017,No Results,No Results,No Results,2020-03-30,2020-08-03,None
465,NCT04261270,ClinicalTrials.gov,2020-02-04,2020-02-01,True,Tongji Hospital,Recruiting,Phase 3,Interventional,China,"A Randomized,Open,Controlled Clinical Study to Evaluate the Efficacy of ASC09F and Ritonavir for 2019-nCoV Pneumonia",Drug,ASCO9F + Ritonavir vs. Ritonavir + Oseltamivir vs. Oseltamivir,60,2020-05-01,2020-07-01,https://clinicaltrials.gov/show/NCT04261270,No Results,No Results,No Results,2020-03-30,2020-08-03,None
466,NCT04327570,ClinicalTrials.gov,2020-03-26,2020-03-27,False,UZLeuven,Not Recruiting,Not Applicable,Observational,No Country Given,In-depth Immunological Investigation of COVID-19.,Clinical Presentation,No Intervention,100,2020-09-30,2020-09-30,https://clinicaltrials.gov/show/NCT04327570,No Results,No Results,No Results,2020-04-06,2020-04-07,None
467,ChiCTR2000031539,ChiCTR,2020-04-03,2020-03-15,True,Wuhan Women and Children's Health Care Center,Not Recruiting,Not Applicable,Observational,China,A Medical Records Based Study for the Correlation between Angiotensin II Type 1 Receptor Blockers (ARBs) and  the Progression and Outcome of Novel Coronavirus Pneumonia (COVID-19),Drug,ARBs,180,Not Available,2020-06-30,http://www.chictr.org.cn/showproj.aspx?proj=51893,No Results,No Results,No Results,2020-04-06,2020-04-07,None
468,ChiCTR2000030944,ChiCTR,2020-03-18,2020-09-01,False,The Second Affiliated Hospital of Nanchang University,Not Recruiting,Phase 1,Interventional,China,Clinical study of human NK cells and MSCs transplantation for severe novel coronavirus pneumonia (COVID-19),ATMP,"Cells, (mesenchymal/NK)",20,Not Available,2020-08-31,http://www.chictr.org.cn/showproj.aspx?proj=50199,No Results,No Results,No Results,2020-03-23,2020-03-25,None
469,ChiCTR2000030225,ChiCTR,2020-02-26,2020-02-22,True,Yueyang Hospital of Integrated Traditional Chinese Medicine and Western Medicine Affiliated to Shanghai University of Tranditional Medicine,Not Recruiting,Not Applicable,Interventional,China,Clinical Reseach of Acupuncture in the treatment of Novel Coronavirus Pneumonia (COVID-19),Traditional Medicine (Other),Traditional Medicine,186,Not Available,2020-12-31,http://www.chictr.org.cn/showproj.aspx?proj=49945,No Results,No Results,No Results,2020-03-02,2020-08-03,None
470,ChiCTR2000031494,ChiCTR,2020-04-02,2020-02-01,True,Huangshi Hospital of Traditional Chinese Medicine,Recruiting,Phase 1,Interventional,China,Clinical study for stem cells in the treatment of severe novel coronavirus pneumonia (COVID-19),ATMP,Cells (mesenchymal),36,Not Available,2020-12-02,http://www.chictr.org.cn/showproj.aspx?proj=51904,No Results,No Results,No Results,2020-04-06,2020-04-07,None
471,ChiCTR2000030942,ChiCTR,2020-03-18,2020-01-20,True,Shanghai Kongjiang Hospital,Not Recruiting,Not Applicable,Observational,China,Combined diagnostic value of novel coronavirus (2019-CoV) infection detected by NLR and CRP,Diagnostics,Diagnostic Test or Assessment,191,Not Available,2020-06-30,http://www.chictr.org.cn/showproj.aspx?proj=50981,No Results,No Results,No Results,2020-03-23,2020-03-25,None
472,ChiCTR2000031465,ChiCTR,2020-04-02,2020-03-25,True,The First People's Hospital of Jiangxia District,Not Recruiting,Not Applicable,Diagnostic test,China,Novel coronavirus (2019-nCOV) IgG detection kit (magnetic particle chemiluminescence) clinical trial,Diagnostics,Diagnostic Test or Assessment,200,Not Available,2021-03-31,http://www.chictr.org.cn/showproj.aspx?proj=51538,No Results,No Results,No Results,2020-04-06,2020-04-07,None
473,NCT04264858,ClinicalTrials.gov,2020-02-08,2020-03-17,False,"Wuhan Union Hospital, China",Not Recruiting,Not Applicable,Interventional,China,Treatment of Acute Severe 2019-nCoV Pneumonia With Immunoglobulin From Cured Patients,ATMP,Immunoglobulin,10,2020-04-30,2020-05-31,https://clinicaltrials.gov/show/NCT04264858,No Results,No Results,No Results,2020-03-30,2020-08-03,None
474,NCT04278963,ClinicalTrials.gov,2020-02-19,2020-02-27,False,China Academy of Chinese Medical Sciences,Not Recruiting,Phase 2/Phase 3,Interventional,China,Yinhu Qingwen Decoction for the Treatment of Mild / Common CoVID-19,Traditional Medicine (Drug),Traditional Medicine,300,2021-01-01,2021-01-01,https://clinicaltrials.gov/show/NCT04278963,No Results,No Results,No Results,2020-03-30,2020-08-03,None
475,ChiCTR2000030919,ChiCTR,2020-03-17,2020-03-20,False,Xiangya Hospital of Central South University,Not Recruiting,Not Applicable,Observational,China,An observational study for cardiac and pulmonary ultrasound and evaluation of treatment of severe patients with novel coronavirus pneumonia (COVID-19),Clinical Presentation,No Intervention,80,Not Available,2020-05-31,http://www.chictr.org.cn/showproj.aspx?proj=51149,No Results,No Results,No Results,2020-03-23,2020-03-25,None
476,ChiCTR2000031454,ChiCTR,2020-04-01,2020-01-25,True,The Fifth Affiliated Hospital of Sun Yat-Sen University,Recruiting,Not Applicable,Interventional,China,Clinical study for prevention and treatment of digestive tract lesions caused by novel coronavirus pneumonia (COVID-19),Drug,Rabeprazole + chloroquine vs. lopinavir + rabeprazole,56,Not Available,2021-07-31,http://www.chictr.org.cn/showproj.aspx?proj=51693,No Results,No Results,No Results,2020-04-06,2020-04-07,None
477,ChiCTR2000030539,ChiCTR,2020-03-06,2020-03-06,False,Guangzhou Eighth People's Hospital,Not Recruiting,Not Applicable,Interventional,China,Study for clinical oral characteristics of patients with novel coronavirus pneumonia (COVID-19) and Effect of 3% hydrogen peroxide gargle on the Intraoral novel coronavirus,Drug,Hydrogen peroxide,40,Not Available,2021-03-05,http://www.chictr.org.cn/showproj.aspx?proj=50660,No Results,No Results,No Results,2020-03-23,2020-08-03,None
478,ChiCTR2000030095,ChiCTR,2020-02-23,2020-02-23,False,The First Affiliated Hospital of Nanchang University,Recruiting,Not Applicable,Observational,China,A medical records based study for optimization and evaluation of the comprehensive diagnosis and treatment of novel coronavirus pneumonia (COVID-19) and the assessment of risk factors for severe pneumonia,Clinical Presentation,No Intervention,94,Not Available,2020-07-31,http://www.chictr.org.cn/showproj.aspx?proj=49845,No Results,No Results,No Results,2020-03-23,2020-03-18,None
479,ChiCTR2000031439,ChiCTR,2020-04-01,2020-03-20,True,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Not Recruiting,Not Applicable,Observational,No Country Given,A medical records based study for novel coronavirus pneumonia (COVID-19) patients undergoing endotracheal intubation,Other (physical),Mechanical ventilation,Not Available,Not Available,2020-03-12,http://www.chictr.org.cn/showproj.aspx?proj=51837,No Results,No Results,No Results,2020-04-06,2020-04-07,None
480,NCT04292964,ClinicalTrials.gov,2020-03-01,2020-03-01,False,Chongqing Medical University,Not Recruiting,Not Applicable,Observational,China,Prognostic Factors of Patients With COVID-19,Prognosis,No Intervention,201,2020-03-13,2020-03-13,https://clinicaltrials.gov/show/NCT04292964,Pre-Print Article,2020-03-10,https://doi.org/10.1101/2020.03.07.20031575,2020-03-30,2020-03-18,None
481,NCT04306497,ClinicalTrials.gov,2020-03-01,2020-03-02,False,"Jiangsu Famous Medical Technology Co., Ltd.",Recruiting,Not Applicable,Observational,China,Clinical Trial on Regularity of TCM Syndrome and Differentiation Treatment of COVID-19.,Traditional Medicine (Unspecified),Traditional Medicine,340,2020-05-01,2020-05-01,https://clinicaltrials.gov/show/NCT04306497,No Results,No Results,No Results,2020-03-30,2020-03-18,None
482,NCT04312100,ClinicalTrials.gov,2020-03-13,2020-02-01,True,Henan Provincial People's Hospital,Recruiting,Not Applicable,Observational,China,Sequential Oxygen Therapy Strategy for Patients With COVID-19,Drug,Oxygen,30,2020-10-01,2021-02-01,https://clinicaltrials.gov/show/NCT04312100,No Results,No Results,No Results,2020-03-30,2020-03-25,None
483,ChiCTR2000031428,ChiCTR,2020-03-31,2020-02-05,True,Wuhan Asia Heart Hospital,Not Recruiting,Not Applicable,Diagnostic test,China,Clinical application value of multiple tests for novel coronavirus pneumonia (COVID-19),Diagnostics,Diagnostic Test or Assessment,500,Not Available,2020-10-04,http://www.chictr.org.cn/showproj.aspx?proj=51813,No Results,No Results,No Results,2020-04-06,2020-04-07,None
484,ChiCTR2000029868,ChiCTR,2020-02-15,2020-02-11,True,"Ruijin Hospital, Shanghai Jiao Tong University School of Medicine",Not Recruiting,Phase 4,Interventional,China,"Hydroxychloroquine treating novel coronavirus pneumonia (COVID-19): a randomized controlled, open label, multicenter trial",Drug,Hydroxychloroquine,360,Not Available,2020-06-30,http://www.chictr.org.cn/showproj.aspx?proj=49524,Pre-Print Article,2020-04-14,https://doi.org/10.1101/2020.04.10.20060558,2020-03-23,2020-08-03,None
485,ChiCTR2000031376,ChiCTR,2020-03-29,2020-03-28,True,Peking University Third Hospital,Recruiting,Not Applicable,Observational,China,A medical records based study for safety and effectiveness analysis of data from novel coronavirus pneumonia (COVID-19) patients with conventional therapy,Drug,Unspecified Drug,600,Not Available,2020-05-29,http://www.chictr.org.cn/showproj.aspx?proj=51724,No Results,No Results,No Results,2020-04-06,2020-04-01,None
486,NCT04318418,ClinicalTrials.gov,2020-03-19,2020-03-23,False,Neuromed IRCCS,Not Recruiting,Not Applicable,Observational,Italy,"ACE Inhibitors, Angiotensin II Type-I Receptor Blockers and Severity of COVID-19",Drug,ACE inhibitors or ARBs,5000,2020-04-10,2020-04-30,https://clinicaltrials.gov/show/NCT04318418,No Results,No Results,No Results,2020-03-30,2020-04-01,None
487,ChiCTR2000031356,ChiCTR,2020-03-28,2020-04-12,False,"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology",Not Recruiting,Not Applicable,Observational,China,Study for the changes of the brain structure and function in healed patients of novel coronavirus pneumonia (COVID-19),Clinical Presentation,No Intervention,600,Not Available,2021-04-04,http://www.chictr.org.cn/showproj.aspx?proj=51499,No Results,No Results,No Results,2020-03-30,2020-04-01,None
488,JPRN-jRCTs041190120,JPRN,2020-03-02,2020-03-02,False,Doi Yohei,Recruiting,Phase 2,Interventional,Japan,Favipiravir for SARS-CoV-infected patients,Drug,Favipiravir,86,Not Available,Not Available,https://jrct.niph.go.jp/latest-detail/jRCTs041190120,No Results,No Results,No Results,2020-03-23,2020-03-25,None
489,EUCTR2020-001271-33-FR,EU Clinical Trials Register,2020-03-24,2020-03-31,False,CHU Angers,Authorised,Phase 3,Interventional,France,HYCOVID - Hydroxychloroquine versus placebo chez les patients ayant une infection COVID-19  risque daggravation secondaire : tude prospective multicentrique randomise en double aveugle,Drug,Hydroxychloroquine,1300,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001271-33,No Results,No Results,No Results,2020-04-06,2020-04-07,None
490,ChiCTR2000031330,ChiCTR,2020-03-27,2020-03-18,True,Shandong Eye Institute,Recruiting,Not Applicable,Observational,China,Analysis for prevention and control effects of orthokeratology lens on myopia adolescents during the novel coronavirus pneumonia (COVID-19) pandemic situation,Other (device),Orthokeratology lens,160,Not Available,2021-06-18,http://www.chictr.org.cn/showproj.aspx?proj=51504,No Results,No Results,No Results,2020-03-30,2020-04-01,None
491,JPRN-UMIN000039873,JPRN,2020-03-19,2020-03-19,False,National Center for Global Health and Medicine,Recruiting,Not Applicable,Observational,Japan,COVID-19 Registry,Clinical Presentation,No Intervention,9999,Not Available,2021-01-31,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000045453,No Results,No Results,No Results,2020-03-23,2020-03-25,None
492,ChiCTR2000031329,ChiCTR,2020-03-27,2020-03-11,True,Guangdong Second Provincial General Hospital,Recruiting,Not Applicable,Observational,No Country Given,"Influence of novel coronavirus pneumonia (COVID-19) on disease activity, medical and mental condition of patients with rheumatic diseases",Clinical Presentation,No Intervention,120,Not Available,2023-12-31,http://www.chictr.org.cn/showproj.aspx?proj=51667,No Results,No Results,No Results,2020-03-30,2020-04-01,None
493,EUCTR2020-001281-11-FR,EU Clinical Trials Register,2020-03-26,2020-03-30,False,CHU de Saint Etienne,Authorised,Phase 4,Interventional,France,Evaluation of the concentration/viral effect relationship of hydroxychloroquine in COVID-19 patients in the intensive care unit..,Drug,Hydroxychloroquine,50,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001281-11,No Results,No Results,No Results,2020-04-06,2020-04-07,None
494,NCT04272710,ClinicalTrials.gov,2020-02-12,2020-01-25,True,Chongqing Medical University,Not Recruiting,Not Applicable,Observational,China,Prognositc Factors in COVID-19 Patients Complicated With Hypertension,Drug,ACE inhibitors,Not Available,2020-03-31,2020-04-30,https://clinicaltrials.gov/show/NCT04272710,No Results,No Results,No Results,2020-03-30,2020-08-03,None
495,NCT04304313,ClinicalTrials.gov,2020-02-14,2020-02-09,True,Tongji Hospital,Recruiting,Phase 3,Interventional,China,A Pilot Study of Sildenafil in COVID-19,Drug,Sildenafil,10,2020-03-01,2020-11-09,https://clinicaltrials.gov/show/NCT04304313,No Results,No Results,No Results,2020-03-30,2020-03-18,None
496,NCT04306705,ClinicalTrials.gov,2020-03-08,2020-02-20,True,Tongji Hospital,Recruiting,Not Applicable,Observational,China,Tocilizumab vs CRRT in Management of Cytokine Release Syndrome (CRS) in COVID-19,Drug,Tocilizumab,120,2020-05-30,2020-06-20,https://clinicaltrials.gov/show/NCT04306705,No Results,No Results,No Results,2020-03-30,2020-03-18,None
497,ChiCTR2000031328,ChiCTR,2020-03-27,2020-03-13,True,The First Teaching Hospital of Tianjin University of Traditional Chinese Medicine,Recruiting,Not Applicable,Interventional,China,The protective effect of sleep psychology and music therapy of novel coronavirus pneumonia (COVID-19) mild and moderate type patients,Other,Sleep aids,60,Not Available,2020-04-30,http://www.chictr.org.cn/showproj.aspx?proj=51425,No Results,No Results,No Results,2020-03-30,2020-04-01,None
498,NCT04314232,ClinicalTrials.gov,2020-03-17,2020-03-23,False,"University Hospital, Akershus",Not Recruiting,Not Applicable,Observational,No Country Given,Mechanisms to Morbidity and Mortality for Covid-19,Prognosis,No Intervention,200,2021-12-31,2021-12-31,https://clinicaltrials.gov/show/NCT04314232,No Results,No Results,No Results,2020-03-30,2020-03-25,None
499,NCT04314817,ClinicalTrials.gov,2020-03-17,2020-03-17,False,Groupe Hospitalier Piti Salptrire,Recruiting,Not Applicable,Observational,France,Adverse Events Related to Treatments Used Against Coronavirus Disease 2019,Traditional Medicine (Unspecified),Traditional Medicine,1000,2021-01-01,2023-01-01,https://clinicaltrials.gov/show/NCT04314817,No Results,No Results,No Results,2020-03-30,2020-03-25,None
500,NCT04316884,ClinicalTrials.gov,2020-03-13,2020-03-12,True,Uppsala University,Recruiting,Not Applicable,Observational,Sweden,Mechanisms for Organ Dysfunction in Covid-19,Clinical Presentation,No Intervention,100,2020-12-31,2021-12-31,https://clinicaltrials.gov/show/NCT04316884,No Results,No Results,No Results,2020-03-30,2020-03-25,None
501,ChiCTR2000031301,ChiCTR,2020-03-27,2020-02-01,True,China-Japan Union Hospital of Jilin Unversity,Not Recruiting,Not Applicable,Observational,China,A retrospective study of clinical characteristics and prognosis of novel coronavirus pneumonia (COVID-19) patients with myocardial injury,Prognosis,No Intervention,100,Not Available,2020-04-27,http://www.chictr.org.cn/showproj.aspx?proj=51603,No Results,No Results,No Results,2020-03-30,2020-04-01,None
502,ChiCTR2000030223,ChiCTR,2020-02-26,2020-02-20,True,No Sponsor Name Given,Recruiting,Not Applicable,Health services research,China,Quality of life among Chinese residents during and after novel coronavirus pneumonia (COVID19) outbreak: an online survey,Other (psych),No Intervention,5000,Not Available,2022-05-19,http://www.chictr.org.cn/showproj.aspx?proj=50026,No Results,No Results,No Results,2020-03-02,2020-03-18,None
503,NCT04320238,ClinicalTrials.gov,2020-03-21,2020-01-21,True,Shanghai Jiaotong University,Recruiting,Phase 3,Interventional,China,Experimental Trial of rhIFNa Nasal Drops to Prevent 2019-nCOV in Medical Staff,Drug,Interferon Alpha vs. Interferon Alpha + Thymosin Alpha,2944,2020-05-01,2020-06-01,https://clinicaltrials.gov/show/NCT04320238,Pre-Print Article,2020-04-17,https://doi.org/10.1101/2020.04.11.20061473,2020-04-14,2020-04-01,None
504,NCT04322188,ClinicalTrials.gov,2020-03-24,2020-03-19,True,A.O. Ospedale Papa Giovanni XXIII,Recruiting,Not Applicable,Observational,Italy,An Observational Case-control Study of the Use of Siltuximab in ARDS Patients Diagnosed With COVID-19 Infection,Drug,Siltuximab,50,2020-05-19,2020-05-19,https://clinicaltrials.gov/show/NCT04322188,Pre-Print Article,2020-04-03,https://doi.org/10.1101/2020.04.01.20048561,2020-04-14,2020-04-01,None
505,ChiCTR2000031247,ChiCTR,2020-03-25,2020-03-01,True,West China Hospital of Sichuan University,Recruiting,Not Applicable,Observational,No Country Given,Study on the mental state of medical staff  during the epidemic period of novel coronavirus pneumonia (COVID-19),Other (psych),No Intervention,500,Not Available,2021-03-01,http://www.chictr.org.cn/showproj.aspx?proj=51540,No Results,No Results,No Results,2020-03-30,2020-04-01,None
506,ChiCTR2000031361,ChiCTR,2020-03-28,2020-03-31,False,Hubei Maternal and Child Health Care Hospital,Not Recruiting,Not Applicable,Observational,China,Retrospective analysis of anesthesia management of emergency cesarean section in non-pneumonia hospital of Wuhan during pandemic of novel coronavirus pneumonia (COVID-19),Drug,Other,2000,Not Available,Not Available,http://www.chictr.org.cn/showproj.aspx?proj=51385,No Results,No Results,No Results,2020-03-30,2020-04-01,None
507,NCT04326452,ClinicalTrials.gov,2020-03-25,2020-03-27,False,TMC HealthCare,Recruiting,Not Applicable,Interventional,United States,Treating COVID-19 With a Bidirectional Oxygenation Valve,Other (device),Bidirectional Oxygenation Valve,15,2020-05-01,2020-06-01,https://clinicaltrials.gov/show/NCT04326452,No Results,No Results,No Results,2020-04-14,2020-04-07,None
508,NCT04327531,ClinicalTrials.gov,2020-03-27,2020-03-26,True,Kanuni Sultan Suleyman Training and Research Hospital,Not Recruiting,Not Applicable,Observational,Turkey,"Evaluation of Covid 19 Knowledge Anxiety and Expectation Levels of Turkish Physicians, Survey Study",Other (psych),No Intervention,200,2020-04-26,2020-04-28,https://clinicaltrials.gov/show/NCT04327531,No Results,No Results,No Results,2020-04-14,2020-04-07,None
509,NCT04330521,ClinicalTrials.gov,2020-03-30,2020-04-01,False,Stanford University,Not Recruiting,Not Applicable,Observational,No Country Given,Impact of the Coronavirus (COVID-19) on Patients With Cancer,Clinical Presentation,No Intervention,50,2022-05-01,2022-05-01,https://clinicaltrials.gov/show/NCT04330521,No Results,No Results,No Results,2020-04-14,2020-04-07,None
510,ChiCTR2000031214,ChiCTR,2020-03-24,2020-03-31,False,Wuhan Third Hospital,Not Recruiting,Not Applicable,Observational,China,Clinical study on the correlation between novel coronavirus pneumonia (COVID-19) clinical rehabilitation assessment and prognosis,Prognosis,No Intervention,60,Not Available,2022-03-31,http://www.chictr.org.cn/showproj.aspx?proj=51509,No Results,No Results,No Results,2020-03-30,2020-04-01,None
511,ChiCTR2000031336,ChiCTR,2020-03-28,2020-04-12,False,"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology",Not Recruiting,Not Applicable,Diagnostic test,China,AI based prognostic evaluation of novel coronavirus pneumonia (COVID-19),Prognosis,No Intervention,1000,Not Available,2021-03-31,http://www.chictr.org.cn/showproj.aspx?proj=51517,No Results,No Results,No Results,2020-03-30,2020-04-01,None
512,ChiCTR2000031198,ChiCTR,2020-03-23,2020-04-01,False,Nothern Jiangsu People's Hospital,Recruiting,Not Applicable,Observational,China,A medical records based study for clinical characteristics and risk factors of novel coronavirus pneumonia (COVID-19),Clinical Presentation,No Intervention,150,Not Available,2022-06-30,http://www.chictr.org.cn/showproj.aspx?proj=51488,No Results,No Results,No Results,2020-03-30,2020-04-01,None
513,ChiCTR2000031324,ChiCTR,2020-03-27,2020-04-10,False,Nanjing University Medical College Affiliated Drum Tower Hospital,Not Recruiting,Not Applicable,Observational,No Country Given,The investigation on medical adhesive-related skin injury caused by protective dressings of medical staffs during the period of novel coronavirus pneumonia (COVID-19),Other (device),No Intervention,300,Not Available,2021-01-01,http://www.chictr.org.cn/showproj.aspx?proj=51668,No Results,No Results,No Results,2020-03-30,2020-04-01,None
514,ChiCTR2000031272,ChiCTR,2020-03-26,2020-02-18,True,China European International Business School (CEIBS),Not Recruiting,Not Applicable,Interventional,China,The effectiveness of mindfulness intervention in improving people's psychological and physical well-being during novel coronavirus pneumonia (COVID-19) outbreak,Other (psych),Psychological,110,Not Available,2020-03-02,http://www.chictr.org.cn/showproj.aspx?proj=51455,No Results,No Results,No Results,2020-03-30,2020-04-01,None
515,ChiCTR2000031196,ChiCTR,2020-03-23,2020-01-10,True,The Fifth Medical Center of PLA General Hospital,Recruiting,Not Applicable,Interventional,China,Efficacy and optimization of antiviral therapy for novel coronavirus pneumonia (COVID-19) patients,Drug,Lopinavir/ritonavir + Interferon,90,Not Available,2020-12-31,http://www.chictr.org.cn/showproj.aspx?proj=51112,No Results,No Results,No Results,2020-03-30,2020-04-01,None
516,NCT04331613,ClinicalTrials.gov,2020-02-06,2020-01-27,True,Chinese Academy of Sciences,Recruiting,Phase 1/Phase 2,Interventional,China,Safety and Efficacy of CAStem for Severe COVID-19 Associated With/Without ARDS,ATMP,Cells (IMRC),9,2020-12-01,2020-12-01,https://clinicaltrials.gov/show/NCT04331613,No Results,No Results,No Results,2020-04-14,2020-04-07,None
517,NCT04333251,ClinicalTrials.gov,2020-03-27,2020-04-01,False,Baylor Research Institute,Not Recruiting,Phase 1,Interventional,No Country Given,Study Testing Convalescent Plasma vs Best Supportive Care,ATMP,Plasma,115,2022-12-31,2022-12-31,https://clinicaltrials.gov/show/NCT04333251,No Results,No Results,No Results,2020-04-14,2020-04-07,None
518,ChiCTR2000031252,ChiCTR,2020-03-25,2020-02-10,True,Chongqing Medical University,Not Recruiting,Not Applicable,Observational,China,Outcomes and infectivity of patients with asymptomatic novel coronavirus (COVID-19) infection,Clinical Presentation,No Intervention,60,Not Available,2020-06-30,http://www.chictr.org.cn/showproj.aspx?proj=51559,No Results,No Results,No Results,2020-03-30,2020-04-01,None
519,ChiCTR2000030988,ChiCTR,2020-03-20,2020-03-23,False,Guangdong Provincial Hospital of Chinese Medicine,Not Recruiting,Not Applicable,Interventional,China,A RCT for Hua-Shi Bai-Du granules in patients with novel coronavirus pneumonia (COVID-19),Traditional Medicine (Drug),Traditional Medicine,204,Not Available,2020-05-31,http://www.chictr.org.cn/showproj.aspx?proj=51317,No Results,No Results,No Results,2020-03-30,2020-03-25,None
520,ChiCTR2000029899,ChiCTR,2020-02-16,2020-02-17,False,Peking University Third Hospital,Recruiting,Phase 4,Interventional,China,"Evaluation the Efficacy and Safety of Hydroxychloroquine Sulfate in Comparison with Phosphate Chloroquine in Mild and Commen Patients with Novel Coronavirus Pneumonia (COVID-19): a Randomized, Open-label, Parallel, Controlled Trial",Drug,Hydroxychloroquine vs. Chloroquine,100,Not Available,2020-04-30,http://www.chictr.org.cn/showproj.aspx?proj=49536,No Results,No Results,No Results,2020-03-02,2020-08-03,None
521,ChiCTR2000031246,ChiCTR,2020-03-25,2020-02-01,True,Chongqing Medical University,Not Recruiting,Not Applicable,Observational,China,Epidemiological survey of close contacts of novel coronavirus pneumonia (COVID-19),Clinical Presentation (Epidemiology),No Intervention,68,Not Available,2021-04-30,http://www.chictr.org.cn/showproj.aspx?proj=51535,No Results,No Results,No Results,2020-03-30,2020-04-01,None
522,NCT04333693,ClinicalTrials.gov,2020-03-31,2020-04-01,False,Spanish Society for Angiology and Vascular Surgery,Not Recruiting,Not Applicable,Observational,Spain,Outcomes of Vascular Surgery in COVID-19 Infection: National Cohort Study,Clinical Presentation,No Intervention,50,2020-10-01,2020-11-01,https://clinicaltrials.gov/show/NCT04333693,No Results,No Results,No Results,2020-04-14,2020-04-07,None
523,NCT04334967,ClinicalTrials.gov,2020-04-02,2020-03-30,True,Providence Health & Services,Recruiting,Phase 4,Interventional,United States,Hydroxychloroquine in Patients With Newly Diagnosed COVID-19 Compared to Standard of Care,Drug,Hydroxychloroquine vs. Vitamin C,1250,2021-09-30,2023-09-30,https://clinicaltrials.gov/show/NCT04334967,No Results,No Results,No Results,2020-04-14,2020-04-15,None
524,ChiCTR2000031244,ChiCTR,2020-03-25,2020-03-25,False,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Not Recruiting,Not Applicable,Observational,China,Shedding virus and functional prognosis in patients with novel coronavirus pneumonia (COVID-19): a medical records based study,Prognosis,No Intervention,200,Not Available,2020-08-25,http://www.chictr.org.cn/showproj.aspx?proj=51486,No Results,No Results,No Results,2020-03-30,2020-04-01,None
525,ChiCTR2000030288,ChiCTR,2020-02-27,2020-02-27,False,China Academy of Chinese Medical Sciences,Recruiting,Not Applicable,Interventional,China,Efficacy of Traditional Chinese Medicine in the Treatment of Novel Coronavirus Pneumonia (COVID-19): a Randomized Controlled Trial,Traditional Medicine (Unspecified),Traditional Medicine,204,Not Available,2020-12-31,http://www.chictr.org.cn/showproj.aspx?proj=50202,No Results,No Results,No Results,2020-03-30,2020-08-03,None
526,ChiCTR2000029898,ChiCTR,2020-02-16,2020-02-17,False,Peking University Third Hospital,Recruiting,Phase 4,Interventional,China,"Evaluation the Efficacy and Safety of Hydroxychloroquine Sulfate in Comparison with Phosphate Chloroquine in Severe Patients with Novel Coronavirus Pneumonia (COVID-19): a Randomized, Open-Label, Parallel, Controlled Trial",Drug,Hydroxychloroquine vs. Chloroquine,100,Not Available,2020-04-30,http://www.chictr.org.cn/showproj.aspx?proj=49482,No Results,No Results,No Results,2020-03-02,2020-08-03,None
527,ChiCTR2000030256,ChiCTR,2020-02-26,2020-02-01,True,"Daping Hospital,Army Medical University",Not Recruiting,Not Applicable,Epidemiological research,China,"Epidemiological and clinical characteristics of COVID-19: a large-scale investigation in epicenter Wuhan, China",Clinical Presentation (Epidemiology),No Intervention,1000,Not Available,2020-03-31,http://www.chictr.org.cn/showproj.aspx?proj=50078,No Results,No Results,No Results,2020-03-30,2020-08-03,None
528,ChiCTR2000031203,ChiCTR,2020-03-24,2020-03-16,True,Zhengzhou People's Hospital,Recruiting,Not Applicable,Interventional,China,Study for the effect of Moxibustion Guidance and Intervention based on internet for the discharged patients with novel coronavirus pneumonia (COVID-19),Traditional Medicine (Other),Traditional Medicine,28,Not Available,2022-02-28,http://www.chictr.org.cn/showproj.aspx?proj=51030,No Results,No Results,No Results,2020-03-30,2020-04-01,None
529,NCT04335019,ClinicalTrials.gov,2020-04-02,2020-04-01,True,Assistance Publique  Hpitaux de Paris,Not Recruiting,Not Applicable,Observational,No Country Given,Interest of the Use of Pulmonary Ultrasound in the Referral of Patients With or Suspected COVID-19 +,Diagnostics,Diagnostic Test or Assessment,300,2020-04-01,2020-05-01,https://clinicaltrials.gov/show/NCT04335019,No Results,No Results,No Results,2020-04-14,2020-04-15,None
530,NCT04335201,ClinicalTrials.gov,2020-03-31,2020-04-06,False,IRCCS San Raffaele,Not Recruiting,Phase 2,Interventional,No Country Given,Defibrotide in COVID-19 Pneumonia,Drug,Defibrotide,50,2020-09-30,2020-12-31,https://clinicaltrials.gov/show/NCT04335201,No Results,No Results,No Results,2020-04-14,2020-04-15,None
531,ChiCTR2000030198,ChiCTR,2020-02-25,2020-02-24,True,West China Hospital of Sichuan University,Not Recruiting,Not Applicable,Interventional,China,Clinical research of pulmonary rehabilitation in survivors due to severe or critial novel coronavirus pneumonia (COVID-19),Other (physio),Physio,60,Not Available,2020-08-24,http://www.chictr.org.cn/showproj.aspx?proj=50066,No Results,No Results,No Results,2020-03-30,2020-08-03,None
532,ChiCTR2000031176,ChiCTR,2020-03-23,2020-02-20,True,Zhengzhou People's Hospital,Recruiting,Not Applicable,Observational,China,Study on home pharmaceutical care for chronic patients over the novel coronavirus pneumonia (COVID-19) epidemic,Other,No Intervention,100,Not Available,2021-03-11,http://www.chictr.org.cn/showproj.aspx?proj=51443,No Results,No Results,No Results,2020-03-30,2020-04-01,None
533,ACTRN12620000448943,ANZCTR,2020-04-06,2020-06-01,False,Deakin University,Not Recruiting,Not Applicable,Interventional,Australia,Expressive Writing To Combat Distress Associated With The COVID-19 Pandemic In People With Inflammatory Bowel Disease,Other (psych),Psychological,154,Not Available,2021-03-01,https://anzctr.org.au/ACTRN12620000448943.aspx,No Results,No Results,No Results,2020-04-14,2020-04-07,None
534,ChiCTR2000030552,ChiCTR,2020-03-07,2020-03-08,False,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Not Applicable,Observational,China,Critical ultrasound in evaluating cardiopulmonary function in critical patients infected with 2019 novel coronavirus pneumonia (COVID-19),Clinical Presentation,No Intervention,70,Not Available,2020-05-08,http://www.chictr.org.cn/showproj.aspx?proj=49708,No Results,No Results,No Results,2020-03-09,2020-08-03,None
535,ChiCTR2000030962,ChiCTR,2020-03-20,2020-03-01,True,Hospital of Chengdu University of Traditional Chinese Medicine,Not Recruiting,Not Applicable,Observational,China,"Clinical efficacy of TCM syndrome differentiation in the treatment of severe/critical type of novel coronavirus pneumonia (COVID-19): a prospective, observational, one-arm clinical study",Traditional Medicine (Other),Traditional Medicine,60,Not Available,2020-12-31,http://www.chictr.org.cn/showproj.aspx?proj=51254,No Results,No Results,No Results,2020-03-30,2020-03-25,None
536,EUCTR2020-000919-69-NL,EU Clinical Trials Register,2020-03-17,2020-03-17,False,UMC Utrecht,Authorised,Phase 4,Interventional,Netherlands,Reducing health care workers absenteeism in Coronavirus 2019 pandemic nu enhancement of the immune system through vaccination with Bacillus Calmette-Gurin,ATMP,Vaccine,1000,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-000919-69,No Results,No Results,No Results,2020-03-30,2020-04-01,None
537,ChiCTR2000031794,ChiCTR,2020-04-10,2020-04-08,True,Huanggang Central Hospital,Not Recruiting,Not Applicable,Observational,China,A medical records based retrospective study for analysis clinical characteristics and risk factors of death in patients with novel coronavirus pneumonia (COVID-19),Clinical Presentation,No Intervention,130,Not Available,2020-05-08,http://www.chictr.org.cn/showproj.aspx?proj=52193,No Results,No Results,No Results,2020-04-13,2020-04-15,None
538,ChiCTR2000030535,ChiCTR,2020-03-06,2020-02-20,True,Wuhan Red Cross Hospital,Recruiting,Phase 4,Interventional,China,Multi-Center Clinical Study on the Treatment of Patients with Novel Coronavirus Pneumonia (COVID-19) by Ebastine,Drug,Ebastine + Interferon alpha + Lopinavir vs. Interferon alpha + Lopinavir,100,Not Available,2020-03-30,http://www.chictr.org.cn/showproj.aspx?proj=49790,No Results,No Results,No Results,2020-03-09,2020-08-03,None
539,ChiCTR2000030938,ChiCTR,2020-03-18,2020-02-28,True,The First Teaching Hospital of Tianjin University of Traditional Chinese Medicine,Recruiting,Not Applicable,Observational,China,Clinical investigation and reseach on TCM syndrome of novel coronavirus pneumonia (COVID-19),Traditional Medicine (Other),Traditional Medicine,160,Not Available,2021-06-30,http://www.chictr.org.cn/showproj.aspx?proj=51239,No Results,No Results,No Results,2020-03-30,2020-03-25,None
540,ChiCTR2000031783,ChiCTR,2020-04-10,2020-03-24,True,No Sponsor Name Given,Not Recruiting,Not Applicable,Observational,Bolivia,Investigation for Prevention Awareness against COVID-19,Other,No Intervention,883,Not Available,2020-03-13,http://www.chictr.org.cn/showproj.aspx?proj=51832,No Results,No Results,No Results,2020-04-13,2020-04-15,None
541,EUCTR2020-001023-14-GB,EU Clinical Trials Register,2020-03-17,2020-03-17,False,Synairgen Research Limited,Authorised,Phase 2,Interventional,United Kingdom,a trial of an inhaled antiviral drug to treat or prevent severe respiratory difficulties in patients with COVID-19,Drug,Interferon beta,400,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001023-14,No Results,No Results,No Results,2020-03-30,2020-03-25,None
542,ChiCTR2000030817,ChiCTR,2020-03-15,2020-02-28,True,"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Not Applicable,Observational,China,Multicenter clinical study of evaluation of multi-organ function in patients with novel coronavirus pneumonia (COVID-19) by ultrasound,Clinical Presentation,No Intervention,800,Not Available,2022-02-28,http://www.chictr.org.cn/showproj.aspx?proj=50631,No Results,No Results,No Results,2020-03-30,2020-03-18,None
543,ChiCTR2000030522,ChiCTR,2020-03-06,2020-03-09,False,Affiliated Hospital of Chengdu University of Traditional Chinese Medicine,Recruiting,Not Applicable,Interventional,China,Efficacy and safety of Ma-Xing-Gan-Shi decoction in the treatment of novel coronavirus pneumonia (COVID-19),Traditional Medicine (Drug),Traditional Medicine,100,Not Available,2020-09-09,http://www.chictr.org.cn/showproj.aspx?proj=44213,No Results,No Results,No Results,2020-03-09,2020-08-03,None
544,ChiCTR2000031734,ChiCTR,2020-04-08,2020-03-19,True,Huo-Shen-Shan Hospital,Recruiting,Not Applicable,Interventional,China,"Evaluation Danorevir sodium tablets combined with ritonavir in the treatment of novel Coronavirus Pneumonia (COVID-19): a randomized, open-label, controlled trial",Drug,Danorevir + ritonavir,40,Not Available,2020-05-29,http://www.chictr.org.cn/showproj.aspx?proj=52103,No Results,No Results,No Results,2020-04-13,2020-04-15,None
545,ChiCTR2000029982,ChiCTR,2020-02-18,2020-03-26,False,"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Not Applicable,Observational,China,Prediction of prognosis and antiviral effect of patients with neocoronavirus infected pneumonia based on Peripheral blood exosomal metabolomics analysis and radiomics in CT of lung and its mechanism,Genomics,No Intervention,150,Not Available,2021-12-31,http://www.chictr.org.cn/showproj.aspx?proj=49724,No Results,No Results,No Results,2020-03-30,2020-08-03,None
546,NCT04305106,ClinicalTrials.gov,2020-03-09,2020-03-17,False,Qilu Hospital of Shandong University,Recruiting,Not Applicable,Interventional,China,Bevacizumab in Severe or Critically Severe Patients With COVID-19 Pneumonia-RCT,Drug,Bevacizumab,140,2020-06-30,2020-07-31,https://clinicaltrials.gov/show/NCT04305106,No Results,No Results,No Results,2020-04-06,2020-03-18,None
547,NCT04321928,ClinicalTrials.gov,2020-03-20,2020-04-01,False,University of Pecs,Not Recruiting,Not Applicable,Interventional,No Country Given,Personalized Health Education Against the Health Damage of Novel Coronavirus (COVID-19) Outbreak in Hungary,Other,Health Education,7576,2021-04-21,2021-08-21,https://clinicaltrials.gov/show/NCT04321928,No Results,No Results,No Results,2020-04-06,2020-04-01,None
548,ChiCTR2000031705,ChiCTR,2020-04-07,2020-03-10,True,Shanghai Jiao Tong University Affiliated Sixth People's Hospital,Recruiting,Not Applicable,Observational,China,Study for early biological warning signals in patients with acute renal injury caused by novel coronavirus pneumonia (COVID-19),Clinical Presentation,No Intervention,200,Not Available,2022-12-31,http://www.chictr.org.cn/showproj.aspx?proj=51793,No Results,No Results,No Results,2020-04-13,2020-04-15,None
549,ChiCTR2000030503,ChiCTR,2020-03-05,2020-01-20,True,The First Affiliated Hospital of Zhejiang University School of Medicine,Recruiting,Not Applicable,Interventional,China,Extracorporeal blood purification therapy using Li's Artifical Liver System for patients with severe novel coronavirus pneumonia (COVID19) patient,Traditional Medicine (Other),Traditional Medicine,60,Not Available,2022-06-30,http://www.chictr.org.cn/showproj.aspx?proj=49632,No Results,No Results,No Results,2020-03-09,2020-08-03,None
550,NCT04288713,ClinicalTrials.gov,2020-02-27,2020-02-25,True,Hudson Medical,Not Recruiting,Phase 2,Expanded Access,No Country Given,Eculizumab (Soliris) in Covid-19 Infected Patients,Drug,Eculizumab,Not Available,Not Available,Not Available,https://clinicaltrials.gov/show/NCT04288713,No Results,No Results,No Results,2020-04-06,2020-08-03,None
551,NCT04290871,ClinicalTrials.gov,2020-02-27,2020-03-23,False,Xijing Hospital,Not Recruiting,Phase 2,Interventional,No Country Given,Nitric Oxide Gas Inhalation for Severe Acute Respiratory Syndrome in COVID-19.,Drug,Nitric oxide,Not Available,2021-03-01,2022-03-01,https://clinicaltrials.gov/show/NCT04290871,No Results,No Results,No Results,2020-04-06,2020-03-18,None
552,NCT04322786,ClinicalTrials.gov,2020-03-23,1998-01-01,True,"University College, London",Not Recruiting,Not Applicable,Observational,No Country Given,"The Use of Angiotensin Converting Enzyme Inhibitors and Incident Respiratory Infections, Are They Harmful or Protective?",Drug,ACE inhibitors,1302508,2016-05-31,2020-03-31,https://clinicaltrials.gov/show/NCT04322786,No Results,No Results,No Results,2020-04-06,2020-04-01,None
553,NCT04324996,ClinicalTrials.gov,2020-03-25,2020-03-21,True,Chongqing Public Health Medical Center,Recruiting,Phase 1/Phase 2,Interventional,China,A Phase I/II Study of Universal Off-the-shelf NKG2D-ACE2 CAR-NK Cells for Therapy of COVID-19,ATMP,Cells (NK),90,2020-05-31,2020-09-30,https://clinicaltrials.gov/show/NCT04324996,No Results,No Results,No Results,2020-04-06,2020-04-01,None
554,NCT04325412,ClinicalTrials.gov,2020-03-25,2020-03-23,True,UMC Utrecht,Recruiting,Not Applicable,Observational,Netherlands,Cardiac complicAtions in Patients With SARS Corona vIrus 2 regisTrY,Clinical Presentation,No Intervention,1000,2021-03-23,2021-06-23,https://clinicaltrials.gov/show/NCT04325412,No Results,No Results,No Results,2020-04-06,2020-04-01,None
555,NCT04326309,ClinicalTrials.gov,2020-03-26,2020-03-25,True,HealthMode Inc.,Recruiting,Not Applicable,Observational,United States,Audio Data Collection for Identification and Classification of Coughing,Diagnostics,Diagnostic Test or Assessment,1000,2022-09-25,2022-09-25,https://clinicaltrials.gov/show/NCT04326309,No Results,No Results,No Results,2020-04-06,2020-04-07,None
556,ChiCTR2000030487,ChiCTR,2020-03-04,2020-03-04,False,The First Affiliated Hospital of He'nan University of Chinese Medicine,Recruiting,Not Applicable,Interventional,China,"A single-center, single-arm clinical trial for azvudine in the treatment of novel coronavirus pneumonia (COVID-19)",Drug,Azvudine,10,Not Available,2020-05-04,http://www.chictr.org.cn/showproj.aspx?proj=50507,No Results,No Results,No Results,2020-03-09,2020-08-03,None
557,NCT04316299,ClinicalTrials.gov,2020-03-17,2020-02-26,True,Zhenhua Zen,Not Recruiting,Not Applicable,Observational,China,Acute Kidney Injury in Patients Hospitalized With COVID-19,Clinical Presentation,No Intervention,287,2020-02-28,2020-03-08,https://clinicaltrials.gov/show/NCT04316299,No Results,No Results,No Results,2020-04-06,2020-03-25,None
558,NCT04318314,ClinicalTrials.gov,2020-03-17,2020-03-18,False,"University College, London",Recruiting,Not Applicable,Observational,United Kingdom,COVID-19: Healthcare Worker Bioresource: Immune Protection and Pathogenesis in SARS-CoV-2,Clinical Presentation,No Intervention,400,2020-12-31,2021-12-31,https://clinicaltrials.gov/show/NCT04318314,No Results,No Results,No Results,2020-04-06,2020-04-01,None
559,EUCTR2020-001381-11-FR,EU Clinical Trials Register,2020-03-29,2020-04-08,False,Assistance Publique  Hpitaux de Paris,Authorised,Phase 3,Interventional,France,COVID-19 - ACORES-2 study: ACE inhibitors or ARBs discontinuation for Clinical Outcome Risk reduction in patients hospitalized for the Endemic Severe acute respiratory syndrome coronavirus (SARS-CoV-2) infection,Drug,ACE inhibitors or ARBs,554,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001381-11,No Results,No Results,No Results,2020-04-14,2020-04-15,None
560,ChiCTR2000031627,ChiCTR,2020-04-05,2020-04-20,False,Second People's Hospital of Fuyang City,Not Recruiting,Not Applicable,Basic Science,China,Study for the Mechanism of the Relationship between Infection of novel coronavirus pneumonia (COVID-19) and Host Innate Immune,Clinical Presentation,No Intervention,60,Not Available,2021-04-20,http://www.chictr.org.cn/showproj.aspx?proj=51865,No Results,No Results,No Results,2020-04-06,2020-04-07,None
561,ChiCTR2000030485,ChiCTR,2020-03-03,2020-03-03,False,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Not Recruiting,Not Applicable,Observational,China,Study for timing of mechanical ventilation for critically ill patients with novel coronavirus pneumonia (COVID-19): A medical records based retrospective Cohort study,Other (physical),Mechanical ventilation,90,Not Available,2021-02-01,http://www.chictr.org.cn/showproj.aspx?proj=50459,No Results,No Results,No Results,2020-03-09,2020-08-03,None
562,NCT04322344,ClinicalTrials.gov,2020-03-23,2020-03-23,False,University of Catanzaro,Recruiting,Phase 2/Phase 3,Interventional,Italy,Escin in Patients With Covid-19 Infection,Traditional Medicine (Drug),Traditional Medicine,120,2020-06-30,2020-08-30,https://clinicaltrials.gov/show/NCT04322344,No Results,No Results,No Results,2020-04-06,2020-04-01,None
563,NCT04323644,ClinicalTrials.gov,2020-03-25,2020-03-31,False,University of Birmingham,Not Recruiting,Not Applicable,Observational,No Country Given,Outcomes of Surgery in COVID-19 Infection: International Cohort Study (CovidSurg),Other (surgery),No Intervention,1000,2020-09-30,2020-09-30,https://clinicaltrials.gov/show/NCT04323644,No Results,No Results,No Results,2020-04-06,2020-04-01,None
564,ChiCTR2000031533,ChiCTR,2020-04-03,2020-04-10,False,Peking Union Medical College Hospital,Not Recruiting,Not Applicable,Health services research,China,Survey of psychological status and related factors of emergency medical staff in the country during the novel coronavirus pneumonia (COVID-19) pandemic,Other (psych),No Intervention,7000,Not Available,2020-06-30,http://www.chictr.org.cn/showproj.aspx?proj=51835,No Results,No Results,No Results,2020-04-06,2020-04-07,None
565,EUCTR2020-001435-27-FR,EU Clinical Trials Register,2020-04-01,2020-04-10,False,CHU de Bordeaux,Authorised,Phase 3,Interventional,France,"Home treatment of elderly patients with symptomatic SARS-CoV-2 infection (COVID-19) : a multiarm, multi-stage (MAMS) randomized trial to assess the efficacy and safety
of several experimental treatments to reduce the risk of hospitalization or death
(COVERAGE trial)",Drug,Hydroxychloroquine vs. imatinib vs. favipiravir vs. telmisartan,1057,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001435-27,No Results,No Results,No Results,2020-04-14,2020-04-15,None
566,ChiCTR2000031630,ChiCTR,2020-04-05,2020-02-17,True,Guangzhou Eighth People's Hospital,Recruiting,Not Applicable,Interventional,China,Clinical study for Celebrex in the treatment of novel coronavirus pneumonia (COVID-19),Drug,Celecoxib,60,Not Available,2020-06-17,http://www.chictr.org.cn/showproj.aspx?proj=50474,Pre-Print Article,2020-05-11,https://doi.org/10.1101/2020.05.05.20077610,2020-04-06,2020-04-07,None
567,ChiCTR2000031199,ChiCTR,2020-03-23,2020-02-04,True,Xiangya Hospital of Central South University,Recruiting,Not Applicable,Observational,China,A Medical Records Based Retrospective Study for Clinical Characteristics of severe Novel Coronavirus Pneumonia (COVID-19),Clinical Presentation,No Intervention,120,Not Available,2020-04-09,http://www.chictr.org.cn/showproj.aspx?proj=51478,No Results,No Results,No Results,2020-04-06,2020-04-01,None
568,ChiCTR2000031589,ChiCTR,2020-04-05,2020-03-06,True,Renmin Hospital of Wuhan University,Not Recruiting,Not Applicable,Observational,China,Investigation for the sleep quality in non-health care workers during the pandemic of novel coronavirus pneumonia (COVID-19),Other (psych),No Intervention,462,Not Available,2020-03-10,http://www.chictr.org.cn/showproj.aspx?proj=51969,No Results,No Results,No Results,2020-04-06,2020-04-07,None
569,ChiCTR2000031587,ChiCTR,2020-04-04,2020-01-27,True,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Not Applicable,Observational,China,"A paired clinical study for novel coronavirus pneumonia (COVID-19) patients with ordinary, severe, critical, and deceased patients in Tongji Hospital",Clinical Presentation,No Intervention,2000,Not Available,2022-12-31,http://www.chictr.org.cn/showproj.aspx?proj=51952,No Results,No Results,No Results,2020-04-06,2020-04-07,None
570,EUCTR2020-001409-21-ES,EU Clinical Trials Register,2020-04-03,2020-04-01,True,Fundacin para la Formacin e Investigacin Sanitarias de la Regin de Murcia (FFIS),Authorised,Phase 2,Interventional,Spain,DEFIBROTIDE AS PREVENTION AND TREATMENT OF RESPIRATORY DISTRESS AND CYTOKINE RELEASE SYNDROME OF COVID-19,Drug,Defibrotide,120,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001409-21,No Results,No Results,No Results,2020-04-14,2020-04-15,None
571,NCT04275414,ClinicalTrials.gov,2020-02-14,2020-02-15,False,Qilu Hospital of Shandong University,Recruiting,Phase 2/Phase 3,Interventional,"Italy, China",Bevacizumab in Severe or Critical Patients With COVID-19 Pneumonia,Drug,Bevacizumab,20,2020-04-01,2020-05-01,https://clinicaltrials.gov/show/NCT04275414,No Results,No Results,No Results,2020-04-14,2020-03-18,None
572,NCT04315298,ClinicalTrials.gov,2020-03-15,2020-03-18,False,Regeneron Pharmaceuticals,Recruiting,Phase 2/Phase 3,Interventional,United States,Evaluation of the Efficacy and Safety of Sarilumab in Hospitalized Patients With COVID-19,Drug,Sarilumab,400,2021-03-09,2021-04-01,https://clinicaltrials.gov/show/NCT04315298,No Results,No Results,No Results,2020-04-14,2020-03-25,None
573,ChiCTR2000031540,ChiCTR,2020-04-03,2020-02-05,True,Affiliated Hospital of Zunyi Medical University,Recruiting,Phase 1,Interventional,China,Study for clinical effect of rehabilitation nursing program for patients with novel coronavirus pneumonia (COVID-19),Other (physio),Physio,100,Not Available,2020-12-05,http://www.chictr.org.cn/showproj.aspx?proj=51684,No Results,No Results,No Results,2020-04-06,2020-04-07,None
574,EUCTR2020-001492-33-FR,EU Clinical Trials Register,2020-04-01,2020-04-10,False,L'Hpital Fondation Adolphe de Rothschild,Authorised,Phase 3,Interventional,France,Interest in the administration of Dornase alpha aerosol in Acute Respiratory Distress Syndrome secondary to respiratory infection by the coronavirus SRASCoV-2 / COVID-19,Drug,Dornase alfa,100,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001492-33,No Results,No Results,No Results,2020-04-14,2020-04-15,None
575,NCT04318366,ClinicalTrials.gov,2020-03-19,2020-03-19,False,Universita Vita-Salute San Raffaele,Recruiting,Not Applicable,Observational,Italy,"COVID-19 Patients Characterization, Biobank, Treatment Response and Outcome Predictor",Prognosis,No Intervention,1000,2022-03-19,2022-03-19,https://clinicaltrials.gov/show/NCT04318366,Journal Article,2020-05-07,https://doi.org/10.1016/S2665-9913(20)30127-2,2020-04-14,2020-04-01,None
576,NCT04321811,ClinicalTrials.gov,2020-03-23,2020-03-21,True,xCures,Recruiting,Not Applicable,Observational,United States,"Behavior, Environment And Treatments for Covid-19",Clinical Presentation,No Intervention,100000,2021-03-20,2022-03-20,https://clinicaltrials.gov/show/NCT04321811,No Results,No Results,No Results,2020-04-14,2020-04-01,None
577,ChiCTR2000031538,ChiCTR,2020-04-03,2020-04-03,False,"Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine",Not Recruiting,Not Applicable,Health services research,China,Assessment of mental health status of first-line dental emergency medical personnel during novel coronavirus pneumonia (COVID-19) pandemic,Other (psych),No Intervention,123,Not Available,2020-09-30,http://www.chictr.org.cn/showproj.aspx?proj=51938,No Results,No Results,No Results,2020-04-06,2020-04-07,None
578,EUCTR2020-001194-69-ES,EU Clinical Trials Register,2020-04-07,2020-03-30,True,Flix Gutirrez Rodero,Authorised,Phase 3,Interventional,Spain,Pilot study to evaluate the efficacy and safety of mefloquine as prophylaxis in people exposed to the disease caused by the new SARS-CoV-2 coronavirus (COVID-19),Drug (Chemoprophylaxis),Mefloquine,200,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001194-69,No Results,No Results,No Results,2020-04-14,2020-04-15,None
579,ChiCTR2000031504,ChiCTR,2020-04-03,2019-12-01,True,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Not Recruiting,Not Applicable,Observational,China,A multi-center telephone follow-up study of disease management and infection in rheumatic patients during novel coronavirus pneumonia (COVID-19) pandemic in Hubei province,Clinical Presentation,No Intervention,2000,Not Available,2021-03-31,http://www.chictr.org.cn/showproj.aspx?proj=51781,No Results,No Results,No Results,2020-04-06,2020-04-07,None
580,NCT04324047,ClinicalTrials.gov,2020-03-25,2020-03-27,True,Assistance Publique  Hpitaux de Paris,Recruiting,Not Applicable,Observational,France,Cohort Multiple Randomized Controlled Trials Open-label of Immune Modulatory Drugs and Other Treatments in COVID-19 Patients,Drug,Unspecified Drug,1000,2021-03-27,2021-12-31,https://clinicaltrials.gov/show/NCT04324047,No Results,No Results,No Results,2020-04-14,2020-04-01,EUCTR2020-001246-18
581,NCT04325867,ClinicalTrials.gov,2020-03-21,2020-03-31,False,Professor Adrian Covic,Recruiting,Not Applicable,Interventional,Romania,Integrated Distance Management Strategy for Patients With Cardiovascular Diseases in the Context of COVID-19,Other,Other,200,2020-10-01,2020-10-01,https://clinicaltrials.gov/show/NCT04325867,No Results,No Results,No Results,2020-04-14,2020-04-07,None
582,EUCTR2020-001565-37-ES,EU Clinical Trials Register,2020-04-07,2020-04-03,True,ISGlobal,Authorised,Phase 3,Interventional,Spain,Prevention of novel Coronavirus infection with hydroxychloroquine,Drug,Hydroxychloroquine,440,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001565-37,No Results,No Results,No Results,2020-04-14,2020-04-15,None
583,ChiCTR2000031499,ChiCTR,2020-04-02,2020-02-10,True,Shanghai Oriental Hospital,Not Recruiting,Not Applicable,Observational,China,Sleep quality of patients with novel coronavirus pneumonia (COVID-19) treated in mobile cabin hospital: a retrospective study,Other,Sleep aids,55,Not Available,2020-02-25,http://www.chictr.org.cn/showproj.aspx?proj=51915,No Results,No Results,No Results,2020-04-06,2020-04-07,None
584,NCT04326075,ClinicalTrials.gov,2020-03-26,2020-04-06,False,Mario Negri Institute for Pharmacological Research,Not Recruiting,Not Applicable,Interventional,No Country Given,Early CPAP in COVID Patients With Respiratory Failure.,Other (physical),Mechanical ventilation,900,2020-10-05,2020-11-09,https://clinicaltrials.gov/show/NCT04326075,No Results,No Results,No Results,2020-04-14,2020-04-07,None
585,NCT04326114,ClinicalTrials.gov,2020-03-26,2020-04-26,False,Complutense University of Madrid,Not Recruiting,Not Applicable,Interventional,No Country Given,Effectiveness and Safety of Respiratory Training in the Prevention and Severity of COVID-19,Other (training),Other,240,2020-09-26,2020-10-12,https://clinicaltrials.gov/show/NCT04326114,No Results,No Results,No Results,2020-04-14,2020-04-07,None
586,ChiCTR2000031453,ChiCTR,2020-04-01,2020-04-01,False,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Not Recruiting,Phase 4,Interventional,China,"Efficacy and safety of Nintedanib esilate soft capsules in the treatment of pulmonary fibrosis in healed moderate to severe patients of novel coronavirus pneumonia (COVID-19): a single-center, randomized, placebo-controlled trial",Drug,Nintedanib,80,Not Available,2020-08-01,http://www.chictr.org.cn/showproj.aspx?proj=51859,No Results,No Results,No Results,2020-04-06,2020-04-07,None
587,NCT04274322,ClinicalTrials.gov,2020-02-16,2020-02-19,False,Peking University Third Hospital,Not Recruiting,Not Applicable,Observational,China,Identifying Critically-ill Patients With COVID-19 Who Will Benefit Most From Nutrition Support Therapy: Validation of the NUTRIC Nutritional Risk Assessment Tool,Other (nutrition),Nutrition,117,2020-04-04,2020-07-01,https://clinicaltrials.gov/show/NCT04274322,No Results,No Results,No Results,2020-04-20,2020-03-18,None
588,NCT04291729,ClinicalTrials.gov,2020-02-27,2020-02-17,True,The Ninth Hospital of Nanchang,Not Recruiting,Phase 4,Interventional,China,Evaluation of Ganovo (Danoprevir ) Combined With Ritonavir in the Treatment of SARS-CoV-2 Infection,Drug,Danoprevir + Ritonavir (w/ or w/o Interferon),11,2020-03-19,2020-03-19,https://clinicaltrials.gov/show/NCT04291729,Pre-Print Article,2020-03-24,https://doi.org/10.1101/2020.03.22.20034041,2020-04-20,2020-03-18,None
589,NCT04329507,ClinicalTrials.gov,2020-03-26,2020-03-25,True,NHS Lothian,Not Recruiting,Not Applicable,Observational,No Country Given,Non-invasive Detection of Pneumonia in Context of Covid-19 Using Gas Chromatography - Ion Mobility Spectrometry (GC-IMS),Diagnostics,Diagnostic Test or Assessment,200,2020-03-25,2020-03-25,https://clinicaltrials.gov/show/NCT04329507,No Results,No Results,No Results,2020-04-14,2020-04-07,None
590,NCT04330144,ClinicalTrials.gov,2020-03-30,2020-04-01,True,Gangnam Severance Hospital,Not Recruiting,Phase 3,Interventional,No Country Given,Hydroxychloroquine as Post Exposure Prophylaxis for SARS-CoV-2(HOPE Trial),Drug (Chemoprophylaxis),Hydroxychloroquine,2486,2021-03-30,2022-03-30,https://clinicaltrials.gov/show/NCT04330144,No Results,No Results,No Results,2020-04-14,2020-04-07,KCT0004907
591,ChiCTR2000031438,ChiCTR,2020-04-01,2020-04-01,False,Affiliated Hospital of Southwest Medical University,Not Recruiting,Not Applicable,Observational,China,Analysis of changes in high risk factors of cervical spondylosis during novel coronavirus pneumonia (COVID-19) pandemic,Clinical Presentation,No Intervention,820,Not Available,2020-04-30,http://www.chictr.org.cn/showproj.aspx?proj=51815,No Results,No Results,No Results,2020-04-06,2020-04-07,None
592,NCT04303299,ClinicalTrials.gov,2020-02-24,2020-04-15,False,Rajavithi Hospital,Not Recruiting,Phase 3,Interventional,Thailand,"Various Combination of Protease Inhibitors, Oseltamivir, Favipiravir, and Hydroxychloroquine for Treatment of COVID-19 : A Randomized Control Trial",Drug,"Various Combinations of: Oseltamivir, Chloroquine, Lopipinavir/Ritonavir, Darunavir/ritonavir, Favipiravir",320,2020-10-31,2020-11-30,https://clinicaltrials.gov/show/NCT04303299,No Results,No Results,No Results,2020-04-20,2020-03-18,None
593,NCT04305457,ClinicalTrials.gov,2020-03-09,2020-03-21,False,Massachusetts General Hospital,Recruiting,Phase 2,Interventional,United States,Nitric Oxide Gas Inhalation Therapy for Mild/Moderate COVID-19,Drug,Nitric oxide,240,2021-04-01,2022-04-01,https://clinicaltrials.gov/show/NCT04305457,No Results,No Results,No Results,2020-04-20,2020-03-18,None
594,NCT04330586,ClinicalTrials.gov,2020-03-31,2020-04-01,False,Korea University Guro Hospital,Not Recruiting,Phase 2,Interventional,No Country Given,A Trial of Ciclesonide in Adults With Mild COVID-19,Drug,Ciclesonide + hydroxychloroquine vs. hydroxychloroquine,141,2020-06-30,2020-09-30,https://clinicaltrials.gov/show/NCT04330586,No Results,No Results,No Results,2020-04-14,2020-04-07,None
595,NCT04333862,ClinicalTrials.gov,2020-04-01,2020-03-19,True,"University Hospital, Bern",Recruiting,Not Applicable,Observational,Switzerland,Assessment of Covid-19 Infection Rates in Healthcare Workers Using a Desynchronization Strategy,Health System,No Intervention,500,2020-06-30,2021-12-31,https://clinicaltrials.gov/show/NCT04333862,No Results,No Results,No Results,2020-04-14,2020-04-07,None
596,ChiCTR2000031429,ChiCTR,2020-03-31,2020-04-01,False,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Not Recruiting,Not Applicable,Observational,China,"The Effects of novel coronavirus pneumonia (COVID-19) Risk Factors on Dynamic Changes of  Immunological, biochemical, and Metabolic Parameters: a Retrospective Observational Study",Clinical Presentation,No Intervention,2000,Not Available,2021-03-31,http://www.chictr.org.cn/showproj.aspx?proj=51816,No Results,No Results,No Results,2020-04-06,2020-04-07,None
597,ChiCTR2000030472,ChiCTR,2020-03-03,2020-02-25,True,Shenyang Sixth People's Hospital,Recruiting,Not Applicable,Interventional,China,An open and controlled clinical study to evaluate the efficacy and safety of Ganovo combined with ritonavir in the treatment of novel coronavirus pneumonia (COVID-19),Traditional Medicine + Western Medicine,Traditional Medicine,20,Not Available,2020-06-30,http://www.chictr.org.cn/showproj.aspx?proj=49753,No Results,No Results,No Results,2020-03-09,2020-08-03,None
598,NCT04306393,ClinicalTrials.gov,2020-03-10,2020-03-21,True,Massachusetts General Hospital,Recruiting,Phase 2,Interventional,United States,Nitric Oxide Gas Inhalation in Severe Acute Respiratory Syndrome in COVID-19,Drug,Nitric oxide,200,2021-03-21,2022-03-21,https://clinicaltrials.gov/show/NCT04306393,No Results,No Results,No Results,2020-04-20,2020-03-18,EUCTR2020-001490-68
599,NCT04310228,ClinicalTrials.gov,2020-03-09,2020-03-08,True,Peking University First Hospital,Recruiting,Not Applicable,Interventional,China,Favipiravir Combined With Tocilizumab in the Treatment of Corona Virus Disease 2019,Drug,Favipiravir + tocilizumab vs. favipiravir vs. tocilizumab,150,2020-05-01,2020-05-01,https://clinicaltrials.gov/show/NCT04310228,No Results,No Results,No Results,2020-04-20,2020-03-25,None
600,ACTRN12620000438954,ANZCTR,2020-04-06,2020-04-20,False,Griffith University,Not Recruiting,Not Applicable,Observational,Australia,Utilizing lung ultrasound in COVID-19 patients in ICU  comparison of management strategies on survival and time on ventilation.,Diagnostics,Diagnostic Test or Assessment,60,Not Available,2020-10-31,https://anzctr.org.au/ACTRN12620000438954.aspx,No Results,No Results,No Results,2020-04-14,2020-04-07,None
601,ACTRN12620000449932,ANZCTR,2020-04-06,2020-04-10,False,University of Melbourne,Not Recruiting,Not Applicable,Observational,Australia,Maternal and neonatal outcomes from women infected with SARS-COV2 (COVID-19) during pregnancy,Clinical Presentation,No Intervention,200,Not Available,2021-12-31,https://anzctr.org.au/ACTRN12620000449932.aspx,No Results,No Results,No Results,2020-04-14,2020-04-07,None
602,NCT04315480,ClinicalTrials.gov,2020-03-14,2020-03-12,True,Universit Politecnica delle Marche,Not Recruiting,Phase 2,Interventional,Italy,Tocilizumab for SARS-CoV2 (COVID-19) Severe Pneumonitis,Drug,Tocilizumab,38,2020-04-09,2020-05-01,https://clinicaltrials.gov/show/NCT04315480,No Results,No Results,No Results,2020-04-20,2020-04-15,None
603,NCT04321369,ClinicalTrials.gov,2020-03-23,2020-03-09,True,Dr. Deneen Vojta,Not Recruiting,Not Applicable,Observational,United States,Impact of Swab Site and Sample Collector on Testing Sensitivity for COVID-19 Virus in Symptomatic Individuals,Diagnostics,Diagnostic Test or Assessment,533,2020-03-23,2020-03-23,https://clinicaltrials.gov/show/NCT04321369,Pre-Print Article,2020-04-06,https://doi.org/10.1101/2020.04.01.20050005,2020-04-20,2020-04-07,None
604,ChiCTR2000031427,ChiCTR,2020-03-31,2020-03-25,True,The First People's Hospital of Jiangxia District,Not Recruiting,Not Applicable,Diagnostic test,China,Novel coronavirus infection (COVID-19) IgM detection kit (magnetic particle chemiluminescence) clinical trial,Diagnostics,Diagnostic Test or Assessment,200,Not Available,2020-03-31,http://www.chictr.org.cn/showproj.aspx?proj=51809,No Results,No Results,No Results,2020-04-06,2020-04-07,None
605,ACTRN12620000454976,ANZCTR,2020-04-08,2020-04-09,False,Austin Health,Not Recruiting,Phase 1/Phase 2,Interventional,Australia,Can intravenous high dose zinc improve clinical outcomes in patients with COVID-19 infection?,Drug,Zinc,160,Not Available,2021-04-09,https://anzctr.org.au/ACTRN12620000454976.aspx,No Results,No Results,No Results,2020-04-14,2020-04-15,None
606,ChiCTR2000031836,ChiCTR,2020-04-11,2020-01-23,True,The First Affiliated Hospital of Yangtze University,Not Recruiting,Not Applicable,Observational,China,A Medical Records Based study for the Clinical Characteristics Of Hospitalized Novel Coronavirus Pneumonia (COVID-19) Patients With Acute Respiratory Distress Syndrome,Clinical Presentation,No Intervention,45,Not Available,2020-12-31,http://www.chictr.org.cn/showproj.aspx?proj=52213,No Results,No Results,No Results,2020-04-13,2020-04-15,None
607,NCT04324021,ClinicalTrials.gov,2020-03-25,2020-04-02,False,Swedish Orphan Biovitrum,Recruiting,Phase 2/Phase 3,Interventional,Italy,Efficacy and Safety of Emapalumab and Anakinra in Reducing Hyperinflammation and Respiratory Distress in Patients With COVID-19 Infection.,Drug,Emapalumab + Anakinra,54,2020-07-01,2020-09-01,https://clinicaltrials.gov/show/NCT04324021,No Results,No Results,No Results,2020-04-20,2020-04-01,None
608,NCT04326387,ClinicalTrials.gov,2020-03-26,2020-04-06,False,Cambridge Clinical Trials Unit (CCTU),Recruiting,Not Applicable,Observational,United Kingdom,Evaluation of Novel Diagnostic Tests for COVID-19,Diagnostics,Diagnostic Test or Assessment,200,2021-04-07,2021-10-07,https://clinicaltrials.gov/show/NCT04326387,No Results,No Results,No Results,2020-04-20,2020-04-07,None
609,EUCTR2020-001236-10-NL,EU Clinical Trials Register,2020-03-31,2020-03-31,False,UMC Amsterdam,Authorised,Phase 2,Interventional,Netherlands,Countering Lung Damage in COVID-19 infection: the CounterCovid Study,Drug,Imatinib,304,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001236-10,No Results,No Results,No Results,2020-04-06,2020-04-07,None
610,ChiCTR2000031782,ChiCTR,2020-04-10,2020-04-13,False,The Second Xiangya Hospital of Central South University,Not Recruiting,Not Applicable,Observational,China,A questionnaire investigation of hydroxychloroquine for its potential protective effect against novel coronavirus infection (COVID-19),Drug (Chemoprophylaxis),Hydroxychloroquine,550,Not Available,2020-06-30,http://www.chictr.org.cn/showproj.aspx?proj=51934,No Results,No Results,No Results,2020-04-13,2020-04-15,None
611,NCT04331470,ClinicalTrials.gov,2020-03-30,2020-04-04,False,Fasa University of Medical Sciences,Recruiting,Phase 2/Phase 3,Interventional,Iran,Evaluation of Efficacy of Levamisole and Formoterol+Budesonide in Treatment of COVID-19,Drug,Levamisole + budesonide/formoterol + lopinavir/ritonavir + hydroxychloroquine,30,2020-04-20,2020-05-20,https://clinicaltrials.gov/show/NCT04331470,No Results,No Results,No Results,2020-04-20,2020-04-07,None
612,NCT04331509,ClinicalTrials.gov,2020-03-31,2020-03-23,True,King's College London,Recruiting,Not Applicable,Observational,"United Kingdom, United States",COVID-19 Symptom Tracker,Clinical Presentation,No Intervention,10000000,2022-03-23,2022-03-23,https://clinicaltrials.gov/show/NCT04331509,Pre-Print Article,2020-05-12,https://doi.org/10.1101/2020.04.29.20084111,2020-04-20,2020-04-07,None
613,EUCTR2020-001010-38-NO,EU Clinical Trials Register,2020-03-16,2020-03-23,False,Akershus University Hospital,Authorised,Phase 4,Interventional,Norway,NORWEGIAN CORONAVIRUS DISEASE 2019 [NO-COVID-19] STUDY: A TRIAL TO EVALUATE THE ANTIVIRAL EFFECT OF CHLOROQUINE IN ADULT PATIENTS WITH SARS-COV-2 INFECTION,Drug,Hydroxychloroquine,200,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001010-38,No Results,No Results,No Results,2020-04-06,2020-04-01,None
614,ChiCTR2000031781,ChiCTR,2020-04-10,2020-04-09,True,Jiangsu Provincial Center for Disease Control and Prevention,Not Recruiting,Phase 2,Interventional,China,"A randomized, double-blinded, placebo-controlled phase II clinical trial for Recombinant Novel Coronavirus (2019-nCOV) Vaccine (Adenovirus Vector)",ATMP,Vaccine,500,Not Available,2021-01-31,http://www.chictr.org.cn/showproj.aspx?proj=52006,No Results,No Results,No Results,2020-04-13,2020-04-15,None
615,ChiCTR2000030471,ChiCTR,2020-03-02,2020-03-02,False,Maoming People's Hospital,Recruiting,Phase 4,Interventional,China,Efficacy and safety of lipoic acid injection in reducing the risk of progression in common patients with novel coronavirus pneumonia (COVID-19),Traditional Medicine (Drug),Traditional Medicine,394,Not Available,2020-04-30,http://www.chictr.org.cn/showproj.aspx?proj=50421,No Results,No Results,No Results,2020-03-09,2020-08-03,None
616,ChiCTR2000031779,ChiCTR,2020-04-10,2020-01-01,True,Shandong Provincial Hospital,Not Recruiting,Not Applicable,Observational,No Country Given,Effect of novel coronavirus pneumonia (COVID-19) upon male reproductive system,Clinical Presentation,No Intervention,50,Not Available,2021-04-01,http://www.chictr.org.cn/showproj.aspx?proj=52051,No Results,No Results,No Results,2020-04-13,2020-04-15,None
617,NCT04331834,ClinicalTrials.gov,2020-04-01,2020-04-03,False,Barcelona Institute for Global Health,Recruiting,Phase 3,Interventional,Spain,Pre-Exposure Prophylaxis With Hydroxychloroquine for High-Risk Healthcare Workers During the COVID-19 Pandemic,Drug (Chemoprophylaxis),Hydroxychloroquine,440,2020-10-03,2020-10-30,https://clinicaltrials.gov/show/NCT04331834,No Results,No Results,No Results,2020-04-20,2020-04-07,None
618,NCT04332094,ClinicalTrials.gov,2020-03-31,2020-04-02,False,Fundaci Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau,Recruiting,Phase 2,Interventional,Spain,"Clinical Trial of Combined Use of Hydroxychloroquine, Azithromycin, and Tocilizumab for the Treatment of COVID-19",Drug,Hydroxychloroquine + Azithromycin + Tocilizumab,276,2020-09-01,2020-10-01,https://clinicaltrials.gov/show/NCT04332094,No Results,No Results,No Results,2020-04-20,2020-04-07,None
619,ACTRN12620000421932,ANZCTR,2020-03-30,2020-03-05,True,The Prince Charles Hospital,Recruiting,Not Applicable,Observational,"Japan, Singapore, Italy, Indonesia, Vietnam, Australia, South Korea, China, United Kingdom, Thailand, Hong Kong, United States",ExtraCorporeal Membrane Oxygenation for 2019 novel Coronavirus Acute Respiratory Disease (COVID-19),Drug,Oxygen,400,Not Available,2020-07-31,https://anzctr.org.au/ACTRN12620000421932.aspx,No Results,No Results,No Results,2020-04-06,2020-04-01,None
620,NCT04333407,ClinicalTrials.gov,2020-04-01,2020-04-03,False,Imperial College London,Recruiting,Not Applicable,Interventional,United Kingdom,Preventing Cardiac Complication of COVID-19 Disease With Early Acute Coronary Syndrome Therapy: A Randomised Controlled Trial.,Drug,Aspirin + clopidogrel + rivaroxaban + atorvastatin + omeprazole,3170,2021-03-30,2021-03-30,https://clinicaltrials.gov/show/NCT04333407,No Results,No Results,No Results,2020-04-20,2020-04-07,None
621,NCT04334005,ClinicalTrials.gov,2020-03-29,2020-04-10,False,University of Granada,Not Recruiting,Not Applicable,Interventional,Spain,Vitamin D on Prevention and Treatment of COVID-19,Drug,Vitamin D,200,2020-06-30,2020-06-30,https://clinicaltrials.gov/show/NCT04334005,No Results,No Results,No Results,2020-04-20,2020-04-07,None
622,ChiCTR2000031700,ChiCTR,2020-04-07,2020-04-21,False,Chinese PLA General Hospital,Not Recruiting,Not Applicable,Diagnostic test,China,Development and clinical application of novel coronavirus pneumonia (COVID-19) antigen reagent,Diagnostics,Diagnostic Test or Assessment,600,Not Available,2020-05-31,http://www.chictr.org.cn/showproj.aspx?proj=52052,No Results,No Results,No Results,2020-04-13,2020-04-15,None
623,NCT04320732,ClinicalTrials.gov,2020-03-23,2020-03-27,False,Oslo University Hospital,Recruiting,Not Applicable,Observational,Norway,Risk Factors for Community- and Workplace Transmission of COVID-19,Clinical Presentation,No Intervention,50000,2022-03-27,2030-03-20,https://clinicaltrials.gov/show/NCT04320732,No Results,No Results,No Results,2020-04-14,2020-04-01,None
624,NCT04323878,ClinicalTrials.gov,2020-03-25,2020-04-06,False,Mario Negri Institute for Pharmacological Research,Not Recruiting,Not Applicable,Observational,No Country Given,Early CPAP in COVID Patients With Respiratory Failure. A Prospective Cohort Study.,Other (physical),Mechanical ventilation,3000,2020-10-05,2020-11-09,https://clinicaltrials.gov/show/NCT04323878,No Results,No Results,No Results,2020-04-14,2020-04-01,None
625,NCT04335630,ClinicalTrials.gov,2020-04-02,2020-03-30,True,Memorial Hermann Health System,Recruiting,Not Applicable,Observational,United States,Cardiovascular Manifestations of COVID-19,Clinical Presentation,No Intervention,500,2021-03-01,2022-03-01,https://clinicaltrials.gov/show/NCT04335630,No Results,No Results,No Results,2020-04-20,2020-04-15,None
626,ChiCTR2000031699,ChiCTR,2020-04-07,2020-02-01,True,Wenzhou Central Hospital,Not Recruiting,Not Applicable,Diagnostic test,China,Study for immune antibody and multi-group function of novel coronavirus pneumonia (COVID-19) patients,Clinical Presentation,No Intervention,33,Not Available,2021-01-31,http://www.chictr.org.cn/showproj.aspx?proj=51924,No Results,No Results,No Results,2020-04-13,2020-04-15,None
627,NCT04326036,ClinicalTrials.gov,2020-03-26,2020-03-25,True,Healeon Medical Inc,Recruiting,Phase 1,Interventional,United States,Use of cSVF Via IV Deployment for Residual Lung Damage After Symptomatic COVID-19 Infection,ATMP,Stromal Vascular Fraction,10,2021-11-01,2021-12-31,https://clinicaltrials.gov/show/NCT04326036,No Results,No Results,No Results,2020-04-14,2020-04-07,None
628,NCT04327180,ClinicalTrials.gov,2020-03-25,2020-03-30,False,"University Hospital, Lille",Recruiting,Not Applicable,Observational,France,PREdiction of DIagnosed Covid-19 infecTion in IUC Patients,Diagnostics,Diagnostic Test or Assessment,500,2021-09-01,2021-09-01,https://clinicaltrials.gov/show/NCT04327180,No Results,No Results,No Results,2020-04-14,2020-04-07,None
629,NCT04337996,ClinicalTrials.gov,2020-04-01,2020-04-01,False,Tourcoing Hospital,Not Recruiting,Not Applicable,Interventional,No Country Given,Dynamic Evaluation of COVID-19 Diagnostic Tests,Diagnostics,Diagnostic Test or Assessment,176,2020-07-01,2020-10-01,https://clinicaltrials.gov/show/NCT04337996,No Results,No Results,No Results,2020-04-20,2020-04-15,None
630,NCT04338698,ClinicalTrials.gov,2020-04-04,2020-04-07,False,Shehnoor Azhar,Not Recruiting,Phase 3,Interventional,No Country Given,"Hydroxychloroquine, Oseltamivir and Azithromycin for the Treatment of COVID-19 Infection: An RCT",Drug,"Monotherapy and all Combinations of: Hydroxychloroquine, oseltamivir, and azithromycin",500,2020-09-01,2020-11-30,https://clinicaltrials.gov/show/NCT04338698,No Results,No Results,No Results,2020-04-20,2020-04-15,None
631,EUCTR2020-001301-23-FR,EU Clinical Trials Register,2020-03-26,2020-04-10,False,Assistance Publique  Hpitaux de Paris,Authorised,Phase 3,Interventional,France,Efficacy of Addition of Naproxen for COVID-19 Infection / Enacovid Study,Drug,Naproxen,584,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001301-23,No Results,No Results,No Results,2020-04-14,2020-04-15,None
632,NCT04327349,ClinicalTrials.gov,2020-03-24,2020-03-28,False,Mazandaran University of Medical Sciences,Recruiting,Not Applicable,Interventional,Iran,Investigating Effect of Convalescent Plasma on COVID-19 Patients Outcome: A Clinical Trial,ATMP,Plasma,30,2020-05-20,2020-09-30,https://clinicaltrials.gov/show/NCT04327349,No Results,No Results,No Results,2020-04-14,2020-04-07,None
633,NCT04327674,ClinicalTrials.gov,2020-03-27,2020-03-14,True,Aarhus University,Recruiting,Not Applicable,Observational,Denmark,The Use of Focused Lung Ultrasound in Patients Suspected of COVID-19,Diagnostics,Diagnostic Test or Assessment,375,2020-05-15,2020-05-15,https://clinicaltrials.gov/show/NCT04327674,No Results,No Results,No Results,2020-04-14,2020-04-07,None
634,EUCTR2020-001335-28-NL,EU Clinical Trials Register,2020-03-27,2020-03-29,False,InflaRx GmbH,Authorised,Phase 2/Phase 3,Interventional,Netherlands,An open label phase II/III study of IFX-1 in patients with severe COVID-19 Pneumonia,Drug,IFX-1,130,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001335-28,No Results,No Results,No Results,2020-04-14,2020-04-15,None
635,ChiCTR2000030469,ChiCTR,2020-03-02,2020-02-27,True,Shanghai University of Traditional Chinese Medicine,Recruiting,Not Applicable,Interventional,China,A randomized parallel controlled trial for LIUSHENWAN in Treatment of Novel Coronavirus Pneumonia (COVID-19),Traditional Medicine (Drug),Traditional Medicine,96,Not Available,2020-05-27,http://www.chictr.org.cn/showproj.aspx?proj=50082,No Results,No Results,No Results,2020-03-09,2020-08-03,None
636,NCT04338906,ClinicalTrials.gov,2020-04-03,2020-06-01,False,Heinrich-Heine University,Not Recruiting,Phase 4,Interventional,No Country Given,Combination Therapy With Camostat Mesilate + Hydroxychloroquine for COVID-19,Drug,Camostat Mesilate + hydroxychloroquine vs. hydroxychloroquine,334,2021-06-01,2021-12-31,https://clinicaltrials.gov/show/NCT04338906,No Results,No Results,No Results,2020-04-20,2020-04-15,None
637,NCT04339322,ClinicalTrials.gov,2020-04-07,2020-05-01,False,Assiut University,Not Recruiting,Not Applicable,Observational,No Country Given,Characteristics and Outcome of Coronavirus Disease 2019 (COVID-19) in Egypt,Clinical Presentation,No Intervention,200,2020-07-30,2020-07-30,https://clinicaltrials.gov/show/NCT04339322,No Results,No Results,No Results,2020-04-20,2020-04-15,None
638,NCT04339660,ClinicalTrials.gov,2020-04-02,2020-02-01,True,Puren Hospital Affiliated to Wuhan University of Science and Technology,Recruiting,Phase 1/Phase 2,Interventional,China,Clinical Research of Human Mesenchymal Stem Cells in the Treatment of COVID-19 Pneumonia,ATMP,Cells (mesenchymal),30,2020-06-30,2020-06-30,https://clinicaltrials.gov/show/NCT04339660,No Results,No Results,No Results,2020-04-20,2020-04-15,None
639,NCT04328454,ClinicalTrials.gov,2020-03-27,2020-01-30,True,Shanghai 10th People's Hospital,Recruiting,Not Applicable,Observational,China,Clinical Characteristics and Prognostic Factors of Patients With COVID-19,Prognosis,No Intervention,120,2020-04-02,2020-04-15,https://clinicaltrials.gov/show/NCT04328454,No Results,No Results,No Results,2020-04-14,2020-04-07,None
640,NCT04329559,ClinicalTrials.gov,2020-03-29,2020-03-30,False,Hepatopancreatobiliary Surgery Institute of Gansu Province,Recruiting,Not Applicable,Observational,China,COVID-19 in Patients With Pre-existing Cirrhosis (COVID-Cirrhosis-CHESS2002): A Multicentre Observational Study,Clinical Presentation,No Intervention,50,2020-06-29,2021-06-29,https://clinicaltrials.gov/show/NCT04329559,No Results,No Results,No Results,2020-04-14,2020-04-07,None
641,NCT04340219,ClinicalTrials.gov,2020-03-31,2020-03-30,True,"University Hospital, Ghent",Recruiting,Not Applicable,Observational,Belgium,"Oncology-patient-reported Anxiety, Mood, and QoL During the COVID-19 Pandemic",Other (psych),No Intervention,180,2020-04-10,2020-09-01,https://clinicaltrials.gov/show/NCT04340219,No Results,No Results,No Results,2020-04-20,2020-04-15,None
642,NCT04340544,ClinicalTrials.gov,2020-04-03,2020-04-10,False,"University Hospital, Tbingen",Not Recruiting,Phase 3,Interventional,Germany,Hydroxychloroquine for the Treatment of Mild COVID-19 Disease,Drug,Hydroxychloroquine,2700,2021-11-30,2022-09-30,https://clinicaltrials.gov/show/NCT04340544,No Results,No Results,No Results,2020-04-20,2020-04-15,None
643,ChiCTR2000030468,ChiCTR,2020-03-02,2020-02-28,True,Affiliated Hospital of Shandong University of Traditional Chinese Medicine,Recruiting,Not Applicable,Observational,China,Study for the key technique of integrative therapy of Novel Coronavirus Pneumonia (COVID-19): the TCM symptoms and treatment regulation,Traditional Medicine (Unspecified),Traditional Medicine,950,Not Available,2020-07-30,http://www.chictr.org.cn/showproj.aspx?proj=50390,No Results,No Results,No Results,2020-03-09,2020-08-03,None
644,NCT04331600,ClinicalTrials.gov,2020-03-30,2020-04-06,True,Wroclaw Medical University,Not Recruiting,Phase 4,Interventional,No Country Given,ChloroQUine As antiviRal treAtmeNT In coroNavirus infEction 2020,Drug,Chloroquine,400,2020-09-30,2020-12-31,https://clinicaltrials.gov/show/NCT04331600,No Results,No Results,No Results,2020-04-14,2020-04-07,EUCTR2020-001469-35
645,NCT04333472,ClinicalTrials.gov,2020-04-01,2020-04-06,False,Can-Fite BioPharma,Not Recruiting,Phase 2,Interventional,Israel,Piclidenoson for Treatment of COVID-19,Drug,Piclidenoson,40,2020-06-06,2020-07-06,https://clinicaltrials.gov/show/NCT04333472,No Results,No Results,No Results,2020-04-14,2020-04-07,None
646,EUCTR2020-001457-43-FR,EU Clinical Trials Register,2020-04-02,2020-04-10,False,Assistance Publique  Hpitaux de Paris,Authorised,Phase 3,Interventional,France,Dexamethasone and oxygen support strategies in ICU patients with Covid-19 pneumonia,Drug,Dexamethasone + Oxygen,550,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001457-43,No Results,No Results,No Results,2020-04-14,2020-04-15,None
647,NCT04341103,ClinicalTrials.gov,2020-03-16,2020-04-01,False,CareDx,Not Recruiting,Not Applicable,Observational,No Country Given,AlloSure Guided Immuno-Optimization for COVID-19: An Early Experience,Clinical Presentation,No Intervention,500,2020-12-01,2021-03-01,https://clinicaltrials.gov/show/NCT04341103,No Results,No Results,No Results,2020-04-20,2020-04-15,None
648,NCT04341519,ClinicalTrials.gov,2020-04-07,2020-04-09,False,Assistance Publique  Hpitaux de Paris,Not Recruiting,Not Applicable,Observational,France,"Psychological Burden in ICU Survivors of Severe COVID-19 Pneumonia, Their Relatives and Their Healthcare Providers",Other (psych),No Intervention,1464,2020-11-30,2021-12-31,https://clinicaltrials.gov/show/NCT04341519,No Results,No Results,No Results,2020-04-20,2020-04-15,None
649,ACTRN12620000444987,ANZCTR,2020-04-06,2020-04-07,False,South Metropolitan Health Service,Not Recruiting,Not Applicable,Observational,Australia,COVID-19 Research Response (ISARIC/WHO Clinical Characterisation Protocol for Severe Emerging Infections COVID-19 Research Response Trial),Clinical Presentation,No Intervention,100000,Not Available,Not Available,https://anzctr.org.au/ACTRN12620000444987.aspx,No Results,No Results,No Results,2020-04-14,2020-04-07,None
650,ACTRN12620000447954,ANZCTR,2020-04-06,2020-03-31,True,Royal Brisbane & Women's Hospital,Recruiting,Not Applicable,Interventional,Australia,Use of therapeutic drug monitoring (TDM) to optimise oral/enteral hydroxychloroquine dosing in critically ill patients with COVID-19,Drug,Hydroxychloroquine,150,Not Available,2020-08-31,https://anzctr.org.au/ACTRN12620000447954.aspx,No Results,No Results,No Results,2020-04-14,2020-04-07,None
651,EUCTR2020-001442-19-ES,EU Clinical Trials Register,2020-04-03,2020-04-02,True,Institut de Recerca Hospital de la Santa Creu i Sant Pau,Authorised,Phase 2,Interventional,Spain,"Clinical trial of combined use of hydroxychloroquine, azithromycin, and tocilizumab for the treatment of COVID-19",Drug,Tocilizumab + hydroxychloroquine + azithromycin,276,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001442-19,No Results,No Results,No Results,2020-04-14,2020-04-15,None
652,NCT04341610,ClinicalTrials.gov,2020-04-07,2020-04-20,False,"Rigshospitalet, Denmark",Not Recruiting,Phase 1/Phase 2,Interventional,Denmark,ASC Therapy for Patients With Severe Respiratory COVID-19,ATMP,Cells (mesenchymal),40,2021-01-30,2021-04-30,https://clinicaltrials.gov/show/NCT04341610,No Results,No Results,No Results,2020-04-20,2020-04-15,None
653,NCT04341935,ClinicalTrials.gov,2020-04-06,2020-04-30,False,University of Miami,Not Recruiting,Phase 4,Interventional,United States,Effects of DPP4 Inhibition on COVID-19,Drug,Linagliptin,20,2020-10-30,2020-12-30,https://clinicaltrials.gov/show/NCT04341935,No Results,No Results,No Results,2020-04-20,2020-04-15,None
654,ChiCTR2000031860,ChiCTR,2020-04-12,2020-04-27,False,Beijing Sports University,Not Recruiting,Not Applicable,Observational,China,Study for the exercise rehabilitation therapy for the dysfunction of cured discharged novel coronavirus pneumonia (COVID-19) patients,Other (exercise),Exercise,150,Not Available,2020-09-16,http://www.chictr.org.cn/showproj.aspx?proj=52198,No Results,No Results,No Results,2020-04-13,2020-04-15,None
655,ACTRN12620000473965,ANZCTR,2020-04-15,2020-06-01,False,The University of Queensland,Not Recruiting,Phase 3,Interventional,Australia,Reducing acute severe respiratory events in health care workers during the Covid-19 pandemic with OM85,Drug (Chemoprophylaxis),OM85,1000,Not Available,2021-04-30,https://anzctr.org.au/ACTRN12620000473965.aspx,No Results,No Results,No Results,2020-04-20,2020-04-22,None
656,EUCTR2020-001385-11-ES,EU Clinical Trials Register,2020-04-03,2020-03-28,True,Plan Nacional sobre el Sida (PNS),Authorised,Phase 3,Interventional,Spain,EPICOS - Experimental clinical trial for PreventIon or COronavirus in health Care professionalS,Drug (Chemoprophylaxis),Emtricitabine/tenofovir + hydroxychloroquine,4000,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001385-11,No Results,No Results,No Results,2020-04-14,2020-04-15,None
657,ChiCTR2000031834,ChiCTR,2020-04-11,2020-04-20,False,Jiangsu Province Hospital,Not Recruiting,Not Applicable,Interventional,China,A clinical study for the effect of remote monitoring exercise rehabilitation on the discharged patients with novel coronavirus pneumonia (COVID-19),Telehealth,Telehealth,120,Not Available,2020-10-20,http://www.chictr.org.cn/showproj.aspx?proj=52216,No Results,No Results,No Results,2020-04-13,2020-04-15,None
658,ACTRN12620000474954,ANZCTR,2020-04-15,2020-04-27,False,Sir Charles Gairdner Hospital,Not Recruiting,Not Applicable,Observational,Australia,Airway Pressure Release Ventilation for mechanically ventilated patients with COVID-19 in Western Australian Intensive Care Units: an observational study,Other (physical),Mechanical ventilation,100,Not Available,Not Available,https://anzctr.org.au/ACTRN12620000474954.aspx,No Results,No Results,No Results,2020-04-20,2020-04-22,None
659,EUCTR2020-001307-16-ES,EU Clinical Trials Register,2020-04-08,2020-04-01,True,Fundacin para la Investigacin Biomdica Hospital Ramn y Cajal,Authorised,Phase 3,Interventional,Spain,Efficacy and Safety of corticoids in patients with adult respiratory distress syndrome (ARDS) secondary to coronavirus infection.,Drug,Corticosteroids,104,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001307-16,No Results,No Results,No Results,2020-04-14,2020-04-15,None
660,ChiCTR2000032009,ChiCTR,2020-04-17,2020-02-08,True,"Renji Hospital, Shanghai Jiaotong University School of Medicine",Not Recruiting,Not Applicable,Observational,China,Clinical characteristics and risk factors of novel coronavirus pneumonia (COVID-19) patients with chronic liver disease,Clinical Presentation,No Intervention,30,Not Available,2020-04-30,http://www.chictr.org.cn/showproj.aspx?proj=52490,No Results,No Results,No Results,2020-04-20,2020-04-22,None
661,ChiCTR2000031735,ChiCTR,2020-04-08,2020-03-01,True,Huzhou Central Hospital,Not Recruiting,Not Applicable,Interventional,China,Clinical study for natural killer (NK) cells from umbilical cord blood in the treatment of novel coronavirus pneumonia (COVID-19),ATMP,Cells (NK),20,Not Available,2021-02-28,http://www.chictr.org.cn/showproj.aspx?proj=50613,No Results,No Results,No Results,2020-04-13,2020-04-15,None
662,ChiCTR2000031982,ChiCTR,2020-04-16,2020-04-01,True,The Fifth Affiliated Hospital of Sun Yat-Sen University,Not Recruiting,Not Applicable,Observational,China,Clinical observation for the effect of Ke-Gan-Li-Yan oral liquid on the relief of laryngeal symptoms of novel coronavirus pneumonia (COVID-19) convalescence and suspected patients and other susceptible people,Traditional Medicine (Drug),Traditional Medicine,240,Not Available,2020-08-31,http://www.chictr.org.cn/showproj.aspx?proj=52341,No Results,No Results,No Results,2020-04-20,2020-04-22,None
663,ChiCTR2000031675,ChiCTR,2020-04-06,2020-04-06,False,Women's Hospital of Zhejiang University School of Medicine,Recruiting,Not Applicable,Observational,China,A medical records based retrospective analysis of maternal and infant outcomes in Cesarean delivery in Hangzhou non pneumonia Hospital during pandemic of Novel coronovirus pneumonia(COVID-19),Clinical Presentation,No Intervention,2000,Not Available,Not Available,http://www.chictr.org.cn/showproj.aspx?proj=52037,No Results,No Results,No Results,2020-04-13,2020-04-15,None
664,ChiCTR2000031955,ChiCTR,2020-04-16,2020-04-01,True,Beijing University of Chinese Medicine,Recruiting,Not Applicable,Interventional,China,Study for prevention of novel coronavirus pneumonia (COVID-19) in high risk population by Chinese medicine,Clinical Presentation (Epidemiology),No Intervention,3808,Not Available,2020-12-31,http://www.chictr.org.cn/showproj.aspx?proj=52364,No Results,No Results,No Results,2020-04-20,2020-04-22,None
665,NCT04245631,ClinicalTrials.gov,2020-01-26,2020-01-01,True,Beijing Ditan Hospital,Recruiting,Not Applicable,Observational,China,"Development of a Simple, Fast and Portable Recombinase Aided Amplification Assay for 2019-nCoV",Diagnostics,Diagnostic Test or Assessment,50,2020-12-31,2020-12-31,https://clinicaltrials.gov/show/NCT04245631,No Results,No Results,No Results,2020-04-20,2020-08-03,None
666,NCT04306055,ClinicalTrials.gov,2020-03-08,2020-03-13,False,Guangzhou Blood Center,Not Recruiting,Not Applicable,Interventional,China,Blood Donor Recruitment During Epidemic of COVID-19,Other,No Intervention,19491,2020-03-13,2020-04-03,https://clinicaltrials.gov/show/NCT04306055,No Results,No Results,No Results,2020-04-20,2020-03-18,None
667,ChiCTR2000030494,ChiCTR,2020-03-05,2020-03-01,True,West China Hospital of Sichuan University,Not Recruiting,Not Applicable,Observational,China,Early risk stratification of the novel coronavirus infected diseases (COVID-19): a multicenter retrospective study  (ERS-COVID-19 study),Prognosis,No Intervention,600,Not Available,2020-04-01,http://www.chictr.org.cn/showproj.aspx?proj=50077,No Results,No Results,No Results,2020-04-13,2020-08-03,None
668,ChiCTR2000031944,ChiCTR,2020-04-15,2020-04-16,False,China Academy of Chinese Medical Sciences,Recruiting,Not Applicable,Interventional,China,Efficacy of Chinese Herbal Tea in the Prevention of Novel Coronavirus Pneumonia (COVID-19): a Randomized Controlled Trial,Traditional Medicine (Other),Traditional Medicine,2000,Not Available,2020-12-31,http://www.chictr.org.cn/showproj.aspx?proj=52414,No Results,No Results,No Results,2020-04-20,2020-04-22,None
669,ChiCTR2000031928,ChiCTR,2020-04-14,2020-06-01,False,The Chinese University of Hong Kong,Not Recruiting,Not Applicable,Observational,China,"Delineate the prevalence, risk factors, temporal distribution and epidemiological characteristics of hidden novel coronavirus (2019-nCoV) infection in the community",Clinical Presentation (Epidemiology),No Intervention,3000,Not Available,2021-04-14,http://www.chictr.org.cn/showproj.aspx?proj=52353,No Results,No Results,No Results,2020-04-20,2020-04-22,None
670,ChiCTR2000030331,ChiCTR,2020-02-28,2020-02-01,True,The First Affiliated Hospital Division of Life Sciences and Medicine University of Science and Technology of China,Recruiting,Not Applicable,Epidemiological research,China,Construction of a Bio information platform for novel coronavirus pneumonia (COVID-19) patients follow-up in Anhui,Clinical Presentation,No Intervention,498,Not Available,2022-02-01,http://www.chictr.org.cn/showproj.aspx?proj=50271,No Results,No Results,No Results,2020-04-13,2020-08-03,None
671,NCT04323800,ClinicalTrials.gov,2020-03-24,2020-05-01,False,Johns Hopkins University,Not Recruiting,Phase 2,Interventional,No Country Given,Efficacy and Safety Human Coronavirus Immune Plasma (HCIP) vs. Control (SARS-CoV-2 Non-immune Plasma) Among Adults Exposed to COVID-19,ATMP,Plasma,150,2022-12-31,2023-01-01,https://clinicaltrials.gov/show/NCT04323800,No Results,No Results,No Results,2020-04-20,2020-04-01,None
672,NCT04328467,ClinicalTrials.gov,2020-03-27,2020-04-06,False,University of Minnesota,Recruiting,Phase 3,Interventional,United States,Pre-exposure Prophylaxis for SARS-Coronavirus-2,Drug (Chemoprophylaxis),Hydroxychloroquine,3500,2020-08-01,2020-08-01,https://clinicaltrials.gov/show/NCT04328467,No Results,No Results,No Results,2020-04-20,2020-04-07,None
673,ChiCTR2000029976,ChiCTR,2020-02-18,2020-02-18,False,Shanghai University of Traditional Chinese Medicine,Recruiting,Not Applicable,Interventional,China,The effect of Gymnastic Qigong Yangfeifang on functional recovery and quality of life in patients with mild novel coronavirus pneumonia (COVID-19),Traditional Medicine (Other),Traditional Medicine,160,Not Available,2022-02-19,http://www.chictr.org.cn/showproj.aspx?proj=49631,No Results,No Results,No Results,2020-04-20,2020-03-18,None
674,EUCTR2020-001333-13-FR,EU Clinical Trials Register,2020-04-02,2020-04-09,False,Groupe Hospitalier Paris Saint-Joseph,Authorised,Phase 3,Interventional,France,Dexamethasone associated with hydroxychloroquine vs. hydroxychloroquine alone for the early treatment of severe ARDS caused by COVID-19 : a randomized controlled trial,Drug,Dexamethasone + hydroxychloroquine vs. hydroxychloroquine,122,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001333-13,No Results,No Results,No Results,2020-04-14,2020-04-15,None
675,NCT04329832,ClinicalTrials.gov,2020-03-30,2020-03-30,False,"Intermountain Health Care, Inc.",Recruiting,Phase 2,Interventional,United States,Hydroxychloroquine vs. Azithromycin for Hospitalized Patients With Suspected or Confirmed COVID-19,Drug,Hydroxychloroquine vs. Azithromycin,300,2020-12-31,2021-12-31,https://clinicaltrials.gov/show/NCT04329832,No Results,No Results,No Results,2020-04-20,2020-04-07,None
676,NCT04331106,ClinicalTrials.gov,2020-03-27,2020-03-27,False,Charit University,Recruiting,Not Applicable,Observational,Germany,Survey of the Anxiety Associated With the COVID-19 Pandemic,Other (psych),No Intervention,6000,2020-09-01,2021-09-01,https://clinicaltrials.gov/show/NCT04331106,No Results,No Results,No Results,2020-04-20,2020-04-15,None
677,EUCTR2020-001160-28-ES,EU Clinical Trials Register,2020-04-13,2020-04-09,True,Medica Scientia Innovation Research S.L. (MEDSIR),Authorised,Phase 2,Interventional,Spain,Tocilizumab plus Pembrolizumab in COVID-19,Drug,Tocilizumab + Pembrolizumab,24,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001160-28,No Results,No Results,No Results,2020-04-20,2020-04-22,None
678,EUCTR2020-001421-31-ES,EU Clinical Trials Register,2020-04-07,2020-04-06,True,Sociedad Espaola de Farmacia Hospitalaria,Authorised,Phase 4,Interventional,Spain,Clinical trial for evaluation of efficacy and safety of hydroxychloroquine chemoprophylaxis against SARS-CoV-2 (COVID-19) infection in healthcare professionals.,Drug (Chemoprophylaxis),Hydroxychloroquine,1530,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001421-31,No Results,No Results,No Results,2020-04-14,2020-04-15,None
679,ChiCTR2000030453,ChiCTR,2020-03-02,2020-03-02,False,The First Affiliated Hospital of Wenzhou Medical University,Not Recruiting,Not Applicable,Observational,China,Clinical study for the effects of ACEIs/ARBs on the infection of novel coronavirus pneumonia (CoVID-19),Drug,ACE inhibitors or ARBs,100,Not Available,Not Available,http://www.chictr.org.cn/showproj.aspx?proj=50381,No Results,No Results,No Results,2020-03-09,2020-08-03,None
680,NCT04334512,ClinicalTrials.gov,2020-04-02,2020-04-01,True,ProgenaBiome,Not Recruiting,Phase 2,Interventional,United States,A Study of Quintuple Therapy to Treat COVID-19 Infection,Drug,Hydroxychloroquine + azithromycin + vitamin C + vitamin D + zinc,600,2021-05-01,2021-08-01,https://clinicaltrials.gov/show/NCT04334512,No Results,No Results,No Results,2020-04-20,2020-04-15,None
681,NCT04335747,ClinicalTrials.gov,2020-04-03,2020-04-08,False,Salome Kristensen,Not Recruiting,Not Applicable,Observational,Denmark,COVID-19 Infection in Vulnerable Patients With Inflammatory Rheumatic Diseases,Clinical Presentation,No Intervention,333,2021-08-01,2021-09-01,https://clinicaltrials.gov/show/NCT04335747,No Results,No Results,No Results,2020-04-20,2020-04-15,None
682,EUCTR2020-001606-33-ES,EU Clinical Trials Register,2020-04-07,2020-04-07,False,Instituto Investigacin Sanitario Biocruces Bizkaia,Authorised,Phase 3,Interventional,Spain,Randomized clinical trial to evaluate the efficacy of hydroxychloroquine associated or not with azithromycin as a treatment for COVID-19 infection,Drug,Hydroxychloroquine + azithromycin vs. hydroxychloroquine,132,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001606-33,No Results,No Results,No Results,2020-04-14,2020-04-15,None
683,NCT04336254,ClinicalTrials.gov,2020-03-28,2020-04-06,False,Renmin Hospital of Wuhan University,Recruiting,Phase 1/Phase 2,Interventional,China,Safety and Efficacy Study of Allogeneic Human Dental Pulp Mesenchymal Stem Cells to Treat Severe COVID-19 Patients,ATMP,Cells (mesenchymal),20,2020-12-31,2021-03-31,https://clinicaltrials.gov/show/NCT04336254,No Results,No Results,No Results,2020-04-20,2020-04-15,None
684,EUCTR2020-001321-31-ES,EU Clinical Trials Register,2020-04-13,2020-04-11,True,Hospital Universitario de Fuenlabrada,Authorised,Phase 2,Interventional,Spain,Clinical trial phase II to evaluate the efficacy of  3 types of treatment in patients with pneumonia by COVID-19,Drug,Hydroxychloroquine + baricitinib or imatinib or lopinavir/ritonavir,165,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001321-31,No Results,No Results,No Results,2020-04-20,2020-04-22,None
685,NCT04252274,ClinicalTrials.gov,2020-01-29,2020-01-30,False,Shanghai Public Health Clinical Center,Recruiting,Phase 3,Interventional,China,Efficacy and Safety of Darunavir and Cobicistat for Treatment of COVID-19,Drug,Darunavir + Cobicistat,30,2020-08-31,2020-12-31,https://clinicaltrials.gov/show/NCT04252274,No Results,No Results,No Results,2020-04-20,2020-08-03,None
686,NCT04261517,ClinicalTrials.gov,2020-02-06,2020-02-06,False,Shanghai Public Health Clinical Center,Not Recruiting,Phase 3,Interventional,China,Efficacy and Safety of Hydroxychloroquine for Treatment of COVID-19,Drug,Hydroxychloroquine,30,2020-02-25,2020-02-25,https://clinicaltrials.gov/show/NCT04261517,Journal Article,2020-03-06,https://doi.org/10.3785/j.issn.1008-9292.2020.03.03,2020-04-20,2020-08-03,None
687,NCT04337502,ClinicalTrials.gov,2020-04-06,2019-12-23,True,Maastricht University,Not Recruiting,Not Applicable,Observational,China,Clinical and Radiomic Model of COVID-19,Other (software),Other,300,2020-01-20,2020-03-03,https://clinicaltrials.gov/show/NCT04337502,No Results,No Results,No Results,2020-04-20,2020-04-15,None
688,NCT04337541,ClinicalTrials.gov,2020-04-02,2020-04-02,False,"Rigshospitalet, Denmark",Recruiting,Not Applicable,Interventional,Denmark,Reduction in COVID-19 Infection Using Surgical Facial Masks Outside the Healthcare System,Other (device),Masks,6000,2020-07-01,2020-07-01,https://clinicaltrials.gov/show/NCT04337541,No Results,No Results,No Results,2020-04-20,2020-04-15,None
689,EUCTR2020-001413-20-ES,EU Clinical Trials Register,2020-04-13,2020-04-07,True,Fundaci Clnic per a la Recerca Biomdica,Authorised,Phase 2,Interventional,Spain,Efficacy and safety of siltuximab vs. corticosteroids in hospitalized patients with COVID-19 pneumonia,Drug,Siltuximab vs. Corticosteroids,100,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001413-20,No Results,No Results,No Results,2020-04-20,2020-04-22,None
690,NCT04317092,ClinicalTrials.gov,2020-03-19,2020-03-19,True,National Cancer Institute,Recruiting,Phase 2,Interventional,Italy,Tocilizumab in COVID-19 Pneumonia (TOCIVID-19),Drug,Tocilizumab,400,2020-12-19,2022-12-19,https://clinicaltrials.gov/show/NCT04317092,No Results,No Results,No Results,2020-04-20,2020-03-25,EUCTR2020-001110-38
691,NCT04325672,ClinicalTrials.gov,2020-03-26,2020-04-01,False,Mayo Clinic,Not Recruiting,Phase 2,Interventional,United States,Convalescent Plasma to Limit Coronavirus Associated Complications,ATMP,Plasma,Not Available,2022-12-31,2022-12-31,https://clinicaltrials.gov/show/NCT04325672,No Results,No Results,No Results,2020-04-20,2020-04-01,None
692,NCT04337762,ClinicalTrials.gov,2020-04-06,2020-04-06,False,Beat COVID LLC,Recruiting,Not Applicable,Observational,United States,Beat COVID-19 - Observational Trial,Clinical Presentation,No Intervention,100000,2020-12-01,2021-07-01,https://clinicaltrials.gov/show/NCT04337762,No Results,No Results,No Results,2020-04-20,2020-04-15,None
693,NCT04337983,ClinicalTrials.gov,2020-03-30,2020-04-15,False,Bicetre Hospital,Not Recruiting,Not Applicable,Observational,France,Hemodynamic Characteristics of Patients With SARS-CoV-2,Clinical Presentation,No Intervention,200,2020-10-01,2021-04-01,https://clinicaltrials.gov/show/NCT04337983,No Results,No Results,No Results,2020-04-20,2020-04-15,None
694,EUCTR2020-001765-37-ES,EU Clinical Trials Register,2020-04-13,2020-04-11,True,Institut Catal d'Oncologia,Authorised,Phase 2,Interventional,Spain,Pragmatic clinical trial of hydroxychloroquine in the treatment of oncohematological patients and health professionals with COVID-19 infection without radiological alteration.,Drug,Hydroxychloroquine,103,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001765-37,No Results,No Results,No Results,2020-04-20,2020-04-22,None
695,NCT04326725,ClinicalTrials.gov,2020-03-26,2020-03-20,True,Istinye University,Recruiting,Not Applicable,Observational,Turkey,Proflaxis Using Hydroxychloroquine Plus Vitamins-Zinc During COVID-19 Pandemia,Drug (Chemoprophylaxis),Hydroxychloroquine + Zinc + Vitamin C,80,2020-07-01,2020-09-01,https://clinicaltrials.gov/show/NCT04326725,No Results,No Results,No Results,2020-04-20,2020-04-07,None
696,NCT04328012,ClinicalTrials.gov,2020-03-27,2020-04-06,False,Bassett Healthcare,Recruiting,Phase 2/Phase 3,Interventional,United States,COVID MED Trial - Comparison Of Therapeutics for Hospitalized Patients Infected With SARS-CoV-2,Drug,Lopinavir/ritonavir vs. hydroxychloroquine vs. ARB (Losartan),4000,2021-01-01,2021-04-01,https://clinicaltrials.gov/show/NCT04328012,No Results,No Results,No Results,2020-04-20,2020-04-07,None
697,NCT04338828,ClinicalTrials.gov,2020-04-05,2020-04-01,True,Massachusetts General Hospital,Not Recruiting,Phase 2,Interventional,United States,Nitric Oxide Inhalation Therapy for COVID-19 Infections in the ED,Drug,Nitric oxide,260,2021-04-01,2022-04-01,https://clinicaltrials.gov/show/NCT04338828,No Results,No Results,No Results,2020-04-20,2020-04-15,None
698,NCT04340349,ClinicalTrials.gov,2020-04-02,2020-04-10,False,Instituto Nacional de Rehabilitacion,Not Recruiting,Phase 1,Interventional,Mexico,Low-dose Hydroxychloroquine and Bromhexine: a Novel Regimen for COVID-19 Prophylaxis in Healthcare Professionals,Drug (Chemoprophylaxis),Hydroxychloroquine + bromhexine vs. bromhexine,100,2020-07-20,2020-08-20,https://clinicaltrials.gov/show/NCT04340349,No Results,No Results,No Results,2020-04-20,2020-04-15,None
699,NCT04329546,ClinicalTrials.gov,2020-03-29,2020-03-27,True,"University Hospital, Geneva",Recruiting,Not Applicable,Observational,Switzerland,Understanding COVID-19,Clinical Presentation,No Intervention,250,2022-01-31,2022-03-31,https://clinicaltrials.gov/show/NCT04329546,No Results,No Results,No Results,2020-04-20,2020-04-07,None
700,NCT04333953,ClinicalTrials.gov,2020-03-31,2020-04-01,False,University of Missouri-Columbia,Recruiting,Not Applicable,Observational,United States,COVID-19 in Patients With HIV,Clinical Presentation,No Intervention,500,2020-10-01,2020-10-01,https://clinicaltrials.gov/show/NCT04333953,No Results,No Results,No Results,2020-04-20,2020-04-07,None
701,EUCTR2020-001466-11-GR,EU Clinical Trials Register,2020-04-14,2020-04-15,False,Hellenic Institute for the Study of Sepsis,Authorised,Phase 2,Interventional,Greece,Prevention of severe respiratory failure in Covid-19,Drug,Anakinra,100,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001466-11,No Results,No Results,No Results,2020-04-20,2020-04-22,None
702,NCT04341012,ClinicalTrials.gov,2020-04-07,2019-09-10,True,Mayo Clinic,Recruiting,Not Applicable,Observational,United States,Breath Analysis Based Disease Biomarkers of COVID-19 and Other Diseases,Diagnostics,Diagnostic Test or Assessment,120,2021-12-31,2021-12-31,https://clinicaltrials.gov/show/NCT04341012,No Results,No Results,No Results,2020-04-20,2020-04-15,None
703,NCT04341038,ClinicalTrials.gov,2020-04-07,2020-04-01,False,Hospital Universitari de Bellvitge,Recruiting,Phase 3,Interventional,Spain,Clinical Trial to Evaluate Methylprednisolone Pulses and Tacrolimus in Patients With COVID-19 Lung Injury,Drug,Tacrolimus + Corticosteroids,84,2020-06-01,2020-07-01,https://clinicaltrials.gov/show/NCT04341038,No Results,No Results,No Results,2020-04-20,2020-04-15,EUCTR2020-001445-39
704,NCT04334382,ClinicalTrials.gov,2020-04-02,2020-04-02,False,"Intermountain Health Care, Inc.",Recruiting,Phase 3,Interventional,United States,Hydroxychloroquine vs. Azithromycin for Outpatients in Utah With COVID-19,Drug,Hydroxychloroquine vs. azithromycin,1550,2020-12-31,2021-12-31,https://clinicaltrials.gov/show/NCT04334382,No Results,No Results,No Results,2020-04-20,2020-04-15,None
705,NCT04336761,ClinicalTrials.gov,2020-04-03,2020-04-01,True,"University Hospital, Lille",Not Recruiting,Not Applicable,Observational,France,Prevalence of Covid-19 in Children Admitted to Paediatric Emergency Departments During the Pandemic Period in France,Clinical Presentation (Epidemiology),No Intervention,914,2020-12-01,2020-12-01,https://clinicaltrials.gov/show/NCT04336761,No Results,No Results,No Results,2020-04-20,2020-04-15,None
706,EUCTR2020-001379-34-ES,EU Clinical Trials Register,2020-04-14,2020-04-14,False,Instituto de Investigacin Sanitaria INCLIVA,Authorised,Phase 4,Interventional,Spain,Sedation with sevoflurane versus propofol in patients with Acute Respiratory Distress Syndrome caused by COVID-19 infection,Drug,Sevoflurane vs. Propofol,50,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001379-34,No Results,No Results,No Results,2020-04-20,2020-04-22,None
707,NCT04341480,ClinicalTrials.gov,2020-04-07,2020-04-10,False,Tongji Hospital,Not Recruiting,Not Applicable,Observational,China,The Safety of Chemotherapy for Patients With Gynecological Malignancy in High-risk Region of COVID-19,Clinical Presentation,No Intervention,207,2020-07-10,2020-07-10,https://clinicaltrials.gov/show/NCT04341480,No Results,No Results,No Results,2020-04-20,2020-04-22,None
708,NCT04342104,ClinicalTrials.gov,2020-04-08,2020-04-01,True,Hospital General Universitario Morales Meseguer,Recruiting,Not Applicable,Observational,Spain,NIV and CPAP Failure Predictors in COVID-19 Associated Respiratory Failure,Clinical Presentation,No Intervention,100,2020-06-01,2020-07-01,https://clinicaltrials.gov/show/NCT04342104,No Results,No Results,No Results,2020-04-20,2020-04-15,None
709,NCT04336787,ClinicalTrials.gov,2020-04-03,2020-04-12,False,Istanbul Koltor University,Not Recruiting,Not Applicable,Observational,Turkey,"Physical Activity Level, Stress Level, Sleep Quality in Pregnant Women During Covid-19 Quarantine",Other (psych),No Intervention,100,2020-05-10,2020-06-10,https://clinicaltrials.gov/show/NCT04336787,No Results,No Results,No Results,2020-04-20,2020-04-15,None
710,NCT04337346,ClinicalTrials.gov,2020-04-05,2020-04-05,False,Kanuni Sultan Suleyman Training and Research Hospital,Not Recruiting,Not Applicable,Observational,Turkey,Evaluation of Covid 19 Anxiety in Endometriosis Patients,Other (psych),No Intervention,80,2020-04-20,2020-04-25,https://clinicaltrials.gov/show/NCT04337346,No Results,No Results,No Results,2020-04-20,2020-04-15,None
711,NCT04337489,ClinicalTrials.gov,2020-04-01,2020-04-01,False,Imperial College London,Not Recruiting,Not Applicable,Observational,No Country Given,Remote Monitoring Use In Cases Of Suspected COVID-19 (Coronavirus),Other (device),Wearable,200,2021-04-01,2021-04-01,https://clinicaltrials.gov/show/NCT04337489,No Results,No Results,No Results,2020-04-20,2020-04-15,None
712,NCT04343404,ClinicalTrials.gov,2020-04-08,2020-04-01,True,"University Hospital, Strasbourg",Recruiting,Not Applicable,Observational,France,PLACE OF VENOVENOUS ECMO IN THE MANAGEMENT OF SEVERE REFRACTORY ARDS ASSOCIATED WITH SARS-COV-2,Drug,Oxygen,100,2020-04-15,2020-04-15,https://clinicaltrials.gov/show/NCT04343404,No Results,No Results,No Results,2020-04-20,2020-04-15,None
713,NCT04344080,ClinicalTrials.gov,2020-04-09,2020-04-01,True,"University Hospital, Hamburg-Eppendorf",Recruiting,Not Applicable,Interventional,Germany,Effect of CytoSorb Adsorber on Hemodynamic and Immunological Parameters in Critical Ill Patients With COVID-19,Other (device),Cytokine Adsorber,24,2020-12-01,2021-02-01,https://clinicaltrials.gov/show/NCT04344080,No Results,No Results,No Results,2020-04-20,2020-04-22,None
714,CTRI/2020/04/024442,CTRI,2020-04-01,2020-04-08,False,Max Super Speciality Hospital,Not Recruiting,Not Applicable,Observational,India,Screening for symptoms of COVID-19,Clinical Presentation,No Intervention,5000,Not Available,Not Available,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=42687,No Results,No Results,No Results,2020-04-20,2020-04-22,None
715,NCT04337788,ClinicalTrials.gov,2020-04-03,2020-04-01,True,"University Hospital, Limoges",Not Recruiting,Not Applicable,Interventional,No Country Given,Gerontological Telemonitoring of Older Adults Living in Nursing Homes With COVID-19 Disease,Telehealth,Telehealth,200,2020-07-01,2020-09-01,https://clinicaltrials.gov/show/NCT04337788,No Results,No Results,No Results,2020-04-20,2020-04-15,None
716,NCT04338360,ClinicalTrials.gov,2020-04-03,2019-01-10,True,Mayo Clinic,Not Recruiting,Not Applicable,Expanded Access,United States,Expanded Access to Convalescent Plasma for the Treatment of Patients With COVID-19,ATMP,Plasma,Not Available,Not Available,Not Available,https://clinicaltrials.gov/show/NCT04338360,Pre-Print Article,2020-05-14,https://doi.org/10.1101/2020.05.12.20099879,2020-04-20,2020-04-15,None
717,IRCT20200310046736N1,IRCT,2020-04-01,No Date Available,False,Ahvaz University of Medical Sciences,Not Recruiting,Phase 2/Phase 3,Interventional,Iran,Comparison of The Therapeutic Effect of Convalescent Plasma and Plasma-derived Immunoglobulin-enriched solution on COVID-19 Patients,ATMP,Plasma,45,Not Available,Not Available,http://en.irct.ir/trial/46424,No Results,No Results,No Results,2020-04-21,2020-04-22,None
718,NCT04344925,ClinicalTrials.gov,2020-04-03,2020-04-01,True,Lawson Health Research Institute,Not Recruiting,Not Applicable,Observational,No Country Given,Non Invasive Positive Pressure Ventilation to Minimize Aerosolization for COVID 19,Other (device),Mask,50,2020-06-01,2020-08-01,https://clinicaltrials.gov/show/NCT04344925,No Results,No Results,No Results,2020-04-20,2020-04-22,None
719,NCT04344951,ClinicalTrials.gov,2020-04-06,2020-04-06,False,Uni-Pharma Kleon Tsetis Pharmaceutical Laboratories S.A.,Recruiting,Phase 2,Interventional,Greece,"Chloroquine Phosphate Against Infection by the Novel Coronavirus SARS-CoV-2 (COVID-19): The HOPE Open-Label, Non Randomized Clinical Trial",Drug,Chloroquine,60,2021-04-01,2021-04-30,https://clinicaltrials.gov/show/NCT04344951,No Results,No Results,No Results,2020-04-20,2020-04-22,None
720,IRCT20151113025025N3,IRCT,2020-03-29,2020-04-05,False,Tehran University of Medical Sciences,Recruiting,Phase 4,Interventional,Iran,Clinical Trial of renin-angiotensin-aldosterone system inhibitors with halting their administration and the effect on clinical outcomes of patients with corona virus disease-2019 (COVID-19) referring to Sina Hospital in 2020,Drug,RAAS inhibitors,60,Not Available,Not Available,http://en.irct.ir/trial/46531,No Results,No Results,No Results,2020-04-21,2020-04-22,None
721,NCT04338802,ClinicalTrials.gov,2020-04-01,2020-04-02,False,Huilan Zhang,Not Recruiting,Phase 2,Interventional,No Country Given,Efficacy and Safety of Nintedanib in the Treatment of Pulmonary Fibrosis in Patients With Moderate to Severe COVID -19,Drug,Nintedanib,96,2020-05-04,2020-08-01,https://clinicaltrials.gov/show/NCT04338802,No Results,No Results,No Results,2020-04-20,2020-04-15,None
722,NCT04339998,ClinicalTrials.gov,2020-04-06,2020-04-15,False,University of Minnesota,Not Recruiting,Not Applicable,Observational,United States,Assessment of Exam Findings in Coronavirus Disease 2019 (COVID-19) With Point-of-Care Ultrasonography (POCUS),Diagnostics,Diagnostic Test or Assessment,500,2020-10-01,2020-10-01,https://clinicaltrials.gov/show/NCT04339998,No Results,No Results,No Results,2020-04-20,2020-04-15,None
723,ACTRN12620000468921,ANZCTR,2020-04-14,2020-04-20,False,UNSW Sydney,Not Recruiting,Not Applicable,Interventional,Australia,Effect of a Brief Problem Management Intervention on Covid 19-Related Anxiety and Depression,Other (psych),Psychological,140,Not Available,2020-11-09,https://anzctr.org.au/ACTRN12620000468921.aspx,No Results,No Results,No Results,2020-04-20,2020-04-15,None
724,IRCT20100228003449N30,IRCT,2020-03-22,2020-03-15,True,Tehran University of Medical Sciences,Recruiting,Phase 2/Phase 3,Interventional,Iran,Combination therapy in COVID 19,Drug,Hydroxychloroquine +  Oseltamivir + Lopinavir/ritonavir or Atazanavir/ritonavir ,50,Not Available,Not Available,http://en.irct.ir/trial/46536,No Results,No Results,No Results,2020-04-21,2020-03-25,None
725,ACTRN12620000480987,ANZCTR,2020-04-16,2020-06-01,False,University of Auckland,Not Recruiting,Not Applicable,Interventional,New Zealand,Stress-reduction Using Probiotics to Promote Ongoing Resilience Throughout COVID-19 for Healthcare Workers (SUPPORT COVID-19 Healthcare Workers),Supplement,Probiotics,507,Not Available,2020-10-18,https://anzctr.org.au/ACTRN12620000480987.aspx,No Results,No Results,No Results,2020-04-20,2020-04-22,None
726,NCT04340414,ClinicalTrials.gov,2020-03-03,2020-03-03,False,Peking Union Medical College Hospital,Recruiting,Not Applicable,Interventional,China,Safety and Effectiveness of Low-flow ECMO Driving by CVVH Machine in Severe NCP,Drug,Oxygen,10,2020-08-15,2020-10-15,https://clinicaltrials.gov/show/NCT04340414,No Results,No Results,No Results,2020-04-20,2020-04-15,None
727,NCT04341207,ClinicalTrials.gov,2020-04-08,2020-04-03,True,Institut Gustave Roussy,Recruiting,Phase 2,Interventional,France,Epidemiology of SARS-CoV-2 and Mortality to Covid19 Disease in French Cancer Patients,Drug,Hydroxychloroquine + Azithromycin vs. Hydroxychloroquine,1000,2022-04-01,2022-04-01,https://clinicaltrials.gov/show/NCT04341207,No Results,No Results,No Results,2020-04-20,2020-04-15,EUCTR2020-001250-21
728,IRCT20200312046749N1,IRCT,2020-03-28,2020-03-27,True,Tehran University of Medical Sciences,Recruiting,Phase 2/Phase 3,Interventional,Iran,Efficacy of Tumor Necrosis Factor alpha inhibitor in COVID-19,Drug,TNF-alpha inhibitor,80,Not Available,Not Available,http://en.irct.ir/trial/46551,No Results,No Results,No Results,2020-04-21,2020-04-22,None
729,NCT04341415,ClinicalTrials.gov,2020-04-07,2020-04-01,True,Fondation Ophtalmologique Adolphe de Rothschild,Not Recruiting,Not Applicable,Interventional,France,Impact of Auricular Vagus Nerve Neuromodulation on COVID-19 Positive Inpatients Outcome,Procedure,Auricular neuromodulation,60,2020-07-01,2020-07-01,https://clinicaltrials.gov/show/NCT04341415,No Results,No Results,No Results,2020-04-20,2020-04-15,None
730,NCT04341506,ClinicalTrials.gov,2020-04-07,2020-04-15,False,Northwestern Medicine,Not Recruiting,Not Applicable,Observational,No Country Given,Non-contact ECG Sensor System for COVID19,Clinical Presentation,No Intervention,100,2020-07-15,2020-09-15,https://clinicaltrials.gov/show/NCT04341506,No Results,No Results,No Results,2020-04-20,2020-04-15,None
731,EUCTR2020-001257-51-DK,EU Clinical Trials Register,2020-03-26,2020-04-15,False,"Rigshospitalet, Denmark",Authorised,Phase 3,Interventional,Denmark,Hydroxychloroquine for prevention of COVID-19 in patients on chronic dialysis,Drug (Chemoprophylaxis),Hydroxychloroquine,568,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001257-51,No Results,No Results,No Results,2020-04-20,2020-04-22,None
732,IRCT20200316046792N1,IRCT,2020-03-17,2020-03-16,True,Iran University of Medical Sciences,Recruiting,Phase 2/Phase 3,Interventional,Iran,Effect of herbal syrup and solution in treatment of COVID-19,Traditional Medicine (Drug),Traditional Medicine,150,Not Available,Not Available,http://en.irct.ir/trial/46554,No Results,No Results,No Results,2020-04-21,2020-03-25,None
733,NCT04341714,ClinicalTrials.gov,2020-04-08,2020-03-16,True,Pierre and Marie Curie University,Recruiting,Not Applicable,Observational,France,Efficiency and Satisfaction With Telephone Consultation in Neuro-urology: Experience of the COVID-19 Pandemic,Telehealth,Telehealth,400,2020-05-30,2020-06-15,https://clinicaltrials.gov/show/NCT04341714,No Results,No Results,No Results,2020-04-20,2020-04-15,None
734,NCT04341922,ClinicalTrials.gov,2020-04-07,2020-04-10,False,Karolinska Institutet,Not Recruiting,Not Applicable,Interventional,Sweden,A Online-delivered Cognitive-behavioral Intervention for Dysfunctional Worry Related to the Covid-19 Pandemic,Other (psych),Psychological,670,2020-09-10,2021-09-10,https://clinicaltrials.gov/show/NCT04341922,No Results,No Results,No Results,2020-04-20,2020-04-15,None
735,IRCT20200317046797N1,IRCT,2020-04-03,2020-04-08,False,Tabriz University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Effect of Camostate mesylate on the outcome of Coronavirus (COVID-19)-induced pneumonia,Drug,Camostat Mesilate,40,Not Available,Not Available,http://en.irct.ir/trial/46573,No Results,No Results,No Results,2020-04-21,2020-04-22,None
736,EUCTR2020-001290-74-ES,EU Clinical Trials Register,2020-04-13,2020-04-11,True,Consorci Parc de Salut Mar (PSMAR),Authorised,Phase 3,Interventional,Spain,Efficacy and safety of sarilumab in the early treament of hospitalized patients with mild-moderate neumonia and COVID19 infection versus standard of care,Drug,Sarilumab vs. Hydroxychloroquine + Azithromycin,216,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001290-74,No Results,No Results,No Results,2020-04-20,2020-04-22,None
737,ACTRN12620000478910,ANZCTR,2020-04-16,2020-06-01,False,Monash Health,Not Recruiting,Not Applicable,Interventional,Australia,Cord Blood Therapy to prevent progression of COVID-19 related pneumonia,ATMP,Cells (stem cells),24,Not Available,2021-04-30,https://anzctr.org.au/ACTRN12620000478910.aspx,No Results,No Results,No Results,2020-04-20,2020-04-22,None
738,IRCT20120826010664N6,IRCT,2020-04-05,2020-03-29,True,Tehran University of Medical Sciences,Recruiting,Not Applicable,Interventional,Iran,Effect of hydroxychloroquine on prevention of covid-19 virus,Drug (Chemoprophylaxis),Hydroxychloroquine,310,Not Available,Not Available,http://en.irct.ir/trial/46603,No Results,No Results,No Results,2020-04-21,2020-04-22,None
739,EUCTR2020-001406-27-FR,EU Clinical Trials Register,2020-04-03,2020-04-07,False,"University Hospital, Montpellier",Authorised,Phase 3,Interventional,France,efficacy and safety of a bitherapy by hydroxychloroquine + azythromycin vs monotherapy by hydroxychoroquine in adult patients with documentated infection by covid19,Drug,Hydroxychloroquine vs. Azithromycin vs. Hydroxychloroquine,120,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001406-27,No Results,No Results,No Results,2020-04-20,2020-04-22,None
740,ChiCTR2000032098,ChiCTR,2020-04-19,2020-01-20,True,"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Not Applicable,Interventional,China,Danggui Shaoyao Powder in the synergistic treatment of novel coronavirus pneumonia (COVID-19),Traditional Medicine (Drug),Traditional Medicine,300,Not Available,2020-07-31,http://www.chictr.org.cn/showproj.aspx?proj=52477,No Results,No Results,No Results,2020-04-20,2020-04-22,None
741,IRCT20140528017891N8,IRCT,2020-03-28,2020-03-24,True,MOM Research and Innovation Center,Not Recruiting,Phase 3,Interventional,Iran,The effect of stem cell transplantation in the treatment of COVID-19,ATMP,Cells (mesenchymal),10,Not Available,Not Available,http://en.irct.ir/trial/46623,No Results,No Results,No Results,2020-04-21,2020-04-22,None
742,EUCTR2020-001530-35-ES,EU Clinical Trials Register,2020-04-13,2020-04-09,True,Fundacin para la Investigacin Biomdica Hospital Universitario La Paz (FIBHULP),Authorised,Phase 4,Interventional,Spain,Clinical trial to avoid infection by SARS-CoV-2 in high-risk population. COVID-19,Drug,Melatonin,450,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001530-35,No Results,No Results,No Results,2020-04-20,2020-04-22,None
743,ChiCTR2000032095,ChiCTR,2020-04-19,2020-03-18,True,The Third Affiliated Hospital of Sun Yat-sen University,Recruiting,Not Applicable,Observational,China,"Study for Healthy Behavior, Psychological Analysis and Psychological Reconstruction Strategies of Students Population Keeping in Home Under the Pandemic of Novel Coronavirus Pneumonia (COVID-19)",Other (psych),No Intervention,130,Not Available,2021-03-18,http://www.chictr.org.cn/showproj.aspx?proj=52565,No Results,No Results,No Results,2020-04-20,2020-04-22,None
744,IRCT20150914024017N1,IRCT,2020-04-03,2020-03-27,True,Tehran University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,ReciGen for treatment of Covid-19,Drug,Interferon beta,40,Not Available,Not Available,http://en.irct.ir/trial/46665,No Results,No Results,No Results,2020-04-21,2020-04-22,None
745,ChiCTR2000031954,ChiCTR,2020-04-16,2020-04-15,True,"International Peace Maternity and Child Health Hospital, Shanghai Jiao Tong University",Recruiting,Not Applicable,Observational,China,Medical Records Based Study for Maternal and Perinatal Outcomes of Women with novel coronavirus pneumonia (COVID-19),Clinical Presentation,No Intervention,30,Not Available,2020-04-30,http://www.chictr.org.cn/showproj.aspx?proj=52365,No Results,No Results,No Results,2020-04-20,2020-04-22,None
746,EUCTR2020-001587-29-ES,EU Clinical Trials Register,2020-04-13,2020-04-08,True,Barcelona Institute for Global Health,Authorised,Phase 4,Interventional,Spain,Preventing SARS-CoV-2 virus infection and severity of COVID-19 diseases during pregnancy with hydroxychloroquine,Drug (Chemoprophylaxis),Hydroxychloroquine,714,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001587-29,No Results,No Results,No Results,2020-04-20,2020-04-22,None
747,IRCT20160310026998N10,IRCT,2020-03-26,2020-03-20,True,Tabriz University of Medical Sciences,Not Recruiting,Phase 3,Interventional,Iran,Study of the metformin effect on the survival and recovery rate of patients with COVID-19,Drug,Metformin,200,Not Available,Not Available,http://en.irct.ir/trial/46693,No Results,No Results,No Results,2020-04-21,2020-04-22,None
748,EUCTR2020-001634-36-ES,EU Clinical Trials Register,2020-04-13,2020-04-09,True,Rosario Garca de Vicua,Authorised,Phase 2,Interventional,Spain,Randomized open pilot study to evaluate the efficacy of subcutaneous sarilumab in patients with moderate-severe COVID-19 infection.,Drug,Sarilumab,30,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001634-36,No Results,No Results,No Results,2020-04-20,2020-04-22,None
749,IRCT20200324046850N2,IRCT,2020-03-29,2020-03-18,True,Abadan University of Medical Sciences,Not Recruiting,Phase 2,Interventional,Iran,Comparison of the effect of Sofosbuvir + Daclatasvir (Sovodac) and Ribavirin in Covid-19,Drug,Daclatasvir/sofosbuvir vs. Ribavirin,60,Not Available,Not Available,http://en.irct.ir/trial/46713,No Results,No Results,No Results,2020-04-21,2020-04-22,None
750,EUCTR2020-001420-34-DK,EU Clinical Trials Register,2020-04-01,2020-04-14,False,Aarhus University,Authorised,Phase 2,Interventional,Denmark,Senicapoc treatment of COVID-19 positive patients in intensive care,Drug,Senicapoc,46,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001420-34,No Results,No Results,No Results,2020-04-20,2020-04-22,None
751,EUCTR2020-001689-12-ES,EU Clinical Trials Register,2020-04-13,2020-04-11,True,Montreal Heart Institute,Authorised,Phase 3,Interventional,Spain,COLCHICINA TEST IN THE SARS-COV2 CORONAVIRUS (COLCORONA-COVID-19),Drug,Colchicine,1000,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001689-12,No Results,No Results,No Results,2020-04-20,2020-04-22,None
752,IRCT20200324046850N1,IRCT,2020-03-29,2020-03-29,False,Abadan University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Comparison of vitamin D3 and N-acetylcysteine prescription in COVID-19 patients   and their effect on recovery process,Drug,Vitamin D vs. N-acetylcysteine vs. Vitamin D + N-acetylcysteine,100,Not Available,Not Available,http://en.irct.ir/trial/46732,No Results,No Results,No Results,2020-04-21,2020-04-22,None
753,EUCTR2020-001511-25-ES,EU Clinical Trials Register,2020-04-15,2020-04-14,True,Fundacin para la Formacin e Investigacin Sanitarias de la Regin de Murcia (FFIS),Authorised,Phase 3,Interventional,Spain,Randomized open-blind controlled trial to study the benefit of Colchicine in Patients with COVID-19,Drug,Colchicine,102,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001511-25,No Results,No Results,No Results,2020-04-20,2020-04-22,None
754,IRCT20200324046850N5,IRCT,2020-04-04,2020-04-19,False,Abadan University of Medical Sciences,Recruiting,Phase 2,Interventional,Iran,Study of the effect of vitamin C in patients with Covid-19,Drug,Vitamin C w or w/o Hydroxychloroquine or Chloroquine + Lopinavir/Ritonavir,40,Not Available,Not Available,http://en.irct.ir/trial/46751,No Results,No Results,No Results,2020-04-21,2020-04-22,None
755,EUCTR2020-001262-11-ES,EU Clinical Trials Register,2020-04-13,2020-04-09,True,Instituto de Investigacin Sanitaria Fundacin Jimnez Daz,Authorised,Phase 4,Interventional,Spain,Clinical trial to assess the efficacy and safety of cyclosporin A treatment associated with standard treatment versus standard treatment only in hospitalized patients with confirmed coronavirus infection,Drug,cyclosporine A vs. lopinavir/ritonavir + interferon beta + darunavir + spironolactone + tocilizumab + chloroquine,120,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001262-11,No Results,No Results,No Results,2020-04-20,2020-04-22,None
756,CTRI/2020/04/024413,CTRI,2020-04-01,2020-04-09,False,K M Amran Hossain,No Status Given,Not Applicable,Observational,Bangladesh,"Knowledge, attitude and fear of COVID-19 in Bangladesh",Other (psych),No Intervention,1000,Not Available,Not Available,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=42718,No Results,No Results,No Results,2020-04-20,2020-04-22,None
757,IRCT20160313027033N2,IRCT,2020-04-16,2020-04-02,True,Kerman University of Medical Sciences,Recruiting,Not Applicable,Interventional,Iran,The effect of MCT Oil on COVID-19,Drug,Medium-chain triglycerides,120,Not Available,Not Available,http://en.irct.ir/trial/46762,No Results,No Results,No Results,2020-04-21,2020-04-22,None
758,CTRI/2020/04/024479,CTRI,2020-04-07,2020-04-13,False,Command Hospital Airforce,Not Recruiting,Not Applicable,Interventional,India,Study of the effect of Chloroquine in addition to standard therapy in COVID-19 patients,Drug,Chloroquine,32,Not Available,Not Available,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=42713,No Results,No Results,No Results,2020-04-20,2020-04-22,None
759,IRCT20200317046797N2,IRCT,2020-04-03,2020-04-08,False,Tabriz University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Effect of Fingolimod for treatment of COVID-19-induced cytokine storm,Drug,Fingolimod,40,Not Available,Not Available,http://en.irct.ir/trial/46786,No Results,No Results,No Results,2020-04-21,2020-04-22,None
760,EUCTR2020-001437-12-ES,EU Clinical Trials Register,2020-04-13,2020-04-09,True,Vall d'Hebron Research Institute (VHIR),Authorised,Phase 4,Interventional,Spain,"Random, controlled, open, one-site clinical trial in adult patients with COVID-19 severe pneumonia treated with immunomodulatory drugs",Drug,"Cyclosporine, Tocilizumab",290,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001437-12,No Results,No Results,No Results,2020-04-20,2020-04-22,None
761,CTRI/2020/04/024636,CTRI,2020-04-15,2020-05-01,False,DACH Jaipur,Not Recruiting,Not Applicable,Observational,India,Assessment of Objective clinical scoring system to rule out COVID-19 with high sensitivity,Diagnostics,Diagnostic Test or Assessment,1000,Not Available,Not Available,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=42961,No Results,No Results,No Results,2020-04-20,2020-04-22,None
762,EUCTR2020-001682-36-ES,EU Clinical Trials Register,2020-04-14,2020-04-13,True,CITOSPIN S.L.,Authorised,Phase 2,Interventional,Spain,Treatment of COVID-19 with allogeneic mesenchymal cells (MSV).,ATMP,Cells (mesenchymal),24,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001682-36,No Results,No Results,No Results,2020-04-20,2020-04-22,None
763,IRCT20200325046860N2,IRCT,2020-04-01,2020-03-28,True,Bagheiat-allah University of Medical Sciences,Not Recruiting,Phase 1,Interventional,Iran,Mesenchymal Stem Cell therapy in COVID19,ATMP,Cells (mesenchymal),5,Not Available,2020-04-29,http://en.irct.ir/trial/46789,No Results,No Results,No Results,2020-04-21,2020-04-22,None
764,CTRI/2020/04/024659,CTRI,2020-04-15,2020-04-27,False,SSV Phytopharmaceuticals,Not Recruiting,Phase 3,Interventional,India,Study of Shreepad Shree Vallabh SSV Formulation to improve immunity in quarantine patients of COVID-19,Traditional Medicine (Drug),Traditional Medicine,30,Not Available,Not Available,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=42967,No Results,No Results,No Results,2020-04-20,2020-04-22,None
765,EUCTR2020-001266-11-ES,EU Clinical Trials Register,2020-04-16,2020-04-16,False,Fundacin Instituto de Investigacin Sanitaria Fundacin Jimenez Diaz,Authorised,Phase 2,Interventional,Spain,Clinical trial of administration of MSC to patients with respiratory distress type COVID-19,ATMP,Cells (mesenchymal),100,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001266-11,No Results,No Results,No Results,2020-04-20,2020-04-22,None
766,IRCT20100228003449N28,IRCT,2020-03-19,2020-03-15,True,Tehran University of Medical Sciences,Not Recruiting,Phase 2/Phase 3,Interventional,Iran,Interferon in treatment of COVID-19,Drug,Interferon beta vs. hydroxychloroquine + oseltamivir + Lopinavir/ritonavir,30,Not Available,Not Available,http://en.irct.ir/trial/46538,No Results,No Results,No Results,2020-04-21,2020-03-25,None
767,IRCT20200319046819N1,IRCT,2020-04-04,2020-04-02,True,Tehran University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,supplementation in COVID-19,Drug,Vitamin A + Vitamin D + Vitamin C + Vitamin B,60,Not Available,Not Available,http://en.irct.ir/trial/46838,No Results,No Results,No Results,2020-04-21,2020-04-22,None
768,EUCTR2020-001448-24-GB,EU Clinical Trials Register,2020-04-17,2020-04-15,True,University of Birmingham,Authorised,Phase 3,Interventional,"Ghana, Nigeria, United Kingdom, South Africa, India",Preventing Pulmonary Complications in Surgical Patients at Risk of COVID-19,Drug (Chemoprophylaxis),"Hydroxychloroquine, Lopinavir/Ritonavir",6400,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001448-24,No Results,No Results,No Results,2020-04-20,2020-04-22,None
769,CTRI/2020/03/024402,CTRI,2020-03-31,2020-04-08,False,Dr. Remesh Bhasi,Not Recruiting,Phase 3,Interventional,India,"Hydroxy Chloroquine, in open labelled, Randomised intervention for prevention of new infection and adverse outcomes following COVID-19 infection -A Tertiary Hospital based study",Drug,Hydroxychloroquine,500,Not Available,Not Available,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=42638,No Results,No Results,No Results,2020-04-20,2020-04-22,None
770,IRCT20100228003449N27,IRCT,2020-03-16,2020-03-15,True,Tehran University of Medical Sciences,Recruiting,Phase 2/Phase 3,Interventional,Iran,Interferon  in treatment  of COVID-19,Drug,Interferon beta vs. hydroxychloroquine + oseltamivir + Lopinavir/ritonavir,30,Not Available,Not Available,http://en.irct.ir/trial/46545,No Results,No Results,No Results,2020-04-21,2020-03-25,None
771,IRCT20130917014693N10,IRCT,2020-04-08,2020-04-07,True,Shahid Beheshti University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Evaluation the effects of Hydroxychloroquine administration for COVID-19 prophylaxis,Drug (Chemoprophylaxis),Hydroxychloroquine,100,Not Available,Not Available,http://en.irct.ir/trial/46849,No Results,No Results,No Results,2020-04-21,2020-04-22,None
772,CTRI/2020/04/024473,CTRI,2020-04-03,2020-04-15,False,Discovery the Critical Care Research Network,Not Recruiting,Not Applicable,Observational,"Italy, United States, United Kingdom, India",Viral Infection and Respiratory illness Universal Study,Clinical Presentation,No Intervention,50000,Not Available,Not Available,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=42684,No Results,No Results,No Results,2020-04-20,2020-04-22,None
773,IRCT20150303021315N17,IRCT,2020-04-12,2020-03-15,True,Aryogen Pharmed,Recruiting,Phase 3,Interventional,Iran,Tocilizumab in COVID-19,Drug,Tocilizumab,500,Not Available,Not Available,http://en.irct.ir/trial/46550,No Results,No Results,No Results,2020-04-21,2020-04-22,None
774,IRCT20200401046909N1,IRCT,2020-04-09,2020-04-15,False,Tehran University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Evaluation of the  efficacy of oral 25-hydroxyvitamin D3 on COVID-19,Drug,Calcifediol,260,Not Available,Not Available,http://en.irct.ir/trial/46875,No Results,No Results,No Results,2020-04-21,2020-04-22,None
775,IRCT20200128046294N2,IRCT,2020-03-14,2020-03-26,False,Digestive Disease Research Institute,Recruiting,Phase 3,Interventional,Iran,Study to Evaluate the Safety and Efficacy of Sofosbuvir/Daclatasvir in Participants with Moderate to Severe Coronavirus Disease (COVID-19),Drug,Sofosbuvir + Daclatasvir,70,Not Available,Not Available,http://en.irct.ir/trial/46463,No Results,No Results,No Results,2020-04-21,2020-03-25,None
776,IRCT20200402046923N1,IRCT,2020-04-09,2020-04-05,True,Tehran University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,"Effect of herbal capsule, Viroherb, and herbal syrup, Fenugreek in treatment of COVID-19",Traditional Medicine (Drug),Traditional Medicine,110,Not Available,Not Available,http://en.irct.ir/trial/46879,No Results,No Results,No Results,2020-04-21,2020-04-22,None
777,IRCT20190727044343N1,IRCT,2020-04-05,2020-03-16,True,Mazandaran University of Medical Sciences,Not Recruiting,Phase 3,Interventional,Iran,?Effect of febuxostat against coronavirus,Drug,Acetaminophen + Febuxostat vs.  Acetaminophen + Hydroxychloroquine,60,Not Available,2020-04-09,http://en.irct.ir/trial/46629,No Results,No Results,No Results,2020-04-21,2020-04-22,None
778,IRCT20200314046764N1,IRCT,2020-04-20,2020-04-26,False,Kermanshah University of Medical Sciences,Not Recruiting,Phase 3,Interventional,Iran,Pirfenidine in SARS-COV2,Drug,"Interventional: Pirfenidine


Both Arms: Lopinavir/ritonavir + chloroquine + osiltamivir",40,Not Available,Not Available,http://en.irct.ir/trial/46533,No Results,No Results,No Results,2020-04-21,2020-04-22,None
779,IRCT20200404046937N1,IRCT,2020-04-09,2020-04-09,False,Ahvaz University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Evaluating the effect of Marshmallow and Licorice on COVID 19 patients,Traditional Medicine (Drug),Traditional Medicine,60,Not Available,Not Available,http://en.irct.ir/trial/46903,No Results,No Results,No Results,2020-04-21,2020-04-22,None
780,IRCT20140617018126N2,IRCT,2020-03-29,2020-04-03,False,Tabriz University of Medical Sciences,Not Recruiting,Phase 3,Interventional,Iran,Persian Medicine Products in Covid-19,Traditional Medicine (Drug),Traditional Medicine,60,Not Available,Not Available,http://en.irct.ir/trial/46637,No Results,No Results,No Results,2020-04-21,2020-04-22,None
781,IRCT20151227025726N12,IRCT,2020-03-23,2020-03-03,True,Shahid Beheshti University of Medical Sciences,Not Recruiting,Phase 3,Interventional,Iran,Evaluting the therapeutic and adverse effects of Interferon beta 1-a in patients with novel Coronavirus(COVID-19),Drug,Interferon beta + hydroxychloroquine + osletamivir + lopinavir/ritonavir,20,Not Available,Not Available,http://en.irct.ir/trial/46561,No Results,No Results,No Results,2020-04-21,2020-03-25,None
782,IRCT20080901001157N16,IRCT,2020-04-08,2020-03-30,True,HomaPharmed  Company,Recruiting,Phase 1/Phase 2,Interventional,Iran,Effect of IMFLUNA herbal compound on covid-19 pneumonia symptoms,Traditional Medicine (Drug),Traditional Medicine,60,Not Available,Not Available,http://en.irct.ir/trial/46907,No Results,No Results,No Results,2020-04-21,2020-04-22,None
783,IRCT20160625028622N1,IRCT,2020-03-22,2020-03-19,True,Qazvin University of Medical Sciences,Not Recruiting,Phase 2,Interventional,Iran,The effect of Noscapine  on clinical and pulmonary manifestations of COVID-19 patients,Drug,Noscapine,125,Not Available,Not Available,http://en.irct.ir/trial/46576,No Results,No Results,No Results,2020-04-21,2020-03-25,None
784,IRCT20190727044343N2,IRCT,2020-04-19,2020-04-05,True,Mazandaran University of Medical Sciences,Not Recruiting,Phase 2/Phase 3,Interventional,Iran,Atorvastatin effect on COVID-19,Drug,Atorvastatin,100,Not Available,Not Available,http://en.irct.ir/trial/46639,No Results,No Results,No Results,2020-04-21,2020-04-22,None
785,IRCT20200321046828N1,IRCT,2020-03-26,2020-03-22,True,RNA Biotechnology,Not Recruiting,Phase 1/Phase 2,Interventional,Iran,Remedy of human coroviruse infection with genetic nanocomposit drug,Drug,Unspecified,30,Not Available,Not Available,http://en.irct.ir/trial/46624,No Results,No Results,No Results,2020-04-21,2020-04-22,None
786,IRCT20180610040049N3,IRCT,2020-03-29,2020-04-08,False,Arak University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,The effect of Trachyspermum copticum syrup on clinical manifestations of patients with COVID-19,Traditional Medicine (Drug),Traditional Medicine,60,Not Available,Not Available,http://en.irct.ir/trial/46697,No Results,No Results,No Results,2020-04-21,2020-04-22,None
787,IRCT20171122037571N2,IRCT,2020-04-12,2020-03-20,True,Tehran University of Medical Sciences,Recruiting,Phase 2/Phase 3,Interventional,Iran,Remdesivir in treatment of COVID-19,Drug,Remdesivir + hydroxychloroquine or chloroquine + lopinavir/ritonavir or atazanavir,120,Not Available,Not Available,http://en.irct.ir/trial/46660,No Results,No Results,No Results,2020-04-21,2020-04-22,None
788,IRCT20200405046958N1,IRCT,2020-04-14,2020-04-13,True,Mashhad University of Medical Sciences,Recruiting,Phase 2/Phase 3,Interventional,Iran,Prevention of Novel Coronavirus Disease by Hydroxychloroquine in cancer patients.,Drug,Hydroxychloroquine,60,Not Available,Not Available,http://en.irct.ir/trial/46946,No Results,No Results,No Results,2020-04-21,2020-04-22,None
789,IRCT20200324046852N1,IRCT,2020-04-05,2020-04-01,True,Fasa University of Medical Sciences,Not Recruiting,Phase 2/Phase 3,Interventional,Iran,Comparison of efficacy of oral Levamisole and  Formoterol+Budesonide inhaler with standard treatment of Corona infection.,Drug,Levamisole + Formoterol + Budesonide + hydroxychloroquine + Lopinavir/ritonavir vs. hydroxychloroquine + Lopinavir/ritonavir,30,Not Available,Not Available,http://en.irct.ir/trial/46706,No Results,No Results,No Results,2020-04-21,2020-04-22,None
790,IRCT20151227025726N13,IRCT,2020-03-26,2020-03-11,True,Shahid Beheshti University of Medical Sciences,Recruiting,Phase 2,Interventional,Iran,Evaluation the Efficacy and Safety of Tocilizumab in COVID-19,Drug,Tocilizumab + hydroxychloroquine + oseltamivir + lopinavir/ritonavir,40,Not Available,Not Available,http://en.irct.ir/trial/46681,No Results,No Results,No Results,2020-04-21,2020-04-22,None
791,IRCT20160310026998N11,IRCT,2020-03-27,2020-03-20,True,Tabriz University of Medical Sciences,Not Recruiting,Phase 3,Interventional,Iran,Effect of metformin in COVID-19  symptom improvement and death,Drug,Metformin,200,Not Available,Not Available,http://en.irct.ir/trial/46690,No Results,No Results,No Results,2020-04-21,2020-04-22,None
792,IRCT20180520039738N2,IRCT,2020-04-10,2020-04-07,True,Saveh University of Medical Sciences,Not Recruiting,Phase 3,Interventional,Iran,Evaluation and comparison of the effectiveness of standard treatment with stand treatment plus Vitamin A in treatment in covid19 patients,Drug,Vitamin A,140,Not Available,Not Available,http://en.irct.ir/trial/46974,No Results,No Results,No Results,2020-04-21,2020-04-22,None
793,IRCT20140907019073N4,IRCT,2020-03-29,2020-04-03,False,Iran University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Evaluation of the effectiveness of Ipecac homeopathic remedy  in control of Clinical manifestations of COVID-19,Traditional Medicine (Drug),Traditional Medicine,60,Not Available,Not Available,http://en.irct.ir/trial/46736,No Results,No Results,No Results,2020-04-21,2020-04-22,None
794,IRCT20200323046841N1,IRCT,2020-03-28,2020-03-28,False,Mashhad University of Medical Sciences,Recruiting,Phase 2/Phase 3,Interventional,Iran,Efficacy evaluation of an herbal compound in COVID-19,Traditional Medicine (Drug),Traditional Medicine,60,Not Available,Not Available,http://en.irct.ir/trial/46715,No Results,No Results,No Results,2020-04-21,2020-04-22,None
795,IRCT20081019001369N3,IRCT,2020-04-11,2020-04-20,False,Mashhad University of Medical Sciences,Recruiting,Phase 2,Interventional,Iran,Effect of crocetin on COVID-19,Traditional Medicine (Drug),Traditional Medicine,40,Not Available,Not Available,http://en.irct.ir/trial/46978,No Results,No Results,No Results,2020-04-21,2020-04-22,None
796,IRCT20190804044429N1,IRCT,2020-04-11,2020-03-25,True,Mazandaran University of Medical Sciences,Recruiting,Phase 2/Phase 3,Interventional,Iran,Interferon beta 1b in COVID-19,Drug,"Interventional: Interferon beta

Both Arms: Hydroxychloroquine + lopinavir/ritonavir",70,Not Available,Not Available,http://en.irct.ir/trial/46741,No Results,No Results,No Results,2020-04-21,2020-04-22,None
797,IRCT20180923041093N4,IRCT,2020-03-28,2020-04-02,False,Kerman University of Medical Sciences,Recruiting,Not Applicable,Interventional,Iran,Efficacy of the barley-based remedy in the treatment of novel corona,Traditional Medicine (Drug),Traditional Medicine,100,Not Available,Not Available,http://en.irct.ir/trial/46728,No Results,No Results,No Results,2020-04-21,2020-04-22,None
798,IRCT20200204046369N1,IRCT,2020-04-08,2020-04-14,False,Shiraz University of Medical Sciences,Recruiting,Phase 2/Phase 3,Interventional,Iran,Effect of Methylprednisolone in treatment of COVID-19 patients,Drug,Corticosteroids,48,Not Available,Not Available,http://en.irct.ir/trial/46776,No Results,No Results,No Results,2020-04-21,2020-04-22,None
799,IRCT20200317046797N5,IRCT,2020-04-19,2020-04-20,False,Tabriz University of Medical Sciences,Recruiting,Phase 2,Interventional,Iran,Treatment of COVID-19-induced cytokine storm by hemoperfusion,Other (device),Hemoperfusion,10,Not Available,Not Available,http://en.irct.ir/trial/47015,No Results,No Results,No Results,2020-04-21,2020-04-22,None
800,IRCT20200322046833N1,IRCT,2020-04-03,2020-03-28,True,Center for Progress and Development of Iran,Not Recruiting,Phase 3,Interventional,Iran,Umifenovir effectiveness in the treatment of COVID-19,Drug,"Umifenovir

All Arms: Hydroxychloroquine + Atazanavir/Ritonavir",100,Not Available,Not Available,http://en.irct.ir/trial/46731,No Results,No Results,No Results,2020-04-21,2020-04-22,None
801,IRCT20180923041093N5,IRCT,2020-04-10,2020-04-15,False,Shahid Beheshti University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Evaluation the efficacy of hot foot-bath on COVID-19,Procedure,Foot bath,60,Not Available,Not Available,http://en.irct.ir/trial/47018,No Results,No Results,No Results,2020-04-21,2020-04-22,None
802,IRCT20180712040449N2,IRCT,2020-04-01,2020-03-23,True,Tehran University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Effect of oral multi-herbal preparation on COVID-19,Traditional Medicine (Drug),Traditional Medicine,68,Not Available,Not Available,http://en.irct.ir/trial/46782,No Results,No Results,No Results,2020-04-21,2020-04-22,None
803,IRCT20160131026298N2,IRCT,2020-04-20,2020-03-10,True,Bagheiat-allah University of Medical Sciences,Not Recruiting,Phase 2/Phase 3,Interventional,Iran,The effect of PHR spray on patients with coronavirus-19,Traditional Medicine (Drug),Traditional Medicine,64,Not Available,2020-03-24,http://en.irct.ir/trial/46733,No Results,No Results,No Results,2020-04-21,2020-04-22,None
804,IRCT20080901001165N46,IRCT,2020-04-15,2020-03-30,True,Center for Progress and Development of Iran,Recruiting,Phase 3,Interventional,Iran,Investigating the efficacy and safety of Umifenovir in controlling the symptoms of patients with COVID-19,Drug,Umifenovir,200,Not Available,Not Available,http://en.irct.ir/trial/47087,No Results,No Results,No Results,2020-04-21,2020-04-22,None
805,IRCT20200318046812N1,IRCT,2020-04-01,2020-04-01,False,Bagheiat-allah University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Comparison of the safety and efficacy of Favipiravir and kaletra in COVID-19,Drug,Favipiravir + hydroxychloroquine vs. Lopinavir/ritonavir + hydroxychloroquine,324,Not Available,Not Available,http://en.irct.ir/trial/46783,No Results,No Results,No Results,2020-04-21,2020-04-22,None
806,ChiCTR2000030304,ChiCTR,2020-02-28,2020-03-10,False,The Third Affiliated Hospital of Sun Yat-sen University,Not Recruiting,Not Applicable,Observational,China,Protective factors of mental resilience in first-line nurses with novel coronavirus pneumonia (COVID-19),Other (psych),No Intervention,300,Not Available,2022-12-31,http://www.chictr.org.cn/showproj.aspx?proj=49653,No Results,No Results,No Results,2020-03-09,2020-08-03,None
807,IRCT20101219005416N2,IRCT,2020-04-03,2020-03-24,True,Kerman University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Evaluation of  the effect of traditional  Iranian medicine product on improvement of clinical menifestation of COVID -19,Traditional Medicine (Other),Traditional Medicine,80,Not Available,Not Available,http://en.irct.ir/trial/46775,No Results,No Results,No Results,2020-04-21,2020-04-22,None
808,IRCT20151228025732N51,IRCT,2020-04-08,2020-03-18,True,Semnan University of Medical Sciences,Recruiting,Not Applicable,Interventional,Iran,"Effect of Algomed, Menta longifolia, Chamomile, Althaea rosea, Malva sylvestris, Lepidium sativum supplements on the Severity and Consequences of Coronavirus 19 disease (COVID-19)",Traditional Medicine (Drug),Traditional Medicine,60,Not Available,Not Available,http://en.irct.ir/trial/46828,No Results,No Results,No Results,2020-04-21,2020-04-22,None
809,IRCT20191125045492N2,IRCT,2020-04-18,2020-04-23,False,Bagheiat-allah University of Medical Sciences,Not Recruiting,Phase 2/Phase 3,Interventional,Iran,Effect of Ozone therapy in treatment of COVID-19,Drug,Ozone,80,Not Available,Not Available,http://en.irct.ir/trial/47149,No Results,No Results,No Results,2020-04-21,2020-04-22,None
810,ChiCTR2000029550,ChiCTR,2020-02-04,2020-01-29,True,Hospital of Chengdu University of Traditional Chinese Medicine,Recruiting,Not Applicable,Interventional,China,Recommendations for Diagnosis and Treatment of Influenza Patients in the Hospital of Chengdu University of Traditional Chinese Medicine Under the Raging of Novel Coronavirus Pneumonia (COVID-19),Traditional Medicine (Unspecified),Traditional Medicine,300,Not Available,2020-05-01,http://www.chictr.org.cn/showproj.aspx?proj=48775,No Results,No Results,No Results,2020-03-09,2020-03-18,None
811,IRCT20130812014333N145,IRCT,2020-03-30,2020-04-08,False,Kermanshah University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Comparative assessment of the efficacy and safety of add ontreatment with Sofosbuvir standard of care therapeutic regimenVelpatasvir to standard of caretherapeutic regimen in patients with COVID-19,Drug,Sofosbuvir/Velpatasvir with and without Hydroxychloroquine + lopinavir/ritonavir,80,Not Available,Not Available,http://en.irct.ir/trial/46790,No Results,No Results,No Results,2020-04-21,2020-04-22,None
812,IRCT20150704023055N2,IRCT,2020-04-03,2020-03-24,True,Babol University of Medical Sciences,Not Recruiting,Phase 2,Interventional,Iran,Hemoperfusion in patients with COVID-19,Other (device),Hemoperfusion,10,Not Available,Not Available,http://en.irct.ir/trial/46837,No Results,No Results,No Results,2020-04-21,2020-04-22,None
813,IRCT20161204031229N3,IRCT,2020-04-08,2020-03-30,True,Iran University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Evaluation the Effect of Ticoplanin  in Patients With Coronavirus Disease,Drug,Teicoplanin with and without Hydroxychloroquine + lopinavir/ritonavir or atazanavir,40,Not Available,Not Available,http://en.irct.ir/trial/46814,No Results,No Results,No Results,2020-04-21,2020-04-22,None
814,IRCT20200328046886N1,IRCT,2020-04-12,2020-03-05,True,Mazandaran University of Medical Sciences,Not Recruiting,Phase 3,Interventional,Iran,The effectiveness of Sovodak (sofosbuvir+daclatasvir) in Covid-19 patients,Drug,Daclatasvir/sofosbuvir,48,Not Available,2020-05-04,http://en.irct.ir/trial/46885,No Results,No Results,No Results,2020-04-21,2020-04-22,None
815,JPRN-jRCTs031190269,JPRN,2020-03-27,2020-03-27,False,Sugiyama Haruhito,Recruiting,Phase 2,Interventional,Japan,"A multicenter, open-label, randomized controlled trial to evaluate the efficacy and safety of inhaled ciclesonide for asymptomatic and mild patients with COVID-19",Drug,Ciclesonide,100,Not Available,Not Available,https://jrct.niph.go.jp/latest-detail/jRCTs031190269,No Results,No Results,No Results,2020-04-20,2020-04-22,None
816,ChiCTR2000029549,ChiCTR,2020-02-04,2020-02-03,True,Hospital of Chengdu University of Traditional Chinese Medicine,Recruiting,Not Applicable,Interventional,China,Recommendations of Integrated Traditional Chinese and Western Medicine for Novel Coronavirus Pneumonia (COVID-19),Traditional Medicine + Western Medicine,Traditional Medicine,400,Not Available,2020-05-01,http://www.chictr.org.cn/showproj.aspx?proj=49014,No Results,No Results,No Results,2020-03-09,2020-08-03,None
817,IRCT20180802040678N4,IRCT,2020-04-01,2020-03-31,True,Tabriz University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Evaluation of the effects of Losartan in patients with corona virus disease 2019,Drug,Losartan vs. amlodipine,100,Not Available,Not Available,http://en.irct.ir/trial/46824,No Results,No Results,No Results,2020-04-21,2020-04-22,None
818,JPRN-UMIN000040162,JPRN,2020-04-15,2020-04-14,True,Tokyo University,Recruiting,Not Applicable,Observational,Japan,Multicenter observational study to examine the efficacy of protection during endoscopy examination for Covid-19 infection,Other,No Intervention,1000,Not Available,2021-03-31,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000045790,No Results,No Results,No Results,2020-04-20,2020-04-22,None
819,IRCT20200404046933N1,IRCT,2020-04-12,2020-04-20,False,Mashhad University of Medical Sciences,Recruiting,Phase 2,Interventional,Iran,Evaluation the effect of licorice for treatment of coronavirus,Traditional Medicine (Drug),Traditional Medicine,40,Not Available,Not Available,http://en.irct.ir/trial/46893,No Results,No Results,No Results,2020-04-21,2020-04-22,None
820,ChiCTR2000029479,ChiCTR,2020-02-02,2020-01-30,True,Hospital of Chengdu University of Traditional Chinese Medicine,Recruiting,Not Applicable,Interventional,China,Research for Traditional Chinese Medicine Technology Prevention and Control of Novel Coronavirus Pneumonia (COVID-19) in the Community Population,Traditional Medicine (Unspecified),Traditional Medicine,20000,Not Available,2020-05-01,http://www.chictr.org.cn/showproj.aspx?proj=48773,No Results,No Results,No Results,2020-03-09,2020-08-03,None
821,IRCT20180610040049N4,IRCT,2020-04-03,2020-04-07,False,Ghoum University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,The effect of Tanacetum parthenium (L) Sch syrup on clinical manifestations of patients with COVID-19,Traditional Medicine (Drug),Traditional Medicine,60,Not Available,Not Available,http://en.irct.ir/trial/46850,No Results,No Results,No Results,2020-04-21,2020-04-22,None
822,PACTR202004801273802,PACTR,2020-04-02,2020-04-17,False,Lagos State Government,Not Recruiting,Phase 3,Interventional,Nigeria,"Lagos COVID-19 Chloroquine Treatment Trial (LACCTT)
",Drug,Chloroquine vs. Hydroxychloroquine,600,Not Available,2020-10-16,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=10928,No Results,No Results,No Results,2020-04-20,2020-04-22,None
823,IRCT20130306012728N8,IRCT,2020-04-12,2020-04-20,False,Tabriz University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Post-exposure hydroxycloroquine prophylaxis for Covid 19,Drug (Chemoprophylaxis),Hydroxychloroquine,500,Not Available,Not Available,http://en.irct.ir/trial/46932,No Results,No Results,No Results,2020-04-21,2020-04-22,None
824,ChiCTR2000030896,ChiCTR,2020-03-16,2020-02-06,True,Zhengzhou People's Hospital,Recruiting,Not Applicable,Interventional,China,Clinical Application and Theoretical Discussion of Fu-Zheng Qing-Fei Thought in Treating Non-Critical Novel Coronavirus Pneumonia (COVID-19),Traditional Medicine (Other),Traditional Medicine,24,Not Available,2021-03-30,http://www.chictr.org.cn/showproj.aspx?proj=51028,No Results,No Results,No Results,2020-03-16,2020-03-18,None
825,IRCT20180429039463N2,IRCT,2020-04-10,2020-03-20,True,Torbate-Heidaria University of Medical Sciences,Not Recruiting,Not Applicable,Interventional,Iran,"The Impact of Family-Based Empowerment Model on Stress, Anxiety and Satisfaction",Other (psych),Psychological,30,Not Available,Not Available,http://en.irct.ir/trial/46933,No Results,No Results,No Results,2020-04-21,2020-04-22,None
826,IRCT20180725040596N2,IRCT,2020-04-18,2020-04-29,False,Iran University of Medical Sciences,Not Recruiting,Phase 3,Interventional,Iran,Effect of Arbidol in treatment of COVID-19,Drug,Umifenovir + Hydroxychloroquine vs. Lopinavir/ritonavir vs. Hydroxychloroquine,100,Not Available,Not Available,http://en.irct.ir/trial/46897,No Results,No Results,No Results,2020-04-21,2020-04-22,None
827,IRCT20200404046935N1,IRCT,2020-04-20,2020-04-18,True,Mazandaran University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,"Effect of herbal medicine containing Saatar, Hofarigon and Fennel on COVID-19 patients",Traditional Medicine (Drug),Traditional Medicine,40,Not Available,Not Available,http://en.irct.ir/trial/46940,No Results,No Results,No Results,2020-04-21,2020-04-22,None
828,RBR-6m69fc,REBEC,2020-04-02,2020-04-01,True,University of Sevilla,Recruiting,Not Applicable,Interventional,Spain,"Therapeutic Pulmonary Telerehabilitation Protocol in patients affected by COVID-19, confined in their homes",Telehealth,Rehabilitation,99,Not Available,2020-04-15,http://www.ensaiosclinicos.gov.br/rg/RBR-6m69fc/,No Results,No Results,No Results,2020-04-21,2020-04-22,None
829,IRCT20151227025726N14,IRCT,2020-04-10,2020-04-05,True,Shahid Beheshti University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Evaluation the effects of Favipiravir in COVID-19 patients,Drug,Favipiravir vs. Lopinavir/ritonavir,84,Not Available,Not Available,http://en.irct.ir/trial/46942,No Results,No Results,No Results,2020-04-21,2020-04-22,None
830,IRCT20200404046947N1,IRCT,2020-04-15,2020-03-28,True,Tehran University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Effect of Methylprednisolone on treatment of COVID-19,Drug,Corticosteroids,40,Not Available,Not Available,http://en.irct.ir/trial/46904,No Results,No Results,No Results,2020-04-21,2020-04-22,None
831,IRCT20150808023559N20,IRCT,2020-04-11,2020-04-29,False,Ardabil University of Medical Sciences,Not Recruiting,Phase 1/Phase 2,Interventional,Iran,Efficacy of hydroxychloroquine plus favipiravir drug regimen in comparison with hydroxychloroquine plus kaletra in  hospitalized patients with COVID-19,Drug,Favipravir + hydroxychloroquine vs. lopinavir/ritonavir + hydroxychloroquine,100,Not Available,Not Available,http://en.irct.ir/trial/47022,No Results,No Results,No Results,2020-04-21,2020-04-22,None
832,RBR-9pgwfc,REBEC,2020-04-09,2020-04-07,True,Hospital Universitrio Bettina Ferro de Souza,Recruiting,Not Applicable,Observational,"Canada, France, Brazil, Portugal, Colombia, United Kingdom, United States, Chile, Spain",Psychological effects of social isolation in the coronavirus pandemic,Other (psych),No Intervention,2300,Not Available,2020-05-30,http://www.ensaiosclinicos.gov.br/rg/RBR-9pgwfc/,No Results,No Results,No Results,2020-04-21,2020-04-22,None
833,IRCT20200403046926N1,IRCT,2020-04-11,2020-04-08,True,Mazandaran University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,The effect of SOVODAK in the treatment of COVID-19 patients,Drug,Daclatasvir/sofosbuvir + hydroxychloroquine vs. hydroxychloroquine,60,Not Available,Not Available,http://en.irct.ir/trial/46926,No Results,No Results,No Results,2020-04-21,2020-04-22,None
834,IRCT20200217046526N1,IRCT,2020-04-13,2020-03-15,True,Iranian Academic Center for Education Culture and Research,Not Recruiting,Phase 1/Phase 2,Interventional,Iran,Mesenchymal Stem Cell Therapy for Acute Respiratory Distress Syndrome in Coronavirus Infection,ATMP,Cells (mesenchymal),6,Not Available,2020-04-25,http://en.irct.ir/trial/47030,No Results,No Results,No Results,2020-04-21,2020-04-22,None
835,ChiCTR2000030895,ChiCTR,2020-03-16,2020-03-14,True,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Not Recruiting,Not Applicable,Observational,China,Retrospective and Prospective Study for Nosocomial infection in Stomatology Department under the Background of novel coronavirus pneumonia (COVID-19) epidemic period,Clinical Presentation,No Intervention,1000,Not Available,2020-04-30,http://www.chictr.org.cn/showproj.aspx?proj=51034,No Results,No Results,No Results,2020-03-16,2020-03-18,None
836,IRCT20151228025732N53,IRCT,2020-04-10,2020-04-20,False,Semnan University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Therapeutic effects of plasma of recovered people from COVID-19 on hospitalized patients with this disease,ATMP,Plasma,12,Not Available,Not Available,http://en.irct.ir/trial/46931,No Results,No Results,No Results,2020-04-21,2020-04-22,None
837,IRCT20200413047053N1,IRCT,2020-04-15,2020-04-20,False,Mashhad University of Medical Sciences,Recruiting,Phase 2,Interventional,Iran,Evaluation the effect of asafoetida in the treatment of coronavirus infection,Traditional Medicine (Drug),Traditional Medicine,60,Not Available,Not Available,http://en.irct.ir/trial/47139,No Results,No Results,No Results,2020-04-21,2020-04-22,None
838,IRCT20200406046965N1,IRCT,2020-04-12,2020-04-20,False,Mashhad University of Medical Sciences,Recruiting,Phase 2,Interventional,Iran,The effect of elderberry syrup against COVID-19 symptoms,Traditional Medicine (Drug),Traditional Medicine,40,Not Available,Not Available,http://en.irct.ir/trial/46958,No Results,No Results,No Results,2020-04-21,2020-04-22,None
839,RBR-8969zg,REBEC,2020-04-13,2020-04-14,False,University de So Paulo,Not Recruiting,Not Applicable,Interventional,Brazil,Treatment of 2019-nCoV Pneumonia with N-acetylcysteine,Drug,N-acetylcysteine,200,Not Available,2020-10-14,http://www.ensaiosclinicos.gov.br/rg/RBR-8969zg/,No Results,No Results,No Results,2020-04-21,2020-04-22,None
840,LBCTR2020043459,LBCTR,2020-04-16,2020-04-14,True,Htel-Dieu de France Hospital,Not Recruiting,Not Applicable,Observational,Lebanon,The effect of confinement on the mental health of individuals during the COVID-19 pandemic: an online survey,Other (psych),No Intervention,500,Not Available,2020-05-18,http://lbctr.emro.who.int/Trials/Details/3459,No Results,No Results,No Results,2020-04-20,2020-04-22,None
841,IRCT20200404046948N1,IRCT,2020-04-15,2020-04-13,True,Artesh University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Efficacy and safety of convalescent plasma in the treatment of COVID-19,ATMP,Plasma,60,Not Available,Not Available,http://en.irct.ir/trial/46973,No Results,No Results,No Results,2020-04-21,2020-04-22,None
842,TCTR20200401002,TCTR,2020-03-31,2020-06-01,False,Wellcome Trust,Not Recruiting,Not Applicable,Observational,"United Kingdom, Italy, Malaysia, Thailand","Social, ethical and behavioural aspects of the novel coronavirus pandemic",Other,No Intervention,2640,2020-12-31,2020-12-31,http://www.clinicaltrials.in.th/index.php?tp=regtrials&menu=trialsearch&smenu=fulltext&task=search&task2=view1&id=5997,No Results,No Results,No Results,2020-04-21,2020-04-22,None
843,ChiCTR2000030894,ChiCTR,2020-03-16,2020-03-01,True,Peking University First Hospital,Recruiting,Phase 4,Interventional,China,"Favipiravir Combined With Tocilizumab in the Treatment of novel coronavirus pneumonia (COVID-19) - A Multicenter, Randomized, Controlled Trial",Drug,Favipiravir + Tocilizumab vs. Favipiravir vs. Tocilizumab,150,Not Available,2020-05-31,http://www.chictr.org.cn/showproj.aspx?proj=51126,No Results,No Results,No Results,2020-03-16,2020-03-18,None
844,IRCT20081019001369N4,IRCT,2020-04-11,2020-04-20,False,Mashhad University of Medical Sciences,Recruiting,Phase 2,Interventional,Iran,Effect of minocycline on COVID-19,Drug,Minocycline,40,Not Available,Not Available,http://en.irct.ir/trial/46977,No Results,No Results,No Results,2020-04-21,2020-04-22,None
845,PACTR202004693933092,PACTR,2020-04-12,2020-04-15,False,Misr University for Science and Technology,Not Recruiting,Not Applicable,Interventional,Egypt,Effectiveness of Measles Vaccine in Health Care Professionals During COVID-19 Outbreak (Randomized Controlled Trial),ATMP,Vaccine,200,Not Available,2020-06-30,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=10953,No Results,No Results,No Results,2020-04-20,2020-04-22,None
846,NCT04257656,ClinicalTrials.gov,2020-01-31,2020-02-06,False,Capital Medical University,Not Recruiting,Phase 3,Interventional,China,A Trial of Remdesivir in Adults With Severe COVID-19,Drug,Remdesivir,237,2020-03-30,2020-04-10,https://clinicaltrials.gov/show/NCT04257656,Journal Article,2020-04-29,https://doi.org/10.1016/S0140-6736(20)31022-9,2020-04-27,2020-08-03,None
847,IRCT20200408046992N1,IRCT,2020-04-14,2020-04-16,False,Birjand University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Effect of Trifluoperazine in treatment of COVID-19,Drug,Trifluoprazine + Hydroxychloroquine vs. Hydroxychloroquine,70,Not Available,Not Available,http://en.irct.ir/trial/47006,No Results,No Results,No Results,2020-04-21,2020-04-22,None
848,PACTR202004761408382,PACTR,2020-04-13,2020-05-01,False,Neimeth International Pharmaceuticals Plc.,Not Recruiting,Not Applicable,Interventional,Nigeria,"Efficacy and safety of IHP Detox Tea (a special blend of Andrographis paniculata, Garcinia kola and Psidium guajava) for treatment of Corona virus disease 2019 (COVID-19): a pilot placebo-controlled randomized trial",Traditional Medicine (Drug),Traditional Medicine,72,Not Available,2020-08-31,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=10957,No Results,No Results,No Results,2020-04-20,2020-04-22,None
849,NCT04299152,ClinicalTrials.gov,2020-02-28,2020-05-10,False,Tianhe Stem Cell Biotechnologies Inc.,Not Recruiting,Phase 2,Interventional,No Country Given,Stem Cell Educator Therapy Treat the Viral Inflammation in COVID-19,ATMP,Cells (stem cells),20,2020-10-09,2020-11-10,https://clinicaltrials.gov/show/NCT04299152,No Results,No Results,No Results,2020-04-27,2020-03-18,None
850,NCT04315987,ClinicalTrials.gov,2020-03-18,2020-04-01,False,Azidus Brasil,Not Recruiting,Phase 1,Interventional,Brazil,NestCell Mesenchymal Stem Cell to Treat Patients With Severe COVID-19 Pneumonia,ATMP,Cells (mesenchymal),66,2020-05-01,2020-06-01,https://clinicaltrials.gov/show/NCT04315987,No Results,No Results,No Results,2020-04-27,2020-03-25,None
851,IRCT20200404046937N2,IRCT,2020-04-13,2020-04-13,False,Ahvaz University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Evaluating the effect of Phyllanthus Emblica on COVID 19 patients,Traditional Medicine (Drug),Traditional Medicine,60,Not Available,Not Available,http://en.irct.ir/trial/47016,No Results,No Results,No Results,2020-04-21,2020-04-22,None
852,RBR-3cbs3w,REBEC,2020-04-08,2020-04-10,False,EMS Pharmaceuticals,Not Recruiting,Phase 3,Interventional,Brazil,Evaluation of Hydroxychloroquine for prevention of hospitalization and respiratory complications in patients with confirmed diagnosis or suspected infection by (COVID-19),Drug,Hydroxychloroquine,1300,Not Available,2020-07-10,http://www.ensaiosclinicos.gov.br/rg/RBR-3cbs3w/,No Results,No Results,No Results,2020-04-21,2020-04-22,None
853,IRCT20200406046968N1,IRCT,2020-04-14,2020-04-21,False,Tabriz University of Medical Sciences,Recruiting,Phase 2/Phase 3,Interventional,Iran,The  effect of IL-6 inhibitor (Tocilizumab) on the prognosis of covid-19 patients with acute respiratory failure hospitalized in Imam Reza Hospital in Tabriz,Drug,Tocilizumab,10,Not Available,Not Available,http://en.irct.ir/trial/47021,No Results,No Results,No Results,2020-04-21,2020-04-22,None
854,NCT04322565,ClinicalTrials.gov,2020-03-24,2020-04-20,False,AOU di Parma,Not Recruiting,Phase 2,Interventional,No Country Given,Colchicine Counteracting Inflammation in COVID-19 Pneumonia,Drug,Colchicine,310,2020-06-20,2020-07-20,https://clinicaltrials.gov/show/NCT04322565,No Results,No Results,No Results,2020-04-27,2020-04-01,None
855,NCT04325061,ClinicalTrials.gov,2020-03-25,2020-04-03,True,Dr. Negrin University Hospital,Recruiting,Phase 4,Interventional,Spain,Efficacy of Dexamethasone Treatment for Patients With ARDS Caused by COVID-19,Drug,Corticosteroids,200,2020-10-30,2020-10-30,https://clinicaltrials.gov/show/NCT04325061,No Results,No Results,No Results,2020-04-27,2020-04-01,EUCTR2020-001278-31
856,RBR-9d8z6m,REBEC,2020-03-27,2020-03-30,False,Hospital do Corao,Recruiting,Phase 3,Interventional,Brazil,Safety and Efficacy of Hydroxychloroquine Associated With Azythromycin in SARS-Cov-2 Virus,Drug,Hydroxychloroquine + Azithromycin vs. Hydroxychloroquine ,630,Not Available,2020-07-31,http://www.ensaiosclinicos.gov.br/rg/RBR-9d8z6m/,No Results,No Results,No Results,2020-04-21,2020-04-22,None
857,IRCT20200409047007N1,IRCT,2020-04-12,2020-04-13,False,Mashhad University of Medical Sciences,Recruiting,Not Applicable,Interventional,Iran,Effect of COVID 19 survivors plasma in COVID 19 patients with ARDS,ATMP,Plasma,32,Not Available,Not Available,http://en.irct.ir/trial/47058,No Results,No Results,No Results,2020-04-21,2020-04-22,None
858,TCTR20200404004,TCTR,2020-03-31,2020-04-27,False,Health Systems Research Institute (HSRI),Not Recruiting,Phase 4,Interventional,Thailand,Comparative effectiveness of Chloroquine and Vitamin C prophylaxis in household contacts of confirmed COVID-19 patients,Drug,Chloroquine + Vitamin C,400,2020-07-31,2020-07-31,http://www.clinicaltrials.in.th/index.php?tp=regtrials&menu=trialsearch&smenu=fulltext&task=search&task2=view1&id=5995,No Results,No Results,No Results,2020-04-21,2020-04-22,None
859,NCT04327804,ClinicalTrials.gov,2020-03-26,2020-03-25,True,Dr. Deneen Vojta,Recruiting,Not Applicable,Observational,United States,A Longitudinal Study of COVID-19 Positive Patients Testing Nasal Swabs and Collecting Blood Samples for Research,Diagnostics,Diagnostic Test or Assessment,120,2020-04-03,2020-04-10,https://clinicaltrials.gov/show/NCT04327804,No Results,No Results,No Results,2020-04-27,2020-04-22,None
860,NCT04328129,ClinicalTrials.gov,2020-03-23,2020-03-23,False,Institut Pasteur,Recruiting,Not Applicable,Interventional,French Guiana,Household Transmission Investigation Study for COVID-19 in French Guiana,Clinical Presentation (Epidemiology),No Intervention,450,2022-03-23,2022-03-23,https://clinicaltrials.gov/show/NCT04328129,No Results,No Results,No Results,2020-04-27,2020-04-07,None
861,IRCT20190122042450N4,IRCT,2020-04-16,2020-04-20,False,Iran University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,The effect of hydroxychloroquine to prevent coronavirus disease,Drug (Chemoprophylaxis),Hydroxychloroquine,1000,Not Available,Not Available,http://en.irct.ir/trial/47090,No Results,No Results,No Results,2020-04-21,2020-04-22,None
862,NCT04329611,ClinicalTrials.gov,2020-03-29,2020-04-13,False,Dr. Michael Hill,Recruiting,Phase 3,Interventional,Canada,ALBERTA HOPE COVID-19 for the Prevention of Severe COVID19 Disease,Drug,Hydroxychloroquine,1660,2020-08-31,2020-09-30,https://clinicaltrials.gov/show/NCT04329611,No Results,No Results,No Results,2020-04-27,2020-04-07,None
863,NCT04331054,ClinicalTrials.gov,2020-03-29,2020-04-13,False,Assistance Publique  Hpitaux de Paris,Recruiting,Phase 3,Interventional,France,Protective Role of Inhaled Steroids for Covid-19 Infection,Drug,Budesonide/formoterol,436,2020-07-13,2020-07-13,https://clinicaltrials.gov/show/NCT04331054,No Results,No Results,No Results,2020-04-27,2020-04-07,None
864,IRCT20200411047030N1,IRCT,2020-04-17,2020-04-14,True,Mazandaran University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,The effect of melatonin on the quality of sleep in COVID-19 patients,Drug,Melatonin + Hydroxychloroquine + Azithormycin vs. Hydroxychloroquine + Azithormycin,82,Not Available,Not Available,http://en.irct.ir/trial/47099,No Results,No Results,No Results,2020-04-21,2020-04-22,None
865,NCT04244591,ClinicalTrials.gov,2020-01-23,2020-01-26,False,Peking Union Medical College Hospital,Not Recruiting,Phase 2/Phase 3,Interventional,China,Glucocorticoid Therapy for COVID-19 Critically Ill Patients With Severe Acute Respiratory Failure,Drug,Corticosteroids,80,2020-04-13,2020-04-13,https://clinicaltrials.gov/show/NCT04244591,No Results,No Results,No Results,2020-04-27,2020-08-03,None
866,NCT04333628,ClinicalTrials.gov,2020-04-01,2020-04-01,False,"HaEmek Medical Center, Israel",Not Recruiting,Phase 2/Phase 3,Interventional,No Country Given,Chloroquine for Mild Symptomatic and Asymptomatic COVID-19,Drug,Chloroquine,210,2021-04-01,2021-12-01,https://clinicaltrials.gov/show/NCT04333628,No Results,No Results,No Results,2020-04-27,2020-04-07,None
867,NCT04334044,ClinicalTrials.gov,2020-04-01,2020-04-15,False,Grupo Cooperativo Hemopatas Malignas,Recruiting,Phase 1/Phase 2,Interventional,Mexico,Treatment of SARS Caused by COVID-19 With Ruxolitinib,Drug,Ruxolitinib,20,2020-06-01,2020-06-01,https://clinicaltrials.gov/show/NCT04334044,No Results,No Results,No Results,2020-04-27,2020-04-07,None
868,IRCT20200413047056N1,IRCT,2020-04-17,2020-04-18,False,Birjand University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Comparison between the efficacy of intravenous immunoglobulin and convalescent plasma in COVID-19,ATMP,Plasma vs. Immunoglobulin,15,Not Available,Not Available,http://en.irct.ir/trial/47212,No Results,No Results,No Results,2020-04-21,2020-04-22,None
869,NCT04252664,ClinicalTrials.gov,2020-01-31,2020-02-12,False,Capital Medical University,Not Recruiting,Phase 3,Interventional,China,A Trial of Remdesivir in Adults With Mild and Moderate COVID-19,Drug,Remdesivir,308,2020-04-10,2020-04-27,https://clinicaltrials.gov/show/NCT04252664,No Results,No Results,No Results,2020-04-27,2020-08-03,None
870,NCT04273321,ClinicalTrials.gov,2020-02-15,2020-02-14,True,"Beijing Chaoyang Hospital, Capital Medical University",Not Recruiting,Not Applicable,Interventional,China,Efficacy and Safety of Corticosteroids in COVID-19,Drug,Corticosteroids,400,2020-04-15,2020-04-15,https://clinicaltrials.gov/show/NCT04273321,No Results,No Results,No Results,2020-04-27,2020-08-03,None
871,JPRN-UMIN000039997,JPRN,2020-04-01,2020-04-01,False,Jichi Medical University,Not Recruiting,Not Applicable,Observational,Japan,"Prevention of COVID-19 infection in a medical institution 
and maintenance of medical system",Other,No Intervention,3700,Not Available,2021-12-31,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000045600,No Results,No Results,No Results,2020-04-20,2020-04-22,None
872,NCT04334148,ClinicalTrials.gov,2020-04-02,2020-04-01,True,Duke University,Not Recruiting,Phase 3,Interventional,No Country Given,Healthcare Worker Exposure Response and Outcomes of Hydroxychloroquine,Drug (Chemoprophylaxis),Hydroxychloroquine,15000,2020-07-01,2020-07-01,https://clinicaltrials.gov/show/NCT04334148,No Results,No Results,No Results,2020-04-27,2020-04-15,None
873,NCT04336956,ClinicalTrials.gov,2020-03-30,2020-04-07,False,Centre Hospitalier Intercommunal Creteil,Recruiting,Not Applicable,Observational,France,Covid-19 Pediatric Observatory,Clinical Presentation,No Intervention,250,2021-06-30,2021-06-30,https://clinicaltrials.gov/show/NCT04336956,No Results,No Results,No Results,2020-04-27,2020-04-15,None
874,TCTR20200409006,TCTR,2020-04-03,2020-05-01,False,King Chulalongkorn Memorial Hospital,Not Recruiting,Not Applicable,Interventional,Thailand,Efficacy of HA330 Hemoperfusion in Critically Ill Patients with Severe COVID-19,Other (device),HA330,206,2020-05-01,2020-05-01,http://www.clinicaltrials.in.th/index.php?tp=regtrials&menu=trialsearch&smenu=fulltext&task=search&task2=view1&id=6016,No Results,No Results,No Results,2020-04-21,2020-04-22,None
875,NCT04276688,ClinicalTrials.gov,2020-02-11,2020-02-10,True,The University of Hong Kong,Not Recruiting,Phase 2,Interventional,Hong Kong,"Lopinavir/ Ritonavir, Ribavirin and IFN-beta Combination for nCoV Treatment",Drug,Lopinavir/ritonavir + Ribavirin + Interferon beta,127,2020-03-30,2020-03-31,https://clinicaltrials.gov/show/NCT04276688,Journal Article,2020-05-08,https://doi.org/10.1016/S0140-6736(20)31042-4,2020-04-27,2020-03-18,None
876,NCT04280224,ClinicalTrials.gov,2020-02-13,2020-02-15,False,Xinxiang Medical University,Recruiting,Phase 1,Interventional,China,NK Cells Treatment for COVID-19,ATMP,Cells (NK),30,2020-09-30,2020-12-30,https://clinicaltrials.gov/show/NCT04280224,No Results,No Results,No Results,2020-04-27,2020-03-18,None
877,NCT04338568,ClinicalTrials.gov,2020-04-04,2020-04-13,False,Hasselt University,Recruiting,Not Applicable,Interventional,Belgium,Screening COVID-19 by Point-of-care Lung Ultrasound: a Validation Study,Diagnostics,Diagnostic Test or Assessment,50,2020-04-30,2020-04-30,https://clinicaltrials.gov/show/NCT04338568,No Results,No Results,No Results,2020-04-27,2020-04-15,None
878,NCT04342663,ClinicalTrials.gov,2020-04-08,2020-04-10,False,Washington University in St. Louis,Recruiting,Phase 2,Interventional,United States,"A Double-blind, Placebo-controlled Clinical Trial of Fluvoxamine for Symptomatic Individuals With COVID-19 Infection",Drug,Fluvoxamine,152,2020-06-01,2020-07-01,https://clinicaltrials.gov/show/NCT04342663,No Results,No Results,No Results,2020-04-27,2020-04-15,None
879,TCTR20200405001,TCTR,2020-04-05,2020-03-19,True,Chulalongkorn University,Recruiting,Not Applicable,Observational,Thailand,Use of Covid-19 Rapid Test for Hospital Care: GI Procedure,Diagnostics,Diagnostic Test or Assessment,20,2020-06-30,2020-06-30,http://www.clinicaltrials.in.th/index.php?tp=regtrials&menu=trialsearch&smenu=fulltext&task=search&task2=view1&id=6023,No Results,No Results,No Results,2020-04-21,2020-04-22,None
880,ChiCTR2000030893,ChiCTR,2020-03-16,2020-03-19,False,Zhengzhou People's Hospital,Not Recruiting,Not Applicable,Observational,China,Study for effects of crisis intervention based on positive psychology for medical staffs working in the novel coronavirus pneumonia (COVID-19) field,Other (psych),Psychological,50,Not Available,2021-03-11,http://www.chictr.org.cn/showproj.aspx?proj=51073,No Results,No Results,No Results,2020-03-16,2020-03-18,None
881,TCTR20200324001,TCTR,2020-03-21,2020-03-24,False,Study Group for Efficiency and Quality of Emergency Departments and Non-Scheduled Activities Departm,Not Recruiting,Not Applicable,Observational,France,Covid-19 preparedness among Emergency Departments: a cross-sectional study in France.,Health System,No Intervention,650,2020-03-31,2020-03-31,http://www.clinicaltrials.in.th/index.php?tp=regtrials&menu=trialsearch&smenu=fulltext&task=search&task2=view1&id=5976,No Results,No Results,No Results,2020-04-21,2020-03-25,None
882,TCTR20200321001,TCTR,2020-03-20,2020-03-20,False,Study Group for Efficiency and Quality of Emergency Departments and Non-Scheduled Activities Departm,Not Recruiting,Not Applicable,Observational,France,ED Response against Covid-19 pandemic,Other,No Intervention,5000,2020-04-14,2020-04-14,http://www.clinicaltrials.in.th/index.php?tp=regtrials&menu=trialsearch&smenu=fulltext&task=search&task2=view1&id=5975,No Results,No Results,No Results,2020-04-21,2020-03-25,None
883,NCT04304690,ClinicalTrials.gov,2020-03-09,2020-03-16,False,Assistance Publique  Hpitaux de Paris,Recruiting,Not Applicable,Interventional,France,"COVID-19 Seroconversion Among Front Line Medical and Paramedical Staff in Emergency, Intensive Care Units and Infectious Disease Departments During the 2020 Epidemic",Clinical Presentation (Epidemiology),No Intervention,1000,2020-07-16,2020-10-16,https://clinicaltrials.gov/show/NCT04304690,No Results,No Results,No Results,2020-04-27,2020-04-15,None
884,NCT04315896,ClinicalTrials.gov,2020-03-18,2020-04-14,False,"National Institute of Respiratory Diseases, Mexico",Recruiting,Phase 3,Interventional,Mexico,Hydroxychloroquine Treatment for Severe COVID-19 Pulmonary Infection (HYDRA Trial),Drug,Hydroxychloroquine,500,2020-10-31,2021-03-22,https://clinicaltrials.gov/show/NCT04315896,No Results,No Results,No Results,2020-04-27,2020-03-25,None
885,NCT04343183,ClinicalTrials.gov,2020-04-07,2020-04-01,True,Ochsner Health System,Not Recruiting,Not Applicable,Interventional,United States,Hyperbaric Oxygen Therapy (HBOT) as a Treatment for COVID-19 (COVID-19) Infection,Drug,Oxygen,48,2020-06-01,2020-06-01,https://clinicaltrials.gov/show/NCT04343183,No Results,No Results,No Results,2020-04-27,2020-04-15,None
886,NCT04343690,ClinicalTrials.gov,2020-04-09,2020-04-13,False,Duke University,Not Recruiting,Not Applicable,Interventional,United States,COPING With COVID-19( CWC-19),Other (psych),Psychological,100,2020-06-30,2020-06-30,https://clinicaltrials.gov/show/NCT04343690,No Results,No Results,No Results,2020-04-27,2020-04-15,None
887,NCT04252118,ClinicalTrials.gov,2020-01-27,2020-01-27,False,Beijing 302 Hospital,Recruiting,Phase 1,Interventional,China,Mesenchymal Stem Cell Treatment for Pneumonia Patients Infected With COVID-19,ATMP,Cells (mesenchymal),20,2020-12-01,2021-12-01,https://clinicaltrials.gov/show/NCT04252118,No Results,No Results,No Results,2020-04-27,2020-03-18,None
888,NCT04273646,ClinicalTrials.gov,2020-02-14,2020-04-20,False,"Wuhan Union Hospital, China",Not Recruiting,Not Applicable,Interventional,China,Study of Human Umbilical Cord Mesenchymal Stem Cells in the Treatment of Severe COVID-19,ATMP,Cells (mesenchymal),48,2020-06-30,2022-02-15,https://clinicaltrials.gov/show/NCT04273646,No Results,No Results,No Results,2020-04-27,2020-08-03,None
889,NCT04344015,ClinicalTrials.gov,2020-04-09,2020-04-13,False,Thomas Jefferson University,Recruiting,Not Applicable,Interventional,United States,COVID-19 Plasma Collection,ATMP,Plasma,2000,2021-04-12,2021-04-12,https://clinicaltrials.gov/show/NCT04344015,No Results,No Results,No Results,2020-04-27,2020-04-22,None
890,NCT04344119,ClinicalTrials.gov,2020-04-09,2020-04-09,False,CHU de Nice,Recruiting,Not Applicable,Observational,France,Assessment of Chilbains Occuring During Covid-19 Infection,Clinical Presentation,No Intervention,30,2020-06-30,2020-06-30,https://clinicaltrials.gov/show/NCT04344119,No Results,No Results,No Results,2020-04-27,2020-04-22,None
891,NCT04318015,ClinicalTrials.gov,2020-03-19,2020-04-14,False,"National Institute of Respiratory Diseases, Mexico",Recruiting,Phase 3,Interventional,Mexico,Hydroxychloroquine Chemoprophylaxis in Healthcare Personnel in Contact With COVID-19 Patients (PHYDRA Trial),Drug (Chemoprophylaxis),Hydroxychloroquine,400,2020-12-31,2021-03-31,https://clinicaltrials.gov/show/NCT04318015,No Results,No Results,No Results,2020-04-27,2020-04-01,None
892,NCT04321174,ClinicalTrials.gov,2020-03-18,2020-04-17,False,Darrell Tan,Recruiting,Phase 3,Interventional,Canada,COVID-19 Ring-based Prevention Trial With Lopinavir/Ritonavir,Drug,Lopinavir/ritonavir,1220,2021-03-31,2022-03-31,https://clinicaltrials.gov/show/NCT04321174,No Results,No Results,No Results,2020-04-27,2020-04-01,None
893,ChiCTR2000030863,ChiCTR,2020-03-16,2020-01-22,True,"Jinling Hospital, Medical School of Nanjing University",Recruiting,Not Applicable,Observational,China,Clinical and CT imaging Characteristics of novel coronavirus pneumonia (COVID-19): An Multicenter Cohort Study,Clinical Presentation,No Intervention,5000,Not Available,2021-03-31,http://www.chictr.org.cn/showproj.aspx?proj=50767,No Results,No Results,No Results,2020-03-16,2020-03-18,None
894,NCT04304053,ClinicalTrials.gov,2020-03-05,2020-03-18,True,Fundaci Lluita contra la SIDA,Recruiting,Phase 3,Interventional,Spain,Treatment of COVID-19 Cases and Chemoprophylaxis of Contacts as Prevention,Drug (Chemoprophylaxis),Darunavir + cobicistat + hydroxychloroquine,3040,2020-06-15,2020-06-15,https://clinicaltrials.gov/show/NCT04304053,No Results,No Results,No Results,2020-04-27,2020-03-18,EUCTR2020-001031-27
895,NCT04320953,ClinicalTrials.gov,2020-03-21,2020-03-16,True,Changhai Hospital,Not Recruiting,Not Applicable,Interventional,China,Non-contact Endoscopy at Covid-19 Outbreak,Other (device),Non-contact Endoscopy,5,2020-03-26,2020-04-09,https://clinicaltrials.gov/show/NCT04320953,No Results,No Results,No Results,2020-04-27,2020-04-01,None
896,NCT04344756,ClinicalTrials.gov,2020-04-09,2020-04-20,False,Assistance Publique  Hpitaux de Paris,Not Recruiting,Phase 2,Interventional,France,"Trial Evaluating Efficacy and Safety of Anticoagulation in Patients With COVID-19 Infection, Nested in the Corimmuno-19 Cohort",Drug,Tinzaparin or Heparin,808,2020-07-31,2020-09-30,https://clinicaltrials.gov/show/NCT04344756,No Results,No Results,No Results,2020-04-27,2020-04-22,None
897,NCT04344782,ClinicalTrials.gov,2020-04-09,2020-04-15,False,Assistance Publique  Hpitaux de Paris,Not Recruiting,Phase 2,Interventional,No Country Given,"Trial Evaluating Efficacy and Safety of Bevacizumab (Avastin/Zeribev) in Patients With COVID-19 Infection, Nested in the Corimmuno-19 Cohort",Drug,Bevacizumab,130,2020-09-30,2020-11-30,https://clinicaltrials.gov/show/NCT04344782,No Results,No Results,No Results,2020-04-27,2020-04-22,None
898,ChiCTR2000030862,ChiCTR,2020-03-16,2020-01-24,True,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Not Recruiting,Not Applicable,Observational,China,Correlation analysis of blood eosinophil cell levels and clinical type category of novel coronavirus pneumonia (COVID-19): a medical records based retrospective study,Clinical Presentation,No Intervention,150,Not Available,2020-06-16,http://www.chictr.org.cn/showproj.aspx?proj=51107,No Results,No Results,No Results,2020-03-16,2020-03-18,None
899,NCT04323228,ClinicalTrials.gov,2020-03-23,2020-05-01,False,King Saud University,Not Recruiting,Phase 4,Interventional,No Country Given,Anti-inflammatory/Antioxidant Oral Nutrition Supplementation in COVID-19,Supplement,Oral nutrition supplement,30,2020-10-01,2020-10-30,https://clinicaltrials.gov/show/NCT04323228,No Results,No Results,No Results,2020-04-27,2020-04-01,None
900,NCT04324073,ClinicalTrials.gov,2020-03-25,2020-03-27,False,Assistance Publique  Hpitaux de Paris,Not Recruiting,Phase 2/Phase 3,Interventional,France,Cohort Multiple Randomized Controlled Trials Open-label of Immune Modulatory Drugs and Other Treatments in COVID-19 Patients - Sarilumab Trial - CORIMUNO-19 - SARI,Drug,Sarilumab,239,2021-03-27,2021-12-31,https://clinicaltrials.gov/show/NCT04324073,No Results,No Results,No Results,2020-04-27,2020-04-01,None
901,NCT04324190,ClinicalTrials.gov,2020-03-26,2020-04-08,False,Gunther Meinlschmidt,Recruiting,Not Applicable,Interventional,Germany,DIgital Online SuPport for COVID-19 StrEss,Other (psych),Psychological,600,2020-06-01,2021-12-01,https://clinicaltrials.gov/show/NCT04324190,No Results,No Results,No Results,2020-04-27,2020-04-01,None
902,NCT04345549,ClinicalTrials.gov,2020-04-10,2020-02-26,True,Aarogyam UK,Not Recruiting,Not Applicable,Interventional,United Kingdom,Ayurveda Self-Management for Flu Like Symptoms During the Covid-19 Outbreak,Traditional Medicine (Other),Traditional Medicine,18,2020-03-30,2020-03-30,https://clinicaltrials.gov/show/NCT04345549,No Results,No Results,No Results,2020-04-27,2020-04-22,None
903,NCT04345640,ClinicalTrials.gov,2020-04-10,2020-04-14,False,"Institute of Liver and Biliary Sciences, India",Recruiting,Not Applicable,Observational,India,The Spectrum and Profile of COVID-19 Infection and Its Impact on Liver.,Clinical Presentation,No Intervention,100,2020-06-30,2020-06-30,https://clinicaltrials.gov/show/NCT04345640,No Results,No Results,No Results,2020-04-27,2020-04-22,None
904,NCT04323345,ClinicalTrials.gov,2020-03-23,2020-04-15,False,Misr University for Science and Technology,Recruiting,Phase 3,Interventional,Egypt,Efficacy of Natural Honey Treatment in Patients With Novel Coronavirus,Traditional Medicine (Other),Traditional Medicine,1000,2020-12-15,2021-01-15,https://clinicaltrials.gov/show/NCT04323345,No Results,No Results,No Results,2020-04-27,2020-04-01,None
905,NCT04327401,ClinicalTrials.gov,2020-03-26,2020-04-13,False,"Luiz F. L. Reis, Ph.D.",Recruiting,Phase 3,Interventional,Brazil,COVID-19-associated ARDS Treated With Dexamethasone: Alliance Covid-19 Brasil III,Drug,Dexamethasone,290,2020-08-30,2020-08-30,https://clinicaltrials.gov/show/NCT04327401,No Results,No Results,No Results,2020-04-27,2020-04-07,None
906,NCT04324736,ClinicalTrials.gov,2020-03-25,2020-03-10,True,Nantes University Hospital,Recruiting,Not Applicable,Observational,France,"""COVID-19 and Diabetes Outcomes""",Clinical Presentation,No Intervention,1000,2020-04-10,2020-05-08,https://clinicaltrials.gov/show/NCT04324736,No Results,No Results,No Results,2020-04-27,2020-04-22,None
907,NCT04325048,ClinicalTrials.gov,2020-03-25,2020-04-01,False,Cordio Medical,Not Recruiting,Not Applicable,Observational,No Country Given,Clinical Evaluation of Cordio Application in Adult COVID-19 Virus Positive Patients,Other (software),eHealth,5000,2021-06-01,2021-09-01,https://clinicaltrials.gov/show/NCT04325048,No Results,No Results,No Results,2020-04-27,2020-04-22,None
908,NCT04345887,ClinicalTrials.gov,2020-04-10,2020-04-21,False,Istanbul University-Cerrahpasa,Not Recruiting,Phase 4,Interventional,Turkey,Spironolactone in Covid-19 Induced ARDS,Drug,Spironolactone,60,2020-07-21,2020-10-21,https://clinicaltrials.gov/show/NCT04345887,No Results,No Results,No Results,2020-04-27,2020-04-22,None
909,NCT04346121,ClinicalTrials.gov,2020-04-10,2020-04-15,False,Nantes University Hospital,Not Recruiting,Not Applicable,Observational,France,Non-COVID Patient-safety Incidents Reported by General Practitioners in Time of Lockdown: Protocol for a Cross-sectional Descriptive Study.cRisis,Other,No Intervention,1000,2020-06-15,2020-06-15,https://clinicaltrials.gov/show/NCT04346121,No Results,No Results,No Results,2020-04-27,2020-04-22,None
910,NCT04329533,ClinicalTrials.gov,2020-03-26,2020-04-13,False,University of Arizona,Recruiting,Not Applicable,Interventional,United States,Effects of Using Mobile App on Perceived Stress During COVID-19 Pandemic,Other (psych),Psychological,150,2020-06-30,2020-07-30,https://clinicaltrials.gov/show/NCT04329533,No Results,No Results,No Results,2020-04-27,2020-04-07,None
911,NCT04331366,ClinicalTrials.gov,2020-03-31,2020-04-08,False,Emory University,Recruiting,Not Applicable,Interventional,United States,Bidirectional Oxygenation Valve in the Management of Pulmonary Complications of COVID-19,Other (device),Bidirectional Oxygenation Valve,5,2020-05-01,2020-05-01,https://clinicaltrials.gov/show/NCT04331366,No Results,No Results,No Results,2020-04-27,2020-04-07,None
912,NCT04326426,ClinicalTrials.gov,2020-03-26,2020-04-13,False,Vanda Pharmaceuticals,Recruiting,Phase 3,Interventional,United States,ODYSSEY: A Study to Investigate the Efficacy of Tradipitant in Treating Severe or Critical COVID-19 Infection,Drug,Tradipitant,300,2020-08-01,2020-08-31,https://clinicaltrials.gov/show/NCT04326426,No Results,No Results,No Results,2020-04-27,2020-04-07,None
913,NCT04328961,ClinicalTrials.gov,2020-03-23,2020-03-31,False,University of Washington,Recruiting,Phase 2/Phase 3,Interventional,United States,Hydroxychloroquine for COVID-19 PEP,Drug (Chemoprophylaxis),Hydroxychloroquine vs. Vitamin C,2000,2020-09-30,2020-10-31,https://clinicaltrials.gov/show/NCT04328961,No Results,No Results,No Results,2020-04-27,2020-04-07,None
914,NCT04346329,ClinicalTrials.gov,2020-04-10,2020-04-20,False,National University of Colombia,Not Recruiting,Phase 3,Interventional,Colombia,Immune Monitoring of Prophylactic Effect of Hydroxychloroquine in Healthcare Providers Highly Exposed to COVID-19,Drug (Chemoprophylaxis),Hydroxychloroquine,86,2020-06-01,2020-10-01,https://clinicaltrials.gov/show/NCT04346329,No Results,No Results,No Results,2020-04-27,2020-04-22,None
915,NCT04346355,ClinicalTrials.gov,2020-04-12,2020-03-31,True,Azienda Unit Sanitaria Locale Reggio Emilia,Recruiting,Phase 2,Interventional,Italy,Efficacy of Early Administration of Tocilizumab in COVID-19 Patients,Drug,Tocilizumab,398,2020-05-30,2020-05-30,https://clinicaltrials.gov/show/NCT04346355,No Results,No Results,No Results,2020-04-27,2020-04-22,None
916,ChiCTR2000030861,ChiCTR,2020-03-16,2019-02-27,True,The First Affiliated Hospital of the Guangzhou Medical University,Recruiting,Not Applicable,Health services research,No Country Given,Development and application of a new intelligent robot for novel coronavirus (2019-nCOV) oropharygeal sampling,Other (physical),Other,90,Not Available,2020-07-01,http://www.chictr.org.cn/showproj.aspx?proj=51103,No Results,No Results,No Results,2020-03-16,2020-03-18,None
917,NCT04336215,ClinicalTrials.gov,2020-04-02,2020-04-07,False,Rutgers University,Recruiting,Not Applicable,Observational,United States,Rutgers COVID-19 Cohort Study,Clinical Presentation,No Intervention,750,2020-09-01,2021-10-21,https://clinicaltrials.gov/show/NCT04336215,Pre-Print Article,2020-04-24,https://doi.org/10.1101/2020.04.20.20072470,2020-04-27,2020-04-15,None
918,NCT04338672,ClinicalTrials.gov,2020-04-04,2020-04-05,False,Sheba Medical Center,Recruiting,Not Applicable,Observational,Israel,The Impact of the Covid-19 Outbreak on Emergency Room Attendances of Surgical Patients,Health System,No Intervention,10000,2021-04-01,2022-04-01,https://clinicaltrials.gov/show/NCT04338672,No Results,No Results,No Results,2020-04-27,2020-04-15,None
919,NCT04329650,ClinicalTrials.gov,2020-03-31,2020-04-15,False,Judit Pich Martnez,Recruiting,Phase 2,Interventional,Spain,Efficacy and Safety of Siltuximab vs. Corticosteroids in Hospitalized Patients With COVID-19 Pneumonia,Drug,Siltuximab vs. Corticosteroids,200,2020-05-20,2020-05-20,https://clinicaltrials.gov/show/NCT04329650,No Results,No Results,No Results,2020-04-27,2020-04-07,None
920,NCT04331171,ClinicalTrials.gov,2020-03-30,2020-03-17,True,Weprom,Recruiting,Not Applicable,Observational,France,Epidemiological Observation From a Smartphone Self-monitoring Application for Suspected COVID-19 Patients' Triage,Other (device),Other,3000000,2020-03-31,2020-07-31,https://clinicaltrials.gov/show/NCT04331171,No Results,No Results,No Results,2020-04-27,2020-04-07,None
921,NCT04346420,ClinicalTrials.gov,2020-04-08,2020-04-09,False,"University Clinic, UCLouvain",Recruiting,Not Applicable,Interventional,Belgium,Impact of the Double-Trunk Mask on Oxygenation Titration in COVID-19,Other (device),Mask,15,2020-06-30,2020-06-30,https://clinicaltrials.gov/show/NCT04346420,No Results,No Results,No Results,2020-04-27,2020-04-22,None
922,NCT04346628,ClinicalTrials.gov,2020-04-10,2020-04-01,True,Stanford University,Not Recruiting,Phase 2,Interventional,United States,Oral Favipiravir Compared to Standard Supportive Care in Subjects With Mild COVID-19,Drug,Favipiravir,120,2021-04-01,2021-04-01,https://clinicaltrials.gov/show/NCT04346628,No Results,No Results,No Results,2020-04-27,2020-04-22,None
923,ChiCTR2000030860,ChiCTR,2020-03-16,2020-03-16,False,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Not Applicable,Observational,China,A medical records based study for investigation of dynamic profile of RT-PCR test for SARS-CoV-2 nucleic acid of novel coronavirus pneumonia (COVID-19) patients,Diagnostics,Diagnostic Test or Assessment,100,Not Available,Not Available,http://www.chictr.org.cn/showproj.aspx?proj=51102,No Results,No Results,No Results,2020-03-16,2020-03-18,None
924,NCT04341168,ClinicalTrials.gov,2020-04-03,2020-04-01,True,"University Hospital, Cologne",Not Recruiting,Not Applicable,Observational,Germany,"Clinical and Immunological Characterisation of COVID-19 in Children, Adolescents and Adults",Clinical Presentation,No Intervention,160,2020-10-01,2020-10-01,https://clinicaltrials.gov/show/NCT04341168,No Results,No Results,No Results,2020-04-27,2020-04-15,None
925,NCT04341285,ClinicalTrials.gov,2020-03-30,2020-06-01,False,"University Hospital, Tbingen",Not Recruiting,Not Applicable,Interventional,Germany,Early Versus Late ECMO Therapy in COVID-19 Induced ARDS (ECMO-VID),Drug,Oxygen,200,2024-06-01,2025-12-01,https://clinicaltrials.gov/show/NCT04341285,No Results,No Results,No Results,2020-04-27,2020-04-15,None
926,NCT04334252,ClinicalTrials.gov,2020-04-02,2020-04-17,False,Jessa Hospital,Not Recruiting,Not Applicable,Observational,No Country Given,Descriptive Study Regarding Ambulant Screening During COVID-19 Pandemia,Diagnostics,Diagnostic Test or Assessment,5000,2022-12-20,2023-12-20,https://clinicaltrials.gov/show/NCT04334252,No Results,No Results,No Results,2020-04-27,2020-04-15,None
927,NCT04336384,ClinicalTrials.gov,2020-03-30,2020-03-01,True,"University Hospital, Montpellier",Recruiting,Not Applicable,Observational,France,Impact of Covid-19 in Congenital Heart Disease,Clinical Presentation,No Intervention,5000,2020-12-01,2020-12-30,https://clinicaltrials.gov/show/NCT04336384,No Results,No Results,No Results,2020-04-27,2020-04-15,None
928,NCT04347070,ClinicalTrials.gov,2020-04-10,2017-04-01,True,"University Hospital, Montpellier",Recruiting,Not Applicable,Observational,France,Implementation of Physiotherapy on COVID-19 Patients in ICU,Other (physio),Physio,150,2020-09-01,2022-12-01,https://clinicaltrials.gov/show/NCT04347070,No Results,No Results,No Results,2020-04-27,2020-04-22,None
929,NCT04347538,ClinicalTrials.gov,2020-04-11,2020-05-01,False,Vanderbilt University,Not Recruiting,Not Applicable,Interventional,United States,Impact of Nasal Saline Irrigations on Viral Load in Patients With COVID-19,Procedure,Saline Nasal Irrigation,90,2021-06-01,2022-06-01,https://clinicaltrials.gov/show/NCT04347538,No Results,No Results,No Results,2020-04-27,2020-04-22,None
930,NCT04343248,ClinicalTrials.gov,2020-04-08,2020-04-30,False,Romark Laboratories L.C.,Not Recruiting,Phase 3,Interventional,No Country Given,Trial to Evaluate the Efficacy and Safety of Nitazoxanide (NTZ) for Post-Exposure Prophylaxis of COVID-19 and Other Viral Respiratory Illnesses in Elderly Residents of Long-Term Care Facilities (LTCF),Drug (Chemoprophylaxis),Nitazoxanide,600,2020-08-31,2020-08-31,https://clinicaltrials.gov/show/NCT04343248,No Results,No Results,No Results,2020-04-27,2020-04-15,None
931,NCT04343755,ClinicalTrials.gov,2020-04-08,2020-04-09,False,Hackensack Meridian Health,Recruiting,Phase 2,Interventional,United States,Convalescent Plasma as Treatment for Hospitalized Subjects With COVID-19 Infection,ATMP,Plasma,55,2021-04-01,2021-04-01,https://clinicaltrials.gov/show/NCT04343755,No Results,No Results,No Results,2020-04-27,2020-04-15,None
932,NCT04347980,ClinicalTrials.gov,2020-04-09,2020-04-01,True,Centre Chirurgical Marie Lannelongue,Recruiting,Phase 3,Interventional,France,Dexamethasone Treatment for Severe Acute Respiratory Distress Syndrome Induced by COVID-19,Drug,Dexamethasone + Hydroxychloroquine vs. Hydroxychloroquine,122,2020-06-01,2020-08-01,https://clinicaltrials.gov/show/NCT04347980,No Results,No Results,No Results,2020-04-27,2020-04-22,None
933,NCT04348396,ClinicalTrials.gov,2020-04-10,2020-04-01,True,Istituto Nazionale di Ricovero e Cura per Anziani,Not Recruiting,Not Applicable,Observational,Italy,Clinical and Biological Predictors of COVID-19 Disease in Older Patients,Clinical Presentation,No Intervention,300,2020-12-01,2020-12-01,https://clinicaltrials.gov/show/NCT04348396,No Results,No Results,No Results,2020-04-27,2020-04-22,None
934,NCT04339634,ClinicalTrials.gov,2020-04-07,2020-04-07,False,Tabula Rasa HealthCare,Not Recruiting,Not Applicable,Observational,United States,Simulation of Risk of Adverse Drug Events Associated With the Initiation of Drugs Repurposed for the Treatment of COVID-19 in Frail Elderly Adults With Polypharmacy,Clinical Presentation,No Intervention,12123,2020-07-07,2021-04-06,https://clinicaltrials.gov/show/NCT04339634,No Results,No Results,No Results,2020-04-27,2020-04-15,None
935,NCT04340050,ClinicalTrials.gov,2020-04-07,2020-04-10,False,University of Chicago,Recruiting,Phase 1,Interventional,United States,COVID-19 Convalescent Plasma,ATMP,Plasma,10,2020-12-31,2021-12-31,https://clinicaltrials.gov/show/NCT04340050,No Results,No Results,No Results,2020-04-27,2020-04-15,None
936,ChiCTR2000030812,ChiCTR,2020-03-15,2020-01-31,True,Shanghai Ninth People's Hospital,Recruiting,Not Applicable,Observational,China,Study for the virus molecular evolution which driven the immune-pathological responses and the protection mechanisms of novel coronavirus pneumonia (COVID-19) patients,Clinical Presentation,No Intervention,50,Not Available,2021-01-31,http://www.chictr.org.cn/showproj.aspx?proj=50947,No Results,No Results,No Results,2020-03-16,2020-03-18,None
937,NCT04343781,ClinicalTrials.gov,2020-04-09,2020-03-22,True,"University Hospital, Angers",Not Recruiting,Not Applicable,Observational,France,National Survey of Symptoms of People Aged 70 and Overs Diagnosed With COVID-19,Clinical Presentation,No Intervention,353,2020-04-05,2020-04-05,https://clinicaltrials.gov/show/NCT04343781,No Results,No Results,No Results,2020-04-27,2020-04-15,None
938,NCT04343794,ClinicalTrials.gov,2020-02-20,2020-04-01,False,The University of Hong Kong,Recruiting,Not Applicable,Interventional,Hong Kong,Using Biovitals Sentinel to Monitor Disease Progression in Subjects Quarantined for Suspected COVID-19,Other (device),Biosensors,200,2021-12-31,2022-01-31,https://clinicaltrials.gov/show/NCT04343794,No Results,No Results,No Results,2020-04-27,2020-04-15,None
939,NCT04341142,ClinicalTrials.gov,2020-04-08,2020-04-09,False,Hospices Civils de Lyon,Recruiting,Not Applicable,Interventional,France,Assessment of Serological Techniques for Screening Patients Regarding COVID-19-COVID-SER,Diagnostics,Diagnostic Test or Assessment,400,2020-09-09,2020-09-09,https://clinicaltrials.gov/show/NCT04341142,No Results,No Results,No Results,2020-04-27,2020-04-15,None
940,NCT04342195,ClinicalTrials.gov,2020-04-08,2020-03-25,True,Columbia University,Recruiting,Not Applicable,Observational,United States,Acquiring Convalescent Specimens for COVID-19 Antibodies,Clinical Presentation,No Intervention,12,2021-03-01,2021-03-01,https://clinicaltrials.gov/show/NCT04342195,No Results,No Results,No Results,2020-04-27,2020-04-15,None
941,NCT04348513,ClinicalTrials.gov,2020-04-09,2020-05-02,False,Uni-Pharma Kleon Tsetis Pharmaceutical Laboratories S.A.,Not Recruiting,Phase 2,Interventional,Greece,Triiodothyronine for the Treatment of Critically Ill Patients With COVID-19 Infection,Drug,Triiodothyronine,60,2021-05-02,2021-05-31,https://clinicaltrials.gov/show/NCT04348513,No Results,No Results,No Results,2020-04-27,2020-04-22,None
942,NCT04348695,ClinicalTrials.gov,2020-04-13,2020-04-12,False,Fundacin de Investigacin HM Hospitales,Recruiting,Phase 2,Interventional,Spain,Study of Ruxolitinib Plus Simvastatin in the Prevention and Treatment of Respiratory Failure of COVID-19.,Drug,Ruxolitinib + Simvastatin,94,2020-05-13,2020-05-13,https://clinicaltrials.gov/show/NCT04348695,No Results,No Results,No Results,2020-04-27,2020-04-22,EUCTR2020-001405-23
943,NCT04342728,ClinicalTrials.gov,2020-04-08,2020-04-08,False,The Cleveland Clinic,Recruiting,Not Applicable,Interventional,United States,Coronavirus 2019 (COVID-19)- Using Ascorbic Acid and Zinc Supplementation,Drug,Zinc + Vitamin C vs Zinc vs. Vitamin C,520,2020-12-30,2021-04-30,https://clinicaltrials.gov/show/NCT04342728,No Results,No Results,No Results,2020-04-27,2020-04-15,None
944,NCT04343144,ClinicalTrials.gov,2020-04-09,2020-04-15,False,Assistance Publique  Hpitaux de Paris,Not Recruiting,Phase 2,Interventional,France,"Trial Evaluating Efficacy and Safety of Nivolumab (Optivo) in Patients With COVID-19 Infection, Nested in the Corimmuno-19 Cohort.",Drug,Nivolumab,92,2020-07-31,2020-09-30,https://clinicaltrials.gov/show/NCT04343144,No Results,No Results,No Results,2020-04-27,2020-04-15,None
945,NCT04344288,ClinicalTrials.gov,2020-04-10,2020-04-01,False,Hospices Civils de Lyon,Recruiting,Phase 2,Interventional,France,Corticosteroids During Covid-19 Viral Pneumonia Related to SARS-Cov-2 Infection,Drug,Prednisone,304,2020-11-01,2020-11-01,https://clinicaltrials.gov/show/NCT04344288,No Results,No Results,No Results,2020-04-27,2020-04-22,EUCTR2020-001553-48
946,NCT04344535,ClinicalTrials.gov,2020-04-10,2020-04-08,True,Stony Brook University,Recruiting,Phase 1/Phase 2,Interventional,United States,Convalescent Plasma vs. Standard Plasma for COVID-19,ATMP,Plasma,500,2021-04-30,2021-08-31,https://clinicaltrials.gov/show/NCT04344535,No Results,No Results,No Results,2020-04-27,2020-04-22,None
947,NCT04349371,ClinicalTrials.gov,2020-04-12,2020-04-01,True,Columbia University,Recruiting,Phase 2,Interventional,United States,Saved From COVID-19,Drug (Chemoprophylaxis),Chloroquine,350,2021-04-01,2021-04-01,https://clinicaltrials.gov/show/NCT04349371,No Results,No Results,No Results,2020-04-27,2020-04-22,None
948,NCT04350671,ClinicalTrials.gov,2020-04-14,2020-04-15,False,Shahid Beheshti University of Medical Sciences,Recruiting,Phase 4,Interventional,Iran,Interferon Beta 1a in Hospitalized COVID-19 Patients,Drug,Interferon beta + Lopinavir/Ritonavir + Hydroxychlroquine vs. Lopinavir/Ritonavir + Hydroxychloroquine,40,2020-04-20,2020-04-24,https://clinicaltrials.gov/show/NCT04350671,No Results,No Results,No Results,2020-04-27,2020-04-22,None
949,ChiCTR2000030810,ChiCTR,2020-03-15,2020-02-23,True,Hubei Provincial Hospital of Integrated Chinese and Western Medicine,Recruiting,Phase 1,Interventional,China,Clinical observation and evaluation of traditional Chinese medicine in the treatment of novel coronavirus pneumonia (COVID-19) in Hubei 672 Orthopaedics Hospital of Integrated Chinese&Western Medicine,Traditional Medicine (Unspecified),Traditional Medicine,100,Not Available,2020-03-30,http://www.chictr.org.cn/showproj.aspx?proj=50986,No Results,No Results,No Results,2020-03-16,2020-03-18,None
950,NCT04344834,ClinicalTrials.gov,2020-04-11,2020-05-01,False,Assiut University,Not Recruiting,Not Applicable,Observational,No Country Given,Impact of Covid-19 on Egyptian Health Care Workers and General Population Mental Health,Other (psych),No Intervention,300,2020-10-01,2020-10-01,https://clinicaltrials.gov/show/NCT04344834,No Results,No Results,No Results,2020-04-27,2020-04-22,None
951,NCT04345159,ClinicalTrials.gov,2020-04-10,2020-04-01,True,Fondation Ophtalmologique Adolphe de Rothschild,Not Recruiting,Not Applicable,Observational,France,Association Between Long-term Hydroxychloroquine Treatment and Outcome of a History of Symptoms Suggestive of COVID-19 Infection During the Epidemic Period in France in Patients With Autoimmune Disease,Clinical Presentation,No Intervention,1500,2020-04-30,2020-07-01,https://clinicaltrials.gov/show/NCT04345159,No Results,No Results,No Results,2020-04-27,2020-04-22,None
952,NCT04344002,ClinicalTrials.gov,2020-04-09,2020-05-15,False,Spanish Lung Cancer Group,Not Recruiting,Not Applicable,Observational,Spain,LunG canceR pAtients coVId19 Disease (GRAVID),Clinical Presentation,No Intervention,200,2020-09-15,2020-12-15,https://clinicaltrials.gov/show/NCT04344002,No Results,No Results,No Results,2020-04-27,2020-04-22,None
953,NCT04344106,ClinicalTrials.gov,2020-04-08,2020-04-01,True,ELHARRAR Xavier,Recruiting,Not Applicable,Interventional,France,Prone Positioning in Spontaneously Breathing Nonintubated Covid-19 Patient: a Pilot Study,Procedure,Positioning,25,2020-04-15,2020-05-01,https://clinicaltrials.gov/show/NCT04344106,No Results,No Results,No Results,2020-04-27,2020-04-22,None
954,NCT04351347,ClinicalTrials.gov,2020-04-15,2020-04-17,False,Tanta University,Not Recruiting,Phase 2/Phase 3,Interventional,Egypt,The Efficacy of Ivermectin and Nitazoxanide in COVID-19 Treatment,Drug,Chloroquine + Nitazoxanide vs. Chloroquine + Ivermectin vs. Chloroquine ,60,2030-12-01,2030-12-01,https://clinicaltrials.gov/show/NCT04351347,No Results,No Results,No Results,2020-04-27,2020-04-22,None
955,NCT04351529,ClinicalTrials.gov,2020-04-16,2020-04-01,True,AGMT,Recruiting,Not Applicable,Observational,Austria,Austrian COVID-19 Registry,Clinical Presentation,No Intervention,1000,2021-12-01,2021-12-01,https://clinicaltrials.gov/show/NCT04351529,No Results,No Results,No Results,2020-04-27,2020-04-22,None
956,NCT04345406,ClinicalTrials.gov,2020-04-11,2020-04-15,False,Tanta University,Not Recruiting,Phase 3,Interventional,Egypt,Angiotensin Converting Enzyme Inhibitors in Treatment of Covid 19,Drug,Ace inhibitors,60,2029-12-01,2029-12-01,https://clinicaltrials.gov/show/NCT04345406,No Results,No Results,No Results,2020-04-27,2020-04-22,None
957,NCT04346043,ClinicalTrials.gov,2020-04-13,2020-04-20,False,Ain Shams University,Not Recruiting,Not Applicable,Observational,Egypt,To Access the Egyptian COVID-19 Whole Genome by NGS and Compare to the International Worldwide Database,Genomics,No Intervention,100,2020-10-01,2020-12-01,https://clinicaltrials.gov/show/NCT04346043,No Results,No Results,No Results,2020-04-27,2020-04-22,None
958,NCT04351646,ClinicalTrials.gov,2020-04-07,2020-04-15,False,"St. George's, University of London",Not Recruiting,Not Applicable,Observational,United Kingdom,Diagnostics of COVID-19/DARTS (Development and Assessment of Rapid Testing for SARS-CoV-2 Outbreak),Diagnostics,Diagnostic Test or Assessment,500,2022-04-15,2022-04-15,https://clinicaltrials.gov/show/NCT04351646,No Results,No Results,No Results,2020-04-27,2020-04-22,None
959,NCT04351763,ClinicalTrials.gov,2020-04-14,2020-04-27,False,Nicolaus Copernicus University,Recruiting,Phase 2/Phase 3,Interventional,Poland,Amiodarone or Verapamil in COVID-19 Hospitalized Patients With Symptoms,Drug,Amiodarone or Verapamil,804,2021-03-02,2021-04-10,https://clinicaltrials.gov/show/NCT04351763,No Results,No Results,No Results,2020-04-27,2020-04-22,None
960,NCT04344210,ClinicalTrials.gov,2020-04-07,2020-04-17,False,Federal University of Rio Grande do Sul,Recruiting,Not Applicable,Interventional,Brazil,Impact of Tele-interventions During the COVID-19 Pandemic in Patients With Diabetes Mellitus,Telehealth,Telehealth,149,2020-08-20,2020-08-30,https://clinicaltrials.gov/show/NCT04344210,No Results,No Results,No Results,2020-04-27,2020-04-22,None
961,NCT04344236,ClinicalTrials.gov,2020-04-08,2020-04-09,False,NYU Langone Health,Recruiting,Phase 2,Interventional,United States,Gargling and Nasal Rinses to Reduce Oro- and Nasopharyngeal Viral Load in Patients With COVID-19,Other,Povidone/Iodine rinse,48,2020-05-01,2020-05-09,https://clinicaltrials.gov/show/NCT04344236,No Results,No Results,No Results,2020-04-27,2020-04-22,None
962,NCT04344444,ClinicalTrials.gov,2020-04-10,2020-04-10,False,LCMC Health,Recruiting,Phase 3,Interventional,United States,Treatment in Patients With Suspected or Confirmed COVID-19 With Early Moderate or Severe Disease,Drug,Hydroxychloroquine + Azithromycin vs. Hydroxychloroquine,600,2021-04-10,2021-12-10,https://clinicaltrials.gov/show/NCT04344444,No Results,No Results,No Results,2020-04-27,2020-04-22,None
963,NCT04344548,ClinicalTrials.gov,2020-04-10,2020-04-13,False,National University of Colombia,Not Recruiting,Phase 1/Phase 2,Interventional,Colombia,Phase I / II Clinical Study of Immunotherapy Based on Adoptive Cell Transfer as a Therapeutic Alternative for Patients With COVID-19 in Colombia,ATMP,Cells (NK),10,2020-06-10,2020-11-10,https://clinicaltrials.gov/show/NCT04344548,No Results,No Results,No Results,2020-04-27,2020-04-22,None
964,NCT04346056,ClinicalTrials.gov,2020-04-13,2020-04-14,False,Ain Shams University,Recruiting,Not Applicable,Observational,Egypt,Retrospective Study on Severe Respiratory Illness to Access the Presence of COVID-19,Clinical Presentation,No Intervention,500,2020-10-01,2020-12-01,https://clinicaltrials.gov/show/NCT04346056,No Results,No Results,No Results,2020-04-27,2020-04-22,None
965,NCT04346264,ClinicalTrials.gov,2020-04-13,2020-04-27,False,Ludwig Boltzmann Institute for Lung Health,Recruiting,Not Applicable,Observational,Austria,CoVid-19 - Infection and Antibody Formation in the Viennese Population,Clinical Presentation (Epidemiology),No Intervention,5500,2020-06-01,2020-09-30,https://clinicaltrials.gov/show/NCT04346264,No Results,No Results,No Results,2020-04-27,2020-04-22,None
966,ChiCTR2000030809,ChiCTR,2020-03-15,2020-02-22,True,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Not Applicable,Observational,China,A medical records based study for clinical outcomes and follow-up of novel coronavirus pneumonia (COVID-19) patients,Clinical Presentation,No Intervention,1000,Not Available,2021-03-30,http://www.chictr.org.cn/showproj.aspx?proj=51015,No Results,No Results,No Results,2020-03-16,2020-03-18,None
967,NCT04353154,ClinicalTrials.gov,2020-04-15,2020-04-15,False,Ottawa Heart Institute Research Corporation,Not Recruiting,Not Applicable,Observational,No Country Given,The RAPID COVID TRIAGE Algorithm,Diagnostics,Diagnostic Test or Assessment,20,2020-08-31,2021-02-28,https://clinicaltrials.gov/show/NCT04353154,No Results,No Results,No Results,2020-04-27,2020-04-29,None
968,NCT04354155,ClinicalTrials.gov,2020-04-13,2020-05-15,False,Neil Goldenberg,Not Recruiting,Phase 2,Interventional,United States,COVID-19 Anticoagulation in Children - Thromboprophlaxis (COVAC-TP) Trial,Drug,Enoxaparin,38,2022-09-15,2022-10-15,https://clinicaltrials.gov/show/NCT04354155,No Results,No Results,No Results,2020-04-27,2020-04-29,None
969,ChiCTR2000030795,ChiCTR,2020-03-15,2020-03-20,False,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Not Recruiting,Not Applicable,Observational,China,A multicenter retrospective study of rheumatic  patients with novel coronavirus pneumonia (COVID-19),Clinical Presentation,No Intervention,90,Not Available,2020-05-31,http://www.chictr.org.cn/showproj.aspx?proj=50982,No Results,No Results,No Results,2020-03-16,2020-03-18,None
970,NCT04344730,ClinicalTrials.gov,2020-04-09,2020-04-10,False,Assistance Publique  Hpitaux de Paris,Recruiting,Not Applicable,Interventional,France,Dexamethasone and Oxygen Support Strategies in ICU Patients With Covid-19 Pneumonia,Drug,"Dexamethasone, Oxygen",550,2020-12-31,2020-12-31,https://clinicaltrials.gov/show/NCT04344730,No Results,No Results,No Results,2020-04-27,2020-04-22,None
971,NCT04344938,ClinicalTrials.gov,2020-04-10,2020-04-01,True,Assiut University,Not Recruiting,Not Applicable,Observational,No Country Given,Covid 19 Pandemic. Emerging Legal and Ehical Disputes Over Patient Confidentiality,Other,No Intervention,874,2020-06-01,2020-07-01,https://clinicaltrials.gov/show/NCT04344938,No Results,No Results,No Results,2020-04-27,2020-04-22,None
972,NCT04346277,ClinicalTrials.gov,2020-04-13,2020-04-27,False,Implicit Bioscience,Not Recruiting,Not Applicable,Expanded Access,Italy,Compassionate Use Open-Label Anti-CD14 Treatment in Patients With SARS-CoV-2 (COVID-19),Drug,IC14,Not Available,Not Available,Not Available,https://clinicaltrials.gov/show/NCT04346277,No Results,No Results,No Results,2020-04-27,2020-04-22,None
973,NCT04346693,ClinicalTrials.gov,2020-04-08,2020-04-08,False,Burnasyan Federal Medical Biophysical Center,Recruiting,Phase 3,Interventional,Russian Federation,An Open Randomized Study of Dalargin Effectiveness in Patients With Severe and Critical Manifestations of SARS-COVID-19,Drug,Dalargin + Hydroxychloroquine + azithromycin + / - tocilizumab vs. Hydroxychloroquine + azithromycin + / - tocilizumab,320,2020-12-01,2020-12-01,https://clinicaltrials.gov/show/NCT04346693,No Results,No Results,No Results,2020-04-27,2020-04-22,None
974,ChiCTR2000030778,ChiCTR,2020-03-14,2020-01-20,True,Ningbo First Hospital,Not Recruiting,Not Applicable,Observational,China,A medical records based study for epidemic and clinical features of novel coronavirus pneumonia (COVID-19) in Ningbo First Hospital,Clinical Presentation,No Intervention,40,Not Available,2020-02-29,http://www.chictr.org.cn/showproj.aspx?proj=50987,No Results,No Results,No Results,2020-03-16,2020-03-18,None
975,NCT04354272,ClinicalTrials.gov,2020-04-10,2020-04-13,False,Assistance Publique  Hpitaux de Paris,Not Recruiting,Not Applicable,Observational,No Country Given,Evaluation of Dental Emergency Treatments During COVID19 Crisis,Clinical Presentation (Epidemiology),No Intervention,840,2020-06-20,2020-06-20,https://clinicaltrials.gov/show/NCT04354272,No Results,No Results,No Results,2020-04-27,2020-04-29,None
976,NCT04354805,ClinicalTrials.gov,2020-04-17,2020-05-01,False,Cairo University,Not Recruiting,Phase 1/Phase 2,Interventional,Egypt,Administration of Chloropromazine as a Treatment for COVID-19,Drug,Chlorpromazine,60,2020-08-01,2020-09-01,https://clinicaltrials.gov/show/NCT04354805,No Results,No Results,No Results,2020-04-27,2020-04-29,None
977,NCT04345315,ClinicalTrials.gov,2020-04-10,2020-03-27,True,Istituto Scientifico Romagnolo per lo Studio e la cura dei Tumori,Recruiting,Not Applicable,Observational,Italy,"Correlative Study on Cancer Patients and Healthcare Professionals Exposed to Infection by Severe Acute Respiratory Syndrome-Corona Virus-2 (SARS-Cov-2), COVID-19 Causative Agent.",Clinical Presentation (Epidemiology),No Intervention,500,2021-03-01,2022-03-01,https://clinicaltrials.gov/show/NCT04345315,No Results,No Results,No Results,2020-04-27,2020-04-22,None
978,NCT04345445,ClinicalTrials.gov,2020-04-08,2020-04-15,False,University of Malaya,Not Recruiting,Phase 3,Interventional,Malaysia,Study to Evaluate the Efficacy and Safety of Tocilizumab Versus Corticosteroids in Hospitalised COVID-19 Patients With High Risk of Progression,Drug,Tocilizumab vs. Corticosteroids,310,2020-10-31,2020-10-31,https://clinicaltrials.gov/show/NCT04345445,No Results,No Results,No Results,2020-04-27,2020-04-22,None
979,NCT04346927,ClinicalTrials.gov,2020-04-13,2020-04-10,True,Yasemin Airak,Not Recruiting,Not Applicable,Interventional,No Country Given,Telerehabilitation for Patients Diagnosed With Coronavirus,Telehealth,Rehabilitation,30,2020-06-10,2020-07-31,https://clinicaltrials.gov/show/NCT04346927,No Results,No Results,No Results,2020-04-27,2020-04-22,None
980,NCT04346953,ClinicalTrials.gov,2020-04-13,2020-04-20,False,Istinye University,Not Recruiting,Not Applicable,Interventional,No Country Given,Video-Based Exercise for Individuals With Social Isolation Due to Coronavirus (COVID-19),Other (exercise),Exercise,128,2020-06-01,2020-07-31,https://clinicaltrials.gov/show/NCT04346953,No Results,No Results,No Results,2020-04-27,2020-04-22,None
981,NCT04355247,ClinicalTrials.gov,2020-04-17,2020-04-14,True,Auxilio Mutuo Cancer Center,Recruiting,Phase 2,Interventional,Puerto Rico,Prophylactic Corticosteroid to Prevent COVID-19 Cytokine Storm,Drug (Chemoprophylaxis),Corticosteroids,20,2020-07-31,2021-04-30,https://clinicaltrials.gov/show/NCT04355247,No Results,No Results,No Results,2020-04-27,2020-04-29,None
982,NCT04355494,ClinicalTrials.gov,2020-04-17,2020-04-17,False,Alexion Pharmaceuticals,Not Recruiting,Not Applicable,Expanded Access,France,SOLIRIS (Eculizumab) Treatment of Participants With COVID-19,Drug,Eculizumab,Not Available,Not Available,Not Available,https://clinicaltrials.gov/show/NCT04355494,No Results,No Results,No Results,2020-04-27,2020-04-29,None
983,ChiCTR2000030759,ChiCTR,2020-03-13,2020-02-15,True,The First Affiliated Hospital of Wenzhou Medical University,Not Recruiting,Not Applicable,Interventional,China,Study for the therapeutic effect and mechanism of traditional Chinese medicine in the treatment of novel coronavirus pneumonia (COVID-19),Traditional Medicine (Unspecified),Traditional Medicine,70,Not Available,2020-05-17,http://www.chictr.org.cn/showproj.aspx?proj=49284,No Results,No Results,No Results,2020-03-16,2020-03-18,None
984,NCT04345536,ClinicalTrials.gov,2020-04-05,2020-03-15,True,Oslo University Hospital,Recruiting,Not Applicable,Observational,Norway,Prospective Quality Register of Patients With Confirmed Covid-19 at Oslo University Hospital,Clinical Presentation,No Intervention,400,2021-01-01,2021-05-01,https://clinicaltrials.gov/show/NCT04345536,No Results,No Results,No Results,2020-04-27,2020-04-22,None
985,NCT04345653,ClinicalTrials.gov,2020-04-08,2020-04-14,False,Hackensack Meridian Health,Recruiting,Phase 2,Interventional,United States,Hydroxychloroquine as Chemoprevention for COVID-19 for High Risk Healthcare Workers,Drug (Chemoprophylaxis),Hydroxychloroquine,45,2021-04-08,2022-04-08,https://clinicaltrials.gov/show/NCT04345653,No Results,No Results,No Results,2020-04-27,2020-04-22,None
986,NCT04347369,ClinicalTrials.gov,2020-03-18,2020-01-17,True,Xinqiao Hospital of Chongqing,Recruiting,Not Applicable,Observational,China,A Retrospective Study of Neural Network Model to Dynamically Quantificate the Severity in COVID-19 Disease,Clinical Presentation,No Intervention,1000,2020-04-30,2020-05-31,https://clinicaltrials.gov/show/NCT04347369,No Results,No Results,No Results,2020-04-27,2020-04-22,None
987,NCT04347382,ClinicalTrials.gov,2020-04-11,2020-04-20,False,Sohaib Ashraf,Recruiting,Phase 3,Interventional,Pakistan,Efficacy of Nigella Sativa and Natural Honey Against COVID-19,Traditional Medicine (Drug),Traditional Medicine,30,2020-07-25,2020-07-30,https://clinicaltrials.gov/show/NCT04347382,No Results,No Results,No Results,2020-04-27,2020-04-22,None
988,NCT04355676,ClinicalTrials.gov,2020-04-17,2020-04-30,False,Karyopharm Therapeutics Inc,Not Recruiting,Phase 2,Interventional,No Country Given,Evaluation of Activity and Safety of Two Regimens of Low Dose Oral Selinexor in Participants With Moderate or Severe COVID-19,Drug,Selinexor,80,2020-08-30,2020-08-30,https://clinicaltrials.gov/show/NCT04355676,No Results,No Results,No Results,2020-04-27,2020-04-29,None
989,NCT04355767,ClinicalTrials.gov,2020-04-17,2020-05-01,False,Stanford University,Not Recruiting,Phase 2,Interventional,United States,Convalescent Plasma vs. Placebo in Emergency Room Patients With COVID-19,ATMP,Plasma,206,2022-12-01,2022-12-01,https://clinicaltrials.gov/show/NCT04355767,No Results,No Results,No Results,2020-04-27,2020-04-29,None
990,NCT04347798,ClinicalTrials.gov,2020-04-13,2020-04-15,False,University of Alberta,Recruiting,Not Applicable,Observational,Canada,IMPACT: IMPact of Antimalarials on Covid-19 Infections in RAPPORT,Drug,Hydroxychloroquine or Chloroquine,500,2021-04-01,2021-04-01,https://clinicaltrials.gov/show/NCT04347798,No Results,No Results,No Results,2020-04-27,2020-04-22,None
991,NCT04348214,ClinicalTrials.gov,2020-04-13,2020-04-20,False,Ain Shams University,Not Recruiting,Not Applicable,Observational,Egypt,Screening & Risk Assessment of Healthcare Workers & Infection Control in University & COVID-19 Quarantine Hospitals,Clinical Presentation,No Intervention,3000,2020-10-01,2020-12-01,https://clinicaltrials.gov/show/NCT04348214,No Results,No Results,No Results,2020-04-27,2020-04-22,None
992,NCT04345991,ClinicalTrials.gov,2020-04-10,2020-04-14,False,Assistance Publique  Hpitaux de Paris,Not Recruiting,Phase 2,Interventional,France,"Efficacy of Convalescent Plasma to Treat COVID-19 Patients, a Nested Trial in the CORIMUNO-19 Cohort",ATMP,Plasma,120,2020-05-15,2020-06-01,https://clinicaltrials.gov/show/NCT04345991,No Results,No Results,No Results,2020-04-27,2020-04-22,None
993,NCT04346017,ClinicalTrials.gov,2020-04-13,2020-03-20,True,Francis Corazza,Recruiting,Not Applicable,Interventional,Belgium,Evaluation of Interleukine 6 (and Other Cytokines and Inflammatory Markers) in COVID-19 Patients With a Systemic Inflammatory Response Syndrome,Clinical Presentation,No Intervention,200,2020-12-01,2020-12-01,https://clinicaltrials.gov/show/NCT04346017,No Results,No Results,No Results,2020-04-27,2020-04-22,None
994,ChiCTR2000030758,ChiCTR,2020-03-13,2020-03-10,True,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Not Recruiting,Not Applicable,Observational,China,A medical records based study for sedation and Analgesia Usage in critically ill patients with novel coronavirus pneumonia (COVID-19),Drug,Unspecified sedation and analgesia,200,Not Available,2020-04-30,http://www.chictr.org.cn/showproj.aspx?proj=50590,No Results,No Results,No Results,2020-03-16,2020-03-18,None
995,NCT04356443,ClinicalTrials.gov,2020-04-16,2020-04-15,True,Massachusetts General Hospital,Recruiting,Not Applicable,Observational,United States,Non-Invasive Monitoring of Respiratory Function in Spontaneously Breathing Patients With COVID-19 Infection,Other (device),Respiratory Monitor,500,2020-12-31,2020-12-31,https://clinicaltrials.gov/show/NCT04356443,No Results,No Results,No Results,2020-04-27,2020-04-29,None
996,NCT04356534,ClinicalTrials.gov,2020-04-15,2020-04-19,False,Royal College of Surgeons in Ireland - Medical University of Bahrain,Not Recruiting,Not Applicable,Interventional,Bahrain,Convalescent Plasma Trial in COVID -19 Patients,ATMP,Plasma,40,2020-05-30,2020-06-30,https://clinicaltrials.gov/show/NCT04356534,No Results,No Results,No Results,2020-04-27,2020-04-29,None
997,NCT04348227,ClinicalTrials.gov,2020-04-10,2019-01-01,True,Hpital Universitaire Fattouma Bourguiba,Not Recruiting,Not Applicable,Observational,Tunisia,How COVID-19 Virus Outbreak Affects Antimicrobial Resistance in a Low-middle-income Country's ICU?,Clinical Presentation,No Intervention,120,2020-01-01,2021-02-04,https://clinicaltrials.gov/show/NCT04348227,No Results,No Results,No Results,2020-04-27,2020-04-22,None
998,NCT04348422,ClinicalTrials.gov,2020-04-13,2020-04-20,False,Assaf-Harofeh Medical Center,Not Recruiting,Not Applicable,Observational,No Country Given,Evaluating the Immune Response for COVID-19,Clinical Presentation,No Intervention,1000,2020-12-01,2020-12-31,https://clinicaltrials.gov/show/NCT04348422,No Results,No Results,No Results,2020-04-27,2020-04-22,None
999,NCT04346199,ClinicalTrials.gov,2020-04-09,2020-04-24,False,AstraZeneca,Not Recruiting,Phase 2,Interventional,Spain,Acalabrutinib Study With Best Supportive Care Versus Best Supportive Care in Subjects Hospitalized With COVID-19. CALAVI (Calquence Against the Virus),Drug,Acalabrutinib,428,2020-11-30,2020-11-30,https://clinicaltrials.gov/show/NCT04346199,No Results,No Results,No Results,2020-04-27,2020-04-22,None
1000,NCT04346342,ClinicalTrials.gov,2020-04-09,2020-03-06,True,UMC Amsterdam,Recruiting,Not Applicable,Observational,Netherlands,PRactice of VENTilation in COVID-19 Patients (PRoVENT-COVID),Other (physical),Mechanical ventilation,1000,2020-05-01,2020-08-01,https://clinicaltrials.gov/show/NCT04346342,No Results,No Results,No Results,2020-04-27,2020-04-22,None
1001,ChiCTR2000030757,ChiCTR,2020-03-13,2020-03-13,False,Shenzhen-Peking University; The Hong Kong University of Science & Technology Medical Center,Not Recruiting,Not Applicable,Observational,China,Impact of Novel Coronavirus Pneumonia (COVID-19) Epidemic Period on the Management of investigator-initiated clinical trial and the resilience of medical service providers,Other (psych),No Intervention,100,Not Available,2020-06-30,http://www.chictr.org.cn/showproj.aspx?proj=50648,No Results,No Results,No Results,2020-03-16,2020-03-18,None
1002,NCT04357769,ClinicalTrials.gov,2020-04-16,2020-04-10,True,Federico II University,Recruiting,Not Applicable,Observational,Italy,COVID-19 Pandemic Burden in Severe Mental Disease Patients,Other (psych),No Intervention,400,2020-04-20,2020-04-25,https://clinicaltrials.gov/show/NCT04357769,No Results,No Results,No Results,2020-04-27,2020-04-29,None
1003,ACTRN12620000486921,ANZCTR,2020-04-17,2020-04-20,False,Royal North Shore Hospital,Not Recruiting,Not Applicable,Observational,Australia,"AUSTRALIAN CARDIOVASCULAR COVID-19 REGISTRY (AUS-COVID) 
",Clinical Presentation,No Intervention,865,Not Available,2020-09-19,https://anzctr.org.au/ACTRN12620000486921.aspx,No Results,No Results,No Results,2020-04-27,2020-04-22,None
1004,NCT04348448,ClinicalTrials.gov,2020-04-13,2020-04-01,True,AUSL Romagna Rimini,Not Recruiting,Not Applicable,Observational,No Country Given,"Observational Study, Use of Canakinumab Administered Subcutaneously in the Treatment COVID-19 Pneumonia",Drug,Canakinumab,100,2020-07-01,2020-09-01,https://clinicaltrials.gov/show/NCT04348448,No Results,No Results,No Results,2020-04-27,2020-04-22,None
1005,NCT04348461,ClinicalTrials.gov,2020-04-10,2020-04-06,True,Instituto de Investigacin Sanitaria Fundacin Jimnez Daz,Not Recruiting,Phase 2,Interventional,No Country Given,BAttLe Against COVID-19 Using MesenchYmal Stromal Cells,ATMP,Cells (mesenchymal),100,2020-09-15,2020-09-30,https://clinicaltrials.gov/show/NCT04348461,No Results,No Results,No Results,2020-04-27,2020-04-22,None
1006,ACTRN12620000492954,ANZCTR,2020-04-20,2020-05-01,False,University of New South Wales,Not Recruiting,Not Applicable,Interventional,Australia,A Facebook delivered physical activity focused group lifestyle intervention for older adults during the COVID-19 pandemic,Other (exercise),Exercise,20,Not Available,Not Available,https://anzctr.org.au/ACTRN12620000492954.aspx,No Results,No Results,No Results,2020-04-27,2020-04-22,None
1007,NCT04347174,ClinicalTrials.gov,2020-03-31,2020-04-20,False,Cadila Pharnmaceuticals,Not Recruiting,Not Applicable,Interventional,India,A Clinical Trial of Mycobacterium w in Critically Ill COVID 19 Patients,Drug,Mycobacterium,40,2020-06-30,2020-07-30,https://clinicaltrials.gov/show/NCT04347174,No Results,No Results,No Results,2020-04-27,2020-04-22,None
1008,NCT04347850,ClinicalTrials.gov,2020-04-09,2020-02-01,True,"University Hospital, Montpellier",Recruiting,Not Applicable,Observational,France,A Cohort of Patients With Possible or Confirmed SARS-CoV-2 (COVID-19),Clinical Presentation,No Intervention,500,2022-12-01,2022-12-30,https://clinicaltrials.gov/show/NCT04347850,Pre-Print Article,2020-05-12,https://doi.org/10.1101/2020.05.04.20090027,2020-04-27,2020-04-22,None
1009,ChiCTR2000032412,ChiCTR,2020-04-27,2020-05-15,False,Shanghai Public Health Clinical Center,Not Recruiting,Not Applicable,Observational,China,A medical records based retrospective study for the effectiveness and safety of Xi-Yan-Ping injection combined with conventional protocol in the treatment of common type novel coronavirus pneumonia (COVID-19),Traditional Medicine (Drug),Traditional Medicine,426,Not Available,2020-08-22,http://www.chictr.org.cn/showproj.aspx?proj=52988,No Results,No Results,No Results,2020-04-27,2020-04-29,None
1010,ChiCTR2000030756,ChiCTR,2020-03-13,2020-02-20,True,Shenzhen Hospital of Southern Medical University,Recruiting,Not Applicable,Observational,China,Detection of SARS-CoV-2 in EPS / semen of patients with novel coronavirus pneumonia (COVID-19),Clinical Presentation ,No Intervention,60,Not Available,2020-08-20,http://www.chictr.org.cn/showproj.aspx?proj=50705,Pre-Print Article,2020-03-30,https://doi.org/10.1101/2020.03.26.20044198,2020-03-16,2020-03-18,None
1011,NCT04348864,ClinicalTrials.gov,2020-04-13,2020-04-16,False,Neuroganics LLC,Recruiting,Not Applicable,Interventional,United States,COVID-19 Antibody Self-testing Using Virtual Point-of-care,Diagnostics,Diagnostic Test or Assessment,100,2021-04-01,2021-04-01,https://clinicaltrials.gov/show/NCT04348864,No Results,No Results,No Results,2020-04-27,2020-04-22,None
1012,NCT04348877,ClinicalTrials.gov,2020-04-13,2020-04-20,False,Ain Shams University,Not Recruiting,Not Applicable,Interventional,Egypt,Plasma Rich Antibodies From Recovered Patients From COVID19,ATMP,Plasma,20,2020-10-01,2020-12-01,https://clinicaltrials.gov/show/NCT04348877,No Results,No Results,No Results,2020-04-27,2020-04-22,None
1013,NCT04347876,ClinicalTrials.gov,2020-04-14,2020-04-11,True,Assiut University,Recruiting,Not Applicable,Observational,Egypt,Outcome of COVID-19 Cases Based on Tuberculin Test: Can Previous BCG Alter the Prognosis?,Diagnostics,Diagnostic Test or Assessment,100,2020-06-16,2020-06-30,https://clinicaltrials.gov/show/NCT04347876,No Results,No Results,No Results,2020-04-27,2020-04-22,None
1014,NCT04347941,ClinicalTrials.gov,2020-04-08,2020-04-11,False,University College Hospital Galway,Not Recruiting,Not Applicable,Interventional,Ireland,Awake Prone Positioning to Reduce Invasive VEntilation in COVID-19 Induced Acute Respiratory failurE,Procedure,Positioning,200,2021-03-11,2021-05-11,https://clinicaltrials.gov/show/NCT04347941,No Results,No Results,No Results,2020-04-27,2020-04-22,None
1015,NCT04349982,ClinicalTrials.gov,2020-04-10,2020-04-08,True,Medical University of Graz,Recruiting,Not Applicable,Observational,Austria,ICU Trial in Critical Ill COVID-19 Patients,Clinical Presentation,No Intervention,50,2020-06-30,2020-07-31,https://clinicaltrials.gov/show/NCT04349982,No Results,No Results,No Results,2020-04-27,2020-04-22,None
1016,NCT04350593,ClinicalTrials.gov,2020-04-14,2020-04-15,False,Saint Luke's Health System,Recruiting,Phase 3,Interventional,United States,Dapagliflozin in Respiratory Failure in Patients With COVID-19,Drug,Dapagliflozin,900,2020-10-01,2020-12-01,https://clinicaltrials.gov/show/NCT04350593,No Results,No Results,No Results,2020-04-27,2020-04-22,None
1017,ChiCTR2000032239,ChiCTR,2020-04-23,2020-01-29,True,The First People's Hospital of Jiangxia District,Recruiting,Not Applicable,Observational,China,A medical records based study for epidemiological characteristics of 88 patients with new coronavirus pneumonia (COVID-19) and its impact on severe disease,Clinical Presentation (Epidemiology),No Intervention,88,Not Available,2020-03-16,http://www.chictr.org.cn/showproj.aspx?proj=52507,No Results,No Results,No Results,2020-04-27,2020-04-29,None
1018,NCT04348383,ClinicalTrials.gov,2020-04-08,2020-04-08,False,Fundacin para la Formacin e Investigacin Sanitarias de la Regin de Murcia (FFIS),Recruiting,Phase 2,Interventional,Spain,Defibrotide as Prevention and Treatment of Respiratory Distress and Cytokine Release Syndrome of Covid 19.,Drug,Defibrotide,120,2020-07-08,2020-08-08,https://clinicaltrials.gov/show/NCT04348383,No Results,No Results,No Results,2020-04-27,2020-04-22,None
1019,NCT04348500,ClinicalTrials.gov,2020-04-13,2020-04-21,False,Cedars-Sinai Medical Center,Not Recruiting,Phase 2,Interventional,No Country Given,Clazakizumab (Anti-IL- 6 Monoclonal) Compared to Placebo for COVID19 Disease,Drug,Clazakizumab,60,2020-12-31,2021-03-31,https://clinicaltrials.gov/show/NCT04348500,No Results,No Results,No Results,2020-04-27,2020-04-22,None
1020,NCT04351295,ClinicalTrials.gov,2020-04-15,2020-04-17,False,Tanta University,Not Recruiting,Phase 2/Phase 3,Interventional,Egypt,Efficacy of Faviprevir in COVID-19 Treatment,Drug,Favipiravir,40,2030-12-01,2030-12-01,https://clinicaltrials.gov/show/NCT04351295,No Results,No Results,No Results,2020-04-27,2020-04-22,None
1021,NCT04351490,ClinicalTrials.gov,2020-04-14,2020-04-01,True,"University Hospital, Lille",Not Recruiting,Not Applicable,Interventional,No Country Given,Impact of Zinc and Vitamin D3 Supplementation on the Survival of Aged Patients Infected With COVID-19,Drug,Zinv + Vitamin D,3140,2020-07-01,2020-07-01,https://clinicaltrials.gov/show/NCT04351490,No Results,No Results,No Results,2020-04-27,2020-04-29,None
1022,ChiCTR2000032237,ChiCTR,2020-04-23,2020-04-01,True,Ezhou Hospital of Traditional Chinese Medicine,Recruiting,Not Applicable,Interventional,No Country Given,"A multicenter, randomized, double-blind, placebo-controlled trial for Xiang-Sha-Liu-Jun Pill in the treatment of novel coronavirus pneumonia (COVID-19) decline in digestive function during convalescence",Traditional Medicine (Drug),Traditional Medicine,200,Not Available,2020-06-30,http://www.chictr.org.cn/showproj.aspx?proj=52699,No Results,No Results,No Results,2020-04-27,2020-04-29,None
1023,NCT04349241,ClinicalTrials.gov,2020-04-13,2020-04-20,False,Ain Shams University,Not Recruiting,Phase 3,Interventional,Egypt,Efficacy and Safety of Favipiravir in Management of COVID-19,Drug,Favipiravir,100,2020-10-01,2020-12-01,https://clinicaltrials.gov/show/NCT04349241,No Results,No Results,No Results,2020-04-27,2020-04-22,None
1024,NCT04350450,ClinicalTrials.gov,2020-04-14,2020-04-01,True,Montefiore Medical Center,Not Recruiting,Phase 2,Interventional,United States,Hydroxychloroquine Treatment of Healthcare Workers With COVID19 Illness at Montefiore,Drug,Hydroxychloroquine,100,2020-08-01,2020-08-01,https://clinicaltrials.gov/show/NCT04350450,No Results,No Results,No Results,2020-04-27,2020-04-22,None
1025,ChiCTR2000030742,ChiCTR,2020-03-13,2020-03-15,False,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Not Recruiting,Not Applicable,Observational,China,"Characteristics, prognosis, and treatments effectiveness of critically ill patients with Novel Coronavirus Pneumonia (COVID-19)",Clinical Presentation,No Intervention,200,Not Available,2020-04-15,http://www.chictr.org.cn/showproj.aspx?proj=50857,No Results,No Results,No Results,2020-03-16,2020-03-18,None
1026,NCT04351711,ClinicalTrials.gov,2020-04-10,2020-04-01,True,CHU de Nimes,Not Recruiting,Not Applicable,Observational,France,Immunological Profiling of Patients With COVID-19 in Respiratory Distress,Clinical Presentation,No Intervention,60,2020-10-01,2020-10-01,https://clinicaltrials.gov/show/NCT04351711,No Results,No Results,No Results,2020-04-27,2020-04-22,None
1027,NCT04352582,ClinicalTrials.gov,2020-04-13,2020-04-14,False,"University Hospital, Geneva",Recruiting,Not Applicable,Observational,United Kingdom,COVID-19 and Vaccination Attitudes,Other,No Intervention,1000,2020-04-30,2020-04-30,https://clinicaltrials.gov/show/NCT04352582,No Results,No Results,No Results,2020-04-27,2020-04-29,None
1028,ChiCTR2000032213,ChiCTR,2020-04-23,2020-04-23,False,The First Affiliated Hospital of Chongqing Medical University,Recruiting,Not Applicable,Observational,China,A medical records based study for the impact of wearing medical masks on oxygen saturation in adult surgical patients after general anaesthesia during novel coronavirus pneumonia (COVID-19) pandemic,Other (device),Masks,151,Not Available,2020-05-23,http://www.chictr.org.cn/showproj.aspx?proj=52788,No Results,No Results,No Results,2020-04-27,2020-04-29,None
1029,NCT04350684,ClinicalTrials.gov,2020-04-14,2020-04-15,False,Shahid Beheshti University of Medical Sciences,Recruiting,Phase 4,Interventional,Iran,Umifenovir in Hospitalized COVID-19 Patients,Drug,Umifenovir + Interferon beta + Lopinavir/Ritonavir + Hydroxychloroquine vs. Interferon beta + Lopinavir/Ritonavir + Hydroxycholroquine,40,2020-04-22,2020-04-24,https://clinicaltrials.gov/show/NCT04350684,No Results,No Results,No Results,2020-04-27,2020-04-22,None
1030,NCT04351243,ClinicalTrials.gov,2020-04-15,2020-04-01,True,Kinevant Sciences GmbH,Recruiting,Phase 2,Interventional,United States,A Study to Assess the Efficacy and Safety of of Gimsilumab in Subjects With Lung Injury or Acute Respiratory Distress Syndrome Secondary to COVID-19.,Drug,Grimsilumab,270,2020-07-01,2020-10-01,https://clinicaltrials.gov/show/NCT04351243,No Results,No Results,No Results,2020-04-27,2020-04-29,None
1031,ChiCTR2000032162,ChiCTR,2020-04-21,2020-04-22,False,"Bayi Children's Hospital, Seventh Medical Centre, PLA General Hospital",Not Recruiting,Not Applicable,Observational,China,A medical records based study for ECMO in the rescue therapy of extremely critical novel coronavirus pneumonia (COVID-19) patients,Drug,Oxygen,80,Not Available,2020-05-21,http://www.chictr.org.cn/showproj.aspx?proj=52694,No Results,No Results,No Results,2020-04-27,2020-04-29,None
1032,NCT04352803,ClinicalTrials.gov,2020-04-16,2020-04-01,True,Regeneris Medical,Not Recruiting,Phase 1,Interventional,No Country Given,Adipose Mesenchymal Cells for Abatement of SARS-CoV-2 Respiratory Compromise in COVID-19 Disease,ATMP,Cells (mesenchymal),20,2024-04-01,2026-04-01,https://clinicaltrials.gov/show/NCT04352803,No Results,No Results,No Results,2020-04-27,2020-04-29,None
1033,NCT04352985,ClinicalTrials.gov,2020-04-15,2020-05-01,False,Spectral Diagnostics (US) Inc.,Not Recruiting,Not Applicable,Expanded Access,No Country Given,Evaluating the Use of Polymyxin B Cartridge Hemoperfusion for Patients With Septic Shock and COVID 19,Other (device),Hemoperfusion,Not Available,Not Available,Not Available,https://clinicaltrials.gov/show/NCT04352985,No Results,No Results,No Results,2020-04-27,2020-04-29,None
1034,ChiCTR2000030741,ChiCTR,2020-03-13,2020-02-01,True,Shandong Provincial Chest hospital,Recruiting,Not Applicable,Observational,China,Observational Study for Prone Position Ventilation and Conventional Respiratory Support in ARDS Patients with  Novel Coronavirus Pneumonia (COVID-19),Other (physical),Mechanical ventilation,100,Not Available,2020-08-31,http://www.chictr.org.cn/showproj.aspx?proj=50907,No Results,No Results,No Results,2020-03-16,2020-03-18,None
1035,NCT04351542,ClinicalTrials.gov,2020-04-14,2020-03-06,True,Aarogyam UK,Not Recruiting,Not Applicable,Interventional,United Kingdom,Ayurveda for Flu Like Illness During Covid-19 Outbreak,Traditional Medicine (Drug),Traditional Medicine,32,2020-04-06,2020-04-12,https://clinicaltrials.gov/show/NCT04351542,No Results,No Results,No Results,2020-04-27,2020-04-22,None
1036,NCT04351659,ClinicalTrials.gov,2020-04-16,2020-04-01,True,KK Women's and Children's Hospital,Recruiting,Not Applicable,Observational,Singapore,Novel Adoptive Cellular Therapy With SARS-CoV-2 Specific T Cells in Patients With Severe COVID-19,ATMP,Plasma,8,2020-08-01,2020-08-01,https://clinicaltrials.gov/show/NCT04351659,Pre-Print Article,2020-04-30,https://doi.org/10.1101/2020.04.24.20077487,2020-04-27,2020-04-22,None
1037,ISRCTN14326006,ISRCTN,2020-04-14,2020-04-13,True,"University Health Network, Toronto",Recruiting,Phase 3,Interventional,Canada,Does taking hydroxychloroquine before and during exposure to patients protect frontline healthcare workers from coronavirus?,Drug (Chemoprophylaxis),Hydroxychloroquine,988,Not Available,2022-01-30,http://isrctn.com/ISRCTN14326006,No Results,No Results,No Results,2020-04-27,2020-04-22,None
1038,NCT04353206,ClinicalTrials.gov,2020-04-16,2020-05-01,False,Noah Merin,Not Recruiting,Phase 1,Interventional,United States,Convalescent Plasma in ICU Patients With COVID-19-induced Respiratory Failure,ATMP,Plasma,90,2021-05-01,2021-05-01,https://clinicaltrials.gov/show/NCT04353206,No Results,No Results,No Results,2020-04-27,2020-04-29,None
1039,NCT04354753,ClinicalTrials.gov,2020-04-17,2020-03-28,True,Aarogyam UK,Not Recruiting,Not Applicable,Observational,United Kingdom,AiM COVID for Covid 19 Tracking and Prediction,Clinical Presentation (Epidemiology),No Intervention,80,2020-04-14,2020-04-17,https://clinicaltrials.gov/show/NCT04354753,No Results,No Results,No Results,2020-04-27,2020-04-29,None
1040,NCT04352400,ClinicalTrials.gov,2020-04-03,2020-04-01,True,University Hospital Padova,Not Recruiting,Phase 2/Phase 3,Interventional,No Country Given,Efficacy of Nafamostat in Covid-19 Patients (RACONA Study),Drug,Nafamostat,256,2021-12-01,2021-12-01,https://clinicaltrials.gov/show/NCT04352400,No Results,No Results,No Results,2020-04-27,2020-04-29,None
1041,NCT04352517,ClinicalTrials.gov,2020-04-10,2020-03-16,True,University of Extremadura,Recruiting,Not Applicable,Observational,"Uruguay, Chile, Brazil",Influence Physical Activity Psychological Responses COVID-19 Pandemic,Other (exercise),Exercise,3500,2020-08-31,2020-09-30,https://clinicaltrials.gov/show/NCT04352517,No Results,No Results,No Results,2020-04-27,2020-04-29,None
1042,NCT04355624,ClinicalTrials.gov,2020-04-17,2020-04-15,True,CHU de Nice,Recruiting,Not Applicable,Observational,France,Kidney Involvement in COVID-19 Disease (COVKID),Clinical Presentation,No Intervention,80,2020-04-30,2020-07-30,https://clinicaltrials.gov/show/NCT04355624,No Results,No Results,No Results,2020-04-27,2020-04-29,None
1043,NCT04355871,ClinicalTrials.gov,2020-04-19,2020-03-18,True,Fundacin SEIMC-GESIDA,Not Recruiting,Not Applicable,Observational,Spain,Characteristics and Outcomes of Hospitalized Patients With COVID-19 in Spain,Clinical Presentation,No Intervention,3000,2020-04-15,2020-04-17,https://clinicaltrials.gov/show/NCT04355871,No Results,No Results,No Results,2020-04-27,2020-04-29,None
1044,ISRCTN80453162,ISRCTN,2020-04-14,2020-04-09,True,University Hospitals Coventry and Warwickshire NHS Trust,Recruiting,Not Applicable,Observational,"Libya, Mayotte, Marshall Islands, Antigua and Barbuda, Qatar, Cuba, Christmas Island, Morocco, Guinea, Australia, Reunion, Serbia, Kuwait, Guernsey, Iceland, Vanuatu, Tuvalu, Benin, Slovakia, Belize, Jordan, Malta, Seychelles, Cote d'Ivoire, Central African Republic, Belarus, United States Minor Outlying Islands, Panama, Monaco, Azerbaijan, United Kingdom, Brunei, Palestinian Territory, Chile, Norfolk Island, Swaziland, Pakistan, Ghana, Indonesia, China, Vietnam, Eritrea, Taiwan, Bolivia, Sudan, Georgia, Laos, Palau, Burkina Faso, Comoros, Spain, Botswana, Denmark, Mauritania, British Indian Ocean Territory, Saint Pierre and Miquelon, Micronesia, Federated States of, Angola, Mauritius, Solomon Islands, Nepal, Iraq, Gabon, Papua New Guinea, Somalia, Kyrgyzstan, United Arab Emirates, Cape Verde, Costa Rica, Malaysia, Algeria, Estonia, Montenegro, Oman, Cyprus, Korea, South, South Georgia and the South Sandwich Is, Bermuda, Grenada, Greece, Heard Island and Mcdonald Islands, Venezuela, Bouvet Island, Saint Helena, Croatia, Iran, Mongolia, Nicaragua, Congo, Democratic Republic, Lebanon, Pitcairn, France, Uruguay, Saudi Arabia, Latvia, New Zealand, Lithuania, Svalbard and Jan Mayen, Sri Lanka, Guatemala, Israel, French Guiana, Guam, Netherlands Antilles, Trinidad and Tobago, Isle of Man, Brazil, Kazakhstan, Tonga, Ukraine, Chad, Poland, Armenia, Switzerland, Equatorial Guinea, Nigeria, Rwanda, Greenland, India, Moldova, Wallis and Futuna, Congo, Bahrain, Saint Vincent and the Grenadines, Tanzania, Fiji, Madagascar, Saint Lucia, Ireland, Egypt, Macedonia, Zambia, Turkey, Barbados, Uganda, Syria, Antarctica, Afghanistan, Liberia, Puerto Rico, Virgin Islands, British, Germany, Kenya, Malawi, Jamaica, Ethiopia, Gibraltar, Guinea-Bissau, Suriname, Maldives, Sierra Leone, Turkmenistan, Kosovo, Montserrat, Cook Islands, Slovenia, Belgium, Jersey, Guyana, Netherlands, Singapore, Niger, Dominican Republic, Cambodia, Timor-Leste, Bulgaria, Philippines, Curacao, Myanmar, Saint Kitts and Nevis, Liechtenstein, Tokelau, Mexico, Saint Barthelemy, Virgin Islands, U.S., Uzbekistan, Nauru, Bhutan, Zimbabwe, Cocos (Keeling) Islands, Ecuador, Gambia, Japan, Canada, Andorra, Sweden, Guadeloupe, New Caledonia, Russian Federation, French Polynesia, Haiti, French Southern Territories, Turks and Caicos Islands, Holy See (Vatican City State), Kiribati, Bangladesh, Faroe Islands, Dominica, Martinique, San Marino, Aruba, Czech Republic, El Salvador, Cameroon, Djibouti, Macao, Burundi, Bonaire Saint Eustatius and Saba, Samoa, Albania, Falkland Islands, Paraguay, Tajikistan, Argentina, Tunisia, Northern Mariana Islands, Bosnia and Herzegovina, Lesotho, Anguilla, Mozambique, Finland, Luxembourg, Romania, Saint Martin (French part), Mali, American Samoa, Senegal, Norway, Korea, North, Hungary, Thailand, Hong Kong, Austria, South Africa, United States, Peru, Sint Maarten (Dutch part), South Sudan, Niue, Sao Tome and Principe, Italy, Portugal, Colombia, Namibia, Yemen, Cayman Islands, Togo, Western Sahara, Honduras, Bahamas","The impact of the COVID-19 pandemic on the provision, practice, and outcomes of vascular surgery (COVER study)",Clinical Presentation,No Intervention,200,Not Available,2022-04-01,http://isrctn.com/ISRCTN80453162,No Results,No Results,No Results,2020-04-27,2020-04-22,None
1045,NCT04352842,ClinicalTrials.gov,2020-04-16,2020-02-19,True,RenJi Hospital,Not Recruiting,Not Applicable,Observational,China,Echocardiographic Manifestation in Patient With Coronavirus Disease 2019 (COVID-19),Clinical Presentation,No Intervention,55,2020-04-04,2020-04-06,https://clinicaltrials.gov/show/NCT04352842,No Results,No Results,No Results,2020-04-27,2020-04-29,None
1046,NCT04352933,ClinicalTrials.gov,2020-04-07,2020-04-01,False,Cambridge University Hospitals NHS Foundation Trust,Not Recruiting,Phase 3,Interventional,No Country Given,PROLIFIC ChemoprophylaxisTrial (COVID-19),Drug (Chemoprophylaxis),Hydroxychloroquine,1000,2020-10-31,2021-04-01,https://clinicaltrials.gov/show/NCT04352933,No Results,No Results,No Results,2020-04-27,2020-04-22,EUCTR2020-001331-26
1047,NCT04356495,ClinicalTrials.gov,2020-04-11,2020-04-15,False,"University Hospital, Bordeaux",Not Recruiting,Phase 3,Interventional,France,Treatments to Decrease the Risk of Hospitalization or Death in Elderly Outpatients With Symptomatic SARS-CoV-2 Infection (COVID-19),Drug,Hydroxychloroquine vs. Imatinib vs. Favipiravir vs. Telmisartan vs. Vitamins,1057,2020-07-31,2020-08-15,https://clinicaltrials.gov/show/NCT04356495,No Results,No Results,No Results,2020-04-27,2020-04-29,None
1048,NCT04356508,ClinicalTrials.gov,2020-04-10,2020-04-14,False,Dr. Gerry Gin Wai Kwok,Not Recruiting,Phase 2,Interventional,No Country Given,COVID-19: A Pilot Study of Adaptive Immunity and Anti-PD1,Drug,Nivolumab,15,2020-06-30,2021-08-31,https://clinicaltrials.gov/show/NCT04356508,No Results,No Results,No Results,2020-04-27,2020-04-29,None
1049,ISRCTN16912075,ISRCTN,2020-04-06,2020-04-06,False,University of Warwick,Recruiting,Not Applicable,Interventional,United Kingdom,"RECOVERY Respiratory Support: Respiratory Strategies in patients with coronavirus COVID-19  CPAP, high-flow nasal oxygen, and standard care",Drug,Oxygen,4002,Not Available,2021-05-05,http://isrctn.com/ISRCTN16912075,No Results,No Results,No Results,2020-04-27,2020-04-07,None
1050,NCT04352959,ClinicalTrials.gov,2020-04-15,2020-04-27,False,Claude Bernard University,Not Recruiting,Not Applicable,Interventional,No Country Given,COVID-19: Nasal and Salivary Detection of the SARS-CoV-2 Virus After Antiviral Mouthrinses,Drug,Bta-cyclodextrin + citrox,178,2020-05-20,2020-06-20,https://clinicaltrials.gov/show/NCT04352959,No Results,No Results,No Results,2020-04-27,2020-04-29,None
1051,NCT04353284,ClinicalTrials.gov,2020-04-16,2020-04-30,False,Yale University,Not Recruiting,Phase 2,Interventional,No Country Given,Camostat Mesylate in COVID-19 Outpatients,Drug,Camostat Mesilate,114,2021-05-31,2021-05-31,https://clinicaltrials.gov/show/NCT04353284,No Results,No Results,No Results,2020-04-27,2020-04-29,None
1052,NCT04356937,ClinicalTrials.gov,2020-04-19,2020-04-27,False,Massachusetts General Hospital,Not Recruiting,Phase 3,Interventional,United States,Efficacy of Tocilizumab on Patients With COVID-19,Drug,Tocilizumab,300,2020-06-30,2020-08-30,https://clinicaltrials.gov/show/NCT04356937,No Results,No Results,No Results,2020-04-27,2020-04-29,None
1053,ACTRN12620000445976,ANZCTR,2020-04-06,2020-04-10,False,University of Melbourne,Not Recruiting,Phase 3,Interventional,"Australia, New Zealand","To compare the effectiveness of two drugs (hydroxychloroquine and lopinavir/ritonavir alone or combined in treating hospitalized patients with confirmed COVID-19 compared to standard of care

",Drug,Lopinavir/ritonavir + hydroxychloroquine vs. lopinavir/ritonavir vs. hydroxychloroquine,2500,Not Available,Not Available,https://anzctr.org.au/ACTRN12620000445976.aspx,No Results,No Results,No Results,2020-04-27,2020-04-07,None
1054,EUCTR2020-001391-15-IE,EU Clinical Trials Register,2020-03-31,2020-04-24,False,Royal College of Surgeons Ireland,Authorised,Phase 2,Interventional,Ireland,A randomized double-blind placebo-controlled trial of intravenous plasma-purified alpha-1 antitrypsin for severe COVID-19 illness.,ATMP,Alpha-1-proteinase inhibitor,36,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001391-15,No Results,No Results,No Results,2020-04-29,2020-04-29,None
1055,NCT04354558,ClinicalTrials.gov,2020-04-06,2020-04-01,True,CHU de Amiens,Not Recruiting,Not Applicable,Observational,France,French Single Centre Experience of Critically Ill Patients With Covid 19,Clinical Presentation,No Intervention,200,2021-04-01,2021-04-01,https://clinicaltrials.gov/show/NCT04354558,No Results,No Results,No Results,2020-04-27,2020-04-29,None
1056,NCT04354584,ClinicalTrials.gov,2020-04-13,2020-04-06,True,"Copenhagen University Hospital, Hvidovre",Recruiting,Not Applicable,Observational,Denmark,Compartmental Inflammation in Mechanically Ventilated Patients With COVID-19,Clinical Presentation,No Intervention,20,2021-04-06,2021-04-06,https://clinicaltrials.gov/show/NCT04354584,No Results,No Results,No Results,2020-04-27,2020-04-29,None
1057,ACTRN12620000457943,ANZCTR,2020-04-08,2020-04-14,False,Medical Research Institute of New Zealand,Not Recruiting,Phase 2,Interventional,New Zealand,Hydroxychloroquine for the Community-Based Treatment of COVID-19,Drug,Hydroxychloroquine,70,Not Available,2021-01-29,https://anzctr.org.au/ACTRN12620000457943.aspx,No Results,No Results,No Results,2020-04-27,2020-04-15,None
1058,NCT04355026,ClinicalTrials.gov,2020-04-15,2020-04-10,True,Celje General Hospital,Recruiting,Phase 4,Interventional,Slovenia,Use of Bromhexine and Hydroxychloroquine for Treatment of COVID-19 Pneumonia,Drug,Bromhexine + Hydroxychloroquine vs. Hydroxychloroquine,90,2020-06-30,2020-07-31,https://clinicaltrials.gov/show/NCT04355026,No Results,No Results,No Results,2020-04-27,2020-04-29,None
1059,NCT04357340,ClinicalTrials.gov,2020-04-13,2020-04-20,False,Tehran University of Medical Sciences,Not Recruiting,Not Applicable,Interventional,Iran,The Effects of Pulmonary Physiotherapy Treatments on Patients With COVID-19,Other (physio),Physio,40,2020-06-20,2020-08-01,https://clinicaltrials.gov/show/NCT04357340,No Results,No Results,No Results,2020-04-27,2020-04-29,None
1060,ChiCTR2000032233,ChiCTR,2020-04-23,2020-04-23,False,Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine,Not Recruiting,Not Applicable,Observational,China,Clinical study for the potential impact of novel coronavirus pneumonia (COVID-19) on endocrine system,Clinical Presentation,No Intervention,28,Not Available,2020-05-06,http://www.chictr.org.cn/showproj.aspx?proj=52796,No Results,No Results,No Results,2020-04-27,2020-04-29,None
1061,NCT04357847,ClinicalTrials.gov,2020-04-09,2020-04-09,False,"University Hospital, Rouen",Recruiting,Not Applicable,Observational,France,Assessment of Endothelial and Haemostatic Changes During Severe SARS-CoV-2 Infection,Clinical Presentation,No Intervention,100,2020-07-31,2020-08-31,https://clinicaltrials.gov/show/NCT04357847,No Results,No Results,No Results,2020-04-27,2020-04-29,None
1062,ChiCTR2000032214,ChiCTR,2020-04-23,2020-05-01,False,Hubei Hospital of Traditional Chinese Medicine,Not Recruiting,Not Applicable,Interventional,China,Screening of proprietary Chinese medicines in convalescent rehabilitation of novel coronavirus pneumonia (COVID-19) convalescent patients,Traditional Medicine (Drug),Traditional Medicine,200,Not Available,2020-07-10,http://www.chictr.org.cn/showproj.aspx?proj=52781,No Results,No Results,No Results,2020-04-27,2020-04-29,None
1063,ChiCTR2000032205,ChiCTR,2020-04-23,2020-04-15,True,Wuhan Hospital Of Traditional Chinese and Western Medicine,Not Recruiting,Not Applicable,Interventional,China,"A multicenter randomized, double-blind, placebo-controlled trial for Sheng-Mai-Yin for improvement of the pulmonary heart function related symptoms of convalescence patients of new coronavirus pneumonia",Traditional Medicine (Drug),Traditional Medicine,200,Not Available,2020-07-15,http://www.chictr.org.cn/showproj.aspx?proj=52662,No Results,No Results,No Results,2020-04-27,2020-04-29,None
1064,EUCTR2020-001622-64-ES,EU Clinical Trials Register,2020-04-20,2020-04-19,True,Dr. Ana Pueyo Bastida,Authorised,Phase 4,Interventional,Spain,OUTPATIENT TREATMENT OF COVID-19 WITH EARLY PULMONARY CORTICOSTEROIDS AS AN OPPORTUNITY TO MODIFY THE COURSE OF THE DISEASE,Drug,Corticosteroids,200,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001622-64,No Results,No Results,No Results,2020-04-29,2020-04-29,None
1065,ChiCTR2000032161,ChiCTR,2020-04-21,2020-02-01,True,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Not Applicable,Observational,China,A retrospective study for evolution and clinical outcomes study of novel coronavirus pneumonia (COVID-19) patients,Clinical Presentation,No Intervention,2000,Not Available,2020-06-30,http://www.chictr.org.cn/showproj.aspx?proj=52561,No Results,No Results,No Results,2020-04-27,2020-04-29,None
1066,ChiCTR2000032165,ChiCTR,2020-04-21,2020-04-25,False,Hubei Hospital of Traditional Chinese Medicine,Not Recruiting,Not Applicable,Interventional,China,"A multicenter, randomized, double-blind, parallel-controlled trial for Qi-Mai-Fei-Luo-Ping Mixture in the improvement of lung function of novel coronavirus pneumonia (COVID-19) in the convalescent period",Traditional Medicine (Drug),Traditional Medicine,60,Not Available,2021-03-31,http://www.chictr.org.cn/showproj.aspx?proj=52679,No Results,No Results,No Results,2020-04-27,2020-04-29,None
1067,ISRCTN18348009,ISRCTN,2020-04-15,2020-04-16,False,University of Valladolid,Not Recruiting,Not Applicable,Observational,Spain,Occupational health and safety among health care personnel in a COVID-19 pandemic,Clinical Presentation,No Intervention,80,Not Available,2020-04-22,http://isrctn.com/ISRCTN18348009,No Results,No Results,No Results,2020-04-27,2020-04-22,None
1068,ISRCTN51255782,ISRCTN,2020-04-14,2020-04-14,False,Labormedizinisches Zentrum Dr. Risch,Recruiting,Not Applicable,Observational,Liechtenstein,Can the Ava fertility tracker device detect early signs of COVID-19?,Diagnostics,Diagnostic Test or Assessment,2170,Not Available,2021-12-31,http://isrctn.com/ISRCTN51255782,No Results,No Results,No Results,2020-04-27,2020-04-22,None
1069,ISRCTN40092247,ISRCTN,2020-04-01,2020-03-20,True,University of Oxford,Recruiting,Not Applicable,Observational,United Kingdom,UKOSS: Pandemic COVID-19 in pregnancy,Clinical Presentation,No Intervention,500,Not Available,2022-12-31,http://isrctn.com/ISRCTN40092247,No Results,No Results,No Results,2020-04-27,2020-04-07,None
1070,ISRCTN10077335,ISRCTN,2020-04-07,2020-03-19,True,Klinikum der Universitt Mnchen,Recruiting,Not Applicable,Observational,Germany,Comparison of lung water in COVID-19 patients and other patients with acute respiratory failure,Clinical Presentation,No Intervention,25,Not Available,2020-04-30,http://isrctn.com/ISRCTN10077335,No Results,No Results,No Results,2020-04-27,2020-04-15,None
1071,EUCTR2020-001417-21-BE,EU Clinical Trials Register,2020-04-01,2020-04-12,False,Institute of Tropical Medicine,Authorised,Phase 2,Interventional,Belgium,An open label single center randomized controlled trial to evaluate the effect of hydroxychloroquine on viral shedding in mild COVID-19,Drug,Hydroxychloroquine,206,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001417-21,No Results,No Results,No Results,2020-04-29,2020-04-29,None
1072,ISRCTN13694948,ISRCTN,2020-04-01,2020-04-02,False,"University Hospital, Bern",Recruiting,Not Applicable,Observational,"Turkey, Cyprus, Sweden, Greece, Australia, French Southern Territories, Croatia, Germany, Lebanon, Slovakia, France, New Zealand, Lithuania, Malta, Czech Republic, Israel, United Kingdom, Isle of Man, Belgium, Brazil, Slovenia, Netherlands, Finland, Luxembourg, Switzerland, Norway, Bulgaria, Austria, South Africa, Spain, United States, Denmark, Liechtenstein, Italy, Portugal, Ireland",Distress and resilience of healthcare professionals during the COVID-19 (coronavirus) pandemic,Other (psych),No Intervention,400,Not Available,2021-01-01,http://isrctn.com/ISRCTN13694948,No Results,No Results,No Results,2020-04-27,2020-04-07,None
1073,EUCTR2020-001244-26-AT,EU Clinical Trials Register,2020-03-31,2020-04-11,False,Medical University of Vienna,Authorised,Phase 2,Interventional,Austria,COVID-19: Efficacy of solnatide to treat pulmonary permeability oedema in SARS-Cov-2 positive patients with moderate-to-severe ARDS,Drug,Solnatide,40,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001244-26,No Results,No Results,No Results,2020-04-29,2020-04-29,None
1074,NCT04313946,ClinicalTrials.gov,2020-03-17,2020-03-18,False,Professor Adrian Covic,Recruiting,Not Applicable,Observational,"Italy, United Kingdom, Romania",Artificial Intelligence Algorithms for Discriminating Between COVID-19 and Influenza Pneumonitis Using Chest X-Rays,Diagnostics,Diagnostic Test or Assessment,200,2020-08-16,2020-08-18,https://clinicaltrials.gov/show/NCT04313946,No Results,No Results,No Results,2020-05-04,2020-03-25,None
1075,NCT04318444,ClinicalTrials.gov,2020-03-20,2020-03-29,False,Columbia University,Recruiting,Phase 2/Phase 3,Interventional,United States,Hydroxychloroquine Post Exposure Prophylaxis for Coronavirus Disease (COVID-19),Drug (Chemoprophylaxis),Hydroxychloroquine,1600,2021-03-01,2022-03-01,https://clinicaltrials.gov/show/NCT04318444,No Results,No Results,No Results,2020-05-04,2020-04-01,None
1076,EUCTR2020-001440-26-ES,EU Clinical Trials Register,2020-04-20,2020-04-19,True,Fundacin Pblica Andaluza para la Gestin de la Investigacin en Salud de Sevilla (FISEVI),Authorised,Phase 3,Interventional,Spain,Study for the prevention of COVID-19 infection in healthcare personnel,Drug (Chemoprophylaxis),Hydroxychloroquine,184,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001440-26,No Results,No Results,No Results,2020-04-29,2020-04-29,None
1077,EUCTR2020-001459-42-DK,EU Clinical Trials Register,2020-04-14,2020-04-22,False,Zealand University Hospital,Authorised,Phase 2,Interventional,Denmark,"Ruxolitinib Treatment in Patients with Severe COVID-19 Infection. A Danish Safety and Efficacy Study.
",Drug,Ruxolitinib,40,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001459-42,No Results,No Results,No Results,2020-04-29,2020-04-29,None
1078,NCT04320056,ClinicalTrials.gov,2020-03-19,2020-04-20,False,Laval University,Recruiting,Not Applicable,Interventional,Canada,Closed-Loop Oxygen to Verify That Healthcare Workers Interventions Decrease During SARS-CoV-2 Pneumonia (COVID-19),Drug,Oxygen,216,2021-04-30,2021-10-31,https://clinicaltrials.gov/show/NCT04320056,No Results,No Results,No Results,2020-05-04,2020-04-01,None
1079,NCT04321421,ClinicalTrials.gov,2020-03-23,2020-03-17,True,Foundation IRCCS San Matteo Hospital,Recruiting,Not Applicable,Interventional,Italy,Hyperimmune Plasma for Critical Patients With COVID-19,ATMP,Plasma,49,2020-05-31,2020-05-31,https://clinicaltrials.gov/show/NCT04321421,No Results,No Results,No Results,2020-05-04,2020-04-01,None
1080,EUCTR2020-001270-29-GB,EU Clinical Trials Register,2020-03-30,2020-04-02,False,Sanofi,Authorised,Phase 2/Phase 3,Interventional,"France, Denmark, Czech Republic, United Kingdom, Hungary, Germany",Hydroxychloroquine for COVID 19 in moderately to severely ill hospitalized patients,Drug,Hydroxychloroquine,350,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001270-29,No Results,No Results,No Results,2020-04-29,2020-04-07,None
1081,NCT04323839,ClinicalTrials.gov,2020-03-24,2020-03-20,True,"University of California, San Francisco",Recruiting,Not Applicable,Observational,United States,COVID-19 PRIORITY (Pregnancy CoRonavIrus Outcomes RegIsTrY),Clinical Presentation,No Intervention,2000,2024-03-31,2024-03-31,https://clinicaltrials.gov/show/NCT04323839,No Results,No Results,No Results,2020-05-04,2020-04-01,None
1082,NCT04324463,ClinicalTrials.gov,2020-03-25,2020-04-21,False,Population Health Research Institute,Recruiting,Phase 3,Interventional,Canada,Anti-Coronavirus Therapies to Prevent Progression of Coronavirus Disease 2019 (COVID-19) Trial,Drug,Chloroquine + azithromycin,1500,2020-09-30,2020-12-31,https://clinicaltrials.gov/show/NCT04324463,No Results,No Results,No Results,2020-05-04,2020-04-01,None
1083,EUCTR2020-001310-38-DE,EU Clinical Trials Register,2020-03-31,2020-04-06,False,DRK-Bluspendedienst Baden-Wrttemberg - Hessen gGmbH,Authorised,Phase 2,Interventional,Germany,Clinical Study to assess positive value of blood plasma from donors having built immunity against the new corona virus (SARS-CoV-2) transfused to patients suffering from SARS-CoV-2 infection,ATMP,Plasma,120,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001310-38,No Results,No Results,No Results,2020-04-29,2020-04-15,None
1084,EUCTR2020-001327-13-AT,EU Clinical Trials Register,2020-03-30,2020-04-14,False,Medical University of Vienna,Authorised,Phase 2,Interventional,Austria,"A SINGLE-BLINDED RANDOMIZED, PLACEBO-CONTROLLED PHASE II TRIAL OF PROPHYLACTIC TREATMENT WITH ORAL AZITHROMYCIN VERSUS PLACEBO IN CANCER PATIENTS UNDERGOING ANTINEOPLASTIC TREATMENT DURING THE COVID-19 PANDEMIC",Drug,Azithromycin,200,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001327-13,No Results,No Results,No Results,2020-04-29,2020-04-29,None
1085,EUCTR2020-001614-38-BE,EU Clinical Trials Register,2020-04-06,2020-04-22,False,UZLeuven,Authorised,Phase 2,Interventional,Belgium,"Covid-19: A randomized, open-label, adaptive, proof-of- concept clinical trial of new antiviral drug candidates against SARS-CoV-2.",Drug,Azithromycin,240,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001614-38,No Results,No Results,No Results,2020-04-29,2020-04-29,None
1086,NCT04326920,ClinicalTrials.gov,2020-03-24,2020-03-24,False,"University Hospital, Ghent",Recruiting,Phase 4,Interventional,"Belgium, Italy",Sargramostim in Patients With Acute Hypoxic Respiratory Failure Due to COVID-19 (SARPAC),Drug,Sargramostim,80,2020-10-31,2020-12-31,https://clinicaltrials.gov/show/NCT04326920,No Results,No Results,No Results,2020-05-04,2020-04-07,None
1087,NCT04331899,ClinicalTrials.gov,2020-03-27,2020-04-24,False,Stanford University,Recruiting,Phase 2,Interventional,United States,Single-Blind Study of a Single Dose of Peginterferon Lambda-1a Compared With Placebo in Outpatients With Mild COVID-19,Drug,Interferon lambda,120,2021-05-31,2022-05-31,https://clinicaltrials.gov/show/NCT04331899,No Results,No Results,No Results,2020-05-04,2020-04-07,None
1088,NCT04256395,ClinicalTrials.gov,2020-02-01,2020-02-01,False,Beijing Tsinghua Chang Gung Hospital,Recruiting,Not Applicable,Observational,China,Efficacy of a Self-test and Self-alert Mobile Applet in Detecting Susceptible Infection of COVID-19,Diagnostics,Diagnostic Test or Assessment,300000,2020-07-31,2020-07-31,https://clinicaltrials.gov/show/NCT04256395,No Results,No Results,No Results,2020-05-04,2020-03-18,None
1089,NCT04320017,ClinicalTrials.gov,2020-03-20,2020-03-20,False,Groupe Hospitalier Piti Salptrire,Recruiting,Not Applicable,Observational,France,Joint Use of Electrocardiogram and Transthoracic Echocardiography With Other Clinico-biological Parameters in an Observational Study to Monitor Cardio-vascular Events and Predict Outcomes in Patients Diagnosed With COVID-19,Clinical Presentation,No Intervention,500,2020-05-20,2020-05-20,https://clinicaltrials.gov/show/NCT04320017,Pre-Print Article,2020-05-08,https://doi.org/10.1101/2020.05.04.20090118,2020-05-04,2020-04-01,None
1090,NCT04321278,ClinicalTrials.gov,2020-03-23,2020-03-28,False,Hospital Israelita Albert Einstein,Recruiting,Phase 3,Interventional,Brazil,Safety and Efficacy of Hydroxychloroquine Associated With Azithromycin in SARS-CoV2 Virus (Coalition Covid-19 Brasil II),Drug,Hydroxychloroquine + Azithromycin vs. Hydroxychloroquine,440,2020-08-30,2020-08-30,https://clinicaltrials.gov/show/NCT04321278,No Results,No Results,No Results,2020-05-04,2020-04-01,None
1091,NCT04333654,ClinicalTrials.gov,2020-04-01,2020-04-12,False,Sanofi,Recruiting,Phase 1,Interventional,"France, United States, Netherlands",Hydroxychloroquine in Outpatient Adults With COVID-19,Drug,Hydroxychloroquine,210,2020-05-01,2020-05-01,https://clinicaltrials.gov/show/NCT04333654,No Results,No Results,No Results,2020-05-04,2020-04-07,None
1092,NCT04334291,ClinicalTrials.gov,2020-04-01,2020-03-23,True,Ivn J. Nez Gil,Recruiting,Not Applicable,Observational,Spain,"International COVID19 Clinical Evaluation Registry,",Clinical Presentation,No Intervention,6000,2020-05-01,2020-05-05,https://clinicaltrials.gov/show/NCT04334291,No Results,No Results,No Results,2020-05-04,2020-04-15,None
1093,NCT04317040,ClinicalTrials.gov,2020-03-19,2020-04-08,False,"OncoImmune, Inc.",Recruiting,Phase 3,Interventional,United States,CD24Fc as a Non-antiviral Immunomodulator in COVID-19 Treatment,ATMP,Gene-derived protein,230,2021-05-01,2022-05-01,https://clinicaltrials.gov/show/NCT04317040,No Results,No Results,No Results,2020-05-04,2020-03-25,None
1094,NCT04319016,ClinicalTrials.gov,2020-03-20,2020-01-01,True,Federico II University,Recruiting,Not Applicable,Observational,Italy,Clinical Characteristics of Coronavirus Disease 2019 (COVID-19) in Pregnancy,Clinical Presentation,No Intervention,200,2020-04-30,2020-05-01,https://clinicaltrials.gov/show/NCT04319016,No Results,No Results,No Results,2020-05-04,2020-04-01,None
1095,NCT04322682,ClinicalTrials.gov,2020-03-23,2020-03-23,False,Montreal Heart Institute,Recruiting,Phase 3,Interventional,"Canada, United States, Spain",Colchicine Coronavirus SARS-CoV2 Trial (COLCORONA),Drug,Colchicine,6000,2020-09-01,2020-09-01,https://clinicaltrials.gov/show/NCT04322682,No Results,No Results,No Results,2020-05-04,2020-04-01,None
1096,NCT04327479,ClinicalTrials.gov,2020-03-26,2020-03-26,False,"University Hospital, Essen",Recruiting,Not Applicable,Observational,Germany,Characterization of Cardiovascular Diseases and Risk Factors in Patients With Suspected SARS-CoV2/Covid-19 Infection,Clinical Presentation,No Intervention,728,2026-03-25,2026-03-25,https://clinicaltrials.gov/show/NCT04327479,No Results,No Results,No Results,2020-05-04,2020-04-07,None
1097,NCT04335097,ClinicalTrials.gov,2020-04-01,2020-04-22,False,Lars Wik,Recruiting,Not Applicable,Interventional,Norway,Sensor Based Vital Signs Monitoring of Covid 19 Patients During Home Isolation,Other (device),Biosensors,214,2021-04-08,2025-12-20,https://clinicaltrials.gov/show/NCT04335097,No Results,No Results,No Results,2020-05-04,2020-04-15,None
1098,NCT04336410,ClinicalTrials.gov,2020-04-03,2020-04-03,False,Inovio Pharmaceuticals,Recruiting,Phase 1,Interventional,United States,"Safety, Tolerability and Immunogenicity of INO-4800 for COVID-19 in Healthy Volunteers",Drug,INO-4800,40,2021-04-01,2021-04-01,https://clinicaltrials.gov/show/NCT04336410,No Results,No Results,No Results,2020-05-04,2020-04-15,None
1099,NCT04330599,ClinicalTrials.gov,2020-03-31,2020-05-05,False,Queen Mary University of London,Not Recruiting,Not Applicable,Observational,No Country Given,Longitudinal Population-based Observational Study of COVID-19 in the UK Population,Clinical Presentation,No Intervention,12000,2025-04-01,2025-04-01,https://clinicaltrials.gov/show/NCT04330599,No Results,No Results,No Results,2020-05-04,2020-04-07,None
1100,NCT04330638,ClinicalTrials.gov,2020-03-31,2020-04-01,False,"University Hospital, Ghent",Recruiting,Phase 3,Interventional,Belgium,Treatment of COVID-19 Patients With Anti-interleukin Drugs,Drug,Anakinta + Siltuximab vs. Tocilizumab + Anakinra vs. Tocilizumab vs. Siltuximab vs. Anakinra,342,2020-09-01,2020-12-01,https://clinicaltrials.gov/show/NCT04330638,No Results,No Results,No Results,2020-05-04,2020-04-07,None
1101,NCT04319445,ClinicalTrials.gov,2020-03-20,2020-03-22,False,Wake Forest University,Recruiting,Not Applicable,Interventional,United States,Mindfulness During COVID-19,Other (psych),Psychological,200,2020-12-01,2020-12-01,https://clinicaltrials.gov/show/NCT04319445,No Results,No Results,No Results,2020-05-04,2020-04-01,None
1102,NCT04321993,ClinicalTrials.gov,2020-03-24,2020-04-17,False,Lisa Barrett,Recruiting,Phase 2,Interventional,Canada,Treatment of Moderate to Severe Coronavirus Disease (COVID-19) in Hospitalized Patients,Drug,Lopinavir/ritonavir vs. hydroxychloroquine vs. baricitinib vs. sarilumab,1000,2021-02-01,2021-07-01,https://clinicaltrials.gov/show/NCT04321993,No Results,No Results,No Results,2020-05-04,2020-04-01,None
1103,NCT04337918,ClinicalTrials.gov,2020-04-06,2020-04-27,False,Sanotize Research and Development corp.,Not Recruiting,Phase 2,Interventional,No Country Given,Nitric Oxide Releasing Solutions to Prevent and Treat Mild/Moderate COVID-19 Infection,Drug,Nitric oxide,200,2020-07-31,2020-09-30,https://clinicaltrials.gov/show/NCT04337918,No Results,No Results,No Results,2020-05-04,2020-04-15,None
1104,NCT04341675,ClinicalTrials.gov,2020-04-05,2020-04-24,False,University of Cincinnati,Recruiting,Phase 2,Interventional,United States,Sirolimus Treatment in Hospitalized Patients With COVID-19 Pneumonia,Drug,Sirolimus,30,2020-07-01,2020-09-01,https://clinicaltrials.gov/show/NCT04341675,No Results,No Results,No Results,2020-05-04,2020-04-15,None
1105,NCT04331808,ClinicalTrials.gov,2020-03-31,2020-03-30,True,Assistance Publique  Hpitaux de Paris,Not Recruiting,Phase 2,Interventional,France,CORIMUNO-19 - Tocilizumab Trial - TOCI (CORIMUNO-TOCI),Drug,Tocilizumab,228,2021-03-31,2021-12-31,https://clinicaltrials.gov/show/NCT04331808,No Results,No Results,No Results,2020-05-04,2020-04-07,None
1106,NCT04333589,ClinicalTrials.gov,2020-04-01,2020-04-01,False,Peking University First Hospital,Recruiting,Not Applicable,Interventional,China,Corona Virus Disease 2019 Patients Whose Nucleic Acids Changed From Negative to Positive,Drug,Favipiravir,210,2020-06-01,2020-09-15,https://clinicaltrials.gov/show/NCT04333589,No Results,No Results,No Results,2020-05-04,2020-04-07,None
1107,NCT04327505,ClinicalTrials.gov,2020-03-25,2020-05-08,False,Karolinska Institutet,Not Recruiting,Phase 2/Phase 3,Interventional,No Country Given,Safety and Efficacy of Hyperbaric Oxygen for ARDS in Patients With COVID-19,Drug,Oxygen,200,2021-11-30,2022-12-31,https://clinicaltrials.gov/show/NCT04327505,No Results,No Results,No Results,2020-05-04,2020-04-07,None
1108,NCT04329572,ClinicalTrials.gov,2020-03-29,2020-04-23,False,Azidus Brasil,Not Recruiting,Phase 1,Interventional,Brazil,Efficacy and Safety of Hydroxychloroquine and Azithromycin for the Treatment of Hospitalized Patients With Moderate to Severe COVID-19,Drug,Hydroxychloroquine + Azithromycin,400,2020-05-31,2020-06-30,https://clinicaltrials.gov/show/NCT04329572,No Results,No Results,No Results,2020-05-04,2020-04-07,None
1109,ChiCTR2000030740,ChiCTR,2020-03-13,2020-02-01,True,Shandong Provincial Chest hospital,Recruiting,Not Applicable,Observational,China,Analysis of the incidence and risk factors of ARDS in patients with Novel Coronavirus Pneumonia (COVID-19).,Clinical Presentation,No Intervention,100,Not Available,2020-08-31,http://www.chictr.org.cn/showproj.aspx?proj=50900,No Results,No Results,No Results,2020-03-16,2020-03-18,None
1110,NCT04345601,ClinicalTrials.gov,2020-04-10,2020-05-01,False,Baylor University,Not Recruiting,Phase 1,Interventional,United States,Mesenchymal Stromal Cells for the Treatment of SARS-CoV-2 Induced Acute Respiratory Failure (COVID-19 Disease),ATMP,Cells (mesenchymal),30,2022-02-01,2022-02-01,https://clinicaltrials.gov/show/NCT04345601,No Results,No Results,No Results,2020-05-04,2020-04-22,None
1111,NCT04345679,ClinicalTrials.gov,2020-04-11,2020-04-14,False,Orthosera Kft.,Not Recruiting,Phase 1,Interventional,No Country Given,Anti COVID-19 Convalescent Plasma Therapy,ATMP,Plasma,20,2020-06-01,2021-04-01,https://clinicaltrials.gov/show/NCT04345679,No Results,No Results,No Results,2020-05-04,2020-04-22,None
1112,NCT04332380,ClinicalTrials.gov,2020-03-30,2020-05-01,False,Del Rosario University,Not Recruiting,Phase 2,Interventional,Colombia,Convalescent Plasma for Patients With COVID-19: A Pilot Study,ATMP,Plasma,10,2020-08-31,2020-12-31,https://clinicaltrials.gov/show/NCT04332380,No Results,No Results,No Results,2020-05-04,2020-04-07,None
1113,NCT04332835,ClinicalTrials.gov,2020-03-31,2020-05-01,False,Del Rosario University,Not Recruiting,Phase 2/Phase 3,Interventional,Colombia,"Convalescent Plasma for Patients With COVID-19: A Randomized, Open Label, Parallel, Controlled Clinical Study",ATMP (+ Drug),Plasma + Hydroxychloroquine vs. Hydroxychloroquine,80,2020-08-31,2020-12-31,https://clinicaltrials.gov/show/NCT04332835,No Results,No Results,No Results,2020-05-04,2020-04-07,None
1114,NCT04335084,ClinicalTrials.gov,2020-04-02,2020-04-01,True,ProgenaBiome,Not Recruiting,Phase 2,Interventional,United States,"A Study of Hydroxychloroquine, Vitamin C, Vitamin D, and Zinc for the Prevention of COVID-19 Infection",Drug,Hydroxychloroquine + vitamin C + vitamin D + zinc,600,2021-05-01,2021-08-01,https://clinicaltrials.gov/show/NCT04335084,No Results,No Results,No Results,2020-05-04,2020-04-15,None
1115,NCT04335123,ClinicalTrials.gov,2020-03-31,2020-03-25,True,University of Kansas Medical Center,Recruiting,Phase 1,Interventional,United States,Study of Open Label Losartan in COVID-19,Drug,ARB (Losartan),50,2020-09-01,2020-10-01,https://clinicaltrials.gov/show/NCT04335123,No Results,No Results,No Results,2020-05-04,2020-04-15,None
1116,NCT04346212,ClinicalTrials.gov,2020-04-10,2020-04-14,False,Hospital de Matar,Recruiting,Not Applicable,Observational,Spain,Oropharyngeal Dysphagia in Patients With COVID-19,Diagnostics,Diagnostic Test or Assessment,100,2020-07-01,2020-08-01,https://clinicaltrials.gov/show/NCT04346212,No Results,No Results,No Results,2020-05-04,2020-04-22,None
1117,NCT04347512,ClinicalTrials.gov,2020-04-11,2020-05-01,False,"University Hospital, Strasbourg",Not Recruiting,Phase 3,Interventional,No Country Given,EVALUATION OF THE EFFICACY OF THE HYDROXYCHLOROQUINE-AZITHROMYCIN COMBINATION IN THE IN THE PREVENTION OF COVID-19 RELATED SDRA,Drug,Hydroxychloroquine + Azithromycin vs. Hydroxychloroquine,405,2021-08-01,2021-08-01,https://clinicaltrials.gov/show/NCT04347512,No Results,No Results,No Results,2020-05-04,2020-05-05,None
1118,NCT04332991,ClinicalTrials.gov,2020-03-31,2020-04-02,False,Massachusetts General Hospital,Recruiting,Phase 3,Interventional,United States,Outcomes Related to COVID-19 Treated With Hydroxychloroquine Among In-patients With Symptomatic Disease,Drug,Hydroxychloroquine,510,2021-04-01,2021-07-01,https://clinicaltrials.gov/show/NCT04332991,No Results,No Results,No Results,2020-05-04,2020-04-07,None
1119,NCT04334980,ClinicalTrials.gov,2020-03-31,2020-04-30,False,Symvivo Corporation,Not Recruiting,Phase 1,Interventional,Canada,"Evaluating the Safety, Tolerability and Immunogenicity of bacTRL-Spike Vaccine for Prevention of COVID-19",ATMP,Vaccine,84,2021-08-31,2021-12-31,https://clinicaltrials.gov/show/NCT04334980,No Results,No Results,No Results,2020-05-04,2020-04-15,None
1120,NCT04335279,ClinicalTrials.gov,2020-04-01,2020-04-09,False,Lady Davis Institute,Recruiting,Not Applicable,Interventional,Canada,Evaluation of the Scleroderma Patient-centered Intervention Network COVID-19 Home-isolation Activities Together Program,Other (psych),Psychological,195,2020-06-03,2020-06-03,https://clinicaltrials.gov/show/NCT04335279,No Results,No Results,No Results,2020-05-04,2020-04-15,None
1121,NCT04336345,ClinicalTrials.gov,2020-04-02,2020-04-01,True,Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran,Recruiting,Not Applicable,Observational,Mexico,Outcomes of Patients With COVID-19 in the Intensive Care Unit,Clinical Presentation,No Intervention,150,2020-04-30,2020-05-30,https://clinicaltrials.gov/show/NCT04336345,No Results,No Results,No Results,2020-05-04,2020-04-15,None
1122,NCT04335032,ClinicalTrials.gov,2020-04-01,2020-04-13,False,S.L.A. Pharma AG,Not Recruiting,Phase 3,Interventional,No Country Given,EPA-FFA to Treat Hospitalised Patients With COVID-19 (SARS-CoV-2),Drug,Eicosapentaenoic acid,240,2020-07-13,2020-07-31,https://clinicaltrials.gov/show/NCT04335032,No Results,No Results,No Results,2020-05-04,2020-04-15,None
1123,NCT04337008,ClinicalTrials.gov,2020-04-03,2020-04-03,False,Assistance Publique  Hpitaux de Marseille,Recruiting,Not Applicable,Interventional,France,Renin Angiotensin System - CoronaVirus,Clinical Presentation,No Intervention,50,2020-06-03,2020-07-31,https://clinicaltrials.gov/show/NCT04337008,No Results,No Results,No Results,2020-05-04,2020-04-15,None
1124,NCT04348240,ClinicalTrials.gov,2020-04-15,2020-04-16,False,National Institute of Dental and Craniofacial Research (NIDCR),Recruiting,Not Applicable,Observational,United States,Transmissibility and Viral Load of SARS-CoV-2 in Oral Secretions,Clinical Presentation,No Intervention,60,2020-07-01,2020-07-01,https://clinicaltrials.gov/show/NCT04348240,No Results,No Results,No Results,2020-05-04,2020-04-22,None
1125,NCT04348929,ClinicalTrials.gov,2020-04-10,2020-04-16,False,CHU de Nancy,Recruiting,Not Applicable,Interventional,France,Birth Experience During COVID-19 Confinement,Clinical Presentation,No Intervention,600,2021-08-16,2021-11-01,https://clinicaltrials.gov/show/NCT04348929,No Results,No Results,No Results,2020-05-04,2020-04-22,None
1126,NCT04338009,ClinicalTrials.gov,2020-04-01,2020-03-31,True,University of Pennsylvania,Recruiting,Not Applicable,Interventional,United States,Elimination or Prolongation of ACE Inhibitors and ARB in Coronavirus Disease 2019,Drug,ACE inhibitors or ARBs,152,2020-12-31,2020-12-31,https://clinicaltrials.gov/show/NCT04338009,No Results,No Results,No Results,2020-05-04,2020-04-15,None
1127,NCT04343092,ClinicalTrials.gov,2020-04-05,2020-04-18,False,University of Baghdad,Recruiting,Phase 1,Interventional,Iraq,Ivermectin Adjuvant to Hydroxychloroquin and Azithromycine in COVID19 Patients,Drug,Ivermectin + hydroxychloroquine vs. hydroxychloroquine,50,2020-08-01,2020-08-01,https://clinicaltrials.gov/show/NCT04343092,No Results,No Results,No Results,2020-05-04,2020-04-15,None
1128,NCT04339712,ClinicalTrials.gov,2020-04-01,2020-04-02,True,Hellenic Institute for the Study of Sepsis,Recruiting,Phase 2,Interventional,Greece,Personalised Immunotherapy for SARS-CoV-2 (COVID-19) Associated With Organ Dysfunction,Drug,Anakinra or Tocilizumab,40,2022-04-01,2022-04-01,https://clinicaltrials.gov/show/NCT04339712,No Results,No Results,No Results,2020-05-04,2020-04-15,EUCTR2020-001039-29
1129,NCT04342689,ClinicalTrials.gov,2020-04-08,2020-05-01,False,Yale University,Not Recruiting,Phase 3,Interventional,No Country Given,The Role of Resistant Starch in COVID-19 Infection,Supplement,Resistant Potato Starch,1500,2021-05-01,2021-05-01,https://clinicaltrials.gov/show/NCT04342689,No Results,No Results,No Results,2020-05-04,2020-04-15,None
1130,NCT04349202,ClinicalTrials.gov,2020-04-13,2020-04-10,True,William Beaumont Hospitals,Recruiting,Not Applicable,Observational,United States,Beaumont Health Large-scale Automated Serologic Testing for COVID-19,Clinical Presentation,No Intervention,50000,2021-06-01,2021-06-01,https://clinicaltrials.gov/show/NCT04349202,No Results,No Results,No Results,2020-05-04,2020-04-22,None
1131,NCT04353037,ClinicalTrials.gov,2020-04-09,2020-04-07,True,UnitedHealth Group,Recruiting,Phase 2,Interventional,United States,PATCH 2&3:Prevention & Treatment of COVID-19 (Severe Acute Respiratory Syndrome Coronavirus 2) With Hydroxychloroquine,Drug,Hydroxychloroquine,850,2021-04-01,2021-06-15,https://clinicaltrials.gov/show/NCT04353037,No Results,No Results,No Results,2020-05-04,2020-04-29,None
1132,NCT04343976,ClinicalTrials.gov,2020-04-09,2020-05-15,False,Raymond Chung,Not Recruiting,Phase 2,Interventional,United States,Pegylated Interferon Lambda Treatment for COVID-19,Drug,Interferon lambda,20,2020-10-01,2021-12-31,https://clinicaltrials.gov/show/NCT04343976,No Results,No Results,No Results,2020-05-04,2020-04-22,None
1133,NCT04344431,ClinicalTrials.gov,2020-04-09,2020-04-14,False,Direction Centrale du Service de Sant des Armes,Recruiting,Phase 2/Phase 3,Interventional,France,Management by Hyperbaric Oxygen Therapy of Patients With Hypoxaemic Pneumonia With SARS-CoV-2 (COVID-19),Drug,Oxygen,100,2021-04-01,2021-05-01,https://clinicaltrials.gov/show/NCT04344431,No Results,No Results,No Results,2020-05-04,2020-04-22,None
1134,NCT04344184,ClinicalTrials.gov,2020-04-09,2020-06-01,False,Virginia Commonwealth University,Not Recruiting,Phase 2,Interventional,United States,Early Infusion of Vitamin C for Treatment of Novel COVID-19 Acute Lung Injury (EVICT-CORONA-ALI),Drug,Vitamin C,200,2021-05-01,2021-05-01,https://clinicaltrials.gov/show/NCT04344184,No Results,No Results,No Results,2020-05-04,2020-04-22,None
1135,NCT04344327,ClinicalTrials.gov,2020-04-09,2020-04-10,False,French Cardiology Society,Not Recruiting,Not Applicable,Observational,France,Early Risk Stratification of Patient Hospitalized for SARS-CoV2 Infection: Critical COVID-19 France CCF,Clinical Presentation,No Intervention,2878,2020-04-21,2020-04-21,https://clinicaltrials.gov/show/NCT04344327,No Results,No Results,No Results,2020-05-04,2020-04-22,None
1136,NCT04353128,ClinicalTrials.gov,2020-04-16,2020-04-01,True,Instituto de Investigacin Hospital Universitario La Paz,Not Recruiting,Phase 2/Phase 3,Interventional,No Country Given,Efficacy of Melatonin in the Prophylaxis of Coronavirus Disease 2019 (COVID-19) Among Healthcare Workers.,Drug (Chemoprophylaxis),Melatonin,450,2021-04-01,2021-07-01,https://clinicaltrials.gov/show/NCT04353128,No Results,No Results,No Results,2020-05-04,2020-04-29,None
1137,NCT04353518,ClinicalTrials.gov,2020-04-16,2020-04-30,False,Cadila Pharnmaceuticals,Not Recruiting,Phase 3,Interventional,No Country Given,Clinical Trial to Evaluate Mycobacterium w in Preventing COVID-19 in Subjects at Risk of Getting Infected With COVID-19,Drug,Mycobacterium,4000,2021-03-30,2021-05-30,https://clinicaltrials.gov/show/NCT04353518,No Results,No Results,No Results,2020-05-04,2020-04-29,None
1138,NCT04347993,ClinicalTrials.gov,2020-04-13,2020-03-27,True,Hackensack Meridian Health,Recruiting,Not Applicable,Observational,United States,"A Prospective ""Universal"" Observational Database for COVID-19",Clinical Presentation,No Intervention,5000,2021-04-01,2021-04-01,https://clinicaltrials.gov/show/NCT04347993,Pre-Print Article,2020-04-29,https://doi.org/10.1101/2020.04.24.20077388,2020-05-04,2020-04-22,None
1139,NCT04351724,ClinicalTrials.gov,2020-04-10,2020-04-16,True,Medical University of Vienna,Recruiting,Phase 2/Phase 3,Interventional,Austria,Austrian CoronaVirus Adaptive Clinical Trial (COVID-19),Drug,"Chloroquine or Hydroxychloroquine vs. lopinavir/ritonavir

Substudies: Rovaroxaban, Clazakizumab, Candesartan",500,2020-12-01,2020-12-31,https://clinicaltrials.gov/show/NCT04351724,No Results,No Results,No Results,2020-05-04,2020-04-22,EUCTR2020-001302-30
1140,NCT04353596,ClinicalTrials.gov,2020-04-14,2020-04-15,False,Medical University Innsbruck,Recruiting,Phase 4,Interventional,"Germany, Austria",Stopping ACE-inhibitors in COVID-19,Drug,ACE inhibitors or ARBs,208,2021-05-15,2022-05-15,https://clinicaltrials.gov/show/NCT04353596,No Results,No Results,No Results,2020-05-04,2020-04-29,None
1141,NCT04354389,ClinicalTrials.gov,2020-04-15,2020-04-25,False,"Ansun Biopharma, Inc.",Not Recruiting,Phase 2/Phase 3,Interventional,Italy,DAS181 for STOP COVID-19,Drug,DAS181,82,2020-06-30,2020-10-31,https://clinicaltrials.gov/show/NCT04354389,No Results,No Results,No Results,2020-05-04,2020-04-29,None
1142,NCT04345861,ClinicalTrials.gov,2020-04-05,2020-04-11,False,"University Hospital, Montpellier",Recruiting,Phase 2/Phase 3,Interventional,France,Hydroxychloroquine Plus Azithromycin Versus Hydroxychloroquine for COVID-19 Pneumonia (COVIDOC Trial),Drug,Hydroxychloroquine + Azithromycin vs. Hydroxychloroquine,150,2020-09-06,2021-04-06,https://clinicaltrials.gov/show/NCT04345861,No Results,No Results,No Results,2020-05-04,2020-04-22,None
1143,NCT04347681,ClinicalTrials.gov,2020-04-08,2020-04-12,False,King Fahad Specialist Hospital,Recruiting,Phase 2,Interventional,Saudi Arabia,Potential Efficacy of Convalescent Plasma to Treat Severe COVID-19 and Patients at High Risk of Developing Severe COVID-19,ATMP,Plasma,40,2020-12-31,2021-04-11,https://clinicaltrials.gov/show/NCT04347681,No Results,No Results,No Results,2020-05-04,2020-04-22,None
1144,NCT04352348,ClinicalTrials.gov,2020-03-31,2020-03-31,False,Assistance Publique  Hpitaux de Paris,Recruiting,Not Applicable,Interventional,France,Cohort of Patients Infected With SARS-CoV2 (COVID-19) or Suspected of Being,Prognosis,No Intervention,2000,2021-05-31,2022-03-31,https://clinicaltrials.gov/show/NCT04352348,No Results,No Results,No Results,2020-05-04,2020-04-29,None
1145,NCT04352491,ClinicalTrials.gov,2020-04-14,2020-04-22,False,"Institute of Liver and Biliary Sciences, India",Recruiting,Not Applicable,Observational,India,An Online Survey to Understand Feelings Related to COVID-19 Among ILBS Patients With Liver Disease,Other (psych),No Intervention,1500,2020-04-30,2020-04-30,https://clinicaltrials.gov/show/NCT04352491,No Results,No Results,No Results,2020-05-04,2020-04-29,None
1146,NCT04347694,ClinicalTrials.gov,2020-04-12,2020-04-11,True,Medical University of Vienna,Recruiting,Not Applicable,Observational,Austria,Study to Determine the Immunization Status Among Nephrological Health Care Personnel Against SARS-CoV-2 in a Single Center Over the Course of 12 Months During the Worldwide COVID-19 Pandemic.,Clinical Presentation,No Intervention,400,2021-04-11,2021-04-11,https://clinicaltrials.gov/show/NCT04347694,No Results,No Results,No Results,2020-05-04,2020-04-22,None
1147,NCT04347824,ClinicalTrials.gov,2020-04-09,2020-04-27,False,"University Hospital, Gttingen",Recruiting,Not Applicable,Observational,Germany,Predict Adverse Events by Covid-19 Nephritis,Clinical Presentation,No Intervention,100,2020-12-31,2021-12-31,https://clinicaltrials.gov/show/NCT04347824,No Results,No Results,No Results,2020-05-04,2020-04-22,None
1148,NCT04354714,ClinicalTrials.gov,2020-04-16,2020-06-30,False,Washington University in St. Louis,Not Recruiting,Phase 2,Interventional,United States,Ruxolitinib to Combat COVID-19,Drug,Ruxolitinib,25,2021-07-31,2021-12-31,https://clinicaltrials.gov/show/NCT04354714,No Results,No Results,No Results,2020-05-04,2020-04-29,None
1149,NCT04355351,ClinicalTrials.gov,2020-04-17,2020-04-22,False,CHU de Nice,Not Recruiting,Not Applicable,Interventional,France,Study of Immune Response During SARS-CoV-2 Infection - (COVID-19),Clinical Presentation,No Intervention,400,2020-10-22,2020-10-22,https://clinicaltrials.gov/show/NCT04355351,No Results,No Results,No Results,2020-05-04,2020-04-29,None
1150,NCT04352608,ClinicalTrials.gov,2020-04-14,2020-04-16,False,"Sinovac Research and Development Co., Ltd.",Recruiting,Phase 1/Phase 2,Interventional,China,Safety and Immunogenicity Study of Inactivated Vaccine for Prophylaxis of SARS CoV-2 Infection (COVID-19),ATMP,Vaccine,744,2020-08-13,2020-12-13,https://clinicaltrials.gov/show/NCT04352608,No Results,No Results,No Results,2020-05-04,2020-04-29,None
1151,NCT04353609,ClinicalTrials.gov,2020-04-15,2020-04-18,False,"University Hospital, Lille",Recruiting,Not Applicable,Observational,France,"Covid-19 in Patients With Chronic Inflammatory Rheumatism, Auto-immune or Auto-inflammatory Rare and Non-rare Diseases",Clinical Presentation,No Intervention,13770,2020-12-01,2020-12-01,https://clinicaltrials.gov/show/NCT04353609,No Results,No Results,No Results,2020-05-04,2020-04-29,None
1152,ChiCTR2000030708,ChiCTR,2020-03-11,2020-03-10,True,West China Hospital of Sichuan University,Recruiting,Not Applicable,Observational,China,Cross sectional study of dialysis treatment and mental status under the outbreak of novel coronavirus pneumonia (COVID-2019) in China,Other (renal),Dialysis,1000,Not Available,2020-04-02,http://www.chictr.org.cn/showproj.aspx?proj=50083,No Results,No Results,No Results,2020-03-16,2020-03-18,None
1153,NCT04354870,ClinicalTrials.gov,2020-04-16,2020-04-03,True,NYU Langone Health,Recruiting,Phase 2,Interventional,United States,COVID-19 PrEP HCW HCQ Study,Drug,Hydroxychloroquine,350,2020-08-01,2020-09-01,https://clinicaltrials.gov/show/NCT04354870,No Results,No Results,No Results,2020-05-04,2020-04-29,None
1154,NCT04355338,ClinicalTrials.gov,2020-04-17,2020-05-15,False,Butantan Institute,Not Recruiting,Not Applicable,Observational,No Country Given,Assessment of Incidence of SARS-CoV-2 Infection and COVID-19 in Brazil (AVISA),Clinical Presentation (Epidemiology),No Intervention,4100,2020-11-30,2022-05-15,https://clinicaltrials.gov/show/NCT04355338,No Results,No Results,No Results,2020-05-04,2020-04-29,None
1155,NCT04355507,ClinicalTrials.gov,2020-04-17,2020-04-01,True,Assistance Publique  Hpitaux de Paris,Not Recruiting,Not Applicable,Observational,France,Computed Tomography for COVID-19 Diagnosis,Diagnostics,Diagnostic Test or Assessment,10000,2020-05-01,2020-07-01,https://clinicaltrials.gov/show/NCT04355507,No Results,No Results,No Results,2020-05-04,2020-04-29,None
1156,NCT04355702,ClinicalTrials.gov,2020-04-17,2020-03-01,True,"University Hospital, Montpellier",Recruiting,Not Applicable,Observational,France,Covid-19 in Lupus Patients,Clinical Presentation,No Intervention,130,2020-05-01,2020-05-30,https://clinicaltrials.gov/show/NCT04355702,No Results,No Results,No Results,2020-05-04,2020-04-29,None
1157,NCT04348942,ClinicalTrials.gov,2020-04-13,2020-04-20,False,ObvioHealth,Not Recruiting,Not Applicable,Observational,No Country Given,"A COVID-19 Symptom, Exposure and Immune Response Registry",Clinical Presentation,No Intervention,10000,2021-05-01,2021-05-01,https://clinicaltrials.gov/show/NCT04348942,No Results,No Results,No Results,2020-05-04,2020-04-22,None
1158,NCT04350580,ClinicalTrials.gov,2020-04-08,2020-04-11,True,Centre Hospitalier St Anne,Recruiting,Phase 3,Interventional,France,Polyvalent Immunoglobulin in COVID-19 Related ARds,ATMP,Immunoglobulin,138,2020-06-01,2020-08-01,https://clinicaltrials.gov/show/NCT04350580,No Results,No Results,No Results,2020-05-04,2020-04-22,EUCTR2020-001570-30
1159,ChiCTR2000030707,ChiCTR,2020-03-11,2020-03-20,False,"Ganzi Hospital of West China Hospital, Sichuan University",Not Recruiting,Not Applicable,Observational,China,Retrospective study on novel coronavirus pneumonia (COVID-19) in Tibetan Plateau,Clinical Presentation,No Intervention,78,Not Available,2022-03-19,http://www.chictr.org.cn/showproj.aspx?proj=50160,No Results,No Results,No Results,2020-03-16,2020-03-18,None
1160,NCT04355481,ClinicalTrials.gov,2020-04-17,2020-04-17,False,Assistance Publique  Hpitaux de Paris,Recruiting,Not Applicable,Observational,France,Dissemination of SARS-COV-2 (COVID-19) in the Environment of Infected Patients Admitted to Intensive Care Unit,Clinical Presentation,No Intervention,150,2020-10-17,2020-12-17,https://clinicaltrials.gov/show/NCT04355481,No Results,No Results,No Results,2020-05-04,2020-04-29,None
1161,NCT04355884,ClinicalTrials.gov,2020-04-19,2020-04-20,False,The University of Hong Kong,Not Recruiting,Not Applicable,Observational,Hong Kong,Opportunistic Screening for Asymptomatic Left Ventricular Dysfunction in Coronavirus Disease 2019 (COVID19) Survivors,Diagnostics,Diagnostic Test or Assessment,100,2020-05-01,2020-05-01,https://clinicaltrials.gov/show/NCT04355884,No Results,No Results,No Results,2020-05-04,2020-04-29,None
1162,NCT04351854,ClinicalTrials.gov,2020-04-16,2020-04-20,False,University of Cologne,Not Recruiting,Not Applicable,Observational,Germany,Registry for Clinical Presentation and Management of Patients With COVID-19 in the Emergency Room,Clinical Presentation,No Intervention,500,2025-12-31,2026-08-31,https://clinicaltrials.gov/show/NCT04351854,No Results,No Results,No Results,2020-05-04,2020-04-29,None
1163,NCT04352764,ClinicalTrials.gov,2020-04-16,2020-03-27,True,Texas Cardiac Arrhythmia Research Foundation,Recruiting,Not Applicable,Observational,United States,ANTIBODY BASED TESTS FOR SARSCoV-2 COVID-19) - Evaluation of Patients and Healthcare Providers in the Confines of Healthcare Settings,Diagnostics,Diagnostic Test or Assessment,5000,2020-12-31,2021-01-31,https://clinicaltrials.gov/show/NCT04352764,No Results,No Results,No Results,2020-05-04,2020-04-29,None
1164,NCT04356365,ClinicalTrials.gov,2020-04-21,2020-03-31,True,University of Oslo,Not Recruiting,Not Applicable,Observational,Norway,The Mental Health Status of the General Population During the COVID-19 Pandemic and Its Association With Adherence to Government-initiated Non-pharmacological Epidemiological Interventions (NPI's),Other (psych),No Intervention,10084,2020-04-07,2020-04-07,https://clinicaltrials.gov/show/NCT04356365,No Results,No Results,No Results,2020-05-04,2020-04-29,None
1165,NCT04356586,ClinicalTrials.gov,2020-04-17,2020-04-30,False,Sciensano,Recruiting,Not Applicable,Observational,Belgium,Immune Response to Covid-19 in 300 Health Care Workers With Mild Symptoms,Clinical Presentation,No Intervention,300,2020-07-30,2020-07-30,https://clinicaltrials.gov/show/NCT04356586,No Results,No Results,No Results,2020-05-04,2020-04-29,None
1166,ChiCTR2000030690,ChiCTR,2020-03-10,2020-02-10,True,The Third Affiliated Hospital of the Second Military Medical University,Recruiting,Not Applicable,Basic Science,China,Study for immune cell subsets in convalescent patients with novel coronavirus pneumonia (COVID-19),Clinical Presentation,No Intervention,30,Not Available,2021-02-10,http://www.chictr.org.cn/showproj.aspx?proj=50261,Pre-Print Article,2020-03-31,https://doi.org/10.1101/2020.03.23.20039362,2020-03-16,2020-03-18,None
1167,NCT04352946,ClinicalTrials.gov,2020-04-16,2020-04-24,False,GeoSentinel Foundation,Not Recruiting,Phase 3,Interventional,United States,HEalth Care Worker pROphylaxis Against COVID-19: The HERO Trial,Drug (Chemoprophylaxis),Hydroxychloroquine,374,2020-06-24,2020-08-24,https://clinicaltrials.gov/show/NCT04352946,No Results,No Results,No Results,2020-05-04,2020-04-29,None
1168,NCT04354519,ClinicalTrials.gov,2020-04-06,2020-03-14,True,Swansea University,Recruiting,Not Applicable,Observational,United Kingdom,The United Kingdom Multiple Sclerosis Register Covid-19 Substudy,Clinical Presentation,No Intervention,3000,2021-07-14,2022-07-14,https://clinicaltrials.gov/show/NCT04354519,No Results,No Results,No Results,2020-05-04,2020-04-29,None
1169,NCT04357418,ClinicalTrials.gov,2020-04-16,2020-04-01,True,Centre Hospitalier de Ville-Evrard,Not Recruiting,Not Applicable,Observational,France,Psychological Outcome of COVID-19 Lockdown on Psychiatric Hospital Staff and Close Relatives,Other (psych),No Intervention,1320,2020-06-30,2020-06-30,https://clinicaltrials.gov/show/NCT04357418,No Results,No Results,No Results,2020-05-04,2020-04-29,None
1170,NCT04357639,ClinicalTrials.gov,2020-04-20,2020-04-30,False,Centre Hospitalier Intercommunal Creteil,Not Recruiting,Not Applicable,Observational,France,Impact of Long-term Protease Inhibitors in Patients Living With HIV on the Incidence of COVID-19 ( COVIP ),Clinical Presentation,No Intervention,794,2020-05-31,2020-10-31,https://clinicaltrials.gov/show/NCT04357639,No Results,No Results,No Results,2020-05-04,2020-04-29,None
1171,NCT04356560,ClinicalTrials.gov,2020-04-13,2020-03-23,True,"Rigshospitalet, Denmark",Recruiting,Not Applicable,Observational,Denmark,COVID-19 Surveillance of Patients and Healthcare Workers in a Hospital Department,Diagnostics,Diagnostic Test or Assessment,300,2020-09-30,2020-12-31,https://clinicaltrials.gov/show/NCT04356560,No Results,No Results,No Results,2020-05-04,2020-04-29,None
1172,NCT04357431,ClinicalTrials.gov,2020-04-21,2020-04-01,True,Assiut University,Not Recruiting,Not Applicable,Observational,No Country Given,COVID-19 Among Egyptian Health Care Providers,Other,No Intervention,600,2020-05-05,2020-05-30,https://clinicaltrials.gov/show/NCT04357431,No Results,No Results,No Results,2020-05-04,2020-04-29,None
1173,NCT04357613,ClinicalTrials.gov,2020-04-20,2020-05-01,False,Versailles Hospital,Not Recruiting,Phase 2,Interventional,France,IMATINIB IN COVID-19 DISEASE IN AGED PATIENTS.,Drug,Imatinib,99,2020-11-01,2020-12-01,https://clinicaltrials.gov/show/NCT04357613,No Results,No Results,No Results,2020-05-04,2020-04-29,None
1174,ChiCTR2000030580,ChiCTR,2020-03-08,2020-02-01,True,Shanghai General Hospital,Recruiting,Phase 4,Interventional,China,Efficacy and safety of tozumab combined with adamumab(Qletli) in severe and critical patients with novel coronavirus pneumonia (COVID-19),Drug,Adamumab,60,Not Available,2020-03-30,http://www.chictr.org.cn/showproj.aspx?proj=50693,No Results,No Results,No Results,2020-03-16,2020-08-03,None
1175,NCT04355052,ClinicalTrials.gov,2020-04-16,2020-04-11,True,Sheba Medical Center,Recruiting,Phase 3,Interventional,Israel,"Open Label Study to Compare Efficacy, Safety and Tolerability of Hydroxychloroquine Combined With Azithromycin Compared to Hydroxychloroquine Combined With Camostat Mesylate and to ""no Treatment"" in SARS CoV 2 Virus",Drug,Camostat Mesilate + Hydroxychloroquine vs. Hydroxychloroquine + Azithromycin,250,2020-10-11,2020-12-11,https://clinicaltrials.gov/show/NCT04355052,No Results,No Results,No Results,2020-05-04,2020-04-29,None
1176,NCT04355429,ClinicalTrials.gov,2020-04-17,2020-05-05,False,Assistance Publique  Hpitaux de Paris,Not Recruiting,Phase 2,Interventional,France,Efficacy of Captopril in Covid-19 Patients With Severe Acute Respiratory Syndrome (SARS) CoV-2 Pneumonia (CAPTOCOVID),Drug,Captopril,230,2020-07-01,2020-08-01,https://clinicaltrials.gov/show/NCT04355429,No Results,No Results,No Results,2020-05-04,2020-04-29,None
1177,NCT04357782,ClinicalTrials.gov,2020-04-17,2020-04-16,True,Veteran Affairs Medical Center,Recruiting,Phase 1/Phase 2,Interventional,United States,Administration of Intravenous Vitamin C in Novel Coronavirus Infection (COVID-19) and Decreased Oxygenation,Drug,Vitamin C,20,2020-06-01,2020-08-01,https://clinicaltrials.gov/show/NCT04357782,No Results,No Results,No Results,2020-05-04,2020-04-29,None
1178,NCT04357808,ClinicalTrials.gov,2020-04-14,2020-04-13,True,Maria del Rosario Garcia de Vicua Pinedo,Recruiting,Phase 2,Interventional,Spain,Efficacy of Subcutaneous Sarilumab in Hospitalised Patients With Moderate-severe COVID-19 Infection (SARCOVID),Drug,Sarilumab,30,2020-06-01,2020-06-01,https://clinicaltrials.gov/show/NCT04357808,No Results,No Results,No Results,2020-05-04,2020-04-29,None
1179,NCT04358549,ClinicalTrials.gov,2020-04-16,2020-04-17,False,"Fujifilm Pharmaceuticals U.S.A., Inc.",Recruiting,Phase 2,Interventional,United States,Study of the Use of Favipiravir in Hospitalized Subjects With COVID-19,Drug,Favipiravir,50,2020-08-01,2020-12-01,https://clinicaltrials.gov/show/NCT04358549,No Results,No Results,No Results,2020-05-04,2020-04-29,None
1180,NCT04358640,ClinicalTrials.gov,2020-04-21,2020-04-09,True,CHU de Nimes,Recruiting,Not Applicable,Observational,France,Anxiety and Work Resilience Among Tertiary University Hospital Workers During the COVID-19 Outbreak: An Online Survey,Other (psych),No Intervention,2000,2020-04-22,2020-04-22,https://clinicaltrials.gov/show/NCT04358640,No Results,No Results,No Results,2020-05-04,2020-04-29,None
1181,NCT04355715,ClinicalTrials.gov,2020-04-17,2019-04-01,True,"University Hospital, Montpellier",Not Recruiting,Not Applicable,Observational,France,Combination of Chest Scanography and Nasal Viral Detection Test to Detect COVID-19 Positive Patients Before Surgical Intervention in a University Hospital During Coronavirus Pandemia,Diagnostics,Diagnostic Test or Assessment,200,2020-10-01,2020-10-20,https://clinicaltrials.gov/show/NCT04355715,No Results,No Results,No Results,2020-05-04,2020-04-29,None
1182,NCT04355754,ClinicalTrials.gov,2020-04-16,2020-04-15,True,Medical University of Gdask,Recruiting,Not Applicable,Interventional,Poland,Ventil Device Usefulness in Mechanically Ventilated ICU Patients,Other (physical),Mechanical ventilation,40,2020-05-01,2020-12-31,https://clinicaltrials.gov/show/NCT04355754,No Results,No Results,No Results,2020-05-04,2020-04-29,None
1183,NCT04358783,ClinicalTrials.gov,2020-04-21,2020-04-27,False,Hospital Universitario Dr. Jose E. Gonzalez,Not Recruiting,Phase 2,Interventional,Mexico,Convalescent Plasma Compared to the Best Available Therapy for the Treatment of SARS-CoV-2 Pneumonia,ATMP,Plasma,30,2021-02-01,2021-05-30,https://clinicaltrials.gov/show/NCT04358783,No Results,No Results,No Results,2020-05-04,2020-04-29,None
1184,NCT04359290,ClinicalTrials.gov,2020-04-15,2020-05-01,False,Philipps University Marburg Medical Center,Not Recruiting,Phase 2,Interventional,No Country Given,Ruxolitinib for Treatment of Covid-19 Induced Lung Injury ARDS,Drug,Ruxolitinib,15,2020-09-01,2020-11-01,https://clinicaltrials.gov/show/NCT04359290,No Results,No Results,No Results,2020-05-04,2020-04-29,None
1185,NCT04357886,ClinicalTrials.gov,2020-04-20,2020-05-01,False,Istanbul University-Cerrahpasa,Not Recruiting,Not Applicable,Observational,Turkey,Comparison of New Coronavirus (COVID-19) Awareness in Individuals of Different Age Groups: Analysis of Turkey,Other,No Intervention,1000,2020-05-01,2020-06-01,https://clinicaltrials.gov/show/NCT04357886,No Results,No Results,No Results,2020-05-04,2020-04-29,None
1186,NCT04358029,ClinicalTrials.gov,2020-04-20,2020-04-09,True,Vivek Reddy,Recruiting,Not Applicable,Observational,United States,Cardiac Arrhythmias In Patients With Coronavirus Disease (COVID-19),Clinical Presentation,No Intervention,10000,2021-05-01,2021-12-01,https://clinicaltrials.gov/show/NCT04358029,No Results,No Results,No Results,2020-05-04,2020-04-29,None
1187,NCT04355793,ClinicalTrials.gov,2020-04-18,2020-04-15,True,Incyte Corporation,Not Recruiting,Not Applicable,Expanded Access,No Country Given,Expanded Access Program of Ruxolitinib for the Emergency Treatment of Cytokine Storm From COVID-19 Infection,Drug,Ruxolitinib,Not Available,Not Available,Not Available,https://clinicaltrials.gov/show/NCT04355793,No Results,No Results,No Results,2020-05-04,2020-04-29,None
1188,NCT04356677,ClinicalTrials.gov,2020-04-20,2020-04-01,True,"Bausch Health Americas, Inc.",Not Recruiting,Phase 1,Interventional,No Country Given,Study to Evaluate the Safety and Efficacy of VIRAZOLE in Hospitalized Adult Participants With Respiratory Distress Due to COVID-19,Drug,Ribavirin,50,2021-04-01,2021-04-01,https://clinicaltrials.gov/show/NCT04356677,No Results,No Results,No Results,2020-05-04,2020-04-29,None
1189,NCT04359316,ClinicalTrials.gov,2020-04-18,2020-04-20,False,Shahid Beheshti University of Medical Sciences,Not Recruiting,Phase 4,Interventional,Iran,Azithromycin in Hospitalized COVID-19 Patients,Drug,Azithromycin vs. Hydroxychloroquine,40,2020-05-03,2020-05-05,https://clinicaltrials.gov/show/NCT04359316,No Results,No Results,No Results,2020-05-04,2020-04-29,None
1190,NCT04359615,ClinicalTrials.gov,2020-04-18,2020-04-20,False,Shahid Beheshti University of Medical Sciences,Not Recruiting,Phase 4,Interventional,Iran,Favipiravir in Hospitalized COVID-19 Patients,Drug,Favipiravir + Hydroxychloroquine vs. Hydroxychloroquine,40,2020-05-03,2020-05-05,https://clinicaltrials.gov/show/NCT04359615,No Results,No Results,No Results,2020-05-04,2020-04-29,None
1191,NCT04358211,ClinicalTrials.gov,2020-04-17,2020-05-01,False,Dr. Nakhle Saba,Not Recruiting,Not Applicable,Expanded Access,United States,Expanded Access to Convalescent Plasma to Treat and Prevent Pulmonary Complications Associated With COVID-19,ATMP,Plasma,Not Available,Not Available,Not Available,https://clinicaltrials.gov/show/NCT04358211,No Results,No Results,No Results,2020-05-04,2020-04-29,None
1192,NCT04358536,ClinicalTrials.gov,2020-04-20,2020-04-01,True,Dascena,Not Recruiting,Not Applicable,Observational,United States,Classification of COVID-19 Infection in Posteroanterior Chest X-rays,Diagnostics,Diagnostic Test or Assessment,230,2020-04-17,2020-04-17,https://clinicaltrials.gov/show/NCT04358536,No Results,No Results,No Results,2020-05-04,2020-04-29,None
1193,NCT04359095,ClinicalTrials.gov,2020-04-15,2020-05-11,False,National University of Colombia,Not Recruiting,Phase 2/Phase 3,Interventional,Colombia,Effectiveness and Safety of Medical Treatment for SARS-CoV-2 (COVID-19) in Colombia,Drug,Hydroxychloroquine + Azithromycin vs. Hydroxychloroquine + Lopinavir/Ritonavir vs. Hydroxychloroquine,1600,2020-10-11,2020-10-31,https://clinicaltrials.gov/show/NCT04359095,No Results,No Results,No Results,2020-05-04,2020-04-29,None
1194,ChiCTR2000030187,ChiCTR,2020-02-24,2020-02-25,False,Jingzhou First People's Hospital,Recruiting,Not Applicable,Interventional,China,Clinical study for Lopinavir and Ritonavir in the treatment of novel coronavirus pneumonia (COVID-19),Drug,Lopinavir/ritonavir,60,Not Available,2020-03-25,http://www.chictr.org.cn/showproj.aspx?proj=50057,No Results,No Results,No Results,2020-03-16,2020-08-03,None
1195,NCT04357457,ClinicalTrials.gov,2020-04-20,2020-04-01,True,Assistance Publique  Hpitaux de Paris,Not Recruiting,Phase 3,Interventional,France,Efficacy of Intravenous Almitrine in Reducing the Need for Mechanical Ventilation in Patients With Hypoxemic Acute Respiratory Failure Due to Covid-19-related Pneumonia,Drug,Almitrine,212,2020-07-01,2020-07-01,https://clinicaltrials.gov/show/NCT04357457,No Results,No Results,No Results,2020-05-04,2020-04-29,None
1196,NCT04357496,ClinicalTrials.gov,2020-04-20,2020-04-20,False,Centogene,Not Recruiting,Not Applicable,Observational,No Country Given,COVID-19 Epidemic Response Study,Clinical Presentation,No Intervention,400,2020-10-30,2020-10-30,https://clinicaltrials.gov/show/NCT04357496,No Results,No Results,No Results,2020-05-04,2020-04-29,None
1197,NCT04359667,ClinicalTrials.gov,2020-04-16,2020-04-16,False,"University Hospital for Infectious Diseases, Croatia",Recruiting,Not Applicable,Observational,Croatia,Serum IL-6 and Soluble IL-6 Receptor in Severe COVID-19 Pneumonia Treated With Tocilizumab,Drug,Tocilizumab,30,2020-04-16,2021-04-15,https://clinicaltrials.gov/show/NCT04359667,No Results,No Results,No Results,2020-05-04,2020-04-29,None
1198,NCT04359849,ClinicalTrials.gov,2020-04-20,2020-05-01,False,Portsmouth Hospitals NHS Trust,Recruiting,Not Applicable,Observational,United Kingdom,Sequencing and Tracking of Phylogeny in COVID-19 Study,Genomics,No Intervention,500,2022-05-01,2022-09-01,https://clinicaltrials.gov/show/NCT04359849,No Results,No Results,No Results,2020-05-04,2020-04-29,None
1199,NCT04358380,ClinicalTrials.gov,2020-04-18,2020-04-15,True,Austral University,Recruiting,Not Applicable,Observational,Argentina,Liver Injury in Patients With COVID-19,Clinical Presentation,No Intervention,34,2020-12-31,2020-12-31,https://clinicaltrials.gov/show/NCT04358380,No Results,No Results,No Results,2020-05-04,2020-04-29,None
1200,NCT04358406,ClinicalTrials.gov,2020-04-16,2020-06-01,False,BioAegis Therapeutics Inc.,Not Recruiting,Phase 2,Interventional,No Country Given,Rhu-pGSN for Severe Covid-19 Pneumonia,ATMP,Plasma,60,2020-08-01,2020-09-01,https://clinicaltrials.gov/show/NCT04358406,No Results,No Results,No Results,2020-05-04,2020-04-29,None
1201,NCT04359329,ClinicalTrials.gov,2020-04-21,2020-04-20,True,Sharon Nachman,Recruiting,Phase 2,Interventional,United States,Estrogen Patch for COVID-19 Symptoms,Drug,Estradiol,110,2020-11-15,2020-11-15,https://clinicaltrials.gov/show/NCT04359329,No Results,No Results,No Results,2020-05-04,2020-04-29,None
1202,NCT04359537,ClinicalTrials.gov,2020-04-20,2020-04-25,False,Shaheed Zulfiqar Ali Bhutto Medical University,Not Recruiting,Phase 2,Interventional,No Country Given,Efficacy of Various Doses of Hydroxychloroquine in Pre-Exposure Prophylaxis for COVID 19,Drug (Chemoprophylaxis),Hydroxychloroquine,200,2020-08-25,2020-09-25,https://clinicaltrials.gov/show/NCT04359537,No Results,No Results,No Results,2020-05-04,2020-04-29,None
1203,NCT04359875,ClinicalTrials.gov,2020-04-18,2020-04-01,True,CHU de Tours,Not Recruiting,Not Applicable,Interventional,France,A Phone-call With a Student/General Practitioner Team to Impact Morbidity of Chronic Patients During COVID-19 Containment,Telehealth,Telehealth,22000,2020-06-01,2020-12-01,https://clinicaltrials.gov/show/NCT04359875,No Results,No Results,No Results,2020-05-04,2020-04-29,None
1204,NCT04359992,ClinicalTrials.gov,2020-04-16,2020-04-17,False,"University Hospital, Strasbourg",Not Recruiting,Not Applicable,Observational,No Country Given,Study of Hemostasis in Case of Severe COVID-19,Clinical Presentation,No Intervention,50,2021-04-17,2021-05-01,https://clinicaltrials.gov/show/NCT04359992,No Results,No Results,No Results,2020-05-04,2020-04-29,None
1205,NCT04358588,ClinicalTrials.gov,2020-04-21,2014-02-01,True,Bellerophon,Not Recruiting,Not Applicable,Expanded Access,No Country Given,Pulsed Inhaled Nitric Oxide for the Treatment of Patients With Mild or Moderate COVID-19,Drug,Nitric oxide,Not Available,Not Available,Not Available,https://clinicaltrials.gov/show/NCT04358588,No Results,No Results,No Results,2020-05-04,2020-04-29,None
1206,NCT04358614,ClinicalTrials.gov,2020-04-19,2020-03-16,True,Fabrizio Cantini,Not Recruiting,Phase 2/Phase 3,Interventional,Italy,Baricitinib Therapy in COVID-19,Drug,Baricitinib,12,2020-04-05,2020-04-07,https://clinicaltrials.gov/show/NCT04358614,No Results,No Results,No Results,2020-05-04,2020-04-29,None
1207,NCT04358627,ClinicalTrials.gov,2020-04-15,2020-04-15,False,Hospital Clinic of Barcelona,Not Recruiting,Not Applicable,Observational,No Country Given,Dexmedetomidine to Improve Outcomes of ARDS in Critical Care COVID-19 Patients,Drug,Dexmedetomidine,80,2020-05-30,2020-06-30,https://clinicaltrials.gov/show/NCT04358627,No Results,No Results,No Results,2020-05-04,2020-04-29,None
1208,NCT04359836,ClinicalTrials.gov,2020-04-20,2020-04-16,True,ProgenaBiome,Recruiting,Not Applicable,Observational,United States,A Study to Explore the Role of Gut Flora in COVID-19 Infection,Clinical Presentation,No Intervention,250,2021-04-30,2021-07-31,https://clinicaltrials.gov/show/NCT04359836,No Results,No Results,No Results,2020-05-04,2020-04-29,None
1209,NCT04359953,ClinicalTrials.gov,2020-04-17,2020-04-24,True,"University Hospital, Strasbourg",Not Recruiting,Phase 3,Interventional,France,"Efficacy of Hydroxychloroquine, Telmisartan and Azithromycin on the Survival of Hospitalized Elderly Patients With COVID-19",Drug,Hydroxychloroquine + Telmisartan + Azithromycin,1600,2021-06-01,2021-06-01,https://clinicaltrials.gov/show/NCT04359953,No Results,No Results,No Results,2020-05-04,2020-04-22,EUCTR2020-001303-16
1210,NCT04360733,ClinicalTrials.gov,2020-04-22,2020-04-20,True,University of Bonn,Recruiting,Not Applicable,Observational,Germany,Precision Immunology to Determine the Immune Response in Patients With COVID-19,Clinical Presentation,No Intervention,200,2022-04-01,2022-09-01,https://clinicaltrials.gov/show/NCT04360733,No Results,No Results,No Results,2020-05-04,2020-04-29,None
1211,NCT04360850,ClinicalTrials.gov,2020-04-21,2020-04-24,False,University of Washington,Recruiting,Not Applicable,Observational,United States,Use of Telehealth Technology by Mental Health Care Professionals in Times of COVID-19 Pandemic,Telehealth,Telehealth,10000,2025-10-01,2025-10-01,https://clinicaltrials.gov/show/NCT04360850,No Results,No Results,No Results,2020-05-04,2020-04-29,None
1212,NCT04358809,ClinicalTrials.gov,2020-04-21,2020-04-30,False,Cadila Pharnmaceuticals,Not Recruiting,Phase 3,Interventional,No Country Given,"Clinical Trial of Mycobacterium w in COVID-19 Positive Patients, Hospitalized But Not Critically Ill",Drug,Mycobacterium,480,2021-02-28,2021-04-30,https://clinicaltrials.gov/show/NCT04358809,No Results,No Results,No Results,2020-05-04,2020-04-29,None
1213,NCT04358835,ClinicalTrials.gov,2020-04-16,2020-04-20,False,Johns Hopkins University,Not Recruiting,Not Applicable,Interventional,No Country Given,Keto-diet for Intubated Critical Care COVID-19,Other (nutrition),Nutrition,15,2020-08-01,2020-08-01,https://clinicaltrials.gov/show/NCT04358835,No Results,No Results,No Results,2020-05-04,2020-04-29,None
1214,NCT04360096,ClinicalTrials.gov,2020-04-21,2020-06-01,False,"NeuroRx, Inc.",Not Recruiting,Phase 2/Phase 3,Interventional,No Country Given,Inhaled Aviptadil for the Treatment of Non-Acute Lung Injury in COVID-19,Drug,Aviptadil,144,2020-08-01,2020-10-01,https://clinicaltrials.gov/show/NCT04360096,No Results,No Results,No Results,2020-05-04,2020-04-29,None
1215,NCT04360486,ClinicalTrials.gov,2020-04-20,2020-06-01,False,U.S. Army Medical Research and Development Command,Not Recruiting,Not Applicable,Expanded Access,No Country Given,Treatment Of CORONAVIRUS DISEASE 2019 (COVID-19) With Anti-Sars-CoV-2 Convalescent Plasma (ASCoV2CP),ATMP,Plasma,Not Available,Not Available,Not Available,https://clinicaltrials.gov/show/NCT04360486,No Results,No Results,No Results,2020-05-04,2020-04-29,None
1216,NCT04361474,ClinicalTrials.gov,2020-04-22,2020-04-25,False,Fondation Ophtalmologique Adolphe de Rothschild,Not Recruiting,Phase 3,Interventional,No Country Given,Trial Evaluating the Efficacy of Local Budesonide Therapy in the Management of Hyposmia in COVID-19 Patients Without Signs of Severity,Drug,Budesonide,120,2020-04-25,2021-05-25,https://clinicaltrials.gov/show/NCT04361474,No Results,No Results,No Results,2020-05-04,2020-04-29,None
1217,NCT04361500,ClinicalTrials.gov,2020-04-22,2020-04-15,True,Hannover Medical School,Recruiting,Not Applicable,Observational,Germany,Registry of COVID-19 Patients Treated With the Seraph 100 Microbind Affinity Blood Filter,Other (device),Blood filter,100,2020-10-01,2021-10-01,https://clinicaltrials.gov/show/NCT04361500,No Results,No Results,No Results,2020-05-04,2020-04-29,None
1218,NCT04359251,ClinicalTrials.gov,2020-04-13,2020-03-05,True,"Southeast University, China",Not Recruiting,Not Applicable,Interventional,China,Different PEEP Settings of COVID-19 Induced ARDS,Other (physical),Mechanical ventilation,20,2020-03-25,2020-03-25,https://clinicaltrials.gov/show/NCT04359251,No Results,No Results,No Results,2020-05-04,2020-04-29,None
1219,NCT04359264,ClinicalTrials.gov,2020-04-16,2020-04-20,False,"St. Michael's Hospital, Toronto",Not Recruiting,Not Applicable,Interventional,Canada,Direct Income SupporT and Advice Negating Spread of Epidemic COVID-19: a Randomized Controlled Trial,Other,Other,392,2020-12-31,2021-06-30,https://clinicaltrials.gov/show/NCT04359264,No Results,No Results,No Results,2020-05-04,2020-04-29,None
1220,NCT04360538,ClinicalTrials.gov,2020-04-16,2020-04-08,True,University of Chicago,Recruiting,Not Applicable,Observational,United States,Long Term Outcomes of Patients With COVID-19,Clinical Presentation,No Intervention,500,2021-07-01,2021-12-30,https://clinicaltrials.gov/show/NCT04360538,No Results,No Results,No Results,2020-05-04,2020-04-29,None
1221,NCT04360811,ClinicalTrials.gov,2020-04-22,2020-04-17,True,"University Hospital, Toulouse",Recruiting,Not Applicable,Interventional,France,"Assessment of Obstetric, Fetal and Neonatal Risks and Vertical SARS-CoV-2 Transmission During COVID-19 Pandemic",Diagnostics,Diagnostic Test or Assessment,3600,2021-04-01,2022-04-01,https://clinicaltrials.gov/show/NCT04360811,No Results,No Results,No Results,2020-05-04,2020-04-29,None
1222,NCT04361591,ClinicalTrials.gov,2020-04-22,2020-03-01,True,Hospital Clinic of Barcelona,Recruiting,Not Applicable,Observational,Spain,COVID-19 in Liver Transplant Recipients,Clinical Presentation,No Intervention,200,2021-03-01,2021-03-01,https://clinicaltrials.gov/show/NCT04361591,No Results,No Results,No Results,2020-05-04,2020-04-29,None
1223,NCT04361916,ClinicalTrials.gov,2020-04-14,2020-04-21,False,Mario Negri Institute for Pharmacological Research,Recruiting,Not Applicable,Interventional,Italy,Home Care for Patients With COVID-19: Active Monitoring in Two Italian Health Units (Casale Monferrato and Torino),Other,Other,425,2020-10-31,2020-12-31,https://clinicaltrials.gov/show/NCT04361916,No Results,No Results,No Results,2020-05-04,2020-04-29,None
1224,NCT04360863,ClinicalTrials.gov,2020-04-22,2020-04-24,False,The University of Hong Kong,Recruiting,Not Applicable,Observational,Hong Kong,The Impact of COVID-19 Pandemic on the Smoking Behaviour of Young Smokers and the Youth Quitline Service in Hong Kong,Other,No Intervention,150,2020-06-30,2020-06-30,https://clinicaltrials.gov/show/NCT04360863,No Results,No Results,No Results,2020-05-04,2020-05-05,None
1225,NCT04360954,ClinicalTrials.gov,2020-04-20,2020-04-27,False,Washington University in St. Louis,Recruiting,Not Applicable,Observational,United States,Evaluation of Antibody Tests for COVID-19,Diagnostics,Diagnostic Test or Assessment,1000,2020-10-27,2020-10-27,https://clinicaltrials.gov/show/NCT04360954,No Results,No Results,No Results,2020-05-04,2020-04-29,None
1226,NCT04359459,ClinicalTrials.gov,2020-04-20,2020-06-01,False,University Medical Center Groningen,Not Recruiting,Not Applicable,Observational,No Country Given,Nasal Epithelial Genetic and Single Cell RNA COVID-19 Study,Clinical Presentation,No Intervention,150,2022-06-01,2022-06-01,https://clinicaltrials.gov/show/NCT04359459,No Results,No Results,No Results,2020-05-04,2020-04-29,None
1227,NCT04359680,ClinicalTrials.gov,2020-04-20,2020-04-30,False,Romark Laboratories L.C.,Not Recruiting,Phase 3,Interventional,No Country Given,Trial to Evaluate the Efficacy and Safety of Nitazoxanide (NTZ) for Pre- or Post Exposure Prophylaxis of COVID-19 and Other Viral Respiratory Illnesses (VRI) in Healthcare Workers,Drug (Chemoprophylaxis),Nitazoxanide,800,2020-08-31,2020-08-31,https://clinicaltrials.gov/show/NCT04359680,No Results,No Results,No Results,2020-05-04,2020-04-29,None
1228,NCT04362124,ClinicalTrials.gov,2020-04-21,2020-04-01,True,University of Antioquia,Not Recruiting,Phase 3,Interventional,Colombia,Performance Evaluation of BCG Vaccination in Healthcare Personnel to Reduce the Severity of SARS-COV-2 Infection,ATMP,Vaccine,1000,2021-06-01,2021-11-01,https://clinicaltrials.gov/show/NCT04362124,No Results,No Results,No Results,2020-05-04,2020-04-29,None
1229,NCT04362332,ClinicalTrials.gov,2020-04-20,2020-04-14,True,UMC Utrecht,Recruiting,Phase 4,Interventional,Netherlands,"Chloroquine, Hydroxychloroquine or Only Supportive Care in Patients AdmItted With Moderate to Severe COVID-19",Drug,Chloroquine vs. hydroxychloroquine,950,2021-04-14,2021-05-14,https://clinicaltrials.gov/show/NCT04362332,No Results,No Results,No Results,2020-05-04,2020-04-29,None
1230,NCT04361253,ClinicalTrials.gov,2020-04-23,2020-04-01,True,Brigham and Women's Hospital,Not Recruiting,Phase 3,Interventional,No Country Given,Evaluation of SARS-CoV-2 (COVID-19) Antibody-containing Plasma thErapy,ATMP,Plasma,220,2021-06-01,2021-12-01,https://clinicaltrials.gov/show/NCT04361253,No Results,No Results,No Results,2020-05-04,2020-04-29,None
1231,NCT04361604,ClinicalTrials.gov,2020-04-20,2020-04-01,True,Assistance Publique  Hpitaux de Paris,Not Recruiting,Not Applicable,Observational,France,Clinical Characterisation Protocol for COVID-19 in People Living With HIV,Clinical Presentation,No Intervention,270,2020-10-01,2020-10-01,https://clinicaltrials.gov/show/NCT04361604,No Results,No Results,No Results,2020-05-04,2020-04-29,None
1232,NCT04359901,ClinicalTrials.gov,2020-04-20,2020-04-10,True,Westyn Branch-Elliman,Recruiting,Phase 2,Interventional,United States,Sarilumab for Patients With Moderate COVID-19 Disease: A Randomized Controlled Trial With a Play-The-Winner Design,Drug,Sarilumab,120,2022-04-01,2023-04-01,https://clinicaltrials.gov/show/NCT04359901,No Results,No Results,No Results,2020-05-04,2020-04-29,None
1233,NCT04359914,ClinicalTrials.gov,2020-04-19,2020-04-15,True,University of Rostock,Recruiting,Not Applicable,Observational,Germany,Neurocognitive Impairment in Patients With COVID-19,Clinical Presentation,No Intervention,80,2020-12-31,2021-04-01,https://clinicaltrials.gov/show/NCT04359914,No Results,No Results,No Results,2020-05-04,2020-04-29,None
1234,NCT04362358,ClinicalTrials.gov,2020-04-21,2020-05-01,False,"University Hospital, Strasbourg",Not Recruiting,Not Applicable,Interventional,No Country Given,Online Cognitive Behavioral Therapy (CBT) for Stress Disorders in Health Workers Involved in the Care of Patients During the Covid-19 Epidemic,Other (psych),Psychological,120,2021-10-01,2021-10-01,https://clinicaltrials.gov/show/NCT04362358,No Results,No Results,No Results,2020-05-04,2020-04-29,None
1235,NCT04363099,ClinicalTrials.gov,2020-04-23,2020-03-01,True,Maison de Sant Pluridisciplinaire de Creil,Recruiting,Not Applicable,Observational,France,Multicentre Observational Study on Management COVID 19 Positive Outpatients in a French Cluster.,Clinical Presentation (Epidemiology),No Intervention,1000,2020-06-30,2020-12-31,https://clinicaltrials.gov/show/NCT04363099,No Results,No Results,No Results,2020-05-04,2020-05-05,None
1236,NCT04363541,ClinicalTrials.gov,2020-04-23,2020-04-01,True,Instituto Nacional de Perinatologa,Not Recruiting,Not Applicable,Interventional,No Country Given,Local Thermotherapy for Patients With Moderate Symptoms of COVID-19,Other (device),Heating pad,298,2020-09-01,2020-11-01,https://clinicaltrials.gov/show/NCT04363541,No Results,No Results,No Results,2020-05-04,2020-05-05,None
1237,NCT04363749,ClinicalTrials.gov,2020-04-20,2020-04-27,False,Assistance Publique  Hpitaux de Paris,Not Recruiting,Not Applicable,Interventional,No Country Given,COVID-19 Infection: Exploration of Respiratory Control Center Abnormalities,Other,Other,30,2021-04-27,2021-11-27,https://clinicaltrials.gov/show/NCT04363749,No Results,No Results,No Results,2020-05-04,2020-05-05,None
1238,NCT04361838,ClinicalTrials.gov,2020-04-16,2020-05-01,False,Kansas City Heart Rhythm Institute,Not Recruiting,Not Applicable,Interventional,No Country Given,The COVID-19 ICU PRAYER Study,Other,Other,1000,2020-08-31,2020-08-31,https://clinicaltrials.gov/show/NCT04361838,No Results,No Results,No Results,2020-05-04,2020-04-29,None
1239,NCT04361903,ClinicalTrials.gov,2020-04-14,2020-04-25,False,Azienda Unit Sanitaria Locale Toscana Nord Ovest,Not Recruiting,Not Applicable,Observational,No Country Given,Ruxolitinib for the Treatment of Acute Respiratory Distress Syndrome in Patients With COVID-19 Infection,Drug,Ruxolitinib,13,2020-05-24,2020-05-31,https://clinicaltrials.gov/show/NCT04361903,No Results,No Results,No Results,2020-05-04,2020-04-29,None
1240,NCT04360356,ClinicalTrials.gov,2020-04-19,2020-05-01,False,Tanta University,Not Recruiting,Phase 2/Phase 3,Interventional,No Country Given,Ivermectin and Nitazoxanide Combination Therapy for COVID-19,Drug,Ivermectin + Nitazoxanide,100,2020-10-01,2020-12-01,https://clinicaltrials.gov/show/NCT04360356,No Results,No Results,No Results,2020-05-04,2020-04-29,None
1241,NCT04360551,ClinicalTrials.gov,2020-04-21,2020-07-01,False,University of Hawaii,Not Recruiting,Phase 2,Interventional,United States,Pilot Clinical Trial of the Safety and Efficacy of Telmisartan for the Mitigation of Pulmonary and Cardiac Complications in COVID-19 Patients,Drug,Telmisartan,40,2021-06-30,2021-06-30,https://clinicaltrials.gov/show/NCT04360551,No Results,No Results,No Results,2020-05-04,2020-04-29,None
1242,NCT04362995,ClinicalTrials.gov,2020-04-22,2020-04-23,False,St. Jude Children's Research Hospital,Recruiting,Not Applicable,Observational,United States,St. Jude Tracking of Viral and Host Factors Associated With COVID-19,Clinical Presentation,No Intervention,1517,2021-04-20,2025-03-20,https://clinicaltrials.gov/show/NCT04362995,No Results,No Results,No Results,2020-05-04,2020-05-05,None
1243,NCT04363346,ClinicalTrials.gov,2020-04-23,2020-05-04,False,University of Minnesota,Not Recruiting,Phase 1,Interventional,United States,Study of FT516 for the Treatment of COVID-19 in Hospitalized Patients With Hypoxia,Drug,FT516,12,2022-01-01,2022-01-01,https://clinicaltrials.gov/show/NCT04363346,No Results,No Results,No Results,2020-05-04,2020-05-05,None
1244,NCT04363866,ClinicalTrials.gov,2020-04-24,2020-05-01,False,Oregon Health and Science University,Not Recruiting,Phase 4,Interventional,United States,A Pilot Study to Assess Hydroxychloroquine in Patients With SARS-CoV-2 (COVID-19),Drug,Hydroxychloroquine,40,2020-12-01,2021-06-01,https://clinicaltrials.gov/show/NCT04363866,No Results,No Results,No Results,2020-05-04,2020-05-05,None
1245,NCT04364984,ClinicalTrials.gov,2020-04-23,2020-04-01,True,Medical Practice Prof D. Ivanov,Recruiting,Not Applicable,Observational,Ukraine,"ARB, ACEi, DRi in COVID-19",Drug,ACE inhibitors,10,2021-04-01,2021-08-01,https://clinicaltrials.gov/show/NCT04364984,No Results,No Results,No Results,2020-05-04,2020-05-05,None
1246,NCT04360759,ClinicalTrials.gov,2020-04-22,2020-05-01,False,University of Cape Town,Not Recruiting,Phase 3,Interventional,South Africa,Chloroquine Outpatient Treatment Evaluation for HIV-Covid-19,Drug,Chloroquine or hydroxychloroquine,560,2021-05-31,2021-07-31,https://clinicaltrials.gov/show/NCT04360759,No Results,No Results,No Results,2020-05-04,2020-04-29,None
1247,NCT04360980,ClinicalTrials.gov,2020-04-22,2020-03-20,True,Shahid Beheshti University of Medical Sciences,Recruiting,Phase 2,Interventional,Iran,The Effects of Standard Protocol With or Without Colchicine in Covid-19 Infection,Drug,Colchicine,80,2020-05-20,2020-05-30,https://clinicaltrials.gov/show/NCT04360980,No Results,No Results,No Results,2020-05-04,2020-04-29,None
1248,NCT04365634,ClinicalTrials.gov,2020-04-25,2020-02-02,True,Tongji Hospital,Not Recruiting,Not Applicable,Observational,China,A Single-center Retrospective Study to Find Prediction Factors Related to Mortality of COVID-19 Patients.,Clinical Presentation,No Intervention,306,2020-03-15,2020-04-01,https://clinicaltrials.gov/show/NCT04365634,No Results,No Results,No Results,2020-05-04,2020-05-05,None
1249,NCT04365699,ClinicalTrials.gov,2020-04-25,2020-04-08,True,NYU Langone Health,Recruiting,Phase 2,Interventional,United States,Cardiovascular Effects of COVID-19,Drug,AT-001,500,2020-12-31,2020-12-31,https://clinicaltrials.gov/show/NCT04365699,No Results,No Results,No Results,2020-05-04,2020-05-05,None
1250,NCT04264533,ClinicalTrials.gov,2020-02-04,2020-02-14,False,ZhiYong Peng,Recruiting,Phase 2,Interventional,China,Vitamin C Infusion for the Treatment of Severe 2019-nCoV Infected Pneumonia,Drug,Vitamin C,140,2020-09-30,2020-09-30,https://clinicaltrials.gov/show/NCT04264533,No Results,No Results,No Results,2020-03-23,2020-08-03,None
1251,NCT04308187,ClinicalTrials.gov,2020-03-12,2020-03-11,True,"University Hospital, Clermont-Ferrand",Not Recruiting,Not Applicable,Observational,France,Influence of the COvid-19 Epidemic on STRESS,Other (psych),No Intervention,50000,2022-03-01,2022-03-01,https://clinicaltrials.gov/show/NCT04308187,No Results,No Results,No Results,2020-03-23,2020-03-18,None
1252,NCT04363463,ClinicalTrials.gov,2020-04-22,2020-05-01,False,Centre Hospitalier Rgional d'Orlans,Not Recruiting,Not Applicable,Interventional,France,Impact of Prone Position in Patients Under Spontaneous Breathing on Intubation or Non-invasive Ventilation or Death Incidence During COVID-19 Acute Respiratory Distress,Procedure,Positioning,400,2022-05-01,2022-05-01,https://clinicaltrials.gov/show/NCT04363463,No Results,No Results,No Results,2020-05-04,2020-05-05,None
1253,NCT04363528,ClinicalTrials.gov,2020-04-23,2020-04-27,False,Versailles Hospital,Not Recruiting,Not Applicable,Interventional,France,Incidence of Deep Vein Thrombosis at Doppler Echo in Covid-19 Patients With SARS-Cov-2 Pneumopathy Hospitalized in ICU,Clinical Presentation,No Intervention,50,2020-10-30,2020-10-30,https://clinicaltrials.gov/show/NCT04363528,No Results,No Results,No Results,2020-05-04,2020-05-05,None
1254,NCT04361019,ClinicalTrials.gov,2020-04-22,2020-04-16,True,Basque Country University,Recruiting,Not Applicable,Observational,Spain,Physical Activity in University Students Around COVID-19 Confinement,Other (exercise),No Intervention,25000,2020-10-20,2020-10-20,https://clinicaltrials.gov/show/NCT04361019,No Results,No Results,No Results,2020-05-04,2020-04-29,None
1255,NCT04361422,ClinicalTrials.gov,2020-04-21,2020-04-21,False,Tanta University,Not Recruiting,Phase 3,Interventional,No Country Given,Isotretinoin in Treatment of COVID-19,Drug,Isotretinoin,300,2020-06-01,2020-09-01,https://clinicaltrials.gov/show/NCT04361422,No Results,No Results,No Results,2020-05-04,2020-04-29,None
1256,NCT04363671,ClinicalTrials.gov,2020-04-21,2020-05-01,False,Hpital Cochin,Not Recruiting,Not Applicable,Observational,France,Adolescents and Health Professionals Faced With the Necessity for Changing to Remote Care During the COVID-19 Outbreak Quarantine (AdoPro-Cov19),Other (psych),No Intervention,30,2020-06-01,2020-12-01,https://clinicaltrials.gov/show/NCT04363671,No Results,No Results,No Results,2020-05-04,2020-05-05,None
1257,NCT04363788,ClinicalTrials.gov,2020-04-23,2020-02-28,True,Lazarski University,Not Recruiting,Not Applicable,Observational,Poland,Needle Stick Injuries in Emergency Medical Service Practice,Procedure,Double Gloves,300,2020-04-24,2020-04-24,https://clinicaltrials.gov/show/NCT04363788,No Results,No Results,No Results,2020-05-04,2020-05-05,None
1258,NCT04365725,ClinicalTrials.gov,2020-04-25,2020-04-01,True,Assistance Publique  Hpitaux de Paris,Not Recruiting,Not Applicable,Observational,France,"Multicenter, Retrospective Study of the Effects of Remdesivir in the Treatment of Severe Covid-19 Infections",Drug,Remdesivir,200,2020-06-01,2020-06-01,https://clinicaltrials.gov/show/NCT04365725,No Results,No Results,No Results,2020-05-04,2020-05-05,None
1259,NCT04365959,ClinicalTrials.gov,2020-04-21,2020-03-20,True,University of Milano Bicocca,Not Recruiting,Not Applicable,Observational,Italy,The Prone Position in Covid-19 Affected Patients,Procedure,Positioning,56,2020-04-09,2020-05-31,https://clinicaltrials.gov/show/NCT04365959,No Results,No Results,No Results,2020-05-04,2020-05-05,None
1260,NCT04361435,ClinicalTrials.gov,2020-04-12,2020-05-01,False,St. Justine's Hospital,Not Recruiting,Not Applicable,Interventional,No Country Given,Lung Recruitment Device for COVID-19,Other (physio),Physio,50,2020-07-31,2020-12-31,https://clinicaltrials.gov/show/NCT04361435,No Results,No Results,No Results,2020-05-04,2020-04-29,None
1261,NCT04361448,ClinicalTrials.gov,2020-04-20,2020-04-20,False,Jessa Hospital,Not Recruiting,Not Applicable,Interventional,Belgium,Performance of 3 Sampling Methods for the Detection of SARS-CoV-2 (COVID-19) With Real-time Reverse Transcriptase PCR,Diagnostics,Diagnostic Test or Assessment,30,2020-05-20,2020-05-20,https://clinicaltrials.gov/show/NCT04361448,No Results,No Results,No Results,2020-05-04,2020-04-29,None
1262,NCT04366050,ClinicalTrials.gov,2020-04-24,2020-04-01,True,"University of California, San Diego",Not Recruiting,Phase 2,Interventional,No Country Given,Ramipril for the Treatment of COVID-19,Drug,Ramipril,560,2021-04-01,2021-04-01,https://clinicaltrials.gov/show/NCT04366050,No Results,No Results,No Results,2020-05-04,2020-05-05,None
1263,ACTRN12620000516987,ANZCTR,2020-04-27,2020-06-02,False,University of Auckland,Not Recruiting,Not Applicable,Interventional,New Zealand,Testing a wellbeing app to support wellbeing during the Covid-19 pandemic,Other (psych),Psychological,90,Not Available,Not Available,https://anzctr.org.au/ACTRN12620000516987.aspx,No Results,No Results,No Results,2020-05-04,2020-04-29,None
1264,ChiCTR2000031115,ChiCTR,2020-03-22,2020-05-01,False,Zhengzhou People's Hospital,Recruiting,Not Applicable,Observational,China,A medical records based study of peripheral blood T lymphocyte subsets in patients with novel coronavirus pneumonia (COVID-19),Clinical Presentation,No Intervention,30,Not Available,2021-03-31,http://www.chictr.org.cn/showproj.aspx?proj=51032,No Results,No Results,No Results,2020-03-23,2020-03-25,None
1265,NCT04363853,ClinicalTrials.gov,2020-04-17,2020-04-01,True,Instituto Nacional de Cancerologa,Recruiting,Phase 2,Interventional,Mexico,Tocilizumab Treatment in Patients With COVID-19,Drug,Tocilizumab,200,2020-06-01,2020-08-01,https://clinicaltrials.gov/show/NCT04363853,No Results,No Results,No Results,2020-05-04,2020-05-05,None
1266,NCT04365738,ClinicalTrials.gov,2020-04-26,2020-03-11,True,Istanbul Bilgi University,Not Recruiting,Not Applicable,Interventional,Turkey,Pulmonary Rehabilitation in Post-Acute Period of COVID-19 Infection,Other (physio),Physio,270,2020-04-10,2020-04-26,https://clinicaltrials.gov/show/NCT04365738,No Results,No Results,No Results,2020-05-04,2020-05-05,None
1267,NCT04361461,ClinicalTrials.gov,2020-04-22,2020-05-04,False,Apsen Farmaceutica S.A.,Not Recruiting,Phase 3,Interventional,Brazil,Use of Hydroxychloroquine Alone or Associated for Inpatients With SARS-CoV2 Virus (COVID-19),Drug,Hydroxychloroquine + Azythromycin vs. Hydroxychloroquine,500,2020-11-04,2020-11-04,https://clinicaltrials.gov/show/NCT04361461,No Results,No Results,No Results,2020-05-04,2020-04-29,None
1268,NCT04362085,ClinicalTrials.gov,2020-04-20,2020-04-01,True,"St. Michael's Hospital, Toronto",Not Recruiting,Phase 3,Interventional,No Country Given,Coagulopathy of COVID-19: A Pragmatic Randomized Controlled Trial of Therapeutic Anticoagulation Versus Standard Care,Drug,Heparin,462,2020-11-01,2020-12-01,https://clinicaltrials.gov/show/NCT04362085,No Results,No Results,No Results,2020-05-04,2020-04-29,None
1269,ISRCTN43900695,ISRCTN,2020-04-08,2020-05-04,False,Northumbria University,Recruiting,Not Applicable,Interventional,United Kingdom,Testing an early online intervention for the treatment of disturbed sleep during the COVID-19 pandemic,Other,Sleep aids,75,Not Available,2022-04-06,http://isrctn.com/ISRCTN43900695,No Results,No Results,No Results,2020-05-04,2020-04-15,None
1270,ChiCTR2000030992,ChiCTR,2020-03-20,2020-03-10,True,"Changzheng Hospital, Naval Military Medical University, Shanghai",Recruiting,Not Applicable,Diagnostic test,No Country Given,A medical records based study for the diagnosis and prognosis prediction AI model of novel coronavirus pneumonia (COVID-19),Diagnostics,Diagnostic Test or Assessment,1000,Not Available,2023-02-28,http://www.chictr.org.cn/showproj.aspx?proj=51338,No Results,No Results,No Results,2020-03-23,2020-03-25,None
1271,NCT04366830,ClinicalTrials.gov,2020-04-24,2020-04-01,True,Mesoblast International Srl,Not Recruiting,Not Applicable,Expanded Access,United States,"Intermediate-size Expanded Access Program (EAP), Mesenchymal Stromal Cells (MSC) for Acute Respiratory Distress Syndrome (ARDS) Due to COVID-19 Infection",ATMP,Cells (mesenchymal),Not Available,Not Available,Not Available,https://clinicaltrials.gov/show/NCT04366830,No Results,No Results,No Results,2020-05-04,2020-05-05,None
1272,ACTRN12620000512921,ANZCTR,2020-04-27,2020-04-29,False,Gold Coast University Hospital,Not Recruiting,Not Applicable,Observational,Australia,SARS-CoV2 in children presenting to hospital: A repeating point prevalence study during the COVID-19 pandemic in South East Queensland,Clinical Presentation (Epidemiology),No Intervention,400,Not Available,2020-09-18,https://anzctr.org.au/ACTRN12620000512921.aspx,No Results,No Results,No Results,2020-05-04,2020-04-29,None
1273,ChiCTR2000032573,ChiCTR,2020-05-03,2020-05-02,True,The First Affiliated Hospital of Guangzhou Medical University,Not Recruiting,Not Applicable,Interventional,China,"A randomized, double-blind, controlled trial for Bu-Fei-Huo-Xue Capsule in the treatment of novel coronavirus pneumonia (COVID-19) convalescence patient with ''Fei-Pi-Qi-Xu zhen''",Traditional Medicine (Drug),Traditional Medicine,120,Not Available,2021-05-01,http://www.chictr.org.cn/showproj.aspx?proj=53225,No Results,No Results,No Results,2020-05-04,2020-05-05,None
1274,NCT04362111,ClinicalTrials.gov,2020-04-21,2020-05-01,False,University of Alabama at Birmingham,Not Recruiting,Phase 3,Interventional,No Country Given,Early Identification and Treatment of Cytokine Storm Syndrome in Covid-19,Drug,Anakinra,20,2020-07-01,2020-12-01,https://clinicaltrials.gov/show/NCT04362111,No Results,No Results,No Results,2020-05-04,2020-04-29,None
1275,NCT04362319,ClinicalTrials.gov,2020-04-23,2020-05-01,False,University of Malaya,Not Recruiting,Not Applicable,Observational,No Country Given,Burnout and Medical Errors in the Anaesthesiology Fraternity During Covid-19 Pandemic,Other (psych),No Intervention,88,2020-05-31,2020-06-30,https://clinicaltrials.gov/show/NCT04362319,No Results,No Results,No Results,2020-05-04,2020-04-29,None
1276,ChiCTR2000032487,ChiCTR,2020-04-29,2020-03-26,True,Shanghai Public Health Clinical Center,Not Recruiting,Phase 4,Interventional,China,Study for using sulfate in the prevention and control of novel coronavirus pneumonia (COVID-19) in high and low prevalence communities,Drug (Chemoprophylaxis),Hydroxychloroquine,2000,Not Available,2020-09-30,http://www.chictr.org.cn/showproj.aspx?proj=52394,No Results,No Results,No Results,2020-05-04,2020-05-05,None
1277,ACTRN12620000517976,ANZCTR,2020-04-27,2020-05-21,False,"St. Vincents Hospital, Melbourne",Not Recruiting,Phase 3,Interventional,Australia,COVID-19: Can Nebulised HepArin Reduce Time to Extubation in SARS-CoV-2 patients requiring mechanical ventilation (CHARTER Study),Drug,Heparin,172,Not Available,2021-07-25,https://anzctr.org.au/ACTRN12620000517976.aspx,No Results,No Results,No Results,2020-05-04,2020-04-29,None
1278,NCT04362930,ClinicalTrials.gov,2020-04-24,2020-04-24,False,Assistance Publique  Hpitaux de Paris,Not Recruiting,Not Applicable,Observational,No Country Given,Cohort of Patients With Covid-19 Presenting Neurological or Psychiatric Disorders (CoCo-Neurosciences),Clinical Presentation,No Intervention,2000,2022-04-24,2022-04-24,https://clinicaltrials.gov/show/NCT04362930,No Results,No Results,No Results,2020-05-04,2020-05-05,None
1279,NCT04362943,ClinicalTrials.gov,2020-04-22,2020-04-20,True,Complejo Hospitalario Universitario de Albacete,Recruiting,Not Applicable,Observational,Spain,Clinical-epidemiological Characterization of COVID-19 Disease in Hospitalized Older Adults,Drug,Baricitinib or Anakinra,576,2020-05-15,2020-07-31,https://clinicaltrials.gov/show/NCT04362943,No Results,No Results,No Results,2020-05-04,2020-05-05,None
1280,ISRCTN13311119,ISRCTN,2020-04-24,2020-04-30,False,Eminentlabs GmbH,Recruiting,Phase 2,Interventional,India,START (Siddha Treatment Accelerating Recovery from SARS-CoV-2 Test) trial of Siddha treatment for patients with novel coronavirus infectious disease (COVID-19),Traditional Medicine (Drug),Traditional Medicine,116,Not Available,2020-06-26,http://isrctn.com/ISRCTN13311119,No Results,No Results,No Results,2020-05-04,2020-04-29,None
1281,ChiCTR2000032460,ChiCTR,2020-04-29,2020-01-20,True,The First Affiliated Hospital of University of Science and Technology of China (Anhui Provincial Hospital),Not Recruiting,Not Applicable,Diagnostic test,China,Early warning model and new biomarker of severe novel coronavirus pneumonia (COVID-19),Diagnostics,Diagnostic Test or Assessment,76,Not Available,2020-05-30,http://www.chictr.org.cn/showproj.aspx?proj=52875,No Results,No Results,No Results,2020-05-04,2020-05-05,None
1282,NCT04362956,ClinicalTrials.gov,2020-04-21,2020-05-01,False,Fundacin Infant,Not Recruiting,Not Applicable,Observational,No Country Given,Clinical and Immunologic Impact of Perinatal SARS-CoV-2 (COVID-19) Infection,Clinical Presentation,No Intervention,200,2020-09-30,2020-09-30,https://clinicaltrials.gov/show/NCT04362956,No Results,No Results,No Results,2020-05-04,2020-05-05,None
1283,NCT04363372,ClinicalTrials.gov,2020-04-24,2020-05-01,False,4D Pharma,Not Recruiting,Phase 2,Interventional,No Country Given,A Study for Efficacy and Safety of Live Biotherapeutic MRx4DP0004 to Treat COVID-19,Drug,MRx-4DP0004,90,2020-08-01,2020-09-01,https://clinicaltrials.gov/show/NCT04363372,No Results,No Results,No Results,2020-05-04,2020-05-05,None
1284,ChiCTR2000032632,ChiCTR,2020-05-04,2020-03-20,True,The First Affiliated Hospital of Xinjiang Medical University,Recruiting,Not Applicable,Interventional,China,The influence of COVID-19 pandemic on cardiovascular patients,Clinical Presentation,No Intervention,100,Not Available,2020-05-22,http://www.chictr.org.cn/showproj.aspx?proj=53190,No Results,No Results,No Results,2020-05-04,2020-05-05,None
1285,ChiCTR2000031174,ChiCTR,2020-03-23,2020-03-23,False,Shanghai Public Health Clinical Center,Not Recruiting,Not Applicable,Interventional,China,Effectiveness and safety of hydroxychloroquine sulfate in the preventive treatment of novel coronavirus pneumonia (COVID-19),Drug (Chemoprophylaxis),Hydroxychloroquine,1000,Not Available,2020-09-30,http://www.chictr.org.cn/showproj.aspx?proj=51437,No Results,No Results,No Results,2020-05-04,2020-05-05,None
1286,ChiCTR2000032574,ChiCTR,2020-05-03,2020-01-01,True,Ganzhou People's Hospital,Not Recruiting,Not Applicable,Diagnostic test,China,Diagnostic value of chest CT in outpatient for novel coronavirus pneumonia (COVID-19) compared to RT-PCR,Diagnostics,Diagnostic Test or Assessment,248,Not Available,2020-02-29,http://www.chictr.org.cn/showproj.aspx?proj=53122,No Results,No Results,No Results,2020-05-04,2020-05-05,None
1287,NCT04363385,ClinicalTrials.gov,2020-04-21,2020-05-01,False,Centre Hospitalier Intercommunal Creteil,Not Recruiting,Not Applicable,Interventional,France,Collection of Biological Samples With Clinical Characterization of Covid-19 Patients,Clinical Presentation,No Intervention,500,2020-12-15,2020-12-15,https://clinicaltrials.gov/show/NCT04363385,No Results,No Results,No Results,2020-05-04,2020-05-05,None
1288,NCT04363606,ClinicalTrials.gov,2020-04-24,2020-04-01,True,CHU de Saint Etienne,Not Recruiting,Not Applicable,Interventional,France,Chronic Fatigue Etiology and Recovery in Covid-19 Patients: the Role of Fatigability,Clinical Presentation,No Intervention,52,2021-04-01,2021-12-01,https://clinicaltrials.gov/show/NCT04363606,No Results,No Results,No Results,2020-05-04,2020-05-05,None
1289,EUCTR2020-001686-36-FR,EU Clinical Trials Register,2020-04-14,2020-04-23,False,Assistance Publique  Hpitaux de Marseille,Authorised,Phase 2,Interventional,France,"A double-blind, randomized study versus placebo of avdoralimab (IPH5401), an anti-C5aR antibody, in patients with COVID-19 induced pneumonia",Drug,Avdoralimab,116,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001686-36,No Results,No Results,No Results,2020-05-04,2020-05-05,None
1290,ChiCTR2000032514,ChiCTR,2020-05-01,2020-05-05,False,Zhongnan Hospital of Wuhan University,Not Recruiting,Not Applicable,Basic Science,China,Direct evidence of rectal cancer patient infected with novel coronavirus pneumonia (COVID-19),Clinical Presentation,No Intervention,13,Not Available,2020-05-16,http://www.chictr.org.cn/showproj.aspx?proj=53181,No Results,No Results,No Results,2020-05-04,2020-05-05,None
1291,NCT04363840,ClinicalTrials.gov,2020-04-24,2020-05-01,False,Louisiana State University Health Sciences Center in New Orleans,Not Recruiting,Phase 2,Interventional,No Country Given,"The LEAD COVID-19 Trial: Low-risk, Early Aspirin and Vitamin D to Reduce COVID-19 Hospitalizations",Drug,Aspirin + Vitamin D vs. Aspirin,1080,2020-12-01,2020-12-01,https://clinicaltrials.gov/show/NCT04363840,No Results,No Results,No Results,2020-05-04,2020-05-05,None
1292,NCT04364022,ClinicalTrials.gov,2020-04-23,2020-04-01,True,Calmy Alexandra,Recruiting,Phase 3,Interventional,Switzerland,Efficacy of Pragmatic Same-day COVID-19 Ring Prophylaxis for Adult Individuals Exposed to SARS-CoV-2 in Switzerland,Drug (Chemoprophylaxis),Hydroxychloroquine vs. Lopinavir/Ritonavir,420,2020-10-01,2020-10-01,https://clinicaltrials.gov/show/NCT04364022,No Results,No Results,No Results,2020-05-04,2020-05-05,None
1293,ChiCTR2000032480,ChiCTR,2020-04-29,2020-04-29,False,China Academy of Chinese Medical Sciences,Not Recruiting,Not Applicable,Observational,China,Study on data management and diagnosis-treatment mode of TCM intervention for novel coronavirus pneumonia (COVID-19)  convalescence,Traditional Medicine (Other),Traditional Medicine,1000,Not Available,2021-04-22,http://www.chictr.org.cn/showproj.aspx?proj=52698,No Results,No Results,No Results,2020-05-04,2020-05-05,None
1294,EUCTR2020-001717-20-ES,EU Clinical Trials Register,2020-04-27,2020-04-20,True,Fundacin para la Investigacin Biomdica de Crdoba,Authorised,Phase 2,Interventional,Spain,Prevention and treatment with Calcifediol of respiratory problems caused by COVID-19,Drug,Calcifediol,1008,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001717-20,No Results,No Results,No Results,2020-05-04,2020-05-05,None
1295,ChiCTR2000032478,ChiCTR,2020-04-29,2020-02-03,True,"Guang'anmen Hospital, China Academy of Chinese Medical Sciences",Recruiting,Not Applicable,Observational,China,TCM Intervention study for novel coronavirus pneumonia (COVID-19) patient during home/designate-unit isolation based on community prevention and control,Traditional Medicine (Other),Traditional Medicine,3000,Not Available,2020-05-01,http://www.chictr.org.cn/showproj.aspx?proj=52777,No Results,No Results,No Results,2020-05-04,2020-05-05,None
1296,ChiCTR2000030989,ChiCTR,2020-03-20,2020-03-20,False,Beijing Normal University,Not Recruiting,Not Applicable,Interventional,China,Internet based Solution Focused Brief Therapy treating adolescent anxiety under the novel coronavirus pneumonia (COVID-19) outbreak: A randomized controlled trial,Other (psych),Psychological,76,Not Available,2020-08-08,http://www.chictr.org.cn/showproj.aspx?proj=51331,No Results,No Results,No Results,2020-03-23,2020-03-25,None
1297,NCT04364698,ClinicalTrials.gov,2020-04-24,2020-04-01,True,Assistance Publique  Hpitaux de Paris,Not Recruiting,Not Applicable,Observational,France,Observational Cohort of COVID-19 Patients at Raymond-Poincare,Clinical Presentation,No Intervention,500,2020-06-01,2020-06-01,https://clinicaltrials.gov/show/NCT04364698,Pre-Print Article,2020-05-11,https://doi.org/10.1101/2020.05.05.20088757,2020-05-04,2020-05-05,None
1298,NCT04364711,ClinicalTrials.gov,2020-04-20,2020-05-01,False,UMC Utrecht,Not Recruiting,Not Applicable,Observational,No Country Given,EuRopean Study of MAjor Infectious Disease Syndromes Related to COVID-19,Clinical Presentation,No Intervention,2000,2022-04-30,2022-04-30,https://clinicaltrials.gov/show/NCT04364711,No Results,No Results,No Results,2020-05-04,2020-05-05,None
1299,NCT04364893,ClinicalTrials.gov,2020-04-07,2020-04-06,True,D'Or Institute for Research and Education,Recruiting,Not Applicable,Interventional,Brazil,Angiotensin Receptor Blockers and Angiotensin-converting Enzyme Inhibitors and Adverse Outcomes in Patients With COVID19,Drug,ACE inhibitors or ARBs,500,2020-10-01,2020-12-01,https://clinicaltrials.gov/show/NCT04364893,No Results,No Results,No Results,2020-05-04,2020-05-05,None
1300,ChiCTR2000032461,ChiCTR,2020-04-29,2020-05-06,False,Hospital of Chengdu University of Traditional Chinese Medicine,Not Recruiting,Not Applicable,Observational,China,A medical records based retrospective study for effect of applying individualized Chinese herbal medicine in treatment of patients with novel coronavirus pneumonia (COVID-19),Traditional Medicine (Drug),Traditional Medicine,500,Not Available,2020-07-31,http://www.chictr.org.cn/showproj.aspx?proj=52482,No Results,No Results,No Results,2020-05-04,2020-05-05,None
1301,ChiCTR2000030941,ChiCTR,2020-03-18,2020-01-28,True,"Hu'nan Provincial People's Hospital, Hu'nan Normal University",Recruiting,Not Applicable,Observational,China,"A medical records based study for clinical features and prognosis of severe patients with novel coronavirus pneumonia (COVID-19) in Huanggan, Hubei in Huanggang.",Clinical Presentation,No Intervention,200,Not Available,2020-12-15,http://www.chictr.org.cn/showproj.aspx?proj=51000,No Results,No Results,No Results,2020-03-23,2020-03-25,None
1302,EUCTR2020-001770-30-BE,EU Clinical Trials Register,2020-04-15,2020-04-21,False,CHU Ambroise Par,Authorised,Phase 2,Interventional,Belgium,Experimental use of tocilizumab in COVID-19 related pneumonia.,Drug,Tocilizumab,60,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001770-30,No Results,No Results,No Results,2020-05-04,2020-04-29,None
1303,NCT04365101,ClinicalTrials.gov,2020-04-22,2020-04-30,False,Celularity Incorporated,Not Recruiting,Phase 1/Phase 2,Interventional,No Country Given,Natural Killer Cell (CYNK-001) Infusions in Adults With COVID-19 (CYNK-001-COVID-19),ATMP,Cells (NK),86,2020-11-30,2021-11-30,https://clinicaltrials.gov/show/NCT04365101,No Results,No Results,No Results,2020-05-04,2020-05-05,None
1304,NCT04365127,ClinicalTrials.gov,2020-04-24,2020-04-27,False,Sara Ghandehari,Recruiting,Phase 1,Interventional,United States,Progesterone for the Treatment of COVID-19 in Hospitalized Men,Drug,Progesterone,40,2020-09-01,2021-04-17,https://clinicaltrials.gov/show/NCT04365127,No Results,No Results,No Results,2020-05-04,2020-05-05,None
1305,ChiCTR2000032459,ChiCTR,2020-04-29,2020-04-29,False,Henan Provincial Center for Disease Control and Prevention,Recruiting,Phase 1/Phase 2,Interventional,China,A phase I/II clinical trial for inactivated novel coronavirus (2019-CoV) vaccine (Vero cells),ATMP,Vaccine,288,Not Available,2021-11-28,http://www.chictr.org.cn/showproj.aspx?proj=53003,No Results,No Results,No Results,2020-05-04,2020-05-05,None
1306,EUCTR2020-001408-41-DE,EU Clinical Trials Register,2020-04-07,2020-04-21,True,"University Hospital, Freiburg",Authorised,Phase 2,Interventional,Germany,Evaluation of efficacy and safety of an tocilizumab treatment in patients with severe COVID-19 pneumonia,Drug,Tocilizumab,200,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001408-41,No Results,No Results,No Results,2020-05-04,2020-04-29,DRKS00021238
1307,NCT04365153,ClinicalTrials.gov,2020-04-24,2020-04-24,False,The Cleveland Clinic,Recruiting,Phase 2,Interventional,United States,Canakinumab to Reduce Deterioration of Cardiac and Respiratory Function Due to COVID-19,Drug,Canakinumab,45,2020-12-31,2020-12-31,https://clinicaltrials.gov/show/NCT04365153,No Results,No Results,No Results,2020-05-04,2020-05-05,None
1308,NCT04365348,ClinicalTrials.gov,2020-04-25,2020-04-27,False,The University of Hong Kong,Not Recruiting,Not Applicable,Observational,Hong Kong,The Psychological Impact of COVID-19 Outbreak on COVID-19 Survivors and Their Families,Other (psych),No Intervention,300,2021-03-31,2021-06-30,https://clinicaltrials.gov/show/NCT04365348,No Results,No Results,No Results,2020-05-04,2020-05-05,None
1309,ChiCTR2000032135,ChiCTR,2020-04-20,2020-04-22,False,Shanghai Public Health Clinical Center,Not Recruiting,Phase 4,Interventional,China,Efficacy and Safety of ulinastatin in the Treatment of novel coronavirus pneumonia (COVID-19),Drug,Ulinastatin,50,Not Available,2020-12-31,http://www.chictr.org.cn/showproj.aspx?proj=52506,No Results,No Results,No Results,2020-05-04,2020-04-29,None
1310,EUCTR2020-001198-55-DK,EU Clinical Trials Register,2020-03-21,2020-04-03,False,Chronic Obstructive Pulmonary Disease Trial Network,Authorised,Phase 2,Interventional,Denmark,Early Treatment to Patients with Coronavirus (COVID),Drug,Hydroxychloroquine + Azithromycin,226,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001198-55,No Results,No Results,No Results,2020-05-04,2020-05-05,None
1311,NCT04365582,ClinicalTrials.gov,2020-04-23,2020-04-28,False,Groupe Hospitalier Paris Saint-Joseph,Not Recruiting,Phase 3,Interventional,France,OUTpatient Treatment of COVID-19 in Patients With Risk Factor for Poor Outcome,Drug,Hydroxychloroquine vs. Azithromycin vs. Lopinavir/ritonavir,640,2020-07-28,2021-01-28,https://clinicaltrials.gov/show/NCT04365582,No Results,No Results,No Results,2020-05-04,2020-05-05,None
1312,NCT04365764,ClinicalTrials.gov,2020-04-25,2020-03-14,True,Groupe Hospitalier Piti Salptrire,Recruiting,Not Applicable,Observational,France,Effect of Treatments in Patients Hospitalized for Severe COVID-19 Pneumonia: a Multicenter Cohort Study,Drug,Unspecified Drug,400,2020-05-31,2020-12-31,https://clinicaltrials.gov/show/NCT04365764,No Results,No Results,No Results,2020-05-04,2020-05-05,None
1313,NCT04251871,ClinicalTrials.gov,2020-01-28,2020-01-22,True,Beijing 302 Hospital,Recruiting,Not Applicable,Interventional,China,Treatment and Prevention of Traditional Chinese Medicines (TCMs) on COVID-19 Infection,Traditional Medicine (Unspecified),Traditional Medicine,150,2021-01-22,2021-01-22,https://clinicaltrials.gov/show/NCT04251871,No Results,No Results,No Results,2020-05-11,2020-08-03,None
1314,EUCTR2020-001823-15-FR,EU Clinical Trials Register,2020-04-15,2020-04-28,False,CHU de Saint Etienne,Authorised,Phase 4,Interventional,France,Evaluation of the concentration-effect relationship of enoxaparin for thromboembolic prevention in COVID-19 resuscitation patients. COV-ENOX study,Drug,Enoxaparine,200,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001823-15,No Results,No Results,No Results,2020-05-04,2020-05-05,None
1315,ACTRN12620000527965,ANZCTR,2020-04-29,2020-05-01,False,Hunter New England Local Health District,Not Recruiting,Not Applicable,Observational,Australia,Neonatal CoVID-19 Study to evaluate the population health impacts of COVID-19 in mothers and their newborn infants cared for in tertiary and non-tertiary hospitals in Australia.,Clinical Presentation,No Intervention,1000,Not Available,2022-11-30,https://anzctr.org.au/ACTRN12620000527965.aspx,No Results,No Results,No Results,2020-05-04,2020-05-05,None
1316,NCT04292899,ClinicalTrials.gov,2020-02-28,2020-03-06,True,Gilead Sciences,Recruiting,Phase 3,Interventional,"Japan, France, Netherlands, Singapore, Sweden, Italy, China, Switzerland, South Korea, Taiwan, United Kingdom, United States, Germany, Hong Kong, Spain",Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734) in Participants With Severe Coronavirus Disease (COVID-19),Drug,Remdesivir,6000,2020-05-01,2020-05-01,https://clinicaltrials.gov/show/NCT04292899,No Results,No Results,No Results,2020-05-11,2020-03-18,EUCTR2020-000841-15
1317,NCT04312009,ClinicalTrials.gov,2020-03-13,2020-04-13,False,University of Minnesota,Recruiting,Phase 2,Interventional,United States,Losartan for Patients With COVID-19 Requiring Hospitalization,Drug,ARB (Losartan),200,2021-04-01,2021-04-01,https://clinicaltrials.gov/show/NCT04312009,No Results,No Results,No Results,2020-05-11,2020-03-25,None
1318,ISRCTN17898730,ISRCTN,2020-04-23,2020-04-07,True,Psychosocial Innovation Network,Recruiting,Not Applicable,Interventional,Serbia,Expressive writing for the reduction of psychological difficulties during the COVID-19 pandemic,Other (psych),Psychological,150,Not Available,2020-12-20,http://isrctn.com/ISRCTN17898730,No Results,No Results,No Results,2020-05-04,2020-04-29,None
1319,NCT04318301,ClinicalTrials.gov,2020-03-20,2020-03-21,False,Zhenhua Zen,Not Recruiting,Not Applicable,Observational,China,Hypertension in Patients Hospitalized With COVID-19,Clinical Presentation,No Intervention,275,2020-03-28,2020-03-30,https://clinicaltrials.gov/show/NCT04318301,No Results,No Results,No Results,2020-05-11,2020-04-01,None
1320,NCT04322123,ClinicalTrials.gov,2020-03-24,2020-04-01,False,Hospital do Corao,Recruiting,Phase 3,Interventional,Brazil,Safety and Efficacy of Hydroxychloroquine Associated With Azithromycin in SARS-Cov-2 Virus (COVID-19),Drug,Hydroxychloroquine + Azithromycin vs. Hydroxychloroquine,630,2020-08-30,2020-08-30,https://clinicaltrials.gov/show/NCT04322123,No Results,No Results,No Results,2020-05-11,2020-04-01,None
1321,ChiCTR2000031327,ChiCTR,2020-03-27,2020-04-01,False,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Not Recruiting,Not Applicable,Observational,China,Clinical characteristics and death risk factors in severe novel coronavirus pneumonia (COVID-19) patients: a single-center respective analysis based on medical records,Clinical Presentation,No Intervention,120,Not Available,2020-04-10,http://www.chictr.org.cn/showproj.aspx?proj=51669,No Results,No Results,No Results,2020-05-04,2020-04-01,None
1322,NCT04280705,ClinicalTrials.gov,2020-02-20,2020-02-21,True,National Institute of Allergy and Infectious Diseases (NIAID),Recruiting,Phase 3,Interventional,"Japan, Denmark, Singapore, Mexico, Greece, South Korea, United Kingdom, United States, Germany, Spain",Adaptive COVID-19 Treatment Trial (ACTT),Drug,Remdesivir,800,2023-04-01,2023-04-01,https://clinicaltrials.gov/show/NCT04280705,No Results,No Results,No Results,2020-05-11,2020-03-18,EUCTR2020-001052-18; JPRN-jRCT2031190264
1323,NCT04307459,ClinicalTrials.gov,2020-03-10,2020-03-19,False,University of Milan,Recruiting,Not Applicable,Observational,Italy,Acute Respiratory Failure and COVID-19 in Real Life,Clinical Presentation,No Intervention,50,2020-09-01,2020-12-31,https://clinicaltrials.gov/show/NCT04307459,No Results,No Results,No Results,2020-05-11,2020-03-18,None
1324,NCT04322513,ClinicalTrials.gov,2020-03-23,2020-03-24,False,University of Catanzaro,Recruiting,Not Applicable,Observational,Italy,Biomarkers for Identification of COVID-19 Infection,Diagnostics,Diagnostic Test or Assessment,110,2020-06-30,2020-08-30,https://clinicaltrials.gov/show/NCT04322513,No Results,No Results,No Results,2020-05-11,2020-04-01,None
1325,NCT04326790,ClinicalTrials.gov,2020-03-26,2020-04-03,True,National and Kapodistrian University of Athens,Recruiting,Phase 2,Interventional,Gibraltar,The GReek Study in the Effects of Colchicine in Covid-19 cOmplications Prevention,Drug,Colchicine,180,2020-08-31,2020-09-30,https://clinicaltrials.gov/show/NCT04326790,No Results,No Results,No Results,2020-05-11,2020-04-07,EUCTR2020-001455-40
1326,EUCTR2020-001678-31-FR,EU Clinical Trials Register,2020-04-17,2020-04-28,False,Assistance Publique  Hpitaux de Paris,Authorised,Phase 3,Interventional,France,"Randomized controlled trial evaluating the efficacy of vaccination with Bacillus Calmette and Gurin (BCG) in the Prevention of COVID-19 via the strengthening of innate immunity in Health Care Workers.
COVID-BCG",ATMP,Vaccine,1120,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001678-31,No Results,No Results,No Results,2020-05-04,2020-05-05,None
1327,NCT04327206,ClinicalTrials.gov,2020-03-25,2020-03-30,False,Murdoch Childrens Research Institute,Recruiting,Phase 3,Interventional,Australia,BCG Vaccination to Protect Healthcare Workers Against COVID-19,ATMP,Vaccine,4170,2020-10-30,2022-03-30,https://clinicaltrials.gov/show/NCT04327206,No Results,No Results,No Results,2020-05-11,2020-04-07,None
1328,NCT04328285,ClinicalTrials.gov,2020-03-25,2020-04-14,True,CHU de Saint Etienne,Recruiting,Phase 3,Interventional,France,Chemoprophylaxis of SARS-CoV-2 Infection (COVID-19) in Exposed Healthcare Workers,Drug (Chemoprophylaxis),Hydroxychloroquine,1200,2020-11-30,2020-11-30,https://clinicaltrials.gov/show/NCT04328285,No Results,No Results,No Results,2020-05-11,2020-04-06,EUCTR2020-001188-96
1329,EUCTR2020-001734-36-FR,EU Clinical Trials Register,2020-04-15,2020-04-20,False,CHU de Tours,Authorised,Phase 3,Interventional,France,Efficacy and safety of ANAkinra during Adult  COVID-19  with Aggravating respiratory symptoms: a multicenter open-label controlled randomized trial,Drug,Anakinra,240,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001734-36,No Results,No Results,No Results,2020-05-04,2020-05-05,None
1330,ChiCTR2000030939,ChiCTR,2020-03-18,2020-03-16,True,PLA General Hospital,Recruiting,Not Applicable,Interventional,China,Preliminary evaluation of the safety and efficacy of oral LL-37 antiviral peptide (CAS001) in the treatment of novel coronavirus pneumonia (COVID-19),ATMP,Gene-derived protein,10,Not Available,2020-10-01,http://www.chictr.org.cn/showproj.aspx?proj=51059,Pre-Print Article,2020-05-15,https://doi.org/10.1101/2020.05.11.20064584,2020-03-23,2020-03-25,None
1331,NCT04323761,ClinicalTrials.gov,2020-03-24,2020-03-24,True,Gilead Sciences,Not Recruiting,Not Applicable,Expanded Access,"Canada, Australia, United States, Germany, France, Israel, United Kingdom, Belgium, Czech Republic, Slovenia, Netherlands, Romania, Switzerland, Hungary, Spain, Italy, Portugal, Ireland, Estonia",Expanded Access Treatment Protocol: Remdesivir (RDV; GS-5734) for the Treatment of SARS-CoV2 (CoV) Infection (COVID-19),Drug,Remdesivir,Not Available,Not Available,Not Available,https://clinicaltrials.gov/show/NCT04323761,No Results,No Results,No Results,2020-05-11,2020-04-22,EUCTR2020-001453-49
1332,NCT04328480,ClinicalTrials.gov,2020-03-30,2020-04-17,False,Estudios Clnicos Latino Amrica,Recruiting,Phase 3,Interventional,Argentina,The ECLA PHRI COLCOVID Trial. Effects of Colchicine on Moderate/High-risk Hospitalized COVID-19 Patients.,Drug,Colchicine,2500,2020-06-30,2020-08-30,https://clinicaltrials.gov/show/NCT04328480,No Results,No Results,No Results,2020-05-11,2020-04-07,None
1333,NCT04328441,ClinicalTrials.gov,2020-03-27,2020-03-25,True,UMC Utrecht,Recruiting,Phase 3,Interventional,Netherlands,Reducing Health Care Workers Absenteeism in Covid-19 Pandemic Through BCG Vaccine,ATMP,Vaccine,1500,2020-10-25,2020-12-25,https://clinicaltrials.gov/show/NCT04328441,No Results,No Results,No Results,2020-05-11,2020-04-07,None
1334,EUCTR2020-001722-66-ES,EU Clinical Trials Register,2020-04-27,2020-04-23,True,Fundaci Clnic per a la Recerca Biomdica,Authorised,Phase 2,Interventional,Spain,Plasma turnover in patients with COVID-19 disease and invasive mechanical ventilation,ATMP,Plasma,116,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001722-66,No Results,No Results,No Results,2020-05-04,2020-05-05,None
1335,NCT04329923,ClinicalTrials.gov,2020-03-30,2020-04-09,False,"Ravi Amaravadi, MD",Recruiting,Phase 2,Interventional,United States,The PATCH Trial (Prevention And Treatment of COVID-19 With Hydroxychloroquine),Drug,Hydroxychloroquine,400,2021-04-01,2021-12-01,https://clinicaltrials.gov/show/NCT04329923,No Results,No Results,No Results,2020-05-11,2020-04-07,None
1336,NCT04331795,ClinicalTrials.gov,2020-04-01,2020-04-04,False,University of Chicago,Recruiting,Phase 2,Interventional,United States,"Tocilizumab to Prevent Clinical Decompensation in Hospitalized, Non-critically Ill Patients With COVID-19 Pneumonitis",Drug,Tocilizumab,50,2020-07-01,2020-12-01,https://clinicaltrials.gov/show/NCT04331795,No Results,No Results,No Results,2020-05-11,2020-04-07,None
1337,NCT04331886,ClinicalTrials.gov,2020-03-31,2020-04-13,False,"Target PharmaSolutions, Inc.",Recruiting,Not Applicable,Observational,United States,An Observational Study of Patients With Coronavirus Disease 2019,Clinical Presentation,No Intervention,5000,2021-03-01,2021-03-01,https://clinicaltrials.gov/show/NCT04331886,No Results,No Results,No Results,2020-05-11,2020-04-07,None
1338,NCT04332107,ClinicalTrials.gov,2020-03-30,2020-05-21,False,Thomas M. Lietman,Not Recruiting,Phase 3,Interventional,United States,Azithromycin for COVID-19 Treatment in Outpatients Nationwide,Drug,Azithromycin,2271,2020-08-30,2021-08-30,https://clinicaltrials.gov/show/NCT04332107,No Results,No Results,No Results,2020-05-11,2020-04-07,None
1339,EUCTR2020-001505-22-ES,EU Clinical Trials Register,2020-04-27,2020-04-23,True,Banc de Sang i Teixits,Authorised,Phase 1/Phase 2,Interventional,Spain,Efficacy and safety evaluation of umbilical cord mesenchymal stem cells for the treatment of patients with respiratory failure due to coronavirus (COVID-19),ATMP,Cells (mesenchymal),30,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001505-22,No Results,No Results,No Results,2020-05-04,2020-05-05,None
1340,NCT04332081,ClinicalTrials.gov,2020-03-30,2020-04-06,False,NYU Langone Health,Recruiting,Not Applicable,Interventional,United States,Hyperbaric Oxygen for COVID-19 Patients,Drug,Oxygen,40,2020-07-01,2020-07-01,https://clinicaltrials.gov/show/NCT04332081,No Results,No Results,No Results,2020-05-11,2020-04-07,None
1341,NCT04334629,ClinicalTrials.gov,2020-04-02,2020-04-27,False,King's College London,Not Recruiting,Phase 4,Interventional,No Country Given,LIBERATE Trial in COVID-19,Drug,Ibuprofen,230,2020-08-26,2020-11-26,https://clinicaltrials.gov/show/NCT04334629,No Results,No Results,No Results,2020-05-11,2020-04-15,None
1342,EUCTR2020-001541-39-ES,EU Clinical Trials Register,2020-04-27,2020-04-24,True,Fundacin para la Investigacin Biomdica de Crdoba,Authorised,Phase 2,Interventional,Spain,Pilot study of bevacizumab as a treatment for respiratory distress in patients with COVID-19,Drug,Bevacizumab,22,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001541-39,No Results,No Results,No Results,2020-05-04,2020-05-05,None
1343,NCT04333355,ClinicalTrials.gov,2020-03-31,2020-05-25,False,Hospital San Jose Tec de Monterrey,Recruiting,Phase 1,Interventional,Mexico,Safety in Convalescent Plasma Transfusion to COVID-19,ATMP,Plasma,20,2020-12-20,2021-04-30,https://clinicaltrials.gov/show/NCT04333355,No Results,No Results,No Results,2020-05-11,2020-04-07,None
1344,NCT04333550,ClinicalTrials.gov,2020-04-01,2020-04-01,False,Kermanshah University of Medical Sciences,Recruiting,Phase 1/Phase 2,Interventional,Iran,Application of Desferal to Treat COVID-19,Drug,Deferoxamine,50,2020-09-01,2021-03-01,https://clinicaltrials.gov/show/NCT04333550,No Results,No Results,No Results,2020-05-11,2020-04-07,None
1345,NCT04334928,ClinicalTrials.gov,2020-04-02,2020-04-15,False,Plan Nacional sobre el Sida (PNS),Recruiting,Phase 3,Interventional,Spain,Randomized Clinical Trial for the Prevention of SARS-CoV-2 Infection (COVID-19) in Healthcare Personnel,Drug,Emtricitabine/tenofovir disoproxil + hydroxychloroquine vs. hydroxychloroquine vs. Emtricitabine/tenofovir disoproxil,4000,2020-06-30,2020-07-31,https://clinicaltrials.gov/show/NCT04334928,No Results,No Results,No Results,2020-05-11,2020-04-15,None
1346,NCT04337359,ClinicalTrials.gov,2020-04-03,2020-04-07,False,Novartis Pharmaceuticals,Not Recruiting,Not Applicable,Expanded Access,No Country Given,Ruxolitinib Managed Access Program (MAP) for Patients Diagnosed With Severe/Very Severe COVID-19 Illness,Drug,Ruxolitinib,Not Available,Not Available,Not Available,https://clinicaltrials.gov/show/NCT04337359,No Results,No Results,No Results,2020-05-11,2020-04-15,None
1347,EUCTR2020-001618-39-ES,EU Clinical Trials Register,2020-04-27,2020-04-24,True,Oryzon Genomics S. A.,Authorised,Phase 2,Interventional,Spain,Study to evaluate the efficacy and tolerability of treatment with vafidemstat in combination with standard of care treatment to prevent Acute Respiratory Distress Syndrome in adult severely ill patients with COVID-19.,Drug,Vafidemstat,40,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001618-39,No Results,No Results,No Results,2020-05-04,2020-05-05,None
1348,NCT04335786,ClinicalTrials.gov,2020-04-02,2020-04-17,True,Radboud University,Recruiting,Phase 4,Interventional,Netherlands,Valsartan for Prevention of Acute Respiratory Distress Syndrome in Hospitalized Patients With SARS-COV-2 (COVID-19) Infection Disease,Drug,Valsartan,651,2020-10-01,2021-10-01,https://clinicaltrials.gov/show/NCT04335786,No Results,No Results,No Results,2020-05-11,2020-04-15,EUCTR2020-001320-34
1349,NCT04336332,ClinicalTrials.gov,2020-03-31,2020-04-01,False,Rutgers University,Recruiting,Phase 2,Interventional,United States,Randomized Comparison of Combination Azithromycin and Hydroxychloroquine vs. Hydroxychloroquine Alone for the Treatment of Confirmed COVID-19,Drug,Hydroxychloroquine + azithromycin vs. hydroxychloroquine,160,2021-04-30,2021-04-30,https://clinicaltrials.gov/show/NCT04336332,No Results,No Results,No Results,2020-05-11,2020-04-15,None
1350,NCT04338347,ClinicalTrials.gov,2020-03-31,2020-07-01,False,Capricor Inc.,Not Recruiting,Not Applicable,Expanded Access,United States,CAP-1002 in Severe COVID-19 Disease,ATMP,Cells (allogeneic cardiosphere-derived),Not Available,Not Available,Not Available,https://clinicaltrials.gov/show/NCT04338347,No Results,No Results,No Results,2020-05-11,2020-04-15,None
1351,NCT04338958,ClinicalTrials.gov,2020-04-07,2020-04-22,False,University of Jena,Recruiting,Phase 2,Interventional,Germany,Ruxolitinib in Covid-19 Patients With Defined Hyperinflammation,Drug,Ruxolitinib,200,2021-01-31,2021-08-31,https://clinicaltrials.gov/show/NCT04338958,No Results,No Results,No Results,2020-05-11,2020-04-15,None
1352,NCT04283461,ClinicalTrials.gov,2020-02-21,2020-03-16,False,National Institute of Allergy and Infectious Diseases (NIAID),Recruiting,Phase 1,Interventional,United States,Safety and Immunogenicity Study of 2019-nCoV Vaccine (mRNA-1273) for Prophylaxis of SARS-CoV-2 Infection (COVID-19),ATMP,Vaccine,105,2021-09-20,2021-09-20,https://clinicaltrials.gov/show/NCT04283461,No Results,No Results,No Results,2020-05-11,2020-08-03,None
1353,NCT04292730,ClinicalTrials.gov,2020-02-28,2020-03-15,True,Gilead Sciences,Recruiting,Phase 3,Interventional,"Japan, France, Netherlands, Singapore, Sweden, Italy, China, Switzerland, South Korea, Taiwan, United Kingdom, United States, Germany, Hong Kong, Iran, Spain",Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734) in Participants With Moderate Coronavirus Disease (COVID-19) Compared to Standard of Care Treatment,Drug,Remdesivir,1600,2020-05-01,2020-05-01,https://clinicaltrials.gov/show/NCT04292730,No Results,No Results,No Results,2020-05-11,2020-03-18,EUCTR2020-000842-32
1354,NCT04340232,ClinicalTrials.gov,2020-04-03,2020-06-01,False,"University of Colorado, Denver",Not Recruiting,Phase 2/Phase 3,Interventional,United States,Safety and Efficacy of Baricitinib for COVID-19,Drug,Baricitinib,80,2020-08-01,2020-10-01,https://clinicaltrials.gov/show/NCT04340232,No Results,No Results,No Results,2020-05-11,2020-04-15,None
1355,NCT04341116,ClinicalTrials.gov,2020-04-04,2020-04-11,False,I-Mab Biopharma Co. Ltd.,Recruiting,Phase 1/Phase 2,Interventional,United States,Study of TJ003234 (Anti-GM-CSF Monoclonal Antibody) in Subjects With Severe Coronavirus Disease 2019 (COVID-19),Drug,TJ003234,144,2020-09-01,2020-09-01,https://clinicaltrials.gov/show/NCT04341116,No Results,No Results,No Results,2020-05-11,2020-04-15,None
1356,NCT04339790,ClinicalTrials.gov,2020-04-08,2020-05-13,False,National Institute of Mental Health (NIMH),Recruiting,Not Applicable,Observational,United States,Mental Health Impact of COVID-19 Pandemic on NIMH Research Participants and Volunteers,Other (psych),No Intervention,5000,2022-03-01,2022-04-01,https://clinicaltrials.gov/show/NCT04339790,No Results,No Results,No Results,2020-05-11,2020-04-15,None
1357,NCT04342182,ClinicalTrials.gov,2020-03-31,2020-04-08,False,Erasmus Medical Center,Recruiting,Phase 2/Phase 3,Interventional,Netherlands,Convalescent Plasma as Therapy for Covid-19 Severe SARS-CoV-2 Disease (CONCOVID Study),ATMP,Plasma,426,2020-07-01,2020-07-01,https://clinicaltrials.gov/show/NCT04342182,No Results,No Results,No Results,2020-05-11,2020-04-15,None
1358,NCT04312997,ClinicalTrials.gov,2020-03-16,2020-05-01,False,"Pulmotect, Inc.",Not Recruiting,Phase 2,Interventional,United States,The Use of PUL-042 Inhalation Solution to Reduce the Severity of COVID-19 in Adults Positive for SARS-CoV-2 Infection,Drug,"PUL-042, unspecified immunomodulatory drug",100,2020-09-01,2020-10-01,https://clinicaltrials.gov/show/NCT04312997,No Results,No Results,No Results,2020-05-11,2020-03-25,None
1359,NCT04313023,ClinicalTrials.gov,2020-03-16,2020-05-01,False,"Pulmotect, Inc.",Not Recruiting,Phase 2,Interventional,United States,The Use PUL-042 to Reduce the Infection Rate and Progression to COVID-19 in Adults Exposed to SARS-CoV-2,Drug,"PUL-042, unspecified immunomodulatory drug",200,2020-09-01,2020-10-01,https://clinicaltrials.gov/show/NCT04313023,No Results,No Results,No Results,2020-05-11,2020-03-25,None
1360,NCT04342897,ClinicalTrials.gov,2020-04-10,2020-04-20,False,Eli Lilly and Company,Recruiting,Phase 2,Interventional,United States,A Study of LY3127804 in Participants With COVID-19,Drug,LY3127804,200,2020-06-12,2020-07-16,https://clinicaltrials.gov/show/NCT04342897,No Results,No Results,No Results,2020-05-11,2020-04-15,None
1361,NCT04343729,ClinicalTrials.gov,2020-04-09,2020-04-18,False,Fundao de Medicina Tropical Dr. Heitor Vieira Dourado,Recruiting,Phase 2,Interventional,Brazil,Methylprednisolone in the Treatment of Patients With Signs of Severe Acute Respiratory Syndrome in Covid-19,Drug,Corticosteroids,420,2020-09-01,2020-09-01,https://clinicaltrials.gov/show/NCT04343729,No Results,No Results,No Results,2020-05-11,2020-04-22,None
1362,NCT04343261,ClinicalTrials.gov,2020-04-08,2020-04-10,False,Saint Francis Care,Recruiting,Phase 2,Interventional,United States,Convalescent Plasma in the Treatment of COVID 19,ATMP,Plasma,15,2020-12-01,2021-04-01,https://clinicaltrials.gov/show/NCT04343261,No Results,No Results,No Results,2020-05-11,2020-04-15,None
1363,NCT04343768,ClinicalTrials.gov,2020-04-08,2020-04-09,False,Shahid Beheshti University of Medical Sciences,Not Recruiting,Phase 2,Interventional,Iran,"An Investigation Into Beneficial Effects of Interferon Beta 1a, Compared to Interferon Beta 1b And The Base Therapeutic Regiment in Moderate to Severe COVID-19: A Randomized Clinical Trial",Drug,Hydroxychloroquine + Lopinavir/ritonavir + interferon beta 1a vs. hydroxychloroquine + Lopinavir/ritonavir + interferon beta 1b vs. hydroxychloroquine + Lopinavir/ritonavir,60,2020-04-27,2020-04-27,https://clinicaltrials.gov/show/NCT04343768,No Results,No Results,No Results,2020-05-11,2020-04-15,None
1364,NCT04315948,ClinicalTrials.gov,2020-03-13,2020-03-22,True,INSERM,Recruiting,Phase 3,Interventional,"Luxembourg, France",Trial of Treatments for COVID-19 in Hospitalized Adults,Drug,Remdesivir vs. Lopinavir/ritonavir vs. Lopinavir/ritonavir + Interferon beta vs. Hydroxychloroquine,3100,2023-03-01,2023-03-01,https://clinicaltrials.gov/show/NCT04315948,No Results,No Results,No Results,2020-05-11,2020-03-25,EUCTR2020-000936-23
1365,NCT04320511,ClinicalTrials.gov,2020-03-23,2020-06-01,False,William Beaumont Hospitals,Not Recruiting,Not Applicable,Observational,United States,Beaumont Quantitative Lung Function Imaging to Characterize Patients With SARS-COV 2,Clinical Presentation,No Intervention,25,2021-03-01,2022-03-01,https://clinicaltrials.gov/show/NCT04320511,No Results,No Results,No Results,2020-05-11,2020-04-01,None
1366,NCT04344249,ClinicalTrials.gov,2020-04-08,2020-04-10,False,Nantes University Hospital,Recruiting,Not Applicable,Observational,France,Cohort of Patients With Inflammatory Bowel Disease During COVID-19 Pandemic,Clinical Presentation,No Intervention,850,2020-09-30,2021-09-01,https://clinicaltrials.gov/show/NCT04344249,No Results,No Results,No Results,2020-05-11,2020-04-22,None
1367,NCT04345614,ClinicalTrials.gov,2020-04-07,2020-04-08,False,"CalciMedica, Inc.",Recruiting,Phase 2,Interventional,United States,A Study of CM4620-Injectable Emulsion (IE) in Patients With Severe COVID-19 Pneumonia,Drug,CM4620-Injectable Emulsion,120,2020-07-01,2020-09-01,https://clinicaltrials.gov/show/NCT04345614,No Results,No Results,No Results,2020-05-11,2020-04-22,None
1368,NCT04344457,ClinicalTrials.gov,2020-04-08,2020-04-16,False,"Perseverance Research Center, LLC",Recruiting,Phase 1/Phase 2,Interventional,United States,"Evaluate the Efficacy and Safety of Oral Hydroxychloroquine, Indomethacin and Zithromax in Subjects With Mild Symptoms of COVID-19",Drug,Hydroxychloroquine + Indomethacin + Azithromycin,80,2020-06-20,2020-09-30,https://clinicaltrials.gov/show/NCT04344457,No Results,No Results,No Results,2020-05-11,2020-04-22,None
1369,NCT04345419,ClinicalTrials.gov,2020-04-11,2020-04-30,False,Tanta University,Not Recruiting,Phase 2/Phase 3,Interventional,Egypt,A Real-life Experience on Treatment of Patients With COVID 19,Drug,Chloroquine vs. Favipiravir vs. Nitazoxanide vs. Ivermectin vs. Niclosamide,120,2029-12-01,2029-12-01,https://clinicaltrials.gov/show/NCT04345419,No Results,No Results,No Results,2020-05-11,2020-04-22,None
1370,NCT04321096,ClinicalTrials.gov,2020-03-23,2020-04-04,True,Aarhus University,Recruiting,Phase 1/Phase 2,Interventional,Denmark,The Impact of Camostat Mesilate on COVID-19 Infection,Drug,Camostat Mesilate,580,2020-12-31,2021-05-01,https://clinicaltrials.gov/show/NCT04321096,No Results,No Results,No Results,2020-05-11,2020-04-01,EUCTR2020-001200-42
1371,NCT04325646,ClinicalTrials.gov,2020-03-26,2020-03-13,True,Institut Pasteur,Recruiting,Not Applicable,Observational,France,Sero-epidemiological Study of the SARS-CoV-2 Virus Responsible for COVID-19 in France,Clinical Presentation (Epidemiology),No Intervention,1000,2021-02-28,2023-02-28,https://clinicaltrials.gov/show/NCT04325646,Pre-Print Article,2020-04-23,https://doi.org/10.1101/2020.04.18.20071134,2020-05-11,2020-04-01,None
1372,NCT04346589,ClinicalTrials.gov,2020-04-09,2020-04-15,False,A.O. Ospedale Papa Giovanni XXIII,Recruiting,Not Applicable,Interventional,Italy,Convalescent Antibodies Infusion in Critically Ill COVID 19 Patients,ATMP,Plasma,10,2020-07-01,2020-07-01,https://clinicaltrials.gov/show/NCT04346589,No Results,No Results,No Results,2020-05-11,2020-04-22,None
1373,NCT04348071,ClinicalTrials.gov,2020-04-13,2020-06-01,False,"University of Colorado, Denver",Not Recruiting,Phase 2/Phase 3,Interventional,No Country Given,Safety and Efficacy of Ruxolitinib for COVID-19,Drug,Ruxolitinib,80,2020-08-01,2020-10-01,https://clinicaltrials.gov/show/NCT04348071,No Results,No Results,No Results,2020-05-11,2020-04-22,None
1374,NCT04345848,ClinicalTrials.gov,2020-04-07,2020-04-28,False,"University Hospital, Geneva",Recruiting,Phase 3,Interventional,Switzerland,Preventing COVID-19 Complications With Low- and High-dose Anticoagulation,Drug,Enoxaparin,200,2020-11-30,2020-11-30,https://clinicaltrials.gov/show/NCT04345848,No Results,No Results,No Results,2020-05-11,2020-04-22,None
1375,NCT04346615,ClinicalTrials.gov,2020-04-09,2020-04-25,False,"Biohaven Pharmaceuticals, Inc.",Recruiting,Phase 2/Phase 3,Interventional,United States,Safety and Efficacy Trial of Vazegepant Intranasal for Hospitalized Patients With COVID-19 Requiring Supplemental Oxygen,Drug,Vazegepant,120,2020-07-01,2020-09-01,https://clinicaltrials.gov/show/NCT04346615,No Results,No Results,No Results,2020-05-11,2020-04-22,None
1376,NCT04328493,ClinicalTrials.gov,2020-03-27,2020-04-07,False,University of Oxford,Recruiting,Phase 2,Interventional,Vietnam,The Vietnam Chloroquine Treatment on COVID-19,Drug,Chloroquine,250,2021-04-01,2022-04-01,https://clinicaltrials.gov/show/NCT04328493,No Results,No Results,No Results,2020-05-11,2020-04-07,None
1377,NCT04333225,ClinicalTrials.gov,2020-04-01,2020-04-03,False,Baylor Research Institute,Not Recruiting,Phase 2,Interventional,United States,Hydroxychloroquine in the Prevention of COVID-19 Infection in Healthcare Workers,Drug (Chemoprophylaxis),Hydroxychloroquine,228,2020-07-30,2020-07-30,https://clinicaltrials.gov/show/NCT04333225,No Results,No Results,No Results,2020-05-11,2020-04-07,None
1378,NCT04349098,ClinicalTrials.gov,2020-04-14,2020-04-17,True,Karyopharm Therapeutics Inc,Recruiting,Phase 2,Interventional,"France, Israel, United Kingdom, United States, Austria, Spain",Evaluation of Activity and Safety of Oral Selinexor in Participants With Severe COVID-19 Infection,Drug,Selinexor,230,2020-08-31,2020-08-31,https://clinicaltrials.gov/show/NCT04349098,No Results,No Results,No Results,2020-05-11,2020-04-22,EUCTR2020-001411-25
1379,NCT04351152,ClinicalTrials.gov,2020-04-15,2020-04-30,False,"Humanigen, Inc.",Recruiting,Phase 3,Interventional,United States,Phase 3 Study to Evaluate Efficacy and Safety of Lenzilumab in Hospitalized Patients With COVID-19 Pneumonia,Drug,Lenzilumab,238,2020-09-01,2020-09-01,https://clinicaltrials.gov/show/NCT04351152,No Results,No Results,No Results,2020-05-11,2020-04-22,None
1380,NCT04346667,ClinicalTrials.gov,2020-04-13,2020-04-14,False,"Government of Punjab, Specialized Healthcare and Medical Education Department",Recruiting,Phase 4,Interventional,Pakistan,Post-Exposure Prophylaxis for Asymptomatic SARS-CoV-2 COVID-19 Patients With choloroquinE Compounds,Drug (Chemoprophylaxis),Hydroxychloroquine vs. Chloroquine ,400,2020-05-30,2021-06-30,https://clinicaltrials.gov/show/NCT04346667,No Results,No Results,No Results,2020-05-11,2020-04-22,None
1381,NCT04347408,ClinicalTrials.gov,2020-04-07,2020-05-06,False,"Queen's University, Belfast",Not Recruiting,Not Applicable,Observational,United Kingdom,Seroprevalence of SARS-Cov-2 Antibodies in Children,Diagnostics,Diagnostic Test or Assessment,700,2020-12-13,2020-12-13,https://clinicaltrials.gov/show/NCT04347408,No Results,No Results,No Results,2020-05-11,2020-04-22,None
1382,NCT04351906,ClinicalTrials.gov,2020-04-09,2020-05-03,False,University of Giessen,Recruiting,Not Applicable,Interventional,Germany,Low-flow Extracorporeal Carbon Dioxide Removal in COVID-19-associated Acute Respiratory Distress Syndrome,Other (device),ECCO2R,20,2020-07-01,2020-09-01,https://clinicaltrials.gov/show/NCT04351906,No Results,No Results,No Results,2020-05-11,2020-04-22,None
1383,NCT04352751,ClinicalTrials.gov,2020-04-16,2020-05-01,False,Hilton Pharma,Recruiting,Not Applicable,Interventional,Pakistan,Experimental Use of Convalescent Plasma for Passive Immunization in Current COVID-19 Pandemic in Pakistan in 2020,ATMP,Plasma,2000,2021-04-01,2021-04-01,https://clinicaltrials.gov/show/NCT04352751,No Results,No Results,No Results,2020-05-11,2020-04-29,None
1384,NCT04335071,ClinicalTrials.gov,2020-04-02,2020-04-26,False,"University Hospital, Bern",Recruiting,Phase 2,Interventional,Switzerland,Tocilizumab in the Treatment of Coronavirus Induced Disease (COVID-19),Drug,Tocilizumab,100,2020-10-01,2020-10-01,https://clinicaltrials.gov/show/NCT04335071,No Results,No Results,No Results,2020-05-11,2020-04-15,None
1385,NCT04335136,ClinicalTrials.gov,2020-04-01,2020-04-30,True,Apeiron Biologics,Recruiting,Phase 2,Interventional,"Germany, Denmark, Austria",Recombinant Human Angiotensin-converting Enzyme 2 (rhACE2) as a Treatment for Patients With COVID-19,Drug,ACE enzyme,200,2020-09-01,2020-11-01,https://clinicaltrials.gov/show/NCT04335136,No Results,No Results,No Results,2020-05-11,2020-04-15,EUCTR2020-001172-15
1386,NCT04347954,ClinicalTrials.gov,2020-04-13,2020-05-01,False,Stanford University,Not Recruiting,Phase 1/Phase 2,Interventional,United States,PVP-I Nasal Sprays and SARS-CoV-2 Nasopharyngeal Titers (for COVID-19),Drug,Povidone-iodine,45,2020-07-01,2020-08-01,https://clinicaltrials.gov/show/NCT04347954,No Results,No Results,No Results,2020-05-11,2020-04-22,None
1387,NCT04351191,ClinicalTrials.gov,2020-04-14,2020-04-15,False,"Government of Punjab, Specialized Healthcare and Medical Education Department",Recruiting,Phase 4,Interventional,Pakistan,PRophylaxis of Exposed COVID-19 Individuals With Mild Symptoms Using choloroquinE Compounds,Drug (Chemoprophylaxis),Hydroxychloroquine vs. Chloroquine ,400,2020-05-30,2020-06-30,https://clinicaltrials.gov/show/NCT04351191,No Results,No Results,No Results,2020-05-11,2020-04-22,None
1388,NCT04353583,ClinicalTrials.gov,2020-04-06,2020-04-21,False,University of Giessen,Recruiting,Not Applicable,Observational,Germany,Renal Outcome in Patients With COVID-19,Clinical Presentation,No Intervention,50,2020-08-01,2020-08-01,https://clinicaltrials.gov/show/NCT04353583,No Results,No Results,No Results,2020-05-11,2020-04-29,None
1389,NCT04354766,ClinicalTrials.gov,2020-04-17,2020-04-29,False,Hospices Civils de Lyon,Recruiting,Not Applicable,Observational,France,COVID-19 : Neutralizing Human Monoclonal Antibodies Against SARS-Cov-2,ATMP,Plasma,10,2020-07-01,2020-07-01,https://clinicaltrials.gov/show/NCT04354766,No Results,No Results,No Results,2020-05-11,2020-04-29,None
1390,NCT04335162,ClinicalTrials.gov,2020-04-03,2020-02-28,True,CHU de Nice,Recruiting,Not Applicable,Observational,France,Cardiovascular Complications and COVID-19 (CovCardioVasc),Clinical Presentation,No Intervention,100,2020-08-28,2020-08-28,https://clinicaltrials.gov/show/NCT04335162,No Results,No Results,No Results,2020-05-11,2020-04-15,None
1391,NCT04340479,ClinicalTrials.gov,2020-04-06,2020-05-01,False,"University of Colorado, Denver",Not Recruiting,Not Applicable,Observational,United States,The Use of Ultrasound in Establishing COVID-19 Infection as Part of a Trauma Evaluation,Diagnostics,Diagnostic Test or Assessment,20,2021-05-01,2021-05-01,https://clinicaltrials.gov/show/NCT04340479,No Results,No Results,No Results,2020-05-11,2020-04-15,None
1392,NCT04352634,ClinicalTrials.gov,2020-04-08,2020-04-26,False,University of Chile,Recruiting,Not Applicable,Observational,"Czech Republic, Turkey, Saudi Arabia, Netherlands, Italy, Guatemala, Mexico, Chile, Puerto Rico, Nigeria, Venezuela, United States, Bolivia, Germany, Argentina, Spain, Lebanon",The Covid-19 HEalth caRe wOrkErS (HEROES) Study,Clinical Presentation,No Intervention,2000,2021-12-31,2021-12-31,https://clinicaltrials.gov/show/NCT04352634,No Results,No Results,No Results,2020-05-11,2020-04-29,None
1393,NCT04353011,ClinicalTrials.gov,2020-04-15,2020-04-20,False,"University Hospital, Lille",Recruiting,Not Applicable,Observational,France,Psychological Impact of Quarantine in Chronic Pain Patient During COVID-19 Outbreak,Other (psych),No Intervention,50,2020-12-01,2020-12-01,https://clinicaltrials.gov/show/NCT04353011,No Results,No Results,No Results,2020-05-11,2020-04-29,None
1394,NCT04354792,ClinicalTrials.gov,2020-04-16,2020-04-25,False,Kasr El Aini Hospital,Not Recruiting,Not Applicable,Observational,No Country Given,Asymptomatic COVID-19 Infection Among Healthcare Workers,Diagnostics,Diagnostic Test or Assessment,1000,2020-06-30,2020-07-10,https://clinicaltrials.gov/show/NCT04354792,No Results,No Results,No Results,2020-05-11,2020-04-29,None
1395,NCT04355611,ClinicalTrials.gov,2020-04-17,2020-04-20,False,Assistance Publique  Hpitaux de Paris,Recruiting,Not Applicable,Observational,France,Epidemiological Characteristics of COVID-19 in Patients With MS or NMO,Clinical Presentation (Epidemiology),No Intervention,2000,2022-04-20,2022-04-20,https://clinicaltrials.gov/show/NCT04355611,No Results,No Results,No Results,2020-05-11,2020-04-29,None
1396,NCT04342702,ClinicalTrials.gov,2020-04-04,2020-03-16,True,The Second Affiliated Hospital of Wenzhou Medical University,Not Recruiting,Not Applicable,Observational,China,A Study on the Prospective Cohort Library of COVID-19 in Southeran,Clinical Presentation,No Intervention,504,2021-03-01,2021-03-01,https://clinicaltrials.gov/show/NCT04342702,No Results,No Results,No Results,2020-05-11,2020-04-15,None
1397,NCT04342806,ClinicalTrials.gov,2020-04-08,2020-04-10,False,Duke University,Recruiting,Not Applicable,Observational,United States,"Healthcare Worker Exposure Response and Outcomes (HERO) Registry Study, COVID-19",Clinical Presentation,No Intervention,100000,2099-12-31,2099-12-31,https://clinicaltrials.gov/show/NCT04342806,No Results,No Results,No Results,2020-05-11,2020-04-15,None
1398,NCT04342884,ClinicalTrials.gov,2020-04-08,2020-04-08,False,Wake Forest University,Not Recruiting,Not Applicable,Observational,United States,COVID-19 Community Research Partnership,Clinical Presentation,No Intervention,150000,2021-12-01,2021-12-01,https://clinicaltrials.gov/show/NCT04342884,No Results,No Results,No Results,2020-05-11,2020-04-15,None
1399,NCT04353674,ClinicalTrials.gov,2020-04-07,2020-04-28,False,Lawson Health Research Institute,Recruiting,Phase 1,Interventional,Canada,Modulation of Hyperinflammation in COVID-19,Other (device),Dialysis,40,2020-07-28,2021-01-01,https://clinicaltrials.gov/show/NCT04353674,No Results,No Results,No Results,2020-05-11,2020-04-29,None
1400,NCT04354701,ClinicalTrials.gov,2020-04-16,2020-03-17,True,Vanderbilt-Ingram Cancer Center,Recruiting,Not Applicable,Observational,United States,COVID-19 and Cancer Consortium Registry,Clinical Presentation,No Intervention,1000,2021-12-01,2022-12-01,https://clinicaltrials.gov/show/NCT04354701,No Results,No Results,No Results,2020-05-11,2020-04-29,None
1401,ChiCTR2000030922,ChiCTR,2020-03-17,2020-02-26,True,Foshan First People's Hospital,Recruiting,Not Applicable,Interventional,China,"Prospective, open-label, controlled, multicenter cohort study of long-acting interferon plus ribavirin in patients with novel coronavirus pneumonia (COVID-19)",Drug,Interferon + Ribavirin vs. Umifenovir + Ribavirin,30,Not Available,2020-08-26,http://www.chictr.org.cn/showproj.aspx?proj=51141,No Results,No Results,No Results,2020-03-23,2020-03-25,None
1402,NCT04357314,ClinicalTrials.gov,2020-04-19,2020-05-31,False,French Cardiology Society,Not Recruiting,Not Applicable,Observational,No Country Given,Myocardial Infarction Rates Overview During COVID-19 Pandemic In France: MODIF Study,Clinical Presentation,No Intervention,80,2020-07-31,2020-07-31,https://clinicaltrials.gov/show/NCT04357314,No Results,No Results,No Results,2020-05-11,2020-04-29,None
1403,NCT04358068,ClinicalTrials.gov,2020-04-20,2020-05-01,False,National Institute of Allergy and Infectious Diseases (NIAID),Not Recruiting,Phase 2,Interventional,No Country Given,Evaluating the Efficacy of Hydroxychloroquine and Azithromycin to Prevent Hospitalization or Death in Persons With COVID-19,Drug,Hydroxychloroquine + Azithromycin,2000,2020-10-09,2021-03-05,https://clinicaltrials.gov/show/NCT04358068,No Results,No Results,No Results,2020-05-11,2020-04-29,None
1404,NCT04355533,ClinicalTrials.gov,2020-04-17,2020-04-01,True,Assistance Publique  Hpitaux de Paris,Not Recruiting,Not Applicable,Interventional,France,Immunity Against SARS-CoV2 in Children and Their Parents / COVID-19,Diagnostics,Diagnostic Test or Assessment,1920,2020-04-01,2021-07-01,https://clinicaltrials.gov/show/NCT04355533,No Results,No Results,No Results,2020-05-11,2020-04-29,None
1405,NCT04355637,ClinicalTrials.gov,2020-04-15,2020-04-21,False,Sara Varea,Recruiting,Phase 4,Interventional,Spain,Inhaled Corticosteroid Treatment of COVID19 Patients With Pneumonia,Drug,Corticosteroids,300,2020-08-31,2020-10-18,https://clinicaltrials.gov/show/NCT04355637,No Results,No Results,No Results,2020-05-11,2020-04-29,None
1406,ChiCTR2000030906,ChiCTR,2020-03-17,2020-03-10,True,Jiangsu Provincial Center for Disease Control and Prevention,Recruiting,Phase 1,Prevention,China,A phase I clinical trial for recombinant novel coronavirus (2019-COV) vaccine (adenoviral vector),ATMP,Adenovirus vector,108,Not Available,2020-12-31,http://www.chictr.org.cn/showproj.aspx?proj=51154,No Results,No Results,No Results,2020-03-23,2020-03-25,None
1407,NCT04343898,ClinicalTrials.gov,2020-04-09,2020-04-01,True,Brigham and Women's Hospital,Recruiting,Not Applicable,Observational,United States,Study of the Treatment and Outcomes in Critically Ill Patients With COVID-19,Clinical Presentation,No Intervention,4000,2020-06-15,2022-06-01,https://clinicaltrials.gov/show/NCT04343898,No Results,No Results,No Results,2020-05-11,2020-04-15,None
1408,NCT04343989,ClinicalTrials.gov,2020-04-09,2020-03-31,True,NYU Langone Health,Recruiting,Phase 2,Interventional,United States,A Randomized Placebo-controlled Safety and Dose-finding Study for the Use of the IL-6 Inhibitor Clazakizumab in Patients With Life-threatening COVID-19 Infection,Drug,Clazakizumab,90,2020-07-01,2020-07-01,https://clinicaltrials.gov/show/NCT04343989,No Results,No Results,No Results,2020-05-11,2020-04-22,None
1409,NCT04358926,ClinicalTrials.gov,2020-04-21,2020-04-30,False,Assaf-Harofeh Medical Center,Recruiting,Not Applicable,Interventional,Israel,Hyperbaric Oxygen Therapy Effect in COVID-19 RCT (HBOTCOVID19),Drug,Oxygen,30,2020-06-30,2020-07-30,https://clinicaltrials.gov/show/NCT04358926,No Results,No Results,No Results,2020-05-11,2020-04-29,None
1410,NCT04359277,ClinicalTrials.gov,2020-04-20,2020-04-16,True,NYU Langone Health,Recruiting,Phase 3,Interventional,United States,A Randomized Trial of Anticoagulation Strategies in COVID-19,Drug,"Enoxaparin, Heparin",1000,2021-04-16,2021-04-16,https://clinicaltrials.gov/show/NCT04359277,No Results,No Results,No Results,2020-05-11,2020-04-29,None
1411,ChiCTR2000030519,ChiCTR,2020-03-05,2020-03-06,False,Guangzhou Eighth People's Hospital,Not Recruiting,Not Applicable,Observational,China,Study for the clinical characteristics and digestive system damage of novel coronavirus pneumonia (COVID-19),Clinical Presentation,No Intervention,40,Not Available,2021-03-05,http://www.chictr.org.cn/showproj.aspx?proj=50604,No Results,No Results,No Results,2020-03-23,2020-08-03,None
1412,NCT04356690,ClinicalTrials.gov,2020-04-17,2020-05-01,False,Boston Medical Center,Not Recruiting,Phase 2,Interventional,No Country Given,Etoposide in Patients With COVID-19 Infection,Drug,Etoposide,134,2020-12-01,2021-12-01,https://clinicaltrials.gov/show/NCT04356690,No Results,No Results,No Results,2020-05-11,2020-04-29,None
1413,NCT04356833,ClinicalTrials.gov,2020-04-14,2020-04-22,True,"University College, London",Recruiting,Phase 2,Interventional,United Kingdom,Nebulised Rt-PA for ARDS Due to COVID-19,Drug,Recombinant Tissue-Plasminogen Activator,24,2021-01-14,2021-01-14,https://clinicaltrials.gov/show/NCT04356833,No Results,No Results,No Results,2020-05-11,2020-04-29,EUCTR2020-001640-26
1414,NCT04344041,ClinicalTrials.gov,2020-04-09,2020-04-15,True,"University Hospital, Angers",Recruiting,Phase 3,Interventional,France,COvid-19 and Vitamin D Supplementation: a Multicenter Randomized Controlled Trial of High Dose Versus Standard Dose Vitamin D3 in High-risk COVID-19 Patients (CoVitTrial),Drug,Vitamin D,260,2020-07-01,2020-07-01,https://clinicaltrials.gov/show/NCT04344041,No Results,No Results,No Results,2020-05-11,2020-04-22,EUCTR2020-001602-34
1415,NCT04346082,ClinicalTrials.gov,2020-04-07,2020-05-01,False,Chinese University of Hong Kong,Not Recruiting,Not Applicable,Interventional,Hong Kong,Feasibility of Online Based Mindfulness Interventions During COVID-19 Outbreak,Other (psych),Psychological,30,2021-04-30,2021-04-30,https://clinicaltrials.gov/show/NCT04346082,No Results,No Results,No Results,2020-05-11,2020-04-22,None
1416,NCT04357535,ClinicalTrials.gov,2020-04-19,2020-04-12,True,Hakeam Abdulaziz Hakeam,Not Recruiting,Not Applicable,Observational,Saudi Arabia,Prognosis of Coronavirus Disease 2019 (COVID-19) Patients Receiving Receiving Antihypertensives,Drug,ACE inhibitors or ARBs,17,2020-05-03,2020-05-03,https://clinicaltrials.gov/show/NCT04357535,No Results,No Results,No Results,2020-05-11,2020-04-29,None
1417,NCT04358939,ClinicalTrials.gov,2020-04-16,2020-04-27,False,CHU de Tours,Recruiting,Not Applicable,Interventional,France,Prone Position in Patients on High-flow Nasal Oxygen Therapy for COVID-19 (HIGH-PRONE-COVID-19),Procedure,Positioning,248,2020-11-10,2020-11-24,https://clinicaltrials.gov/show/NCT04358939,No Results,No Results,No Results,2020-05-11,2020-04-29,None
1418,NCT04359511,ClinicalTrials.gov,2020-04-20,2020-05-01,False,CHU de Tours,Not Recruiting,Phase 3,Interventional,No Country Given,Efficacy and Safety of Corticosteroids in Oxygen-dependent Patients With COVID-19 Pneumonia,Drug,Corticosteroids,210,2020-11-01,2020-11-01,https://clinicaltrials.gov/show/NCT04359511,No Results,No Results,No Results,2020-05-11,2020-04-29,None
1419,NCT04359797,ClinicalTrials.gov,2020-04-20,2020-04-27,False,Vanderbilt University,Recruiting,Not Applicable,Interventional,United States,COVID-19 Patient Positioning Pragmatic Trial,Procedure,Positioning,300,2021-04-01,2021-06-01,https://clinicaltrials.gov/show/NCT04359797,No Results,No Results,No Results,2020-05-11,2020-04-29,None
1420,NCT04346147,ClinicalTrials.gov,2020-04-07,2020-04-13,False,Hospital Universitario de Fuenlabrada,Recruiting,Phase 2,Interventional,Spain,Clinical Trial to Evaluate Efficacy of 3 Types of Treatment in Patients With Pneumonia by COVID-19,Drug,"Lopinavir/ritonavir vs. Imatinib vs. Baricitinib

All in comibination with Hydroxychloroquine ",165,2020-08-01,2020-09-01,https://clinicaltrials.gov/show/NCT04346147,No Results,No Results,No Results,2020-05-11,2020-04-22,None
1421,NCT04346446,ClinicalTrials.gov,2020-04-14,2020-04-21,False,"Institute of Liver and Biliary Sciences, India",Recruiting,Phase 2,Interventional,India,Efficacy of Convalescent Plasma Therapy in Severely Sick COVID-19 Patients,ATMP,Plasma,40,2020-06-30,2020-06-30,https://clinicaltrials.gov/show/NCT04346446,No Results,No Results,No Results,2020-05-11,2020-04-22,None
1422,NCT04359810,ClinicalTrials.gov,2020-04-21,2020-04-21,False,Max R. O'Donnell,Recruiting,Phase 2,Interventional,United States,Plasma Therapy of COVID-19 in Critically Ill Patients,ATMP,Plasma,105,2020-12-01,2021-04-01,https://clinicaltrials.gov/show/NCT04359810,No Results,No Results,No Results,2020-05-11,2020-04-29,None
1423,NCT04360278,ClinicalTrials.gov,2020-04-22,2020-04-21,True,National Institutes of Health Clinical Center (CC),Recruiting,Not Applicable,Observational,United States,Plasma Collection From Convalescent and/or Immunized Donors for the Treatment of COVID-19,ATMP,Plasma,1500,2030-04-14,2030-04-14,https://clinicaltrials.gov/show/NCT04360278,No Results,No Results,No Results,2020-05-11,2020-04-29,None
1424,NCT04360837,ClinicalTrials.gov,2020-04-22,2020-05-01,False,Szeged University,Not Recruiting,Not Applicable,Interventional,No Country Given,PEEP Incremental and Decremental Alveolar Recruitment of Critically Ill Corona Virus Disease-19 (COVID-19) Patients,Diagnostics,Diagnostic Test or Assessment,10,2021-04-19,2021-04-19,https://clinicaltrials.gov/show/NCT04360837,No Results,No Results,No Results,2020-05-11,2020-04-29,None
1425,NCT04361643,ClinicalTrials.gov,2020-04-23,2020-04-27,False,Hospital Universitario Getafe,Not Recruiting,Phase 4,Interventional,Spain,Low-dose Lenalidomide for Non-severe COVID-19 Treatment Trial,Drug,Lenalidomide,120,2020-08-31,2020-12-31,https://clinicaltrials.gov/show/NCT04361643,No Results,No Results,No Results,2020-05-11,2020-04-29,None
1426,NCT04348370,ClinicalTrials.gov,2020-03-30,2020-04-20,False,Texas A&M University,Recruiting,Phase 4,Interventional,United States,BCG Vaccine for Health Care Workers as Defense Against COVID 19,ATMP,Vaccine,1800,2021-05-01,2021-11-01,https://clinicaltrials.gov/show/NCT04348370,No Results,No Results,No Results,2020-05-11,2020-05-05,None
1427,NCT04348435,ClinicalTrials.gov,2020-04-14,2020-04-23,False,Hope Biosciences,Recruiting,Phase 2,Interventional,United States,"A Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Determine the Safety and Efficacy of Hope Biosciences Allogeneic Mesenchymal Stem Cell Therapy (HB-adMSCs) to Provide Protection Against COVID-19",ATMP,Cells (mesenchymal),100,2020-12-31,2021-04-30,https://clinicaltrials.gov/show/NCT04348435,No Results,No Results,No Results,2020-05-11,2020-04-22,None
1428,NCT04361396,ClinicalTrials.gov,2020-04-22,2020-05-01,False,Centre Hospitalier Ren Dubos,Recruiting,Not Applicable,Interventional,France,Assessment of the Presence of the SARS-COV-2 Virus in the Peritoneum of COVID-19 Patients,Clinical Presentation,No Intervention,40,2020-10-01,2020-10-01,https://clinicaltrials.gov/show/NCT04361396,No Results,No Results,No Results,2020-05-11,2020-04-29,None
1429,NCT04362345,ClinicalTrials.gov,2020-04-20,2020-04-09,True,"University Hospital, Strasbourg",Recruiting,Not Applicable,Observational,France,Clinical Features and Risk Factors Associated With Worse Outcome in Patients Hospitalized for Covid-19 Pneumonia,Clinical Presentation,No Intervention,100,2020-05-17,2020-05-17,https://clinicaltrials.gov/show/NCT04362345,No Results,No Results,No Results,2020-05-11,2020-04-29,None
1430,NCT04361942,ClinicalTrials.gov,2020-04-17,2020-04-01,True,Red de Terapia Celular,Recruiting,Phase 2,Interventional,Spain,Treatment of Severe COVID-19 Pneumonia With Allogeneic Mesenchymal Stromal Cells (COVID_MSV),ATMP,Cells (mesenchymal),24,2020-11-30,2020-12-31,https://clinicaltrials.gov/show/NCT04361942,No Results,No Results,No Results,2020-05-11,2020-04-29,None
1431,NCT04362059,ClinicalTrials.gov,2020-04-20,2020-04-27,False,University Hospital Southampton NHS Foundation Trust,Not Recruiting,Not Applicable,Interventional,No Country Given,A Clinical Trial of Nebulized Surfactant for the Treatment of Moderate to Severe COVID-19,Drug,Bovactant,24,2020-07-27,2020-11-02,https://clinicaltrials.gov/show/NCT04362059,No Results,No Results,No Results,2020-05-11,2020-04-29,None
1432,NCT04348656,ClinicalTrials.gov,2020-04-13,2020-04-27,False,Hamilton Health Sciences Corporation,Not Recruiting,Phase 3,Interventional,Canada,CONvalescent Plasma for Hospitalized Adults With COVID-19 Respiratory Illness (CONCOR-1),ATMP,Plasma,1200,2020-10-31,2020-12-31,https://clinicaltrials.gov/show/NCT04348656,No Results,No Results,No Results,2020-05-11,2020-04-22,None
1433,NCT04350320,ClinicalTrials.gov,2020-04-14,2020-04-30,False,Fundacin para la Formacin e Investigacin Sanitarias de la Regin de Murcia (FFIS),Recruiting,Phase 3,Interventional,Spain,Trial to Study the Benefit of Colchicine in Patients With COVID-19,Drug,Colchicine,102,2020-10-20,2020-11-20,https://clinicaltrials.gov/show/NCT04350320,No Results,No Results,No Results,2020-05-11,2020-04-22,None
1434,ChiCTR2000030254,ChiCTR,2020-02-26,2020-02-20,True,Zhongnan Hospital of Wuhan University,Not Recruiting,Not Applicable,Interventional,China,"the Efficacy and Safety of Favipiravir for novel coronavirusinfected pneumonia: A multicenter, randomized, open, positive, parallel-controlled clinical study",Drug,Favipiravir vs. Umifenovir,240,Not Available,2020-03-20,http://www.chictr.org.cn/showproj.aspx?proj=50137,Pre-Print Article,2020-03-27,https://doi.org/10.1101/2020.03.17.20037432,2020-03-23,2020-08-03,None
1435,NCT04362865,ClinicalTrials.gov,2020-04-24,2020-04-27,False,National Cancer Institute (NCI),Recruiting,Not Applicable,Observational,United States,Investigation of the B- and T-cell Repertoire and Immune Response in Patients With Acute and Resolved COVID-19 Infection,Clinical Presentation,No Intervention,150,2023-12-01,2024-12-01,https://clinicaltrials.gov/show/NCT04362865,No Results,No Results,No Results,2020-05-11,2020-05-05,None
1436,NCT04362969,ClinicalTrials.gov,2020-04-23,2020-05-01,False,"Hospital San Carlos, Madrid",Not Recruiting,Not Applicable,Observational,Ecuador,"COVID-EC Study: Clinical Characteristics of Patients With COVID-19 in Guayaquil, Ecuador",Clinical Presentation,No Intervention,300,2020-05-01,2020-05-01,https://clinicaltrials.gov/show/NCT04362969,No Results,No Results,No Results,2020-05-11,2020-05-05,None
1437,NCT04362150,ClinicalTrials.gov,2020-04-23,2020-04-21,True,"University of California, San Francisco",Recruiting,Not Applicable,Observational,United States,Long-term Impact of Infection With Novel Coronavirus (COVID-19),Clinical Presentation,No Intervention,800,2022-12-31,2024-12-21,https://clinicaltrials.gov/show/NCT04362150,No Results,No Results,No Results,2020-05-11,2020-04-29,None
1438,NCT04363008,ClinicalTrials.gov,2020-04-21,2020-03-30,True,University of British Columbia,Recruiting,Not Applicable,Observational,Canada,COVID 19 Biomarkers,Diagnostics,Diagnostic Test or Assessment,150,2020-04-30,2021-09-30,https://clinicaltrials.gov/show/NCT04363008,No Results,No Results,No Results,2020-05-11,2020-05-05,None
1439,NCT04350476,ClinicalTrials.gov,2020-04-14,2020-04-01,True,Vivek Reddy,Not Recruiting,Not Applicable,Interventional,United States,COVID-19 Remote Monitoring,Clinical Presentation,No Intervention,1000,2021-04-01,2021-04-01,https://clinicaltrials.gov/show/NCT04350476,No Results,No Results,No Results,2020-05-11,2020-04-22,None
1440,NCT04350736,ClinicalTrials.gov,2020-04-14,2020-04-23,False,Theravance Biopharma,Recruiting,Phase 1,Interventional,United Kingdom,"First in Human SAD and MAD Study of Inhaled TD-0903, a Potential Treatment for ALI Associated With COVID-19",Drug,TD-0903,54,2020-06-01,2020-06-01,https://clinicaltrials.gov/show/NCT04350736,No Results,No Results,No Results,2020-05-11,2020-04-22,None
1441,NCT04363814,ClinicalTrials.gov,2020-04-19,2020-05-10,False,Inmunotek S.L.,Not Recruiting,Phase 3,Interventional,No Country Given,Clinical Impact of BACTEK-R in Subject With Mild Pneumonia Due to COVID-19 Infection,Drug,Bactek-R,100,2020-07-01,2020-07-31,https://clinicaltrials.gov/show/NCT04363814,No Results,No Results,No Results,2020-05-11,2020-05-05,None
1442,NCT04364009,ClinicalTrials.gov,2020-04-17,2020-04-27,False,CHU de Tours,Recruiting,Phase 3,Interventional,France,Anakinra for COVID-19 Respiratory Symptoms,Drug,Anakinra,240,2020-09-10,2020-09-24,https://clinicaltrials.gov/show/NCT04364009,No Results,No Results,No Results,2020-05-11,2020-05-12,None
1443,NCT04363333,ClinicalTrials.gov,2020-04-19,2020-04-27,False,Ko University,Recruiting,Not Applicable,Observational,Turkey,Obstructive Sleep Apnea & Covid-19 Outcomes,Clinical Presentation,No Intervention,275,2020-11-30,2020-12-31,https://clinicaltrials.gov/show/NCT04363333,No Results,No Results,No Results,2020-05-11,2020-05-05,None
1444,NCT04363437,ClinicalTrials.gov,2020-04-23,2020-04-26,False,Maimonides Medical Center,Recruiting,Phase 2,Interventional,United States,COlchicine in Moderate-severe Hospitalized Patients Before ARDS to Treat COVID-19,Drug,Colchicine,70,2020-05-31,2020-06-14,https://clinicaltrials.gov/show/NCT04363437,No Results,No Results,No Results,2020-05-11,2020-05-05,None
1445,NCT04352465,ClinicalTrials.gov,2020-04-15,2020-05-01,False,Azidus Brasil,Not Recruiting,Phase 1/Phase 2,Interventional,Brazil,Efficacy and Safety of MTX-loaded Nanoparticles to Treat Severe COVID-19 Patients,Drug,Methotrexate,42,2020-06-30,2020-11-30,https://clinicaltrials.gov/show/NCT04352465,No Results,No Results,No Results,2020-05-11,2020-04-29,None
1446,NCT04354428,ClinicalTrials.gov,2020-04-16,2020-04-16,False,University of Washington,Recruiting,Phase 2/Phase 3,Interventional,United States,Treatment for COVID-19 in High-Risk Adult Outpatients,Drug,Hydroxychloroquine + Azithromycin vs. Hydroxychloroquine vs. Vitamin C + Folic Acid,630,2020-07-01,2020-10-01,https://clinicaltrials.gov/show/NCT04354428,No Results,No Results,No Results,2020-05-11,2020-04-29,None
1447,NCT04364737,ClinicalTrials.gov,2020-04-22,2020-04-17,True,NYU Langone Health,Recruiting,Phase 2,Interventional,United States,Convalescent Plasma to Limit COVID-19 Complications in Hospitalized Patients,ATMP,Plasma,300,2023-01-31,2023-04-30,https://clinicaltrials.gov/show/NCT04364737,No Results,No Results,No Results,2020-05-11,2020-05-05,None
1448,NCT04364763,ClinicalTrials.gov,2020-04-20,2020-06-01,False,"Renibus Therapuetics, Inc.",Not Recruiting,Phase 2,Interventional,No Country Given,The Effect of RBT-9[Stannous Protoporphyrin (SnPP)] on Progression of COVID-19 Infection in High-Risk Individuals,Drug,Stannous protoporphyrin,252,2021-06-30,2021-12-31,https://clinicaltrials.gov/show/NCT04364763,No Results,No Results,No Results,2020-05-11,2020-05-05,None
1449,NCT04363827,ClinicalTrials.gov,2020-04-24,2020-05-01,False,Istituto Scientifico Romagnolo per lo Studio e la cura dei Tumori,Not Recruiting,Phase 2,Interventional,Italy,Protect: Study With Hydroxychloroquine for Prevention and Early Phase Treatment of Coronavirus Disease (COVID-19),Drug (+ chemoprophylaxis),Hydroxychloroquine,2300,2020-09-01,2021-03-01,https://clinicaltrials.gov/show/NCT04363827,No Results,No Results,No Results,2020-05-11,2020-05-05,None
1450,NCT04365166,ClinicalTrials.gov,2020-04-19,2020-04-20,False,Direction Centrale du Service de Sant des Armes,Recruiting,Not Applicable,Observational,France,Study of Clinical and Immune Severity Profiles of Patients Infected With SARS-Cov2 (COVID-19),Clinical Presentation,No Intervention,100,2022-04-21,2022-04-21,https://clinicaltrials.gov/show/NCT04365166,No Results,No Results,No Results,2020-05-11,2020-05-05,None
1451,NCT04354597,ClinicalTrials.gov,2020-04-09,2020-05-01,False,King Hussein Cancer Center,Not Recruiting,Not Applicable,Interventional,Jordan,Hydroxychloroquine and Azithromycin as Prophylaxis for Healthcare Workers Dealing With COVID19 Patients,Drug (Chemoprophylaxis),Hydroxychloroquine + Azithromycin,200,2020-08-15,2020-10-15,https://clinicaltrials.gov/show/NCT04354597,No Results,No Results,No Results,2020-05-11,2020-04-29,None
1452,NCT04354610,ClinicalTrials.gov,2020-04-14,2020-04-27,False,CHU de Nancy,Recruiting,Not Applicable,Interventional,France,Cardiovascular and Renal Biomarkers to Predict Acute Heart or Kidney Injury in Severe Covid-19 Infection,Clinical Presentation,No Intervention,57,2020-07-18,2020-10-18,https://clinicaltrials.gov/show/NCT04354610,No Results,No Results,No Results,2020-05-11,2020-04-29,None
1453,NCT04365322,ClinicalTrials.gov,2020-04-25,2020-04-20,True,CHU de Besanon,Recruiting,Not Applicable,Observational,France,Study of Specific Viral Immune Responses Induced by SARS-CoV-2 (COVID-19),Clinical Presentation,No Intervention,60,2020-06-01,2025-04-20,https://clinicaltrials.gov/show/NCT04365322,No Results,No Results,No Results,2020-05-11,2020-05-05,None
1454,NCT04365361,ClinicalTrials.gov,2020-04-25,2020-04-26,False,The University of Hong Kong,Not Recruiting,Not Applicable,Observational,No Country Given,The Psychological Impact of the COVID-19 on Students.,Other (psych),No Intervention,300,2020-12-30,2021-03-31,https://clinicaltrials.gov/show/NCT04365361,No Results,No Results,No Results,2020-05-11,2020-05-05,None
1455,NCT04365335,ClinicalTrials.gov,2020-04-24,2020-04-01,True,Direction Centrale du Service de Sant des Armes,Recruiting,Not Applicable,Observational,France,Stress Biomarkers Leading to Professional Burnout Among People Involved in a Mobile Intensive Care Unit During the COVID-19 Pandemic,Other (psych),No Intervention,60,2020-06-13,2020-06-13,https://clinicaltrials.gov/show/NCT04365335,No Results,No Results,No Results,2020-05-11,2020-05-05,None
1456,NCT04365517,ClinicalTrials.gov,2020-04-14,2020-04-30,False,University of Milan,Not Recruiting,Phase 3,Interventional,Italy,The Effect of Sitagliptin Treatment in COVID-19 Positive Diabetic Patients,Drug,Sitagliptin,170,2020-06-30,2020-12-30,https://clinicaltrials.gov/show/NCT04365517,No Results,No Results,No Results,2020-05-11,2020-05-05,None
1457,NCT04355728,ClinicalTrials.gov,2020-04-13,2020-04-25,False,Camillo Ricordi,Recruiting,Phase 1/Phase 2,Interventional,United States,Use of UC-MSCs for COVID-19 Patients,ATMP,Cells (mesenchymal),24,2020-12-31,2021-05-01,https://clinicaltrials.gov/show/NCT04355728,No Results,No Results,No Results,2020-05-11,2020-04-29,None
1458,NCT04356482,ClinicalTrials.gov,2020-04-17,2020-05-01,False,Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado,Not Recruiting,Phase 1/Phase 2,Interventional,Mexico,CONVALESCENT PLASMA FOR ILL PATIENTS BY COVID-19,ATMP,Plasma,90,2020-11-01,2020-12-01,https://clinicaltrials.gov/show/NCT04356482,No Results,No Results,No Results,2020-05-11,2020-04-29,None
1459,NCT04365530,ClinicalTrials.gov,2020-04-26,2020-04-01,True,Groupe Hospitalier Paris Saint-Joseph,Recruiting,Not Applicable,Observational,France,Become of Patients Infected or Suspected of Being Infected by Covid-19 and Supported by the GHPSJ and the Establishments of the Paris Plaisance Hospital City,Clinical Presentation,No Intervention,2000,2022-04-01,2022-12-31,https://clinicaltrials.gov/show/NCT04365530,No Results,No Results,No Results,2020-05-11,2020-05-05,None
1460,NCT04366115,ClinicalTrials.gov,2020-04-26,2020-06-01,False,AVM Biotechnology LLC,Not Recruiting,Phase 1/Phase 2,Interventional,No Country Given,Evaluating AVM0703 for Treatment of COVID-19,Drug,AVM0703,126,2022-06-01,2023-06-01,https://clinicaltrials.gov/show/NCT04366115,No Results,No Results,No Results,2020-05-11,2020-05-05,None
1461,NCT04365816,ClinicalTrials.gov,2020-04-24,2020-05-01,False,"University Hospital, Grenoble",Not Recruiting,Not Applicable,Observational,No Country Given,NutriCovid30 : Nutritional Evaluation for Covid-19 Infection at D30,Clinical Presentation,No Intervention,600,2020-07-01,2020-11-01,https://clinicaltrials.gov/show/NCT04365816,No Results,No Results,No Results,2020-05-11,2020-05-05,None
1462,NCT04365972,ClinicalTrials.gov,2020-04-24,2020-04-23,True,Tel Aviv University,Not Recruiting,Not Applicable,Interventional,Israel,Attention Bias Modification for Reducing Health Anxiety During the Coronavirus Pandemic,Other (psych),Psychological,20,2020-04-30,2020-04-30,https://clinicaltrials.gov/show/NCT04365972,No Results,No Results,No Results,2020-05-11,2020-05-05,None
1463,NCT04357730,ClinicalTrials.gov,2020-04-18,2020-04-01,True,Denver Health and Hospital Authority,Not Recruiting,Phase 2,Interventional,No Country Given,Fibrinolytic Therapy to Treat ARDS in the Setting of COVID-19 Infection: A Phase 2a Clinical Trial,Drug,Alteplase,60,2020-08-01,2020-10-01,https://clinicaltrials.gov/show/NCT04357730,No Results,No Results,No Results,2020-05-11,2020-04-29,None
1464,NCT04357990,ClinicalTrials.gov,2020-04-20,2020-05-01,False,Kerecis Ltd.,Recruiting,Not Applicable,Interventional,Iceland,Kerecis Oral and Nasal Spray for Treating the Symptoms of COVID-19,Drug,Omega 3,81,2020-07-01,2020-07-01,https://clinicaltrials.gov/show/NCT04357990,No Results,No Results,No Results,2020-05-11,2020-04-29,None
1465,NCT04366180,ClinicalTrials.gov,2020-04-27,2020-04-24,True,Biosearch S.A.,Recruiting,Not Applicable,Interventional,Spain,Evaluation of the Probiotic Lactobacillus Coryniformis K8 on COVID-19 Prevention in Healthcare Workers,Supplement,Probiotics,314,2020-06-01,2020-10-01,https://clinicaltrials.gov/show/NCT04366180,No Results,No Results,No Results,2020-05-11,2020-05-05,None
1466,NCT04366245,ClinicalTrials.gov,2020-04-22,2020-04-01,True,Andalusian Network for Design and Translation of Advanced Therapies,Recruiting,Phase 1/Phase 2,Interventional,Spain,Clinical Trial to Evaluate the Efficacy of Treatment With Hyperimmune Plasma Obtained From Convalescent Antibodies of COVID-19 Infection,ATMP (+ Drug),Plasma vs. Hydroxychloroquine + Azithromycin or Hydroxychloroquine + Interferon beta + Lopinavir/ritonavir,72,2021-12-01,2021-12-01,https://clinicaltrials.gov/show/NCT04366245,No Results,No Results,No Results,2020-05-11,2020-05-05,None
1467,NCT04366063,ClinicalTrials.gov,2020-04-20,2020-04-05,True,Royan Institute,Recruiting,Phase 2/Phase 3,Interventional,Iran,Mesenchymal Stem Cell Therapy for SARS-CoV-2-related Acute Respiratory Distress Syndrome,ATMP,Cells (mesenchymal),60,2020-06-06,2020-12-10,https://clinicaltrials.gov/show/NCT04366063,No Results,No Results,No Results,2020-05-11,2020-05-05,None
1468,NCT04366089,ClinicalTrials.gov,2020-04-22,2020-03-26,True,Dr. Roberto Poscia,Recruiting,Phase 2,Interventional,Italy,Oxygen-Ozone as Adjuvant Treatment in Early Control of COVID-19 Progression and Modulation of the Gut Microbial Flora,Drug,Oxygen,152,2020-10-30,2020-12-31,https://clinicaltrials.gov/show/NCT04366089,No Results,No Results,No Results,2020-05-11,2020-05-05,None
1469,NCT04358003,ClinicalTrials.gov,2020-04-20,2020-04-27,False,Marker Therapeutics AG,Recruiting,Not Applicable,Interventional,United States,Plasma Adsorption in Patients With Confirmed COVID-19,Other (device),Plasma Adsorption Cartridge,2000,2020-08-01,2020-12-01,https://clinicaltrials.gov/show/NCT04358003,No Results,No Results,No Results,2020-05-11,2020-04-29,None
1470,NCT04359602,ClinicalTrials.gov,2020-04-21,2020-04-08,True,"University of California, Los Angeles",Recruiting,Not Applicable,Observational,United States,COVID-19 Recovered Volunteer Research Participant Pool Registry,Other,No Intervention,10000,2022-04-20,2042-04-20,https://clinicaltrials.gov/show/NCT04359602,No Results,No Results,No Results,2020-05-11,2020-04-29,None
1471,NCT04366206,ClinicalTrials.gov,2020-04-19,2020-03-14,True,Centre Hospitalier Intercommunal Robert Ballanger,Recruiting,Not Applicable,Observational,France,Factors Associated With Clinical Outcomes in Patients Hospitalized for Covid-19 in GHT-93 Est,Clinical Presentation,No Intervention,143,2020-07-31,2020-07-31,https://clinicaltrials.gov/show/NCT04366206,No Results,No Results,No Results,2020-05-11,2020-05-05,None
1472,NCT04366232,ClinicalTrials.gov,2020-04-27,2020-05-01,False,Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer,Not Recruiting,Phase 2,Interventional,France,Efficacy of Intravenous Anakinra and Ruxolitinib During COVID-19 Inflammation (JAKINCOV),Drug,Anakinra + Ruxolitinib vs. Anakinra,50,2020-08-31,2020-08-31,https://clinicaltrials.gov/show/NCT04366232,No Results,No Results,No Results,2020-05-11,2020-05-05,None
1473,NCT04366791,ClinicalTrials.gov,2020-04-24,2020-04-23,True,Emory University,Recruiting,Phase 1/Phase 2,Interventional,United States,Radiation Eliminates Storming Cytokines and Unchecked Edema as a 1-Day Treatment for COVID-19,Other,Radiation,10,2020-06-01,2020-07-01,https://clinicaltrials.gov/show/NCT04366791,No Results,No Results,No Results,2020-05-11,2020-05-05,None
1474,NCT04366856,ClinicalTrials.gov,2020-04-26,2020-04-01,True,Assistance Publique  Hpitaux de Paris,Not Recruiting,Not Applicable,Interventional,France,PROne Positioning in coVID-19 Oxygeno-dependent Patients in Spontaneous Ventilation (PROVID Study),Procedure,Positioning,500,2020-05-01,2020-07-01,https://clinicaltrials.gov/show/NCT04366856,No Results,No Results,No Results,2020-05-11,2020-05-05,None
1475,NCT04359654,ClinicalTrials.gov,2020-04-21,2020-05-01,False,"University College, London",Not Recruiting,Phase 2,Interventional,United Kingdom,Nebulised Dornase Alfa for Treatment of COVID-19,Drug,Dornase alfa,50,2020-08-01,2020-11-01,https://clinicaltrials.gov/show/NCT04359654,No Results,No Results,No Results,2020-05-11,2020-04-29,None
1476,NCT04359693,ClinicalTrials.gov,2020-04-21,2020-04-01,True,"University Hospital, Lille",Not Recruiting,Not Applicable,Observational,No Country Given,Impact of COVID-19 Infection on the Incidence of Ventilator-acquired Infections,Clinical Presentation,No Intervention,1071,2020-07-01,2020-07-01,https://clinicaltrials.gov/show/NCT04359693,No Results,No Results,No Results,2020-05-11,2020-05-05,None
1477,NCT04366960,ClinicalTrials.gov,2020-04-24,2020-05-01,False,Niguarda Hospital,Not Recruiting,Phase 3,Interventional,Italy,Comparison of Two Doses of Enoxaparin for Thromboprophylaxis in Hospitalized COVID-19 Patients,Drug,Enoxaparin,2712,2020-08-01,2020-11-01,https://clinicaltrials.gov/show/NCT04366960,No Results,No Results,No Results,2020-05-11,2020-05-05,None
1478,NCT04366986,ClinicalTrials.gov,2020-04-23,2020-05-01,False,Pregistry,Not Recruiting,Not Applicable,Observational,United States,International Registry of Coronavirus (COVID-19) Exposure in Pregnancy,Clinical Presentation,No Intervention,25000,2024-04-30,2024-04-30,https://clinicaltrials.gov/show/NCT04366986,No Results,No Results,No Results,2020-05-11,2020-05-05,None
1479,NCT04366323,ClinicalTrials.gov,2020-04-22,2020-04-01,True,Andalusian Network for Design and Translation of Advanced Therapies,Not Recruiting,Phase 1/Phase 2,Interventional,No Country Given,Clinical Trial to Assess the Safety and Efficacy of Intravenous Administration of Allogeneic Adult Mesenchymal Stem Cells of Expanded Adipose Tissue in Patients With Severe Pneumonia Due to COVID-19,ATMP,Cells (mesenchymal),26,2021-10-01,2021-10-01,https://clinicaltrials.gov/show/NCT04366323,No Results,No Results,No Results,2020-05-11,2020-05-05,None
1480,NCT04366817,ClinicalTrials.gov,2020-04-20,2020-04-01,True,Assistance Publique  Hpitaux de Paris,Not Recruiting,Not Applicable,Interventional,France,Psychological Impact of the Lockdown on Patients Giving Birth During the COVID-19 Epidemic Short Title : Isolement and Childbirth: Psychological Impact,Other (psych),No Intervention,120,2020-04-01,2020-06-01,https://clinicaltrials.gov/show/NCT04366817,No Results,No Results,No Results,2020-05-11,2020-05-05,None
1481,NCT04359706,ClinicalTrials.gov,2020-04-21,2020-04-01,True,"University Hospital, Lille",Not Recruiting,Not Applicable,Observational,No Country Given,Bacterial and Fungal Microbiota of Patients With Severe Viral Pneumonia With COVID-19,Clinical Presentation,No Intervention,30,2020-09-01,2020-09-01,https://clinicaltrials.gov/show/NCT04359706,No Results,No Results,No Results,2020-05-11,2020-05-05,None
1482,NCT04360824,ClinicalTrials.gov,2020-04-13,2020-05-06,False,University of Iowa,Not Recruiting,Phase 4,Interventional,No Country Given,Covid-19 Associated Coagulopathy,Drug,Enoxaparin,170,2021-04-16,2021-04-16,https://clinicaltrials.gov/show/NCT04360824,No Results,No Results,No Results,2020-05-11,2020-04-29,None
1483,NCT04361877,ClinicalTrials.gov,2020-04-20,2020-03-30,True,Klinikum der Universitt Mnchen,Recruiting,Not Applicable,Observational,Germany,Cardiovascular Prevention During COVID-19 Pandemic Lockdown in Young Adults (COLA Trial),Clinical Presentation,No Intervention,1900,2020-04-20,2020-04-20,https://clinicaltrials.gov/show/NCT04361877,No Results,No Results,No Results,2020-05-11,2020-04-29,None
1484,NCT04367142,ClinicalTrials.gov,2020-04-27,2020-05-01,False,"University Hospital, Lille",Not Recruiting,Not Applicable,Observational,No Country Given,Rapid Detection of COVID-19 by Portable and Connected Biosensor,Other (device),Biosensors,200,2020-09-01,2020-09-01,https://clinicaltrials.gov/show/NCT04367142,No Results,No Results,No Results,2020-05-11,2020-05-05,None
1485,NCT04367545,ClinicalTrials.gov,2020-04-27,2020-04-01,True,"University Hospital, Rouen",Recruiting,Not Applicable,Interventional,France,Development of a Molecular Diagnostic Strategy for SARS-CoV2 Based on Saliva in the Context of the COVID-19 Pandemic,Diagnostics,Diagnostic Test or Assessment,50,2020-05-01,2020-05-01,https://clinicaltrials.gov/show/NCT04367545,No Results,No Results,No Results,2020-05-11,2020-05-05,None
1486,NCT04366947,ClinicalTrials.gov,2020-04-23,2020-04-14,True,Lazarski University,Not Recruiting,Not Applicable,Interventional,Poland,Intravascular Access in Suspected/Confirmed COVID-19 Patient,Other (device),Intraosseous/Intravenous access device,60,2020-05-20,2020-05-20,https://clinicaltrials.gov/show/NCT04366947,No Results,No Results,No Results,2020-05-11,2020-05-05,None
1487,NCT04367129,ClinicalTrials.gov,2020-04-16,2020-04-14,True,"University Hospital, Ferrara",Recruiting,Not Applicable,Observational,Italy,Electrocardiogram Analysis in COVID-19 Patients,Clinical Presentation,No Intervention,1000,2020-12-01,2021-12-01,https://clinicaltrials.gov/show/NCT04367129,No Results,No Results,No Results,2020-05-11,2020-05-05,None
1488,NCT04362813,ClinicalTrials.gov,2020-04-24,2020-04-30,True,Novartis Pharmaceuticals,Recruiting,Phase 3,Interventional,"United Kingdom, United States, Spain",Study of Efficacy and Safety of Canakinumab Treatment for CRS in Participants With COVID-19-induced Pneumonia,Drug,Canakinumab,450,2020-07-10,2020-10-16,https://clinicaltrials.gov/show/NCT04362813,No Results,No Results,No Results,2020-05-11,2020-05-05,EUCTR2020-001370-30
1489,NCT04363450,ClinicalTrials.gov,2020-04-23,2020-04-27,False,Louisiana State University Health Sciences Center in New Orleans,Recruiting,Phase 3,Interventional,United States,Hydroxychloroquine as Prophylaxis for COVID-19 in Healthcare Workers (HCQPreP),Drug (Chemoprophylaxis),Hydroxychloroquine,1700,2020-07-06,2020-08-03,https://clinicaltrials.gov/show/NCT04363450,No Results,No Results,No Results,2020-05-11,2020-05-05,None
1490,NCT04367636,ClinicalTrials.gov,2020-04-20,2020-04-20,False,University of Ghent,Not Recruiting,Not Applicable,Interventional,Belgium,The Effects of Attention Training on Emotion Regulation and Stress Related Complaints During COVID-19,Other (psych),Psychological,100,2020-08-01,2020-08-01,https://clinicaltrials.gov/show/NCT04367636,No Results,No Results,No Results,2020-05-11,2020-05-05,None
1491,NCT04367740,ClinicalTrials.gov,2020-04-27,2020-04-28,False,"University of North Carolina, Chapel Hill",Recruiting,Not Applicable,Observational,United States,"ScreenNC, a Study to Determine the Number of Asymptomatic Individuals Who Have Antibodies to the Virus That Causes COVID-19",Diagnostics,Diagnostic Test or Assessment,10000,2021-04-01,2021-04-01,https://clinicaltrials.gov/show/NCT04367740,No Results,No Results,No Results,2020-05-11,2020-05-05,None
1492,NCT04363502,ClinicalTrials.gov,2020-04-23,2020-05-01,False,Johns Hopkins University,Not Recruiting,Phase 2,Interventional,No Country Given,Use of the Interleukin-6 Inhibitor Clazakizumab in Patients With Life-threatening COVID-19 Infection,Drug,Clazakizumab,30,2020-08-01,2020-08-01,https://clinicaltrials.gov/show/NCT04363502,No Results,No Results,No Results,2020-05-11,2020-05-05,None
1493,NCT04363593,ClinicalTrials.gov,2020-04-24,2020-05-04,False,Centre Hospitalier de Cornouaille,Recruiting,Not Applicable,Interventional,France,Serology COVID-19 From the Cornwall Hospital Union,Clinical Presentation (Epidemiology),No Intervention,3200,2020-11-04,2020-11-04,https://clinicaltrials.gov/show/NCT04363593,No Results,No Results,No Results,2020-05-11,2020-05-05,None
1494,NCT04367402,ClinicalTrials.gov,2020-04-17,2020-03-30,True,Azienda Ospedaliera San Paolo,Recruiting,Not Applicable,Observational,Italy,"COST (COvid STudio) ACTION: Study for the Evaluation of Specific Antibodies Anti Covid-19 Linked to Covid-19 Infection, Symptoms and Genetic Expression of ACE2 Polymorphisms in Patients (COST ACTION)",Diagnostics,Diagnostic Test or Assessment,600,2020-04-24,2020-09-01,https://clinicaltrials.gov/show/NCT04367402,No Results,No Results,No Results,2020-05-11,2020-05-05,None
1495,NCT04367662,ClinicalTrials.gov,2020-04-16,2020-04-09,True,"University Hospital, Rouen",Recruiting,Not Applicable,Interventional,France,Study of the Vascular Compartment and Hypercoagulability During Coronavirus Infection COVID-19,Clinical Presentation,No Intervention,100,2020-07-01,2020-07-01,https://clinicaltrials.gov/show/NCT04367662,No Results,No Results,No Results,2020-05-11,2020-05-05,None
1496,NCT04367870,ClinicalTrials.gov,2020-04-28,2020-05-01,False,UNICANCER,Not Recruiting,Not Applicable,Observational,France,COVID-19 Detection Test in Oncology,Clinical Presentation (Epidemiology),No Intervention,2500,2020-08-01,2021-05-01,https://clinicaltrials.gov/show/NCT04367870,No Results,No Results,No Results,2020-05-11,2020-05-05,None
1497,NCT04367896,ClinicalTrials.gov,2020-04-27,2020-03-24,True,Fondazione Policlinico Universitario Agostino Gemelli IRCCS,Not Recruiting,Not Applicable,Observational,Italy,COVID-19 OUTBREAK AND SOLID ORGAN TRANSPLANTATION (SOT) : AN INTERNATIONAL WEB-BASED SURVEY,Clinical Presentation,No Intervention,1819,2020-04-17,2020-04-17,https://clinicaltrials.gov/show/NCT04367896,No Results,No Results,No Results,2020-05-11,2020-05-05,None
1498,NCT04368013,ClinicalTrials.gov,2020-04-27,2020-04-28,False,Johan Normark,Not Recruiting,Not Applicable,Interventional,Sweden,"Host-pathogen Interactions, Immune Response, and Clinical Prognosis at COVID-19 - the CoVUm Trial",Prognosis,No Intervention,400,2026-04-14,2026-04-14,https://clinicaltrials.gov/show/NCT04368013,No Results,No Results,No Results,2020-05-11,2020-05-05,None
1499,NCT04366141,ClinicalTrials.gov,2020-04-24,2020-05-01,False,University of British Columbia,Not Recruiting,Not Applicable,Interventional,No Country Given,COVID-19 (Coronavirus Disease 2019) Intubation Barrier Box,Other (device),Barrier,120,2021-04-01,2021-04-01,https://clinicaltrials.gov/show/NCT04366141,No Results,No Results,No Results,2020-05-11,2020-05-05,None
1500,NCT04366154,ClinicalTrials.gov,2020-04-16,2020-04-15,True,Centre Francois Baclesse,Recruiting,Not Applicable,Observational,France,Impact of the COVID-19 Infectious Epidemic on the Management of Oncology and Onco-hematology Patients and on the Psychological Consequences for Patients and Caregivers,Other (psych),No Intervention,385,2020-07-01,2020-12-01,https://clinicaltrials.gov/show/NCT04366154,No Results,No Results,No Results,2020-05-11,2020-05-05,None
1501,NCT04367857,ClinicalTrials.gov,2020-04-28,2020-04-18,True,Columbia University,Recruiting,Not Applicable,Observational,United States,ARMOR Study: COVID-19 Seroprevalence Among Healthcare Workers,Clinical Presentation (Epidemiology),No Intervention,1000,2021-10-01,2021-10-01,https://clinicaltrials.gov/show/NCT04367857,No Results,No Results,No Results,2020-05-11,2020-05-05,None
1502,NCT04368000,ClinicalTrials.gov,2020-04-24,2020-04-01,True,University of Utah,Not Recruiting,Not Applicable,Interventional,No Country Given,Prone Positioning in Awake Patients With COVID-19 Requiring Hospitalization,Procedure,Positioning,60,2020-12-01,2021-01-01,https://clinicaltrials.gov/show/NCT04368000,No Results,No Results,No Results,2020-05-11,2020-05-05,None
1503,NCT04368221,ClinicalTrials.gov,2020-04-24,2020-04-01,True,Rennes University Hospital,Not Recruiting,Not Applicable,Observational,France,Characterization of Fungal Infections in COVID-19 Infected and Mechanically Ventilated Patients in ICU,Clinical Presentation,No Intervention,250,2021-05-01,2021-05-01,https://clinicaltrials.gov/show/NCT04368221,No Results,No Results,No Results,2020-05-11,2020-05-05,None
1504,NCT04368338,ClinicalTrials.gov,2020-04-28,2020-04-28,False,CHU de Amiens,Recruiting,Not Applicable,Observational,France,Lung Ultrasound to Diagnose COVID-19,Diagnostics,Diagnostic Test or Assessment,100,2020-09-28,2020-09-28,https://clinicaltrials.gov/show/NCT04368338,No Results,No Results,No Results,2020-05-11,2020-05-05,None
1505,NCT04368143,ClinicalTrials.gov,2020-04-27,2020-04-01,True,Institute of Tropical Medicine,Recruiting,Not Applicable,Observational,Belgium,COVID-19 Immune Repertoire Sequencing,Genomics,No Intervention,100,2020-06-30,2020-12-31,https://clinicaltrials.gov/show/NCT04368143,No Results,No Results,No Results,2020-05-11,2020-05-05,None
1506,NCT04368208,ClinicalTrials.gov,2020-04-28,2020-05-01,False,Poitiers University Hospital,Not Recruiting,Not Applicable,Observational,No Country Given,Impact of Giving Birth During the Covid 19 Pandemia on Postnatal Women's Depression,Other (psych),No Intervention,900,2020-05-01,2020-12-01,https://clinicaltrials.gov/show/NCT04368208,No Results,No Results,No Results,2020-05-11,2020-05-05,None
1507,NCT04366167,ClinicalTrials.gov,2020-04-24,2020-04-18,True,Barts & The London NHS Trust,Recruiting,Not Applicable,Observational,United Kingdom,Patient Recovery From Heart Surgery During the Covid-19 Pandemic,Clinical Presentation,No Intervention,100,2021-04-19,2021-12-31,https://clinicaltrials.gov/show/NCT04366167,No Results,No Results,No Results,2020-05-11,2020-05-05,None
1508,NCT04366739,ClinicalTrials.gov,2020-04-24,2020-04-29,False,Centre Hospitalier St Anne,Not Recruiting,Phase 3,Interventional,France,Repurposing of Chlorpromazine in Covid-19 Treatment,Drug,Chlorpromazine,40,2020-08-30,2020-09-30,https://clinicaltrials.gov/show/NCT04366739,No Results,No Results,No Results,2020-05-11,2020-05-05,None
1509,NCT04368871,ClinicalTrials.gov,2020-04-29,2020-04-28,True,Max Healthcare Insititute Limited,Not Recruiting,Not Applicable,Observational,India,Radiographic Findings and Their Temporal Changes in COVID-19 Positive Changes Patients: A Prospective Study,Clinical Presentation,No Intervention,200,2020-06-30,2021-05-30,https://clinicaltrials.gov/show/NCT04368871,No Results,No Results,No Results,2020-05-11,2020-05-05,None
1510,NCT04368897,ClinicalTrials.gov,2020-04-27,2020-05-01,False,"Applied Biology, Inc.",Not Recruiting,Not Applicable,Observational,Spain,In-vitro Diagnostic Test to Predict COVID-19 Mortality and Disease Severity,Diagnostics,Diagnostic Test or Assessment,200,2020-09-01,2020-12-01,https://clinicaltrials.gov/show/NCT04368897,No Results,No Results,No Results,2020-05-11,2020-05-05,None
1511,NCT04263402,ClinicalTrials.gov,2020-02-02,2020-02-01,True,Tongji Hospital,Recruiting,Phase 4,Interventional,China,The Efficacy of Different Hormone Doses in 2019-nCoV Severe Pneumonia,Drug,Corticosteroids,100,2020-06-01,2020-07-01,https://clinicaltrials.gov/show/NCT04263402,No Results,No Results,No Results,2020-03-30,2020-08-03,None
1512,NCT04283396,ClinicalTrials.gov,2020-02-13,2020-02-21,False,"Wuhan Union Hospital, China",Recruiting,Not Applicable,Observational,China,Study for Novel Coronavirus Pneumonia (NCP),Clinical Presentation,No Intervention,2000,2020-05-30,2020-07-30,https://clinicaltrials.gov/show/NCT04283396,No Results,No Results,No Results,2020-03-30,2020-03-18,None
1513,NCT04368234,ClinicalTrials.gov,2020-04-27,2020-05-05,False,Duke University,Recruiting,Not Applicable,Observational,United States,Duke COVID-19 Shared Data and Specimen Repository,Clinical Presentation,No Intervention,100000,2025-04-30,2025-04-30,https://clinicaltrials.gov/show/NCT04368234,No Results,No Results,No Results,2020-05-11,2020-05-05,None
1514,NCT04368260,ClinicalTrials.gov,2020-04-24,2020-04-24,False,University of Virginia,Recruiting,Not Applicable,Interventional,United States,Clinical Validation of New Injection Molded Flocked Nasopharyngeal Swabs in Response to the COVID-19 Pandemic,Diagnostics,Diagnostic Test or Assessment,40,2020-07-31,2020-07-31,https://clinicaltrials.gov/show/NCT04368260,No Results,No Results,No Results,2020-05-11,2020-05-05,None
1515,NCT04366752,ClinicalTrials.gov,2020-04-27,2020-04-22,True,CHU de Amiens,Recruiting,Not Applicable,Observational,France,Thrombo Embolic Events in Critical Care Patients With Covid-19 Serious Acute Pneumopathy,Clinical Presentation,No Intervention,100,2020-08-22,2020-09-22,https://clinicaltrials.gov/show/NCT04366752,No Results,No Results,No Results,2020-05-11,2020-05-05,None
1516,NCT04366765,ClinicalTrials.gov,2020-04-06,2020-03-19,True,"University Hospital, Basel",Recruiting,Not Applicable,Observational,Switzerland,COVID-19 Survival - The COVIVA Study,Clinical Presentation (Epidemiology),No Intervention,1500,2021-06-30,2021-06-30,https://clinicaltrials.gov/show/NCT04366765,No Results,No Results,No Results,2020-05-11,2020-05-05,None
1517,NCT04287686,ClinicalTrials.gov,2020-02-21,2020-02-01,True,The First Affiliated Hospital of Guangzhou Medical University,Not Recruiting,Not Applicable,Interventional,China,Recombinant Human Angiotensin-converting Enzyme 2 (rhACE2) as a Treatment for Patients With COVID-19,Drug,ACE enzyme,Not Available,2020-04-01,2020-04-01,https://clinicaltrials.gov/show/NCT04287686,No Results,No Results,No Results,2020-03-30,2020-03-18,None
1518,NCT04308317,ClinicalTrials.gov,2020-03-04,2020-03-05,False,Henan Provincial People's Hospital,Recruiting,Phase 4,Interventional,China,Tetrandrine Tablets Used in the Treatment of COVID-19,Drug,Tetrandrine,60,2021-03-01,2021-05-01,https://clinicaltrials.gov/show/NCT04308317,No Results,No Results,No Results,2020-03-30,2020-03-25,None
1519,NCT04368988,ClinicalTrials.gov,2020-04-24,2020-05-15,False,Novavax,Not Recruiting,Phase 1,Interventional,Australia,Evaluation of the Safety and Immunogenicity of a SARS-CoV-2 rS (COVID-19) Nanoparticle Vaccine With/Without Matrix-M Adjuvant,ATMP,Vaccine,131,2020-12-31,2021-07-31,https://clinicaltrials.gov/show/NCT04368988,No Results,No Results,No Results,2020-05-11,2020-05-05,None
1520,NCT04369469,ClinicalTrials.gov,2020-04-28,2020-05-01,False,Alexion Pharmaceuticals,Not Recruiting,Phase 3,Interventional,No Country Given,Efficacy and Safety Study of IV Ravulizumab in Patients With COVID-19 Severe Pneumonia,Drug,Ravulizumab,270,2020-11-01,2021-02-01,https://clinicaltrials.gov/show/NCT04369469,No Results,No Results,No Results,2020-05-11,2020-05-05,None
1521,NCT04366778,ClinicalTrials.gov,2020-04-23,2020-05-01,False,Hospices Civils de Lyon,Recruiting,Not Applicable,Observational,France,Thrombosis and Covid-19,Diagnostics,Diagnostic Test or Assessment,300,2020-12-01,2020-12-01,https://clinicaltrials.gov/show/NCT04366778,No Results,No Results,No Results,2020-05-11,2020-05-05,None
1522,NCT04367064,ClinicalTrials.gov,2020-04-26,2020-04-25,True,Max Healthcare Insititute Limited,Recruiting,Not Applicable,Observational,India,To Study the Clinical Characteristics and Treatment Outcome of COVID-19 Patients Admitted in Hospitals of Max Healthcare (SCOPe Study),Clinical Presentation,No Intervention,1000,2020-06-25,2020-07-25,https://clinicaltrials.gov/show/NCT04367064,No Results,No Results,No Results,2020-05-11,2020-05-05,None
1523,NCT04368351,ClinicalTrials.gov,2020-04-27,2020-03-01,True,University of Roma La Sapienza,Not Recruiting,Not Applicable,Observational,Italy,Bacteriotherapy in the Treatment of COVID-19,Drug,Bacteriotherapy + Azithromycin + Hydroxychloroquine vs. Azithromycin + Hydrixychloroquine,70,2020-06-30,2020-07-31,https://clinicaltrials.gov/show/NCT04368351,No Results,No Results,No Results,2020-05-11,2020-05-05,None
1524,NCT04368676,ClinicalTrials.gov,2020-04-26,2020-05-10,False,Lawson Health Research Institute,Not Recruiting,Phase 1,Interventional,Canada,Breath Regulation and Yogic Exercise An Online Therapy for Calm and Happiness,Traditional Medicine (other),Traditional Medicine,60,2021-06-30,2021-06-30,https://clinicaltrials.gov/show/NCT04368676,No Results,No Results,No Results,2020-05-11,2020-05-05,None
1525,NCT04369742,ClinicalTrials.gov,2020-04-25,2020-04-15,True,NYU Langone Health,Recruiting,Phase 2,Interventional,United States,Treating COVID-19 With Hydroxychloroquine (TEACH),Drug,Hydroxychloroquine,626,2020-06-01,2020-06-01,https://clinicaltrials.gov/show/NCT04369742,No Results,No Results,No Results,2020-05-11,2020-05-05,None
1526,NCT04369794,ClinicalTrials.gov,2020-04-27,2020-06-01,False,"University of Campinas, Brazil",Not Recruiting,Phase 4,Interventional,Brazil,"COVID-19: BCG As Therapeutic Vaccine, Transmission Limitation, and Immunoglobulin Enhancement",ATMP,Vaccine,1000,2021-06-01,2022-05-01,https://clinicaltrials.gov/show/NCT04369794,No Results,No Results,No Results,2020-05-11,2020-05-05,None
1527,NCT04312464,ClinicalTrials.gov,2020-03-04,2020-01-01,True,"Wuhan Union Hospital, China",Recruiting,Not Applicable,Observational,China,Myocardial Damage in COVID-19,Clinical Presentation,No Intervention,500,2020-03-15,2020-03-18,https://clinicaltrials.gov/show/NCT04312464,No Results,No Results,No Results,2020-03-30,2020-03-25,None
1528,NCT04313322,ClinicalTrials.gov,2020-03-15,2020-03-16,False,Stem Cells Arabia,Recruiting,Phase 1,Interventional,Jordan,Treatment of COVID-19 Patients Using Wharton's Jelly-Mesenchymal Stem Cells,ATMP,Cells (mesenchymal),5,2020-06-30,2020-09-30,https://clinicaltrials.gov/show/NCT04313322,No Results,No Results,No Results,2020-03-30,2020-03-25,None
1529,NCT04368884,ClinicalTrials.gov,2020-04-29,2020-04-22,True,Max Healthcare Insititute Limited,Recruiting,Not Applicable,Observational,India,Observational Study to Assess the Seroconversion Status of Health Care Workers and Suspected or Confirmed Cases of COVID-19 Patients,Clinical Presentation (Epidemiology),No Intervention,1000,2020-06-30,2020-07-30,https://clinicaltrials.gov/show/NCT04368884,No Results,No Results,No Results,2020-05-11,2020-05-05,None
1530,NCT04368975,ClinicalTrials.gov,2020-04-27,2020-03-12,True,Hospital Clinic of Barcelona,Recruiting,Not Applicable,Observational,Spain,ARDS Caused by COVID-19,Clinical Presentation,No Intervention,500,2020-04-21,2020-12-31,https://clinicaltrials.gov/show/NCT04368975,No Results,No Results,No Results,2020-05-11,2020-05-05,None
1531,NCT04367077,ClinicalTrials.gov,2020-04-27,2020-05-01,False,"Athersys, Inc",Recruiting,Phase 2/Phase 3,Interventional,United States,MultiStem Administration for COVID-19 Induced ARDS (MACoVIA),ATMP,Cells (stem cells),400,2021-09-01,2022-08-01,https://clinicaltrials.gov/show/NCT04367077,No Results,No Results,No Results,2020-05-11,2020-05-05,None
1532,NCT04367337,ClinicalTrials.gov,2020-04-28,2020-03-25,True,"University of Social Sciences and Humanities, Warsaw",Recruiting,Not Applicable,Observational,"Canada, France, Gambia, Singapore, Italy, China, Poland, Israel, Portugal, Romania, Switzerland, Australia, Germany, Malaysia",Health Behavior Change During COVID-19 Pandemic,Other,No Intervention,5600,2021-03-24,2021-03-24,https://clinicaltrials.gov/show/NCT04367337,No Results,No Results,No Results,2020-05-11,2020-05-05,None
1533,ChiCTR2000031366,ChiCTR,2020-03-29,2020-04-01,False,Chinese PLA General Hospital,Not Recruiting,Not Applicable,Observational,China,Causes of fever in outpatient outside Wuhan during novel coronavirus pneumonia pandemic: a medical records based retrospective analysis,Clinical Presentation,No Intervention,5000,Not Available,2020-05-31,http://www.chictr.org.cn/showproj.aspx?proj=51692,No Results,No Results,No Results,2020-03-30,2020-04-01,None
1534,NCT04369456,ClinicalTrials.gov,2020-04-27,2020-04-22,True,CHU de Nice,Recruiting,Not Applicable,Interventional,France,Blood Biomarkers as Predictors of COVID-19 Disease Progression in Recently Infected Kidney Transplant Patients,Clinical Presentation,No Intervention,115,2020-10-22,2020-10-22,https://clinicaltrials.gov/show/NCT04369456,No Results,No Results,No Results,2020-05-11,2020-05-05,None
1535,NCT04369989,ClinicalTrials.gov,2020-04-28,2020-04-14,True,OSF Healthcare System,Recruiting,Not Applicable,Observational,United States,Observational Study of COVID-19 Treatment Efficacy,Clinical Presentation,No Intervention,1000,2021-04-14,2021-04-14,https://clinicaltrials.gov/show/NCT04369989,No Results,No Results,No Results,2020-05-11,2020-05-05,None
1536,NCT04369859,ClinicalTrials.gov,2020-04-29,2020-04-23,True,Assistance Publique  Hpitaux de Marseille,Recruiting,Not Applicable,Observational,France,Obstetric and Perinatal Outcomes of Women With COVID-19,Clinical Presentation,No Intervention,1300,2021-04-22,2021-04-22,https://clinicaltrials.gov/show/NCT04369859,No Results,No Results,No Results,2020-05-11,2020-05-05,None
1537,NCT04370210,ClinicalTrials.gov,2020-04-29,2020-05-01,False,Centre Hospitalier Ren Dubos,Not Recruiting,Not Applicable,Observational,France,Sleep Quality During COVID-19 Containment in Children Whether or Not Usually Followed in Child Psychiatry,Other (psych),No Intervention,464,2020-06-01,2020-06-01,https://clinicaltrials.gov/show/NCT04370210,No Results,No Results,No Results,2020-05-11,2020-05-05,None
1538,NCT04367350,ClinicalTrials.gov,2020-04-28,2020-03-20,True,"University Hospital, Tbingen",Recruiting,Not Applicable,Observational,Germany,Prospective Registry of Corona Virus Disease 2019 (Covid-19) Patients With Neuromuscular Involvement,Clinical Presentation,No Intervention,500,2021-03-31,2022-03-31,https://clinicaltrials.gov/show/NCT04367350,No Results,No Results,No Results,2020-05-11,2020-05-05,None
1539,NCT04367363,ClinicalTrials.gov,2020-04-17,2020-03-08,True,Jean Liu,Recruiting,Not Applicable,Observational,Singapore,Social Media and COVID-19,Other,No Intervention,150,2020-05-31,2020-05-31,https://clinicaltrials.gov/show/NCT04367363,No Results,No Results,No Results,2020-05-11,2020-05-05,None
1540,ChiCTR2000031365,ChiCTR,2020-03-29,2020-01-17,True,Westlake University,Recruiting,Not Applicable,Diagnostic test,China,To explore the pathogenesis and course prediction of novel coronavirus pneumonia (COVID-19) severe patients,Prognosis,No Intervention,0,Not Available,2022-01-31,http://www.chictr.org.cn/showproj.aspx?proj=51694,Pre-Print Article,2020-04-07,https://doi.org/10.1101/2020.04.07.20054585,2020-03-30,2020-04-01,None
1541,NCT04370197,ClinicalTrials.gov,2020-04-29,2020-03-03,True,"University Hospital, Strasbourg",Recruiting,Not Applicable,Observational,France,Covid-19 Epidemic on Acute Stroke Management,Clinical Presentation,No Intervention,300,2020-04-30,2020-04-30,https://clinicaltrials.gov/show/NCT04370197,No Results,No Results,No Results,2020-05-11,2020-05-05,None
1542,NCT04370223,ClinicalTrials.gov,2020-04-27,2020-05-04,False,Institut d'Investigaci Biomdica de Girona Dr. Josep Trueta,Not Recruiting,Phase 3,Interventional,Spain,Ozone Auto-hemotherapy for COVID-19 Pneumonia,Drug,Ozone,208,2020-10-25,2020-12-25,https://clinicaltrials.gov/show/NCT04370223,No Results,No Results,No Results,2020-05-11,2020-05-05,None
1543,ChiCTR2000031319,ChiCTR,2020-03-27,2020-04-01,False,Renmin Hospital of Wuhan University,Not Recruiting,Not Applicable,Interventional,China,Safety and Efficacy Study of Allogeneic Human Dental Pulp Mesenchymal Stem Cells to Treat Severe novel coronavirus pneumonia (COVID-19) patients,ATMP,Cells (mesenchymal),20,Not Available,2020-07-31,http://www.chictr.org.cn/showproj.aspx?proj=51647,No Results,No Results,No Results,2020-03-30,2020-04-01,None
1544,NCT04367714,ClinicalTrials.gov,2020-04-27,2020-03-15,True,Region MidtJylland,Recruiting,Not Applicable,Observational,Denmark,Antibody Response Against SARS-CoV-2 in Dialysis Patients During COVID-19,Clinical Presentation,No Intervention,300,2020-12-01,2021-12-01,https://clinicaltrials.gov/show/NCT04367714,No Results,No Results,No Results,2020-05-11,2020-05-05,None
1545,NCT04368156,ClinicalTrials.gov,2020-04-20,2020-04-20,False,Carlos Tornero,Recruiting,Not Applicable,Interventional,Spain,Study Assessing Vagus Nerve Stimulation in CoViD-19 Respiratory Symptoms,Other (device),Vagus nerve stimulation,90,2020-07-31,2020-07-31,https://clinicaltrials.gov/show/NCT04368156,No Results,No Results,No Results,2020-05-11,2020-05-05,None
1546,NCT04370834,ClinicalTrials.gov,2020-04-30,2020-05-01,False,National Cancer Institute (NCI),Not Recruiting,Phase 2,Interventional,No Country Given,Tocilizumab for Patients With Cancer and COVID-19 Disease,Drug,Tocilizumab,200,2022-01-01,2022-01-01,https://clinicaltrials.gov/show/NCT04370834,No Results,No Results,No Results,2020-05-11,2020-05-05,None
1547,NCT04371302,ClinicalTrials.gov,2020-04-29,2020-05-01,False,University of Malaya,Not Recruiting,Not Applicable,Observational,No Country Given,Nursing Perspective on Burnout and Medical Errors in the Intensive Care Unit During Covid-19 Pandemic,Other (psych),No Intervention,145,2020-06-30,2020-06-30,https://clinicaltrials.gov/show/NCT04371302,No Results,No Results,No Results,2020-05-11,2020-05-05,None
1548,ChiCTR2000031296,ChiCTR,2020-03-27,2020-01-14,True,Yichang Central People's Hospital,Not Recruiting,Not Applicable,Observational,China,A medical records based study for clinical features of novel coronavirus pneumonia (COVID-19) patients and risk factors of death,Clinical Presentation,No Intervention,200,Not Available,2020-03-19,http://www.chictr.org.cn/showproj.aspx?proj=51584,Pre-Print Article,2020-03-30,https://doi.org/10.1101/2020.03.26.20041426,2020-03-30,2020-04-01,None
1549,NCT04370288,ClinicalTrials.gov,2020-04-29,2020-04-19,True,Mashhad University of Medical Sciences,Recruiting,Phase 1,Interventional,Iran,Clinical Application of Methylene Blue for Treatment of Covid-19 Patients,Drug,Methylene blue + Vitamin C + N-acetyl cysteine,20,2020-09-20,2020-09-21,https://clinicaltrials.gov/show/NCT04370288,No Results,No Results,No Results,2020-05-11,2020-05-05,None
1550,NCT04370938,ClinicalTrials.gov,2020-04-29,2020-04-29,False,University of Pittsburgh,Recruiting,Not Applicable,Interventional,United States,Provider Burnout During COVID-19,Other (psych),Psychological,250,2020-10-29,2020-10-29,https://clinicaltrials.gov/show/NCT04370938,No Results,No Results,No Results,2020-05-11,2020-05-05,None
1551,NCT04368377,ClinicalTrials.gov,2020-04-23,2020-04-06,True,University of Milan,Not Recruiting,Phase 2,Interventional,Italy,Enhanced Platelet Inhibition in Critically Ill Patients With COVID-19,Drug,Tirofiban + Clopidogrel + Aspirin + Fondaparinux,5,2020-04-23,2020-04-23,https://clinicaltrials.gov/show/NCT04368377,No Results,No Results,No Results,2020-05-11,2020-05-05,None
1552,NCT04368390,ClinicalTrials.gov,2020-04-28,2020-04-03,True,"University Hospital, Strasbourg",Recruiting,Not Applicable,Observational,France,Neuroradiolological Analysis of COVID-19 Patients,Clinical Presentation,No Intervention,100,2021-04-01,2021-04-01,https://clinicaltrials.gov/show/NCT04368390,No Results,No Results,No Results,2020-05-11,2020-05-05,None
1553,NCT04371393,ClinicalTrials.gov,2020-04-28,2020-04-30,False,Icahn School of Medicine at Mount Sinai,Recruiting,Phase 3,Interventional,United States,MSCs in COVID-19 ARDS,ATMP,Cells (mesenchymal),300,2021-04-01,2022-04-01,https://clinicaltrials.gov/show/NCT04371393,No Results,No Results,No Results,2020-05-11,2020-05-05,None
1554,NCT04371419,ClinicalTrials.gov,2020-04-28,2020-05-08,False,"National Bureau of Economic Research, Inc.",Not Recruiting,Not Applicable,Interventional,No Country Given,COVID-19 Health Messaging to Underserved Communities,Other,Health Education,20000,2021-05-31,2021-06-30,https://clinicaltrials.gov/show/NCT04371419,No Results,No Results,No Results,2020-05-11,2020-05-05,None
1555,ChiCTR2000031293,ChiCTR,2020-03-27,2020-03-16,True,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Not Applicable,Observational,China,Epidemiological study of novel coronavirus infection (COVID-19) in children at medium/low risk,Clinical Presentation (Epidemiology),No Intervention,240,Not Available,2020-05-16,http://www.chictr.org.cn/showproj.aspx?proj=51629,No Results,No Results,No Results,2020-03-30,2020-04-01,None
1556,NCT04371289,ClinicalTrials.gov,2020-04-28,2020-04-01,True,Istituto Auxologico Italiano,Not Recruiting,Not Applicable,Observational,Italy,Predictors of Cardiovascular Risk in Covid-19 Patients During Acute Disease and at Short Term Follow-up,Clinical Presentation,No Intervention,5500,2020-07-10,2020-09-10,https://clinicaltrials.gov/show/NCT04371289,No Results,No Results,No Results,2020-05-11,2020-05-05,None
1557,NCT04371315,ClinicalTrials.gov,2020-04-24,2020-04-27,False,St. Jude Children's Research Hospital,Recruiting,Not Applicable,Observational,United States,"Risk Factors, Clinical Characteristics and Outcomes of Acute Infection With Coronavirus 2019 (COVID-19) In Children",Clinical Presentation,No Intervention,400,2021-06-01,2022-06-30,https://clinicaltrials.gov/show/NCT04371315,No Results,No Results,No Results,2020-05-11,2020-05-05,None
1558,ChiCTR2000031204,ChiCTR,2020-03-24,2020-01-30,True,"Beijing You'an Hospital, Capital Medical University",Recruiting,Phase 2,Interventional,China,"A multicenter, single-blind, randomized controlled clinical trial for chloroquine phosphate in the treatment of novel coronavirus pneumonia (COVID-19)",Drug,Chloroquine,300,Not Available,2020-04-30,http://www.chictr.org.cn/showproj.aspx?proj=49420,No Results,No Results,No Results,2020-03-30,2020-04-01,None
1559,NCT04371510,ClinicalTrials.gov,2020-04-28,2020-04-22,True,CHU de Nice,Recruiting,Not Applicable,Interventional,France,Blood Biomarkers as Predictors of COVID-19 Disease Progression in Recently Infected Chronic Haemodialysis Patients,Clinical Presentation,No Intervention,115,2020-10-22,2021-02-22,https://clinicaltrials.gov/show/NCT04371510,No Results,No Results,No Results,2020-05-11,2020-05-05,None
1560,NCT04371601,ClinicalTrials.gov,2020-03-25,2020-03-01,True,Fuzhou General Hospital,Not Recruiting,Phase 1,Interventional,China,Safety and Effectiveness of Mesenchymal Stem Cells in the Treatment of Pneumonia of Coronavirus Disease 2019,ATMP (+ Drug),Cells (mesenchymal) + Oseltamivir + Oxygen + Hormones vs. Oseltamivir + Oxygen + Hormones,60,2021-12-31,2022-12-31,https://clinicaltrials.gov/show/NCT04371601,No Results,No Results,No Results,2020-05-11,2020-05-05,None
1561,NCT04368637,ClinicalTrials.gov,2020-04-26,2020-05-03,False,Jordan Collaborating Cardiology Group,Recruiting,Not Applicable,Observational,Jordan,Acute Cardiovascular Events Triggered by COVID-19-Related Stress,Clinical Presentation,No Intervention,50,2020-07-30,2020-08-30,https://clinicaltrials.gov/show/NCT04368637,No Results,No Results,No Results,2020-05-11,2020-05-05,None
1562,NCT04368845,ClinicalTrials.gov,2020-04-20,2020-04-30,False,Clinical Exercise Physiology and Rehabilitation Reasearch Laboratory,Not Recruiting,Not Applicable,Interventional,No Country Given,Telerehabilitation in Patients With COVID-19 After Hospitalization. The ATHLOS Study,Telehealth,Rehabilitation,100,2020-07-31,2021-03-01,https://clinicaltrials.gov/show/NCT04368845,No Results,No Results,No Results,2020-05-11,2020-05-05,None
1563,ChiCTR2000031187,ChiCTR,2020-03-23,2020-03-23,False,Wuhan Third Hospital; Tongren Hospital of Wuhan University,Not Recruiting,Not Applicable,Epidemiological research,China,A medical records based retrospective study for novel coronavirus pneumonia (COVID-19),Clinical Presentation,No Intervention,1292,Not Available,2020-04-30,http://www.chictr.org.cn/showproj.aspx?proj=51442,No Results,No Results,No Results,2020-03-30,2020-04-01,None
1564,NCT04371406,ClinicalTrials.gov,2020-04-29,2020-05-02,False,Assistance Publique  Hpitaux de Paris,Not Recruiting,Phase 3,Interventional,No Country Given,Efficacy of Azithromycin-associated Hydroxychloroquine Therapy Given in General Practice in Early-stage Disease in COVID-19 Patients,Drug,Hydroxychloroquine + Azithromycin,2770,2020-08-02,2020-09-02,https://clinicaltrials.gov/show/NCT04371406,No Results,No Results,No Results,2020-05-11,2020-05-05,None
1565,NCT04371523,ClinicalTrials.gov,2020-04-28,2020-05-01,False,St. Joseph's Healthcare Hamilton,Not Recruiting,Phase 3,Interventional,Canada,Hydroxychloroquine to Prevent COVID-19 Disease Amongst Healthcare Workers,Drug (Chemoprophylaxis),Hydroxychloroquine,1100,2020-07-31,2020-08-30,https://clinicaltrials.gov/show/NCT04371523,No Results,No Results,No Results,2020-05-11,2020-05-05,None
1566,NCT04369066,ClinicalTrials.gov,2020-04-27,2020-04-28,False,Institut Curie,Recruiting,Not Applicable,Interventional,France,"COVID-19 Study of the Serological Response Against the Severe Acute Respiratory Syndrome (SARS) Coronavirus 2 (CoV-2) Virus in 2 Types of Employees, Hospital and Non-hospital, at Institute Curie",Clinical Presentation,No Intervention,2500,2020-10-28,2021-01-28,https://clinicaltrials.gov/show/NCT04369066,No Results,No Results,No Results,2020-05-11,2020-05-05,None
1567,NCT04369274,ClinicalTrials.gov,2020-04-23,2020-05-01,False,Massachusetts General Hospital,Not Recruiting,Not Applicable,Interventional,No Country Given,Repeated Measures Trial of Temporary Automated Manual Ventilation Versus Noninvasive Oxygenation or Conventional Vent,Other (physical),Mechanical ventilation,30,2020-11-01,2020-11-01,https://clinicaltrials.gov/show/NCT04369274,No Results,No Results,No Results,2020-05-11,2020-05-05,None
1568,NCT04371744,ClinicalTrials.gov,2020-04-30,2020-04-17,True,Assistance Publique  Hpitaux de Marseille,Recruiting,Not Applicable,Observational,France,QT-Logs : Artificial Intelligence for QT Interval Analysis of ECG From Smartwatches in Patient Receiving Treatment for Covid-19,Other (software),Other,100,2020-05-04,2020-05-11,https://clinicaltrials.gov/show/NCT04371744,No Results,No Results,No Results,2020-05-11,2020-05-05,None
1569,NCT04371835,ClinicalTrials.gov,2020-04-28,2020-05-15,False,Kirby Institute,Not Recruiting,Not Applicable,Observational,No Country Given,COHIVE: Coronavirus (COVID-19) Outcomes in HIV Evaluation in Resource Limited Settings,Clinical Presentation,No Intervention,1500,2021-12-31,2021-12-31,https://clinicaltrials.gov/show/NCT04371835,No Results,No Results,No Results,2020-05-11,2020-05-05,None
1570,ChiCTR2000030936,ChiCTR,2020-03-18,2020-03-10,True,Hospital of Chengdu University of Traditional Chinese Medicine,Recruiting,Not Applicable,Interventional,China,A real-world study for the Chinese medicines ''Xinguan 2'' and ''Xinguan 3'' in the treatment of novel coronavirus pneumonia (COVID-19),Traditional Medicine (Drug),Traditional Medicine,2840,Not Available,2020-05-10,http://www.chictr.org.cn/showproj.aspx?proj=51100,No Results,No Results,No Results,2020-03-30,2020-03-25,None
1571,ChiCTR2000030923,ChiCTR,2020-03-17,2020-02-15,True,Affiliated Hospital of Shaanxi University of Traditional Chinese Medicine,Recruiting,Not Applicable,Interventional,China,The treatment and diagnosis plan of integrated traditional Chinese and Western medicine for novel coronavirus pneumonia (COVID-19),Traditional Medicine + Western Medicine,Traditional Medicine,400,Not Available,2020-04-16,http://www.chictr.org.cn/showproj.aspx?proj=51139,No Results,No Results,No Results,2020-03-30,2020-03-25,None
1572,NCT04371640,ClinicalTrials.gov,2020-04-28,2020-05-01,False,Walter K. Kraft,Recruiting,Phase 1,Interventional,United States,Sirolimus in COVID-19 Phase 1,Drug,Sirolimus,40,2020-07-01,2020-08-01,https://clinicaltrials.gov/show/NCT04371640,No Results,No Results,No Results,2020-05-11,2020-05-05,None
1573,NCT04371822,ClinicalTrials.gov,2020-04-29,2020-05-01,False,Kafrelsheikh University,Not Recruiting,Phase 1,Interventional,No Country Given,Efficacy of Sn-protoporphyrin IX (SnPPIX) and Sulfonatoporphyrin(TPPS)Against Covid-19,Drug,"SnPP Protoporphyrin, Porphyrin",56,2020-06-01,2020-08-01,https://clinicaltrials.gov/show/NCT04371822,No Results,No Results,No Results,2020-05-11,2020-05-05,None
1574,NCT04371926,ClinicalTrials.gov,2020-04-29,2020-06-01,False,Texas Cardiac Arrhythmia Research Foundation,Not Recruiting,Not Applicable,Interventional,No Country Given,Prophylactic Benefit of Hydroxychloroquine in COVID-19 Cases With Mild to Moderate Symptoms and in Healthcare Workers With High Exposure Risk,Drug (Chemoprophylaxis),Hydroxychloroquine,64,2021-06-01,2021-07-01,https://clinicaltrials.gov/show/NCT04371926,No Results,No Results,No Results,2020-05-11,2020-05-05,None
1575,NCT04371952,ClinicalTrials.gov,2020-04-27,2020-05-01,False,Nantes University Hospital,Not Recruiting,Phase 3,Interventional,France,DYNAMIC Study (DoxycYcliNe AMbulatoIre COVID-19),Drug,Doxycycline,330,2020-12-01,2020-12-01,https://clinicaltrials.gov/show/NCT04371952,No Results,No Results,No Results,2020-05-11,2020-05-05,None
1576,NCT04369300,ClinicalTrials.gov,2020-04-28,2020-04-24,True,Max Healthcare Insititute Limited,Not Recruiting,Not Applicable,Observational,No Country Given,Anxiety And Depression During COVID-19 IN INDIA,Other (psych),No Intervention,1000,2020-11-24,2021-02-24,https://clinicaltrials.gov/show/NCT04369300,No Results,No Results,No Results,2020-05-11,2020-05-05,None
1577,NCT04369690,ClinicalTrials.gov,2020-04-20,2020-04-03,True,University of Ottawa,Recruiting,Not Applicable,Observational,Canada,"The Psychological, Social, and Economic Impacts of COVID-19",Other (psych),No Intervention,1000,2021-04-03,2021-04-03,https://clinicaltrials.gov/show/NCT04369690,No Results,No Results,No Results,2020-05-11,2020-05-05,None
1578,NCT04370171,ClinicalTrials.gov,2020-04-27,2020-05-01,False,"University Hospital, Strasbourg",Not Recruiting,Not Applicable,Observational,No Country Given,Management of Diabetic Patients With Telemedicine in the Context of the Covid-19 Epidemic,Telehealth,Telehealth,200,2020-12-01,2020-12-01,https://clinicaltrials.gov/show/NCT04370171,No Results,No Results,No Results,2020-05-11,2020-05-05,None
1579,NCT04371848,ClinicalTrials.gov,2020-04-22,2020-04-16,True,Laval University,Not Recruiting,Not Applicable,Observational,Canada,Impact of the COVID-19 Pandemic on Diet Quality and Food Insecurity: a NutriQubec Sub-study,Other (nutrition),No Intervention,2465,2020-05-07,2020-05-07,https://clinicaltrials.gov/show/NCT04371848,No Results,No Results,No Results,2020-05-11,2020-05-05,None
1580,NCT04371965,ClinicalTrials.gov,2020-04-29,2020-05-01,False,Poitiers University Hospital,Not Recruiting,Phase 2,Interventional,France,"Povidone Iodine Mouthwash, Gargle, and Nasal Spray to Reduce Naso- Pharyngeal Viral Load in Patients With COVID-19",Drug,Povidone-iodine,24,2020-07-01,2020-08-01,https://clinicaltrials.gov/show/NCT04371965,No Results,No Results,No Results,2020-05-11,2020-05-05,None
1581,NCT04370782,ClinicalTrials.gov,2020-04-26,2020-04-28,False,"St. Francis Hospital, New York",Not Recruiting,Phase 4,Interventional,United States,Hydroxychloroquine and Zinc With Either Azithromycin or Doxycycline for Treatment of COVID-19 in Outpatient Setting,Drug,Hydroxychloroquine + Azithromycin + Zinc vs. Hydroxychloroquine + Doxycycline + Zinc,750,2020-09-30,2020-12-31,https://clinicaltrials.gov/show/NCT04370782,No Results,No Results,No Results,2020-05-11,2020-05-05,None
1582,NCT04370808,ClinicalTrials.gov,2020-04-26,2020-06-01,False,University of Lisbon,Not Recruiting,Not Applicable,Observational,Portugal,BREATH: Vitamin D Polymorphisms and Severity of COVID-19 Infection,Clinical Presentation,No Intervention,500,2020-10-01,2021-03-01,https://clinicaltrials.gov/show/NCT04370808,No Results,No Results,No Results,2020-05-11,2020-05-05,None
1583,NCT04372043,ClinicalTrials.gov,2020-04-29,2020-04-30,False,Saint-Joseph University,Not Recruiting,Not Applicable,Observational,Lebanon,Evaluation of the Sleep Hygiene in the Lebanese Population During the COVID-19 Confinement Period.,Other (psych),No Intervention,1200,2020-09-30,2020-09-30,https://clinicaltrials.gov/show/NCT04372043,No Results,No Results,No Results,2020-05-11,2020-05-05,None
1584,NCT04372082,ClinicalTrials.gov,2020-04-30,2020-05-01,False,"University Hospital, Lille",Not Recruiting,Phase 3,Interventional,No Country Given,Hydroxychloroquine or Diltiazem-Niclosamide for the Treatment of COVID-19,Drug,Hydroxychloroquine vs. Diltiazem/Niclosamide,480,2023-05-01,2023-05-01,https://clinicaltrials.gov/show/NCT04372082,No Results,No Results,No Results,2020-05-11,2020-05-05,None
1585,NCT04319211,ClinicalTrials.gov,2020-03-20,2020-03-25,False,Istanbul University-Cerrahpasa,Not Recruiting,Not Applicable,Observational,Turkey,"Effects of Social Isolation From Coronavirus; on Physical Activity, Quality of Life and Stress",Other,Social Isolation,200,2020-05-15,2020-07-20,https://clinicaltrials.gov/show/NCT04319211,No Results,No Results,No Results,2020-04-06,2020-04-01,None
1586,NCT04323332,ClinicalTrials.gov,2020-03-08,2020-03-01,True,"Xiyuan Hospital, Chinese Academy of Traditional Chinese Medicine",Not Recruiting,Phase 3,Interventional,China,Traditional Chinese Medicine for Severe COVID-19,Traditional Medicine (Unspecified),Traditional Medicine,50,2020-03-01,2020-04-01,https://clinicaltrials.gov/show/NCT04323332,No Results,No Results,No Results,2020-04-06,2020-04-01,None
1587,NCT04372030,ClinicalTrials.gov,2020-04-22,2020-05-01,False,UCLouvain,Not Recruiting,Not Applicable,Interventional,No Country Given,Health Care Use During the Covid19 Crisis,Health System,No Intervention,10000,2020-06-30,2021-10-31,https://clinicaltrials.gov/show/NCT04372030,No Results,No Results,No Results,2020-05-11,2020-05-05,None
1588,NCT04372056,ClinicalTrials.gov,2020-04-29,2020-05-06,False,Oslo University Hospital,Recruiting,Not Applicable,Observational,Norway,The COVID-ICU Healthcare Professional Study,Other,No Intervention,2200,2021-05-06,2021-05-06,https://clinicaltrials.gov/show/NCT04372056,No Results,No Results,No Results,2020-05-11,2020-05-05,None
1589,NCT04370821,ClinicalTrials.gov,2020-04-27,2020-04-27,False,Villanova University,Recruiting,Not Applicable,Observational,United States,"COVID-19 CHAMPS Study of Healthcare, First Responder and Service Workers",Other (psych),No Intervention,20000,2040-04-27,2040-04-27,https://clinicaltrials.gov/show/NCT04370821,No Results,No Results,No Results,2020-05-11,2020-05-05,None
1590,NCT04371029,ClinicalTrials.gov,2020-04-28,2020-04-01,True,"University Hospital, Bordeaux",Not Recruiting,Not Applicable,Interventional,France,Impact of Neck Inspiratory Muscle Activation During Sleep in ICU Patients After a COVID 19 ARDS,Other,Polysomnography,25,2020-06-01,2020-09-01,https://clinicaltrials.gov/show/NCT04371029,No Results,No Results,No Results,2020-05-11,2020-05-05,None
1591,NCT04372472,ClinicalTrials.gov,2020-04-29,2020-04-07,True,"Cytovale, Inc.",Not Recruiting,Not Applicable,Observational,United States,SQuISH-COVID: A Pilot Study,Diagnostics,Diagnostic Test or Assessment,300,2020-05-29,2020-05-29,https://clinicaltrials.gov/show/NCT04372472,No Results,No Results,No Results,2020-05-11,2020-05-12,None
1592,NCT04372589,ClinicalTrials.gov,2020-04-24,2020-05-01,False,University of Manitoba,Not Recruiting,Not Applicable,Interventional,Canada,Antithrombotic Therapy to Ameliorate Complications of COVID-19 ( ATTACC ),Drug,Heparin,3000,2021-01-01,2021-01-01,https://clinicaltrials.gov/show/NCT04372589,No Results,No Results,No Results,2020-05-11,2020-05-12,None
1593,NCT04323592,ClinicalTrials.gov,2020-03-19,2020-03-23,False,University of Trieste,Recruiting,Phase 2/Phase 3,Interventional,Italy,Efficacy of Methylprednisolone for Patients With COVID-19 Severe Acute Respiratory Syndrome,Drug,Corticosteroids,104,2020-05-20,2020-05-30,https://clinicaltrials.gov/show/NCT04323592,No Results,No Results,No Results,2020-04-06,2020-04-01,None
1594,NCT04324866,ClinicalTrials.gov,2020-03-24,2020-04-01,False,Universita di Verona,Not Recruiting,Not Applicable,Observational,No Country Given,Prevalence and Incidence of COVID-19 Infection in Patients With Chronic Plaque Psoriasis on Immunosuppressant Therapy,Clinical Presentation (Epidemiology),No Intervention,300,2020-11-01,2020-12-01,https://clinicaltrials.gov/show/NCT04324866,No Results,No Results,No Results,2020-04-06,2020-04-01,None
1595,NCT04371250,ClinicalTrials.gov,2020-04-22,2020-04-30,False,Erasme University Hospital,Not Recruiting,Not Applicable,Observational,Belgium,Study of Resilience and Loneliness in Youth (18 - 25 Years Old) During the COVID-19 Pandemic Lock-down Measures.,Other (psych),No Intervention,800,2020-05-31,2020-12-30,https://clinicaltrials.gov/show/NCT04371250,No Results,No Results,No Results,2020-05-11,2020-05-12,None
1596,NCT04371432,ClinicalTrials.gov,2020-04-29,2020-05-13,False,National Human Genome Research Institute (NHGRI),Recruiting,Not Applicable,Observational,United States,Genetics of COVID-19 Susceptibility and Manifestations,Genomics,No Intervention,2500,2025-06-01,2025-06-01,https://clinicaltrials.gov/show/NCT04371432,No Results,No Results,No Results,2020-05-11,2020-05-05,None
1597,NCT04373148,ClinicalTrials.gov,2020-04-30,2020-04-08,True,Stanford University,Recruiting,Not Applicable,Observational,United States,"Understanding Immunity to SARS-CoV-2, the Coronavirus Causing COVID-19",Clinical Presentation,No Intervention,1000,2022-04-30,2022-04-30,https://clinicaltrials.gov/show/NCT04373148,No Results,No Results,No Results,2020-05-11,2020-05-12,None
1598,NCT04373382,ClinicalTrials.gov,2020-04-30,2020-06-01,False,"Mount Sinai Hospital, Canada",Not Recruiting,Not Applicable,Interventional,Canada,Peer Champion Support for Hospital Staff During and After the COVID-19 Pandemic,Other (psych),Psychological,1000,2022-02-01,2022-02-01,https://clinicaltrials.gov/show/NCT04373382,No Results,No Results,No Results,2020-05-11,2020-05-12,None
1599,ISRCTN14966673,ISRCTN,2020-03-18,2020-03-20,False,University Hospital Southampton NHS Foundation Trust,Recruiting,Not Applicable,Interventional,United Kingdom,Does point-of-care testing for coronavirus in hospital improve patient care compared to laboratory testing?,Diagnostics,Diagnostic Test or Assessment,500,Not Available,2021-04-01,http://isrctn.com/ISRCTN14966673,No Results,No Results,No Results,2020-04-06,2020-03-25,None
1600,NCT04372186,ClinicalTrials.gov,2020-04-29,2020-05-08,False,"Genentech, Inc.",Not Recruiting,Phase 3,Interventional,No Country Given,A Study to Evaluate the Efficacy and Safety of Tocilizumab in Hospitalized Participants With COVID-19 Pneumonia,Drug,Tocilizumab,379,2020-08-05,2020-10-05,https://clinicaltrials.gov/show/NCT04372186,No Results,No Results,No Results,2020-05-11,2020-05-05,None
1601,NCT04372368,ClinicalTrials.gov,2020-04-29,2019-06-19,True,"University of Colorado, Denver",Not Recruiting,Not Applicable,Expanded Access,United States,Convalescent Plasma for the Treatment of Patients With COVID-19,ATMP,Plasma,Not Available,Not Available,Not Available,https://clinicaltrials.gov/show/NCT04372368,No Results,No Results,No Results,2020-05-11,2020-05-12,None
1602,ChiCTR2000031639,ChiCTR,2020-04-05,2020-03-27,True,Peking University Sixth Hospital,Not Recruiting,Not Applicable,Interventional,China,Effects of a single session internet-delivered cognitive behavioral therapy for Acute Insomnia during the pandemic of novel coronavirus pneumonia (COVID-19),Other (psych),Psychological,192,Not Available,2021-03-27,http://www.chictr.org.cn/showproj.aspx?proj=51119,No Results,No Results,No Results,2020-04-06,2020-04-07,None
1603,NCT04371471,ClinicalTrials.gov,2020-04-30,2020-03-01,True,Groupe Hospitalier La Rochelle,Not Recruiting,Not Applicable,Observational,France,Covid-19 Pandemic Triage Score,Diagnostics,Diagnostic Test or Assessment,50,2020-04-30,2020-04-30,https://clinicaltrials.gov/show/NCT04371471,No Results,No Results,No Results,2020-05-11,2020-05-05,None
1604,NCT04371679,ClinicalTrials.gov,2020-04-30,2020-04-01,True,Hasselt University,Recruiting,Not Applicable,Observational,Belgium,Changes in Cardiac and Pulmonary Hemodynamics as Predictor of Outcome in Hospitalized COVID-19 Patients,Clinical Presentation,No Intervention,40,2020-10-01,2020-12-01,https://clinicaltrials.gov/show/NCT04371679,No Results,No Results,No Results,2020-05-11,2020-05-05,None
1605,NCT04373798,ClinicalTrials.gov,2020-05-01,2020-05-04,False,Henning Bliddal,Not Recruiting,Not Applicable,Observational,Denmark,C-reactive Protein Levels Among Individuals With COVID-19,Clinical Presentation,No Intervention,3000,2020-11-30,2020-11-30,https://clinicaltrials.gov/show/NCT04373798,No Results,No Results,No Results,2020-05-11,2020-05-12,None
1606,NCT04373824,ClinicalTrials.gov,2020-04-26,2020-04-25,True,Max Healthcare Insititute Limited,Recruiting,Not Applicable,Interventional,India,Max Ivermectin- COVID 19 Study Versus Standard of Care Treatment for COVID 19 Cases. A Pilot Study,Drug,Ivermectin,50,2020-07-25,2020-07-25,https://clinicaltrials.gov/show/NCT04373824,No Results,No Results,No Results,2020-05-11,2020-05-12,None
1607,NCT04372602,ClinicalTrials.gov,2020-04-30,2020-06-30,False,Washington University in St. Louis,Not Recruiting,Phase 2,Interventional,United States,Duvelisib to Combat COVID-19,Drug,Duvelisib,25,2021-07-31,2021-12-31,https://clinicaltrials.gov/show/NCT04372602,No Results,No Results,No Results,2020-05-11,2020-05-12,None
1608,NCT04372628,ClinicalTrials.gov,2020-04-30,2020-05-01,False,Vanderbilt University,Not Recruiting,Phase 2,Interventional,United States,Trial of Early Therapies During Non-hospitalized Outpatient Window for COVID-19,Drug,Hydroxychloroquein vs. Lopinavir/ritonavir,900,2020-12-01,2021-05-01,https://clinicaltrials.gov/show/NCT04372628,No Results,No Results,No Results,2020-05-11,2020-05-12,None
1609,ChiCTR2000031503,ChiCTR,2020-04-03,2020-04-01,True,Shanghai Sixth People's Hospital,Not Recruiting,Not Applicable,Interventional,China,Application of non-invasive multichannel cardiopulmonary monitoring cloud management platform in patients with Novel Coronavirus Pneumonia (COVID-19),Other (device),Cardiopulmonary monitoring,100,Not Available,2022-10-31,http://www.chictr.org.cn/showproj.aspx?proj=51911,No Results,No Results,No Results,2020-04-06,2020-04-07,None
1610,NCT04371692,ClinicalTrials.gov,2020-04-28,2020-04-01,True,"University Hospital, Lille",Not Recruiting,Not Applicable,Observational,No Country Given,Prevalence of COVID-19 Infection Among HCW in a French University Hospital,Clinical Presentation (Epidemiology),No Intervention,100,2020-09-01,2020-09-01,https://clinicaltrials.gov/show/NCT04371692,No Results,No Results,No Results,2020-05-11,2020-05-05,None
1611,NCT04372576,ClinicalTrials.gov,2020-04-29,2020-04-16,True,Semmelweis University,Recruiting,Not Applicable,Observational,Hungary,Epidemiology and Outcome of Ventilator-associated Pneumonia Among Critically Ill COVID-19 Patients,Clinical Presentation (Epidemiology),No Intervention,30,2020-08-01,2020-08-01,https://clinicaltrials.gov/show/NCT04372576,No Results,No Results,No Results,2020-05-11,2020-05-12,None
1612,NCT04372693,ClinicalTrials.gov,2020-04-27,2020-02-01,True,Kasr El Aini Hospital,Recruiting,Not Applicable,Interventional,Egypt,Unplanned Shifting to Online Distance Learning: Nursing Students' Perception and Achievement,Other,Other,180,2020-05-30,2020-06-30,https://clinicaltrials.gov/show/NCT04372693,No Results,No Results,No Results,2020-05-11,2020-05-12,None
1613,NCT04373044,ClinicalTrials.gov,2020-04-17,2020-04-24,False,University of Southern California,Not Recruiting,Phase 2,Interventional,United States,Antiviral Therapy and Baricitinib for the Treatment of Patients With Moderate or Severe COVID-19,Drug,Baricitinib + one of Hydroxychloroquine or Lopinavir/ritonavir or Remdesivir,59,2021-04-24,2022-04-24,https://clinicaltrials.gov/show/NCT04373044,No Results,No Results,No Results,2020-05-11,2020-05-12,None
1614,NCT04373889,ClinicalTrials.gov,2020-04-13,2020-04-22,False,Sciensano,Recruiting,Not Applicable,Observational,Belgium,COVID-19 Among Healthcare Workers in Belgian Hospitals,Clinical Presentation (Epidemiology),No Intervention,800,2020-09-27,2020-09-27,https://clinicaltrials.gov/show/NCT04373889,No Results,No Results,No Results,2020-05-11,2020-05-12,None
1615,NCT04374032,ClinicalTrials.gov,2020-04-30,2020-05-01,False,Bosnalijek D.D,Recruiting,Phase 2/Phase 3,Interventional,Bosnia and Herzegovina,Clinical Trial to Evaluate the Efficacy and Safety of an Immunomodulatory Therapy for the Treatment of Patients With Moderate to Severe COVID-19 Infection,Drug,Metenkefalin + Tridecactide,120,2020-08-31,2020-10-31,https://clinicaltrials.gov/show/NCT04374032,No Results,No Results,No Results,2020-05-11,2020-05-12,None
1616,NCT04373135,ClinicalTrials.gov,2020-04-30,2020-05-01,False,"University of California, Los Angeles",Not Recruiting,Not Applicable,Interventional,No Country Given,"Understanding Community Considerations, Opinions, Values, Impacts, and Decisions for COVID-19",Other,Other,1000,2020-10-01,2020-12-01,https://clinicaltrials.gov/show/NCT04373135,No Results,No Results,No Results,2020-05-11,2020-05-12,None
1617,NCT04373161,ClinicalTrials.gov,2020-04-30,2020-03-20,True,Swedish Hospital,Not Recruiting,Not Applicable,Interventional,United States,Home Pulse Oximeter Use in Patients With COVID-19,Other (device),Biosensors,209,2020-04-22,2020-04-22,https://clinicaltrials.gov/show/NCT04373161,No Results,No Results,No Results,2020-05-11,2020-05-12,None
1618,ChiCTR2000031501,ChiCTR,2020-04-02,2020-03-17,True,Eastern Theater General Hospital,Not Recruiting,Not Applicable,Interventional,China,"The efficacy  of convalescent plasma in patients with critical novel coronavirus pneumonia (COVID-19): a pragmatic, prospective cohort study",ATMP,Plasma,20,Not Available,2020-07-17,http://www.chictr.org.cn/showproj.aspx?proj=50254,No Results,No Results,No Results,2020-04-06,2020-04-07,None
1619,NCT04372979,ClinicalTrials.gov,2020-04-24,2020-05-01,False,Direction Centrale du Service de Sant des Armes,Not Recruiting,Phase 3,Interventional,France,Efficacy of Convalescent Plasma Therapy in the Early Care of COVID-19 Patients.,ATMP,Plasma,80,2020-10-01,2021-05-01,https://clinicaltrials.gov/show/NCT04372979,No Results,No Results,No Results,2020-05-11,2020-05-12,None
1620,NCT04373005,ClinicalTrials.gov,2020-04-30,2020-05-04,False,"University Health Network, Toronto",Not Recruiting,Not Applicable,Interventional,Canada,Screening of Cancer Patients to Assess Impact of COVID-19,Clinical Presentation,No Intervention,1000,2020-12-04,2020-12-04,https://clinicaltrials.gov/show/NCT04373005,No Results,No Results,No Results,2020-05-11,2020-05-12,None
1621,NCT04374123,ClinicalTrials.gov,2020-04-20,2020-04-20,False,Instituto Ecuatoriano de Enfermedades Digestivas,Recruiting,Not Applicable,Observational,Ecuador,COVID-19 Serology Screening and Strict Protocol in the Endoscopy Unit,Clinical Presentation (Epidemiology),No Intervention,80,2020-05-20,2020-06-01,https://clinicaltrials.gov/show/NCT04374123,No Results,No Results,No Results,2020-05-11,2020-05-12,None
1622,NCT04374149,ClinicalTrials.gov,2020-04-20,2020-04-30,False,Prisma Health-Upstate,Not Recruiting,Phase 2,Interventional,No Country Given,Therapeutic Plasma Exchange Alone or in Combination With Ruxolitinib in COVID-19 Associated CRS,ATMP (+ Drug),Plasma vs. Plasma + Ruxolitinib,20,2020-09-01,2021-04-30,https://clinicaltrials.gov/show/NCT04374149,No Results,No Results,No Results,2020-05-11,2020-05-12,None
1623,NCT04373200,ClinicalTrials.gov,2020-04-22,2020-05-15,False,Rennes University Hospital,Not Recruiting,Not Applicable,Interventional,France,Human Ab Response & immunoMONItoring of COVID-19 Patients,Clinical Presentation,No Intervention,75,2020-11-15,2020-11-15,https://clinicaltrials.gov/show/NCT04373200,No Results,No Results,No Results,2020-05-11,2020-05-12,None
1624,NCT04373213,ClinicalTrials.gov,2020-04-30,2020-05-05,False,Erzincan University,Not Recruiting,Not Applicable,Observational,Turkey,Evaluation of the Fluid Response of SARS-CoV-2 (COVID-19) Patients in Intensive Care; Pleth Variability Index,Diagnostics,Diagnostic Test or Assessment,30,2020-06-05,2020-06-15,https://clinicaltrials.gov/show/NCT04373213,No Results,No Results,No Results,2020-05-11,2020-05-12,None
1625,ChiCTR2000031500,ChiCTR,2020-04-02,2020-03-05,True,Peking University First Hospital,Not Recruiting,Not Applicable,Health services research,China,Impact of measuring distance and cold outdoor environment on the screening of novel coronavirus pneumonia (COVID-19),Diagnostics,Diagnostic Test or Assessment,58,Not Available,2020-04-12,http://www.chictr.org.cn/showproj.aspx?proj=51897,No Results,No Results,No Results,2020-04-06,2020-04-07,None
1626,NCT04374474,ClinicalTrials.gov,2020-04-29,2020-06-01,False,Lawson Health Research Institute,Not Recruiting,Phase 4,Interventional,Canada,Anosmia Rehabilitation in Patients Post Coronavirus Disease (COVID 19),Other (procedure),Rehabilitation,75,2021-06-01,2021-12-01,https://clinicaltrials.gov/show/NCT04374474,No Results,No Results,No Results,2020-05-11,2020-05-12,None
1627,NCT04374539,ClinicalTrials.gov,2020-05-02,2020-04-29,True,Fundaci Clnic per a la Recerca Biomdica,Recruiting,Phase 2,Interventional,Spain,Plasma Exchange in Patients With COVID-19 Disease and Invasive Mechanical Ventilation: a Randomized Controlled Trial,ATMP,Plasma,116,2021-05-05,2021-08-29,https://clinicaltrials.gov/show/NCT04374539,No Results,No Results,No Results,2020-05-11,2020-05-12,None
1628,NCT04373460,ClinicalTrials.gov,2020-04-30,2020-05-11,False,Johns Hopkins University,Not Recruiting,Phase 2,Interventional,No Country Given,Convalescent Plasma to Limit SARS-CoV-2 Associated Complications,ATMP,Plasma,1344,2022-12-21,2023-01-31,https://clinicaltrials.gov/show/NCT04373460,No Results,No Results,No Results,2020-05-11,2020-05-12,None
1629,NCT04373486,ClinicalTrials.gov,2020-04-30,2020-03-03,True,"University Hospital, Strasbourg",Recruiting,Not Applicable,Observational,France,Incidence of Acute Pulmonary Embolism in Covid-19 Patients on CT Angiography and Relationship to D-dimer Levels,Clinical Presentation (Epidemiology),No Intervention,160,2020-04-30,2020-05-01,https://clinicaltrials.gov/show/NCT04373486,No Results,No Results,No Results,2020-05-11,2020-05-12,None
1630,NCT04374045,ClinicalTrials.gov,2020-04-30,2020-04-30,False,CHU de Saint Etienne,Recruiting,Not Applicable,Observational,France,Testing for Dysautonomia in Patients Hospitalized for SARS-CoV-2 Infection (COVID-19) : COVIDANS Study,Clinical Presentation,No Intervention,25,2020-09-01,2020-10-01,https://clinicaltrials.gov/show/NCT04374045,No Results,No Results,No Results,2020-05-11,2020-05-12,None
1631,NCT04374058,ClinicalTrials.gov,2020-05-01,2020-03-20,True,Dialisis Madariaga,Not Recruiting,Not Applicable,Observational,Argentina,Less Frequency Hemodialysis and COVID-19,Other,Other,50,2021-03-01,2021-03-01,https://clinicaltrials.gov/show/NCT04374058,No Results,No Results,No Results,2020-05-11,2020-05-12,None
1632,NCT04374565,ClinicalTrials.gov,2020-04-27,2020-05-05,False,University of Virginia,Recruiting,Phase 2,Interventional,United States,Convalescent Plasma for Treatment of COVID-19 Patients With Pneumonia,ATMP,Plasma,29,2021-04-05,2021-04-05,https://clinicaltrials.gov/show/NCT04374565,No Results,No Results,No Results,2020-05-11,2020-05-12,None
1633,NCT04374656,ClinicalTrials.gov,2020-05-01,2020-05-01,False,Johns Hopkins University,Not Recruiting,Not Applicable,Observational,No Country Given,Prevalence of SARS-CoV-2 in Conjunctival Swab Samples Among Patients With Conjunctivitis During the COVID-19 Pandemic,Clinical Presentation (Epidemiology),No Intervention,50,2021-04-01,2021-04-01,https://clinicaltrials.gov/show/NCT04374656,No Results,No Results,No Results,2020-05-11,2020-05-12,None
1634,ChiCTR2000031432,ChiCTR,2020-03-31,2020-05-01,False,Nanjing University,Not Recruiting,Phase 1,Basic Science,China,A single center clinical study of evaluating the injection of microRNA2911 plasmid in healthy adults,ATMP,RNA Plasmid,15,Not Available,2020-08-31,http://www.chictr.org.cn/showproj.aspx?proj=51646,No Results,No Results,No Results,2020-04-06,2020-04-07,None
1635,NCT04373811,ClinicalTrials.gov,2020-04-26,2020-04-16,True,Groupe Hospitalier Paris Saint-Joseph,Recruiting,Not Applicable,Observational,France,One-Year Quality of Life and Functional Prognosis of COVID-19 Patients in Post-ICU Setting,Prognosis,No Intervention,50,2021-09-16,2021-09-16,https://clinicaltrials.gov/show/NCT04373811,No Results,No Results,No Results,2020-05-11,2020-05-12,None
1636,NCT04374019,ClinicalTrials.gov,2020-05-01,2020-05-01,False,Susanne Arnold,Recruiting,Phase 2,Interventional,United States,Novel Agents for Treatment of High-risk COVID-19 Positive Patients,Drug,Hydroxychloroquine + Azithromycin vs. Hydroxychloroquine + Ivermectin vs. Hydroxychloroquine vs. Camostat Mesilate,240,2021-05-01,2021-05-01,https://clinicaltrials.gov/show/NCT04374019,No Results,No Results,No Results,2020-05-11,2020-05-12,None
1637,NCT04374071,ClinicalTrials.gov,2020-04-30,2020-03-12,True,Henry Ford Health System,Not Recruiting,Not Applicable,Observational,United States,Early Short Course Corticosteroids in COVID-19,Drug,Corticosteroids,250,2020-03-27,2020-04-30,https://clinicaltrials.gov/show/NCT04374071,Pre-Print Article,2020-05-05,https://doi.org/10.1101/2020.05.04.20074609,2020-05-11,2020-05-12,None
1638,NCT04374084,ClinicalTrials.gov,2020-04-20,2020-05-01,False,"Guang'anmen Hospital, China Academy of Chinese Medical Sciences",Not Recruiting,Not Applicable,Interventional,No Country Given,Moxibustion Plus Cupping in Convalescent Patients With COVID-19,Traditional Medicine (Other),Traditional Medicine,60,2021-12-01,2021-12-01,https://clinicaltrials.gov/show/NCT04374084,No Results,No Results,No Results,2020-05-11,2020-05-12,None
1639,NCT04375098,ClinicalTrials.gov,2020-05-03,2020-05-04,False,Pontificia Universidad Catlica de Chile,Recruiting,Phase 2,Interventional,Chile,Efficacy and Safety of Early COVID-19 Convalescent Plasma in Patients Admitted for COVID-19 Infection,ATMP,Plasma,30,2020-12-01,2021-12-01,https://clinicaltrials.gov/show/NCT04375098,No Results,No Results,No Results,2020-05-11,2020-05-12,None
1640,NCT04375124,ClinicalTrials.gov,2020-05-01,2020-04-25,True,Kanuni Sultan Suleyman Training and Research Hospital,Recruiting,Not Applicable,Interventional,Turkey,Treatment of Angiotensin Peptide (1-7) for COVID-19,ATMP,Plasma,20,2020-08-31,2020-09-30,https://clinicaltrials.gov/show/NCT04375124,No Results,No Results,No Results,2020-05-11,2020-05-12,None
1641,ChiCTR2000031430,ChiCTR,2020-03-31,2020-03-20,True,The Fifth Medical Center of PLA General Hospital,Recruiting,Phase 2,Interventional,China,Clinical study of human umbilical cord mesenchymal stem cells in the treatment of novel coronavirus pneumonia (COVID-19) induced pulmonary fibrosis,ATMP,Cells (mesenchymal),200,Not Available,2021-12-31,http://www.chictr.org.cn/showproj.aspx?proj=49254,No Results,No Results,No Results,2020-04-06,2020-04-07,None
1642,NCT04374110,ClinicalTrials.gov,2020-04-22,2020-05-05,False,"Institute of Cardiology, Warsaw",Recruiting,Not Applicable,Observational,Poland,Drug Safety and the Occurrence of Complications During Hospitalization in Patients With COVID-19,Clinical Presentation (Epidemiology),No Intervention,1000,2020-06-24,2021-08-24,https://clinicaltrials.gov/show/NCT04374110,No Results,No Results,No Results,2020-05-11,2020-05-12,None
1643,NCT04374370,ClinicalTrials.gov,2020-05-01,2017-01-16,True,AdventHealth,Not Recruiting,Not Applicable,Expanded Access,United States,SARSCoV2 (COVID-19) Convalescent Plasma (CP) Expanded Access Protocol (EAP),ATMP,Plasma,Not Available,Not Available,Not Available,https://clinicaltrials.gov/show/NCT04374370,No Results,No Results,No Results,2020-05-11,2020-05-12,None
1644,NCT04375748,ClinicalTrials.gov,2020-04-21,2020-04-15,True,"University Hospital, Toulouse",Recruiting,Not Applicable,Observational,France,Hospital Registry of Acute Myocarditis: Evolution of the Proportion of Positive SARS-COV-2 (COVID19) Cases,Clinical Presentation (Epidemiology),No Intervention,400,2021-10-15,2021-10-15,https://clinicaltrials.gov/show/NCT04375748,No Results,No Results,No Results,2020-05-11,2020-05-12,None
1645,NCT04375774,ClinicalTrials.gov,2020-04-17,2020-05-01,False,"University Clinic, UCLouvain",Recruiting,Not Applicable,Interventional,Belgium,Verification of Alternative Do-it-yourself Equipment Respirators for the COVID-19 Personal Protective Equipment (PPE),Other (device),Masks,10,2020-05-01,2020-05-01,https://clinicaltrials.gov/show/NCT04375774,No Results,No Results,No Results,2020-05-11,2020-05-12,None
1646,NCT04374097,ClinicalTrials.gov,2020-05-02,2020-03-31,True,University of Oslo,Not Recruiting,Not Applicable,Observational,Norway,Level and Predictors of Trauma-symptoms Among Health Workers and Public Service Providers During the COVID-19 Outbreak,Other (psych),No Intervention,1778,2020-04-07,2020-04-07,https://clinicaltrials.gov/show/NCT04374097,No Results,No Results,No Results,2020-05-11,2020-05-12,None
1647,NCT04374279,ClinicalTrials.gov,2020-05-04,2020-06-01,False,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,Not Recruiting,Phase 2,Interventional,United States,Trial to Promote Recovery From COVID-19 With Ivermectin or Endocrine Therapy,Drug,Bicalutamide vs. Ivermectin,60,2021-06-01,2021-06-01,https://clinicaltrials.gov/show/NCT04374279,No Results,No Results,No Results,2020-05-11,2020-05-12,None
1648,NCT04374461,ClinicalTrials.gov,2020-05-01,2020-05-01,False,Memorial Sloan Kettering Cancer Center,Recruiting,Phase 2,Interventional,United States,A Study of N-acetylcysteine in Patients With COVID-19 Infection,Drug,N-acetylcysteine,86,2021-05-01,2021-05-01,https://clinicaltrials.gov/show/NCT04374461,No Results,No Results,No Results,2020-05-11,2020-05-12,None
1649,NCT04374552,ClinicalTrials.gov,2020-05-02,2020-05-05,False,Rutgers University,Not Recruiting,Phase 2,Interventional,United States,Asymptomatic COVID-19 Trial,Drug,Hydroxychloroquine + Azithromycin,140,2020-11-01,2021-04-01,https://clinicaltrials.gov/show/NCT04374552,No Results,No Results,No Results,2020-05-11,2020-05-12,None
1650,NCT04376398,ClinicalTrials.gov,2020-05-04,2020-04-06,True,"University Clinic, UCLouvain",Recruiting,Not Applicable,Observational,Belgium,Survey: COVID-19 Patients Managed in the Operating Theatre of Belgian Hospitals,Health System,No Intervention,200,2020-06-30,2020-09-30,https://clinicaltrials.gov/show/NCT04376398,No Results,No Results,No Results,2020-05-11,2020-05-12,None
1651,NCT04376515,ClinicalTrials.gov,2020-03-31,2020-03-20,True,"University of California, Irvine",Not Recruiting,Not Applicable,Interventional,United States,Harnessing Online Peer Education Online Support Intervention for COVID-19 (HOPE COVID-19),Other (psych),Psychological,300,2020-06-01,2020-09-01,https://clinicaltrials.gov/show/NCT04376515,No Results,No Results,No Results,2020-05-11,2020-05-12,None
1652,NCT04374487,ClinicalTrials.gov,2020-04-29,2020-05-09,False,Max Healthcare Insititute Limited,Not Recruiting,Phase 2,Interventional,India,"A Phase II, Open Label, Randomized Controlled Trial to Assess the Safety and Efficacy of Convalescent Plasma to Limit COVID-19 Associated Complications",ATMP,Plasma,100,2021-05-09,2021-05-09,https://clinicaltrials.gov/show/NCT04374487,No Results,No Results,No Results,2020-05-11,2020-05-12,None
1653,NCT04374513,ClinicalTrials.gov,2020-05-02,2020-05-02,False,Damanhour University,Recruiting,Not Applicable,Observational,Egypt,Community Pharmacists Behaviour During Covid-19,Health System,No Intervention,50,2020-10-01,2021-04-01,https://clinicaltrials.gov/show/NCT04374513,No Results,No Results,No Results,2020-05-11,2020-05-12,None
1654,NCT04374643,ClinicalTrials.gov,2020-04-30,2020-04-01,True,"University Hospital, Montpellier",Recruiting,Not Applicable,Observational,France,Descriptive Study of the PSYchological Impact of CONFinement Measures in Subjects With Mood Disorders,Other (psych),No Intervention,500,2020-05-30,2020-11-01,https://clinicaltrials.gov/show/NCT04374643,No Results,No Results,No Results,2020-05-11,2020-05-12,None
1655,NCT04374695,ClinicalTrials.gov,2020-05-03,2020-05-01,True,Versailles Hospital,Not Recruiting,Not Applicable,Observational,No Country Given,"Renin-Angiotensin-Aldosterone System Inhibitors, Hypertension, and COVID-19",Drug,ACE inhibitors or ARBs,700,2020-06-01,2020-07-01,https://clinicaltrials.gov/show/NCT04374695,No Results,No Results,No Results,2020-05-11,2020-05-12,None
1656,NCT04374526,ClinicalTrials.gov,2020-05-02,2020-05-15,False,Fondazione Policlinico Universitario Agostino Gemelli IRCCS,Not Recruiting,Phase 2/Phase 3,Interventional,Italy,Early transfusIon of Convalescent Plasma in Elderly COVID-19 Patients. to Prevent Disease Progression.,ATMP,Plasma,182,2020-09-30,2021-06-30,https://clinicaltrials.gov/show/NCT04374526,No Results,No Results,No Results,2020-05-11,2020-05-12,None
1657,NCT04374942,ClinicalTrials.gov,2020-04-30,2020-04-30,False,Megan Landes,Recruiting,Phase 3,Interventional,Canada,Does Hydroxychloroquine Before & During Patient Exposure Protect Healthcare Workers From Coronavirus?,Drug (Chemoprophylaxis),Hydroxychloroquine,988,2020-08-27,2022-01-30,https://clinicaltrials.gov/show/NCT04374942,No Results,No Results,No Results,2020-05-11,2020-05-12,None
1658,NCT04377074,ClinicalTrials.gov,2020-05-04,2020-03-31,True,University of Oslo,Not Recruiting,Not Applicable,Observational,Norway,Parental Stress During the COVID-19 Pandemic and Its Association With Depression and Anxiety,Other (psych),No Intervention,2880,2020-04-07,2020-04-07,https://clinicaltrials.gov/show/NCT04377074,No Results,No Results,No Results,2020-05-11,2020-05-12,None
1659,NCT04377490,ClinicalTrials.gov,2020-05-05,2020-05-04,True,CHU de Amiens,Recruiting,Not Applicable,Observational,France,Thrombo Embolic Events in Hospitalized Patients With Covid-19 Serious Acute Pneumopathy,Clinical Presentation,No Intervention,100,2020-10-01,2020-11-01,https://clinicaltrials.gov/show/NCT04377490,No Results,No Results,No Results,2020-05-11,2020-05-12,None
1660,EUCTR2020-001386-37-IT,EU Clinical Trials Register,2020-04-02,2020-03-27,True,Azienda Unit Sanitaria Locale Reggio Emilia,Authorised,Phase 2,Interventional,Italy,Efficacy of Tocilizumab - COVID-19,Drug,Tocilizumab,Not Available,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001386-37,No Results,No Results,No Results,2020-04-06,2020-04-07,None
1661,NCT04374786,ClinicalTrials.gov,2020-05-01,2020-05-01,False,University of Arizona,Not Recruiting,Not Applicable,Interventional,United States,Effects of Mobile App in House Staff Health and Well-being During COVID-19 Pandemic,Other (psych),Psychological,328,2020-09-01,2020-10-01,https://clinicaltrials.gov/show/NCT04374786,No Results,No Results,No Results,2020-05-11,2020-05-12,None
1662,NCT04374903,ClinicalTrials.gov,2020-05-03,2020-05-01,True,King Hussein Cancer Center,Not Recruiting,Not Applicable,Interventional,Jordan,Hydroxychloroquine in Combination With Azithromycin or Sirolimus for Treating COVID-19 Patients,Drug,Hydroxychloroquine + Azithromycin vs. Hydroxychloroquine + Sirolimus,58,2020-08-01,2020-09-01,https://clinicaltrials.gov/show/NCT04374903,No Results,No Results,No Results,2020-05-11,2020-05-12,None
1663,NCT04377581,ClinicalTrials.gov,2020-04-30,2020-04-09,True,Milton S. Hershey Medical Center,Recruiting,Not Applicable,Observational,United States,"COVID-19 Health Messaging Efficacy and Its Impact on Public Perception, Anxiety, and Behavior",Other,No Intervention,25000,2020-05-31,2020-05-31,https://clinicaltrials.gov/show/NCT04377581,No Results,No Results,No Results,2020-05-11,2020-05-12,None
1664,NCT04377607,ClinicalTrials.gov,2020-05-04,2020-05-10,False,Nevsehir Public Hospital,Recruiting,Not Applicable,Observational,Turkey,Haemoglobin Concentration on COVID-19,Clinical Presentation,No Intervention,200,2020-05-20,2020-05-30,https://clinicaltrials.gov/show/NCT04377607,No Results,No Results,No Results,2020-05-11,2020-05-12,None
1665,NCT04375137,ClinicalTrials.gov,2020-05-03,2020-04-20,True,Shahid Beheshti University of Medical Sciences,Recruiting,Not Applicable,Observational,Iran,Correlation Between Oxidative Stress Status and COVID-19 Severity,Clinical Presentation,No Intervention,90,2020-06-20,2020-07-01,https://clinicaltrials.gov/show/NCT04375137,No Results,No Results,No Results,2020-05-11,2020-05-12,None
1666,NCT04375176,ClinicalTrials.gov,2020-05-03,2020-04-27,True,Universit degli Studi dell'Insubria,Recruiting,Not Applicable,Observational,Italy,Monocytes and NK Cells Activity in Covid-19 Patients,Clinical Presentation,No Intervention,150,2020-06-30,2020-10-31,https://clinicaltrials.gov/show/NCT04375176,No Results,No Results,No Results,2020-05-11,2020-05-12,None
1667,NCT04375202,ClinicalTrials.gov,2020-04-29,2020-04-18,True,University of Perugia,Recruiting,Phase 2,Interventional,Italy,Colchicine in COVID-19: a Pilot Study,Drug,Colchicine,308,2020-06-30,2020-10-31,https://clinicaltrials.gov/show/NCT04375202,No Results,No Results,No Results,2020-05-11,2020-05-12,None
1668,NCT04375644,ClinicalTrials.gov,2020-05-04,2020-05-11,False,Hospices Civils de Lyon,Not Recruiting,Not Applicable,Observational,France,Impact of the COVID-19 Pandemic on the Quality of Psychological Life (COVID-PRO-IMPACT),Other (psych),No Intervention,1800,2020-08-01,2020-08-01,https://clinicaltrials.gov/show/NCT04375644,No Results,No Results,No Results,2020-05-11,2020-05-12,None
1669,NCT04298060,ClinicalTrials.gov,2020-02-28,2020-04-01,False,"Ansun Biopharma, Inc.",Not Recruiting,Phase 2,Interventional,China,DAS181 for Patients With Severe Hospitalized Flu and SAD-RVs (COVID-19),Drug,DAS181,280,2021-03-01,2022-09-01,https://clinicaltrials.gov/show/NCT04298060,No Results,No Results,No Results,2020-04-14,2020-04-07,None
1670,NCT04377724,ClinicalTrials.gov,2020-05-05,2020-04-27,True,Jrg Goldhahn,Recruiting,Not Applicable,Observational,Switzerland,Spread and Course of COVID-19 Infections,Clinical Presentation (Epidemiology),No Intervention,3000,2021-06-30,2021-06-30,https://clinicaltrials.gov/show/NCT04377724,No Results,No Results,No Results,2020-05-11,2020-05-12,None
1671,NCT04377815,ClinicalTrials.gov,2020-04-24,2020-04-23,True,"University College, London",Recruiting,Not Applicable,Observational,United Kingdom,Finding Out if COVID-19 Infection Can be pREdicted by ChAnges in Smell and/or Taste,Prognosis,No Intervention,500,2020-08-30,2020-12-23,https://clinicaltrials.gov/show/NCT04377815,No Results,No Results,No Results,2020-05-11,2020-05-12,None
1672,NCT04375397,ClinicalTrials.gov,2020-05-04,2020-05-06,False,AbbVie,Not Recruiting,Phase 2,Interventional,No Country Given,Study of Oral Ibrutinib Capsules to Assess Respiratory Failure in Adult Participants With CoronaVirus Induced Disease 2019 (COVID-19) and Pulmonary Distress,Drug,Ibrutinib,46,2020-07-30,2020-08-27,https://clinicaltrials.gov/show/NCT04375397,No Results,No Results,No Results,2020-05-11,2020-05-12,None
1673,NCT04376476,ClinicalTrials.gov,2020-04-28,2020-05-05,False,Hospices Civils de Lyon,Recruiting,Not Applicable,Interventional,France,Host-pathogen Interactions During SARS-CoV-2 Infection,Clinical Presentation,No Intervention,450,2021-06-05,2021-06-05,https://clinicaltrials.gov/show/NCT04376476,No Results,No Results,No Results,2020-05-11,2020-05-12,None
1674,NCT04375735,ClinicalTrials.gov,2020-04-22,2020-05-01,False,Lawson Health Research Institute,Not Recruiting,Phase 1/Phase 2,Interventional,No Country Given,London's Exogenous Surfactant Study for COVID19,Drug,Bovine Lipid Extract Surfactant,20,2021-01-01,2021-07-01,https://clinicaltrials.gov/show/NCT04375735,No Results,No Results,No Results,2020-05-11,2020-05-12,None
1675,NCT04375761,ClinicalTrials.gov,2020-04-30,2020-05-01,False,National Institute of Allergy and Infectious Diseases (NIAID),Recruiting,Not Applicable,Observational,United States,COVID-19: Human Epidemiology and Response to SARS-CoV-2,Clinical Presentation (Epidemiology),No Intervention,8000,2020-12-01,2020-12-01,https://clinicaltrials.gov/show/NCT04375761,No Results,No Results,No Results,2020-05-11,2020-05-12,None
1676,NCT04378257,ClinicalTrials.gov,2020-05-02,2020-06-01,False,Sultan Qaboos University,Not Recruiting,Phase 3,Interventional,No Country Given,Efficacy of Therapist Guided e-Therapy Versus Self-Help Therapy on Psychological Distress Among Individuals in Oman During COVID-19 Pandemic,Other (psych),Psychological,70,2020-09-30,2020-10-20,https://clinicaltrials.gov/show/NCT04378257,No Results,No Results,No Results,2020-05-11,2020-05-12,None
1677,NCT04378582,ClinicalTrials.gov,2020-05-05,2020-05-10,False,University of Sao Paulo General Hospital,Not Recruiting,Not Applicable,Observational,No Country Given,Characteristics and Outcomes of Patients With COVID-19 Admitted to the ICU,Clinical Presentation,No Intervention,300,2020-08-30,2020-12-31,https://clinicaltrials.gov/show/NCT04378582,No Results,No Results,No Results,2020-05-11,2020-05-12,None
1678,NCT04312243,ClinicalTrials.gov,2020-03-15,2020-04-02,False,Massachusetts General Hospital,Not Recruiting,Phase 2,Interventional,No Country Given,NO Prevention of COVID-19 for Healthcare Providers,Drug,Nitric oxide,470,2021-03-20,2022-03-20,https://clinicaltrials.gov/show/NCT04312243,No Results,No Results,No Results,2020-04-14,2020-03-25,None
1679,NCT04316377,ClinicalTrials.gov,2020-03-13,2020-03-25,False,"University Hospital, Akershus",Recruiting,Phase 4,Interventional,Norway,Norwegian Coronavirus Disease 2019 Study,Drug,Hydroxychloroquine,202,2021-04-01,2025-03-03,https://clinicaltrials.gov/show/NCT04316377,No Results,No Results,No Results,2020-04-14,2020-03-25,None
1680,NCT04378881,ClinicalTrials.gov,2020-05-05,2020-05-05,False,Tabula Rasa HealthCare,Not Recruiting,Not Applicable,Observational,No Country Given,Simulation of Risk of Adverse Drug Events Associated With the Initiation of Drugs Repurposed for the Treatment of COVID-19 in Adults With Polypharmacy Using Data From Large Medicare and Commercially Insured Populations,Other,No Intervention,100,2020-11-30,2021-04-30,https://clinicaltrials.gov/show/NCT04378881,No Results,No Results,No Results,2020-05-11,2020-05-12,None
1681,NCT04379232,ClinicalTrials.gov,2020-05-04,2020-03-19,True,Hospices Civils de Lyon,Not Recruiting,Not Applicable,Observational,France,Surgical Activity During the Covid-19 Pandemic: Results for 112 Patients in a French Tertiary Care Center,Clinical Presentation,No Intervention,112,2020-04-20,2020-04-25,https://clinicaltrials.gov/show/NCT04379232,No Results,No Results,No Results,2020-05-11,2020-05-12,None
1682,NCT04376658,ClinicalTrials.gov,2020-05-04,2020-06-15,False,Hospital Moinhos de Vento,Not Recruiting,Not Applicable,Observational,No Country Given,Quality of Life and Patient-centered Outcomes After Hospitalization for COVID-19,Other,No Intervention,1000,2021-09-15,2021-09-15,https://clinicaltrials.gov/show/NCT04376658,No Results,No Results,No Results,2020-05-11,2020-05-12,None
1683,NCT04376684,ClinicalTrials.gov,2020-05-04,2020-05-18,False,GlaxoSmithKline,Not Recruiting,Phase 2,Interventional,No Country Given,Investigating Otilimab in Patients With Severe Pulmonary COVID-19 Related Disease,Drug,Otilimab,800,2020-12-20,2020-12-20,https://clinicaltrials.gov/show/NCT04376684,No Results,No Results,No Results,2020-05-11,2020-05-12,None
1684,NCT04376710,ClinicalTrials.gov,2020-05-04,2020-06-01,False,"University of Colorado, Denver",Not Recruiting,Not Applicable,Observational,United States,Surgical Telemedicine in the COVID-19 Pandemic Era,Telehealth,Telehealth,100,2020-12-31,2020-12-31,https://clinicaltrials.gov/show/NCT04376710,No Results,No Results,No Results,2020-05-11,2020-05-12,None
1685,NCT04376853,ClinicalTrials.gov,2020-04-20,2020-04-15,True,"University Hospital, Heidelberg",Recruiting,Not Applicable,Observational,Germany,CoronaWatch - Early Detection of Cardiovascular Risks in COVID-19 Via SmartWatch,Other (device),Biosensors,50,2020-06-01,2020-07-01,https://clinicaltrials.gov/show/NCT04376853,No Results,No Results,No Results,2020-05-11,2020-05-12,None
1686,NCT04376944,ClinicalTrials.gov,2020-05-04,2020-04-01,True,"University Hospital, Montpellier",Recruiting,Not Applicable,Observational,France,Barrier Measures to Limit Covid-19.Nosocomial Transmission: a Cross-sectional Evaluation,Other,No Intervention,300,2020-12-01,2020-12-30,https://clinicaltrials.gov/show/NCT04376944,No Results,No Results,No Results,2020-05-11,2020-05-12,None
1687,NCT04324528,ClinicalTrials.gov,2020-03-25,2020-03-27,False,Dr. Alexander Supady,Recruiting,Not Applicable,Interventional,Germany,Cytokine Adsorption in Severe COVID-19 Pneumonia Requiring Extracorporeal Membrane Oxygenation,Drug,Oxygen,30,2020-09-26,2020-11-26,https://clinicaltrials.gov/show/NCT04324528,No Results,No Results,No Results,2020-04-14,2020-04-01,None
1688,NCT04328272,ClinicalTrials.gov,2020-03-25,2020-03-28,False,Dr. Umar Farooq,Not Recruiting,Phase 3,Interventional,Pakistan,Effectiveness of Hydroxychloroquine in Covid-19 Patients,Drug,Hydroxychloroquine vs. Hydroxychloroquine + Azithromycin,75,2020-05-28,2020-06-28,https://clinicaltrials.gov/show/NCT04328272,No Results,No Results,No Results,2020-04-14,2020-04-07,None
1689,NCT04379258,ClinicalTrials.gov,2020-04-22,2020-04-27,False,Hospital Universitario Getafe,Not Recruiting,Not Applicable,Observational,No Country Given,Analysis of Mortality of Critically Ill Patients With COVID-19,Clinical Presentation (Epidemiology),No Intervention,650,2020-05-30,2020-05-30,https://clinicaltrials.gov/show/NCT04379258,No Results,No Results,No Results,2020-05-11,2020-05-12,None
1690,NCT04379440,ClinicalTrials.gov,2020-05-03,2020-04-25,True,Raffaele Antonelli Incalzi,Recruiting,Not Applicable,Observational,Italy,Geriatric Population COVID-19 Observational Study (GEROCOVIDobs),Clinical Presentation (Epidemiology),No Intervention,1500,2020-09-30,2020-11-30,https://clinicaltrials.gov/show/NCT04379440,No Results,No Results,No Results,2020-05-11,2020-05-12,None
1691,NCT04376879,ClinicalTrials.gov,2020-05-04,2020-05-01,True,CHU de Nancy,Not Recruiting,Not Applicable,Observational,France,Predicting the Need for Intubation in Hospitalised COVID-19 Patients (PRED ICU COVID19),Prognosis,No Intervention,384,2020-11-01,2020-11-01,https://clinicaltrials.gov/show/NCT04376879,No Results,No Results,No Results,2020-05-11,2020-05-12,None
1692,NCT04376905,ClinicalTrials.gov,2020-04-16,2020-04-01,True,"University Hospital, Montpellier",Recruiting,Not Applicable,Observational,France,Extra Vascular Lung Water and Pulmonary Permeability in Critically Ill Patients With SARS-CoV-2 (COVID-19),Clinical Presentation,No Intervention,30,2020-09-01,2020-09-30,https://clinicaltrials.gov/show/NCT04376905,No Results,No Results,No Results,2020-05-11,2020-05-12,None
1693,NCT04377035,ClinicalTrials.gov,2020-05-01,2020-03-31,True,"Copenhagen University Hospital, Gentofte",Recruiting,Not Applicable,Observational,Denmark,The Role of Ultrasound in COVID-19,Clinical Presentation,No Intervention,1000,2020-05-01,2021-03-01,https://clinicaltrials.gov/show/NCT04377035,No Results,No Results,No Results,2020-05-11,2020-05-12,None
1694,NCT04377412,ClinicalTrials.gov,2020-05-02,2020-05-01,True,"Zelazna Medical Centre, LLC",Recruiting,Not Applicable,Observational,"Czech Republic, France, Sweden, Italy, Poland, Israel, Australia, Albania, Norway, United States, Taiwan, Germany, Hong Kong, Spain, Lebanon",Risk Factors for Anxiety and Depression Among Pregnant Women During the COVID-19 Pandemic,Other (psych),No Intervention,8500,2020-08-31,2020-10-31,https://clinicaltrials.gov/show/NCT04377412,No Results,No Results,No Results,2020-05-11,2020-05-12,None
1695,NCT04379466,ClinicalTrials.gov,2020-05-04,2020-05-01,True,Assistance Publique  Hpitaux de Paris,Not Recruiting,Not Applicable,Observational,No Country Given,Effector and Regulatory T Cell Receptor Repertoire Analyses in Patients Affected by COVID-19,Clinical Presentation,No Intervention,60,2020-07-01,2020-11-01,https://clinicaltrials.gov/show/NCT04379466,No Results,No Results,No Results,2020-05-11,2020-05-12,None
1696,NCT04379531,ClinicalTrials.gov,2020-04-30,2020-05-31,False,Department of Health Care of Moscow,Not Recruiting,Not Applicable,Interventional,Russian Federation,LDCT in COVID-19 Pneumonia: a Prospective Moscow Study,Diagnostics,Diagnostic Test or Assessment,230,2020-06-30,2020-07-31,https://clinicaltrials.gov/show/NCT04379531,No Results,No Results,No Results,2020-05-11,2020-05-12,None
1697,NCT04330261,ClinicalTrials.gov,2020-03-30,2020-03-18,True,University of Calgary,Recruiting,Not Applicable,Observational,Canada,Clinical Characteristics and Outcomes of Pediatric COVID-19,Clinical Presentation,No Intervention,12500,2021-03-17,2022-03-17,https://clinicaltrials.gov/show/NCT04330261,No Results,No Results,No Results,2020-04-14,2020-04-07,None
1698,NCT04331574,ClinicalTrials.gov,2020-03-30,2020-03-10,True,Societ Italiana dell'Ipertensione Arteriosa-Lega Italiana,Recruiting,Not Applicable,Observational,Italy,Renin-Angiotensin System Inhibitors and COVID-19,Drug,ACE Inhibitors or ARBs,2000,2020-04-10,2020-04-30,https://clinicaltrials.gov/show/NCT04331574,No Results,No Results,No Results,2020-04-14,2020-04-07,None
1699,NCT04377477,ClinicalTrials.gov,2020-05-04,2020-05-10,False,Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia,Recruiting,Not Applicable,Interventional,Italy,COVID-19 Pneumonitis Low Dose Lung Radiotherapy (COLOR-19),Other,Radiation,30,2021-05-10,2022-07-23,https://clinicaltrials.gov/show/NCT04377477,No Results,No Results,No Results,2020-05-11,2020-05-12,None
1700,NCT04377503,ClinicalTrials.gov,2020-05-02,2020-05-01,True,Hospital Sao Domingos,Not Recruiting,Phase 2,Interventional,No Country Given,Tocilizumab Versus Methylprednisolone in the Cytokine Release Syndrome of Patients With COVID-19,Drug,Tocilizumab vs. Corticosteroids,40,2020-08-01,2020-11-01,https://clinicaltrials.gov/show/NCT04377503,No Results,No Results,No Results,2020-05-11,2020-05-12,None
1701,NCT04377100,ClinicalTrials.gov,2020-05-05,2020-05-13,False,National Institute of Mental Health (NIMH),Not Recruiting,Not Applicable,Interventional,United States,Impact on Anxiety and Motivation of COVID-19 and Predictors of Individual Responses,Other (psych),No Intervention,500,2021-02-28,2021-02-28,https://clinicaltrials.gov/show/NCT04377100,No Results,No Results,No Results,2020-05-11,2020-05-12,None
1702,NCT04377308,ClinicalTrials.gov,2020-04-18,2020-05-01,False,University of Toledo,Recruiting,Phase 4,Interventional,United States,Fluoxetine to Reduce Intubation and Death After COVID19 Infection,Drug,Fluoxetine,2000,2021-04-20,2021-10-20,https://clinicaltrials.gov/show/NCT04377308,No Results,No Results,No Results,2020-05-11,2020-05-12,None
1703,NCT04380532,ClinicalTrials.gov,2020-04-29,2020-06-15,False,Immunitor LLC,Recruiting,Phase 1/Phase 2,Interventional,Canada,Tableted COVID-19 Therapeutic Vaccine,ATMP,Vaccine,20,2021-05-15,2021-06-15,https://clinicaltrials.gov/show/NCT04380532,No Results,No Results,No Results,2020-05-11,2020-05-12,None
1704,NCT04380766,ClinicalTrials.gov,2020-04-21,2019-01-01,True,Fondazione Policlinico Universitario Agostino Gemelli IRCCS,Recruiting,Not Applicable,Observational,Italy,Covid-19 Pandemic and Pancreatic Surgery in Italy,Clinical Presentation,No Intervention,700,2020-06-30,2020-06-30,https://clinicaltrials.gov/show/NCT04380766,No Results,No Results,No Results,2020-05-11,2020-05-12,None
1705,NCT04377620,ClinicalTrials.gov,2020-05-04,2020-05-08,False,Incyte Corporation,Recruiting,Phase 3,Interventional,United States,Assessment of Efficacy and Safety of Ruxolitinib in Participants With COVID-19-Associated ARDS Who Require Mechanical Ventilation (RUXCOVID-DEVENT),Drug,Ruxolitinib,500,2020-07-29,2020-07-29,https://clinicaltrials.gov/show/NCT04377620,No Results,No Results,No Results,2020-05-11,2020-05-12,None
1706,NCT04377685,ClinicalTrials.gov,2020-05-05,2020-03-01,True,CHU de Saint Etienne,Recruiting,Not Applicable,Observational,France,Prediction of Clinical Course in COVID19 Patients,Prognosis,No Intervention,800,2020-09-30,2020-09-30,https://clinicaltrials.gov/show/NCT04377685,No Results,No Results,No Results,2020-05-11,2020-05-12,None
1707,NCT04332016,ClinicalTrials.gov,2020-03-30,2020-04-02,False,"University Hospital, Bordeaux",Recruiting,Not Applicable,Observational,France,COVID-19 Biological Samples Collection,Clinical Presentation,No Intervention,2000,2023-03-01,2023-03-01,https://clinicaltrials.gov/show/NCT04332016,No Results,No Results,No Results,2020-04-14,2020-04-07,None
1708,NCT04332666,ClinicalTrials.gov,2020-03-27,2020-03-31,False,Erasme University Hospital,Not Recruiting,Phase 2/Phase 3,Interventional,No Country Given,"Angiotensin-(1,7) Treatment in COVID-19: the ATCO Trial",Drug,Angiotensin (1-7),60,2020-05-30,2020-06-15,https://clinicaltrials.gov/show/NCT04332666,No Results,No Results,No Results,2020-04-14,2020-04-07,None
1709,NCT04377334,ClinicalTrials.gov,2020-04-16,2020-05-01,False,"University Hospital, Tbingen",Not Recruiting,Phase 2,Interventional,Germany,Mesenchymal Stem Cells (MSCs) in Inflammation-Resolution Programs of Coronavirus Disease 2019 (COVID-19) Induced Acute Respiratory Distress Syndrome (ARDS),ATMP,Cells (mesenchymal),40,2020-11-01,2021-02-01,https://clinicaltrials.gov/show/NCT04377334,No Results,No Results,No Results,2020-05-11,2020-05-12,None
1710,NCT04377568,ClinicalTrials.gov,2020-04-30,2020-05-01,False,The Hospital for Sick Children,Not Recruiting,Phase 2,Interventional,Canada,Efficacy of Human Coronavirus-immune Convalescent Plasma for the Treatment of COVID-19 Disease in Hospitalized Children,ATMP,Plasma,100,2021-12-01,2022-05-01,https://clinicaltrials.gov/show/NCT04377568,No Results,No Results,No Results,2020-05-11,2020-05-12,None
1711,NCT04380948,ClinicalTrials.gov,2020-05-06,2020-07-31,False,Washington University in St. Louis,Not Recruiting,Phase 1,Interventional,United States,"A Pilot Study Evaluating the Effect of NT-I7, a Long Acting Interleukin-7, to Enhance Immune Clearance of SARS-CoV-2",Drug,NT-17,30,2021-02-28,2021-02-28,https://clinicaltrials.gov/show/NCT04380948,No Results,No Results,No Results,2020-05-11,2020-05-12,None
1712,NCT04381273,ClinicalTrials.gov,2020-05-06,2020-05-08,False,Heidelberg University,Recruiting,Not Applicable,Observational,Germany,Oral Health and Psychosocial Factors During the Covid-19 Pandemic,Clinical Presentation,No Intervention,1000,2020-07-31,2020-07-31,https://clinicaltrials.gov/show/NCT04381273,No Results,No Results,No Results,2020-05-11,2020-05-12,None
1713,NCT04377711,ClinicalTrials.gov,2020-05-05,2020-05-26,False,Covis Pharma,Not Recruiting,Phase 3,Interventional,No Country Given,A Study of the Safety and Efficacy of Ciclesonide in the Treatment of Non-hospitalized COVID-19 Patients,Drug,Ciclesonide,400,2020-09-01,2020-12-01,https://clinicaltrials.gov/show/NCT04377711,No Results,No Results,No Results,2020-05-11,2020-05-12,None
1714,NCT04377737,ClinicalTrials.gov,2020-05-04,2020-05-15,False,Fondation Lenval,Not Recruiting,Not Applicable,Interventional,France,Incidence of Covid-19 in School Children,Clinical Presentation (Epidemiology),No Intervention,914,2020-08-01,2020-09-01,https://clinicaltrials.gov/show/NCT04377737,No Results,No Results,No Results,2020-05-11,2020-05-12,None
1715,NCT04334850,ClinicalTrials.gov,2020-04-02,2020-04-01,True,Assistance Publique  Hpitaux de Paris,Not Recruiting,Not Applicable,Interventional,France,Use of a Respiratory Multiplex PCR and Procalcitonin to Reduce Antibiotics Exposure in Patients With Severe Confirmed COVID-19 Pneumonia,Clinical Presentation,Other (Procedure),194,2020-07-01,2020-08-01,https://clinicaltrials.gov/show/NCT04334850,No Results,No Results,No Results,2020-04-14,2020-04-15,EUCTR2020-001324-33
1716,ACTRN12620000443998,ANZCTR,2020-04-06,2020-05-01,False,Flinders Medical Centre,Not Recruiting,Not Applicable,Interventional,Australia,Home rehabilitation for people with COVID-19: Implementing telehealth approaches to care,Telehealth,Rehabilitation,58,Not Available,Not Available,https://anzctr.org.au/ACTRN12620000443998.aspx,No Results,No Results,No Results,2020-04-14,2020-04-07,None
1717,ACTRN12620000555954,ANZCTR,2020-05-11,2020-06-01,False,UNSW Sydney,Not Recruiting,Not Applicable,Interventional,Australia,"Randomised controlled trial of an app-based intervention, Anchored, to support the mental health of Australians recently unemployed due to COVID-19.",Other (psych),Psychological,492,Not Available,2020-12-30,https://anzctr.org.au/ACTRN12620000555954.aspx,No Results,No Results,No Results,2020-05-11,2020-05-12,None
1718,ChiCTR2000031772,ChiCTR,2020-04-09,2020-01-10,True,Fujian Provincial Maternity and Child Health Hospital,Recruiting,Not Applicable,Interventional,No Country Given,Impact of WeChat-based parenting education for children with autism spectrum disorder and their mothers during the epidemic of Coronavirus disease 2019 (COVID-19),Other,Health Education,105,Not Available,2020-10-31,http://www.chictr.org.cn/showproj.aspx?proj=52165,No Results,No Results,No Results,2020-04-13,2020-04-15,None
1719,NCT04377802,ClinicalTrials.gov,2020-05-04,2020-05-17,False,King Fahad Specialist Hospital,Not Recruiting,Not Applicable,Interventional,Saudi Arabia,Safe Return to Regular Clinical Operation After COVID-19 Pandemic,Health System,No Intervention,400,2020-11-16,2020-12-30,https://clinicaltrials.gov/show/NCT04377802,No Results,No Results,No Results,2020-05-11,2020-05-12,None
1720,NCT04378244,ClinicalTrials.gov,2020-05-04,2020-06-12,False,Aveni Foundation,Not Recruiting,Phase 1/Phase 2,Interventional,No Country Given,CORONA: A Study Using DeltaRex-G Gene Therapy for Symptomatic COVID-19,Other,Gene Therapy,18,2021-01-12,2021-03-12,https://clinicaltrials.gov/show/NCT04378244,No Results,No Results,No Results,2020-05-11,2020-05-12,None
1721,NCT04377750,ClinicalTrials.gov,2020-04-23,2020-04-08,True,Hadassah Medical Organization,Recruiting,Phase 4,Interventional,Israel,The Use of Tocilizumab in the Management of Patients Who Have Severe COVID-19 With Suspected Pulmonary Hyperinflammation,Drug,Tocilizumab,500,2020-04-29,2021-05-08,https://clinicaltrials.gov/show/NCT04377750,No Results,No Results,No Results,2020-05-11,2020-05-12,None
1722,NCT04377763,ClinicalTrials.gov,2020-05-05,2020-05-01,True,Assistance Publique  Hpitaux de Paris,Not Recruiting,Not Applicable,Observational,France,Developement and Evaluation of Serological Assays for COVID-19,Diagnostics,Diagnostic Test or Assessment,500,2020-10-01,2020-10-01,https://clinicaltrials.gov/show/NCT04377763,No Results,No Results,No Results,2020-05-11,2020-05-12,None
1723,ACTRN12620000487910,ANZCTR,2020-04-20,2020-04-07,True,Albury Wodonga Health,Recruiting,Not Applicable,Observational,Australia,Study evaluating Coronavirus (COVID-19) nasal/oral swab results compared to blood antibody results in COVID-19 clinic patients.,Diagnostics,Diagnostic Test or Assessment,500,Not Available,2021-04-07,https://anzctr.org.au/ACTRN12620000487910.aspx,No Results,No Results,No Results,2020-05-11,2020-04-22,None
1724,NCT04378452,ClinicalTrials.gov,2020-04-15,2020-03-31,True,Fundaci Institut Germans Trias i Pujol,Recruiting,Not Applicable,Observational,Spain,Assessment of the Psycho-social Impact of COVID-19 Outbreak,Other (psych),No Intervention,65000,2020-09-01,2020-12-01,https://clinicaltrials.gov/show/NCT04378452,No Results,No Results,No Results,2020-05-11,2020-05-12,None
1725,NCT04378595,ClinicalTrials.gov,2020-05-05,2020-04-10,True,"University of Texas, Austin",Recruiting,Not Applicable,Observational,United States,Assessing Pediatric Food Insecurity During the COVID-19 Pandemic in Austin,Other,No Intervention,1000,2020-12-30,2021-07-30,https://clinicaltrials.gov/show/NCT04378595,No Results,No Results,No Results,2020-05-11,2020-05-12,None
1726,NCT04377776,ClinicalTrials.gov,2020-05-05,2020-05-04,True,IRCCS San Raffaele,Recruiting,Not Applicable,Observational,Italy,"Observational Study Concerning COVID-19 Infection in Transplanted Kidney, Pancreas or Pancreatic Islet Patients",Clinical Presentation,No Intervention,700,2020-05-18,2020-05-18,https://clinicaltrials.gov/show/NCT04377776,No Results,No Results,No Results,2020-05-11,2020-05-12,None
1727,NCT04377789,ClinicalTrials.gov,2020-05-01,2020-03-20,True,Kanuni Sultan Suleyman Training and Research Hospital,Recruiting,Not Applicable,Interventional,Turkey,Effect of Quercetin on Prophylaxis and Treatment of COVID-19,Drug (Chemoprophylaxis),Quercetin,50,2020-07-31,2020-08-31,https://clinicaltrials.gov/show/NCT04377789,No Results,No Results,No Results,2020-05-11,2020-05-12,None
1728,ACTRN12620000557932,ANZCTR,2020-05-11,2020-05-18,False,Dr Karin Ried,Not Recruiting,Not Applicable,Interventional,"Germany, Australia, United States","International ALLIANCE Study of Therapies to prevent progression of COVID-19, a randomized trial",Drug,Hydroxychloroquine + Azithromycin + Zinc + Vitamin D + Vitamin B + Vitamin C vs. Hydroxychloroquine + Azithromycin + Zinc + Vitamin D + Vitamin B,200,Not Available,2021-06-30,https://anzctr.org.au/ACTRN12620000557932.aspx,No Results,No Results,No Results,2020-05-11,2020-05-12,None
1729,NCT04378712,ClinicalTrials.gov,2020-04-29,2020-01-21,True,Guangzhou Institute of Respiratory Disease,Not Recruiting,Not Applicable,Interventional,China,Hydrogen/Oxygen Mixed Gas Inhalation for Coronavirus Disease 2019 (COVID-19),Drug,Hydrogen + Oxygen,90,2020-03-23,2020-03-23,https://clinicaltrials.gov/show/NCT04378712,No Results,No Results,No Results,2020-05-11,2020-05-12,None
1730,NCT04378777,ClinicalTrials.gov,2020-05-01,2020-05-01,False,National Institute of Allergy and Infectious Diseases (NIAID),Recruiting,Not Applicable,Observational,United States,Immunophenotyping Assessment in a COVID-19 Cohort (IMPACC),Genomics,No Intervention,2000,2020-12-01,2021-12-01,https://clinicaltrials.gov/show/NCT04378777,No Results,No Results,No Results,2020-05-11,2020-05-12,None
1731,NCT04377997,ClinicalTrials.gov,2020-05-01,2020-05-15,False,Massachusetts General Hospital,Not Recruiting,Phase 2,Interventional,No Country Given,Safety and Efficacy of Therapeutic Anticoagulation on Clinical Outcomes in Hospitalized Patients With COVID-19,Drug,Enoxaparin,300,2021-01-01,2022-01-01,https://clinicaltrials.gov/show/NCT04377997,No Results,No Results,No Results,2020-05-11,2020-05-12,None
1732,NCT04378829,ClinicalTrials.gov,2020-05-03,2020-05-04,False,Konya Training and Research Hospital,Not Recruiting,Not Applicable,Observational,No Country Given,"Platelet Count, Platelet, Mean Platelet Volume and Platelet Distribution Width in COVID-19",Clinical Presentation,No Intervention,40,2020-05-11,2020-05-13,https://clinicaltrials.gov/show/NCT04378829,No Results,No Results,No Results,2020-05-11,2020-05-12,None
1733,ChiCTR2000032767,ChiCTR,2020-05-09,2020-05-09,False,"Institute of Basic Research for Clinical Medicine, China Academy of Chinese Medical Sciences",Not Recruiting,Not Applicable,Observational,China,A Medical Records Based Study for Clinical Efficacy and Safety of ''clear lung detoxification soup'' in the treatment of Novel Coronavirus Pneumonia (COVID-19),Traditional Medicine (Drug),Traditional Medicine,782,Not Available,2020-07-27,http://www.chictr.org.cn/showproj.aspx?proj=53476,No Results,No Results,No Results,2020-05-11,2020-05-12,None
1734,ChiCTR2000031770,ChiCTR,2020-04-09,2020-01-22,True,Shanghai Jiao Tong University Affiliated Sixth People's Hospital,Not Recruiting,Not Applicable,Observational,China,Experiences in nursing care for patients with suspected novel coronavirus pneumonia (COVID-19) in Shanghai,Clinical Presentation,No Intervention,119,Not Available,2020-02-29,http://www.chictr.org.cn/showproj.aspx?proj=52148,No Results,No Results,No Results,2020-04-13,2020-04-15,None
1735,NCT04378803,ClinicalTrials.gov,2020-05-04,2020-06-15,False,University of Miami,Recruiting,Not Applicable,Interventional,United States,Mindfulness Training for Seniors,Other (psych),Psychological,100,2020-10-01,2020-10-01,https://clinicaltrials.gov/show/NCT04378803,No Results,No Results,No Results,2020-05-11,2020-05-12,None
1736,NCT04378920,ClinicalTrials.gov,2020-05-05,2020-04-14,True,Institut de Cancrologie Strasbourg Europe (ICANS),Recruiting,Phase 1/Phase 2,Interventional,France,A Study of Trans Crocetin in Patients With Acute Respiratory Distress Syndrome Due to COVID-19 Disease (LEAF-4L7520/4L6715),Drug,Trans Crocetin,180,2020-07-31,2020-10-31,https://clinicaltrials.gov/show/NCT04378920,No Results,No Results,No Results,2020-05-11,2020-05-12,None
1737,NCT04378842,ClinicalTrials.gov,2020-05-05,2020-05-01,True,"University Hospital, Lille",Not Recruiting,Not Applicable,Observational,No Country Given,COVID-19 and ICU-acquired MDR Bacteria,Clinical Presentation,No Intervention,690,2021-05-01,2021-05-01,https://clinicaltrials.gov/show/NCT04378842,No Results,No Results,No Results,2020-05-11,2020-05-12,None
1738,NCT04379063,ClinicalTrials.gov,2020-05-05,2020-05-01,True,Jon Bailey,Not Recruiting,Not Applicable,Observational,No Country Given,COVID Pandemic Short Interval National Survey Gauging Psychological Distress,Other (psych),No Intervention,10000,2021-05-01,2022-05-01,https://clinicaltrials.gov/show/NCT04379063,No Results,No Results,No Results,2020-05-11,2020-05-12,None
1739,ChiCTR2000032717,ChiCTR,2020-05-08,2020-02-12,True,Xi'an International Medical Center Hospital,Not Recruiting,Not Applicable,Interventional,China,Efficacy and safety of high-dose vitamin C combined with traditional Chinese medicine in the treatment of moderate and severe novel coronavirus pneumonia (COVID-19),Traditional Medicine (Drug),Traditional Medicine + Vitamin C,40,Not Available,2021-01-31,http://www.chictr.org.cn/showproj.aspx?proj=53322,No Results,No Results,No Results,2020-05-11,2020-05-12,None
1740,NCT04379037,ClinicalTrials.gov,2020-05-05,2020-07-01,False,Nemechek Technologies,Not Recruiting,Not Applicable,Interventional,No Country Given,Vagus Nerve Stimulation ARDS Prevention Trial for COVID-19 Hospitalized Patients,Other (device),Vagus nerve stimulation,50,2020-10-01,2021-01-01,https://clinicaltrials.gov/show/NCT04379037,No Results,No Results,No Results,2020-05-11,2020-05-12,None
1741,NCT04379245,ClinicalTrials.gov,2020-05-04,2020-04-30,True,Hospices Civils de Lyon,Not Recruiting,Not Applicable,Observational,France,COVID-19 Infection in Patients Infected With HIV and/or on PrEP,Clinical Presentation,No Intervention,4200,2020-04-30,2020-05-04,https://clinicaltrials.gov/show/NCT04379245,No Results,No Results,No Results,2020-05-11,2020-05-12,None
1742,ChiCTR2000032666,ChiCTR,2020-05-05,2020-04-01,True,"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Not Applicable,Observational,China,Follow-up study of pregnancy outcomes  of novel coronavirus pneumonia (COVID-19) complicated in the first and second trimester,Clinical Presentation,No Intervention,6,Not Available,2020-12-31,http://www.chictr.org.cn/showproj.aspx?proj=53285,No Results,No Results,No Results,2020-05-11,2020-05-12,None
1743,NCT04379076,ClinicalTrials.gov,2020-05-05,2020-05-11,False,Revimmune,Not Recruiting,Phase 2,Interventional,No Country Given,InterLeukin-7 (CYT107) to Improve Clinical Outcomes in Lymphopenic pAtients With COVID-19 Infection UK Cohort,Drug,CYT107,48,2020-10-30,2020-12-30,https://clinicaltrials.gov/show/NCT04379076,No Results,No Results,No Results,2020-05-11,2020-05-12,None
1744,NCT04379089,ClinicalTrials.gov,2020-04-30,2020-04-29,True,University of Pittsburgh,Recruiting,Not Applicable,Observational,United States,Neurologic Manifestations of COVID 19 in Children,Clinical Presentation,No Intervention,500,2021-12-31,2022-12-31,https://clinicaltrials.gov/show/NCT04379089,No Results,No Results,No Results,2020-05-11,2020-05-12,None
1745,NCT04379336,ClinicalTrials.gov,2020-05-04,2020-05-04,False,TASK Applied Science,Recruiting,Phase 3,Interventional,South Africa,BCG Vaccination for Healthcare Workers in COVID-19 Pandemic,ATMP,Vaccine,500,2021-04-28,2021-04-28,https://clinicaltrials.gov/show/NCT04379336,No Results,No Results,No Results,2020-05-11,2020-05-12,None
1746,NCT04379453,ClinicalTrials.gov,2020-04-27,2020-04-27,False,Hospital Israelita Albert Einstein,Recruiting,Not Applicable,Interventional,Brazil,Robot Assisted Percutaneous Cardiovascular Intervention as a Strategy to Reduce or Risk of Intra-Procedure Contamination by COVID-19 and Other Respiratory Viruses,Procedure,Percutaneous Cardiovascular Intervention,10,2020-04-27,2020-04-27,https://clinicaltrials.gov/show/NCT04379453,No Results,No Results,No Results,2020-05-11,2020-05-12,None
1747,ISRCTN44152751,ISRCTN,2020-05-04,2020-05-11,False,Norwegian Institute of Public Health,Recruiting,Not Applicable,Interventional,Norway,School opening in Norway during the COVID-19 pandemic,Other,Other,116750,Not Available,2020-09-30,http://isrctn.com/ISRCTN44152751,No Results,No Results,No Results,2020-05-11,2020-05-12,None
1748,ChiCTR2000031752,ChiCTR,2020-04-09,2020-01-01,True,the First Affiliated Hospital of Nanjing Medical University,Not Recruiting,Not Applicable,Observational,China,A medical records based observational study for myocardial injury and cardiac function in critically ill patients with novel coronavirus pneumonia (COVID-19),Clinical Presentation,No Intervention,75,Not Available,2020-04-15,http://www.chictr.org.cn/showproj.aspx?proj=52135,No Results,No Results,No Results,2020-04-13,2020-04-15,None
1749,NCT04379271,ClinicalTrials.gov,2020-05-01,2020-05-01,False,Immunic AG,Not Recruiting,Phase 2/Phase 3,Interventional,No Country Given,"A Study to Evaluate the Efficacy, Safety and Tolerability of IMU-838 as Addition to Investigator's Choice of Standard of Care Therapy, in Patients With Coronavirus Disease 19 (COVID-19)",Drug,Vidofludimus calcium,600,2020-10-01,2020-10-01,https://clinicaltrials.gov/show/NCT04379271,No Results,No Results,No Results,2020-05-11,2020-05-12,None
1750,NCT04379297,ClinicalTrials.gov,2020-05-06,2020-04-10,True,Luxembourg Institute of Health,Not Recruiting,Not Applicable,Observational,Luxembourg,COvid-19 National Survey for Assessing VIral Spread by Nonaffected CarriErs (CON-VINCE),Clinical Presentation (Epidemiology),No Intervention,1800,2021-05-28,2021-12-31,https://clinicaltrials.gov/show/NCT04379297,No Results,No Results,No Results,2020-05-11,2020-05-12,None
1751,NCT04379544,ClinicalTrials.gov,2020-05-04,2020-04-23,True,University of Pennsylvania,Not Recruiting,Not Applicable,Observational,United States,Prognostic Value of Point of Care Cardiac and Lung Ultrasound in COVID-19,Prognosis,No Intervention,105,2020-12-01,2020-12-01,https://clinicaltrials.gov/show/NCT04379544,No Results,No Results,No Results,2020-05-11,2020-05-12,None
1752,NCT04379661,ClinicalTrials.gov,2020-05-05,2020-04-03,True,Columbia University,Recruiting,Not Applicable,Interventional,United States,SUNLIGHT Study: Online Support Groups for MS to Address COVID-19,Other,Other,52,2021-04-01,2021-04-01,https://clinicaltrials.gov/show/NCT04379661,No Results,No Results,No Results,2020-05-11,2020-05-12,None
1753,ISRCTN68026880,ISRCTN,2020-04-30,2020-01-01,True,Imperial College London,Recruiting,Not Applicable,Observational,"Canada, Japan, Uganda, Qatar, Russian Federation, Greece, Australia, Germany, Lebanon, Latvia, Malta, Czech Republic, Guatemala, Israel, Ireland, United Kingdom, Chile, Argentina, Tunisia, Belgium, Brazil, Bosnia and Herzegovina, Netherlands, Romania, Indonesia, Nigeria, Thailand, Hungary, Austria, South Africa, India, Peru, Spain, United States, Italy, Portugal, Mexico, Colombia, United Arab Emirates, Egypt, Estonia, Ecuador","A global registry of women affected by COVID-19 in pregnancy and their babies, to guide treatment and prevention",Clinical Presentation,No Intervention,1000,Not Available,2021-09-30,http://isrctn.com/ISRCTN68026880,No Results,No Results,No Results,2020-05-11,2020-05-05,None
1754,ChiCTR2000031751,ChiCTR,2020-04-08,2020-04-01,True,Wuhan Fourth Hospital,Recruiting,Not Applicable,Observational,China,Novel coronavirus pneumonia (COVID-2019) patients' prognosis and their influence on heart and lung function,Prognosis,No Intervention,60,Not Available,2022-04-01,http://www.chictr.org.cn/showproj.aspx?proj=52130,No Results,No Results,No Results,2020-04-13,2020-04-15,None
1755,NCT04380402,ClinicalTrials.gov,2020-05-01,2020-05-08,False,Mount Auburn Hospital,Not Recruiting,Phase 2,Interventional,No Country Given,Atorvastatin in COVID-19,Drug,Atorvastatin,300,2021-12-31,2022-05-08,https://clinicaltrials.gov/show/NCT04380402,No Results,No Results,No Results,2020-05-11,2020-05-12,None
1756,NCT04380519,ClinicalTrials.gov,2020-05-06,2020-04-23,True,"R-Pharm International, LLC",Recruiting,Phase 2/Phase 3,Interventional,Russian Federation,Study of the Efficacy and Safety of a Single Administration of Olokizumab and RPH-104 With Standard Therapy in Patients With Severe Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection (COVID-19),Drug,RPH -104 vs. Olokizumab,372,2020-10-15,2020-11-15,https://clinicaltrials.gov/show/NCT04380519,No Results,No Results,No Results,2020-05-11,2020-05-12,None
1757,NCT04379310,ClinicalTrials.gov,2020-05-04,2020-05-01,True,Nisantasi University,Recruiting,Not Applicable,Observational,Turkey,Evaluation of Clinical Parameters on Admission and Medications in Covid-19 Pneumonia (Corona Virus Disease 2019),Drug,"ACE Inhibitors, Calcium Channel Blockers",60,2020-05-05,2020-05-08,https://clinicaltrials.gov/show/NCT04379310,No Results,No Results,No Results,2020-05-11,2020-05-12,None
1758,NCT04379479,ClinicalTrials.gov,2020-05-01,2020-05-01,False,"National Polytechnic Institute, Mexico",Not Recruiting,Phase 2,Interventional,Mexico,Clinical Effect of Dialyzable Leukocyte Extract in Suspected or Confirmed Cases of COVID-19 (FUTURE-T),Drug,Dialyzable Leukocyte,562,2020-08-01,2020-12-01,https://clinicaltrials.gov/show/NCT04379479,No Results,No Results,No Results,2020-05-11,2020-05-12,None
1759,ISRCTN50189673,ISRCTN,2020-04-02,2020-03-19,True,University of Oxford,Recruiting,Phase 2/Phase 3,Interventional,United Kingdom,A randomised trial of treatments to prevent death in patients hospitalised with COVID-19 (coronavirus),Drug,lopinavir/ritonavir vs. interferon beta vs. dexamethasone vs. hydroxychloroquine,12000,Not Available,2021-06-30,http://isrctn.com/ISRCTN50189673,No Results,No Results,No Results,2020-05-11,2020-04-07,EUCTR2020-001113-21
1760,NCT04380727,ClinicalTrials.gov,2020-04-28,2020-03-20,True,CHU de Nancy,Not Recruiting,Not Applicable,Observational,France,Almitrine and COVID-19 Related Hypoxemia,Clinical Presentation,No Intervention,17,2020-04-14,2020-04-25,https://clinicaltrials.gov/show/NCT04380727,No Results,No Results,No Results,2020-05-11,2020-05-12,None
1761,NCT04380779,ClinicalTrials.gov,2020-05-07,2020-04-13,True,Manuel Monreal,Recruiting,Not Applicable,Observational,Spain,Prevalence of Severe Bleeding in COVID-19 Patients Treated With Higher Than Recommended Thromboprophylaxis Doses,Clinical Presentation,No Intervention,5000,2025-04-13,2025-06-13,https://clinicaltrials.gov/show/NCT04380779,No Results,No Results,No Results,2020-05-11,2020-05-12,None
1762,NCT04379492,ClinicalTrials.gov,2020-05-05,2020-05-05,False,Memorial Sloan Kettering Cancer Center,Recruiting,Phase 2,Interventional,United States,A Study of Hydroxycholoroquine Compared to Placebo as Treatment for People With COVID-19,Drug,Hydroxychloroquine,120,2021-05-01,2021-05-01,https://clinicaltrials.gov/show/NCT04379492,No Results,No Results,No Results,2020-05-11,2020-05-12,None
1763,NCT04379518,ClinicalTrials.gov,2020-05-06,2020-05-30,False,Roswell Park Cancer Institute,Not Recruiting,Phase 1/Phase 2,Interventional,United States,Rintatolimod and IFN Alpha-2b for the Treatment of Mild or Moderate COVID-19 Infection in Cancer Patients,Drug,Interferon alfa + Rintatolimod,80,2021-04-06,2021-04-30,https://clinicaltrials.gov/show/NCT04379518,No Results,No Results,No Results,2020-05-11,2020-05-12,None
1764,NL8536,Netherlands Trial Register,2020-04-15,2020-04-28,False,Zuyderland Medical Centre,Recruiting,Not Applicable,Observational,Netherlands,Neurological Manifestations of COVID-19 and Indications of an Association with Respiratory Failure,Clinical Presentation,No Intervention,285,Not Available,2020-07-31,https://trialregister.nl/trial/8536,No Results,No Results,No Results,2020-05-11,2020-04-29,None
1765,ChiCTR2000031707,ChiCTR,2020-04-07,2020-03-01,True,Shanghai Oriental Hospital,Recruiting,Not Applicable,Observational,China,Study for sleep quality of medical teams members moved to Hubei for the fighting of novel coronavirus pneumonia (COVID-19) pandemic,Other (psych),No Intervention,47,Not Available,2020-04-30,http://www.chictr.org.cn/showproj.aspx?proj=52079,No Results,No Results,No Results,2020-04-13,2020-04-15,None
1766,NCT04380870,ClinicalTrials.gov,2020-05-05,2020-04-11,True,Center for Integrated Care,Recruiting,Not Applicable,Observational,United States,Describing Chinese Herbal Medicine Telehealth Care for Symptoms Related to Infectious Diseases Such as COVID-19,Traditional Medicine (other),Traditional Medicine,500,2021-04-11,2025-04-11,https://clinicaltrials.gov/show/NCT04380870,No Results,No Results,No Results,2020-05-11,2020-05-12,None
1767,NCT04380961,ClinicalTrials.gov,2020-05-07,2020-04-24,True,Janssen Pharmaceutica,Recruiting,Phase 2,Interventional,United States,A Study to Evaluate the Efficacy and Safety of Sirukumab in Confirmed Severe or Critical Confirmed Coronavirus Disease (COVID)-19,Drug,Sirukumab,270,2020-06-25,2020-09-16,https://clinicaltrials.gov/show/NCT04380961,No Results,No Results,No Results,2020-05-11,2020-05-12,None
1768,NL8522,Netherlands Trial Register,2020-04-12,2020-04-08,True,No Sponsor Name Given,Recruiting,Not Applicable,Observational,Netherlands,The Digital Doc in the Emergency Department: The solution for patient care in the Covid-19 pandemic?,Telehealth,Telehealth,50,Not Available,2020-09-01,https://trialregister.nl/trial/8522,No Results,No Results,No Results,2020-05-11,2020-04-29,None
1769,NCT04380376,ClinicalTrials.gov,2020-05-06,2020-04-30,True,"Federal State Budgetary Institution, Pulmonology Scientific Research Institute",Recruiting,Phase 2,Interventional,Russian Federation,Low-doses Melphalan Inhalation in Patients With COVID-19 (CoronavIrus Disease 2019) Pneumonia,Drug,Melphalan,60,2020-10-30,2020-10-30,https://clinicaltrials.gov/show/NCT04380376,No Results,No Results,No Results,2020-05-11,2020-05-12,None
1770,NCT04380792,ClinicalTrials.gov,2020-05-07,2020-04-13,True,Manuel Monreal,Recruiting,Not Applicable,Observational,Spain,Prevalence of DVT or PE in Patients Infected With COVID-19 Admitted to Hospital,Clinical Presentation,No Intervention,5000,2025-04-13,2025-06-30,https://clinicaltrials.gov/show/NCT04380792,No Results,No Results,No Results,2020-05-11,2020-05-12,None
1771,ChiCTR2000031672,ChiCTR,2020-04-06,2020-04-01,True,Beijing University of Chinese Medicine,Not Recruiting,Not Applicable,Interventional,China,Development and application of TCM body regulating protection scheme for the convalescent population of novel coronavirus pneumonia (COVID-19),Traditional Medicine (Drug),Traditional Medicine,150,Not Available,2020-12-31,http://www.chictr.org.cn/showproj.aspx?proj=51940,No Results,No Results,No Results,2020-04-13,2020-04-15,None
1772,NCT04380987,ClinicalTrials.gov,2020-04-30,2020-05-04,False,Luxembourg Institute of Health,Recruiting,Not Applicable,Observational,Luxembourg,Luxembourg Cohort of Positive Patients for COVID-19: a Stratification Study to Predict Patient Prognosis,Clinical Presentation,No Intervention,200,2021-07-31,2021-12-31,https://clinicaltrials.gov/show/NCT04380987,No Results,No Results,No Results,2020-05-11,2020-05-12,None
1773,NCT04381052,ClinicalTrials.gov,2020-05-06,2020-05-01,True,Columbia University,Not Recruiting,Phase 2,Interventional,United States,Study for the Use of the IL-6 Inhibitor Clazakizumab in Patients With Life-threatening COVID-19 Infection,Drug,Clazakizumab,30,2020-08-01,2020-08-01,https://clinicaltrials.gov/show/NCT04381052,No Results,No Results,No Results,2020-05-11,2020-05-12,None
1774,NL8528,Netherlands Trial Register,2020-04-15,2020-04-22,False,UMC Utrecht,Not Recruiting,Not Applicable,Observational,Netherlands,Control of COVID-19 in hospitals,Clinical Presentation (Epidemiology),No Intervention,2000,Not Available,2020-08-31,https://trialregister.nl/trial/8528,No Results,No Results,No Results,2020-05-11,2020-04-29,None
1775,NCT04381286,ClinicalTrials.gov,2020-04-23,2019-04-01,True,"University Hospital, Montpellier",Recruiting,Not Applicable,Observational,France,Transpulmonary Driving Pressure in ARDS COVID19 Patients,Clinical Presentation,No Intervention,40,2021-04-01,2021-12-31,https://clinicaltrials.gov/show/NCT04381286,No Results,No Results,No Results,2020-05-11,2020-05-12,None
1776,NCT04381312,ClinicalTrials.gov,2020-04-10,2020-04-09,True,"University Hospital, Grenoble",Recruiting,Not Applicable,Observational,France,Direct and Indirect Impact of COVID-19 In Older Populations,Clinical Presentation,No Intervention,1000,2021-07-09,2021-10-09,https://clinicaltrials.gov/show/NCT04381312,No Results,No Results,No Results,2020-05-11,2020-05-12,None
1777,NL8529,Netherlands Trial Register,2020-04-14,2020-05-01,False,MCC Omnes (Sittard),Not Recruiting,Not Applicable,Observational,Netherlands,General practice cooperative COVID-19 centre Urmond,Health System,No Intervention,2000,Not Available,2022-01-03,https://trialregister.nl/trial/8529,No Results,No Results,No Results,2020-05-11,2020-04-29,None
1778,NCT04380818,ClinicalTrials.gov,2020-05-04,2020-05-08,False,Grupo de Investigacin Clnica en Oncologa Radioterapia,Recruiting,Not Applicable,Interventional,Spain,Low Dose Anti-inflammatory Radiotherapy for the Treatment of Pneumonia by COVID-19,Other (+ Drug),"Radiation with or without hydroxychloroquine, lopinavir/ritonavir, azithromycin, cortocosteroids, heparin, oxygen",106,2021-05-04,2021-07-01,https://clinicaltrials.gov/show/NCT04380818,No Results,No Results,No Results,2020-05-11,2020-05-12,None
1779,NCT04381000,ClinicalTrials.gov,2020-05-07,2020-04-01,True,Clinical Exercise Physiology and Rehabilitation Reasearch Laboratory,Recruiting,Not Applicable,Interventional,Greece,Quarantine and Telerehabilitation in Chronic Pain Patients During COVID-19 Pandemic.,Telehealth,Rehabilitation,170,2020-05-20,2020-06-30,https://clinicaltrials.gov/show/NCT04381000,No Results,No Results,No Results,2020-05-11,2020-05-12,None
1780,ChiCTR2000032768,ChiCTR,2020-05-09,2020-01-01,True,"The Third Xiangya Hospital, Central South University",Not Recruiting,Not Applicable,Observational,China,Correlation between novel coronavirus pneumonia (COVID-19) and mental health of breast cancer patients: a cross-sectional study in Hunan Province,Other (psych),No Intervention,309,Not Available,2021-02-28,http://www.chictr.org.cn/showproj.aspx?proj=53460,No Results,No Results,No Results,2020-05-11,2020-05-12,None
1781,NL8572,Netherlands Trial Register,2020-04-30,2020-04-19,True,University Medical Center Groningen,Recruiting,Not Applicable,Observational,Netherlands,Prevalence of asymptomatic deep vein thrombosis in admitted COVID-19 patients,Clinical Presentation,No Intervention,100,Not Available,2021-04-19,https://trialregister.nl/trial/8572,No Results,No Results,No Results,2020-05-11,2020-05-05,None
1782,ChiCTR2000032743,ChiCTR,2020-05-09,2020-03-16,True,The First Affiliated Hospital of Dalian Medical University,Not Recruiting,Not Applicable,Observational,China,The effectiveness of diaphragmatic breathing relaxation training for improving sleep quality among nursing staff during the novel coronavirus pneumonia (COVID-19) pandemic: a before and after study,Other,Other,151,Not Available,2020-04-16,http://www.chictr.org.cn/showproj.aspx?proj=53431,No Results,No Results,No Results,2020-05-11,2020-05-12,None
1783,NL8543,Netherlands Trial Register,2020-04-18,2020-04-14,True,No Sponsor Name Given,Recruiting,Not Applicable,Observational,Netherlands,COVID19 ultrasound triage,Diagnostics,Diagnostic Test or Assessment,50,Not Available,2020-06-01,https://trialregister.nl/trial/8543,No Results,No Results,No Results,2020-05-11,2020-04-29,None
1784,NCT04381013,ClinicalTrials.gov,2020-05-07,2020-05-01,True,Stanford University,Not Recruiting,Not Applicable,Interventional,United States,Emergency Ventilator Splitting Between Two or More Patients (COVID-19),Other (device),Other,4,2020-06-01,2020-06-01,https://clinicaltrials.gov/show/NCT04381013,No Results,No Results,No Results,2020-05-11,2020-05-12,None
1785,ACTRN12620000524998,ANZCTR,2020-04-28,2020-04-28,False,South Eastern Sydney Local Health District,Not Recruiting,Not Applicable,Interventional,Australia,Evaluation of a remote monitoring smartphone application and care model of COVID-19 patients in the community  (ReCOVER),Other (software),eHealth,2000,Not Available,2021-04-30,https://anzctr.org.au/ACTRN12620000524998.aspx,No Results,No Results,No Results,2020-05-11,2020-05-05,None
1786,ChiCTR2000032716,ChiCTR,2020-05-08,2020-02-05,True,"Ruijin Hospital, Shanghai Jiao Tong University School of Medicine",Not Recruiting,Not Applicable,Interventional,China,High dose intravenous vitamin C might be used as an important rescue therapy for aggravation of severe and critical novel coronavirus pneumonia (COVID-19) patients,Drug,Vitamin C,12,Not Available,2020-04-30,http://www.chictr.org.cn/showproj.aspx?proj=53389,No Results,No Results,No Results,2020-05-11,2020-05-12,None
1787,ChiCTR2000030750,ChiCTR,2020-03-13,2020-03-01,True,Shenzhen Third People's Hospital,Not Recruiting,Phase 1/Phase 2,Interventional,China,A clinical study for effectiveness and safety evaluation for recombinant chimeric COVID-19 epitope DC vaccine in the treatment of novel coronavirus pneumonia,ATMP,Vaccine,120,Not Available,Not Available,http://www.chictr.org.cn/showproj.aspx?proj=50928,No Results,No Results,No Results,2020-04-13,2020-03-18,None
1788,NL8485,Netherlands Trial Register,2020-03-27,2020-03-27,False,Mxima MC,Recruiting,Not Applicable,Observational,Netherlands,COVID-19 during pregnancy: a prospective observational cohort,Clinical Presentation,No Intervention,20,Not Available,2020-12-31,https://trialregister.nl/trial/8485,No Results,No Results,No Results,2020-05-11,2020-04-07,None
1789,ACTRN12620000554965,ANZCTR,2020-05-11,2020-05-14,False,St. Vincent's Health Network,Not Recruiting,Not Applicable,Observational,Australia,"ADAPT - COVID-19 Study - A prospective, observational cohort study at St Vincents Hospital Sydney",Clinical Presentation,No Intervention,300,Not Available,2022-05-31,https://anzctr.org.au/ACTRN12620000554965.aspx,No Results,No Results,No Results,2020-05-11,2020-05-12,None
1790,ISRCTN87832712,ISRCTN,2020-05-05,2020-05-10,False,University of Ferrara,Recruiting,Not Applicable,Observational,Italy,Investigating the microorganisms found in the mouths of SARS-Cov-2 positive patients,Clinical Presentation,No Intervention,20,Not Available,2020-10-01,http://isrctn.com/ISRCTN87832712,No Results,No Results,No Results,2020-05-11,2020-05-12,None
1791,DRKS00021439,German Clinical Trials Register,2020-04-20,2020-04-20,False,"University Hospital, Freiburg",Recruiting,Not Applicable,Observational,Germany,COVID-19 associated brainstem encephalitis - is SARS-CoV-2 a neurotropic agent?,Clinical Presentation,No Intervention,70,Not Available,Not Available,http://www.drks.de/DRKS00021439,No Results,No Results,No Results,2020-05-11,2020-05-05,None
1792,ISRCTN20867558,ISRCTN,2020-05-04,2020-05-01,True,University of Southampton,Recruiting,Not Applicable,Observational,United Kingdom,Survive and Thrive: exploring the wellbeing of doctors in a post-COVID-19 era,Other (psych),No Intervention,350,Not Available,2021-12-31,http://isrctn.com/ISRCTN20867558,No Results,No Results,No Results,2020-05-11,2020-05-12,None
1793,ISRCTN28342533,ISRCTN,2020-05-04,2020-03-26,True,Sheffield Teaching Hospitals NHS Foundation Trust,Recruiting,Not Applicable,Observational,United Kingdom,Evaluation of COVID-19 assessment in emergency departments and ambulance services,Clinical Presentation,No Intervention,20000,Not Available,2020-07-31,http://isrctn.com/ISRCTN28342533,No Results,No Results,No Results,2020-05-11,2020-05-12,None
1794,ISRCTN97041334,ISRCTN,2020-05-04,2020-03-23,True,"University College, London",Recruiting,Not Applicable,Observational,United Kingdom,COVID-19 social study: the effects of quarantine on mental health,Other (psych),No Intervention,1000000,Not Available,2020-12-31,http://isrctn.com/ISRCTN97041334,No Results,No Results,No Results,2020-05-11,2020-05-12,None
1795,DRKS00021416,German Clinical Trials Register,2020-04-30,2020-04-29,True,Klinik for Ophthalmologie,Recruiting,Not Applicable,Observational,Germany,SARS-CoV-2 in tears in patients with COVID-19,Clinical Presentation,No Intervention,30,Not Available,Not Available,http://www.drks.de/DRKS00021416,No Results,No Results,No Results,2020-05-11,2020-05-05,None
1796,NL8580,Netherlands Trial Register,2020-04-28,2020-04-28,False,No Sponsor Name Given,Recruiting,Not Applicable,Unknown,Netherlands,Metabolic syndrome And Severity of Covid-19,Clinical Presentation,No Intervention,100,Not Available,2020-06-01,https://trialregister.nl/trial/8580,No Results,No Results,No Results,2020-05-11,2020-05-12,None
1797,ISRCTN10666798,ISRCTN,2020-04-23,2020-03-18,True,North Bristol NHS Trust,Recruiting,Not Applicable,Observational,"Ireland, United Kingdom",The COVID-19 Emergency Response Assessment Study: a survey of the psychological health of frontline doctors in the UK and Ireland during the coronavirus pandemic,Other (psych),No Intervention,6000,Not Available,2020-10-01,http://isrctn.com/ISRCTN10666798,No Results,No Results,No Results,2020-05-11,2020-04-29,None
1798,NL8547,Netherlands Trial Register,2020-04-22,2020-04-16,True,Radboud University Medical Centre,Recruiting,Not Applicable,Interventional,Netherlands,"REDUCING HOSPITAL ADMISSION OF ELDERLY IN SARS-CoV-2 PANDEMIC VIA THE INDUCTION OF TRAINED IMMUNITY BY BACILLUS CALMETTE-GURIN VACCINATION, A RANDOMIZED CONTROLLED TRIAL",ATMP,Vaccine,1600,Not Available,2022-04-18,https://trialregister.nl/trial/8547,No Results,No Results,No Results,2020-05-11,2020-04-29,EUCTR2020-001591-15
1799,NL8512,Netherlands Trial Register,2020-04-02,2020-03-18,True,No Sponsor Name Given,Recruiting,Not Applicable,Observational,Netherlands,"The use of ACE2 receptor increasing medication at hospital admission and
mortality rates in COVID-19 patints 
",Drug,ACE inhibitors,400,Not Available,2020-09-18,https://trialregister.nl/trial/8512,No Results,No Results,No Results,2020-05-11,2020-04-15,None
1800,DRKS00021521,German Clinical Trials Register,2020-04-22,2020-04-22,False,Zentrum fr Infektionskrankheiten,Recruiting,Not Applicable,Observational,Germany,Prevalence of COVID-19 in children aged 1-10 years in Baden-Wrttemberg,Clinical Presentation (Epidemiology),No Intervention,2000,Not Available,Not Available,http://www.drks.de/DRKS00021521,No Results,No Results,No Results,2020-05-11,2020-05-05,None
1801,NL8526,Netherlands Trial Register,2020-04-14,2020-04-26,False,Zuyderland Medical Centre,Not Recruiting,Not Applicable,Observational,Netherlands,Neuroinvasion in COVID-19,Clinical Presentation,No Intervention,10,Not Available,2020-06-26,https://trialregister.nl/trial/8526,No Results,No Results,No Results,2020-05-11,2020-04-29,None
1802,NL8551,Netherlands Trial Register,2020-04-23,2020-04-23,False,Zuyderland Medical Centre,Recruiting,Not Applicable,Observational,Netherlands,Covid High-intensity Immunosuppression in Cytokine release syndrome,Drug,Corticosteroids + Tocilizumab,160,Not Available,2020-07-31,https://trialregister.nl/trial/8551,No Results,No Results,No Results,2020-05-11,2020-04-29,None
1803,DRKS00021573,German Clinical Trials Register,2020-04-27,2020-04-30,False,"University Hospital, Heidelberg",Recruiting,Phase 1,Interventional,Germany,"Impact of pantoprazole on absorption and disposition of hydroxychloroquine, a drug used in Covid-19",Drug,Proton pump inhibitor + Hydoxychloroquine + Midazolam + Yohimbine vs. Hydoxychloroquine + Midazolam + Yohimbine,24,Not Available,Not Available,http://www.drks.de/DRKS00021573,No Results,No Results,No Results,2020-05-11,2020-05-05,None
1804,DRKS00021443,German Clinical Trials Register,2020-04-28,2020-04-23,True,University of Oldenburg,Recruiting,Not Applicable,Observational,Germany,Feasibility and usability of video-based physical therapy for older people in the context of the COVID-19 pandemic,Other (physio),Physio,30,Not Available,Not Available,http://www.drks.de/DRKS00021443,No Results,No Results,No Results,2020-05-11,2020-05-05,None
1805,NL8563,Netherlands Trial Register,2020-04-22,2020-04-22,False,No Sponsor Name Given,Recruiting,Not Applicable,Observational,Netherlands,Patients knowledge And behavior oN the COVID-19 disease and as DEterMInants of Contamination,Other,No Intervention,170,Not Available,2020-08-21,https://trialregister.nl/trial/8563,No Results,No Results,No Results,2020-05-11,2020-05-05,None
1806,DRKS00021575,German Clinical Trials Register,2020-04-29,2020-05-03,False,"University Hospital, Halle (Saale)",Not Recruiting,Not Applicable,Observational,Germany,Covid-19 HOspitalized patients RegisTry,Clinical Presentation,No Intervention,750,Not Available,Not Available,http://www.drks.de/DRKS00021575,No Results,No Results,No Results,2020-05-11,2020-05-05,None
1807,NL8521,Netherlands Trial Register,2020-04-13,2020-05-08,False,UMC Amsterdam,Not Recruiting,Not Applicable,Interventional,Netherlands,Continuous positive airway pressure in severe Covid-19 pneumonia,Drug,Oxygen,13,Not Available,2020-07-18,https://trialregister.nl/trial/8521,No Results,No Results,No Results,2020-05-11,2020-04-22,None
1808,DRKS00021395,German Clinical Trials Register,2020-04-17,2020-04-20,False,"University Hospital, Freiburg",Not Recruiting,Not Applicable,Observational,Germany,The effects of the COVID-19 pandemic on mental health,Other (psych),No Intervention,60,Not Available,Not Available,http://www.drks.de/DRKS00021395,No Results,No Results,No Results,2020-05-11,2020-04-22,None
1809,DRKS00021537,German Clinical Trials Register,2020-04-30,2020-04-17,True,Stuttgart Hospital,Recruiting,Not Applicable,Observational,Germany,Long term Analysis and Evaluation of morphologic and clinical Parameters in COVID-19 Patients: prospective development of a practical risk score,Clinical Presentation,No Intervention,150,Not Available,Not Available,http://www.drks.de/DRKS00021537,No Results,No Results,No Results,2020-05-11,2020-05-05,None
1810,DRKS00021523,German Clinical Trials Register,2020-04-27,2020-04-28,False,"University Hospital, Freiburg",Recruiting,Not Applicable,Observational,Germany,The influence of proton pump inhibitor therapy on the clinical course of COVID-19,Drug,Proton pump inhibitor,200,Not Available,Not Available,http://www.drks.de/DRKS00021523,No Results,No Results,No Results,2020-05-11,2020-05-05,None
1811,NL8538,Netherlands Trial Register,2020-04-17,2020-04-17,False,No Sponsor Name Given,Not Recruiting,Not Applicable,Interventional,Netherlands,Sleep position related to hospital length of stay in admitted COVID-19 patients,Procedure,Positioning,342,Not Available,2021-04-17,https://trialregister.nl/trial/8538,No Results,No Results,No Results,2020-05-11,2020-04-29,None
1812,DRKS00021591,German Clinical Trials Register,2020-04-27,2020-05-03,False,Bundeswehrkrankenhaus Berlin,Not Recruiting,Not Applicable,Observational,Germany,Identification of predictive biomarkers for severe progression of COVID-19,Clinical Presentation,No Intervention,100,Not Available,Not Available,http://www.drks.de/DRKS00021591,No Results,No Results,No Results,2020-05-11,2020-05-05,None
1813,DRKS00021506,German Clinical Trials Register,2020-04-22,2020-03-18,True,"University Hospital Carl Gustav Carus, Dresden",Recruiting,Not Applicable,Observational,Germany,Registry of hospitalized pediatric Patients mit SARS-CoV-2 infection (COVID-19),Clinical Presentation,No Intervention,1000,Not Available,Not Available,http://www.drks.de/DRKS00021506,No Results,No Results,No Results,2020-05-11,2020-05-05,None
1814,NCT04288102,ClinicalTrials.gov,2020-02-24,2020-03-05,False,Beijing 302 Hospital,Recruiting,Phase 2,Interventional,China,Treatment With Mesenchymal Stem Cells for Severe Corona Virus Disease 2019(COVID-19),ATMP,Cells (mesenchymal),90,2020-07-15,2020-07-31,https://clinicaltrials.gov/show/NCT04288102,No Results,No Results,No Results,2020-04-20,2020-08-03,None
1815,NL8490,Netherlands Trial Register,2020-03-31,2020-04-12,False,UMC Utrecht,Not Recruiting,Not Applicable,Interventional,Netherlands,"An open label randomized controlled trial of chloroquine, hydroxychloroquine or only supportive care in patients admitted with moderate to severe COVID-19
",Drug,Chloroquine vs. hydroxychloroquine,950,Not Available,2021-04-12,https://trialregister.nl/trial/8490,No Results,No Results,No Results,2020-05-11,2020-04-07,None
1816,DRKS00021214,German Clinical Trials Register,2020-04-01,2020-04-06,False,"University Hospital, Schleswig-Holstein",Not Recruiting,Not Applicable,Interventional,Germany,Improvement of the nutritional status regarding nicotinamide (vitamin B3) and the course of COVID-19 disease,Drug,Vitamin B3,1300,Not Available,Not Available,http://www.drks.de/DRKS00021214,No Results,No Results,No Results,2020-05-11,2020-04-22,None
1817,DRKS00021588,German Clinical Trials Register,2020-05-04,2020-05-06,False,University of Erlangen-Nuremberg,Not Recruiting,Not Applicable,Interventional,Germany,Naturalistic evaluation of an Internet-based psychological training program for mental strain associated with the coronavirus / COVID-19 pandemic,Other (psych),Psychological,1000,Not Available,Not Available,http://www.drks.de/DRKS00021588,No Results,No Results,No Results,2020-05-11,2020-05-12,None
1818,NL8498,Netherlands Trial Register,2020-03-31,2020-03-15,True,Radboud University Medical Centre,Recruiting,Not Applicable,Observational,Netherlands,Lung ultrasound (LUS) as a tool to determine the clinical course in COVID-19 patients,Clinical Presentation,No Intervention,20,Not Available,2020-05-31,https://trialregister.nl/trial/8498,No Results,No Results,No Results,2020-05-11,2020-04-15,None
1819,DRKS00021206,German Clinical Trials Register,2020-03-30,2020-03-26,True,Universitts-Herzzentrum Freiburg Bad Krozingen,Recruiting,Not Applicable,Observational,Germany,COVID-19 Registry Freiburg,Clinical Presentation,No Intervention,400,Not Available,Not Available,http://www.drks.de/DRKS00021206,No Results,No Results,No Results,2020-05-11,2020-04-22,None
1820,DRKS00021226,German Clinical Trials Register,2020-05-04,2020-05-07,False,"University Hospital, Heidelberg",Not Recruiting,Not Applicable,Observational,Germany,"PROTEGO: PRospective Observational cohort Trial Evaluating correlation of clinical findings, symptoms and disease development of German in- or Outpatients infected with SARS-CoV-2 - a CHIR-Net Student-Initiated German Medical Audit trial COVID-19 study (CHIR-Net SIGMA study group)",Clinical Presentation,No Intervention,500,Not Available,Not Available,http://www.drks.de/DRKS00021226,No Results,No Results,No Results,2020-05-11,2020-05-12,None
1821,DRKS00021447,German Clinical Trials Register,2020-04-27,2020-05-01,False,Charit University,Not Recruiting,Phase 2,Interventional,Germany,CytoResc - CytoSorb Rescue for COVID-19 Cytokine Storm,Other (device),Cytokine Adsorber,100,Not Available,Not Available,http://www.drks.de/DRKS00021447,No Results,No Results,No Results,2020-05-11,2020-05-05,None
1822,DRKS00021208,German Clinical Trials Register,2020-03-31,2020-04-03,False,Vorstand der Deutschen Gesellschaft for Perinatale Medizin (DGPM),Recruiting,Not Applicable,Observational,Germany,COVID-19 related obstetric and neonatal outcome study (CRONOS),Clinical Presentation,No Intervention,100,Not Available,Not Available,http://www.drks.de/DRKS00021208,No Results,No Results,No Results,2020-05-11,2020-04-22,None
1823,DRKS00021161,German Clinical Trials Register,2020-04-07,2020-02-15,True,Abteilung fr Krankenhaushygiene,Recruiting,Not Applicable,Observational,Germany,Demographic and epidemiological characteristics of Covid-19 disease in Helios-Hospital and determinants of clinical course,Clinical Presentation (Epidemiology),No Intervention,1000,Not Available,Not Available,http://www.drks.de/DRKS00021161,No Results,No Results,No Results,2020-05-11,2020-04-22,None
1824,DRKS00021516,German Clinical Trials Register,2020-04-22,2020-04-22,False,Kantonsspital Aarau,Recruiting,Not Applicable,Observational,Switzerland,Dysosmia and Dysgeusia in COVID-19 patients,Clinical Presentation,No Intervention,100,Not Available,Not Available,http://www.drks.de/DRKS00021516,No Results,No Results,No Results,2020-05-11,2020-05-05,None
1825,DRKS00021231,German Clinical Trials Register,2020-04-02,2020-04-03,False,Paracelsus Medical University ,Recruiting,Not Applicable,Observational,"Germany, Austria",Accompanying monitoring of primary care in GP practices during the COVID-19 pandemic,Health System,No Intervention,2000,Not Available,Not Available,http://www.drks.de/DRKS00021231,No Results,No Results,No Results,2020-05-11,2020-04-22,None
1826,NCT04290780,ClinicalTrials.gov,2020-02-27,2020-03-09,False,Hospices Civils de Lyon,Recruiting,Not Applicable,Observational,France,COVID-19 - Multicenter Study on Nosocomial Transmission of SARS-CoV-2 Virus,Clinical Presentation,No Intervention,300,2020-10-10,2020-10-30,https://clinicaltrials.gov/show/NCT04290780,No Results,No Results,No Results,2020-04-20,2020-03-18,None
1827,NCT04302766,ClinicalTrials.gov,2020-03-02,2020-04-01,False,U.S. Army Medical Research and Development Command,Not Recruiting,Phase 1,Expanded Access,No Country Given,Expanded Access Remdesivir (RDV; GS-5734),Drug,Remdesivir,Not Available,Not Available,Not Available,https://clinicaltrials.gov/show/NCT04302766,No Results,No Results,No Results,2020-04-20,2020-03-18,None
1828,DRKS00021145,German Clinical Trials Register,2020-04-08,2020-03-16,True,Deutsches Zentrum fr Infektionsforschung (DZIF) e. V.,Recruiting,Not Applicable,Observational,"Belgium, France, Italy, Portugal, Switzerland, Ireland, United Kingdom, Austria, Germany, Iceland, Spain","Lean European Open Survey on 
SARS-CoV-2 (COVID-19)",Clinical Presentation,No Intervention,20000,Not Available,Not Available,http://www.drks.de/DRKS00021145,No Results,No Results,No Results,2020-05-11,2020-04-22,None
1829,DRKS00021297,German Clinical Trials Register,2020-05-04,2020-04-06,True,Nierenzentrum Heidelberg e.V.,Recruiting,Not Applicable,Observational,Germany,Clinical and immunological predictors of SARS-CoV-2 infection and Covid-19 diseases in patients with renal diseases and healthy persons,Clinical Presentation,No Intervention,100,Not Available,Not Available,http://www.drks.de/DRKS00021297,No Results,No Results,No Results,2020-05-11,2020-05-12,None
1830,DRKS00021527,German Clinical Trials Register,2020-04-24,2020-04-14,True,"University Hospital, Leipzig",Not Recruiting,Not Applicable,Interventional,Germany,Evaluation of online support during the coronavirus (COVID-19) pandemic: a group chat program in the psychiatric outpatient clinic of the Leipzig University Hospital,Other (psych),Psychological,100,Not Available,Not Available,http://www.drks.de/DRKS00021527,No Results,No Results,No Results,2020-05-11,2020-05-05,None
1831,NCT04319315,ClinicalTrials.gov,2020-03-16,2020-03-11,True,Assiut University,Recruiting,Not Applicable,Observational,Egypt,Social Media Effect on Knowledge Dissemination During COVID-19 Virus Outbreak,Other,No Intervention,400,2020-04-01,2020-04-16,https://clinicaltrials.gov/show/NCT04319315,No Results,No Results,No Results,2020-04-20,2020-04-01,None
1832,NCT04321265,ClinicalTrials.gov,2020-03-19,2020-03-19,False,Heinrich-Heine University,Recruiting,Not Applicable,Observational,"Germany, France, Denmark, Norway",Outcomes and Prognostic Factors in COVID-19,Prognosis,No Intervention,4000,2020-09-01,2020-12-01,https://clinicaltrials.gov/show/NCT04321265,No Results,No Results,No Results,2020-04-20,2020-04-01,None
1833,DRKS00021152,German Clinical Trials Register,2020-04-07,2020-04-05,True,Medizinische Hochschule Hannover,Not Recruiting,Not Applicable,Observational,Germany,COVID-19 Contact Study - Immunoreaction after possible SARS-CoV-2 / COVID-19 contact,Clinical Presentation (Epidemiology),No Intervention,1000,Not Available,Not Available,http://www.drks.de/DRKS00021152,No Results,No Results,No Results,2020-05-11,2020-04-22,None
1834,DRKS00021514,German Clinical Trials Register,2020-04-24,2020-04-26,False,Forschung in der Operativen Medizin (IFOM),Not Recruiting,Not Applicable,Observational,Germany,Database for diagnosis and therapy of COVID-19 infected patients,Clinical Presentation,No Intervention,150,Not Available,Not Available,http://www.drks.de/DRKS00021514,No Results,No Results,No Results,2020-05-11,2020-05-05,None
1835,DRKS00021268,German Clinical Trials Register,2020-04-09,2020-04-20,False,"University Hospital, Erlangen",Not Recruiting,Not Applicable,Observational,Germany,VOICE: Online-Survey on distress and mental resources of medical health care workers during Covid-19-pandemic,Other (psych),No Intervention,2000,Not Available,Not Available,http://www.drks.de/DRKS00021268,No Results,No Results,No Results,2020-05-11,2020-04-22,None
1836,NCT04322773,ClinicalTrials.gov,2020-03-24,2020-04-05,False,Marius Henriksen,Recruiting,Phase 2,Interventional,Denmark,Anti-il6 Treatment of Serious COVID-19 Disease With Threatening Respiratory Failure,Drug,Tocilizumab vs. sarilumab,200,2021-06-01,2021-06-01,https://clinicaltrials.gov/show/NCT04322773,No Results,No Results,No Results,2020-04-20,2020-04-01,None
1837,NCT04324684,ClinicalTrials.gov,2020-03-25,2020-03-31,False,Catholic University of the Sacred Heart,Recruiting,Not Applicable,Observational,Italy,Prognostic Factors Keeping Track for Covid-19 Pneumonia,Prognosis,No Intervention,198,2020-05-07,2020-05-07,https://clinicaltrials.gov/show/NCT04324684,No Results,No Results,No Results,2020-04-20,2020-04-15,None
1838,DRKS00021306,German Clinical Trials Register,2020-04-14,2020-03-31,True,University Hospital Bonn,Recruiting,Not Applicable,Observational,Germany,Covid-19 Case-Cluster-Study,Clinical Presentation (Epidemiology),No Intervention,1400,Not Available,Not Available,http://www.drks.de/DRKS00021306,No Results,No Results,No Results,2020-05-11,2020-04-22,None
1839,DRKS00021273,German Clinical Trials Register,2020-04-20,2020-04-25,False,Goethe University Frankfurt,Recruiting,Not Applicable,Interventional,"France, Brazil, Singapore, Italy, Chile, Austria, Germany, Argentina, Spain",Effects of digital home exercise programs on physical and mental well-being during the COVID-19 pandemic: a multi-center trial,Other (exercise),Exercise,544,Not Available,Not Available,http://www.drks.de/DRKS00021273,No Results,No Results,No Results,2020-05-11,2020-05-05,None
1840,DRKS00021581,German Clinical Trials Register,2020-04-27,2020-04-27,False,Klinikum der Universitt Mnchen,Recruiting,Not Applicable,Observational,Germany,Alterations in  inflammatory and coagulation variables in COVID-19 patients,Clinical Presentation,No Intervention,100,Not Available,Not Available,http://www.drks.de/DRKS00021581,No Results,No Results,No Results,2020-05-11,2020-05-05,None
1841,NCT04325893,ClinicalTrials.gov,2020-03-25,2020-04-01,False,"University Hospital, Angers",Recruiting,Phase 3,Interventional,"France, Monaco",Hydroxychloroquine Versus Placebo in COVID-19 Patients at Risk for Severe Disease,Drug,Hydroxychloroquine,1300,2020-09-01,2020-09-01,https://clinicaltrials.gov/show/NCT04325893,No Results,No Results,No Results,2020-04-20,2020-04-07,None
1842,NCT04330300,ClinicalTrials.gov,2020-03-30,2020-03-30,False,"National University of Ireland, Galway",Recruiting,Phase 4,Interventional,Ireland,Coronavirus (COVID-19) ACEi/ARB Investigation,Drug,ACE inhibitors or ARBs vs. Calcium Channel Blockers or Thiazide/Thiazide-like diuretics,2414,2021-01-31,2021-03-01,https://clinicaltrials.gov/show/NCT04330300,No Results,No Results,No Results,2020-04-20,2020-04-07,None
1843,DRKS00021289,German Clinical Trials Register,2020-04-14,2020-03-31,True,Performa Nord,Recruiting,Not Applicable,Observational,Germany,Study on SARS-CoV-2-Serology (COVID-19) in Bremen's public sector,Clinical Presentation (Epidemiology),No Intervention,100,Not Available,Not Available,http://www.drks.de/DRKS00021289,No Results,No Results,No Results,2020-05-11,2020-04-22,None
1844,DRKS00021164,German Clinical Trials Register,2020-03-27,2020-03-16,True,Universitt Duisburg-Essen,Recruiting,Not Applicable,Observational,Germany,Psychological distress of the COVID-19 pandemic: A comparison between cancer patients and healthy controls,Other (psych),No Intervention,220,Not Available,Not Available,http://www.drks.de/DRKS00021164,No Results,No Results,No Results,2020-05-11,2020-04-22,None
1845,EUCTR2020-001709-21-FR,EU Clinical Trials Register,2020-04-16,2020-04-29,False,CHU de Nancy,Authorised,Phase 4,Interventional,France,Low-molecular-weight heparin to prevent venous thromboembolism in COVID-19 patients : a randomized controlled trial of different doses,Drug,Heparin,550,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001709-21,No Results,No Results,No Results,2020-05-11,2020-05-12,None
1846,NCT04330495,ClinicalTrials.gov,2020-03-31,2020-04-06,False,Instituto de Investigacin Marqus de Valdecilla,Not Recruiting,Phase 4,Interventional,No Country Given,"Randomized, Controlled, Double-blind Clinical Trial Comparing the Efficacy and Safety of Chemoprophylaxis With Hydroxychloroquine in Patients Under Biological Treatment and / or JAK Inhibitors in the Prevention of SARS-CoV-2 Infection",Drug (Chemoprophylaxis),Hydroxychloroquine,800,2020-11-06,2020-11-06,https://clinicaltrials.gov/show/NCT04330495,No Results,No Results,No Results,2020-04-20,2020-04-07,None
1847,NCT04331665,ClinicalTrials.gov,2020-04-01,2020-04-20,False,"University Health Network, Toronto",Not Recruiting,Not Applicable,Interventional,Canada,Study of the Efficacy and Safety of Ruxolitinib to Treat COVID-19 Pneumonia,Drug,Ruxolitinib,64,2020-10-30,2021-01-31,https://clinicaltrials.gov/show/NCT04331665,No Results,No Results,No Results,2020-04-20,2020-04-07,None
1848,DRKS00021276,German Clinical Trials Register,2020-04-06,2020-04-12,False,"University Hospital, Rostock",Not Recruiting,Not Applicable,Observational,Germany,Dynamics of regional lung aeration non-invasive determined by electrical impedance tomography in patients with COVID 19,Clinical Presentation,No Intervention,24,Not Available,Not Available,http://www.drks.de/DRKS00021276,No Results,No Results,No Results,2020-05-11,2020-04-22,None
1849,DRKS00021153,German Clinical Trials Register,2020-04-06,2020-04-07,False,Leuphana Universitt Lneburg,Recruiting,Not Applicable,Interventional,Germany,get.calm and move.on  tackling worries and finding strength for the crisis (COVID-19) in 10 steps,Other (psych),Psychological,352,Not Available,Not Available,http://www.drks.de/DRKS00021153,No Results,No Results,No Results,2020-05-11,2020-04-22,None
1850,EUCTR2020-001598-66-FR,EU Clinical Trials Register,2020-04-16,2020-05-04,False,Centre Hospitalier de Versailles,Authorised,Phase 2,Interventional,France,Curosurf in Adult Acute Respiratory Distress Syndrome  1,Drug,Poractant alfa,20,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001598-66,No Results,No Results,No Results,2020-05-11,2020-05-12,None
1851,NCT04332913,ClinicalTrials.gov,2020-03-26,2020-04-01,False,University of L'Aquila,Recruiting,Not Applicable,Observational,Italy,Efficacy and Safety of Tocilizumab in the Treatment of SARS-Cov-2 Related Pneumonia,Drug,Tocilizumab,30,2020-12-31,2021-03-31,https://clinicaltrials.gov/show/NCT04332913,No Results,No Results,No Results,2020-04-20,2020-04-07,None
1852,NCT04333849,ClinicalTrials.gov,2020-04-01,2020-03-27,True,"University Hospital, Angers",Recruiting,Not Applicable,Observational,France,Telephony Or Videophony for Isolated elDerly in Maine-Et-Loire 49 During COVID-19,Other,Other,100,2020-09-01,2020-09-01,https://clinicaltrials.gov/show/NCT04333849,No Results,No Results,No Results,2020-04-20,2020-04-07,None
1853,DRKS00021605,German Clinical Trials Register,2020-04-28,2020-04-27,True,Klinikum Konstanz II. Medizin,Recruiting,Not Applicable,Observational,Germany,"COVID-19 in an academic teaching hospital in Konstanz/Germany - evaluation of the ""double rule out - single rule in"" concept (DURO-SIN)",Prognosis,No Intervention,200,Not Available,Not Available,http://www.drks.de/DRKS00021605,No Results,No Results,No Results,2020-05-11,2020-05-05,None
1854,DRKS00021301,German Clinical Trials Register,2020-04-16,2020-04-23,False,Universitt Duisburg-Essen,Not Recruiting,Not Applicable,Interventional,Germany,An e-Mental Health Intervention to Support burdened People in Times of the COVID-19 pandemic: CoPE It,Other (psych),Psychological,90,Not Available,Not Available,http://www.drks.de/DRKS00021301,No Results,No Results,No Results,2020-05-11,2020-04-22,None
1855,EUCTR2020-001632-10-DE,EU Clinical Trials Register,2020-04-20,2020-05-04,False,"University Hospital, Heidelberg",Authorised,Phase 2,Interventional,Germany,A Randomized Open label Phase-II Clinical Trial with or without Infusion of Plasma from Subjects after Convalescence of SARS-CoV-2 Infection in High-Risk Patients with Confirmed Severe SARS-CoV-2 Disease,ATMP,Plasma,174,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001632-10,No Results,No Results,No Results,2020-05-11,2020-05-12,None
1856,NCT04335188,ClinicalTrials.gov,2020-03-31,2020-04-06,False,IHF GmbH - Institut for Herzinfarktforschung,Recruiting,Not Applicable,Observational,Germany,COVID-19 Registry Rhineland-Palatinate (Germany),Clinical Presentation,No Intervention,4000,2021-07-31,2021-09-30,https://clinicaltrials.gov/show/NCT04335188,No Results,No Results,No Results,2020-04-20,2020-04-15,None
1857,NCT04335851,ClinicalTrials.gov,2020-04-02,2020-04-06,False,Biruni University,Not Recruiting,Not Applicable,Interventional,Turkey,Video-Based Exercises and Well-Being During Social Isolation,Other (exercise),Exercise,30,2020-05-13,2020-06-30,https://clinicaltrials.gov/show/NCT04335851,No Results,No Results,No Results,2020-04-20,2020-04-15,None
1858,DRKS00021300,German Clinical Trials Register,2020-04-08,2020-03-29,True,"University Hospital, Freiburg",Recruiting,Phase 2/Phase 3,Interventional,Germany,Cytokine adsorption in severe COVID-19 pneumonia requiring extracorporeal membrane oxygenation,Drug,Oxygen,30,Not Available,Not Available,http://www.drks.de/DRKS00021300,No Results,No Results,No Results,2020-05-11,2020-04-22,None
1859,EUCTR2020-001721-31-GB,EU Clinical Trials Register,2020-04-27,2020-05-01,False,Hampshire Hospitals NHS Foundation Trust,Authorised,Phase 2,Interventional,United Kingdom,Sinus-Wash Pilot Study,Drug,Povidone-iodine,40,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001721-31,No Results,No Results,No Results,2020-05-11,2020-05-12,None
1860,DRKS00021676,German Clinical Trials Register,2020-05-08,2020-04-02,True,"University Hospital, Rostock",Recruiting,Not Applicable,Observational,Germany,Communication in times of the corona virus pandemic (COVID-19),Other (psych),No Intervention,200,Not Available,Not Available,http://www.drks.de/DRKS00021676,No Results,No Results,No Results,2020-05-11,2020-05-12,None
1861,DRKS00021630,German Clinical Trials Register,2020-05-06,2020-05-08,False,"University Hospital, Schleswig-Holstein",Not Recruiting,Not Applicable,Observational,Germany,Detection of a delayed Treatment of urgent ophthalmologic Treatment during the SARS-CoV-2 pandemic (COVID-19),Health System,No Intervention,30,Not Available,Not Available,http://www.drks.de/DRKS00021630,No Results,No Results,No Results,2020-05-11,2020-05-12,None
1862,EUCTR2020-001825-29-ES,EU Clinical Trials Register,2020-05-05,2020-04-28,True,Navarrabiomed - Fundacin Miguel Servet,Authorised,Phase 2/Phase 3,Interventional,Spain,CLINICAL TRIAL OF THE USE OF ANAKINRA (ANTI IL-1) IN CYTOKINE STORM SYNDROME (CSS) SECONDARY TO COVID-19,Drug,Anakinra vs. Hydoxychloroquine + Azithromycin + Lopinavir/ritonavir,180,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001825-29,No Results,No Results,No Results,2020-05-11,2020-05-12,None
1863,EUCTR2020-001768-27-FR,EU Clinical Trials Register,2020-04-16,2020-04-27,False,Centre Hospitalier de Versailles,Authorised,Phase 2,Interventional,France,"""STUDY OF THE EFFICIENCY OF NORMAL HUMAN IMMUNOGLOBULINS (IVIG) IN PATIENTS AGED 75 YEARS AND OVER COVID-19 WITH SEVERE ACUTE RESPIRATORY FAILURE"" GERONIMO 19",ATMP,Immunoglobulin,39,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001768-27,No Results,No Results,No Results,2020-05-11,2020-05-12,None
1864,DRKS00021671,German Clinical Trials Register,2020-05-06,2020-04-03,True,"University Hospital, Heidelberg",Recruiting,Not Applicable,Observational,Germany,Neuroendocrine mechanisms Social isolation and psychobiological stress during the Covid-19 pandemic,Other (psych),No Intervention,200,Not Available,Not Available,http://www.drks.de/DRKS00021671,No Results,No Results,No Results,2020-05-11,2020-05-12,None
1865,NCT04336462,ClinicalTrials.gov,2020-03-25,2020-02-15,True,Shanghai Asclepius Meditec Inc.,Recruiting,Not Applicable,Interventional,China,Hydrogen-Oxygen Generator With Nebulizer in the Improvement of Symptoms in Patients Infected With COVID-19,Drug,Hydrogen + Oxygen vs Oxygen,100,2020-02-21,2020-08-01,https://clinicaltrials.gov/show/NCT04336462,No Results,No Results,No Results,2020-04-20,2020-04-15,None
1866,NCT04336657,ClinicalTrials.gov,2020-04-03,2020-04-01,True,Assiut University,Recruiting,Not Applicable,Observational,Egypt,Corona-Like Illness: Did we Got it Before WHO Announcement of the Disease?,Clinical Presentation (Epidemiology),No Intervention,100,2020-05-01,2020-05-01,https://clinicaltrials.gov/show/NCT04336657,No Results,No Results,No Results,2020-04-20,2020-04-15,None
1867,EUCTR2020-001643-13-GB,EU Clinical Trials Register,2020-04-29,No Date Available,False,University of Dundee,Not Available,Phase 3,Interventional,United Kingdom,A randomised double-blind placebo-controlled trial of Brensocatib (INS1007) in patients with severe COVID-19,Drug,Brensocatib,300,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001643-13,No Results,No Results,No Results,2020-05-11,2020-05-12,None
1868,EUCTR2020-002032-69-ES,EU Clinical Trials Register,2020-05-05,2020-05-04,True,Fundacin para la Investigacin Biomdica Hospital Ramn y Cajal,Authorised,Phase 2,Interventional,Spain,Clinical trial on the efficacy of tocilizumab in modifying the inflammatory parameters of patients with COVID-19,Drug,Tocilizumab,78,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002032-69,No Results,No Results,No Results,2020-05-11,2020-05-12,None
1869,EUCTR2020-001635-27-FR,EU Clinical Trials Register,2020-04-06,2020-05-04,False,AB Science,Authorised,Phase 2,Interventional,France,Evaluation of a combination of Masitinib and Isoquercetin in the Treatment of Hospitalized COVID-19 Patients.,Drug,Masitinib + Isoquercetin vs. Hydroxychloroquine,Not Available,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001635-27,No Results,No Results,No Results,2020-05-11,2020-05-12,None
1870,EUCTR2020-001411-25-AT,EU Clinical Trials Register,2020-04-03,2020-04-14,False,Karyopharm Therapeutics Inc,Authorised,Phase 2,Interventional,"Canada, France, India, Belgium, Italy, Israel, Australia, United Kingdom, United States, Austria, Germany, Malaysia, Spain",A Phase 2 Randomized Single-Blind Study to Evaluate the Activity and Safety of Low Dose Oral Selinexor (KPT-330) in Patients with Severe COVID-19 Infection,Drug,Selinexor,230,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001411-25,No Results,No Results,No Results,2020-05-11,2020-05-12,None
1871,NCT04336904,ClinicalTrials.gov,2020-04-03,2020-03-25,True,Giuliano Rizzardini,Not Recruiting,Phase 3,Interventional,Italy,Clinical Study To Evaluate The Performance And Safety Of Favipiravir in COVID-19,Drug,Favipiravir,100,2020-07-01,2020-07-01,https://clinicaltrials.gov/show/NCT04336904,No Results,No Results,No Results,2020-04-20,2020-04-15,None
1872,NCT04337151,ClinicalTrials.gov,2020-04-03,2020-04-01,True,Royal National Orthopaedic Hospital NHS Trust,Recruiting,Not Applicable,Observational,United Kingdom,Blood Titanium Analysis of Patients With MAGEC Spine Rods in the COVID-19 Environment,Other,No Intervention,100,2021-01-01,2021-03-01,https://clinicaltrials.gov/show/NCT04337151,No Results,No Results,No Results,2020-04-20,2020-04-15,None
1873,EUCTR2020-001827-15-ES,EU Clinical Trials Register,2020-05-05,2020-04-30,True,Navarrabiomed - Fundacin Miguel Servet,Authorised,Phase 3,Interventional,Spain,"EARLY TREATMENT OF PNEUMONIA COVID-19 WITH GLUCOCORTICOIDS.
RANDOMIZED CONTROLLED CLINICAL TRIAL",Drug,Croticosteroids vs. Hydroxychloroquine + Lopinavir/ritonavir + Tocilizumab,72,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001827-15,No Results,No Results,No Results,2020-05-11,2020-05-12,None
1874,EUCTR2020-001736-95-GB,EU Clinical Trials Register,2020-04-23,2020-04-28,False,University Hospital Southampton NHS Foundation Trust,Authorised,Phase 2,Interventional,United Kingdom,A Phase 2 Study for the Treatment of COVID 19 in Hospitalised Patients,Drug (+ ATMP),"Bemcentinib, Immunoglobulin, Acalabrutinib, Zilucoplan, Heparin",825,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001736-95,No Results,No Results,No Results,2020-05-11,2020-05-12,None
1875,EUCTR2020-001909-22-FR,EU Clinical Trials Register,2020-04-16,No Date Available,False,Assistance Publique  Hpitaux de Paris,Authorised,Phase 3,Interventional,France,EFFICACY OF INTRAVENOUS ALMITRINE IN REDUCING THE NEED FOR MECHANICAL VENTILATION IN PATIENTS WITH HYPOXEMIC ACUTE RESPIRATORY FAILURE DUE TO COVID-19-RELATED PNEUMONIA:  A RANDOMIZED CONTROLLED DOUBLE-BLIND STUDYFROM THE SKIP-ICU CONSORTIUM,Drug,Almitrine,212,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001909-22,No Results,No Results,No Results,2020-05-11,2020-05-12,None
1876,EUCTR2020-001449-38-GB,EU Clinical Trials Register,2020-04-17,2020-04-29,False,Chelsea and Westminster Hospital NHS Foundation Trust,Authorised,Phase 3,Interventional,United Kingdom,A Randomised Controlled Trial of Early Intervention in Patients HospItalised with COVID-19: Favipiravir verses HydroxycholorquiNe & Azithromycin & Zinc vErsEs Standard CaRe,Drug,Favipiravir vs. Hydroxychloroquine + Azithromycin + Zinc,450,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001449-38,No Results,No Results,No Results,2020-05-11,2020-05-12,None
1877,EUCTR2020-001684-89-GB,EU Clinical Trials Register,2020-04-17,2020-05-05,False,University of Birmingham,Authorised,Phase 2,Interventional,United Kingdom,"A clinical trial to gather information on the safety and effectiveness of drugs in patients with the COVID-19 infection, that could be used in larger trials.",Drug,Gemtuzumab,84,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001684-89,No Results,No Results,No Results,2020-05-11,2020-05-12,None
1878,EUCTR2020-001994-66-ES,EU Clinical Trials Register,2020-05-08,2020-05-06,True,Fundaci Assistencial Mtua Terrassa,Authorised,Phase 3,Interventional,Spain,Study of the efficacy of ivermectin in the treatment and prevention of COVID-19,Drug,Ivermectin,266,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001994-66,No Results,No Results,No Results,2020-05-11,2020-05-12,None
1879,EUCTR2020-001786-36-GB,EU Clinical Trials Register,2020-04-15,2020-05-06,False,Revimmune,Authorised,Phase 2,Interventional,"Belgium, France, Italy, United Kingdom, United States, Spain",Study of investigational medicinal product of CYT107 in patients with COVID-19 infection who have low number of lymphocytes in their blood (ILIAD 7 trial),Drug,CYT107,200,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001786-36,No Results,No Results,No Results,2020-05-11,2020-05-12,None
1880,EUCTR2020-001783-28-HU,EU Clinical Trials Register,2020-04-29,2020-05-06,False,National Kornyi Institute of Pulmonology,Authorised,Phase 3,Interventional,Hungary,BCG vaccination against COVID-19 infection in Hungary,ATMP,Vaccine,1000,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001783-28,No Results,No Results,No Results,2020-05-11,2020-05-12,None
1881,EUCTR2020-001296-33-DK,EU Clinical Trials Register,2020-04-03,2020-05-06,False,"Copenhagen University Hospital, Capital Region Blood Bank",Authorised,Phase 2,Interventional,Denmark,"Efficacy and safety of 72-hour infusion of Prostacyclin (1 ng/kg/min) in patients with COVID-19 induced respiratory failure  a multicentre randomized, placebo-controlled, blinded, investigator-initiated trial",Drug,Iloprost,80,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001296-33,No Results,No Results,No Results,2020-05-11,2020-05-12,None
1882,NCT04337190,ClinicalTrials.gov,2020-04-03,2020-04-03,False,"University Hospital, Angers",Recruiting,Not Applicable,Observational,France,Impact of Angiotensin II Receptor Blockers Treatment in Patients With COVID 19 (COVID-ARA2),Drug,ARBs,100,2020-10-06,2020-12-06,https://clinicaltrials.gov/show/NCT04337190,No Results,No Results,No Results,2020-04-20,2020-04-15,None
1883,NCT04338074,ClinicalTrials.gov,2020-04-06,2020-04-15,False,University of Alabama at Birmingham,Not Recruiting,Phase 2,Interventional,United States,TXA and Corona Virus 2019 (COVID19) in Outpatients,Drug,Tranexamic acid,100,2020-10-15,2020-10-30,https://clinicaltrials.gov/show/NCT04338074,No Results,No Results,No Results,2020-04-20,2020-04-15,None
1884,EUCTR2020-001777-71-GB,EU Clinical Trials Register,2020-04-30,2020-05-06,False,Guy's and St Thomas' NHS Foundation Trust,Authorised,Phase 4,Interventional,United Kingdom,Ruxolitinib therapy to Avoid Ventilation and improve outcome for deteriorating COVID-19 patients,Drug,Ruxolitinib,59,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001777-71,No Results,No Results,No Results,2020-05-11,2020-05-12,None
1885,NCT04338100,ClinicalTrials.gov,2020-03-31,2020-04-06,False,"University Hospital, Angers",Not Recruiting,Not Applicable,Observational,No Country Given,Point Of Care UltraSonography for Risk-stratification of COVID-19 Patients,Prognosis,No Intervention,300,2020-12-29,2021-01-29,https://clinicaltrials.gov/show/NCT04338100,No Results,No Results,No Results,2020-04-20,2020-04-15,None
1886,NCT04338945,ClinicalTrials.gov,2020-04-07,2020-03-15,True,Ospedale Policlinico San Martino,Recruiting,Not Applicable,Observational,Italy,Impact of Pandemic COVID-19 on Surgical Specialities Residents in Italy,Other,No Intervention,1200,2020-04-15,2020-05-01,https://clinicaltrials.gov/show/NCT04338945,No Results,No Results,No Results,2020-04-20,2020-04-15,None
1887,EUCTR2020-001882-36-GR,EU Clinical Trials Register,2020-04-30,2020-05-07,False,Hellenic Institute for the Study of Sepsis,Authorised,Phase 2,Interventional,Greece,CLARITHROMYCIN IN COVID-19,Drug,Clarithromycin,90,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001882-36,No Results,No Results,No Results,2020-05-11,2020-05-12,None
1888,NCT04339387,ClinicalTrials.gov,2020-04-06,2020-03-01,True,Brigham and Women's Hospital,Recruiting,Not Applicable,Observational,United States,COVID-19 Risk Stratification,Prognosis,No Intervention,1500,2020-04-15,2020-04-15,https://clinicaltrials.gov/show/NCT04339387,No Results,No Results,No Results,2020-04-20,2020-04-15,None
1889,NCT04339608,ClinicalTrials.gov,2020-04-07,2020-04-02,True,Max Healthcare Insititute Limited,Recruiting,Not Applicable,Observational,India,Max COVID19- Study,Clinical Presentation,No Intervention,10000,2020-05-30,2020-06-30,https://clinicaltrials.gov/show/NCT04339608,No Results,No Results,No Results,2020-04-20,2020-04-15,None
1890,EUCTR2020-001206-35-AT,EU Clinical Trials Register,2020-03-26,2020-04-14,False,Medical University Innsbruck,Authorised,Phase 4,Interventional,Austria,Discontinuation of ACE inhibitors in patients with COVID-19 infection,Drug,ACE inhibitors,798,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001206-35,No Results,No Results,No Results,2020-05-11,2020-05-12,None
1891,NCT04339816,ClinicalTrials.gov,2020-04-06,2020-04-20,True,Frantisek Duska,Not Recruiting,Phase 3,Interventional,No Country Given,Azithromycin Added to Hydrochloroquine in Patients Admitted to Intensive Care With COVID-19: Randomised Controlled Trial,Drug,Hydroxychloroquine + azithromycin vs. hydroxychloroquine,240,2021-12-31,2022-06-30,https://clinicaltrials.gov/show/NCT04339816,No Results,No Results,No Results,2020-04-20,2020-04-15,EUCTR2020-001456-18
1892,NCT04340921,ClinicalTrials.gov,2020-04-03,2020-04-10,False,Barts & The London NHS Trust,Not Recruiting,Not Applicable,Observational,No Country Given,The Role of Adaptive Immunity in COVID-19 Associated Myocardial Injury,Clinical Presentation,No Intervention,140,2020-04-10,2020-06-10,https://clinicaltrials.gov/show/NCT04340921,No Results,No Results,No Results,2020-04-20,2020-04-15,None
1893,EUCTR2020-001891-14-ES,EU Clinical Trials Register,2020-05-05,2020-05-04,True,Fundacin Neumosur,Authorised,Phase 2,Interventional,Spain,"Impact of the use of low molecular weight heparins (LMWH), at prophylactic versus intermediate doses, on SARS-CoV2 infection (COVID-19)",Drug,Heparin,140,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001891-14,No Results,No Results,No Results,2020-05-11,2020-05-12,None
1894,NCT04341766,ClinicalTrials.gov,2020-04-01,2020-03-31,True,Centre Hospitalier Intercommunal Creteil,Recruiting,Not Applicable,Observational,France,Evolution of Pulmonary Ultrasound in Patients Hospitalized for Covid (Coronavirus Disease) 19,Clinical Presentation,No Intervention,200,2020-05-01,2020-09-30,https://clinicaltrials.gov/show/NCT04341766,No Results,No Results,No Results,2020-04-20,2020-04-15,None
1895,NCT04341792,ClinicalTrials.gov,2020-04-07,2020-04-01,True,"University Hospital, Lille",Not Recruiting,Not Applicable,Observational,No Country Given,Predictive Biomarkers of Secondary Aggravation in Covid-19 Suspect Patient,Clinical Presentation,No Intervention,1000,2020-08-01,2020-08-01,https://clinicaltrials.gov/show/NCT04341792,No Results,No Results,No Results,2020-04-20,2020-04-15,None
1896,NCT04342208,ClinicalTrials.gov,2020-04-07,2020-04-10,False,Istanbul University-Cerrahpasa,Not Recruiting,Not Applicable,Observational,No Country Given,Evaluate the Working Environments of Individuals Working From Home During Covid-19 Outbreak,Other,Other,500,2020-06-01,2020-07-01,https://clinicaltrials.gov/show/NCT04342208,No Results,No Results,No Results,2020-04-20,2020-04-15,None
1897,NCT04342221,ClinicalTrials.gov,2020-04-08,2020-03-29,True,"University Hospital, Tbingen",Recruiting,Phase 3,Interventional,Germany,Hydroxychloroquine for COVID-19,Drug,Hydroxychloroquine,220,2021-03-01,2022-02-01,https://clinicaltrials.gov/show/NCT04342221,No Results,No Results,No Results,2020-04-20,2020-04-15,EUCTR2020-001224-33
1898,EUCTR2020-001697-30-ES,EU Clinical Trials Register,2020-05-07,2020-04-23,True,Navarrabiomed - Fundacin Miguel Servet,Authorised,Phase 3,Interventional,Spain,PRE-EXPOSURE PROPHYLAXIS WITH HYDROXYCHLOROQUINE IN SANITARIES HIGHLY EXPOSED TO COVID-19. (COVIDNA),Drug (Chemoprophylaxis),Hydroxychloroquine,200,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001697-30,No Results,No Results,No Results,2020-05-11,2020-05-12,None
1899,EUCTR2020-001603-16-ES,EU Clinical Trials Register,2020-05-08,2020-05-06,True,Instituto de Investigacin Marqus de Valdecilla (IDIVAL),Authorised,Phase 3,Interventional,Spain,Ensayo clnico aleatorizado para investigar la eficacia de la administracin anticipada de la colchicina en pacientes mayores de 70 aos y de alto riesgo en tener complicaciones pulmonares como neumona asociada al coronavirus.,Drug,Colchicine,1024,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001603-16,No Results,No Results,No Results,2020-05-11,2020-05-12,None
1900,NCT04343742,ClinicalTrials.gov,2020-04-07,2020-04-01,True,Genesis Foundation,Recruiting,Not Applicable,Observational,Colombia,Determination of the Effectiveness of Oral Chlorine Dioxide in the Treatment of COVID 19,Drug,Chlorine dioxide,20,2020-04-07,2020-06-01,https://clinicaltrials.gov/show/NCT04343742,No Results,No Results,No Results,2020-04-20,2020-04-15,None
1901,NCT04344197,ClinicalTrials.gov,2020-04-09,2020-04-02,True,University of Rome Tor Vergata,Recruiting,Not Applicable,Observational,Italy,"Surgery During Covid-19: The Role of Asymptomatic Patients, a Survey",Clinical Presentation,No Intervention,1200,2020-04-08,2020-04-15,https://clinicaltrials.gov/show/NCT04344197,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1902,ACTRN12620000477921,ANZCTR,2020-04-16,2020-04-20,False,Dr. Michael Soares,Not Recruiting,Not Applicable,Interventional,Australia,The design of an updated iron lung ventilator which can be easily built and used by people with minimal training in situations such as COVID-19 where skilled doctors or normal ventilators are unavailable.,Other (physical),Mechanical ventilation,1,Not Available,2020-04-20,https://anzctr.org.au/ACTRN12620000477921.aspx,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1903,EUCTR2020-001474-29-ES,EU Clinical Trials Register,2020-05-08,2020-05-07,True,Clnica Universidad de Navarra,Authorised,Phase 2,Interventional,Spain,Pilot study to evaluate the potential of ivermectin to reduce COVID-19 transmission,Drug,Ivermectin,24,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001474-29,No Results,No Results,No Results,2020-05-11,2020-05-12,None
1904,ACTRN12620000472976,ANZCTR,2020-04-15,2020-04-27,False,Dr. Simon Joosten,Not Recruiting,Not Applicable,Interventional,Australia,Adapting the Decathlon Group Easybreathe snorkelling face mask for the safer administration of oxygen and/or continuous positive airway pressure and in the intra/interhospital transportation of patients with proven or suspected COVID 19 infection.,Other (device),Mask,100,Not Available,2020-10-27,https://anzctr.org.au/ACTRN12620000472976.aspx,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1905,ACTRN12620000479909,ANZCTR,2020-04-16,2020-05-01,False,The George Institute for Global Health,Not Recruiting,Not Applicable,Observational,"Italy, China, Australia, Germany, Spain, United States",Mental health and wellbeing on general population during the COVID-19 outbreak,Other (psych),No Intervention,3000,Not Available,Not Available,https://anzctr.org.au/ACTRN12620000479909.aspx,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1906,EUCTR2020-001696-32-ES,EU Clinical Trials Register,2020-05-08,2020-05-08,False,"Instituto Grifols, S.A",Authorised,Phase 2,Interventional,Spain,Efficacy and safety study of IVIG in hospitalized subjects with COVID-19,ATMP,Immunoglobulin,100,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001696-32,No Results,No Results,No Results,2020-05-11,2020-05-12,None
1907,ACTRN12620000470998,ANZCTR,2020-04-14,2020-04-20,False,Firebrick Pharma Pty Ltd,Not Recruiting,Not Applicable,Interventional,Australia,Virucidal pilot study of Nasodine Antiseptic Nasal Spray (povidone-iodine 0.5%) in people with COVID-19 and confirmed nasal shedding of SARS-CoV-2 virus.,Drug,Povidone-iodine,20,Not Available,2020-06-30,https://anzctr.org.au/ACTRN12620000470998.aspx,No Results,No Results,No Results,2020-04-20,2020-04-15,None
1908,EUCTR2020-001953-36-ES,EU Clinical Trials Register,2020-05-08,2020-05-08,False,"Instituto Grifols, S.A",Authorised,Phase 2,Interventional,Spain,Study to Evaluate the Safety and Efficacy of Prolastin in Hospitalized Patients with Coronavirus Disease (COVID-19),Drug,Alpha-1-proteinase inhibitor,100,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001953-36,No Results,No Results,No Results,2020-05-11,2020-05-12,None
1909,ChiCTR2000032040,ChiCTR,2020-04-18,2020-04-01,True,Affiliated Hospital of Guangdong Medical University,Recruiting,Not Applicable,Observational,China,A medical records based study for the curative effect of combined traditional Chinese and western medicine in the treatment of severe novel coronavirus pneumonia (COVID-19),Traditional Medicine + Western Medicine,Traditional Medicine,30,Not Available,2020-08-01,http://www.chictr.org.cn/showproj.aspx?proj=52529,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1910,ChiCTR2000032013,ChiCTR,2020-04-17,2020-02-02,True,The Fourth Medical Center of PLA General Hospital,Not Recruiting,Not Applicable,Interventional,China,The prevention and treatment strategy of the protective respirator related facial pressure injuries among healthcare professionals fighting novel coronavirus pneumonia (COVID-19),Other (physical),Mechanical ventilation,8,Not Available,2020-06-30,http://www.chictr.org.cn/showproj.aspx?proj=52483,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1911,ChiCTR2000032011,ChiCTR,2020-04-17,2020-04-17,False,The Sixth Medical Center of PLA General Hospital,Not Recruiting,Not Applicable,Interventional,China,Effecacy and Safety of Hyperbaric Oxygen Therapy to patients with novel coronavirus pneumonia (COVID-19),Drug,Oxygen,45,Not Available,2020-05-17,http://www.chictr.org.cn/showproj.aspx?proj=52142,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1912,ChiCTR2000032010,ChiCTR,2020-04-17,2020-05-01,False,"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology",Not Recruiting,Not Applicable,Diagnostic test,China,Novel coronavirus pneumonia (COVID-19) Intelligent Assistant Analysis System:A Multi-center Clinical Research,Clinical Presentation,No Intervention,3000,Not Available,2022-04-30,http://www.chictr.org.cn/showproj.aspx?proj=52479,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1913,ChiCTR2000031930,ChiCTR,2020-04-15,2020-01-31,True,Affiliated Hospital of Zunyi Medical University,Not Recruiting,Not Applicable,Observational,China,Analysis of clinical characteristics and therapeutic effect of 9 cases of novel coronavirus pneumonia (COVID-19),Clinical Presentation,No Intervention,9,Not Available,2020-03-01,http://www.chictr.org.cn/showproj.aspx?proj=51602,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1914,ChiCTR2000031888,ChiCTR,2020-04-13,2020-02-11,True,Guangzhou Eighth People's Hospital,Recruiting,Not Applicable,Interventional,China,A medical records based study for ''Guangdong Pneumonia NO.1'' in the Treatment of Novel Coronavirus Pneumonia (COVID-19),Traditional Medicine (Drug),Traditional Medicine,300,Not Available,2020-11-30,http://www.chictr.org.cn/showproj.aspx?proj=52106,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1915,ChiCTR2000031712,ChiCTR,2020-04-07,2020-04-01,True,The Chinese University of Hong Kong,Recruiting,Not Applicable,Observational,No Country Given,Study for investigation of contamination by novel coronavirus pneumonia (COVID-19) in the clinical environment,Other,Other,60,Not Available,2021-03-31,http://www.chictr.org.cn/showproj.aspx?proj=51650,No Results,No Results,No Results,2020-04-20,2020-04-15,None
1916,ChiCTR2000029434,ChiCTR,2020-02-01,2020-02-01,False,Hebei Yiling Hospital; Renmin Hospital of Wuhan University,Not Recruiting,Phase 4,Interventional,China,"A randomized, open-label, blank-controlled trial for Lian-Hua Qing-Wen Capsule /Granule in the treatment of novel coronavirus pneumonia (COVID-19)",Traditional Medicine (Drug),Traditional Medicine,240,Not Available,2020-12-01,http://www.chictr.org.cn/showproj.aspx?proj=48889,No Results,No Results,No Results,2020-04-20,2020-03-18,None
1917,ChiCTR2000029433,ChiCTR,2020-02-01,2020-02-01,False,Hebei Yiling Hospital; Renmin Hospital of Wuhan University,Not Recruiting,Phase 4,Interventional,China,"A randomized, open-label, blank-controlled trial for Lian-Hua Qing-Wen Capsule/Granule in the treatment of suspected novel coronavirus pneumonia (COVID-19)",Traditional Medicine (Drug),Traditional Medicine,240,Not Available,2020-12-01,http://www.chictr.org.cn/showproj.aspx?proj=48898,No Results,No Results,No Results,2020-04-20,2020-08-03,None
1918,EUCTR2020-001156-18-ES,EU Clinical Trials Register,2020-04-03,2020-03-27,True,Fundacin para la investigacin Biomdica Hospital Universitario La Paz (FIBHULP),Authorised,Phase 3,Interventional,Spain,Efficacy of different treatments in patients infected with COVID-19,Drug,"Dolquine, Azithromycin, Lopinavir/ritonavir",1000,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001156-18,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1919,EUCTR2020-001254-22-BE,EU Clinical Trials Register,2020-03-24,2020-03-24,False,"University Hospital, Ghent",Authorised,Phase 4,Interventional,Belgium,Sargramostim in patients with acute hypoxic respiratory failure due to COVID-19,Drug,Sargramostin,80,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001254-22,No Results,No Results,No Results,2020-04-20,2020-04-01,None
1920,IRCT20170117032004N3,IRCT,2020-03-29,2020-04-03,False,Tabriz University of Medical Sciences,Recruiting,Not Applicable,Interventional,Iran,Effect of vitamin A in patients with COVID19,Drug,Vitamin A,30,Not Available,Not Available,http://en.irct.ir/trial/46564,No Results,No Results,No Results,2020-04-21,2020-04-22,None
1921,IRCT20100228003449N29,IRCT,2020-03-19,2020-03-18,True,Tehran University of Medical Sciences,Recruiting,Phase 2/Phase 3,Interventional,Iran,?Effect of sofosbuvir/ ledipasvir on COVID-19,Drug,Sofosbuvir + Ledipasvir vs. Hydroxychloroquine + Oseltamivir + Lopinavir/ritonavir,50,Not Available,Not Available,http://en.irct.ir/trial/46567,No Results,No Results,No Results,2020-04-21,2020-03-25,None
1922,IRCT20131113015393N6,IRCT,2020-03-30,2020-02-28,True,Sabzevar University of Medical Sciences,Recruiting,Not Applicable,Interventional,Iran,Effect of Benson Relaxation on Quality of Life and job stress  in nurses,Other (psych),Psychological,62,Not Available,Not Available,http://en.irct.ir/trial/46609,No Results,No Results,No Results,2020-04-21,2020-04-22,None
1923,IRCT20140911019125N6,IRCT,2020-04-04,2020-04-04,False,Kerman University of Medical Sciences,Recruiting,Phase 2,Interventional,Iran,The effect of dental pulp mesenchymal stem cells in treatment of  corona disease,ATMP,Cells (mesenchymal),10,Not Available,Not Available,http://en.irct.ir/trial/46668,No Results,No Results,No Results,2020-04-21,2020-04-22,None
1924,IRCT20160316027081N1,IRCT,2020-03-31,2020-03-23,True,Artesh University of Medical Sciences,Not Recruiting,Phase 3,Interventional,Iran,Effect of Licorice in COVID-19,Traditional Medicine (Drug),Traditional Medicine,374,Not Available,Not Available,http://en.irct.ir/trial/46678,No Results,No Results,No Results,2020-04-21,2020-04-22,None
1925,IRCT20200324046850N3,IRCT,2020-03-30,2020-03-28,True,Abadan University of Medical Sciences,Not Recruiting,Phase 3,Interventional,Iran,The effect of naproxen on the healing process of patients with COVID-19,Drug,"Investigational: Naproxen

All Arms: Hydroxychloroquine + Lopinavir/Ritonavir",40,Not Available,Not Available,http://en.irct.ir/trial/46718,No Results,No Results,No Results,2020-04-21,2020-04-22,None
1926,IRCT20200324046847N1,IRCT,2020-03-31,2020-03-28,True,Tehran University of Medical Sciences,Recruiting,Phase 2,Interventional,Iran,Treatment of patients with Corona virus infection,Drug,Septimeb,30,Not Available,Not Available,http://en.irct.ir/trial/46720,No Results,No Results,No Results,2020-04-21,2020-04-22,None
1927,IRCT20180923041093N3,IRCT,2020-03-28,2020-04-02,False,Kerman University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Efficacy of the myrtle syrup in the treatment of novel corona,Traditional Medicine (Drug),Traditional Medicine,100,Not Available,Not Available,http://en.irct.ir/trial/46721,No Results,No Results,No Results,2020-04-21,2020-04-22,None
1928,IRCT20200325046860N1,IRCT,2020-03-30,2020-03-15,True,Darmanara Co.,Recruiting,Not Applicable,Interventional,Iran,Convalescent Plasma therapy for COVID-19 Patients,ATMP,Plasma,200,Not Available,Not Available,http://en.irct.ir/trial/46759,No Results,No Results,No Results,2020-04-21,2020-04-22,None
1929,IRCT20170611034452N11,IRCT,2020-03-31,2020-03-30,True,Kerman University of Medical Sciences,Not Recruiting,Not Applicable,Interventional,Iran,Investigating the effectiveness of psychological interventions on mental health,Other (psych),Psychological,60,Not Available,Not Available,http://en.irct.ir/trial/46803,No Results,No Results,No Results,2020-04-21,2020-04-22,None
1930,IRCT20190917044805N2,IRCT,2020-03-31,2020-04-03,False,Tehran University of Medical Sciences,Recruiting,Phase 2/Phase 3,Interventional,Iran,Effects of High-dose Vitamin C on COVID-19,Drug,Vitamin C,60,Not Available,Not Available,http://en.irct.ir/trial/46804,No Results,No Results,No Results,2020-04-21,2020-04-22,None
1931,IRCT20120225009124N4,IRCT,2020-04-02,2020-04-18,False,Gorgan University of Medical Sciences,Recruiting,Phase 2/Phase 3,Interventional,Iran,"Efficacy of dexamethasone, IV-IG and Interferone beta for treatment of patients with severe COVID-19",Drug (+ ATMP),"Intreventional: Dexamethason + Immunoglobulin vs. Dexamethason + Immunoglobulin + interferon beta

All Arms: Hydroxychloroquine + antiviral ",105,Not Available,Not Available,http://en.irct.ir/trial/46810,No Results,No Results,No Results,2020-04-21,2020-04-22,None
1932,IRCT20200325046859N1,IRCT,2020-04-02,2020-04-04,False,Mashhad University of Medical Sciences,Recruiting,Phase 2,Interventional,Iran,The efficacy of intravenous immunoglobulin (IVIg) in patients with severe COVID-19 who have not responded to standard three-drug protocol,ATMP,Plasma,50,Not Available,Not Available,http://en.irct.ir/trial/46811,No Results,No Results,No Results,2020-04-21,2020-04-22,None
1933,IRCT20081019001369N2,IRCT,2020-04-07,2020-04-20,False,Mashhad University of Medical Sciences,Recruiting,Phase 2,Interventional,Iran,Effect of berberine on COVID-19,Traditional Medicine (Drug),Traditional Medicine,40,Not Available,Not Available,http://en.irct.ir/trial/46868,No Results,No Results,No Results,2020-04-21,2020-04-22,None
1934,IRCT20200404046934N1,IRCT,2020-04-13,2020-03-10,True,Qom University of Medical Sciences,Not Recruiting,Phase 3,Interventional,Iran,Investigation of the effect of Zufa syrup on clinical symptoms in the with suspected Corona (COVID-19),Traditional Medicine (Drug),Traditional Medicine,130,Not Available,Not Available,http://en.irct.ir/trial/46913,No Results,No Results,No Results,2020-04-21,2020-04-22,None
1935,IRCT20200405046960N1,IRCT,2020-04-08,2020-04-09,False,Ardabil University of Medical Sciences,Recruiting,Phase 1/Phase 2,Interventional,Iran,Efficacy of Kelofan syrup on COVID-19,Traditional Medicine (Drug),Traditional Medicine,15,Not Available,Not Available,http://en.irct.ir/trial/46961,No Results,No Results,No Results,2020-04-21,2020-04-22,None
1936,IRCT20200318046812N2,IRCT,2020-04-08,2020-04-10,False,Bagheiat-allah University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,evaluation of Safety and efficacy of anti inflammatory regimens in COVID-19,Drug,Prednisolone + naproxen + azithromycin + hydroxychloroquine vs. naproxen + azithromycin + hydroxychloroquine vs. hydroxychloroquine + Lopinavit/ritonavir,906,Not Available,Not Available,http://en.irct.ir/trial/46968,No Results,No Results,No Results,2020-04-21,2020-04-22,None
1937,IRCT20200317046797N4,IRCT,2020-04-14,2020-04-18,False,Tabriz University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Effect of Bromhexine Hydrochloride on patients with COVID-19,Drug,Bromhexine,60,Not Available,Not Available,http://en.irct.ir/trial/46969,No Results,No Results,No Results,2020-04-21,2020-04-22,None
1938,IRCT20200401046909N2,IRCT,2020-04-11,2020-04-14,False,Tehran University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Evaluation of the efficacy of oral 25-hydroxyvitamin D3 on COVID-19,Drug,Calcifediol,540,Not Available,Not Available,http://en.irct.ir/trial/47010,No Results,No Results,No Results,2020-04-21,2020-04-22,None
1939,IRCT20180129038542N1,IRCT,2020-04-13,2020-04-06,True,The University of Baqiyatallah,Not Recruiting,Not Applicable,Interventional,Iran,Early tracheostomy in COVID-19,Other (physical),Mechanical ventilation,30,Not Available,2020-04-13,http://en.irct.ir/trial/47013,No Results,No Results,No Results,2020-04-21,2020-04-22,None
1940,IRCT20200317046797N3,IRCT,2020-04-11,2020-04-20,False,Tabriz University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Intravenous immunoglobulin (IVIG) in the treatment of COVID-19-induced cytokine storm,ATMP,"Interventional: Immunoglobulin

Both Arms: hydroxychloroquine + ribavirin + lopinavir/ritonavir",100,Not Available,Not Available,http://en.irct.ir/trial/47014,No Results,No Results,No Results,2020-04-21,2020-04-22,None
1941,IRCT20200408046990N1,IRCT,2020-04-18,2020-05-19,False,Mashhad University of Medical Sciences,Not Recruiting,Phase 3,Interventional,Iran,Evaluation of SinaCurcumin capsule efficacy as an supplement therapy for mild to moderate COVID-19 in Mashhad,Traditional Medicine (Drug),Traditional Medicine,60,Not Available,Not Available,http://en.irct.ir/trial/47061,No Results,No Results,No Results,2020-04-21,2020-04-22,None
1942,IRCT20200217046526N2,IRCT,2020-04-13,2020-04-05,True,Iranian Academic Center for Education Culture and Research,Recruiting,Phase 2/Phase 3,Interventional,Iran,Mesenchymal Stem Cell Therapy for Acute Respiratory Distress Syndrome in Coronavirus Infection,ATMP,Cells (mesenchymal),60,Not Available,Not Available,http://en.irct.ir/trial/47073,No Results,No Results,No Results,2020-04-21,2020-04-22,None
1943,IRCT20200411047025N1,IRCT,2020-04-14,2020-04-18,False,Tehran University of Medical Sciences,Recruiting,Phase 2/Phase 3,Interventional,Iran,Effect of Intravenous vitamin c in Patients with COVID-19,Drug,Vitamin C + Hydroxychloroquine + Atazanavir/ritonavir vs. Hydroxychloroquine + Atazanavir/ritonavir,110,Not Available,Not Available,http://en.irct.ir/trial/47078,No Results,No Results,No Results,2020-04-21,2020-04-22,None
1944,IRCT20200415047089N1,IRCT,2020-04-19,2020-04-18,True,Saveh University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,The effect of herbal drugs (Echinacea and Ginger) on Improvement of clinical symptoms and hospitalizations in suspected COVID-19 outpatient cases,Traditional Medicine (Drug),Traditional Medicine,100,Not Available,Not Available,http://en.irct.ir/trial/47234,No Results,No Results,No Results,2020-04-21,2020-04-22,None
1945,IRCT20200415047092N1,IRCT,2020-04-20,2020-04-24,False,Tehran University of Medical Sciences,Not Recruiting,Phase 3,Interventional,Iran,The effect of azithromycin in treatment of COVID19,Drug,Azithromycin +  Oseltamivir + Lopinavir/ritonavir or Atazanavir + Hydroxychloroquine vs. Oseltamivir + Lopinavir/ritonavir or Atazanavir + Hydroxychloroquine,110,Not Available,Not Available,http://en.irct.ir/trial/47244,No Results,No Results,No Results,2020-04-21,2020-04-22,None
1946,JPRN-JapicCTI-205238,JPRN,2020-03-27,2020-03-31,False,"FUJIFILM Toyama Chemical Co., Ltd.",Recruiting,Phase 3,Interventional,Japan,Phase 3 Clinical Study of Favipiravir in Patients with COVID-19 Non-Severe Pneumonia,Drug,Favipiravir,96,Not Available,Not Available,https://www.clinicaltrials.jp/user/showCteDetailE.jsp?japicId=JapicCTI-205238,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1947,JPRN-jRCTs031190226,JPRN,2020-02-27,2020-03-14,False,Tokue Yutaka,Recruiting,Phase 2,Interventional,Japan,Favipiravir in patients infected with COVID-19,Drug,Favipiravir,50,Not Available,Not Available,https://jrct.niph.go.jp/latest-detail/jRCTs031190226,No Results,No Results,No Results,2020-04-20,2020-03-25,None
1948,JPRN-jRCTs031190227,JPRN,2020-02-27,2020-04-01,False,Tokue Yutaka,Recruiting,Phase 2,Interventional,Japan,Triple combination therapy in patients infected with COVID-19,Drug,Lopinavir/ritonavir + hydroxychloroquine (w/ and w/o oseltamivir),50,Not Available,Not Available,https://jrct.niph.go.jp/latest-detail/jRCTs031190227,No Results,No Results,No Results,2020-04-20,2020-03-25,None
1949,JPRN-UMIN000039986,JPRN,2020-03-31,2020-03-28,True,Yokohama City University,Not Recruiting,Not Applicable,Other,Japan,Risk factors of death from coronavirus disease 2019,Prognosis,No Intervention,Not Available,Not Available,2020-03-28,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000045582,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1950,JPRN-UMIN000040185,JPRN,2020-04-17,2020-04-17,False,Keio University School of Medicine,Recruiting,Not Applicable,Observational,Japan,Multicenter prospective cohort study evaluating outcome of COVID-19 in patients with hepatobiliary-pancreatic disease,Clinical Presentation,No Intervention,600,Not Available,2020-04-17,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000045820,No Results,No Results,No Results,2020-04-20,2020-04-22,None
1951,NCT04313127,ClinicalTrials.gov,2020-03-15,2020-03-16,False,CanSino Biologics Inc.,Not Recruiting,Phase 1,Interventional,China,Phase I Clinical Trial of a COVID-19 Vaccine in 18-60 Healthy Adults,ATMP,Adenovirus vector,108,2020-12-30,2022-12-20,https://clinicaltrials.gov/show/NCT04313127,No Results,No Results,No Results,2020-04-27,2020-03-25,None
1952,NCT04320277,ClinicalTrials.gov,2020-03-20,2020-05-16,False,Hospital of Prato,Not Recruiting,Phase 2/Phase 3,Interventional,Italy,"Baricitinib in Symptomatic Patients Infected by COVID-19: an Open-label, Pilot Study.",Drug,Baricitinib,200,2020-06-30,2020-07-30,https://clinicaltrials.gov/show/NCT04320277,No Results,No Results,No Results,2020-04-27,2020-04-01,None
1953,NCT04322396,ClinicalTrials.gov,2020-03-23,2020-04-06,False,Chronic Obstructive Pulmonary Disease Trial Network,Recruiting,Phase 2,Interventional,Denmark,Proactive Prophylaxis With Azithromycin and Chloroquine in Hospitalized Patients With COVID-19,Drug (Chemoprophylaxis),Hydroxychloroquine + Azithromycin,226,2020-10-31,2021-03-31,https://clinicaltrials.gov/show/NCT04322396,No Results,No Results,No Results,2020-04-27,2020-04-01,None
1954,NCT04322487,ClinicalTrials.gov,2020-03-23,2020-04-08,False,Catholic University of the Sacred Heart,Recruiting,Not Applicable,Observational,Italy,"Simple, Safe, Same: Lung Ultrasound for COVID-19",Diagnostics,Diagnostic Test or Assessment,100,2020-12-31,2021-01-15,https://clinicaltrials.gov/show/NCT04322487,No Results,No Results,No Results,2020-04-27,2020-04-01,None
1955,NCT04323787,ClinicalTrials.gov,2020-03-24,2020-03-30,False,Mayo Clinic,Recruiting,Not Applicable,Observational,United States,Viral Infection and Respiratory Illness Universal Study[VIRUS]: COVID-19 Registry,Clinical Presentation,No Intervention,50000,2021-04-30,2021-04-30,https://clinicaltrials.gov/show/NCT04323787,No Results,No Results,No Results,2020-04-27,2020-04-01,None
1956,NCT04325633,ClinicalTrials.gov,2020-03-26,2020-04-13,False,Assistance Publique  Hpitaux de Paris,Not Recruiting,Phase 3,Interventional,No Country Given,Efficacy of Addition of Naproxen in the Treatment of Critically Ill Patients Hospitalized for COVID-19 Infection,Drug,Naproxen,584,2021-05-13,2021-07-13,https://clinicaltrials.gov/show/NCT04325633,No Results,No Results,No Results,2020-04-27,2020-04-01,None
1957,NCT04333420,ClinicalTrials.gov,2020-04-01,2020-03-31,True,InflaRx GmbH,Recruiting,Phase 2/Phase 3,Interventional,Netherlands,"Open-label, Randomized Study of IFX-1 in Patients With Severe COVID-19 Pneumonia",Drug,IFX-1,130,2020-10-31,2020-12-31,https://clinicaltrials.gov/show/NCT04333420,No Results,No Results,No Results,2020-04-27,2020-04-07,EUCTR2020-001335-28
1958,NCT04334434,ClinicalTrials.gov,2020-04-02,2020-04-20,False,Kubra Koce,Not Recruiting,Not Applicable,Interventional,Turkey,Telerehabilitation in Individuals Over 65 Years of Age Having Social Isolation Due to Coronavirus (Covid-19),Telehealth,Rehabilitation,30,2020-06-01,2020-07-31,https://clinicaltrials.gov/show/NCT04334434,No Results,No Results,No Results,2020-04-27,2020-04-15,None
1959,NCT04335773,ClinicalTrials.gov,2020-04-03,2020-04-03,False,"University Hospital, Akershus",Recruiting,Not Applicable,Observational,Norway,"COVID-19 in Hospitalised Norwegian Children - Risk Factors, Outcomes and Immunology",Clinical Presentation,No Intervention,350,2030-12-31,2030-12-31,https://clinicaltrials.gov/show/NCT04335773,No Results,No Results,No Results,2020-04-27,2020-04-15,None
1960,NCT04339426,ClinicalTrials.gov,2020-04-07,2020-04-20,False,HonorHealth Research Institute,Recruiting,Phase 2,Interventional,United States,Atovaquone and Azithromycin Combination for Confirmed COVID-19 Infection,Drug,Atovaquone + azithromycin,25,2020-10-01,2021-04-01,https://clinicaltrials.gov/show/NCT04339426,No Results,No Results,No Results,2020-04-27,2020-04-15,None
1961,NCT04340466,ClinicalTrials.gov,2020-04-07,2020-04-03,True,CHU de Nimes,Recruiting,Not Applicable,Observational,France,French Multicentre Observational Study on SARS-Cov-2 Infections (COVID-19) ICU Management Study,Clinical Presentation,No Intervention,220,2020-06-30,2021-04-30,https://clinicaltrials.gov/show/NCT04340466,No Results,No Results,No Results,2020-04-27,2020-04-15,None
1962,NCT04341584,ClinicalTrials.gov,2020-04-07,2020-04-01,True,Assistance Publique  Hpitaux de Paris,Not Recruiting,Phase 2,Interventional,No Country Given,CORIMUNO-ANA: Trial Evaluating Efficacy Of Anakinra In Patients With Covid-19 Infection,Drug,Anakinra,240,2020-05-01,2020-12-31,https://clinicaltrials.gov/show/NCT04341584,No Results,No Results,No Results,2020-04-27,2020-04-15,None
1963,NCT04342156,ClinicalTrials.gov,2020-04-08,2020-04-01,True,Tan Tock Seng Hospital,Not Recruiting,Phase 3,Interventional,No Country Given,Safety And Efficacy Of Hydroxychloroquine For At Risk Population (SHARP) Against COVID-19,Drug (Chemoprophylaxis),Hydroxychloroquine,1200,2020-08-01,2020-10-01,https://clinicaltrials.gov/show/NCT04342156,No Results,No Results,No Results,2020-04-27,2020-04-15,None
1964,NCT04342169,ClinicalTrials.gov,2020-04-07,2020-04-14,False,University of Utah,Recruiting,Phase 2,Interventional,United States,University of Utah COVID-19 Hydrochloroquine Trial,Drug,Hydroxychloroquine,400,2022-04-01,2023-04-01,https://clinicaltrials.gov/show/NCT04342169,No Results,No Results,No Results,2020-04-27,2020-04-15,None
1965,NCT04342637,ClinicalTrials.gov,2020-04-07,2020-04-10,False,Al-Azhar University,Recruiting,Not Applicable,Observational,"Egypt, United States, Iran",COVID-19 Endoscopy Survey,Other,Other,40,2020-10-10,2020-12-10,https://clinicaltrials.gov/show/NCT04342637,No Results,No Results,No Results,2020-04-27,2020-04-15,None
1966,NCT04342650,ClinicalTrials.gov,2020-04-04,2020-04-08,False,Fundao de Medicina Tropical Dr. Heitor Vieira Dourado,Recruiting,Phase 2,Interventional,Brazil,Chloroquine Diphosphate in the Prevention of SARS in Covid-19 Infection,Drug,Chloroquine,210,2020-09-01,2020-09-01,https://clinicaltrials.gov/show/NCT04342650,No Results,No Results,No Results,2020-04-27,2020-04-15,None
1967,NCT04343001,ClinicalTrials.gov,2020-04-08,2020-04-01,True,London School of Hygiene and Tropical Medicine,Not Recruiting,Phase 3,Interventional,"Nigeria, Pakistan",Coronavirus Response - Active Support for Hospitalised Covid-19 Patients,Drug,"Monotherapy and all Combinations of: ARB (Losartan), simvastatin, and aspirin",10000,2021-04-01,2021-08-01,https://clinicaltrials.gov/show/NCT04343001,No Results,No Results,No Results,2020-04-27,2020-04-15,None
1968,NCT04343339,ClinicalTrials.gov,2020-04-08,2020-04-08,False,"University Hospital, Montpellier",Recruiting,Not Applicable,Observational,France,Evolution of Psychoactive Substances Consumption in Connection With COVID-19 Containment,Other (psych),No Intervention,100,2020-07-30,2020-09-30,https://clinicaltrials.gov/show/NCT04343339,No Results,No Results,No Results,2020-04-27,2020-04-15,None
1969,NCT04343664,ClinicalTrials.gov,2020-04-09,2020-04-12,False,Tjhin Wiguna,Not Recruiting,Not Applicable,Observational,Indonesia,Mental Health Assessment Among Community Member During the Covid-19 Pandemic in Indonesia,Other (psych),No Intervention,10000,2020-06-30,2020-12-31,https://clinicaltrials.gov/show/NCT04343664,No Results,No Results,No Results,2020-04-27,2020-04-15,None
1970,NCT04343963,ClinicalTrials.gov,2020-04-09,2020-04-04,True,Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran,Recruiting,Phase 2/Phase 3,Interventional,Mexico,Pyridostigmine in Severe SARS-CoV-2 Infection,Drug,Pyridostigmine,436,2020-09-30,2021-04-30,https://clinicaltrials.gov/show/NCT04343963,No Results,No Results,No Results,2020-04-27,2020-04-22,None
1971,NCT04344145,ClinicalTrials.gov,2020-04-09,2020-04-16,False,Universit Libre de Bruxelles,Recruiting,Not Applicable,Observational,Belgium,Exhaustion and Needs in Frontline COVID-19 Healthcare Workers: Cross-sectional Study in a Belgian Population,Other (psych),No Intervention,200,2020-06-15,2020-07-15,https://clinicaltrials.gov/show/NCT04344145,No Results,No Results,No Results,2020-04-27,2020-04-22,None
1972,NCT04344171,ClinicalTrials.gov,2020-04-10,2020-03-30,True,ClarData,Recruiting,Not Applicable,Observational,"Germany, Romania",CovidDB: The Covid-19 Inpatient Database,Clinical Presentation,No Intervention,5000,2022-12-31,2023-06-30,https://clinicaltrials.gov/show/NCT04344171,No Results,No Results,No Results,2020-04-27,2020-04-22,None
1973,NCT04344964,ClinicalTrials.gov,2020-04-10,2020-04-15,False,Austin Health,Not Recruiting,Not Applicable,Observational,No Country Given,Endoscopy-related Phone Consultation During the COVID-19 Outbreak,Telehealth,Telehealth,150,2020-06-15,2020-06-15,https://clinicaltrials.gov/show/NCT04344964,No Results,No Results,No Results,2020-04-27,2020-04-22,None
1974,NCT04345276,ClinicalTrials.gov,2020-04-10,2020-03-18,True,Huo-Shen-Shan Hospital,Recruiting,Phase 4,Interventional,China,Efficacy and Safety of Ganovo (Danoprevir) Combined With Ritonavir in the Treatment of SARS-CoV-2 Infection,Drug,Danoprevir + Ritonavir,40,2020-04-30,2020-05-31,https://clinicaltrials.gov/show/NCT04345276,No Results,No Results,No Results,2020-04-27,2020-04-22,None
1975,NCT04345289,ClinicalTrials.gov,2020-04-10,2020-04-20,True,Thomas Benfield,Not Recruiting,Phase 3,Interventional,Denmark,Efficacy and Safety of Novel Treatment Options for Adults With COVID-19 Pneumonia,Drug (+ ATMP),Plamsa vs. Sarilumab vs. Hydroxychloroquine vs. Baricitinib,1500,2021-06-15,2021-06-15,https://clinicaltrials.gov/show/NCT04345289,No Results,No Results,No Results,2020-04-27,2020-04-22,EUCTR2020-001367-88
1976,NCT04345510,ClinicalTrials.gov,2020-04-12,2020-04-20,False,German Cancer Research Center,Not Recruiting,Not Applicable,Observational,No Country Given,Testing for COVID-19 Infection in Asymptomatic Persons,Clinical Presentation (Epidemiology),No Intervention,500,2020-05-31,2020-12-31,https://clinicaltrials.gov/show/NCT04345510,No Results,No Results,No Results,2020-04-27,2020-04-22,None
1977,NCT04345523,ClinicalTrials.gov,2020-04-02,2020-04-03,False,Cristina Avendao Sol,Recruiting,Phase 2,Interventional,Spain,Convalescent Plasma Therapy vs. SOC for the Treatment of COVID19 in Hospitalized Patients,ATMP,Plasma,278,2020-07-01,2020-07-01,https://clinicaltrials.gov/show/NCT04345523,No Results,No Results,No Results,2020-04-27,2020-04-22,None
1978,NCT04345692,ClinicalTrials.gov,2020-04-09,2020-03-26,True,Queen's Medical Centre,Recruiting,Phase 3,Interventional,United States,A Randomized Controlled Clinical Trial: Hydroxychloroquine for the Treatment of COVID-19 in Hospitalized Patients,Drug,Hydroxychloroquine,350,2021-12-31,2021-12-31,https://clinicaltrials.gov/show/NCT04345692,No Results,No Results,No Results,2020-04-27,2020-04-22,None
1979,NCT04346160,ClinicalTrials.gov,2020-04-10,2020-04-14,False,D'Annunzio University of ChietiPescara,Not Recruiting,Not Applicable,Observational,Italy,"A Study to Assess the Virus RNA, and miRNA Levels Related to Viral Infection, and Inflammatory Response in Tears of Patients Affected by COVID-19 Disease",Diagnostics,Diagnostic Test or Assessment,25,2020-04-30,2020-04-30,https://clinicaltrials.gov/show/NCT04346160,No Results,No Results,No Results,2020-04-27,2020-04-22,None
1980,NCT04346186,ClinicalTrials.gov,2020-04-11,2020-04-15,False,"Copenhagen University Hospital, Herlev Hospital",Not Recruiting,Not Applicable,Observational,Denmark,COVID-19: Investigation of Transmission and Immunisation Among Hospital Staff,Diagnostics,Diagnostic Test or Assessment,30000,2020-10-01,2021-08-01,https://clinicaltrials.gov/show/NCT04346186,No Results,No Results,No Results,2020-04-27,2020-04-22,None
1981,NCT04346368,ClinicalTrials.gov,2020-03-23,2020-04-01,False,Guangzhou Institute of Respiratory Disease,Not Recruiting,Phase 1/Phase 2,Interventional,China,Bone Marrow-Derived Mesenchymal Stem Cell Treatment for Severe Patients With Coronavirus Disease 2019 (COVID-19),ATMP,Cells (mesenchymal),20,2020-12-01,2020-12-01,https://clinicaltrials.gov/show/NCT04346368,No Results,No Results,No Results,2020-04-27,2020-04-22,None
1982,NCT04346810,ClinicalTrials.gov,2020-04-08,2020-04-15,False,Assistance Publique  Hpitaux de Paris,Not Recruiting,Not Applicable,Observational,No Country Given,Burnout Among Caregivers Facing COVID-19 Health Crisis at a Non-conventional Intensive Care Unit Compared to a Conventional Intensive Care Unit,Other (psych),No Intervention,100,2020-08-15,2020-09-01,https://clinicaltrials.gov/show/NCT04346810,No Results,No Results,No Results,2020-04-27,2020-04-22,None
1983,NCT04347278,ClinicalTrials.gov,2020-04-03,2020-04-15,False,Instituto de Investigacin Marqus de Valdecilla,Not Recruiting,Not Applicable,Observational,No Country Given,Observational Study of Follow-up of Hospitalized Patients Diagnosed With COVID-19 to Evaluate the Effectiveness of the Drug Treatment Used to Treat This Disease. COVID-19 Registry,Drug,Unspecified,100,2020-10-15,2021-01-01,https://clinicaltrials.gov/show/NCT04347278,No Results,No Results,No Results,2020-04-27,2020-04-22,None
1984,NCT04347460,ClinicalTrials.gov,2020-04-08,2020-03-27,True,Technische Universitt Mnchen,Recruiting,Not Applicable,Observational,Germany,Establishing a COVID-19 Prospective Cohort for Identification of Secondary HLH,Clinical Presentation,No Intervention,20,2020-07-01,2020-08-31,https://clinicaltrials.gov/show/NCT04347460,No Results,No Results,No Results,2020-04-27,2020-04-22,None
1985,NCT04347889,ClinicalTrials.gov,2020-04-13,2020-04-20,False,Stony Brook University,Not Recruiting,Phase 2,Interventional,No Country Given,Preventing COVID-19 in Healthcare Workers With HCQ: A RCT,Drug (Chemoprophylaxis),Hydroxychloroquine vs. Vitamin C,1212,2020-12-30,2020-12-30,https://clinicaltrials.gov/show/NCT04347889,No Results,No Results,No Results,2020-04-27,2020-04-22,None
1986,NCT04347915,ClinicalTrials.gov,2020-04-14,2020-04-24,False,Bukwang Pharmaceutical,Not Recruiting,Phase 2,Interventional,No Country Given,The Phase 2 Study to Evaluate the Safety and Efficacy of Clevudine in Patients With Moderate COVID-19,Drug,Clevudine vs. Hydroxychloroquine,60,2020-09-30,2020-12-31,https://clinicaltrials.gov/show/NCT04347915,No Results,No Results,No Results,2020-04-27,2020-04-22,None
1987,NCT04347928,ClinicalTrials.gov,2020-04-08,2020-04-01,True,"University Hospital, Lille",Not Recruiting,Not Applicable,Observational,No Country Given,Respiratory and Hemodynamic Changes Induced in Mechanically Ventilated Patients for COVID-19,Clinical Presentation,No Intervention,15,2020-09-01,2020-09-01,https://clinicaltrials.gov/show/NCT04347928,No Results,No Results,No Results,2020-04-27,2020-04-22,None
1988,NCT04348552,ClinicalTrials.gov,2020-04-13,2020-04-15,False,Nantes University Hospital,Not Recruiting,Not Applicable,Observational,France,Non-COVID Patient-safety Incidents Reported by Primary Care Professionals in Time of Lockdown: Protocol for a Cross-sectional Descriptive Study,Other,No Intervention,1000,2020-06-15,2020-06-15,https://clinicaltrials.gov/show/NCT04348552,No Results,No Results,No Results,2020-04-27,2020-04-22,None
1989,NCT04349410,ClinicalTrials.gov,2020-04-11,2020-04-11,False,The Camelot Foundation,Recruiting,Phase 2/Phase 3,Interventional,United States,The Fleming [FMTVDM] Directed CoVid-19 Treatment Protocol,Drug (+ ATMP),Hydroxychloroquine + Azithromycin vs. Hydroxychloroquine + Doxycycline vs. Hydroxychloroquine + Clindamycin vs. Hydroxychloroquine  + Clindamycin + Primaquine vs. Remdesivir vs. Tocilizumab vs. Corticosteroids vs. Interferon alpha vs. Losartan vs. Plasma,500,2020-10-11,2020-11-11,https://clinicaltrials.gov/show/NCT04349410,No Results,No Results,No Results,2020-04-27,2020-04-22,None
1990,NCT04349618,ClinicalTrials.gov,2020-04-08,2020-04-14,False,Hospices Civils de Lyon,Not Recruiting,Not Applicable,Interventional,France,Ultraprotective Ventilation Without Extracorporeal Circulation During COVID 19 Pneumonia,Other (physical),Mechanical ventilation,200,2021-07-14,2022-04-14,https://clinicaltrials.gov/show/NCT04349618,No Results,No Results,No Results,2020-04-27,2020-04-22,None
1991,NCT04350086,ClinicalTrials.gov,2020-04-13,2020-04-20,False,"University Hospital, Limoges",Not Recruiting,Phase 4,Interventional,France,Use of Dexmedetomidine in Light to Moderate Sedation in the Patient in the Palliative Situation of a Sars-cov-2 / COVID-19 Infection,Drug,Dexmedetomidine,10,2020-11-20,2020-11-20,https://clinicaltrials.gov/show/NCT04350086,No Results,No Results,No Results,2020-04-27,2020-04-22,None
1992,NCT04350099,ClinicalTrials.gov,2020-04-11,2020-04-15,False,"University Hospital, Limoges",Not Recruiting,Not Applicable,Observational,France,Emotional Burden of Healthcare Professionals and Covid Infection 19,Other (psych),No Intervention,200,2020-12-15,2021-06-15,https://clinicaltrials.gov/show/NCT04350099,No Results,No Results,No Results,2020-04-27,2020-04-22,None
1993,NCT04350281,ClinicalTrials.gov,2020-04-13,2020-04-09,True,The University of Hong Kong,Recruiting,Phase 2,Interventional,Hong Kong,Double Therapy With IFN-beta 1b and Hydroxychloroquine,Drug,Interferon beta + Hydroxychloroquine vs. Hydroxychloroquine,80,2022-03-31,2022-07-31,https://clinicaltrials.gov/show/NCT04350281,No Results,No Results,No Results,2020-04-27,2020-04-22,None
1994,NCT04350931,ClinicalTrials.gov,2020-04-13,2020-04-20,False,Ain Shams University,Not Recruiting,Phase 3,Interventional,Egypt,Application of BCG Vaccine for Immune-prophylaxis Among Egyptian Healthcare Workers During the Pandemic of COVID-19,ATMP,Vaccine,900,2020-10-01,2020-12-01,https://clinicaltrials.gov/show/NCT04350931,No Results,No Results,No Results,2020-04-27,2020-04-22,None
1995,NCT04351399,ClinicalTrials.gov,2020-04-14,2020-04-01,True,"University Hospital, Lille",Not Recruiting,Not Applicable,Observational,No Country Given,Psychological Impact of Quarantine in Rheumatoid Arthritis Patient During COVID-19 Outbreak,Other (psych),No Intervention,100,2020-12-01,2020-12-01,https://clinicaltrials.gov/show/NCT04351399,No Results,No Results,No Results,2020-04-27,2020-04-22,None
1996,NCT04351620,ClinicalTrials.gov,2020-04-14,2020-04-01,True,University of Chicago,Recruiting,Phase 1,Interventional,United States,High-dose Hydroxychloroquine for the Treatment of Ambulatory Patients With Mild COVID-19,Drug,Hydroxychloroquine,20,2020-06-01,2020-06-01,https://clinicaltrials.gov/show/NCT04351620,No Results,No Results,No Results,2020-04-27,2020-04-22,None
1997,NCT04351789,ClinicalTrials.gov,2020-04-11,2020-04-01,True,"Copenhagen University Hospital, Hvidovre",Not Recruiting,Not Applicable,Interventional,No Country Given,Impact of a Minimal Psychoeducational Intervention on Anxiety Among Hospitalized COVID-19 Patients in Denmark,Other (psych),Psychological,66,2023-04-01,2023-04-01,https://clinicaltrials.gov/show/NCT04351789,No Results,No Results,No Results,2020-04-27,2020-04-22,None
1998,NCT04351802,ClinicalTrials.gov,2020-04-16,2020-04-20,False,University Hospital Plymouth NHS Trust,Not Recruiting,Not Applicable,Observational,No Country Given,CORonavirus (COVID-19) Diagnostic Lung UltraSound Study,Diagnostics,Diagnostic Test or Assessment,180,2021-01-20,2021-01-20,https://clinicaltrials.gov/show/NCT04351802,No Results,No Results,No Results,2020-04-27,2020-04-22,None
1999,NCT04352699,ClinicalTrials.gov,2020-04-14,2020-03-15,True,CHU de Nice,Recruiting,Not Applicable,Observational,France,Outcomes of Urological Surgery During Periods of Social COVID-19 Containemnt: is it Reasonable to Limit Access to Surgical Care for All?,Clinical Presentation,No Intervention,120,2020-04-17,2020-05-01,https://clinicaltrials.gov/show/NCT04352699,No Results,No Results,No Results,2020-04-27,2020-04-29,None
2000,NCT04353323,ClinicalTrials.gov,2020-04-15,2020-04-25,False,"University Hospital, Limoges",Not Recruiting,Not Applicable,Observational,France,COVID 19-Caregivers IGg Seroconversion,Clinical Presentation (Epidemiology),No Intervention,130,2020-06-25,2020-12-25,https://clinicaltrials.gov/show/NCT04353323,No Results,No Results,No Results,2020-04-27,2020-04-29,None
2001,NCT04353336,ClinicalTrials.gov,2020-04-15,2020-04-17,False,Tanta University,Not Recruiting,Phase 2/Phase 3,Interventional,Egypt,Efficacay of Chloroquine in COVID-19 Treatment,Drug,Chloroquine,40,2030-12-01,2030-12-01,https://clinicaltrials.gov/show/NCT04353336,No Results,No Results,No Results,2020-04-27,2020-04-29,None
2002,NCT04354441,ClinicalTrials.gov,2020-04-14,2020-05-01,False,Sir Mortimer B. Davis - Jewish General Hospital,Not Recruiting,Phase 2,Interventional,No Country Given,Effect of Hydroxychloroquine in COVID-19 Positive Pregnant Women,Drug,Hydroxychloroquine,600,2020-11-01,2020-11-01,https://clinicaltrials.gov/show/NCT04354441,No Results,No Results,No Results,2020-04-27,2020-04-29,None
2003,NCT04354857,ClinicalTrials.gov,2020-04-17,2020-03-27,True,CHU de Nimes,Recruiting,Not Applicable,Observational,France,Qualitative and Quantitative Evaluation of Anosmia Over Time in Clinically Symptomatic Patients Tested for COVID-19 Infection,Clinical Presentation,No Intervention,454,2020-07-01,2020-11-01,https://clinicaltrials.gov/show/NCT04354857,No Results,No Results,No Results,2020-04-27,2020-04-29,None
2004,NCT04355741,ClinicalTrials.gov,2020-04-15,2020-04-01,True,University Nova de Lisboa,Not Recruiting,Not Applicable,Observational,Portugal,"Gut Microbiota, ""Spark and Flame"" of COVID-19 Disease",Clinical Presentation,No Intervention,60,2020-07-01,2020-12-01,https://clinicaltrials.gov/show/NCT04355741,No Results,No Results,No Results,2020-04-27,2020-04-29,None
2005,NCT04356417,ClinicalTrials.gov,2020-04-17,2020-04-01,True,Assistance Publique  Hpitaux de Paris,Not Recruiting,Not Applicable,Observational,France,Long-term Use of Drugs That Could Prevent the Risk of Serious COVID-19 Infections or Make it Worse,Drug,Synthetic anti-malarials,6000000,2020-06-01,2020-06-01,https://clinicaltrials.gov/show/NCT04356417,No Results,No Results,No Results,2020-04-27,2020-04-29,None
2006,NCT04357275,ClinicalTrials.gov,2020-04-15,2020-03-13,True,University of Zurich,Recruiting,Not Applicable,Observational,Switzerland,The RIsk Stratification in COVID-19 Patients in the ICU Registry,Clinical Presentation,No Intervention,10000,2021-03-01,2022-03-01,https://clinicaltrials.gov/show/NCT04357275,No Results,No Results,No Results,2020-04-27,2020-04-29,None
2007,ACTRN12620000417987,ANZCTR,2020-03-30,2020-03-30,False,Australian Defence Force Malaria and Infectious Disease Institute,Recruiting,Phase 4,Interventional,Australia,Chloroquine Chemorophylaxis Countermeasure against COVID-19,Drug,Chloroquine,680,Not Available,2020-09-28,https://anzctr.org.au/ACTRN12620000417987.aspx,No Results,No Results,No Results,2020-04-27,2020-04-01,None
2008,ACTRN12620000482965,ANZCTR,2020-04-17,2020-03-17,True,Juan Pedro Fuentes Garca,Not Recruiting,Not Applicable,Interventional,Spain,"Impact of high intensity interval training and aerobic training on stress, depression symptoms, anxiety and resilience in self-isolated people during the COVID-19 health emergency in Spain",Other (exercise),Exercise,34,Not Available,2020-04-26,https://anzctr.org.au/ACTRN12620000482965.aspx,No Results,No Results,No Results,2020-04-27,2020-04-22,None
2009,ACTRN12620000501943,ANZCTR,2020-04-22,2020-04-28,False,Walter and Eliza Hall Institute of Medical Research,Not Recruiting,Phase 2/Phase 3,Interventional,Australia,COVID-19 prophylaxis with hydroxychloroquine in Front-line Health and Allied-Health Care Workers: The COVID-SHIELD Trial,Drug (Chemoprophylaxis),Hydroxychloroquine,2250,Not Available,2020-11-30,https://anzctr.org.au/ACTRN12620000501943.aspx,No Results,No Results,No Results,2020-04-27,2020-04-29,None
2010,ACTRN12620000498998,ANZCTR,2020-04-20,2020-04-22,False,Tenon Hospital,Not Recruiting,Not Applicable,Observational,France,Retrospective Study on surgical outcomes among surgical patients during the COVID-19 (SARS-CoV-2) Pandemic,Clinical Presentation,No Intervention,700,Not Available,2021-04-07,https://anzctr.org.au/ACTRN12620000498998.aspx,No Results,No Results,No Results,2020-04-27,2020-04-29,None
2011,ACTRN12620000493943,ANZCTR,2020-04-20,2020-04-07,True,Albury Wodonga Health,Recruiting,Not Applicable,Observational,Australia,Study evaluating Front-line health care workers serial blood COVID-19 antibody results in relation to symptom presentation,Clinical Presentation,No Intervention,50,Not Available,2021-04-07,https://anzctr.org.au/ACTRN12620000493943.aspx,No Results,No Results,No Results,2020-04-27,2020-04-22,None
2012,ACTRN12620000500954,ANZCTR,2020-04-22,2020-05-01,False,Western Health,Not Recruiting,Not Applicable,Interventional,Australia,A reusable personalised ventilation hood: A phase 1 safety study of a new device (McMonty) in patients with suspected or confirmed COVID-19.,Other (device),Hood,20,Not Available,2020-06-01,https://anzctr.org.au/ACTRN12620000500954.aspx,No Results,No Results,No Results,2020-04-27,2020-04-29,None
2013,ChiCTR2000032400,ChiCTR,2020-04-27,2020-01-01,True,"Ruijin Hospital, Shanghai Jiao Tong University School of Medicine",Recruiting,Not Applicable,Interventional,China,"the efficacy and safety of high dose intravenous vitamin C in the treatment of novel coronavirus pneumonia (COVID-19): a prospective, randomize, controlled trial",Drug,Vitamin C,120,Not Available,2020-06-01,http://www.chictr.org.cn/showproj.aspx?proj=52958,No Results,No Results,No Results,2020-04-27,2020-04-29,None
2014,ChiCTR2000032399,ChiCTR,2020-04-27,2020-04-20,True,Xiaogan Traditional Chinese Medicine Hospital,Recruiting,Not Applicable,Interventional,China,"A multicenter, randomized, double-blind, placebo-controlled trial for Xiaoyao capsule in the improvement of sleep mood disorder of convalescence patients of novel coronavirus pneumonia (COVID-19)",Traditional Medicine (Drug),Traditional Medicine,200,Not Available,2020-07-01,http://www.chictr.org.cn/showproj.aspx?proj=52942,No Results,No Results,No Results,2020-04-27,2020-04-29,None
2015,ChiCTR2000032368,ChiCTR,2020-04-26,2020-04-15,True,China-Japan Friendship Hospital,Not Recruiting,Not Applicable,Health services research,China,Investigation on the mental health status and intervention of the medical staff of the national rescue medical team in hubei province during the pandemic of novel coronavirus pneumonia (COVID-19),Other (psych),Psychological,116,Not Available,2020-10-31,http://www.chictr.org.cn/showproj.aspx?proj=52933,No Results,No Results,No Results,2020-04-27,2020-04-29,None
2016,ChiCTR2000032367,ChiCTR,2020-04-26,2020-02-19,True,Yueyang Hospital of Integrated Traditional Chinese Medicine and Western Medicine Affiliated to Shanghai University of Tranditional Medicine,Recruiting,Not Applicable,Interventional,China,Efficacy of Liu-zi-jue in Patients with 2019 Novel Coronavirus Pneumonia (COVID-19):  a randomized controlled trial,Traditional Medicine (Other),Traditional Medicine,186,Not Available,2020-07-31,http://www.chictr.org.cn/showproj.aspx?proj=52972,No Results,No Results,No Results,2020-04-27,2020-04-29,None
2017,ChiCTR2000032346,ChiCTR,2020-04-26,2020-04-21,True,The First Affiliated Hospital of Guangzhou University of Traditional Chinese Medicine,Recruiting,Not Applicable,Interventional,China,"Lingnan Fire-Needle Therapy Improves the Quality of Life in General Population Under the Pandemic of novel coronavirus pneumonia (COVID-19): A Prospective, Randomized Controlled Trial",Traditional Medicine (Other),Traditional Medicine,120,Not Available,2020-12-31,http://www.chictr.org.cn/showproj.aspx?proj=52692,No Results,No Results,No Results,2020-04-27,2020-04-29,None
2018,ChiCTR2000032314,ChiCTR,2020-04-25,2020-03-01,True,West China Hospital of Sichuan University,Recruiting,Not Applicable,Interventional,China,A randomized clinical trial for the efficacy and safety of Aliskiren and Nifedipine in novel coronavirus pneumonia (COVID-19) patients with hypertension,Drug,Aliskiren vs. Nifedipine,242,Not Available,2020-12-31,http://www.chictr.org.cn/showproj.aspx?proj=52867,No Results,No Results,No Results,2020-04-27,2020-04-29,None
2019,ChiCTR2000032313,ChiCTR,2020-04-25,2020-05-01,False,"Beijing University of Chinese Medicine, Third Affiliated Hospital",Not Recruiting,Not Applicable,Interventional,China,Study for efficacy and safety of Jie-Xing-Jun-Zi granules in the Treatment of convalescent patients of novel coronavious pneumonia (COVID-19),Traditional Medicine (Drug),Traditional Medicine,60,Not Available,2020-12-31,http://www.chictr.org.cn/showproj.aspx?proj=52916,No Results,No Results,No Results,2020-04-27,2020-04-29,None
2020,ChiCTR2000032242,ChiCTR,2020-04-24,2020-04-24,False,Mudanjiang Kang'an Hospital,Not Recruiting,Not Applicable,Interventional,China,"A multicenter, randomized, open, controlled trial for the efficacy and safety of oral kolimycin in the treatment of patients with new coronavirus pneumonia (CoVID-19)",Traditional Medicine (Drug),Traditional Medicine,350,Not Available,2021-05-01,http://www.chictr.org.cn/showproj.aspx?proj=52824,No Results,No Results,No Results,2020-04-27,2020-04-29,None
2021,ISRCTN77353041,ISRCTN,2020-04-07,2020-04-08,False,University of Zurich,Recruiting,Not Applicable,Observational,Switzerland,Cohort study for predicting severe disease courses in patients presenting for coronavirus testing to the University of Zurich COVID-19 Testing Center,Clinical Presentation,No Intervention,2000,Not Available,2020-12-31,http://isrctn.com/ISRCTN77353041,No Results,No Results,No Results,2020-04-27,2020-04-15,None
2022,ISRCTN86534580,ISRCTN,2020-03-22,2020-03-25,True,University of Oxford,Recruiting,Phase 3,Interventional,United Kingdom,A trial evaluating treatments for suspected coronavirus infection in people aged 50 years and above with pre-existing conditions and those aged 65 years and above,Drug,Hydroxychloroquine,3000,Not Available,2021-03-24,http://isrctn.com/ISRCTN86534580,No Results,No Results,No Results,2020-04-27,2020-03-25,EUCTR2020-001209-22
2023,EUCTR2020-001329-30-AT,EU Clinical Trials Register,2020-04-03,2020-04-09,False,Massachusetts General Hospital,Authorised,Phase 4,Interventional,"China, United States, Austria",Therapy with Inhaled Nitric Oxide for Patients Infected with Coronavirus Suffering form Lung Failure,Drug,Nitric oxide,200,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001329-30,No Results,No Results,No Results,2020-04-29,2020-04-29,None
2024,EUCTR2020-001527-14-NL,EU Clinical Trials Register,2020-04-06,2020-04-21,False,Erasmus MC,Authorised,Phase 4,Interventional,Netherlands,COVID-19: addition of azithromycin to chloroquine treatment,Drug,Chloroquine + Azithromycin,60,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001527-14,No Results,No Results,No Results,2020-04-29,2020-04-29,None
2025,EUCTR2020-001363-85-DK,EU Clinical Trials Register,2020-04-17,2020-04-23,False,Odense University Hospital,Authorised,Phase 3,Interventional,Denmark,Medication for prevention of Corona-virus for Danish nursing home residents,Drug (Chemoprophylaxis),Hydroxychloroquine,206,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001363-85,No Results,No Results,No Results,2020-04-29,2020-04-29,None
2026,EUCTR2020-001255-40-ES,EU Clinical Trials Register,2020-04-20,2020-04-16,True,Clnica Universidad de Navarra,Authorised,Phase 2,Interventional,Spain,Sarilumab Treatment In cytoKinE storm caused by infection with COVID-19.,Drug,Sarilumab,60,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001255-40,No Results,No Results,No Results,2020-04-29,2020-04-29,None
2027,EUCTR2020-001659-42-ES,EU Clinical Trials Register,2020-04-20,2020-04-18,True,Fundacin para la Investigacin Biomdica de Crdoba,Authorised,Phase 2,Interventional,Spain,Study of antithrombin as prophylaxis of acute respiratory disease in patients with COVID-19,Drug (Chemoprophylaxis),Antithrombin,46,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001659-42,No Results,No Results,No Results,2020-04-29,2020-04-29,None
2028,EUCTR2020-001536-98-ES,EU Clinical Trials Register,2020-04-20,2020-04-18,True,Mtua Terrassa University Hospital,Authorised,Phase 3,Interventional,Spain,"Prophylaxis of COVID-19 infection with hydroxychloroquine in healthcare
personnel with high risk of infection.",Drug (Chemoprophylaxis),Hydroxychloroquine,300,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001536-98,No Results,No Results,No Results,2020-04-29,2020-04-29,None
2029,EUCTR2020-001500-41-BE,EU Clinical Trials Register,2020-04-04,2020-04-03,True,"University Hospital, Ghent",Authorised,Phase 3,Interventional,Belgium,Treatment of COVID-19 patients with anti-interleukin drugs,Drug,Anakinra or tocilizumab or siltuximab,342,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001500-41,No Results,No Results,No Results,2020-04-29,2020-04-07,None
2030,NCT04303507,ClinicalTrials.gov,2020-03-06,2020-04-01,False,University of Oxford,Not Recruiting,Not Applicable,Interventional,No Country Given,Chloroquine/ Hydroxychloroquine Prevention of Coronavirus Disease (COVID-19) in the Healthcare Setting,Drug,Chloroquine or Hydroxychloroquine,40000,2021-04-01,2021-04-01,https://clinicaltrials.gov/show/NCT04303507,No Results,No Results,No Results,2020-05-04,2020-03-18,None
2031,NCT04311697,ClinicalTrials.gov,2020-03-14,2020-04-01,False,"NeuroRx, Inc.",Not Recruiting,Phase 2,Interventional,"Israel, United States",Intravenous Aviptadil for COVID-19 Associated Acute Respiratory Distress,Drug,Aviptadil,120,2020-08-01,2020-09-01,https://clinicaltrials.gov/show/NCT04311697,No Results,No Results,No Results,2020-05-04,2020-03-25,None
2032,NCT04320472,ClinicalTrials.gov,2020-03-22,2020-03-23,False,Ictal Group,Recruiting,Not Applicable,Observational,"France, United States, Spain",Acute Encephalopathy in Critically Ill Patients With COVID-19,Clinical Presentation,No Intervention,250,2020-12-01,2020-12-01,https://clinicaltrials.gov/show/NCT04320472,No Results,No Results,No Results,2020-05-04,2020-04-01,None
2033,NCT04320615,ClinicalTrials.gov,2020-03-23,2020-04-03,True,Roche,Recruiting,Phase 3,Interventional,"Canada, France, Denmark, Netherlands, Italy, United Kingdom, United States, Germany, Spain",A Study to Evaluate the Safety and Efficacy of Tocilizumab in Patients With Severe COVID-19 Pneumonia,Drug,Tocilizumab,330,2020-08-31,2020-09-30,https://clinicaltrials.gov/show/NCT04320615,No Results,No Results,No Results,2020-05-04,2020-04-01,EUCTR2020-001154-22
2034,NCT04320862,ClinicalTrials.gov,2020-03-23,2020-04-03,False,Duke University,Recruiting,Not Applicable,Observational,United States,COVID-19 Pandemic Response Network,Clinical Presentation (Epidemiology),No Intervention,200000,2021-12-31,2021-12-31,https://clinicaltrials.gov/show/NCT04320862,No Results,No Results,No Results,2020-05-04,2020-04-01,None
2035,NCT04325906,ClinicalTrials.gov,2020-03-26,2020-04-02,False,Rush University Medical Center,Recruiting,Not Applicable,Interventional,United States,Early PP With HFNC Versus HFNC in COVID-19 Induced Moderate to Severe ARDS,Other (device),Nasal cannula,346,2020-05-31,2020-06-30,https://clinicaltrials.gov/show/NCT04325906,No Results,No Results,No Results,2020-05-04,2020-04-07,None
2036,NCT04333914,ClinicalTrials.gov,2020-04-01,2020-04-15,True,Centre Leon Berard,Recruiting,Phase 2,Interventional,France,Prospective Study in Patients With Advanced or Metastatic Cancer and SARS-CoV-2 Infection,Drug,Chloroquine + Nivolumab + Tocilizumab,273,2020-06-01,2020-08-01,https://clinicaltrials.gov/show/NCT04333914,No Results,No Results,No Results,2020-05-04,2020-04-06,EUCTR2020-001373-70
2037,NCT04334265,ClinicalTrials.gov,2020-04-01,2020-04-01,False,Peking University First Hospital,Recruiting,Not Applicable,Interventional,China,Efficacy and Safety of Anluohuaxian in the Treatment of Rehabilitation Patients With Corona Virus Disease 2019,Traditional Medicine (Drug),Traditional Medicine,750,2020-06-01,2020-12-01,https://clinicaltrials.gov/show/NCT04334265,No Results,No Results,No Results,2020-05-04,2020-04-15,None
2038,NCT04335305,ClinicalTrials.gov,2020-03-31,2020-04-14,False,MedSIR,Recruiting,Phase 2,Interventional,Spain,Checkpoint Blockade in COVID-19 Pandemic,Drug,Tocilizumab + Pembrolizumab,24,2020-05-15,2020-05-15,https://clinicaltrials.gov/show/NCT04335305,No Results,No Results,No Results,2020-05-04,2020-04-15,None
2039,NCT04338932,ClinicalTrials.gov,2020-04-07,2020-04-17,False,Jessa Hospital,Not Recruiting,Not Applicable,Observational,No Country Given,COVID-19 and Deep Venous Thrombosis,Clinical Presentation,No Intervention,12,2020-09-30,2020-12-30,https://clinicaltrials.gov/show/NCT04338932,No Results,No Results,No Results,2020-05-04,2020-04-15,None
2040,NCT04341389,ClinicalTrials.gov,2020-04-07,2020-04-12,False,"Insitute of Biotechnology, Academy of Military Medical Sciences, PLA of China",Not Recruiting,Phase 2,Interventional,China,A Phase II Clinical Trial to Evaluate the Recombinant Vaccine for COVID-19 (Adenovirus Vector),ATMP,Vaccine,500,2021-01-31,2021-01-31,https://clinicaltrials.gov/show/NCT04341389,No Results,No Results,No Results,2020-05-04,2020-04-15,None
2041,NCT04341493,ClinicalTrials.gov,2020-04-07,2020-04-06,True,Hugo Mendieta Zeron,Recruiting,Phase 4,Interventional,Mexico,Hydroxychloroquine vs Nitazoxanide in Patients With COVID-19,Drug,Hydroxychloroquine vs. Nitazoxanide,86,2020-08-30,2020-12-30,https://clinicaltrials.gov/show/NCT04341493,No Results,No Results,No Results,2020-05-04,2020-04-15,None
2042,NCT04346797,ClinicalTrials.gov,2020-04-06,2020-04-16,False,Assistance Publique  Hpitaux de Paris,Recruiting,Phase 2,Interventional,France,"CORIMUNO19-ECU: Trial Evaluating Efficacy and Safety of Eculizumab (Soliris) in Patients With COVID-19 Infection, Nested in the CORIMUNO-19 Cohort",Drug,Eculizumab,120,2020-09-30,2020-12-31,https://clinicaltrials.gov/show/NCT04346797,No Results,No Results,No Results,2020-05-04,2020-04-22,None
2043,NCT04348409,ClinicalTrials.gov,2020-04-03,2020-04-12,False,Azidus Brasil,Recruiting,Not Applicable,Interventional,Brazil,Efficacy and Safety of Nitazoxanide for the Treatment of Hospitalized Patients With Moderate COVID-19,Drug,Nitazoxanide,50,2020-05-31,2020-06-30,https://clinicaltrials.gov/show/NCT04348409,No Results,No Results,No Results,2020-05-04,2020-04-22,None
2044,NCT04348474,ClinicalTrials.gov,2020-04-13,2020-04-20,False,Azidus Brasil,Not Recruiting,Phase 1,Interventional,Brazil,Efficacy and Safety of Hydroxychloroquine and Azithromycin for the Treatment of Ambulatory Patients With Mild COVID-19,Drug,Hydroxychloroquine + Azithromycin ,200,2020-06-30,2020-07-31,https://clinicaltrials.gov/show/NCT04348474,No Results,No Results,No Results,2020-05-04,2020-04-22,None
2045,NCT04350073,ClinicalTrials.gov,2020-04-14,2020-04-20,False,Duke University,Recruiting,Not Applicable,Interventional,United States,Longitudinal Energy Expenditure and Metabolic Effects in Patients With COVID-19 (LEEP-COVID),Clinical Presentation,No Intervention,120,2020-10-01,2020-12-01,https://clinicaltrials.gov/show/NCT04350073,No Results,No Results,No Results,2020-05-04,2020-04-22,None
2046,NCT04351139,ClinicalTrials.gov,2020-04-15,2020-04-01,True,Hospices Civils de Lyon,Not Recruiting,Not Applicable,Observational,France,Impact of the COVID-19 Pandemic in Gynecological Oncology,Clinical Presentation,No Intervention,400,2020-11-06,2020-11-06,https://clinicaltrials.gov/show/NCT04351139,No Results,No Results,No Results,2020-05-04,2020-04-22,None
2047,NCT04351503,ClinicalTrials.gov,2020-04-15,2020-04-09,True,"University Hospital, Basel",Recruiting,Not Applicable,Observational,Switzerland,A Systems Approach to Predict the Outcome of SARS-CoV-2 in the Population of a City; COVID-19,Clinical Presentation (Epidemiology),No Intervention,10000,2022-04-01,2022-04-01,https://clinicaltrials.gov/show/NCT04351503,No Results,No Results,No Results,2020-05-04,2020-04-29,None
2048,NCT04354259,ClinicalTrials.gov,2020-04-16,2020-04-21,False,"University Health Network, Toronto",Not Recruiting,Phase 2,Interventional,Canada,Interferon Lambda for Immediate Antiviral Therapy at Diagnosis,Drug,Interferon lambda,140,2020-08-01,2020-11-30,https://clinicaltrials.gov/show/NCT04354259,No Results,No Results,No Results,2020-05-04,2020-04-29,None
2049,NCT04354818,ClinicalTrials.gov,2020-04-16,2020-04-27,False,Kirby Institute,Not Recruiting,Not Applicable,Observational,No Country Given,Coronavirus (COVID-19) Outcomes Registries in Immunocompromised Individuals Australia (CORIA),Clinical Presentation,No Intervention,1000,2022-04-27,2022-04-27,https://clinicaltrials.gov/show/NCT04354818,No Results,No Results,No Results,2020-05-04,2020-04-29,None
2050,NCT04354831,ClinicalTrials.gov,2020-04-14,2020-05-01,False,Medical College of Wisconsin,Not Recruiting,Phase 2,Interventional,No Country Given,A Study Evaluating the Efficacy and Safety of High-Titer Anti-SARS-CoV-2 Plasma in Hospitalized Patients With COVID-19 Infection,ATMP,Plasma,131,2022-05-01,2023-05-01,https://clinicaltrials.gov/show/NCT04354831,No Results,No Results,No Results,2020-05-04,2020-04-29,None
2051,NCT04355234,ClinicalTrials.gov,2020-04-17,2020-04-24,False,Assistance Publique  Hpitaux de Paris,Not Recruiting,Not Applicable,Interventional,No Country Given,"Prevalence and Impact of COVID-19 Infection in Pregnant Women, Fetuses and Newborns",Clinical Presentation (Epidemiology),No Intervention,2200,2021-08-31,2021-08-31,https://clinicaltrials.gov/show/NCT04355234,No Results,No Results,No Results,2020-05-04,2020-05-05,None
2052,NCT04355897,ClinicalTrials.gov,2020-04-15,2020-04-01,True,The Christ Hospital,Recruiting,Phase 1,Interventional,United States,CoVID-19 Plasma in Treatment of COVID-19 Patients,ATMP,Plasma,100,2020-07-01,2020-08-01,https://clinicaltrials.gov/show/NCT04355897,No Results,No Results,No Results,2020-05-04,2020-04-29,None
2053,NCT04355936,ClinicalTrials.gov,2020-04-17,2020-04-01,True,Laboratorio Elea,Recruiting,Phase 2,Interventional,Argentina,Telmisartan for Treatment of COVID-19 Patients,Drug,Telmisartan,400,2020-10-01,2020-10-01,https://clinicaltrials.gov/show/NCT04355936,No Results,No Results,No Results,2020-05-04,2020-04-29,None
2054,NCT04355962,ClinicalTrials.gov,2020-03-26,2020-04-23,False,University of Zurich,Recruiting,Phase 3,Interventional,Switzerland,Sevoflurane in COVID-19 ARDS (SevCov),Drug,Sevoflurane,64,2021-03-31,2021-03-31,https://clinicaltrials.gov/show/NCT04355962,No Results,No Results,No Results,2020-05-04,2020-04-29,None
2055,NCT04357106,ClinicalTrials.gov,2020-04-14,2020-04-13,True,Centro de Hematologia y Medicina Interna,Recruiting,Phase 2,Interventional,Mexico,COPLA Study: Treatment of Severe Forms of COronavirus Infection With Convalescent PLAsma,ATMP,Plasma,10,2020-07-01,2020-08-01,https://clinicaltrials.gov/show/NCT04357106,No Results,No Results,No Results,2020-05-04,2020-04-29,None
2056,NCT04357327,ClinicalTrials.gov,2020-04-15,2020-04-16,False,Universit degli Studi dell'Insubria,Recruiting,Not Applicable,Interventional,Italy,Rapid Salivary Test to Detect SARS-CoV-2 (COVID-19),Diagnostics,Diagnostic Test or Assessment,100,2020-05-31,2020-07-31,https://clinicaltrials.gov/show/NCT04357327,No Results,No Results,No Results,2020-05-04,2020-04-29,None
2057,NCT04357366,ClinicalTrials.gov,2020-04-20,2020-04-15,True,Hellenic Institute for the Study of Sepsis,Recruiting,Phase 2,Interventional,Greece,suPAR-guided Anakinra Treatment for Validation of the Risk and Management of Respiratory Failure by COVID-19 (SAVE),Drug,Anakinra + trimethoprim/sulfamethoxazole,100,2022-04-15,2022-04-15,https://clinicaltrials.gov/show/NCT04357366,No Results,No Results,No Results,2020-05-04,2020-04-29,None
2058,NCT04357574,ClinicalTrials.gov,2020-04-20,2020-04-14,True,Duke University,Recruiting,Not Applicable,Observational,United States,Assessing the System for High-Intensity Evaluation During Radiotherapy During Changes in Response to COVID-19,Telehealth,Telehealth,1000,2021-04-01,2021-04-01,https://clinicaltrials.gov/show/NCT04357574,No Results,No Results,No Results,2020-05-04,2020-04-29,None
2059,NCT04357834,ClinicalTrials.gov,2020-04-17,2020-05-01,False,"University Hospital, Bern",Not Recruiting,Not Applicable,Observational,Switzerland,WAVE. Wearable-based COVID-19 Markers for Prediction of Clinical Trajectories,Other (device),Smartwatch,100,2020-07-31,2020-07-31,https://clinicaltrials.gov/show/NCT04357834,No Results,No Results,No Results,2020-05-04,2020-04-29,None
2060,NCT04357860,ClinicalTrials.gov,2020-04-20,2020-04-27,True,Maimonides Biomedical Research Institute of Cordoba,Not Recruiting,Phase 2,Interventional,Spain,Clinical Trial of Sarilumab in Adults With COVID-19,Drug,Sarilumab,120,2020-07-27,2020-07-27,https://clinicaltrials.gov/show/NCT04357860,No Results,No Results,No Results,2020-05-04,2020-04-29,EUCTR2020-001531-27
2061,NCT04358042,ClinicalTrials.gov,2020-04-08,2020-04-25,False,Nantes University Hospital,Not Recruiting,Not Applicable,Observational,France,PSYCHIATRIC Disorders and Covid-19,Other (psych),No Intervention,250,2022-01-01,2023-01-01,https://clinicaltrials.gov/show/NCT04358042,No Results,No Results,No Results,2020-05-04,2020-04-29,None
2062,NCT04358081,ClinicalTrials.gov,2020-04-08,2020-04-30,False,Novartis Pharmaceuticals,Not Recruiting,Phase 3,Interventional,No Country Given,Hydroxychloroquine Monotherapy and in Combination With Azithromycin in Patients With Moderate and Severe COVID-19 Disease,Drug,Hydroxychloroquine + Azithromycin vs. Hydroxychloroquine,444,2020-07-21,2020-07-21,https://clinicaltrials.gov/show/NCT04358081,No Results,No Results,No Results,2020-05-04,2020-04-29,None
2063,NCT04358510,ClinicalTrials.gov,2020-04-20,2020-04-01,True,Dascena,Not Recruiting,Not Applicable,Observational,United States,COVID-19 Mortality Prediction Model,Prognosis,No Intervention,114,2020-04-17,2020-04-17,https://clinicaltrials.gov/show/NCT04358510,No Results,No Results,No Results,2020-05-04,2020-04-29,None
2064,NCT04360876,ClinicalTrials.gov,2020-04-22,2020-05-01,False,"University of Colorado, Denver",Not Recruiting,Phase 2,Interventional,No Country Given,Targeted Steroids for ARDS Due to COVID-19 Pneumonia: A Pilot Randomized Clinical Trial,Drug,Corticosteroids,90,2020-09-30,2020-12-31,https://clinicaltrials.gov/show/NCT04360876,No Results,No Results,No Results,2020-05-04,2020-04-29,None
2065,NCT04361318,ClinicalTrials.gov,2020-04-18,2020-05-01,False,Tanta University,Not Recruiting,Phase 2/Phase 3,Interventional,No Country Given,Hydroxychloroquine and Nitazoxanide Combination Therapy for COVID-19,Drug,Hydroxychloroquine + Nitazoxanide,100,2020-10-01,2020-12-01,https://clinicaltrials.gov/show/NCT04361318,No Results,No Results,No Results,2020-05-04,2020-04-29,None
2066,NCT04361344,ClinicalTrials.gov,2020-04-16,2020-05-05,False,Centre Hospitalier de Pau,Not Recruiting,Not Applicable,Interventional,No Country Given,Neurodegeneration Markers and Neurological Course in Severe Covid-19 Infection,Clinical Presentation,No Intervention,30,2021-01-05,2021-01-05,https://clinicaltrials.gov/show/NCT04361344,No Results,No Results,No Results,2020-05-04,2020-04-29,None
2067,NCT04361526,ClinicalTrials.gov,2020-04-21,2020-04-17,True,Manuel Castell,Recruiting,Not Applicable,Interventional,Spain,Pilot Study on Cytokine Filtration in COVID-19 ARDS,Other (device),Cytokine Adsorber,40,2020-07-01,2020-07-01,https://clinicaltrials.gov/show/NCT04361526,No Results,No Results,No Results,2020-05-04,2020-04-29,None
2068,NCT04361552,ClinicalTrials.gov,2020-04-07,2020-05-30,False,Emory University,Recruiting,Phase 3,Interventional,United States,Tocilizumab for the Treatment of Cytokine Release Syndrome in Patients With COVID-19 (SARS-CoV-2 Infection),Drug,Tocilizumab,180,2022-05-30,2022-05-30,https://clinicaltrials.gov/show/NCT04361552,No Results,No Results,No Results,2020-05-04,2020-04-29,None
2069,NCT04361565,ClinicalTrials.gov,2020-04-22,2020-03-20,True,CHU de Nice,Recruiting,Not Applicable,Observational,France,Frequency and Clinical Evolution of Olfactory and Taste Disorders in COVID-19 Patients,Clinical Presentation,No Intervention,50,2020-04-10,2020-05-31,https://clinicaltrials.gov/show/NCT04361565,No Results,No Results,No Results,2020-05-04,2020-04-29,None
2070,NCT04361786,ClinicalTrials.gov,2020-04-17,2020-04-01,True,"University Hospital, Montpellier",Recruiting,Not Applicable,Observational,France,Acral Cutaneous Thrombotic Vasculopathy and Covid-19 Infection,Clinical Presentation,No Intervention,10,2020-06-30,2020-10-30,https://clinicaltrials.gov/show/NCT04361786,No Results,No Results,No Results,2020-05-04,2020-04-29,None
2071,NCT04361981,ClinicalTrials.gov,2020-04-23,2020-04-01,True,Sociedad Espaola de Angiologa y Ciruga Vascular (SEACV),Not Recruiting,Not Applicable,Observational,Spain,Influence of COVID-19 Infection in Thromboembolic Venous Disease: National Cohort Study,Diagnostics,Diagnostic Test or Assessment,50,2020-08-31,2020-12-31,https://clinicaltrials.gov/show/NCT04361981,No Results,No Results,No Results,2020-05-04,2020-04-29,None
2072,NCT04362189,ClinicalTrials.gov,2020-04-21,2020-05-15,False,Hope Biosciences,Not Recruiting,Phase 2,Interventional,United States,Efficacy and Safety Study of Allogeneic HB-adMSCs for the Treatment of COVID-19,ATMP,Cells (mesenchymal),110,2020-10-31,2020-10-31,https://clinicaltrials.gov/show/NCT04362189,No Results,No Results,No Results,2020-05-04,2020-04-29,None
2073,NCT04363268,ClinicalTrials.gov,2020-04-23,2020-04-20,True,Medable Inc.,Recruiting,Not Applicable,Observational,United States,ACCESS A Master Digital Surveillance Protocol for COVID-19,Clinical Presentation (Epidemiology),No Intervention,1000000,2030-04-20,2031-10-01,https://clinicaltrials.gov/show/NCT04363268,No Results,No Results,No Results,2020-05-04,2020-05-05,None
2074,NCT04363489,ClinicalTrials.gov,2020-04-23,2020-04-27,False,King's College London,Not Recruiting,Not Applicable,Observational,No Country Given,The CEDiD Study (COVID-19 Early Diagnosis in Doctors),Diagnostics,Diagnostic Test or Assessment,30,2020-05-27,2020-05-27,https://clinicaltrials.gov/show/NCT04363489,No Results,No Results,No Results,2020-05-04,2020-05-05,None
2075,NCT04363736,ClinicalTrials.gov,2020-04-21,2020-05-04,False,Roche,Not Recruiting,Phase 2,Interventional,No Country Given,A Study to Investigate Intravenous Tocilizumab in Participants With Moderate to Severe COVID-19 Pneumonia,Drug,Tocilizumab,100,2020-06-11,2020-08-03,https://clinicaltrials.gov/show/NCT04363736,No Results,No Results,No Results,2020-05-04,2020-05-05,None
2076,NCT04364594,ClinicalTrials.gov,2020-04-22,2020-03-26,True,Fondazione Policlinico Universitario Agostino Gemelli IRCCS,Not Recruiting,Not Applicable,Interventional,Italy,COVID-19 Search in Conjunctival Cells,Diagnostics,Diagnostic Test or Assessment,50,2020-04-30,2020-05-30,https://clinicaltrials.gov/show/NCT04364594,No Results,No Results,No Results,2020-05-04,2020-05-05,None
2077,NCT04364802,ClinicalTrials.gov,2020-04-25,2020-05-01,False,Alexandra Kejner,Not Recruiting,Phase 2,Interventional,United States,COVID-19: Povidone-Iodine Intranasal Prophylaxis in Front-line Healthcare Personnel and Inpatients,Drug,Povidone-iodine,250,2021-05-01,2021-05-01,https://clinicaltrials.gov/show/NCT04364802,No Results,No Results,No Results,2020-05-04,2020-05-05,None
2078,NCT04365439,ClinicalTrials.gov,2020-04-18,2020-04-27,False,Enos Bernasconi,Not Recruiting,Not Applicable,Interventional,No Country Given,Convalescent Plasma for COVID-19,ATMP,Plasma,10,2020-05-30,2020-06-30,https://clinicaltrials.gov/show/NCT04365439,No Results,No Results,No Results,2020-05-04,2020-05-05,None
2079,NCT04365881,ClinicalTrials.gov,2020-04-26,2020-03-31,True,Modum Bad,Not Recruiting,Not Applicable,Observational,Norway,Loneliness During the NPIs for the COVID-19 Pandemic in Norway: Risk Factors and Associations With Psychopathology,Other (psych),No Intervention,10084,2020-04-07,2020-04-07,https://clinicaltrials.gov/show/NCT04365881,No Results,No Results,No Results,2020-05-04,2020-05-05,None
2080,ISRCTN83971151,ISRCTN,2020-03-25,2020-03-26,True,World Health Organization,Recruiting,Phase 3,Interventional,"Canada, Qatar, Iran, Germany, Kenya, Lebanon, Saudi Arabia, Israel, Argentina, Brazil, Indonesia, Switzerland, Norway, Thailand, Philippines, South Africa, Spain, Peru, India, Italy, Ireland, Honduras, Malaysia",Public health emergency SOLIDARITY trial of treatments for COVID-19 infection in hospitalized patients,Drug,Remdesivir vs. chloroquine/hydroxychloroquine vs. lopinavir/ritonavir vs. interferon beta,10000,Not Available,2021-03-25,http://isrctn.com/ISRCTN83971151,No Results,No Results,No Results,2020-05-04,2020-04-01,EUCTR2020-001366-11; NCT04330690; PER-010-20; IRCT20200405046953N1; NCT04321616; EUCTR2020-000982-18
2081,ChiCTR2000032527,ChiCTR,2020-05-01,2020-05-01,False,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Not Recruiting,Not Applicable,Observational,China,"Developing and validating of clinical prediction model for novel coronavirus pneumonia (COVID-19) patients progressing to critical type, acute respiratory distress syndrome and death: a medical records based study",Prognosis,No Intervention,8500,Not Available,2021-04-30,http://www.chictr.org.cn/showproj.aspx?proj=53196,No Results,No Results,No Results,2020-05-04,2020-05-05,None
2082,ChiCTR2000032476,ChiCTR,2020-04-29,2020-03-23,True,Xiangya Hospital of Central South University,Recruiting,Not Applicable,Observational,China,Analysis of clinical features of novel coronavirus  pneumonia (COVID-19): a medical records based study,Clinical Presentation,No Intervention,500,Not Available,2021-03-23,http://www.chictr.org.cn/showproj.aspx?proj=53094,No Results,No Results,No Results,2020-05-04,2020-05-05,None
2083,ChiCTR2000032458,ChiCTR,2020-04-29,2020-02-29,True,Department of Science and Technology of Guizhou Province,Not Recruiting,Not Applicable,Observational,China,A medical records based retrospective study: Leukopenia is more common in asymptomatic patients less than 18 years old with novel coronavirus pneumonia (COVID-19) in convalescence,Clinical Presentation,No Intervention,25,Not Available,Not Available,http://www.chictr.org.cn/showproj.aspx?proj=52779,No Results,No Results,No Results,2020-05-04,2020-05-05,None
2084,ChiCTR2000032457,ChiCTR,2020-04-29,2020-05-01,False,"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology",Not Recruiting,Not Applicable,Observational,China,Application of pulmonary rehabilitation exercise in the treatment of novel coronavirus pneumonia (COVID-19) patients during convalescence period.,Other (physio),Physio,60,Not Available,2020-05-31,http://www.chictr.org.cn/showproj.aspx?proj=52925,No Results,No Results,No Results,2020-05-04,2020-05-05,None
2085,ChiCTR2000032456,ChiCTR,2020-04-29,2020-03-01,True,Shanghai Public Health Clinical Center,Not Recruiting,Not Applicable,Interventional,No Country Given,A Randomized Controlled Trial for the Effects of Low-Oxygen Consumption Instruction on the Prognosis of Patients with Novel Coronavirus Pneumonia (COVID-19),Prognosis,No Intervention,100,Not Available,2020-05-01,http://www.chictr.org.cn/showproj.aspx?proj=53048,No Results,No Results,No Results,2020-05-04,2020-05-05,None
2086,ChiCTR2000032455,ChiCTR,2020-04-29,2020-04-28,True,Ningxia Ning'an Hospital,Recruiting,Not Applicable,Interventional,China,A study for the mental health status of novel coronavirus pneumonia (COVID-19) convalescent patients and first-line medical staff and Isolate residents and Hospital staffand the intervention strategy of psychological crisis in Ningxia,Other (psych),No Intervention,140,Not Available,Not Available,http://www.chictr.org.cn/showproj.aspx?proj=53050,No Results,No Results,No Results,2020-05-04,2020-05-05,None
2087,ChiCTR2000031896,ChiCTR,2020-04-14,2020-02-05,True,Fujian Provincial Hospital,Not Recruiting,Not Applicable,Observational,China,Study for the influence of novel coronavirus pneumonia (COVID-19) on mental health of Chinese public hospital stuffs,Other (psych),No Intervention,923,Not Available,2020-02-10,http://www.chictr.org.cn/showproj.aspx?proj=52332,No Results,No Results,No Results,2020-05-04,2020-04-22,None
2088,ChiCTR2000030262,ChiCTR,2020-02-26,2020-02-01,True,Shanghai Public Health Clinical Center,Recruiting,Not Applicable,Interventional,China,Clinical study of novel coronavirus (SARS-Cov-2) infection treated with aerosol inhalation (IFN-? plus anti-inflammatory factor TFF2),Drug,Interferon kappa + trefoil factor 2 (a gene-derived protein),140,Not Available,2021-01-31,http://www.chictr.org.cn/showproj.aspx?proj=50136,No Results,No Results,No Results,2020-05-04,2020-08-03,None
2089,RPCEC00000306,RPCEC,2020-04-13,2020-03-27,True,"Center for Genetic Engineering and Biotechnology (CIGB), Havana",Recruiting,Phase 1/Phase 2,Interventional,Cuba,CIGB 2020 in contacts and SARS-CoV-2 infection suspects,ATMP,Vaccine,80,Not Available,2020-07-15,http://rpcec.sld.cu/en/trials/RPCEC00000306-En,No Results,No Results,No Results,2020-05-04,2020-04-22,None
2090,RPCEC00000307,RPCEC,2020-04-14,2020-04-10,True,"Center for Genetic Engineering and Biotechnology (CIGB), Havana",Recruiting,Phase 2,Interventional,Cuba,ESPERANZA study,Drug,Interferon alpha,120,Not Available,2020-07-30,http://rpcec.sld.cu/en/trials/RPCEC00000307-En,No Results,No Results,No Results,2020-05-04,2020-05-05,None
2091,RPCEC00000308,RPCEC,2020-05-03,2020-05-04,False,"Center for Genetic Engineering and Biotechnology (CIGB), Havana",Not Recruiting,Phase 1,Interventional,Cuba,Pharmacodynamics of the Nasalferon in healthy volunteers.,Drug,Nasalferon,30,Not Available,2020-06-09,http://rpcec.sld.cu/en/trials/RPCEC00000308-En,No Results,No Results,No Results,2020-05-04,2020-05-05,None
2092,EUCTR2020-001723-13-FR,EU Clinical Trials Register,2020-04-08,2020-04-17,False,Groupe Hospitalier Paris Saint-Joseph,Authorised,Phase 3,Interventional,France,A randomized trial of efficacy and safety of an early OUTpatient treatment of COVID-19 in patients with risk factor for poor outcome : a strategy to prevent hospitalization : OUTCOV Study,Drug,"Azithromycin, Hydroxychloroquine, Lopinavir/Ritonavir",640,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001723-13,No Results,No Results,No Results,2020-05-04,2020-05-05,None
2093,EUCTR2020-001364-29-ES,EU Clinical Trials Register,2020-04-27,2020-04-20,True,Red Andaluza de Diseo y Traslacin de Terapias Avanzadas,Authorised,Phase 1/Phase 2,Interventional,Spain,"Study with stem cells from allogenic adipose tissue, in patients with coronavirus severe pneumonia",ATMP,Cells (mesenchymal) vs. Hydroxychloroquine + Azithromycin or Lopinavir/ritonavir + Interferon beta,26,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001364-29,No Results,No Results,No Results,2020-05-04,2020-05-05,None
2094,EUCTR2020-001888-90-DK,EU Clinical Trials Register,2020-04-16,2020-04-30,False,University of Southern Denmark,Authorised,Phase 3,Interventional,Denmark,BCG vaccine for healthcare workers against COVID-19,ATMP,Vaccine,1500,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001888-90,No Results,No Results,No Results,2020-05-04,2020-05-05,None
2095,EUCTR2020-001345-38-GR,EU Clinical Trials Register,2020-03-31,2020-04-02,False,Uni-Pharma Kleon Tsetis Pharmaceutical Laboratories S.A.,Authorised,Phase 2,Interventional,Greece,CHROLOQUINE PHOSPHATE AGAINST INFECTION BY THE NOVEL CORONAVIRUS,Drug,Chloroquine,60,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001345-38,No Results,No Results,No Results,2020-05-04,2020-04-07,None
2096,NCT04273763,ClinicalTrials.gov,2020-02-14,2020-02-16,False,The Second Affiliated Hospital of Wenzhou Medical University,Not Recruiting,Not Applicable,Interventional,China,Evaluating the Efficacy and Safety of Bromhexine Hydrochloride Tablets Combined With Standard Treatment/ Standard Treatment in Patients With Suspected and Mild Novel Coronavirus Pneumonia (COVID-19),Drug,Bromhexine + Umifenovir + Interferon alpha vs. Umifenovir + interferon alpha,18,2020-05-10,2020-06-01,https://clinicaltrials.gov/show/NCT04273763,No Results,No Results,No Results,2020-05-11,2020-08-03,None
2097,NCT04308668,ClinicalTrials.gov,2020-03-11,2020-03-17,False,University of Minnesota,Recruiting,Phase 3,Interventional,"Canada, United States",Post-exposure Prophylaxis / Preemptive Therapy for SARS-Coronavirus-2,Drug (Chemoprophylaxis),Hydroxychloroquine,3000,2020-05-01,2020-05-14,https://clinicaltrials.gov/show/NCT04308668,No Results,No Results,No Results,2020-05-11,2020-04-01,None
2098,NCT04311177,ClinicalTrials.gov,2020-03-13,2020-04-09,False,University of Minnesota,Recruiting,Phase 2,Interventional,United States,Losartan for Patients With COVID-19 Not Requiring Hospitalization,Drug,ARB (Losartan),580,2021-04-01,2021-04-01,https://clinicaltrials.gov/show/NCT04311177,No Results,No Results,No Results,2020-05-11,2020-03-25,None
2099,NCT04324489,ClinicalTrials.gov,2020-03-25,2020-03-06,True,Renmin Hospital of Wuhan University,Not Recruiting,Not Applicable,Interventional,China,DAS181 for Severe COVID-19: Compassionate Use,Drug,DAS181,4,2020-04-16,2020-04-30,https://clinicaltrials.gov/show/NCT04324489,No Results,No Results,No Results,2020-05-11,2020-04-01,None
2100,NCT04324606,ClinicalTrials.gov,2020-03-20,2020-04-23,True,University of Oxford,Recruiting,Phase 1/Phase 2,Interventional,United Kingdom,A Study of a Candidate COVID-19 Vaccine (COV001),ATMP,Vaccine,1090,2021-05-01,2021-05-01,https://clinicaltrials.gov/show/NCT04324606,No Results,No Results,No Results,2020-05-11,2020-04-01,EUCTR2020-001072-15; ISRCTN15281137
2101,NCT04327388,ClinicalTrials.gov,2020-03-26,2020-03-28,True,Sanofi,Recruiting,Phase 2/Phase 3,Interventional,"Canada, France, Japan, Italy, Russian Federation, Israel, Germany, Spain",Sarilumab COVID-19,Drug,Sarilumab,300,2020-07-01,2020-08-01,https://clinicaltrials.gov/show/NCT04327388,No Results,No Results,No Results,2020-05-11,2020-04-07,EUCTR2020-001162-12
2102,NCT04333732,ClinicalTrials.gov,2020-03-31,2020-05-01,False,Washington University in St. Louis,Not Recruiting,Phase 3,Interventional,"Canada, Zambia, Australia, United Kingdom, United States, Ireland, South Africa",CROWN CORONATION: Chloroquine RepurpOsing to healthWorkers for Novel CORONAvirus mitigaTION,Drug (Chemoprophylaxis),Chloroquine/hydroxychloroquine,55000,2021-02-01,2021-02-01,https://clinicaltrials.gov/show/NCT04333732,No Results,No Results,No Results,2020-05-11,2020-04-07,None
2103,NCT04334460,ClinicalTrials.gov,2020-04-02,2020-05-04,False,Blade Therapeutics,Recruiting,Phase 2,Interventional,United States,Safety and Antiviral Activity of BLD-2660 in COVID-19 Hospitalized Subjects,Drug,BLD-2660,120,2020-08-01,2020-09-01,https://clinicaltrials.gov/show/NCT04334460,No Results,No Results,No Results,2020-05-11,2020-04-15,None
2104,NCT04336774,ClinicalTrials.gov,2020-04-03,2020-05-01,False,Duke University,Recruiting,Not Applicable,Interventional,United States,CAPTION AI to Minimize Risk of COVID Exposure,Other (software),Other,500,2020-11-01,2020-11-09,https://clinicaltrials.gov/show/NCT04336774,No Results,No Results,No Results,2020-05-11,2020-04-15,None
2105,NCT04337047,ClinicalTrials.gov,2020-04-03,2020-03-31,True,Wefight,Not Recruiting,Not Applicable,Observational,France,Distress in Crisis Situations During COVID-19,Other (psych),No Intervention,2000,2020-04-30,2020-05-03,https://clinicaltrials.gov/show/NCT04337047,Pre-Print Article,2020-05-15,https://doi.org/10.1101/2020.05.10.20093161,2020-05-11,2020-04-15,None
2106,NCT04341441,ClinicalTrials.gov,2020-04-07,2020-04-07,False,Henry Ford Health System,Recruiting,Phase 3,Interventional,United States,Will Hydroxychloroquine Impede or Prevent COVID-19,Drug,Hydroxychloroquine,3000,2020-06-30,2021-04-30,https://clinicaltrials.gov/show/NCT04341441,No Results,No Results,No Results,2020-05-11,2020-04-15,None
2107,NCT04341688,ClinicalTrials.gov,2020-04-06,2020-07-01,False,Aga Khan University,Not Recruiting,Not Applicable,Interventional,No Country Given,A Clinical Trial of Gargling Agents in Reducing Intraoral Viral Load Among COVID-19 Patients,Drug,Mouthwash,50,2020-12-31,2021-03-31,https://clinicaltrials.gov/show/NCT04341688,No Results,No Results,No Results,2020-05-11,2020-04-15,None
2108,NCT04341870,ClinicalTrials.gov,2020-04-06,2020-04-11,False,Assistance Publique  Hpitaux de Paris,Not Recruiting,Phase 2/Phase 3,Interventional,France,"Study of Immune Modulatory Drugs and Other Treatments in COVID-19 Patients: Sarilumab, Azithromycin, Hydroxychloroquine Trial - CORIMUNO-19 - VIRO",Drug,Sarilumab + Azithromycin + Hydroxychloroquine vs. Sarilumab,27,2020-05-08,2020-08-01,https://clinicaltrials.gov/show/NCT04341870,No Results,No Results,No Results,2020-05-11,2020-04-15,None
2109,NCT04343651,ClinicalTrials.gov,2020-03-31,2020-04-01,False,"CytoDyn, Inc.",Recruiting,Phase 2,Interventional,United States,Study to Evaluate the Efficacy and Safety of Leronlimab for Mild to Moderate COVID-19,Drug,Leronlimab,75,2020-12-04,2021-04-04,https://clinicaltrials.gov/show/NCT04343651,No Results,No Results,No Results,2020-05-11,2020-04-15,None
2110,NCT04344561,ClinicalTrials.gov,2020-04-10,2020-06-20,False,Johns Hopkins University,Not Recruiting,Not Applicable,Interventional,No Country Given,Incline Positioning in COVID-19 Patients for Improvement in Oxygen Saturation,Procedure,Positioning,70,2021-05-01,2021-05-01,https://clinicaltrials.gov/show/NCT04344561,No Results,No Results,No Results,2020-05-11,2020-04-22,None
2111,NCT04344587,ClinicalTrials.gov,2020-04-08,2020-05-01,False,Boston University,Recruiting,Not Applicable,Interventional,United States,COVID-19 smArtphone-based Trial of Non-ICU Admission Prone Positioning,Procedure,Positioning,380,2020-12-01,2020-12-01,https://clinicaltrials.gov/show/NCT04344587,No Results,No Results,No Results,2020-05-11,2020-04-22,None
2112,NCT04344977,ClinicalTrials.gov,2020-04-13,2020-05-15,False,National Institute of Allergy and Infectious Diseases (NIAID),Recruiting,Not Applicable,Observational,"United States, United States Minor Outlying Islands",Collection of Anti-SARS-CoV-2 Immune Plasma,ATMP,Plasma,1500,2024-07-01,2025-04-01,https://clinicaltrials.gov/show/NCT04344977,No Results,No Results,No Results,2020-05-11,2020-04-22,None
2113,NCT04347226,ClinicalTrials.gov,2020-04-02,2020-04-16,False,Matthew Dallos,Recruiting,Phase 2,Interventional,United States,Anti-Interleukin-8 (Anti-IL-8) for Patients With COVID-19,Drug,Anti-Interleukin-8,138,2021-09-01,2022-09-01,https://clinicaltrials.gov/show/NCT04347226,No Results,No Results,No Results,2020-05-11,2020-04-22,None
2114,NCT04347239,ClinicalTrials.gov,2020-04-13,2020-04-15,False,"CytoDyn, Inc.",Recruiting,Phase 2,Interventional,United States,Study to Evaluate the Efficacy and Safety of Leronlimab for Patients With Severe or Critical Coronavirus Disease 2019 (COVID-19),Drug,Leronlimab,390,2020-12-31,2021-04-01,https://clinicaltrials.gov/show/NCT04347239,No Results,No Results,No Results,2020-05-11,2020-04-22,None
2115,NCT04349631,ClinicalTrials.gov,2020-04-06,2020-05-07,False,Hope Biosciences,Recruiting,Phase 2,Interventional,United States,A Clinical Trial to Determine the Safety and Efficacy of Hope Biosciences Autologous Mesenchymal Stem Cell Therapy (HB-adMSCs) to Provide Protection Against COVID-19,ATMP,Cells (mesenchymal),56,2020-12-31,2020-12-31,https://clinicaltrials.gov/show/NCT04349631,No Results,No Results,No Results,2020-05-11,2020-04-22,None
2116,NCT04351516,ClinicalTrials.gov,2020-04-15,2020-04-21,False,"University Hospital, Tbingen",Recruiting,Phase 2/Phase 3,Interventional,Germany,Test and Treat COVID 65plus+,Drug,Hydroxychloroquine,350,2020-12-31,2021-05-01,https://clinicaltrials.gov/show/NCT04351516,No Results,No Results,No Results,2020-05-11,2020-05-05,None
2117,NCT04351581,ClinicalTrials.gov,2020-04-14,2020-05-08,True,"Copenhagen University Hospital, Gentofte",Recruiting,Not Applicable,Interventional,Denmark,Effects of Discontinuing Renin-angiotensin System Inhibitors in Patients With COVID-19,Drug,ACE inhibitors or ARBs,215,2020-12-01,2020-12-01,https://clinicaltrials.gov/show/NCT04351581,No Results,No Results,No Results,2020-05-11,2020-04-22,EUCTR2020-001544-26
2118,NCT04351633,ClinicalTrials.gov,2020-04-15,2020-04-20,False,"University Hospital, Lille",Recruiting,Not Applicable,Observational,France,Psychological Impact of Quarantine in Osteoporosis Patient During COVID-19 Outbreak,Other (psych),No Intervention,50,2020-12-01,2020-12-01,https://clinicaltrials.gov/show/NCT04351633,No Results,No Results,No Results,2020-05-11,2020-04-22,None
2119,NCT04353141,ClinicalTrials.gov,2020-04-16,2020-04-28,False,KU Leuven,Recruiting,Not Applicable,Observational,"Belgium, United Kingdom, Italy",International Lung UltraSound Analysis (ILUSA) Study,Diagnostics,Diagnostic Test or Assessment,1850,2020-05-31,2020-12-31,https://clinicaltrials.gov/show/NCT04353141,No Results,No Results,No Results,2020-05-11,2020-04-29,None
2120,NCT04353180,ClinicalTrials.gov,2020-04-10,2020-05-01,False,Kafrelsheikh University,Not Recruiting,Phase 3,Interventional,Egypt,Assessment the Activity Value of 13- Cis-Retinoic Acid (Isotretinoin) in the Treatment of COVID-19 (Randomized),Drug,Isotretinoin,45,2020-06-01,2020-07-01,https://clinicaltrials.gov/show/NCT04353180,No Results,No Results,No Results,2020-05-11,2020-04-29,None
2121,NCT04353271,ClinicalTrials.gov,2020-03-25,2020-04-17,False,University of South Alabama,Not Recruiting,Phase 2/Phase 3,Interventional,United States,Trial of Hydroxychloroquine In Covid-19 Kinetics,Drug,Hydroxychloroquine,58,2020-07-01,2020-12-01,https://clinicaltrials.gov/show/NCT04353271,No Results,No Results,No Results,2020-05-11,2020-04-29,None
2122,NCT04355143,ClinicalTrials.gov,2020-04-14,2020-05-01,False,"University of California, Los Angeles",Recruiting,Phase 2,Interventional,United States,Colchicine to Reduce Myocardial Injury in COVID-19 (COLHEART-19),Drug,Colchicine,150,2021-04-25,2021-04-25,https://clinicaltrials.gov/show/NCT04355143,No Results,No Results,No Results,2020-05-11,2020-04-29,None
2123,NCT04355364,ClinicalTrials.gov,2020-04-15,2020-04-15,False,Fondation Ophtalmologique Adolphe de Rothschild,Recruiting,Phase 3,Interventional,France,Efficacy and Safety of Aerosolized Intra-tracheal Dornase Alpha Administration in Patients With COVID19-induced ARDS (COVIDORNASE),Drug,Dornase alfa,100,2020-04-15,2020-08-15,https://clinicaltrials.gov/show/NCT04355364,No Results,No Results,No Results,2020-05-11,2020-04-29,None
2124,NCT04355442,ClinicalTrials.gov,2020-04-16,2020-04-01,True,"University Hospital, Montpellier",Recruiting,Not Applicable,Observational,France,Evolution of Facial Trauma During COVID Containment Measures,Clinical Presentation,No Intervention,300,2020-05-01,2020-05-30,https://clinicaltrials.gov/show/NCT04355442,No Results,No Results,No Results,2020-05-11,2020-04-29,None
2125,NCT04356885,ClinicalTrials.gov,2020-04-19,2020-04-01,True,"University Hospital, Montpellier",Recruiting,Not Applicable,Observational,France,COVID-19 and Psychotic Symptoms in France,Clinical Presentation,No Intervention,600,2020-07-30,2020-08-01,https://clinicaltrials.gov/show/NCT04356885,No Results,No Results,No Results,2020-05-11,2020-04-29,None
2126,NCT04356950,ClinicalTrials.gov,2020-04-16,2020-04-01,True,CHU de Nimes,Not Recruiting,Not Applicable,Observational,France,Analysis of the Coagulopathy Developed by COVID-19 Infected Patients,Clinical Presentation,No Intervention,175,2020-10-01,2021-01-01,https://clinicaltrials.gov/show/NCT04356950,No Results,No Results,No Results,2020-05-11,2020-04-29,None
2127,NCT04357028,ClinicalTrials.gov,2020-04-19,2020-05-01,False,Kasr El Aini Hospital,Not Recruiting,Phase 3,Interventional,Egypt,Measles Vaccine in HCW,ATMP,Vaccine,200,2020-10-01,2020-11-01,https://clinicaltrials.gov/show/NCT04357028,No Results,No Results,No Results,2020-05-11,2020-04-29,None
2128,NCT04357041,ClinicalTrials.gov,2020-04-17,2020-04-17,False,Illinois Institute of Technology,Recruiting,Not Applicable,Observational,United States,"COVID-19 Survey Study on Dietary Intake, Physical Activity and Overall Well-being",Clinical Presentation,No Intervention,500,2020-12-01,2021-04-01,https://clinicaltrials.gov/show/NCT04357041,No Results,No Results,No Results,2020-05-11,2020-04-29,None
2129,NCT04359121,ClinicalTrials.gov,2020-04-21,2020-04-15,True,Medical University of Graz,Recruiting,Not Applicable,Observational,Austria,COVID-19 and the Developement of Phobic Fears of Disease,Other (psych),No Intervention,600,2023-04-15,2024-04-15,https://clinicaltrials.gov/show/NCT04359121,No Results,No Results,No Results,2020-05-11,2020-04-29,None
2130,NCT04359212,ClinicalTrials.gov,2020-04-21,2020-05-01,False,Quovadis Associazione,Not Recruiting,Not Applicable,Observational,No Country Given,Increased Risk of VTE and Higher Hypercoagulability in Patients Recovered in ICU and in Medical Ward for COVID-19,Drug,Heparin or Fondaparinux,90,2020-06-01,2020-06-01,https://clinicaltrials.gov/show/NCT04359212,No Results,No Results,No Results,2020-05-11,2020-04-29,None
2131,NCT04359225,ClinicalTrials.gov,2020-04-16,2020-06-30,False,NHS Greater Glasgow and Clyde,Not Recruiting,Not Applicable,Interventional,United Kingdom,A Comparison of 3D and 2D Telemedicine During Covid 19,Telehealth,Telehealth,80,2021-12-31,2021-12-31,https://clinicaltrials.gov/show/NCT04359225,No Results,No Results,No Results,2020-05-11,2020-04-29,None
2132,NCT04359927,ClinicalTrials.gov,2020-04-21,2020-04-20,True,Hospital Clinic of Barcelona,Recruiting,Not Applicable,Observational,Spain,Long-term Effects of Coronavirus Disease 2019 on the Cardiovascular System: CV COVID-19 Registry,Clinical Presentation,No Intervention,10000,2021-08-31,2025-08-31,https://clinicaltrials.gov/show/NCT04359927,No Results,No Results,No Results,2020-05-11,2020-04-29,None
2133,NCT04360122,ClinicalTrials.gov,2020-04-15,2020-05-20,False,Ain Shams University,Not Recruiting,Phase 3,Interventional,Egypt,Levamisole and Isoprinosine in Immune-prophylaxis of Egyptian Healthcare Workers Facing COVID-19,Drug (Chemoprophylaxis),Levamisole + Isoprinosine vs. Levamisole vs. Isoprinosine,100,2020-11-01,2020-12-01,https://clinicaltrials.gov/show/NCT04360122,No Results,No Results,No Results,2020-05-11,2020-04-29,None
2134,NCT04361032,ClinicalTrials.gov,2020-04-22,2020-05-04,False,Abderrahmane Mami Hospital,Not Recruiting,Phase 3,Interventional,Tunisia,"Assessment of Efficacy and Safety of Tocilizumab Compared to DefeROxamine, Associated With Standards Treatments in COVID-19 (+) Patients Hospitalized In Intensive Care in Tunisia",Drug,Tocilizumab,260,2020-09-04,2020-10-04,https://clinicaltrials.gov/show/NCT04361032,No Results,No Results,No Results,2020-05-11,2020-04-29,None
2135,NCT04361123,ClinicalTrials.gov,2020-04-22,2020-04-01,True,Dr. Michael Runyon,Recruiting,Not Applicable,Observational,United States,Atrium COVID-19 Syndromic and Serologic Surveillance,Clinical Presentation (Epidemiology),No Intervention,450000,2021-12-01,2021-12-01,https://clinicaltrials.gov/show/NCT04361123,No Results,No Results,No Results,2020-05-11,2020-04-29,None
2136,NCT04361214,ClinicalTrials.gov,2020-04-22,2020-04-01,True,University of Chicago,Not Recruiting,Phase 1,Interventional,United States,Leflunomide in Mild COVID-19 Patients,Drug,Leflunomide,20,2020-07-01,2020-07-01,https://clinicaltrials.gov/show/NCT04361214,No Results,No Results,No Results,2020-05-11,2020-04-29,None
2137,NCT04362176,ClinicalTrials.gov,2020-04-21,2020-04-24,False,Vanderbilt University,Recruiting,Phase 3,Interventional,United States,Passive Immunity Trial of Nashville II for COVID-19,ATMP,Plasma,500,2021-04-01,2021-04-01,https://clinicaltrials.gov/show/NCT04362176,No Results,No Results,No Results,2020-05-11,2020-04-29,None
2138,NCT04362267,ClinicalTrials.gov,2020-04-23,2020-04-01,True,"University Hospital, Lille",Not Recruiting,Not Applicable,Observational,No Country Given,Longitudinal Study of Covid-19 Infection Among HCW in a French University Hospital,Clinical Presentation (Epidemiology),No Intervention,150,2020-09-01,2020-09-01,https://clinicaltrials.gov/show/NCT04362267,No Results,No Results,No Results,2020-05-11,2020-05-05,None
2139,NCT04363034,ClinicalTrials.gov,2020-04-23,2020-03-30,True,University of Arkansas,Not Recruiting,Not Applicable,Expanded Access,No Country Given,Arkansas Expanded Access COVID-19 Convalescent Plasma Treatment Program,ATMP,Plasma,Not Available,Not Available,Not Available,https://clinicaltrials.gov/show/NCT04363034,No Results,No Results,No Results,2020-05-11,2020-05-05,None
2140,NCT04363047,ClinicalTrials.gov,2020-04-20,2020-05-01,False,University of Manchester,Not Recruiting,Not Applicable,Observational,United Kingdom,"Immune Cells in Inflammatory Arthritis With Coronaviruses, Including COVID-19",Clinical Presentation,No Intervention,125,2021-05-01,2021-05-01,https://clinicaltrials.gov/show/NCT04363047,No Results,No Results,No Results,2020-05-11,2020-05-05,None
2141,NCT04363060,ClinicalTrials.gov,2020-04-23,2020-04-30,False,Nantes University Hospital,Not Recruiting,Phase 3,Interventional,France,Azithromycin+Amoxicillin/Clavulanate vs Amoxicillin/Clavulanate in COVID19 Patients With Pneumonia in Non-intensive Unit,Drug,Azithromycin + Amoxicillin/Clavulanate vs. Amoxicillin/Clavulanate,104,2020-07-30,2020-07-30,https://clinicaltrials.gov/show/NCT04363060,No Results,No Results,No Results,2020-05-11,2020-05-05,None
2142,NCT04363203,ClinicalTrials.gov,2020-04-23,2020-04-30,False,Dr. Salomeh Keyhani,Recruiting,Phase 3,Interventional,United States,VA Remote and Equitable Access to COVID-19 Healthcare Delivery (VA-REACH TRIAL),Drug,Hydroxychloroquine vs. Azithromycin,300,2021-03-01,2021-08-01,https://clinicaltrials.gov/show/NCT04363203,No Results,No Results,No Results,2020-05-11,2020-05-05,None
2143,NCT04363216,ClinicalTrials.gov,2020-04-23,2020-05-01,False,Thomas Jefferson University,Not Recruiting,Phase 2,Interventional,No Country Given,Pharmacologic Ascorbic Acid as an Activator of Lymphocyte Signaling for COVID-19 Treatment,Drug,Vitamin C,66,2021-05-01,2021-05-01,https://clinicaltrials.gov/show/NCT04363216,No Results,No Results,No Results,2020-05-11,2020-05-05,None
2144,NCT04364815,ClinicalTrials.gov,2020-04-22,2020-05-01,False,University of the Philippines,Not Recruiting,Phase 3,Interventional,No Country Given,The University of the Philippines Hydroxychloroquine PEP Against COVID-19 Trial,Drug (Chemoprophylaxis),Hydroxychloroquine,960,2021-05-01,2021-05-01,https://clinicaltrials.gov/show/NCT04364815,No Results,No Results,No Results,2020-05-11,2020-05-05,None
2145,NCT04364828,ClinicalTrials.gov,2020-04-22,2020-04-01,True,"University Hospital, Tbingen",Not Recruiting,Not Applicable,Interventional,No Country Given,NGS Diagnostic in COVID-19 Hosts - Genetic Cause Relating to the Course of Disease Progression,Diagnostics,Diagnostic Test or Assessment,1000,2021-04-01,2021-08-01,https://clinicaltrials.gov/show/NCT04364828,No Results,No Results,No Results,2020-05-11,2020-05-05,None
2146,NCT04365231,ClinicalTrials.gov,2020-04-23,2020-04-01,True,"Hospital St. Joseph, Marseille",Not Recruiting,Phase 3,Interventional,France,Hydroxychloroquine Azithromycin COVID-19 Pregnancy Trial,Drug,Hydroxychloroquine + Azithromycin,50,2020-06-01,2021-01-01,https://clinicaltrials.gov/show/NCT04365231,No Results,No Results,No Results,2020-05-11,2020-05-05,None
2147,NCT04365257,ClinicalTrials.gov,2020-04-24,2020-05-01,False,Johns Hopkins University,Not Recruiting,Phase 2,Interventional,United States,Prazosin to Prevent COVID-19 (PREVENT-COVID Trial),Drug,Prazosin,220,2020-12-01,2020-12-01,https://clinicaltrials.gov/show/NCT04365257,No Results,No Results,No Results,2020-05-11,2020-05-05,None
2148,NCT04365309,ClinicalTrials.gov,2020-04-24,2020-02-10,True,Xijing Hospital,Recruiting,Phase 2/Phase 3,Interventional,China,Protective Effect of Aspirin on COVID-19 Patients,Drug,Aspirin,128,2020-04-01,2020-06-01,https://clinicaltrials.gov/show/NCT04365309,No Results,No Results,No Results,2020-05-11,2020-05-05,None
2149,NCT04365595,ClinicalTrials.gov,2020-04-24,2020-05-01,False,University of Zurich,Recruiting,Not Applicable,Observational,Switzerland,SARS-CoV-2 Associated Respiratory Failure Recovery (COVID-19 CAir),Clinical Presentation,No Intervention,200,2020-12-01,2020-12-01,https://clinicaltrials.gov/show/NCT04365595,No Results,No Results,No Results,2020-05-11,2020-05-05,None
2150,NCT04365608,ClinicalTrials.gov,2020-04-24,2020-03-20,True,Lazarski University,Recruiting,Not Applicable,Interventional,Poland,Prehospital Intubation of COVID-19 Patient With Personal Protective Equipment,Other (physical),Mechanical ventilation,90,2020-05-20,2020-05-20,https://clinicaltrials.gov/show/NCT04365608,No Results,No Results,No Results,2020-05-11,2020-05-05,None
2151,NCT04365985,ClinicalTrials.gov,2020-04-26,2020-04-29,False,William Beaumont Hospitals,Recruiting,Phase 2,Interventional,United States,Study of Immunomodulation Using Naltrexone and Ketamine for COVID-19,Drug,"Ketamine, Naltrexone",500,2020-05-01,2020-08-01,https://clinicaltrials.gov/show/NCT04365985,No Results,No Results,No Results,2020-05-11,2020-05-05,None
2152,NCT04366024,ClinicalTrials.gov,2020-04-21,2020-01-17,True,Xinqiao Hospital of Chongqing,Recruiting,Not Applicable,Observational,China,A Novel Nomogram to Predict Severity of COVID-19,Prognosis,No Intervention,1000,2020-05-30,2021-12-31,https://clinicaltrials.gov/show/NCT04366024,No Results,No Results,No Results,2020-05-11,2020-05-05,None
2153,NCT04366271,ClinicalTrials.gov,2020-04-23,2020-04-24,False,Hospital Infantil Universitario Nio Jess,Not Recruiting,Phase 2,Interventional,Spain,Clinical Trial of Allogeneic Mesenchymal Cells From Umbilical Cord Tissue in Patients With COVID-19,ATMP,Cells (mesenchymal),106,2020-07-31,2021-05-31,https://clinicaltrials.gov/show/NCT04366271,No Results,No Results,No Results,2020-05-11,2020-05-05,None
2154,NCT04366297,ClinicalTrials.gov,2020-04-23,2020-01-12,True,Lazarski University,Not Recruiting,Not Applicable,Interventional,Poland,Intravascular Access of COVID-19 Patient Under Personal Protective Equipment,Other (device),Intraosseous/Intravenous access device,41,2020-02-25,2020-02-25,https://clinicaltrials.gov/show/NCT04366297,No Results,No Results,No Results,2020-05-11,2020-05-05,None
2155,NCT04366882,ClinicalTrials.gov,2020-04-22,2020-04-14,True,Jessa Hospital,Recruiting,Not Applicable,Interventional,Belgium,Minimal Invasive Autopsies to Investigate Changes in Deceased COVID-19 Patients,Clinical Presentation,No Intervention,45,2020-12-01,2020-12-01,https://clinicaltrials.gov/show/NCT04366882,No Results,No Results,No Results,2020-05-11,2020-05-05,None
2156,NCT04366908,ClinicalTrials.gov,2020-04-25,2020-04-28,False,Maimonides Biomedical Research Institute of Cordoba,Not Recruiting,Phase 2,Interventional,No Country Given,Prevention and Treatment With Calcifediol of COVID-19 Induced Acute Respiratory Syndrome,Drug,Calcifediol,1008,2020-07-28,2020-08-28,https://clinicaltrials.gov/show/NCT04366908,No Results,No Results,No Results,2020-05-11,2020-05-05,None
2157,NCT04366921,ClinicalTrials.gov,2020-04-17,2020-04-10,True,Academic Hospital Maastricht,Recruiting,Not Applicable,Observational,"Sweden, Russian Federation, Greece, Germany, France, Lithuania, Israel, United Kingdom, Czech Republic, Belgium, Netherlands, Poland, Switzerland, Hungary, Austria, Spain, Denmark, Italy, Portugal",European/Euro-ELSO Survey on Adult and Neonatal/ Pediatric COVID-19 Patients in ECMO,Drug,Oxygen,150,2021-04-01,2021-04-01,https://clinicaltrials.gov/show/NCT04366921,No Results,No Results,No Results,2020-05-11,2020-05-05,None
2158,NCT04366934,ClinicalTrials.gov,2020-04-22,2020-05-04,False,Institut Pasteur,Recruiting,Not Applicable,Observational,France,Study of the Pathogenesis of Olfactory Disorders in COVID-19,Clinical Presentation,No Intervention,24,2022-09-15,2022-09-15,https://clinicaltrials.gov/show/NCT04366934,No Results,No Results,No Results,2020-05-11,2020-05-05,None
2159,NCT04367207,ClinicalTrials.gov,2020-04-27,2020-05-01,False,University of Cape Town,Not Recruiting,Not Applicable,Observational,No Country Given,African Covid-19 Critical Care Outcomes Study,Clinical Presentation,No Intervention,2000,2020-12-01,2020-12-31,https://clinicaltrials.gov/show/NCT04367207,No Results,No Results,No Results,2020-05-11,2020-05-05,None
2160,NCT04367792,ClinicalTrials.gov,2020-04-27,2020-04-01,True,A.O. Ospedale Papa Giovanni XXIII,Recruiting,Not Applicable,Observational,Italy,Cardiac Injury in COVID-19: a Pathology Study,Clinical Presentation,No Intervention,50,2020-10-01,2021-03-01,https://clinicaltrials.gov/show/NCT04367792,No Results,No Results,No Results,2020-05-11,2020-05-05,None
2161,NCT04367805,ClinicalTrials.gov,2020-04-27,2020-04-27,False,CHU de Amiens,Recruiting,Not Applicable,Observational,France,COVID-19 Infection in Patients With Hepatocellular Carcinoma,Diagnostics,Diagnostic Test or Assessment,50,2020-10-01,2020-10-01,https://clinicaltrials.gov/show/NCT04367805,No Results,No Results,No Results,2020-05-11,2020-05-05,None
2162,NCT04367831,ClinicalTrials.gov,2020-04-27,2020-05-01,False,Columbia University,Not Recruiting,Phase 4,Interventional,United States,Intermediate or Prophylactic-Dose Anticoagulation for Venous or Arterial Thromboembolism in Severe COVID-19,Drug,Enoxaparin,100,2020-11-01,2021-04-01,https://clinicaltrials.gov/show/NCT04367831,No Results,No Results,No Results,2020-05-11,2020-05-05,None
2163,NCT04368065,ClinicalTrials.gov,2020-04-28,2020-04-02,True,Iqvia Pty Ltd,Recruiting,Not Applicable,Observational,United States,Registry to Study Factors That May Impact COVID-19 Occurrence and Severity,Clinical Presentation,No Intervention,100000,2021-12-31,2022-06-01,https://clinicaltrials.gov/show/NCT04368065,No Results,No Results,No Results,2020-05-11,2020-05-05,None
2164,NCT04368299,ClinicalTrials.gov,2020-04-25,2020-05-01,False,Chinese University of Hong Kong,Not Recruiting,Not Applicable,Interventional,No Country Given,Telemedicine for Follow-up of Systemic Lupus Erythematosus,Telehealth,Telehealth,150,2021-10-31,2021-12-31,https://clinicaltrials.gov/show/NCT04368299,No Results,No Results,No Results,2020-05-11,2020-05-05,None
2165,NCT04368312,ClinicalTrials.gov,2020-04-09,2020-05-06,False,"University Hospital, Essen",Not Recruiting,Not Applicable,Observational,No Country Given,Psychological Impairment Due to Covid-19,Other (psych),No Intervention,100,2020-05-30,2020-05-30,https://clinicaltrials.gov/show/NCT04368312,No Results,No Results,No Results,2020-05-11,2020-05-05,None
2166,NCT04368728,ClinicalTrials.gov,2020-04-27,2020-04-29,False,Biontech SE,Recruiting,Phase 1/Phase 2,Interventional,United States,"Study to Describe the Safety, Tolerability, Immunogenicity, and Potential Efficacy of RNA Vaccine Candidates Against COVID-19 in Healthy Adults",ATMP,Vaccine,7600,2021-08-11,2023-03-08,https://clinicaltrials.gov/show/NCT04368728,No Results,No Results,No Results,2020-05-11,2020-05-05,None
2167,NCT04368923,ClinicalTrials.gov,2020-04-24,2020-03-15,True,Cairo University,Not Recruiting,Not Applicable,Interventional,Egypt,Management of Covid-19 Patients During Home Isolation,Drug,Oxygen,60,2020-05-15,2020-05-20,https://clinicaltrials.gov/show/NCT04368923,No Results,No Results,No Results,2020-05-11,2020-05-05,None
2168,NCT04369365,ClinicalTrials.gov,2020-04-27,2020-04-27,False,Dr. Matthias Preusser,Recruiting,Phase 2,Interventional,Austria,"A Single-blinded, Randomized, Placebo Controlled Phase II Trial of Prophylactic Treatment With Oral Azithromycin Versus Placebo in Cancer Patients Undergoing Antineoplastic Treatment During the Corona Virus Disease 19 (COVID-19) Pandemic",Drug (Chemoprophylaxis),Azithromycin,200,2020-08-27,2020-12-27,https://clinicaltrials.gov/show/NCT04369365,No Results,No Results,No Results,2020-05-11,2020-05-05,None
2169,NCT04369378,ClinicalTrials.gov,2020-04-24,2020-05-02,False,Lake Erie College of Osteopathic Medicine,Not Recruiting,Not Applicable,Interventional,No Country Given,Effectiveness of Using a Meditation App in Reducing Anxiety and Improving Well-being During the Covid-19 Pandemic,Other (psych),Psychological,100,2020-09-15,2020-10-31,https://clinicaltrials.gov/show/NCT04369378,No Results,No Results,No Results,2020-05-11,2020-05-05,None
2170,NCT04369599,ClinicalTrials.gov,2020-04-28,2020-05-01,False,Emory University,Not Recruiting,Not Applicable,Interventional,United States,Trans Thoracic Manipulation of Ventilation/Perfusion: the V/Q Vest,Other (device),Thoracic Manipulation Vest,24,2021-03-01,2021-03-01,https://clinicaltrials.gov/show/NCT04369599,No Results,No Results,No Results,2020-05-11,2020-05-05,None
2171,NCT04369807,ClinicalTrials.gov,2020-04-22,2020-04-21,True,Perspectum Diagnostics Ltd,Recruiting,Not Applicable,Observational,United Kingdom,Mapping Organ Health Following COVID-19 Disease Due to SARS-CoV-2 Infection,Clinical Presentation,No Intervention,507,2023-05-31,2023-05-31,https://clinicaltrials.gov/show/NCT04369807,No Results,No Results,No Results,2020-05-11,2020-05-05,None
2172,NCT04369820,ClinicalTrials.gov,2020-04-29,2020-03-31,True,Assistance Publique  Hpitaux de Marseille,Recruiting,Not Applicable,Interventional,France,C5a Receptor Expression - COVID-19 (C5-COV),Clinical Presentation,No Intervention,100,2020-09-01,2020-11-01,https://clinicaltrials.gov/show/NCT04369820,No Results,No Results,No Results,2020-05-11,2020-05-05,None
2173,NCT04370015,ClinicalTrials.gov,2020-04-27,2020-05-15,False,"Services Institute of Medical Sciences, Pakistan",Not Recruiting,Not Applicable,Interventional,No Country Given,Hydroxychloroquine Chemoprophylaxis for COVID-19 Infection in High-risk Healthcare Workers.,Drug (Chemoprophylaxis),Hydroxychloroquine,374,2020-06-30,2020-10-15,https://clinicaltrials.gov/show/NCT04370015,No Results,No Results,No Results,2020-05-11,2020-05-05,None
2174,NCT04370236,ClinicalTrials.gov,2020-04-29,2020-06-01,False,"Inmune Bio, Inc.",Not Recruiting,Phase 2,Interventional,No Country Given,XPro1595 for the Treatment of Pulmonary Complications From COVID-19,Drug,XPro1595,150,2021-01-01,2021-01-01,https://clinicaltrials.gov/show/NCT04370236,No Results,No Results,No Results,2020-05-11,2020-05-05,None
2175,NCT04370249,ClinicalTrials.gov,2020-04-28,2020-04-09,True,Nantes University Hospital,Recruiting,Not Applicable,Observational,France,Construction of a Composite Clinical-echo Score Predictive of a Risk of Short-term Aggravation of Respiratory Impairment in Patients Suspected of Covid-19,Clinical Presentation,No Intervention,400,2020-06-01,2020-06-01,https://clinicaltrials.gov/show/NCT04370249,No Results,No Results,No Results,2020-05-11,2020-05-05,None
2176,NCT04370262,ClinicalTrials.gov,2020-04-27,2020-04-07,True,Northwell Health,Recruiting,Phase 3,Interventional,United States,Multi-site Adaptive Trials Using Hydroxycholoroquine for COVID-19,Drug,Hydroxychloroquine + Famotidine vs. Hydroxychloroquine,1170,2020-09-07,2021-04-07,https://clinicaltrials.gov/show/NCT04370262,No Results,No Results,No Results,2020-05-11,2020-05-05,None
2177,NCT04370275,ClinicalTrials.gov,2020-04-29,2020-04-23,True,Latisana Hospital,Recruiting,Not Applicable,Observational,Italy,Accuracy of Lung Ultrasound in the Diagnosis of covid19 Pneumonia,Diagnostics,Diagnostic Test or Assessment,235,2020-05-23,2020-05-31,https://clinicaltrials.gov/show/NCT04370275,No Results,No Results,No Results,2020-05-11,2020-05-05,None
2178,NCT04370678,ClinicalTrials.gov,2020-04-24,2020-04-17,True,Region Zealand,Not Recruiting,Not Applicable,Observational,Denmark,Changes in Preference for Surgery of Patients Signed up for Arthroscopic Procedures,Other,No Intervention,79,2020-04-24,2020-04-24,https://clinicaltrials.gov/show/NCT04370678,No Results,No Results,No Results,2020-05-11,2020-05-05,None
2179,NCT04370886,ClinicalTrials.gov,2020-04-28,2020-04-30,False,Guangzhou Blood Center,Recruiting,Not Applicable,Interventional,China,Recruit Blood Donors Via SMS During Epidemic of COVID-19,Other,No Intervention,394578,2020-04-30,2020-05-10,https://clinicaltrials.gov/show/NCT04370886,No Results,No Results,No Results,2020-05-11,2020-05-05,None
2180,NCT04371354,ClinicalTrials.gov,2020-04-28,2020-04-27,True,Fundacin Miguel Servet,Not Recruiting,Not Applicable,Observational,No Country Given,Outcomes of Covid Protective Measures in Endoscopy,Clinical Presentation,No Intervention,100,2020-06-14,2020-07-27,https://clinicaltrials.gov/show/NCT04371354,No Results,No Results,No Results,2020-05-11,2020-05-05,None
2181,NCT04371367,ClinicalTrials.gov,2020-04-29,2020-04-27,True,Assistance Publique  Hpitaux de Marseille,Recruiting,Phase 2,Interventional,France,"Avdoralimab an Anti-C5aR Antibody, in Patients With COVID-19 Severe Pneumonia ( FORCE )",Drug,Avdoralimab,108,2020-06-27,2020-10-27,https://clinicaltrials.gov/show/NCT04371367,No Results,No Results,No Results,2020-05-11,2020-05-05,None
2182,NCT04371562,ClinicalTrials.gov,2020-04-30,2020-03-01,True,Fondazione Policlinico Universitario Agostino Gemelli IRCCS,Not Recruiting,Not Applicable,Observational,Italy,Predicting Death and ICU Admission in COVID-19 Patients in ED,Prognosis,No Intervention,300,2020-03-31,2020-04-15,https://clinicaltrials.gov/show/NCT04371562,No Results,No Results,No Results,2020-05-11,2020-05-05,None
2183,NCT04371978,ClinicalTrials.gov,2020-04-30,2020-05-15,False,Rabin Medical Center,Not Recruiting,Phase 3,Interventional,Israel,Efficacy and Safety of Dipeptidyl Peptidase-4 Inhibitors in Diabetic Patients With Established COVID-19,Drug,Linagliptin,100,2021-06-30,2021-09-30,https://clinicaltrials.gov/show/NCT04371978,No Results,No Results,No Results,2020-05-11,2020-05-05,None
2184,NCT04372004,ClinicalTrials.gov,2020-04-29,2020-05-01,False,Texas Cardiac Arrhythmia Research Foundation,Not Recruiting,Not Applicable,Interventional,No Country Given,Comparison of the Efficacy of Rapid Tests to Identify COVID-19 Infection (CATCh COVID-19),Diagnostics,Diagnostic Test or Assessment,100,2021-05-01,2021-06-01,https://clinicaltrials.gov/show/NCT04372004,No Results,No Results,No Results,2020-05-11,2020-05-05,None
2185,NCT04372017,ClinicalTrials.gov,2020-04-25,2020-04-30,False,Sanford Health,Not Recruiting,Phase 3,Interventional,No Country Given,"Randomized, Double-Blind,Controlled Trial of Hydroxychloroquine as Post-Exposure Prophylaxis Against COVID-19 Infection",Drug (Chemoprophylaxis),Hydroxychloroquine,1739,2022-04-20,2023-04-20,https://clinicaltrials.gov/show/NCT04372017,No Results,No Results,No Results,2020-05-11,2020-05-05,None
2186,NCT04372199,ClinicalTrials.gov,2020-04-29,2020-04-29,False,Fondazione Policlinico Universitario Agostino Gemelli IRCCS,Recruiting,Not Applicable,Observational,Italy,SEVERITY SCORE FOR COVID-19 PNEUMONIA,Clinical Presentation,No Intervention,248,2020-05-27,2020-05-27,https://clinicaltrials.gov/show/NCT04372199,No Results,No Results,No Results,2020-05-11,2020-05-05,None
2187,NCT04372680,ClinicalTrials.gov,2020-04-30,2020-04-22,True,"University Hospital, Toulouse",Recruiting,Not Applicable,Interventional,France,WeanINg From Mechanical Ventilation for ARDS CovId-19 Patients Guided by Combined Thoracic UltraSound,Other (physical),Mechanical ventilation,200,2020-09-22,2020-09-22,https://clinicaltrials.gov/show/NCT04372680,No Results,No Results,No Results,2020-05-11,2020-05-12,None
2188,NCT04373096,ClinicalTrials.gov,2020-04-30,2020-05-07,False,"University Health Network, Toronto",Not Recruiting,Not Applicable,Interventional,No Country Given,Enhanced Hood PPE to Minimize COVID-19 Transmission to Front-line Health Care Workers,Other (device),Hood,42,2020-08-31,2020-08-31,https://clinicaltrials.gov/show/NCT04373096,No Results,No Results,No Results,2020-05-11,2020-05-12,None
2189,NCT04373109,ClinicalTrials.gov,2020-04-16,2020-04-16,False,Jeremia Held,Recruiting,Not Applicable,Observational,Switzerland,Stroke Rehabilitation Outcome During COVID-19 Lockdown,Clinical Presentation,No Intervention,70,2021-04-01,2021-04-01,https://clinicaltrials.gov/show/NCT04373109,No Results,No Results,No Results,2020-05-11,2020-05-12,None
2190,NCT04373291,ClinicalTrials.gov,2020-05-01,2020-05-01,False,Bandim Health Project,Not Recruiting,Phase 3,Interventional,No Country Given,Using BCG Vaccine to Protect Health Care Workers in the COVID-19 Pandemic,ATMP,Vaccine,1500,2020-12-01,2021-01-01,https://clinicaltrials.gov/show/NCT04373291,No Results,No Results,No Results,2020-05-11,2020-05-12,None
2191,NCT04373759,ClinicalTrials.gov,2020-04-30,2020-05-01,False,Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer,Not Recruiting,Not Applicable,Observational,France,Cardiac Arrest Incidence and Outcome Among Patients With COVID-19 in French ICUs,Clinical Presentation,No Intervention,100,2020-09-01,2020-12-01,https://clinicaltrials.gov/show/NCT04373759,No Results,No Results,No Results,2020-05-11,2020-05-12,None
2192,NCT04374422,ClinicalTrials.gov,2020-04-29,2020-04-10,True,Acibadem University,Not Recruiting,Not Applicable,Observational,Turkey,COVID-19 Pandemic and Female Sexual Behavior,Other,No Intervention,58,2020-04-12,2020-04-12,https://clinicaltrials.gov/show/NCT04374422,No Results,No Results,No Results,2020-05-11,2020-05-12,None
2193,NCT04374591,ClinicalTrials.gov,2020-05-02,2020-04-01,True,Mansoura University,Not Recruiting,Phase 1,Interventional,Egypt,Inhalable Sodium Bicarbonate: A Possible Adjuvant Treatment of Patients With Novel COVID-19,Drug,Sodium Bicarbonate,20,2020-06-01,2020-06-01,https://clinicaltrials.gov/show/NCT04374591,No Results,No Results,No Results,2020-05-11,2020-05-12,None
2194,NCT04374617,ClinicalTrials.gov,2020-05-02,2020-04-01,True,Vall d'Hebron Research Institute (VHIR),Not Recruiting,Not Applicable,Observational,Spain,Risk of Venous Thromboembolism in Critically Ill Patients With Severe COVID-19,Clinical Presentation,No Intervention,230,2020-04-25,2020-05-01,https://clinicaltrials.gov/show/NCT04374617,No Results,No Results,No Results,2020-05-11,2020-05-12,None
2195,NCT04374838,ClinicalTrials.gov,2020-05-01,2020-05-15,False,South Egypt Cancer Institute,Not Recruiting,Not Applicable,Observational,No Country Given,Effect of COVID-19 Pandemic on Pediatric Cancer Care,Clinical Presentation,No Intervention,20,2020-12-15,2021-05-15,https://clinicaltrials.gov/show/NCT04374838,No Results,No Results,No Results,2020-05-11,2020-05-12,None
2196,NCT04375046,ClinicalTrials.gov,2020-05-01,2020-08-01,False,Kafrelsheikh University,Not Recruiting,Phase 1,Interventional,No Country Given,Recombinant Bacterial ACE2 Receptors -Like Enzyme of B38-CAP Could be Promising COVID-19 Infection- and Lung Injury Preventing Drug Better Than Recombinant Human ACE2,Drug,ACE enzyme,24,2020-09-01,2020-10-01,https://clinicaltrials.gov/show/NCT04375046,No Results,No Results,No Results,2020-05-11,2020-05-12,None
2197,NCT04375501,ClinicalTrials.gov,2020-05-04,2020-02-01,True,Barts & The London NHS Trust,Recruiting,Not Applicable,Observational,United Kingdom,A Study of Outcomes in Patients With Fractured Neck of Femur During the COVID-19 Pandemic,Clinical Presentation,No Intervention,300,2020-05-04,2020-05-04,https://clinicaltrials.gov/show/NCT04375501,No Results,No Results,No Results,2020-05-11,2020-05-12,None
2198,NCT04375709,ClinicalTrials.gov,2020-05-04,2020-03-15,True,Kantonsspital Winterthur (KSW),Recruiting,Not Applicable,Observational,Switzerland,Quality of Life and Physical Performance After Novel Coronavirus Infection (COVID-19);,Other (exercise),Exercise,60,2021-06-30,2021-08-31,https://clinicaltrials.gov/show/NCT04375709,No Results,No Results,No Results,2020-05-11,2020-05-12,None
2199,NCT04376580,ClinicalTrials.gov,2020-04-30,2020-04-30,False,Carolina Frederico,Recruiting,Not Applicable,Observational,Argentina,Use of the Nasal Cannula During COVID-19,Other (device),Nasal cannula,100,2020-07-31,2020-09-30,https://clinicaltrials.gov/show/NCT04376580,No Results,No Results,No Results,2020-05-11,2020-05-12,None
2200,NCT04376593,ClinicalTrials.gov,2020-05-03,2020-05-01,True,"University of California, Davis",Recruiting,Phase 1,Interventional,United States,PET/CT Imaging in COVID-19 Patients,Diagnostics,Diagnostic Test or Assessment,10,2021-05-01,2022-05-01,https://clinicaltrials.gov/show/NCT04376593,No Results,No Results,No Results,2020-05-11,2020-05-12,None
2201,NCT04376775,ClinicalTrials.gov,2020-05-04,2020-05-15,False,"University Hospital, Bordeaux",Not Recruiting,Not Applicable,Observational,France,Assessment of the Impact of COVID-19 on Transplant Patients and on Patients Awaiting Transplantation,Clinical Presentation,No Intervention,2000,2020-12-15,2020-12-15,https://clinicaltrials.gov/show/NCT04376775,No Results,No Results,No Results,2020-05-11,2020-05-12,None
2202,NCT04376788,ClinicalTrials.gov,2020-05-01,2020-05-05,False,Ain Shams University,Not Recruiting,Phase 2,Interventional,Egypt,Exchange Transfusion Versus Plasma From Convalescent Patients With Methylene Blue in Patients With COVID-19,ATMP,Plasma + Methylene Blue,15,Not Available,Not Available,https://clinicaltrials.gov/show/NCT04376788,No Results,No Results,No Results,2020-05-11,2020-05-12,None
2203,NCT04376814,ClinicalTrials.gov,2020-05-03,2020-03-29,True,Baqiyatallah Medical Sciences University,Recruiting,Not Applicable,Interventional,Iran,Safety and Efficacy of Hydroxychloroquine + Favipiravir Drug Regimen in Comparison With Hydroxychloroquine + Kaletra on the Need for Intensive Care Unit Treatment in Patients With COVID-19,Drug,Favipiravir + Hydroxychloroquine vs. Lopinavir/ritonavir + Hydroxychloroquine,40,2020-04-05,2020-05-25,https://clinicaltrials.gov/show/NCT04376814,No Results,No Results,No Results,2020-05-11,2020-05-12,None
2204,NCT04376996,ClinicalTrials.gov,2020-05-04,2020-04-20,True,University of Ljubljana,Recruiting,Not Applicable,Observational,Slovenia,Slovenian National COVID-19 Prevalence Study,Clinical Presentation (Epidemiology),No Intervention,3000,2020-10-01,2020-12-01,https://clinicaltrials.gov/show/NCT04376996,No Results,No Results,No Results,2020-05-11,2020-05-12,None
2205,NCT04377425,ClinicalTrials.gov,2020-04-29,2020-05-07,False,Aarhus University Hospital,Not Recruiting,Not Applicable,Observational,Denmark,COVID-19 Prevalence and Cognitive Deficits in Neurological Patients,Clinical Presentation,No Intervention,100,2020-11-29,2022-06-30,https://clinicaltrials.gov/show/NCT04377425,No Results,No Results,No Results,2020-05-11,2020-05-12,None
2206,NCT04377464,ClinicalTrials.gov,2020-05-04,2020-05-05,False,Chinese University of Hong Kong,Not Recruiting,Not Applicable,Observational,No Country Given,COVID-19 - Quality of Life After Infection,Other,Other,200,2021-04-30,2022-04-30,https://clinicaltrials.gov/show/NCT04377464,No Results,No Results,No Results,2020-05-11,2020-05-12,None
2207,NCT04377646,ClinicalTrials.gov,2020-05-01,2020-05-04,False,Military Hospital of Tunis,Not Recruiting,Phase 3,Interventional,Tunisia,A Study of Hydroxychloroquine and Zinc in the Prevention of COVID-19 Infection in Military Healthcare Workers,Drug (Chemoprophylaxis),Hydroxychloroquine + Zinc,660,2020-05-24,2020-07-31,https://clinicaltrials.gov/show/NCT04377646,No Results,No Results,No Results,2020-05-11,2020-05-12,None
2208,NCT04377659,ClinicalTrials.gov,2020-05-04,2020-05-01,True,Memorial Sloan Kettering Cancer Center,Recruiting,Phase 2,Interventional,United States,Tocilizumab for Prevention of Respiratory Failure in Patients With Severe COVID-19 Infection,Drug,Tocilizumab,40,2021-05-01,2021-05-01,https://clinicaltrials.gov/show/NCT04377659,No Results,No Results,No Results,2020-05-11,2020-05-12,None
2209,NCT04377672,ClinicalTrials.gov,2020-05-04,2020-05-18,False,Johns Hopkins University,Not Recruiting,Phase 1,Interventional,No Country Given,Human Convalescent Plasma for High Risk Children Exposed or Infected With SARS-CoV-2 (COVID-19),ATMP,Plasma,30,2021-05-18,2022-05-18,https://clinicaltrials.gov/show/NCT04377672,No Results,No Results,No Results,2020-05-11,2020-05-12,None
2210,NCT04379154,ClinicalTrials.gov,2020-04-28,2020-04-14,True,Hpital Foch,Recruiting,Not Applicable,Interventional,France,Analysis of Volatile Organic Compounds by Electronic Noses in Hospitalised Patients for an Infection by SARS-CoV-2 (COVID-19),Other,Other,60,2020-06-28,2020-11-16,https://clinicaltrials.gov/show/NCT04379154,No Results,No Results,No Results,2020-05-11,2020-05-12,None
2211,NCT04379375,ClinicalTrials.gov,2020-05-04,2020-05-11,False,Medical College of Wisconsin,Not Recruiting,Not Applicable,Interventional,No Country Given,Nudges to Limit COVID-19,Other,Other,300,2020-10-10,2020-10-10,https://clinicaltrials.gov/show/NCT04379375,No Results,No Results,No Results,2020-05-11,2020-05-12,None
2212,NCT04380688,ClinicalTrials.gov,2020-05-07,2020-05-12,False,AstraZeneca,Not Recruiting,Phase 2,Interventional,United States,Acalabrutinib Study With Best Supportive Care Versus Best Supportive Care in Subjects Hospitalized With COVID-19.,Drug,Acalabrutinib,60,2020-09-30,2020-09-30,https://clinicaltrials.gov/show/NCT04380688,No Results,No Results,No Results,2020-05-11,2020-05-12,None
2213,NCT04380714,ClinicalTrials.gov,2020-05-07,2020-05-01,True,"University Hospital, Montpellier",Recruiting,Not Applicable,Observational,France,Changes in the Consumption of Psychoactive Substances During Containment Linked to COVID-19,Clinical Presentation,No Intervention,700,2020-05-30,2020-08-01,https://clinicaltrials.gov/show/NCT04380714,No Results,No Results,No Results,2020-05-11,2020-05-12,None
2214,NCT04380896,ClinicalTrials.gov,2020-05-04,2020-04-27,True,Great Ormond Street Hospital for Children NHS Foundation Trust,Recruiting,Not Applicable,Observational,United Kingdom,COVID-19 Staff Testing of Antibody Responses Study (Co-Stars),Clinical Presentation (Epidemiology),No Intervention,1000,2026-07-27,2026-07-27,https://clinicaltrials.gov/show/NCT04380896,No Results,No Results,No Results,2020-05-11,2020-05-12,None
2215,NCT04380909,ClinicalTrials.gov,2020-05-07,2020-05-06,True,University of Bern,Recruiting,Not Applicable,Interventional,Switzerland,ROCO - Self-help for People With Psychological Distress Due to the Covid-19 Situation,Other (psych),Psychological,80,2021-04-01,2021-04-01,https://clinicaltrials.gov/show/NCT04380909,No Results,No Results,No Results,2020-05-11,2020-05-12,None
2216,NCT04380935,ClinicalTrials.gov,2020-05-04,2020-05-11,False,Indonesia University,Not Recruiting,Phase 2/Phase 3,Interventional,Indonesia,Effectiveness and Safety of Convalescent Plasma Therapy on COVID-19 Patients With Acute Respiratory Distress Syndrome,ATMP,Plasma,60,2020-08-31,2020-08-31,https://clinicaltrials.gov/show/NCT04380935,No Results,No Results,No Results,2020-05-11,2020-05-12,None
2217,NCT04381338,ClinicalTrials.gov,2020-05-04,2020-05-10,False,University of Padova,Not Recruiting,Not Applicable,Interventional,Italy,Rehabilitation for People With COVID-19 in ICU,Other (physio),Physio,92,2020-09-30,2020-09-30,https://clinicaltrials.gov/show/NCT04381338,No Results,No Results,No Results,2020-05-11,2020-05-12,None
2218,NCT04381351,ClinicalTrials.gov,2020-05-07,2020-04-16,True,Heinrich-Heine University,Recruiting,Not Applicable,Observational,Germany,Noncoding RNAs in COVID-19 and COVID-19 Related Kidney Dysfunction,Clinical Presentation,No Intervention,50,2021-03-01,2021-07-31,https://clinicaltrials.gov/show/NCT04381351,No Results,No Results,No Results,2020-05-11,2020-05-12,None
2219,NCT04381364,ClinicalTrials.gov,2020-05-07,2020-05-15,False,Dr. Ola Blennow,Not Recruiting,Phase 2,Interventional,Sweden,Inhalation of Ciclesonide for Patients With COVID-19: A Randomised Open Treatment Study (HALT COVID-19),Drug,Ciclesonide,446,2020-12-01,2020-12-31,https://clinicaltrials.gov/show/NCT04381364,No Results,No Results,No Results,2020-05-11,2020-05-12,None
2220,NCT04381377,ClinicalTrials.gov,2020-05-07,2020-04-29,True,NPO Petrovax,Recruiting,Phase 2/Phase 3,Interventional,Russian Federation,Efficacy and Safety of Polyoxidonium in Hospitalized Patients With Coronavirus Disease COVID-19,Drug,Azoximer bromide,394,2021-04-01,2021-04-01,https://clinicaltrials.gov/show/NCT04381377,No Results,No Results,No Results,2020-05-11,2020-05-12,None
2221,ChiCTR2000032770,ChiCTR,2020-05-10,2020-01-29,True,Department of Science and Technology of Guizhou Province,Not Recruiting,Not Applicable,Observational,China,Asymptomatic novel coronavirus pneumonia (COVID-19) patients Have Longer Treatment Cycle Than Mild and Moderate Patients: a medical records based study,Clinical Presentation,No Intervention,52,Not Available,2020-03-31,http://www.chictr.org.cn/showproj.aspx?proj=53228,No Results,No Results,No Results,2020-05-11,2020-05-12,None
2222,ChiCTR2000032769,ChiCTR,2020-05-09,2020-05-12,False,Beijing Ditan Hospital,Recruiting,Not Applicable,Interventional,China,"A randomized,double blinded, parallel  controlled clinical trial for azvudine in the treatment of novel coronavirus pneumonia (COVID-19)",Drug,Azvudine,342,Not Available,Not Available,http://www.chictr.org.cn/showproj.aspx?proj=53368,No Results,No Results,No Results,2020-05-11,2020-05-12,None
2223,ChiCTR2000032737,ChiCTR,2020-05-08,2020-05-08,False,The First Affiliated Hospital of Guangdong Pharmaceutical University; Guangzhou Eighth People's Hospital,Not Recruiting,Not Applicable,Interventional,China,Clinical trial for the washed microbiota transplantation in the treatment of novel coronavirus pneumonia (COVID-19) patients suspected with gut microbiota dysbiosis,Other,Washed microbiota transplantation,60,Not Available,2021-06-08,http://www.chictr.org.cn/showproj.aspx?proj=53458,No Results,No Results,No Results,2020-05-11,2020-05-12,None
2224,ChiCTR2000032686,ChiCTR,2020-05-06,2020-05-04,True,"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology",Not Recruiting,Not Applicable,Observational,China,Study for the application of novel coronavirus pneumonia (COVID-19) intestinal tract toxicity in diagnosis and its prognostic effect,Prognosis,No Intervention,390,Not Available,2021-12-31,http://www.chictr.org.cn/showproj.aspx?proj=53153,No Results,No Results,No Results,2020-05-11,2020-05-12,None
2225,ChiCTR2000032635,ChiCTR,2020-05-04,2020-05-06,False,Hubei Hospital of Traditional Chinese Medicine,Not Recruiting,Not Applicable,Interventional,China,Study for Screening of Chinese Patent Drugs in the Rehabilitation Treatment of novel coronavirus pneumonia (COVID-19),Traditional Medicine (Drug),Traditional Medicine,60,Not Available,2021-03-31,http://www.chictr.org.cn/showproj.aspx?proj=52671,No Results,No Results,No Results,2020-05-11,2020-05-12,None
2226,NL8501,Netherlands Trial Register,2020-04-01,2020-03-23,True,Interactive Studios,Recruiting,Not Applicable,Observational,Netherlands,"Using eHealth to support COVID-19 education, self-assessment and symptom tracking.",Other (software),eHealth,2000,Not Available,2020-06-30,https://trialregister.nl/trial/8501,No Results,No Results,No Results,2020-05-11,2020-04-15,None
2227,NL8523,Netherlands Trial Register,2020-04-13,2020-04-26,False,UMC Utrecht,Not Recruiting,Not Applicable,Interventional,Netherlands,Volatile Anaesthetics in COVID-19  a pilot study,Drug,Isoflurane,20,Not Available,2020-05-31,https://trialregister.nl/trial/8523,No Results,No Results,No Results,2020-05-11,2020-04-29,None
2228,NL8562,Netherlands Trial Register,2020-04-21,2020-04-01,True,None (investigator initiated study),Not Recruiting,Not Applicable,Observational,Netherlands,Bioelectric Impedance Analysis in COVID-19 positive patients. A prospective prevalence study,Clinical Presentation,No Intervention,50,Not Available,2020-04-30,https://trialregister.nl/trial/8562,No Results,No Results,No Results,2020-05-11,2020-05-05,None
2229,NL8570,Netherlands Trial Register,2020-04-29,2020-05-10,False,Franciscus Gasthuis & Vlietland,Not Recruiting,Not Applicable,Observational,Netherlands,COVID-19 infections in health care workers,Clinical Presentation,No Intervention,300,Not Available,2020-12-31,https://trialregister.nl/trial/8570,No Results,No Results,No Results,2020-05-11,2020-05-05,None
2230,NL8576,Netherlands Trial Register,2020-04-20,2020-04-20,False,Franciscus Gasthuis & Vlietland,Not Recruiting,Not Applicable,Observational,Netherlands,Effect van COVID-19 op kwaliteit van leven bij astma,Other (psych),No Intervention,80,Not Available,2020-07-01,https://trialregister.nl/trial/8576,No Results,No Results,No Results,2020-05-11,2020-05-12,None
2231,NL8577,Netherlands Trial Register,2020-05-06,2020-05-15,False,Academic Hospital Maastricht,Not Recruiting,Not Applicable,Interventional,Netherlands,Digital Cardiac Counseling Trial: DCC Trial,Other (software),eHealth,394,Not Available,2022-12-31,https://trialregister.nl/trial/8577,No Results,No Results,No Results,2020-05-11,2020-05-12,None
2232,NL8578,Netherlands Trial Register,2020-05-02,2020-07-13,False,Rode Kruis Ziekenhuis Beverwijk,Not Recruiting,Not Applicable,Interventional,Netherlands,Alkaline phosphatase for reducing systemic inflammatory response syndrome (SIRS) in patients with Sars-CoV-2 infection and acute respiratory insufficiency (COVID 19),Drug,Alkaline phosphatase,124,Not Available,2022-07-13,https://trialregister.nl/trial/8578,No Results,No Results,No Results,2020-05-11,2020-05-12,None
2233,NL8535,Netherlands Trial Register,2020-04-15,2020-03-30,True,CIRO,Recruiting,Not Applicable,Observational,Netherlands,Functional status and health status in COVID-19 patients pre and post rehabilitation,Other (physio),Physio,30,Not Available,2020-11-30,https://trialregister.nl/trial/8535,No Results,No Results,No Results,2020-05-11,2020-04-29,None
2234,NL8513,Netherlands Trial Register,2020-04-07,2020-04-13,False,Reade Research BV,Recruiting,Not Applicable,Observational,Netherlands,COVID-19 in rheumatic patients: a prospective cohort study,Clinical Presentation,No Intervention,8000,Not Available,2021-04-13,https://trialregister.nl/trial/8513,No Results,No Results,No Results,2020-05-11,2020-04-15,None
2235,NL8460,Netherlands Trial Register,2020-03-16,2020-03-16,False,No Sponsor Name Given,Recruiting,Not Applicable,Observational,Netherlands,Biomarkers for prognosis in critically ill COVID-19 patients : a prospective cohort study,Prognosis,No Intervention,100,Not Available,2020-08-16,https://trialregister.nl/trial/8460,No Results,No Results,No Results,2020-05-11,2020-03-25,None
2236,NL8473,Netherlands Trial Register,2020-03-23,2020-03-23,False,National Institute for Public Health and the Environment (RIVM),Not Recruiting,Not Applicable,Observational,Netherlands,Immunity against SARS-CoV-2 in Dutch population,Clinical Presentation,No Intervention,4000,Not Available,2021-09-23,https://trialregister.nl/trial/8473,No Results,No Results,No Results,2020-05-11,2020-04-01,None
2237,NL8483,Netherlands Trial Register,2020-03-26,2020-03-16,True,Fred Foundation; Noaber Foundation,Recruiting,Not Applicable,Interventional,Netherlands,A weapon against COVID-19: (Social) media and influencers,Other,Other,17000,Not Available,2020-03-29,https://trialregister.nl/trial/8483,No Results,No Results,No Results,2020-05-11,2020-04-07,None
2238,NL8491,Netherlands Trial Register,2020-03-31,2020-03-31,False,UMC Amsterdam,Recruiting,Not Applicable,Interventional,Netherlands,Countering Lung Damage in COVID-19 infection (CounterCovid) study,Drug,Imatinib,386,Not Available,2020-06-30,https://trialregister.nl/trial/8491,No Results,No Results,No Results,2020-05-11,2020-04-07,None
2239,NL8497,Netherlands Trial Register,2020-03-31,2020-03-15,True,Radboud University Medical Centre,Recruiting,Not Applicable,Observational,Netherlands,Lung ultrasound vs CT scan in COVID-19 disease,Diagnostics,Diagnostic Test or Assessment,200,Not Available,2020-06-30,https://trialregister.nl/trial/8497,No Results,No Results,No Results,2020-05-11,2020-04-15,None
2240,DRKS00021420,German Clinical Trials Register,2020-04-16,2020-04-01,True,Technische Universitt Mnchen,Recruiting,Phase 1,Interventional,Germany,Observational clinical trial for the evaluation of an automated nasal and pharyngeal swab exam to test COVID-19 patients,Diagnostics,Diagnostic Test or Assessment,30,Not Available,Not Available,http://www.drks.de/DRKS00021420,No Results,No Results,No Results,2020-05-11,2020-04-22,None
2241,DRKS00021432,German Clinical Trials Register,2020-05-04,2020-04-20,True,University of Oldenburg,Recruiting,Not Applicable,Observational,Germany,Limitations of social life in the context of the COVID-19 pandemic - Effects on physical performance and health-related quality of life of older people,Other (psych),No Intervention,100,Not Available,Not Available,http://www.drks.de/DRKS00021432,No Results,No Results,No Results,2020-05-11,2020-05-12,None
2242,DRKS00021399,German Clinical Trials Register,2020-04-20,2020-04-12,True,Dortmund Hospital,Recruiting,Not Applicable,Observational,Germany,Prospective gas chromatographic and spectrometric analysis of the exhalation of healthy test persons and of SARS-CoV2 infected patients as well as  of patients suffering from COVID-19 at the Klinikum Dortmund,Clinical Presentation,No Intervention,450,Not Available,Not Available,http://www.drks.de/DRKS00021399,No Results,No Results,No Results,2020-05-11,2020-05-05,None
2243,DRKS00021522,German Clinical Trials Register,2020-04-22,2020-04-21,True,"University Hospital, Freiburg",Recruiting,Not Applicable,Observational,Germany,Local and systemic markers of inflammation and circadian rhythmicity in COVID-19 disease and their role in the prediction of clinical outcome,Clinical Presentation,No Intervention,50,Not Available,Not Available,http://www.drks.de/DRKS00021522,No Results,No Results,No Results,2020-05-11,2020-05-05,None
2244,DRKS00021578,German Clinical Trials Register,2020-04-28,2020-04-24,True,Universitt Konstanz,Recruiting,Not Applicable,Observational,Germany,Validation of new detection methods for SARS CoV-2 in suspected COVID-19,Diagnostics,Diagnostic Test or Assessment,300,Not Available,Not Available,http://www.drks.de/DRKS00021578,No Results,No Results,No Results,2020-05-11,2020-05-05,None
2245,DRKS00021585,German Clinical Trials Register,2020-04-29,2020-04-24,True,Vivantes Humboldt Klinikum,Recruiting,Not Applicable,Interventional,Germany,Lung Ultrasound in Covid-19 Pneumonia,Diagnostics,Diagnostic Test or Assessment,220,Not Available,Not Available,http://www.drks.de/DRKS00021585,No Results,No Results,No Results,2020-05-11,2020-05-05,None
2246,DRKS00021255,German Clinical Trials Register,2020-04-28,2020-05-01,False,Private Universitt Witten/Herdecke gGmbH,Not Recruiting,Not Applicable,Observational,Germany,Point-of-care coagulation testing in patients suffering from COVID-19,Diagnostics,Diagnostic Test or Assessment,20,Not Available,Not Available,http://www.drks.de/DRKS00021255,No Results,No Results,No Results,2020-05-11,2020-05-05,None
2247,DRKS00021254,German Clinical Trials Register,2020-04-03,2020-04-05,False,Universittsklinikum Schleswig-Holstein,Recruiting,Not Applicable,Observational,Germany,"Investigation of the influence of the new coronavirus pandemic (COVID-19) on pain, mood and everyday life of patients with painful polyneuropathy",Other (psych),No Intervention,50,Not Available,Not Available,http://www.drks.de/DRKS00021254,No Results,No Results,No Results,2020-05-11,2020-04-22,None
2248,DRKS00021225,German Clinical Trials Register,2020-04-01,2020-04-02,False,Klinikum der Universitt Mnchen,Not Recruiting,Not Applicable,Observational,Germany,COVID-19 Registry of the LMU Hospital Munich,Clinical Presentation,No Intervention,1500,Not Available,Not Available,http://www.drks.de/DRKS00021225,No Results,No Results,No Results,2020-05-11,2020-04-22,None
2249,DRKS00021220,German Clinical Trials Register,2020-04-01,2020-04-05,False,"University Hospital, Heidelberg",Not Recruiting,Not Applicable,Observational,Germany,Evaluation of the performance of novel rapid diagnostics for COVID-19 at point-of-care,Diagnostics,Diagnostic Test or Assessment,2000,Not Available,Not Available,http://www.drks.de/DRKS00021220,No Results,No Results,No Results,2020-05-11,2020-04-22,None
2250,DRKS00021166,German Clinical Trials Register,2020-03-27,2020-03-30,False,University Hospital Leipzig,Not Recruiting,Not Applicable,Observational,Germany,Development of a test to measure the immune response in patients with Covid-19,Clinical Presentation,No Intervention,15,Not Available,Not Available,http://www.drks.de/DRKS00021166,No Results,No Results,No Results,2020-05-11,2020-04-22,None
2251,DRKS00021186,German Clinical Trials Register,2020-03-26,2020-03-26,False,KKH Bergstrae Abteilung,Recruiting,Not Applicable,Observational,Germany,"prospective observational study to evaluate transpulmonary pressure, end expiratory lung volume and intraabdominal pressure in mechanical ventilated patients with Covid-19",Clinical Presentation,No Intervention,45,Not Available,Not Available,http://www.drks.de/DRKS00021186,No Results,No Results,No Results,2020-05-11,2020-04-22,None
2252,DRKS00021295,German Clinical Trials Register,2020-05-04,2020-04-06,True,Nierenzentrum Heidelberg e.V.,Recruiting,Not Applicable,Observational,Germany,Clinical characteristics of renal patients with COVID-19 infection,Clinical Presentation,No Intervention,100,Not Available,Not Available,http://www.drks.de/DRKS00021295,No Results,No Results,No Results,2020-05-11,2020-05-12,None
2253,DRKS00021270,German Clinical Trials Register,2020-04-15,2020-04-14,True,Krankenhaus Reinbek St. Adolf-Stift,Not Recruiting,Not Applicable,Observational,Germany,Prospective molecular biological and serological examination for the detection of SARS-CoV-2 (COVID-19) in employees of a hospital of regular care in Germany,Clinical Presentation,No Intervention,800,Not Available,Not Available,http://www.drks.de/DRKS00021270,No Results,No Results,No Results,2020-05-11,2020-04-22,None
2254,DRKS00021134,German Clinical Trials Register,2020-03-19,2020-03-20,False,"University Hospital, Leipzig",Not Recruiting,Not Applicable,Observational,Germany,Identification of host cell respiratory tract cell gene expression and epigenetic pattern after human SARS-CoV-2 infection (COVID-19),Genomics,No Intervention,60,Not Available,Not Available,http://www.drks.de/DRKS00021134,No Results,No Results,No Results,2020-05-11,2020-03-25,None
2255,DRKS00021612,German Clinical Trials Register,2020-04-30,2020-03-30,True,Technische Universitt Mnchen,Recruiting,Not Applicable,Observational,Germany,CORRECT: COvid (Covid-19) Registry REChts der Isar intensive care Trial,Clinical Presentation,No Intervention,500,Not Available,Not Available,http://www.drks.de/DRKS00021612,No Results,No Results,No Results,2020-05-11,2020-05-05,None
2256,DRKS00021658,German Clinical Trials Register,2020-05-05,2020-03-01,True,"University Hospital, Freiburg",Not Recruiting,Not Applicable,Observational,Germany,Incidence and risk factors for acute kidney injury in COVID-19,Clinical Presentation,No Intervention,100,Not Available,2020-04-30,http://www.drks.de/DRKS00021658,No Results,No Results,No Results,2020-05-11,2020-05-12,None
2257,DRKS00021675,German Clinical Trials Register,2020-05-08,2020-05-07,True,"University Hospital, Essen",Recruiting,Not Applicable,Observational,Germany,Sorting the wheat form the chaff  COVID-19 in the Emergency department,Clinical Presentation,No Intervention,340,Not Available,Not Available,http://www.drks.de/DRKS00021675,No Results,No Results,No Results,2020-05-11,2020-05-12,None
2258,EUCTR2020-001700-42-FR,EU Clinical Trials Register,2020-04-11,2020-05-06,False,Assistance Publique  Hpitaux de Paris,Authorised,Phase 2,Interventional,France,Efficacy of captopril  in Covid-19 patients suffering of pneumonia,Drug,Captopril,230,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001700-42,No Results,No Results,No Results,2020-05-11,2020-05-12,None
2259,EUCTR2020-001784-88-FI,EU Clinical Trials Register,2020-04-17,2020-04-29,False,University of Helsinki,Authorised,Phase 3,Interventional,Finland,"A clinical study to evaluate the efficacy of different anti-viral drugs in
SARS-CoV-2 infected patients (COVID-19)",Drug,"Oxiklorin, Hydroxychloroquine, Remdesivir",664,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001784-88,No Results,No Results,No Results,2020-05-11,2020-05-12,None
2260,EUCTR2020-001766-11-FR,EU Clinical Trials Register,2020-04-15,2020-04-29,False,Assistance Publique  Hpitaux de Marseille,Authorised,Phase 2,Interventional,France,Losartan and spironolactone treatment for COVID-19 patients with acute respiratory failure in intensive care unit,Drug,Losartan + Spironolactone,90,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001766-11,No Results,No Results,No Results,2020-05-11,2020-05-12,None
2261,EUCTR2020-001370-30-GB,EU Clinical Trials Register,2020-04-15,2020-04-28,False,Novartis Pharmaceuticals,Authorised,Phase 3,Interventional,"France, Italy, United Kingdom, United States, Germany, Spain",Study of efficacy and safety of canakinumab treatment for CRS in participants with COVID-19-induced pneumonia.,Drug,Canakinumab,450,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001370-30,No Results,No Results,No Results,2020-05-11,2020-05-12,None
2262,EUCTR2020-001228-32-GB,EU Clinical Trials Register,2020-04-21,2020-05-04,False,University of Oxford,Authorised,Phase 2/Phase 3,Interventional,United Kingdom,Investigating a Vaccine Against COVID-19,ATMP,Vaccine,5260,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001228-32,No Results,No Results,No Results,2020-05-11,2020-05-12,None
2263,EUCTR2020-001740-26-GB,EU Clinical Trials Register,2020-04-24,2020-05-05,False,University of Oxford,Authorised,Phase 2,Interventional,United Kingdom,A study of an antibiotic called Azithromycin for those who come to hospital with COVID-19 symptoms who are not admitted to hospital (otherwise known as Ambulatory COVID-19)  ATOMIC2,Drug,Azithromycin,800,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001740-26,No Results,No Results,No Results,2020-05-11,2020-05-12,None
2264,EUCTR2020-000705-86-ES,EU Clinical Trials Register,2020-05-05,2020-04-26,True,Vall d'Hebron University Hospital,Authorised,Phase 4,Interventional,Spain,Control of inflammatory parameters with fish oil in parenteral nutrition,Supplement,Fish oil,117,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-000705-86,No Results,No Results,No Results,2020-05-11,2020-05-12,None
2265,EUCTR2020-001275-32-DK,EU Clinical Trials Register,2020-03-24,2020-04-03,False,The Parker Institute (Bispebjerg and Frederiksberg Hospital),Authorised,Phase 2,Interventional,Denmark,Anti-il6 treatment of serious COVID-19 disease with threatening respiratory failure,Drug,Tocilizumab vs. sarilumab,200,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001275-32,No Results,No Results,No Results,2020-05-11,2020-04-07,None
2266,EUCTR2020-001375-32-NL,EU Clinical Trials Register,2020-04-03,2020-04-03,True,University Medical Center Groningen,Authorised,Phase 2,Interventional,Netherlands,Early intervention with Tocilizumab in patients with COVID-19 and hypoxia,Drug,Tocilizumab,354,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001375-32,No Results,No Results,No Results,2020-05-11,2020-04-29,NL8504
2267,EUCTR2020-001934-37-ES,EU Clinical Trials Register,2020-05-08,2020-05-07,True,Instituto de Investigacin Marqus de Valdecilla (IDIVAL),Authorised,Phase 4,Interventional,Spain,USE OF CORTICOSTEROIDS IN PATIENTS WITH SARS-COV2 CORONAVIRUS INFECTION,Drug,Corticosteroids,200,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001934-37,No Results,No Results,No Results,2020-05-11,2020-05-12,None
2268,EUCTR2020-002123-11-ES,EU Clinical Trials Register,2020-05-08,2020-05-07,True,Tatiana Cobo Ibez,Authorised,Phase 4,Interventional,Spain,CLINICAL STUDY IN WHICH PATIENTS ARE RANDOMIZED TO RECEIVE HYDROXYCHLOROQUINE VS. CYCLOSPORINE - HYDROXYCHLOROQUINE TO COMPARE THEIR EFFICACY IN THE TREATMENT OF COVID-19 PNEUMONIA.,Drug,Hydroxychloroquine vs. Hydroxychloroquine + Cyclosporine,280,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002123-11,No Results,No Results,No Results,2020-05-11,2020-05-12,None
2269,NCT04323527,ClinicalTrials.gov,2020-03-13,2020-03-23,False,Fundao de Medicina Tropical Dr. Heitor Vieira Dourado,Recruiting,Phase 2,Interventional,Brazil,Chloroquine Diphosphate for the Treatment of Severe Acute Respiratory Syndrome Secondary to SARS-CoV2 (CloroCOVID19),Drug,Chloroquine,440,2020-08-31,2020-08-31,https://clinicaltrials.gov/ct2/show/NCT04323527,Journal Article,2020-04-24,https://doi.org/10.1001/jamanetworkopen.2020.8857,2020-04-14,2020-04-06,None
2270,NCT04335552,ClinicalTrials.gov,2020-04-03,2020-04-17,False,Duke University,Recruiting,Phase 2,Interventional,United States,"Pragmatic Factorial Trial of Hydroxychloroquine, Azithromycin, or Both for Treatment of Severe SARS-CoV-2 Infection",Drug,Hydroxychloroquine + Azithromycin vs. Hydroxychloroquine vs. Azithormycin,500,2020-08-01,2020-08-01,https://clinicaltrials.gov/ct2/show/NCT04335552,No Results,No Results,No Results,2020-04-24,2020-04-22,None
2271,NCT04336748,ClinicalTrials.gov,2020-04-04,2020-04-01,True,Medical University of Vienna,Not Recruiting,Phase 3,Interventional,No Country Given,HCQ for Primary Prophylaxis Against COVID19 in Health-care Workers,Drug,Hydroxychloroquine,440,2020-07-01,2020-08-01,https://clinicaltrials.gov/ct2/show/NCT04336748,No Results,No Results,No Results,2020-04-07,2020-04-22,None
2272,NCT04341727,ClinicalTrials.gov,2020-04-04,2020-04-04,False,Washington University in St. Louis,Recruiting,Phase 3,Interventional,United States,"Hydroxychloroquine,Hydroxychloroquine,Azithromycin in the Treatment of SARS CoV-2 Infection (WU352)",Drug,Hydroxychloroquine vs. Hydroxychloroquine + Azithromycin vs. Chloroquine vs. Chloroquine + Azithormycin,500,2021-04-01,2021-08-01,https://clinicaltrials.gov/ct2/show/NCT04341727,No Results,No Results,No Results,2020-04-10,2020-04-22,None
2273,RBR-9ktwx6,REBEC,2020-03-27,2020-03-20,False,Socidade Brasileira de Reumatologia,Recruiting,Not Applicable,Observational,Brazil,Evaluation of the effect of chronic use of Antimalarials on the frequency of infection with the New Corona Virus 2019 (Severe Acute Respiratory Syndrome Coronavirus 2 - SARS-CoV-2) in patients with Immunomedical Rheumatic Diseases,Drug,Hydroxychloroquine or Chloroquine,6000,Not Available,2020-07-30,http://www.ensaiosclinicos.gov.br/rg/RBR-9ktwx6/,No Results,No Results,No Results,2020-04-09,2020-04-22,None
2274,NCT04357444,ClinicalTrials.gov,2020-04-10,2020-04-01,True,Assistance Publique  Hpitaux de Paris,Not Recruiting,Phase 2,Interventional,France,Low Dose of IL-2 In Acute Respiratory DistrEss Syndrome Related to COVID-19,Drug,ILT101,30,2020-05-01,2020-07-01,https://clinicaltrials.gov/show/NCT04357444,No Results,No Results,No Results,2020-04-27,2020-04-29,EUCTR2020-001571-32
2275,NCT04360707,ClinicalTrials.gov,2020-04-22,2020-04-08,True,"University Hospital, Strasbourg",Recruiting,Not Applicable,Observational,France,Solid Organ Transplant Recipients With Covid-19 French Registry,Clinical Presentation,No Intervention,300,2021-04-08,2021-04-08,https://clinicaltrials.gov/show/NCT04360707,No Results,No Results,No Results,2020-05-04,2020-04-29,None
2276,NCT04348305,ClinicalTrials.gov,2020-04-11,2020-04-17,False,Scandinavian Critical Care Trials Group,Recruiting,Phase 3,Interventional,Denmark,Hydrocortisone for COVID-19 and Severe Hypoxia,Drug,Hydrocortisone,1000,2021-03-30,2021-12-30,https://clinicaltrials.gov/show/NCT04348305,No Results,No Results,No Results,2020-05-04,2020-04-22,EUCTR2020-001395-15
2277,NCT04362137,ClinicalTrials.gov,2020-04-22,2020-04-30,True,Novartis Pharmaceuticals,Not Recruiting,Phase 3,Interventional,No Country Given,"Phase 3 Randomized, Double-blind, Placebo-controlled Multi-center Study to Assess the Efficacy and Safety of Ruxolitinib in Patients With COVID-19 Associated Cytokine Storm (RUXCOVID)",Drug,Ruxolitinib,402,2020-07-10,2020-07-13,https://clinicaltrials.gov/show/NCT04362137,No Results,No Results,No Results,2020-05-04,2020-05-05,EUCTR2020-001662-11
